
<html lang="en"     class="pb-page"  data-request-id="80cea8ef-6594-4e1b-bd98-9549a7afb867"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00538;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2017.60.issue-1;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors" /></meta><meta name="dc.Creator" content="Wei  Tuo" /></meta><meta name="dc.Creator" content="Natascha  Leleu-Chavain" /></meta><meta name="dc.Creator" content="John  Spencer" /></meta><meta name="dc.Creator" content="Supojjanee  Sansook" /></meta><meta name="dc.Creator" content="Régis  Millet" /></meta><meta name="dc.Creator" content="Philippe  Chavatte" /></meta><meta name="dc.Description" content="Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anticancer, anxiolytic, and neuroprotectiv..." /></meta><meta name="Description" content="Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anticancer, anxiolytic, and neuroprotectiv..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 14, 2016" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00538" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00538" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00538" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00538" /></link>
        
    
    

<title>Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00538" /></meta><meta property="og:title" content="Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0062.jpeg" /></meta><meta property="og:description" content="Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anticancer, anxiolytic, and neuroprotective efficacies via cannabinoid receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor α (PPAR-α) stimulation. FAEs and ECs are synthesized by a series of endogenous enzymes, including N-acylphosphatidylethanolaminephospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), or phospholipase C (PLC), and their metabolism is mediated by several metabolic enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), N-acylethanolamine acid amidase (NAAA), or cyclooxygenase 2 (COX-2). Over the past decades, increasing the concentration of FAEs and ECs through the inhibition of degrading enzymes has been considered to be a viable therapeutic approach to enhance their antinociceptive and anti-inflammatory effects, as well as to protect the nervous system." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00538"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00538">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00538&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00538&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00538&amp;href=/doi/10.1021/acs.jmedchem.6b00538" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 4-46</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01600" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.6b00963" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and <i>N</i>-Acylethanolamine Acid Amidase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Tuo">Wei Tuo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natascha++Leleu-Chavain">Natascha Leleu-Chavain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Spencer">John Spencer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Supojjanee++Sansook">Supojjanee Sansook</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R%C3%A9gis++Millet">Régis Millet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Chavatte">Philippe Chavatte</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Université de Lille, Inserm, CHU Lille, U995, LIRIC, Lille Inflammation Research International Center, F-59000 Lille, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Chemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, U.K.</span></div><div class="corresp-info"><strong>*</strong>Phone: +33 3 20 96 40 20. Fax: +33 3 20 96 49 06. E-mail: <a href="/cdn-cgi/l/email-protection#85f5edece9ecf5f5e0abe6ede4f3e4f1f1e0c5f0ebecf3a8e9ece9e9e0b7abe3f7"><span class="__cf_email__" data-cfemail="6c1c040500051c1c09420f040d1a0d1818092c1902051a4100050000095e420a1e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00538&amp;href=/doi/10.1021%2Facs.jmedchem.6b00538" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 4–46</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 21, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 April 2016</li><li><span class="item_label"><b>Published</b> online</span>14 November 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 January 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00538" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00538</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4%26pageCount%3D43%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWei%2BTuo%252C%2BNatascha%2BLeleu-Chavain%252C%2BJohn%2BSpencer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D1%26contentID%3Dacs.jmedchem.6b00538%26title%3DTherapeutic%2BPotential%2Bof%2BFatty%2BAcid%2BAmide%2BHydrolase%252C%2BMonoacylglycerol%2BLipase%252C%2Band%2BN-Acylethanolamine%2BAcid%2BAmidase%2BInhibitors%26numPages%3D43%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D46%26publicationDate%3DJanuary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00538"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2814</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">59</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00538" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Tuo&quot;},{&quot;first_name&quot;:&quot;Natascha&quot;,&quot;last_name&quot;:&quot;Leleu-Chavain&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Spencer&quot;},{&quot;first_name&quot;:&quot;Supojjanee&quot;,&quot;last_name&quot;:&quot;Sansook&quot;},{&quot;first_name&quot;:&quot;Régis&quot;,&quot;last_name&quot;:&quot;Millet&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Chavatte&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;4-46&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00538&quot;},&quot;abstract&quot;:&quot;Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anticancer, anxiolytic, and neuroprotective efficacies via cannabinoid receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor α (PPAR-α) stimulation. FAEs and ECs are synthesized by a series of endogenous enzymes, including N-acylphosphatidylethanolaminephospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), or phospholipase C (PLC), and their metabolism is mediated by several metabolic enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), N-acylethanolamine acid amidase (NAAA), or cyclooxygenase 2 (COX-2). Over the past decades, increasing the concentration of FAEs and ECs through the inhibition of degrading enzymes has been considered to be a viable therapeutic approach to enhance their antinociceptive and anti-inflammatory effects, as well as to protect the nervous system.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00538&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00538" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00538&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00538" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00538&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00538" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00538&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00538&amp;href=/doi/10.1021/acs.jmedchem.6b00538" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00538" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00538" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00538%26sid%3Dliteratum%253Aachs%26pmid%3D27766867%26genre%3Darticle%26aulast%3DTuo%26date%3D2017%26atitle%3DTherapeutic%2BPotential%2Bof%2BFatty%2BAcid%2BAmide%2BHydrolase%252C%2BMonoacylglycerol%2BLipase%252C%2Band%2BN-Acylethanolamine%2BAcid%2BAmidase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D1%26spage%3D4%26epage%3D46%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/jmcmar.2017.60.issue-1/20170112/jmcmar.2017.60.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0062.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0062.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anticancer, anxiolytic, and neuroprotective efficacies via cannabinoid receptor type 1 (CB<sub>1</sub>) or type 2 (CB<sub>2</sub>) or via peroxisome proliferator-activated receptor α (PPAR-α) stimulation. FAEs and ECs are synthesized by a series of endogenous enzymes, including <i>N</i>-acylphosphatidylethanolaminephospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), or phospholipase C (PLC), and their metabolism is mediated by several metabolic enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), <i>N</i>-acylethanolamine acid amidase (NAAA), or cyclooxygenase 2 (COX-2). Over the past decades, increasing the concentration of FAEs and ECs through the inhibition of degrading enzymes has been considered to be a viable therapeutic approach to enhance their antinociceptive and anti-inflammatory effects, as well as to protect the nervous system.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) are biosynthetic ligands, which are widely distributed in the central nervous system (CNS), the immune system, and the peripheral tissues of mammals (e.g., human, monkey, dog, mouse and rat).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are two of the most studied members of the endocannabinoid family. Indeed, there is a basal amount of ECs in tissues. The balance and circulation of ECs in different tissues are regulated by related synthases, degrading enzymes, and transporters. The rapid accumulation of ECs is observed in tissues during injury.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> AEA was identified as an agonist of CB<sub>1</sub> receptors by Devane in 1992.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Furthermore, 2-AG was demonstrated to be another biosynthetic agonist of CB<sub>1</sub> receptors in 1995.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Although AEA levels are much lower than 2-AG levels in the brain, AEA has been determined to show greater in vitro affinity for CB<sub>1</sub> receptors (<i>K</i><sub>i</sub> = 50–100 nM) than 2-AG (<i>K</i><sub>i</sub> = 1–10 μM) in a number of binding assays.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Nevertheless, AEA showed only partial agonist effects, whereas 2-AG exerted full efficacy in a [<sup>35</sup>S]GTPγS assay. Additionally, 2-AG has been repored to bind to CB<sub>2</sub>, another cannabinoid receptor subtype. Although AEA was also identified as a CB<sub>2</sub> ligand, it exerts lower affinity for CB<sub>2</sub> than CB<sub>1</sub>.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Aside from CB<sub>1</sub> and CB<sub>2</sub> receptors, AEA and 2-AG also serve as ligands for non-cannabinoid targets, including the transient receptor potential cation channel subfamily V member 1 (TRPV1).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p last">Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) belong to a large family of FAEs, a class of lipid mediators that consist of saturated FAEs, monounsaturated FAEs, and polyunsaturated FAEs. The formation of FAEs is tissue-dependent during the course of proinflammatory stimuli or tissue damage. For instance, inflammation suppresses the production of PEA and OEA in macrophages, whereas the elevation of AEA levels is detected in the same cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, the formation of PEA and OEA appears to be less stimulus-dependent in comparison with AEA in dorsal root ganglion neurons and skin cells.<a onclick="showRef(event, 'ref1 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref7">(1, 7)</a> PEA was identified as a peroxisome proliferator-activated receptor α (PPAR-α) agonist by Lo Verme and co-workers in 2004.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> OEA was described as a PPAR-α agonist in 2003.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> To date, there is sufficient evidence to demonstrate that PEA and OEA do not bind CB receptors with significant affinity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Biosynthesis of FAEs and ECs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">FAEs are derived from a membrane precursor, termed <i>N</i>-acylphosphatidylethanolamine (NAPE), which is formed from phosphatidylcholine and phosphatidylethanolamine by <i>N</i>-acyltransacylase (NAT). On the one hand, NAPE is transformed into FAEs and phosphatidic acid by NAPE-phospholipase D (NAPE-PLD) directly.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> On the other hand, NAPE is hydrolyzed by phospholipase C (PLC) to generate phospho-FAE (P-FAE), which is further dephosphorylated to yield FAEs by phosphatases (e.g., protein tyrosine phosphatase, nonreceptor type 22 (PTPN22) in lymphoid cells).<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> Alternatively, NAPE can also be deacylated by α/β-hydrolase 4 (ABHD4) to generate lyso-NAPE, which is followed by lyso-PLD-mediated removal of acylphosphatidyl moiety to give FAEs directly or by ABHD4-mediated deacylation to yield glycerophospho-FAE (GP-FAE). Afterward, GP-FAE is catabolized into FAEs by a metal-dependent phosphodiesterase GDE1 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biosynthesis and biodegradation of FAEs, including AEA, PEA, and OEA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Conversely, 2-AG is obtained from a membrane phospholipid, termed phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>). PIP<sub>2</sub> is hydrolyzed by the β-isoform PLC (PLC-β) to yield 1,2-diacylglycerol (DAG), which is further degraded into 2-AG through the action of diacylglycerol lipase (DAGL), initiated by calcium signaling.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Additionally, 2-AG can also be synthesized from phosphatidylinositol (PI) via phospholipase A1 (PLA1) and lyso-PLC. First, PI is degraded by PLA1 to produce a lysophospholipid, and then lyso-PLC converts this lysophospholipid into 2-AG (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Biosynthesis and biodegradation of 2-AG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Biodegradation of FAEs and ECs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fatty acid amide hydrolase (FAAH) was first identified as an enzyme that hydrolyzes AEA into arachidonic acid (AA) and ethanolamine.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Additionally, AEA and AA can be oxidized by cyclooxygenase 2 (COX-2) to generate proalgesic prostamides, such as prostaglandin H<sub>2</sub> ethanolamide (PGH<sub>2</sub>-EA) and prostaglandin H<sub>2</sub> (PGH<sub>2</sub>), respectively.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There is growing evidence that cytochrome P450 participates in the catabolism of AEA.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Although FAAH is confirmed as the primary hydrolytic enzyme for hydrolysis of AEA, <i>N</i>-acylethanolamine acid amidase (NAAA) has been identified as another hydrolase for AEA (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">Monoacylglycerol lipase (MAGL) has been demonstrated to be the major hydrolase responsible for the transformation of 2-AG into AA and glycerol. COX-2-regulated oxidations also convert 2-AG into proalgesic lipids, such as prostaglandin H<sub>2</sub> glycerol (PGH<sub>2</sub>-G).<a onclick="showRef(event, 'ref1 ref15'); return false;" href="javascript:void(0);" class="ref ref1 ref15">(1, 15)</a> Apart from MAGL and FAAH, the degradation of 2-AG is attributed to α/β-hydrolase 6 and 12 (ABHD6 and -12).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition, 2-AG levels can be affected by FAAH in vitro but not in intact cells.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Particularly, MAGL is responsible for approximately 85% of 2-AG hydrolysis in mouse brain, while ABHD6 and ABHD12 were shown to mediate around 9% and 4% of 2-AG degradation, respectively. Less than 2% of 2-AG metabolism is attributed to other ezymes (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p last">PEA and OEA are both substrates of FAAH and NAAA. Particularly, FAAH principally metabolizes PEA and OEA into palmitic acid and oleic acid, respectively, in neurons, while NAAA plays a crucial role in downregulating PEA levels in macrophages (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Furthermore, fatty acid amide hydrolase 2 (FAAH-2), an isozyme of FAAH identified only in primates, not in rodents, exhibits superior capacity to hydrolyze OEA compared to PEA or AEA.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">FAEs and ECs-Mediated Effects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The damage of nerves or tissues results in the activation of macrophages by stimulation of Toll-like receptor 4 (TLR4), the activation of mast cells, and the entry of calcium ions into neurons.<a onclick="showRef(event, 'ref1 ref20'); return false;" href="javascript:void(0);" class="ref ref1 ref20">(1, 20)</a> Next, proinflammatory cytokines (such as tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β)) are produced by macrophages and mast cells. The release of neurotransmitters such as acetylcholine (ACh) is initiated by Ca<sup>2+</sup> in neurons.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additionally, activation of TLR4 is also accompanied by the production of AEA and platelet-activating factor (PAF) by macrophages. PAF further activates PAF receptors, which induces the formation and release of 2-AG. The synthesis of AEA and 2-AG by neurons is Ca<sup>2+</sup> and/or neuroreceptor-dependent.<a onclick="showRef(event, 'ref1 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref1 ref21 ref22">(1, 21, 22)</a> Newly formed AEA and 2-AG bind to CB<sub>1</sub>/CB<sub>2</sub> receptors on macrophages and mast cells and to the CB<sub>1</sub> receptor on neurons. Activation of these CB receptors is followed by the inhibition of proinflammatory cytokines produced by macrophages and mast cells, the production of anti-inflammatory cytokines (such as IL-4 and IL-10) by macrophages, the suppression of calcium signaling, and the inhibition of neurotransmitter release in neurons, thereby blocking action potential and excitation transmission (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a).<a onclick="showRef(event, 'ref1 ref20'); return false;" href="javascript:void(0);" class="ref ref1 ref20">(1, 20)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) ECs and (b) related FAEs-mediated biological effects. This work was built upon Servier Medical Art by Servier, which is licensed under a Creative Commons Attribution 3.0 Unported License.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Alternatively, TNF-α and IL-1β released from macrophages and mast cells decrease PEA levels through the modulation of NAPE-PLD-dependent FAEs synthesis<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and activate the nuclear factor κB (NF-κB).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Then, NF-κB further upregulates the expression of COX-2 and proinflammatory cytokine (e.g., TNF-α, IL-1, IL-6, and IL-8).<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> PEA-mediated anti-inflammation is mainly caused by the activation of PPAR-α, associated with negative activation of NF-κB and thereby inhibition of proinflammatory cytokines formation and COX-2 expression (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b).<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a></div><div class="NLM_p">Although PEA and OEA are not endogenous ligands for cannabinoid receptors CB<sub>1</sub> and CB<sub>2</sub>, it is argued that they enhance AEA-dependent activities through purported “entourage” effects.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In 1998, Calignano and colleagues discovered an interesting phenomenon that the PEA-mediated antinociceptive effect was suppressed by a CB<sub>2</sub> receptor antagonist <b>1</b> (SR144528, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) in an in vivo assay after a 0.1 mg/kg intravenous injection in mice.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Indeed, AEA and PEA have been identified as two effective substrates for FAAH.<a onclick="showRef(event, 'ref14 ref27'); return false;" href="javascript:void(0);" class="ref ref14 ref27">(14, 27)</a> As a competitive substrate for FAAH, PEA has been shown to attenuate the biodegradation of AEA. OEA has also been demonstrated to modulate the concentrations of AEA in a similar mechanism.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">FAAH</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">FAAH was identified and cloned by Cravatt and co-workers in 1996.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It is an integral membrane-bound enzyme belonging to the serine hydrolase family.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Its first X-ray crystal structure was disclosed in 2002.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Its binding site comprises three functional channels: the membrane access channel (MAC), the acyl-chain binding pocket (ABP), and the cytosolic port (CP), which are relevant to transporting the substrate to the catalytic site, providing the accommodation of the acyl chain during catalysis, and removing the leaving group after hydrolysis, respectively.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Notably, the substrate is surrounded by the catalytic triad Ser241-Ser217-Lys142<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and the oxyanion hole residues (including Ser241, Gly240, Gly239, and Ile238)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> during catalysis (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). First, Lys142 deprotonates Ser217, which then deprotonates Ser241. The activated hydroxyl group of Ser241 further interacts with the electrophilic carbonyl group of the substrate, which is accompanied by the formation of an acylated enzyme adduct and the release of ethanolamine.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> At the end of the hydrolysis, the acyl group of the substrate is released from the acyl–enzyme complex through the action of a water molecule (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> The oxyanion hole has been demonstrated to stabilize the intermediate during the catalytic triad-mediated catalysis.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Recently, the residues Phe432 and Trp531 were identified to form a “gate” in the MAC. The rotation of Phe432 was demonstrated to result in an “open” or “closed” state of the MAC, which is accompanied by a size alteration of the MAC and the ABP (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The “open” state is proposed to favor the access of substrate into binding cavities. Afterward, the “closed” state provides enlarged ABP, which allows the easy access of substrate from the MAC into the ABP.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The shift of the conformational equilibrium in favor of “open” or “closed” state is due to the hydrophobic interaction between Phe432 and substrate. Molecular dynamics simulations identified that unsaturated substrates (i.e., AEA and OEA) rather than saturated substrates (i.e., PEA) are more likely to trigger the rotation of Phe432, which might be attributed to the fact that the hydrophobic interaction with C═C is stronger than the interaction with C–C. This finding explains why unsaturated substrates are preferred for FAAH rather than saturated substrates (i.e., hydrolysis rates: AEA (4 C═C) > OEA (1 C═C) > PEA (0 C═C)).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Hence, inhibitors, which are designed based on this “gate”, might be more selective over other serine hydrolases with a different “gate” composition. As another two important amino acid residues in the MAC, Asp403 and Arg486 might facilitate the access of substrate into binding cavities (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding pockets of FAAH, exemplified by X-ray cocrystal structure of FAAH combined with inhibitor (in cyan), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5">1MT5</a>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Membrane access channel (MAC), acyl-chain binding pocket (ABP), cytosolic port (CP), oxyanion hole, and catalytic triad are depicted in blue, yellow, red, green, and orange, respectively. The “gate” at the junction of MAC and ABP is formed by Phe432 and Trp531 (in purple). Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mechanism of FAAH-mediated hydrolysis of AEA: (a) formation of acylated FAAH and release of ethanolamine; (b) deacylation of acylated FAAH and release of AA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Equilibrium of “gate” in favor of “open” (left, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA">2VYA</a><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a>) or “closed” (right, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WAP">2WAP</a><a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a>) state and the extension of ABP induced by Phe432 rotation (bottom right). Surfaces of “gate”, MAC, ABP, and extended ABP are depicted in purple, blue, yellow, and orange, respectively. Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">FAAH is first responsible for the degradation of several FAEs (such as AEA, PEA, and OEA). Thus, FAAH inhibitors can alter signaling of FAEs and thereby induce numerous biological responses (such as pain relief, anti-inflammation, injury repair, and neuroprotection) by stimulation of CB<sub>1</sub>/CB<sub>2</sub> receptors and/or PPAR-α.<a onclick="showRef(event, 'ref1 ref8 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref1 ref8 ref21 ref22">(1, 8, 21, 22)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">NAAA</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NAAA, an amidohydrolase of the N-terminal cysteine hydrolase family, was isolated from rat lung in 2001<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and cloned  in 2005.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> NAAA is highly expressed in macrophages and peripheral tissues.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> NAAA-mediated hydrolysis is initiated by self-proteolysis (from 48 kDa form to 30 kDa active form) at pH ≈ 4.5 in the extracellular medium.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Despite the absence of a crystal structure, Cys131 and Cys126 were identified as catalytic residues of NAAA in rat and human, respectively.<a onclick="showRef(event, 'ref7 ref39'); return false;" href="javascript:void(0);" class="ref ref7 ref39">(7, 39)</a> Exemplified by human NAAA, its catalytic site comprises three principal residues Cys126, Arg142, and Asp145.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In particular, as the reactive nucleophilic moiety of NAAA, the thiol group of Cys126 interacts with the electrophilic carbonyl group of the substrate to generate an acyl–enzyme adduct.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> Mutation of any one of these three residues leads to a total loss of catalytic activity, which means that Cys126, Arg142, and Asp145 play a crucial role in the interaction with the substrate.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Unlike FAAH, which exerts optimal activity over a pH range from 8.5 to 10, NAAA is more pH-sensitive. NAAA is almost inactive at neutral, alkaline, or strong acidic pH, and its catalytic activity occurs only at pH 4.5–5.<a onclick="showRef(event, 'ref37 ref39 ref41'); return false;" href="javascript:void(0);" class="ref ref37 ref39 ref41">(37, 39, 41)</a></div><div class="NLM_p last">Recently, NAAA inhibitors have been regarded as a novel, potentially effective treatment for inflammation, pain, and immune disorders, since they enhance PPAR-α-mediated anti-inflammatory, antinociceptive, and immunomodulatory capacities through the increase of related FAEs levels.<a onclick="showRef(event, 'ref8 ref22'); return false;" href="javascript:void(0);" class="ref ref8 ref22">(8, 22)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">MAGL</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">MAGL, a membrane-associated hydrolase, is another important member of serine hydrolase family. It was purified from rat adipose tissue and cloned from mouse adipocytes by Karlsson in 1997.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The first X-ray crystal structures of MAGL were independently reported by Bertrand et al. and by Lambert and co-workers in 2009.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Ser122-Asp239-His269 has been identified as the catalytic triad of MAGL.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Especially, the nucleophilic hydroxyl group of Ser122 was identified to interact with the electrophilic carbonyl group of the substrate.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> The residues Leu174 and Leu176 form the entrance to the catalytic site, whereas Phe93 and Phe209 display “gate”-like functions (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref34 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref43">(34, 43)</a> Interestingly, three cysteines (Cys201, Cys208, Cys242), which are close to the catalytic triad, were hypothesized to stabilize MAGL’s conformation and additionally interact with some substrates (such as maleimides).<a onclick="showRef(event, 'ref44 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref46 ref47">(44, 46, 47)</a> These cysteines were once considered as beneficial targets for the development of selective MAGL inhibitors over other serine hydrolases.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The functional site of MAGL comprises the ABP, the alcohol-binding channel, and the glycerol exit channel, which serve to accommodate the acyl chain, the glycerol moiety, and the leaving group, respectively (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Especially, mild alkaline pH (pH 8.0) is preferred for MAGL-mediated hydrolysis.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Unsaturated monoacylglycerols (MAGs) are preferred substrates for MAGL in comparison with diacylglycerols (DAGs), triacylglycerols (TAGs), and saturated MAGs.<a onclick="showRef(event, 'ref45 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref48">(45, 48)</a> Moreover, MAGL exerts a tissue-dependent control of monoglyceride metabolism. MAGL inhibition brings about an increase of 2-AG levels in the brain, whereas the dramatic elevation of other MAGs (such as monooleoylglycerol) after MAGL blockade mostly occurs in peripheral tissues.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding pockets of MAGL, exemplified by X-ray crystal structure of MAGL, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HJU">3HJU</a>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> ABP, catalytic triad, alcohol-binding channel, and glycerol exit channel are depicted in yellow, blue, green, and red, respectively. The putative “gate” is formed by Phe93 and Phe209 (in purple). The three reactive cysteines are depicted in orange. Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since MAGL was reported to be responsible for the degradation of 2-AG, inhibition of MAGL has been viewed as a new approach to produce analgesic, anti-inflammatory, and neuroprotective effects.<a onclick="showRef(event, 'ref1 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref1 ref17 ref18">(1, 17, 18)</a></div><div class="NLM_p last">Accordingly, over several decades, enhancing the levels of ECs and FAEs via the inhibition of relevant endogenous metabolic enzymes has been considered as an interesting approach to suppress inflammation, pain, and other disorders. In this context, several pathways to terminate the catabolism of endogenous lipids will be reviewed.</div></div><div id="sec7_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Enzyme Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">According to their interactive mechanisms, enzyme inhibitors can be classified as reversible, slowly/partially reversible, and irreversible inhibitors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> As illustrated in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>, the inhibitor initially interacts with the enzyme to form a transition state complex EI. Afterward, the EI either reverses to release free enzyme E or undergoes a tightening interaction (e.g., covalent binding and/or conformational change of enzyme). Irreversible inhibitors induce a permanent tightening form EI* (<i>K</i><sub>d</sub> = 0), whereas slowly/partially reversible inhibitors undergo a conversion from tightening form EI* to transition state form EI (<i>K</i><sub>d</sub> > 0).<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> The EI complex can be reversed by a rapid dilution for reversible inhibitors, whereas reversal of a slowly/partially reversible inhibitor–enzyme complex EI* requires specific treatments (e.g., dialysis).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Binding mechanism of reversible, slowly/partially irreversible, and irreversible inhibitor. This work was built upon Servier Medical Art by Servier, which is licensed under a Creative Commons Attribution 3.0 Unported License.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">FAAH Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first-generation FAAH inhibitors were designed with reactive groups able to form a covalent bond with the catalytic residue Ser241.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> For example, the widely known serine hydrolase inhibitor, phenylmethylsulfonyl fluoride <b>2</b> (PMSF) (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) was demonstrated to completely block FAAH-mediated activities and increase concentrations of AEA in vitro.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Moreover, fluorophosphonate derivative <b>3</b> (MAFP)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and trifluoromethyl ketones <b>4</b> and <b>5</b><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) were disclosed to inhibit FAAH. The replacement of a trifluoromethyl group by a methyl group brought about a dramatic decrease of FAAH inhibitory potency. This result revealed that the electrophilicity of the carbonyl group exerted a notable effect on the molecule’s binding to FAAH.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Although these first generation inhibitors were capable of blocking FAAH in in vitro pharmacological assays, their lack of selectivity made them poor candidates for preclinical applications. Nevertheless, the disclosure of these inhibitors inspired the further exploration of selective FAAH inhibitors.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of representative first-generation FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Over the past decades, the development of FAAH inhibitors has significantly progressed and a plethora of selective FAAH inhibitors have been designed and synthesized. Hereafter, recent FAAH inhibitors will be reviewed.</div><div id="sec7_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 1. α-Ketoheterocycle Derivatives</h3><div class="NLM_p">The first α-ketoheterocycles developed as selective FAAH inhibitors were reported by Boger and co-workers in 2000.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Their work represented a significant breakthrough in the development of selective FAAH inhibitors. The α-ketoheterocycles were derived from the trifluoromethyl oleyl ketone <b>5</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). Different heterocycles were introduced to replace the trifluoromethyl group.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Researchers argued that oxazolopyridines give rise to enhanced potency against FAAH in comparison with other heterocycles (such as benzoxazoles, compound <b>6</b>, <i>K</i><sub>i</sub> = 370 nM) (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Of note, oxazolo[4,5-<i>b</i>]pyridine (<b>7</b>) and oxazolo[5,4-<i>c</i>]pyridine (<b>8</b>) afforded the most obvious improvement in FAAH inhibition (<i>K</i><sub>i</sub> = 2.3 and 3.7 nM, respectively). Oxazolo[4,5-<i>c</i>]pyridine (<b>9</b>) and oxazolo[5,4-<i>b</i>]pyridine (<b>10</b>) gave rise to an approximately 7- to 11-fold increase in potency (<i>K</i><sub>i</sub> = 7.2 and 11 nM, respectively) in comparison with <b>5</b>.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> It was shown that oxazolopyridines enhanced the electrophilicity and reactivity of the carbonyl groups of α-ketoheterocycle derivatives. Additionally, the heterocyclic nitrogen of the pyridine ring contributes to the improvement of FAAH inhibitory efficacy, which is probably due to its ability to form an H-bond with Thr236. Indeed, an X-ray cocrystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PPM">3PPM</a>) of noncovalently bound state of α-ketoheterocycle–FAAH complex identified that an H-bond was established between the pyridine ring and Thr236,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> which was proposed to lock the inhibitor and favor the formation of tetrahedral intermediate with Ser241. Furthermore, different alkyl and phenylalkyl groups were introduced instead of the oleyl moiety. Structure–activity relationships illustrated that alkyl α-ketoheterocycles with 7–11 carbons displayed the best FAAH inhibition (0.57 ≤ <i>K</i><sub>i</sub> ≤ 0.75 nM, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Particularly, the introduction of a phenyl ring at the end of the acyl chain gave rise to a significant enhancement of FAAH inhibition by the molecules (0.20 ≤ <i>K</i><sub>i</sub> ≤ 0.52 nM, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Moreover, optimization of the alkyl chain linker between the oxazolopyridine and the phenyl ring was carried out, indicating an optimal chain length of five carbons (<b>11</b>, <i>K</i><sub>i</sub> = 0.20 nM, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>).<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structural modifications of the trifluoromethyl oleyl ketone <b>5</b>. Enzyme assays were performed by using either solubilized rat liver plasma membrane extracts or purified recombinant rat FAAH expressed in <i>E. coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An extensive development of α-ketoheterocycle derivatives was continued by Boger and co-workers. In 2004, compound <b>12</b> (OL-135, <i>K</i><sub>i</sub> = 4.7 nM, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) was reported to be the best studied FAAH inhibitor.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> It was discovered following structural modifications on α-keto heterocycle-based derivatives. The preliminary pharmacological data showed that the introduction of 5-substituted oxazoles on the ketone provided a significant improvement in FAAH inhibition by the molecules.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Specifically, pyrimidinyl (<b>13</b>, <i>K</i><sub>i</sub> = 16 nM), pyridazinyl (<b>14</b>, <i>K</i><sub>i</sub> = 14 nM), pyridinyl (<b>15</b>, <i>K</i><sub>i</sub> = 18 nM), oxazolyl (<b>16</b>, <i>K</i><sub>i</sub> = 12 nM), and thiazolyl (<b>17</b>, <i>K</i><sub>i</sub> = 16 nM) substituents at the C5 position of an oxazole ring lead to potent FAAH inhibitors (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). At the same time, research on phenylalkyl-substituted α-keto oxazole derivatives was undertaken. It was disclosed that compounds with five to eight carbons between the phenyl and the oxazole ring exhibited good inhibitory potency for FAAH, and a C6 chain was determined to be the optimal chain length (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> These 5-phenylalkyl(pyridin-2-yl)oxazole derivatives displayed potent selectivity for FAAH over triacylglycerol hydrolase (TGH) and the membrane-associated hydrolase KIAA1363.<a onclick="showRef(event, 'ref58 ref60'); return false;" href="javascript:void(0);" class="ref ref58 ref60">(58, 60)</a> According to these results, compound <b>12</b> was identified as a potential candidate for preclinical development with potent inhibition and selectivity for FAAH.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Moreover, compound <b>12</b> was demonstrated to elevate AEA levels in the brain and spinal cord and induced CB<sub>1</sub>-dependent analgesia in vivo<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and was unable to activate cannabinoid receptors (CB<sub>1</sub> and CB<sub>2</sub>) directly or affect P450-dependent activities in vivo.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> A cocrystal structure of <b>12</b>–FAAH revealed that the phenylalkyl group of <b>12</b> was located in the ABP, while its carbonyl function interacted with Ser241 to form a tetrahedral adduct (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>a).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (a) X-ray cocrystal structure of FAAH combined with <b>12</b> (in purple), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WJ2">2WJ2</a>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC. (b) Structural modifications of compound <b>12</b> on the pyridinyl and phenyl groups. (c) Plot of −log <i>K</i><sub>i</sub> (μM) versus σ<sub>p</sub>. Figure on the right is from ref <a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">62</a>. (d) Structural modifications of compound <b>12</b> on the acyl chain and the oxazole moiety. Enzyme assays were performed by using purified recombinant rat FAAH expressed in E. <i>coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, structure–activity relationships on <b>12</b> were undertaken. The pyridinyl group at the C5 position of the oxazole ring was replaced by different nonaromatic or aromatic substituents. The pharmacological assay data revealed that removal of the nitrogen atom of the pyridine led to an appreciable loss of inhibition (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>b).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Structure–activity relationships indicated nonaromatic substituents (such as cyano, trifluoromethyl, and methyl carboxylate groups) with electron-withdrawing properties were found to enhance the inhibitory potency of the molecules (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>b).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Boger and co-workers found a fundamental relationship between the <i>K</i><sub>i</sub> values and the Hammett σ<sub>p</sub> constant of nonaromatic substituents. They made a good correction plot of −log <i>K</i><sub>i</sub> (μM) versus σ<sub>p</sub> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>c),<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> which could be useful for the design of α-ketoheterocycles-based FAAH inhibitors and the prediction of <i>K</i><sub>i</sub> values. Overall, most derivatives with a 2-pyridinyl substituent at the C5 position of the oxazole ring exhibited the favorable selectivity for FAAH over other serine enzymes (e.g., TGH, KIAA1363).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><div class="NLM_p">Modifications of the acyl moiety of <b>12</b> were performed. The terminal phenyl ring of the acyl group was replaced by a series of aromatic groups. Almost all compounds possessed effective potency except for 2-pyridinyl (<b>18</b>, <i>K</i><sub>i</sub> = 120 nM) and carboxyphenyl (<b>19</b>, <b>20</b>, and <b>21</b>, <i>K</i><sub>i</sub> > 600 nM) derivatives that manifested a dramatic loss of activity (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>b).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> In addition, a phenyl ring substituted with electron-withdrawing groups (such as chloro or trifluoromethyl) enhanced FAAH inhibition in comparison with <b>12</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>b).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> It was noteworthy that the 2,3-dichlorophenyl derivative <b>22</b> (<i>K</i><sub>i</sub> = 0.9 nM, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>b) exerted approximately a 5-fold better affinity for FAAH than <b>12</b>.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The biphenyl-4-ethyl chain derivative <b>23</b> (<i>K</i><sub>i</sub> = 0.75 nM, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>d) provided around a 6-fold stronger affinity for FAAH, as compared to <b>12</b>.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> The five-membered ring of <b>12</b> was also modified by introducing additional heteroatoms. 1,2,4-Oxadiazoles <b>24</b> and <b>25</b> (<i>K</i><sub>i</sub> = 0.34 nM and 1.1 nM, respectively, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>d) and 1,3,4-oxadiazole <b>26</b> (<i>K</i><sub>i</sub> = 0.29 nM, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>d) showed dramatically enhanced inhibition with respect to <b>12</b>.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">A systematic exploration of phenylhexyl-α-keto oxazole derivatives has been carried out over the past few years. Several molecules displayed potent FAAH inhibitory capacity. Typically, a compound with a phenoxyphenylhexyl side chain (<b>27</b>, CE-12, <i>K</i><sub>i</sub> = 4.4 nM, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>d) elevated AEA levels in the brain with a duration of action of more than 10 h.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> It was determined to significantly relieve pain in a chronic constriction injury (CCI) model after a 50 mg/kg oral dose.</div><div class="NLM_p">Recently, a new series of extended α-keto oxazole derivatives were reported to target a new binding site: the Cys269 of the CP of FAAH.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> These compounds were obtained by introducing different groups at the C5 position of the pyridine ring of <b>12</b>. Derivatives with electrophilic groups (such as compound <b>28</b>, <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>a) were shown to increase FAE levels in mouse brain. Activity-based protein profiling (ABPP) assays showed that these newly developed molecules possessed high selectivity for FAAH over other serine hydrolases, including TGH, KIAA1363, MAGL, and ABHD6. In addition to interacting with Ser241, these new α-keto oxazole based FAAH inhibitors were determined to bind covalently and irreversibly to the Cys269 by dialysis and X-ray crystal structure studies (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>b and <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>c).<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> Additional binding to Cys269 was argued to endow these novel inhibitors with improved selectivity and prolonged inhibitory activity. Compared to the reversible FAAH inhibitor <b>12</b>, these irreversible inhibitors had a greater ability to enhance AEA signaling over longer periods in mice.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (a) Structure of the phenylhexyl α-keto oxazole derivative <b>28</b>. (b) Interactions between compound <b>28</b> (in purple) and FAAH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J5P">4J5P</a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The carbonyl function of <b>28</b> is surrounded by the catalytic triad and the oxyanion hole. Hydrogen bonds and π–π interactions are depicted as green and purple dashes, respectively. Results were obtained using software programs from Dassault Systèmes BIOVIA, Discovery Studio Visualizer. (c) Mechanism of action of compound <b>28</b>: covalent and irreversible FAAH inhibition. Aside from the interaction with Ser241, the bromo group was identified to covalently interact with Cys269. Enzyme assays were performed by using purified recombinant rat FAAH expressed in <i>E. coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 2. Carbamates</h3><div class="NLM_p">The first class of aryl carbamate derivatives as FAAH inhibitors was disclosed in 2003.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Compound <b>30</b> (URB597, IC<sub>50</sub> = 4.6 nM, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) was shown to inhibit FAAH in the nanomolar range and elevate brain AEA levels after a 0.3 mg/kg intraperitoneal injection in rats.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69, 70)</a> Compound <b>30</b> was devoid of activity in a panel of receptors (e.g., CB<sub>1</sub>/CB<sub>2</sub>, NOP1 receptor), ion channels (e.g., Na<sup>+</sup>, K<sup>+</sup>, and Ca<sup>2+</sup> channels), transporters (e.g., AEA transporter), and enzymes (e.g., COX1/2 and MAGL) at 10 μM.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Nevertheless, compound <b>30</b> was shown to inactivate carboxylesterases and block the expression of tyrosine hydroxylase as off-target effects.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> It manifested potent anxiolytic properties without affecting appetite or body temperature in models of elevated zero-maze and the isolation-induced ultrasonic emission in rats (0.1–0.3 mg/kg intraperitoneal injection) and produced pain relief in the complete Freund’s adjuvant (CFA) model of arthritis pain in rats (0.5 mg/kg intraperitoneal injection).<a onclick="showRef(event, 'ref69 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref71">(69, 71)</a> The X-ray crystal structure of a <b>30</b>–FAAH adduct illustrated that the rotatable <i>N</i>-cyclohexyl ring occupied the ABP. Adjacent to the cyclohexyl group, the carbamate group was confirmed to form a covalent bond with Ser241 (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>a and <a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>b).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The hydroxybiphenyl moiety, which serves as a leaving group, was located in the CP.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of representative covalent and irreversible carbamate-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (a) Mechanism of <b>30</b>-mediated covalent and irreversible FAAH inhibition: formation of an acyl–FAAH adduct. (b) X-ray cocrystal structure of FAAH–<b>30</b> (<i>N</i>-cyclohexylformamide moiety in yellow), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LJ7">3LJ7</a>.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Hydrogen bonds and π–σ interactions are depicted as green and violet dashes, respectively. Results were obtained using software programs from Dassault Systèmes BIOVIA, Discovery Studio Visualizer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although compound <b>30</b> had excellent selectivity for FAAH in brain without affecting other serine hydrolases, it was found to interfere with the function of several liver carboxylesterases.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> To reinforce the selectivity for FAAH and reduce carboxylesterase off-target effects, a further extension was performed based on the scaffold of <b>30</b>. As a representative second generation aryl carbamate based FAAH inhibitor, compound <b>31</b> (URB694, IC<sub>50</sub> = 30 nM, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>), which was obtained by the modification of the substituents of the biphenyl moiety, had weakened affinity for carboxylesterases in comparison with <b>30</b>.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The introduction of polar and electron-donating groups lowered the electrophilicity of the carbamate group, which reduced its hydrogen bond donor interactions but resulted in improved selectivity for FAAH.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> As a result of focusing on the attributes of <b>30</b> and <b>31</b>, a novel carbamate derivative <b>32</b> (URB937, IC<sub>50</sub> = 26.8 nM, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>), containing both carbamoyl and hydroxyl substituents on the biphenyl moiety, was designed. Compound <b>32</b> is a selective FAAH inhibitor, over MAGL in vitro, which produces inhibitory effects in peripheral tissues (e.g., liver) rather than CNS (e.g., brain).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> It attenuated inflammation-related and neural-injury-induced pain in mice after a 1 mg/kg intraperitoneal dose through CB<sub>1</sub>-dependent activity.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">In addition to the <i>O</i>-aryl carbamates, other series of carbamate derivatives, such as oxime<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> and enol<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> carbamates, have been developed over the past decades. Particularly, compound <b>33</b> (ST4070, IC<sub>50</sub> = 9 nM, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) was disclosed as a reversible inhibitor in dialysis studies and a highly selective FAAH inhibitor versus other targets in the endocannabinoid system, including CB<sub>1</sub>, CB<sub>2</sub>, TRPV1, NAPE-PLD, MAGL, and DAGL.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Due to a lack of an X-ray cocrystal structure of a FAAH–<b>33</b> adduct, the reversible mechanism remains unclear. Generally speaking, given its structural similarity with <b>30</b>, the biphenyl enol moiety of <b>33</b> is expected to act as a leaving group, which is accompanied by the covalent carbamoylation of Ser241.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> As illustrated in <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>, the groups forming covalent bonds with Ser241 differ between <b>30</b> and <b>33</b> and are <i>N</i>-cyclohexylformamide (secondary amide) and piperidine-1-formyl (tertiary amide), respectively. The cocrystal structure of FAAH–<b>30</b> showed that the polar hydrogen of <i>N</i>-cyclohexylformamide forms an H-bond with Ser193, which stabilizes the carbamonyl–FAAH adduct. Conversely, due to the lack of a suitable hydrogen, the piperidine-1-formyl  of <b>33</b> is not expected to establish an H-bond interaction with the enzyme. The lack of such an H-bond renders the FAAH–<b>33</b> adduct unstable and hydrolyzable, which confers reversibility to <b>33</b>. In addition, the latter was able to elevate brain AEA and PEA levels in mice at a 30 mg/kg oral dose and was capable of alleviating neuropathic pain and antianxiety at 30 mg/kg oral doses in models of streptozotocin-induced diabetes and CCI-induced pain in mice.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78, 79)</a> As a reversible FAAH inhibitor, compound <b>33</b> can be regarded as a lead for the development of a clinical candidate.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Covalent adducts combined with <b>30</b> and <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, the replacement of a phenyl group in <b>30</b> by a triazolylmethyl group or the introduction of a pyrazole moiety between the two phenyl groups was performed.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a> Since a triazolylmethoxy group acts as a poorer leaving group than phenoxy, such a replacement was deemed to confer higher stability to the molecules. This hypothesis was confirmed by pharmacokinetics studies. O-Substituted triazolylmethyl carbamates (such as <b>34</b> and <b>35</b>, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) were detected in rat plasma 7 h after administration, whereas O-substituted 4-biphenyl carbamate <b>29</b> (URB524, IC<sub>50</sub> = 25.6 nM, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) was undetectable at the same time.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Hence, several O-substituted triazolylmethyl carbamates were prepared by Colombano and co-workers. Particularly, N- and O-disubstituted 1,2,3-triazolylmethyl carbamates (such as <b>36</b>, IC<sub>50</sub> = 5.8 nM, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) exerted optimal inhibitory potency. The replacement of 1,2,3-triazolylmethyl (<b>35</b>, IC<sub>50</sub> = 26.2 nM, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) with 1,2,4-triazolylmethyl (<b>37</b>, IC<sub>50</sub> = 51 500 nM, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) resulted in a dramatic decrease of potency against FAAH, which might be due to the altered electrophilic reactivity of the carbamate.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> This research on the metabolic stability of the molecules in plasma can be considered as an encouraging starting point for extending the duration of action. Moreover, a series of <i>O</i>-pyrazolylphenyl carbamates bearing a 3-alkyloxycarbonyl group on the pyrazole moiety also exerted potent capacity to inhibit FAAH and high selectivity over MAGL (compounds <b>38</b>, <b>39</b>, <b>40</b>, <b>41</b>, and <b>42</b>, 11 nM ≤ IC<sub>50</sub> ≤ 29 nM, selectivity index SI > 1000, <a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The newly introduced alkyloxycarbonyl function at the 3-position of the pyrazole ring was expected to form an H-bond with the hydroxyl group of Thr488, since this latter interaction was previously identified as a means to improve reactivity and selectivity of the molecules toward FAAH.<a onclick="showRef(event, 'ref70 ref81'); return false;" href="javascript:void(0);" class="ref ref70 ref81">(70, 81)</a> These compounds were determined to reversibly bind to FAAH by dialysis studies. This observation is meaningful for the further development of novel selective and reversible FAAH inhibitors.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures of representative triazolylmethyl cabamate based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of representative pyrazolylphenyl cabamate based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most recently, Lehr and co-workers disclosed a novel series of ω-imidazolyl and ω-tetrazolylalkyl carbamates as potent FAAH inhibitors.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Although compound <b>43</b> (IC<sub>50</sub> = 5.3 nM, <a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>) manifested optimal potency against FAAH at single-digit nanomolar concentrations, its instability in plasma made it a poor candidate for systemic administration. Compounds <b>44</b> and <b>45</b> (IC<sub>50</sub> = 11 and 81 nM, respectively, <a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>) exerted potent FAAH inhibition in the two-digit nanomolar range. However, they were shown to be degraded by carboxylesterases in porcine plasma.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Specifically, compounds <b>46</b> and <b>47</b> (IC<sub>50</sub> = 110 and 200 nM, respectively, <a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>) possessed moderate FAAH inhibitory activities but suitable stability in the presence of liver fractions, plasma, or albumin.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Further investigation of structure–activity relationships indicated that a C6 to C8 alkyl chain, notably a C7, appended to the tetrazolyl ring was favorable for FAAH inhibitory potency.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of representative ω-tetrazolylalkyl cabamate based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 3. Sulfonyl Fluorides</h3><div class="NLM_p">The first covalent but nonselective sulfonyl fluoride FAAH inhibitor disclosed was compound <b>2</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> To improve selectivity over other serine enzymes, an extension of the acyl chain was carried out.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Sulfonyl fluorides bearing C14, C16, or C18 length chains exhibited weak affinity for CB<sub>1</sub> receptor and blocked the hydrolysis of AEA.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> For instance, the representative alkylsulfonyl fluoride <b>48</b> (AM374, IC<sub>50</sub> = 13 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>a) with a C16 length side chain manifested approximately 20-fold more potency than compound <b>2</b> (IC<sub>50</sub> = 290 nM).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Nevertheless, compound <b>48</b> was previously disclosed to affect outer-membrane phospholipase A dependent activities.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> To improve selectivity for FAAH over other serine enzymes, a further modification of the acyl chain was performed. The carbon chain between the phenyl ring and the sulfonyl fluoride group of compound <b>2</b> was extended from C1 to C8 length. Particularly, phenylalkylsulfonyl fluorides with five to seven carbons exhibited potent inhibitory potency and selectivity for FAAH.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The introduction of a hydroxyl or benzyloxy group at the 4-position of the phenyl ring appeared to enhance the inhibitory potency for FAAH.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Specifically, 4-hydroxyphenylpentylsulfonyl fluoride <b>49</b> (AM3506, IC<sub>50</sub> = 48 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>a) exerted a potent inhibitory effect for FAAH, without triggering other serine hydrolase-mediated degradation at a dose of 0.1 mg/kg in mouse brain and liver. Nevertheless, it inhibited MAGL and ABHD6 as off-targets at a dose of 1 mg/kg.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Moreover, compound <b>49</b> was disclosed to have a favorable property in suppressing blood pressure and depressing heart rate in a hypertensive model by stimulating CB<sub>1</sub> receptor. In addition, the administration of <b>49</b> was identified to be devoid of hyperglycemia effects.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The absence of inhibitory activities for several serine hydrolases in liver at a dose of 1 mg/kg made <b>49</b> a favorable lead compound, since the inhibition of hepatic FAAH could result in the elevation of hepatic AEA signaling associated with diet-dependent fatty liver.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87, 88)</a> A molecular docking study illustrated that the two oxygen atoms of the sulfonyl group formed H-bonds with Ser241 and the oxyanion hole of FAAH, respectively, the phenylalkyl side chain occupied the ABP, and the phenol interacted with Thr488 (<a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>b).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In particular, the additional formation of a hydrogen bond between the hydroxyl group of <b>49</b> and the Thr488 of FAAH was expected to be advantageous for the improvement of selectivity and inhibitory activity.<a onclick="showRef(event, 'ref70 ref85'); return false;" href="javascript:void(0);" class="ref ref70 ref85">(70, 85)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. (a) Structures of representative sulfonyl fluoride based FAAH inhibitors. (b) Compound <b>49</b> establishes H-bonds with Ser241 and Thr488 of FAAH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 4. Ureas</h3><div class="NLM_p">The first generation urea-based FAAH inhibitors were a result of serendipity. Indeed, compound <b>50</b> (LY-2183240, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>), which belongs to the earliest urea-based FAAH inhibitors, was previously developed to upregulate AEA levels by preventing AEA from transporting across the plasma membrane.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> In 2006, compound <b>50</b> was found to strongly inhibit FAAH and other brain serine hydrolases.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Its carbamoyl moiety was shown to covalently and irreversibly interact with Ser241 of FAAH as shown using mass spectrometry and dilution analysis.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Switching AEA regulation from transporter inhibition to FAAH inhibition is a favorable starting point for the development of urea-based FAAH inhibitors. During the past decade, several major series of urea-based FAAH inhibitors have been explored by Johnson & Johnson, Pfizer, and Takeda.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0022.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of representative urea-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2006, Johnson & Johnson described a series of piperazinyl and piperidinyl ureas as FAAH inhibitors.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Typically, compound <b>51</b> (JNJ-1661010, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>) exerted potent inhibitory efficacy for both rat FAAH and human FAAH (IC<sub>50</sub> = 34 and 33 nM, respectively).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Compound <b>51</b> was discovered to be a FAAH inhibitor by high-throughput screening (HTS) of Johnson & Johnson’s chemical library.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Afterward, an exploration of N-substitutions and an introduction of different functions on the phenyl ring appended to the 1,2,4-thiadiazole ring were performed. Structure–activity relationships (<a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>) illustrated the following: (1) The introduction of a fluoro or chloro group at the 2-position of the <i>N</i>-phenyl ring provides an obvious improvement of inhibitory activity for rat FAAH and a moderate increase of inhibitory capacity for human FAAH, compared to <b>51</b>. (2) The introduction of different substituents on the phenyl ring appended to the 1,2,4-thiadiazole ring leads to a dramatic loss of potency against FAAH. (3) The replacement of the <i>N</i>-phenyl ring with heteroaryl groups (such as 3-/4-pyridinyl, 4-pyrimidinyl, 6-methoxypyrimidine-4-yl, or benzo[<i>c</i>][1,2,5]thiadiazole-4-yl groups) results in a remarkably enhanced inhibitory potency for both rat and human FAAH with respect to <b>51</b>.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Dialysis and mass spectrometry studies identified that the phenyl-1,2,4-thiadiazol-5-piperazinyl moiety of compound <b>51</b> covalently and reversibly bound to FAAH, while the aniline moiety acted as a leaving group during hydrolysis (<a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Compound <b>50</b>, but not compound <b>51</b>, inactivated liver esterases.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> The absence of inhibitory effects toward liver esterases makes <b>51</b> a potential attractive lead compound.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0023.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structural modifications on the <i>N</i>-phenyl ring and the phenyl ring appended to the 1,2,4-thiadiazole ring of compound <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0024.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Mechanism of action of compound <b>51</b>, covalent and reversible FAAH inhibition: (a) acylation of FAAH; (b) deacylation of acylated FAAH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Replacement of the phenylthiadiazole and the <i>N</i>-phenyl moieties of <b>51</b> with arylmethyl and aromatic groups, respectively, was carried out in 2012. Overall, compound <b>52</b> (JNJ-40355003, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>) manifested optimal capacity to elevate three related FAEs (AEA, PEA, OEA) levels in rat, dog, and cynomolgus monkey plasma via the inhibition of FAAH (IC<sub>50</sub>(hFAAH) = 1.4 nM, IC<sub>50</sub>(rFAAH) = 33 nM) in a irreversible manner (dialysis studies).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> It was noteworthy that <b>52</b> did not affect FAAH-2 (IC<sub>50</sub> > 10 μM), whereas another two potent FAAH inhibitors <b>12</b> and <b>30</b> were shown to inactivate FAAH-2 at nanomolar concentrations (IC<sub>50</sub> = 13.4 and 5 nM, respectively).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Compound <b>52</b> dramatically increased FAE levels in monkey plasma after a 5 mg/kg oral administration.<a onclick="showRef(event, 'ref19 ref92'); return false;" href="javascript:void(0);" class="ref ref19 ref92">(19, 92)</a></div><div class="NLM_p">Recently, Janssen Research, part of Johnson & Johnson, disclosed a series of spirocyclic diamine core-based urea FAAH inhibitors, which were obtained through the modification of the aromatic amine and piperazine moieties of <b>52</b>.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Compounds <b>53</b>, <b>54</b>, and <b>55</b> (<a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>) exhibited remarkable FAAH inhibition activities (IC<sub>50</sub>(hFAAH) = 27, 80, and 125 nM, respectively).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> A further screening of different aromatic amine functions was performed. The pharmacological assays indicated that <b>56</b> (JNJ-42119779, <a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>) acted as an irreversible inhibitor in dialysis studies, displaying optimal inhibitory efficacy against both rat and human FAAH (IC<sub>50</sub>(hFAAH) = 8 nM, IC<sub>50</sub>(rFAAH) = 9 nM) and produced analgesia in a spinal nerve ligation (SNL) model after a 20 mg/kg oral dose. Replacement of a 2,7-diazaspiro[3.5]nonane group with a 2,6-diazaspiro[3.3]heptane group (<b>57</b>, IC<sub>50</sub>(hFAAH) = 18 nM, IC<sub>50</sub>(rFAAH) = 42 nM, <a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>) resulted in a slight loss of inhibitory potency against FAAH but almost complete loss of ability to raise central FAEs (AEA, OEA, and PEA) levels in vivo.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> More recently, compound <b>58</b> (JNJ-42165279, <a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>), a selective and slowly reversible (dialysis assays) piperazine urea-based FAAH inhibitor developed by Johnson & Johnson, was reported to be in phase II clinical trials.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Compound <b>58</b> has been reported to time-dependently inhibit rat and human FAAH (IC<sub>50</sub>(hFAAH) = 70 nM, IC<sub>50</sub>(rFAAH) = 313 nM) and to elevate brain FAEs (AEA, PEA, and OEA) levels until 24 h postdose in rats. Moreover, it exhibited high selectivity versus a panel of enzymes, transporters, receptors, and ion channels at 10 μM.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Compound <b>58</b> was demonstrated to produce analgesia in a rat SNL model (22 mg/kg oral dose).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0025.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structural modifications on the piperazine, pyridine, and (4-chlorophenyoxy)benzyl groups of compound <b>52</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pfizer discovered a series of piperidine/piperazine-based urea–FAAH inhibitors through a HTS screening campaign. Of note, compounds <b>59</b> (PF-622, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>) and <b>60</b> (PF-750, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>) were reported to dramatically inhibit FAAH (IC<sub>50</sub>(hFAAH) = 33 and 12.5 nM, respectively).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Furthermore, a time-dependent inhibitory activity assay was performed.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Human FAAH was preincubated with inhibitors, and the substrate was added after a certain time. IC<sub>50</sub> values for <b>59</b> and <b>60</b> were dramatically decreased from 0.991 μM to 0.033 μM and from 0.595 μM to 0.0162 μM, respectively, after a longer preincubation time (60 min instead of 5 min). Compound <b>30</b> also exerted similar time-dependent properties (IC<sub>50</sub> = 0.986 μM after 5 min, IC<sub>50</sub> = 0.109 μM after 60 min). Conversely, the prolonged preincubation time did not affect the FAAH inhibitory capacity of <b>12</b>.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Time-dependent properties of irreversible FAAH inhibitors are probably due to their ability to form a covalent substrate–FAAH complex or induce a conformational change in the enzyme. Hence, the inhibitory activities of irreversible FAAH inhibitors were assessed with <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values (<i>k</i><sub>inact</sub>, maximal rate of enzyme deactivation at a saturating concentration of inhibitor) instead of IC<sub>50</sub> values by Pfizer.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The higher is the value, the better is the activity. <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values were determined for the irreversible FAAH inhibitors <b>30</b> and <b>60</b>. Although these two FAAH inhibitors were reported with remarkable IC<sub>50</sub> values, they only showed modest <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 1590 M<sup>–1</sup> s<sup>–1</sup> and 791 M<sup>–1</sup> s<sup>–1</sup> for <b>30</b> and <b>60</b>, respectively).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> This observation indicated that <b>30</b> and <b>60</b> might possess only moderate binding affinity for FAAH or inactivate FAAH at a moderate rate.</div><div class="NLM_p">Compounds <b>59</b> and <b>60</b> displayed no detectable activity for other serine enzymes at a 500 μM concentration in vitro and at a dose of 30 mg/kg in vivo in ABPP assays. However, compounds <b>30</b> and <b>12</b> had off-target serine enzyme interactions under the same experimental conditions.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The cocrystal structure of <b>60</b>–FAAH indicated that the urea functions of <b>60</b> covalently reacted with Ser241 of FAAH, the piperidine moiety was positioned in the ABP of FAAH (<a class="ref internalNav" href="#fig25" aria-label="Figure 25">Figure 25</a>), and the aniline group was attached to the CP serving as the leaving group after hydrolysis.<a onclick="showRef(event, 'ref50 ref96'); return false;" href="javascript:void(0);" class="ref ref50 ref96">(50, 96)</a> Compounds <b>59</b> and <b>60</b> were shown to irreversibly bind to FAAH, since the hydrolysis capacity of FAAH did not recover after a rapid dilution.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0026.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. X-ray cocrystal structure of <b>60</b>-combined FAAH, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA">2VYA</a>.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Compound <b>60</b> and oxyanion hole are depicted as purple and yellow, respectively. Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inspired by the structures of <b>59</b> and <b>60</b>, a series of benzothiophene-based piperazine/piperidine ureas were described as FAAH inhibitors. The replacement of the <i>N</i>-phenyl ring of benzothiophene urea derivatives with the <i>N</i>-pyridine-3-yl group led to enhanced inhibition by the molecules (<a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Moreover, the introduction of additional substituents on the pyridine ring was reported to markedly alter the inhibitory potency against FAAH. In particular, structure–activity relationships showed that a substituent at the 6-position led to the dramatic loss of inhibition potency except for a methoxy group (<a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>). For instance, a diethylamino substituent at the 6-position of the pyridine ring resulted in around a 20-fold loss of inhibitory activity for human FAAH, in comparison with the amino substituent. It seems that steric effects limit the interaction of the molecule with FAAH.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Furthermore, substituent optimization on the benzothiophene was carried out (<a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>). The methyl group at the 3-position of the benzothiophene seemed to be essential for the FAAH inhibitory capacity of the molecule. Indeed, the replacement of this methyl group with an ethyl group was shown to slightly decrease the inhibitory efficacy and the removal of this substituent dramatically reduced the inhibitory activity (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 2401 M<sup>–1</sup> s<sup>–1</sup>, 1402 M<sup>–1</sup> s<sup>–1</sup>, and 695 M<sup>–1</sup> s<sup>–1</sup>, respectively). The introduction of small groups at the 4-/5-positions appeared to have a slight impact on inhibitory efficacy. However, the introduction of an ethoxy group at the 6-position of the benzothiophene brought about a complete loss of inhibitory activity (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 14 M<sup>–1</sup> s<sup>–1</sup>).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The binding model revealed that the 6-ethoxy benzothiophene substituent was too large to be suitably placed in the binding channel of FAAH according to the mutual exclusion between the ethoxy group and Met436.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Most of these developed benzothiophene urea derivatives were determined to be highly selective as shown using competitive ABPP. Compound <b>61</b> (PF-465, <a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>) alleviated pain response in the complete Freund’s adjuvant (CFA) model of inflammatory pain in rats after a 10 mg/kg dose, with efficacy comparable to that of the nonsteroidal anti-inflammatory drug (NSAID) naproxen at the same dose.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0027.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure–activity relationships of benzothiophene piperazine urea based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As previously described, compound <b>60</b> only showed moderate affinity for FAAH. To improve the binding affinity for FAAH, replacement of the quinoline with different biaryl ether functions was performed and the pharmacological activities were profiled as <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> These modifications led to the discovery of a potent, selective, covalent, irreversible FAAH inhibitor, compound <b>62</b> (PF-3845, <a class="ref internalNav" href="#fig27" aria-label="Figure 27">Figure 27</a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The profile of inhibitory potency indicated that <b>62</b> possessed an impressive <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> value of 12 600 M<sup>–1</sup> s<sup>–1</sup> for hFAAH, which was 8 times and 16 times more than <b>30</b> and <b>60</b>, respectively. Indeed, compound <b>62</b> showed rapid elevation of brain AEA, PEA, and OEA levels in mice brain. The significant increase of brain AEA levels was still detected 24 h after a 10 mg/kg intraperitoneal administration. Conversely, the action of <b>30</b> in improving brain AEA levels was not observable 7 h after a 10 mg/kg intraperitoneal dose.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Compound <b>62</b> produced CB<sub>1</sub>-/CB<sub>2</sub>-dependent pain relief in various models (such as mechanical allodynia model and CFA-induced inflammatory pain) at a 10 mg/kg oral dose.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Selectivity profiling by competitive ABPP showed that <b>62</b> exhibited high selectivity for FAAH without affecting other serine enzymes. Apart from the high selectivity, compound <b>62</b> also exerted prolonged duration of enzyme inactivation (>24 h) and high oral bioavailability (>80%).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> These advantageous characteristics make <b>62</b> a useful tool for the further exploration and investigation of endocannabinoid-system-mediated multiple biological responses.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Recently, compound <b>62</b> was demonstrated to promote neuronal survival and alleviate brain damage in a traumatic brain injury (TBI) model in mice after a 5 mg/kg intraperitoneal dose.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0028.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of representative piperidine urea based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further determination of the X-ray crystal structure of a <b>62</b>–FAAH complex showed that the carboxamide moiety of <b>62</b> covalently interacted with the hydroxyl group of Ser241, the 3-aminopyridine group was positioned in the CP and acted as a leaving group during catalysis, and the biaryl ether piperidine moiety was bound to the ABP.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Notably, the conformation of FAAH was variable according to the rotation of Phe432 and Met436. The data reported showed that the inhibitors induced conformational changes.<a onclick="showRef(event, 'ref77 ref95'); return false;" href="javascript:void(0);" class="ref ref77 ref95">(77, 95)</a> As exemplified by <b>62</b>, overlay of X-ray cocrystal structures of <b>62</b>–FAAH and <b>60</b>–FAAH indicated that the trifluoromethyl group induced a conformational shift of Phe432 from the ABP to the MAC. (<a class="ref internalNav" href="#fig28" aria-label="Figure 28">Figure 28</a>a and <a class="ref internalNav" href="#fig28" aria-label="Figure 28">Figure 28</a>b) This conformational switching is accompanied by a rotation of Met436 and results in the expansion of the ABP and the easier access of inhibitors or substrates from MAC into the ABP.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> In fact, the replacement of the trifluoromethyl group of <b>62</b> with smaller substituents (such as methyl, fluoro) resulted in a sudden decrease of inhibitory potency because the van der Waals interactions between the small substitutions and Phe432/Met436 were too weak to alter the conformation of the enzyme.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Additionally, switching a trifluoromethyl group from the 5-position of the pyridine ring to the 3/6-position also impaired inhibitory capacity, which was possibly due to the steric clash between the inhibitor molecular and the enzyme.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0029.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. (a) Overlap of X-ray cocrystal structures of FAAH–<b>60</b> (in orange, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA">2VYA</a>)<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and FAAH–<b>62</b> (in green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WAP">2WAP</a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> (b) Surfaces of FAAH combined with <b>60</b> (left) and <b>62</b> (right). Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To improve the inhibitory efficacy, a C═C linker was introduced into the basic scaffold of <b>62</b>.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> In particular, the introduction of a  linker between the piperidine ring and the aromatic group confers several advantageous properties. For instance, the C═C moiety provides a rigid conformation with fewer rotatable bonds and lower conformational energy and improves the likelihood of interactions with the ABP (e.g., Phe432).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Indeed, pharmacological assay results indicated that piperidine derivatives with the C═C linker (<b>63</b>, <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>(hFAAH) = 21 600 M<sup>–1</sup> s<sup>–1</sup>) exerted enhanced inhibitory potency in comparison with <b>62</b>. Additionally, the replacement of <i>N</i>-pyridin-3-yl by pyrazin-2-yl (<b>64</b>) or pyridazine-3-yl (<b>65</b>) dramatically improved the inhibitory efficacy (<a class="ref internalNav" href="#fig27" aria-label="Figure 27">Figure 27</a>) and also decreased the hydrophobicity of the molecule and altered physicochemical parameters (such as clogP).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Subsequently, compound <b>65</b> (PF-04457845, <a class="ref internalNav" href="#fig27" aria-label="Figure 27">Figure 27</a>), a novel potent, highly selective, covalent, and irreversible FAAH inhibitor, was identified as a clinical candidate. Compound <b>65</b> was shown by competitive ABPP to possess high selectivity over numerous serine enzymes in kidney, spleen, and testis at 100 μM and to exhibit no off-target activity against a panel of receptors, ion channels, and transporters.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99, 100)</a> It possessed remarkable pharmacokinetic properties in dogs and humans, including rapid absorption after oral administration, a low clearance rate, a high bioavailability of 88% and 58% in rats and dogs, respectively, a low probability of drug–drug interaction based on in vitro cytochromes P450 (CYPs) inhibition investigations, and a long duration of action lasting until 24 h postdose.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Compound <b>65</b> was found to elevate levels of FAEs (e.g., AEA and OEA) and to alleviate inflammation-related pain in a CFA model of inflammatory pain in rats (0.1 mg/kg oral dose) through CB<sub>1</sub>/CB<sub>2</sub>-dependent activities without affecting motility or body temperature.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99, 100)</a> Although oral administration of 0.5–40 mg of <b>65</b> also brought about the elevation of plasma FAEs levels, it failed to produce analgesia in patients with pain induced by osteoarthritic knee in clinical trials.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The complete loss of analgesic potency in humans might be attributed to the difference in biological responses after FAAH inhibition between humans and rodents. Two hypotheses were suggested for this clinical trial failure by Pfizer. First, complex human emotions related to pain are not observable in rodent models.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Indeed, human pain observation was demonstrated to be significantly influenced by emotionality. Pain sensation can be attributed to heightened anxiety or depression. Second, there is sufficient evidence that CB receptor activation induced by AEA elevation after FAAH inhibition is equivalent to that induced by exogenous CB receptor agonists in rodents. However, this has not been confirmed in humans.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Overall, pain and its related symptoms are complicated and might differ in various species. How to translate pain symptoms into rational and reliable data needs be considered carefully. Moreover, pain can be induced by multiple conditions (e.g., inflammation, cancer, or injury); therefore, analgesic mechanisms might differ depending on the types of pain. Nevertheless, clinical trials of compound <b>65</b> in other disorders (e.g., post-traumatic stress disorders and Tourette syndrome) are ongoing.</div><div class="NLM_p">[<sup>11</sup>C-carbonyl] <b>65</b> (<a class="ref internalNav" href="#fig27" aria-label="Figure 27">Figure 27</a>) was shown to be a suitable candidate for FAAH positron emission tomography (PET), which can be used for the neuroimaging study of FAAH and clinical research.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Furthermore, optimization of the core between the urea function and the aromatic group of <b>65</b> was performed. The pharmacological assay identified two series of novel potent urea-based FAAH inhibitors bearing a 1-oxa-8-azaspiro[4.5]decane or a 7-azaspiro[3.5]nonane core instead of a piperidine.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Three compounds (<b>66</b>, <b>67</b>, and <b>68</b>, <a class="ref internalNav" href="#fig29" aria-label="Figure 29">Figure 29</a>) from these two series were profiled and assessed for their selectivity versus more than 200 human serine hydrolases. The competitive ABPP assay indicated that these three compounds were devoid of off-targets at 100 μM. They were further determined to exert low clearance and a low risk of drug–drug interactions.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> To further improve potency against FAAH and to optimize CNS-dependent drug properties, the exploration and screening of aromatic moieties led to the identification of a 7-azaspiro[3.5]nonane urea <b>69</b> (PF-04862853, <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> value = 4190 and 5820 M<sup>–1</sup> s<sup>–1</sup> toward human and rat FAAH, respectively, <a class="ref internalNav" href="#fig29" aria-label="Figure 29">Figure 29</a>) as one of the optimal FAAH inhibitors to date.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> In addition, compound <b>69</b> was determined to possess suitable physiochemical (clogP = 3.8) and pharmacokinetic properties (a half-life of 7.1 h and 53% bioavailability in rats, a half-life of 7.8 h and 33% bioavailability in dogs), to display a pronounced anti-inflammatory effect at 0.3 mg/kg, to almost totally inhibit FAAH in brain at 0.3 mg/kg, and to substantially increase AEA levels to reach the maximum concentration in brain at 1 mg/kg in a CFA model of inflammatory pain in rats.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Given its advantageous druglike properties, compound <b>69</b> was selected as a lead compound.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0030.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of representative azaspiro urea based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Takeda developed a series of heterocyclic piperazine ureas as FAAH inhibitors.<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106, 107)</a> These novel inhibitors were inspired by two identified FAAH inhibitors <b>51</b><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> and <b>70</b> (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>). It was hypothesized that the replacement of the phenyl ring of <b>51</b> with benzoisoxazolyl might improve the inhibitory potency.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In this case, <b>71</b> (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>) was discovered by the hydridization of <b>51</b> and <b>70</b>. Compound <b>71</b> was demonstrated to exhibit remarkable inhibitory capacity against human FAAH (IC<sub>50</sub> = 4.8 nM). However, this <i>N</i>-benzoisoxazolyl substituted urea derivative has poor aqueous solubility and disappointing bioavailability (5%) in rats.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Hence, the replacement of benzoisoxazolyl with isoxazole, pyridazine, or pyridine was performed to improve aqueous solubility and other physicochemical parameters. Particularly, <i>N</i>-(3,4-dimethylisoxazol-5-yl) substituted derivative <b>72</b> (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>) exerted enhanced inhibitory efficacy (IC<sub>50</sub> = 1.7 nM) and moderate aqueous solubility (1.6 μg/mL) with respect to <b>71</b>.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Moreover, the replacement of the 1,2,4-thiadiazole group with a thiazole ring seemed to improve both inhibitory potency and aqueous solubility (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>, IC<sub>50</sub> = 0.92 nM, solubility of 38 μg/mL). Additionally, the exploration of substituents on the terminal phenyl ring was carried out. Notably, the 2-/4-monosubstituted fluoro group and 2,4-disubstituted fluoro group on the terminal phenyl ring appeared to be favorable for inhibition and for maintaining modest aqueous solubility (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> It is noteworthy that mono- or disubstituted fluoro groups at the 2/4 position of the terminal phenyl group enabled potent oral bioavailability (70–98%) in rats and the ability to cross the BBB.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Compound <b>73</b> (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>) not only possessed the optimal inhibitory activity for human and rat FAAH (IC<sub>50</sub> = 0.43 and 0.46 nM, respectively) but also exerted remarkable analgesic potency in the acetic acid induced writhing model in mice at doses of 10 and 30 mg/kg (oral administration).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0031.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structure of thiadiazolylpiperazine urea based FAAH inhibitor <b>71</b> obtained by incorporation of compounds <b>51</b> and <b>70</b> and structural modifications on the benzisoxazole, thiadiazole, and the phenyl groups of compound <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To improve the aqueous solubility, pyridazine and pyrimidine groups were introduced to replace the 3,4-dimethylisoxazole group and the thiazole ring, respectively.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Notably, compound <b>74</b> (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>) was exposed to exert potent inhibitory activity against human/rat FAAH (IC<sub>50</sub> = 0.72/0.28 nM) and to produce analgesic potency in both the spared nerve injury (SNI) induced neuropathic pain and CFA induced inflammatory pain models in rats at 3 mg/kg doses (oral administration).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div></div><div id="sec7_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 5. Boronic Acids</h3><div class="NLM_p">Boronic acid based derivatives have been considered as potential pharmaceutical candidates and demonstrated to potently and reversibly inhibit several serine enzymes.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> In 2008, boronic acids were determined to inhibit FAAH.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The para-substituted hydrophobic or electron-withdrawing groups of phenylboronic acids were shown to be advantageous for the inhibitory activity against FAAH. Notably, (4-nonylphenyl)boronic acid <b>75</b> (<a class="ref internalNav" href="#fig31" aria-label="Figure 31">Figure 31</a>a) exerted potent FAAH inhibitory capacity (IC<sub>50</sub>(rFAAH) = 9.1 nM). Exemplified by compound <b>75</b>, molecular modeling with FAAH assumed that the two hydroxyl groups of <b>75</b> were able to form hydrogen bonds with Met191 and Ser193, respectively. The electrophilic boron atom was hypothesized to interact covalently with the nucleophilic hydroxyl group of Ser241 because of its trigonal planar sp<sup>2</sup>-hybridization and its empty p orbital.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The covalent interaction between <b>75</b> and Ser241 was presumed to form a reversible tetrahedral intermediate (<a class="ref internalNav" href="#fig31" aria-label="Figure 31">Figure 31</a>b).<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> According to recent research on molecular binding simulation of FAAH,<a onclick="showRef(event, 'ref30 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref34">(30, 34)</a> it was hypothesized that 4-nonylphenyl might be located in the ABP. Although the binding mechanism between boronic acid based inhibitors and FAAH is still not clear, the remarkable inhibitory efficacy makes boronic acids useful chemical tools to further elucidate the catalytic mechanism of FAAH. However, boronic acid derivatives have been shown to suppress multiple serine enzymes, which could be a disadvantageous property for preclinical applications.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0032.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. (a) Structure of the boronic acid based FAAH inhibitor <b>75</b>. (b) Interactions between compound <b>75</b> and FAAH. Figure from ref <a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">109</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 6. Arylthioheterocycles</h3><div class="NLM_p">Most recently, a series of arylthioheterocycle-based noncovalent FAAH inhibitors were disclosed by Merck.<a onclick="showRef(event, 'ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref110 ref111">(110, 111)</a> According to the creation of a short-lived complex between noncovalent inhibitors and FAAH, they are expected to decrease potential risk factors over the formation of a long-lived covalent adduct. The development of arylthioheterocycle-based FAAH inhibitors was derived from an HTS hit <b>76</b> (<a class="ref internalNav" href="#fig32" aria-label="Figure 32">Figure 32</a>). However, compound <b>76</b> manifested moderate FAAH inhibitory activity (IC<sub>50</sub> = 119 nM) and poor pharmacokinetic parametres.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> To improve the inhibitory potency and pharmacokinetic properties, structural modifications of <b>76</b> were carried out.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Structure–activity relationships indicated that use of an ether, sulfone, or sulfoxide instead of a thioether as the linker between the aromatic group and heterocycle ring resulted in a dramatic loss of inhibitory activity (<a class="ref internalNav" href="#fig32" aria-label="Figure 32">Figure 32</a>).<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> The introduction of a phenyl, a <i>p</i>-fluorophenyl, or a pyridine group to the N-1 of the pyrazole and the replacement of the dioxane ring with a methyl sulfone or a 1,2,4-oxadiazole led to an improvement to the FAAH inhibitory potency (17 ≤ IC<sub>50</sub> ≤ 32 nM, <a class="ref internalNav" href="#fig32" aria-label="Figure 32">Figure 32</a>). Finally, the oxazole analogue <b>77</b> (MK-4409, <a class="ref internalNav" href="#fig32" aria-label="Figure 32">Figure 32</a>) bearing the optimized substituents, a 4-pyridyl tertiary alcohol, a <i>p</i>-fluorophenyl, and a thiopyridine, drastically improved the pharmacokinetic properties. The profile of analgesic effects in numerous models illustrated that the oxazole-based derivative <b>77</b> reduced inflammatory pain in a CFA model at a 10 mg/kg oral dose and attenuated neuropathic pain in a SNL model at a 3 mg/kg oral dose with a long duration of action until 24 h postdose, and no apparent side effects were observed up to a dose of 100 mg/kg.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> The clinical trials data of <b>77</b> will be reported in due course. Compound <b>77</b> has been presumed to reversibly interact in a noncovalent manner with FAAH. It can be used for further studies of noncovalent binding mechanisms with FAAH.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0033.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Structures of representative arylthioheterocycle-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, arylthioheterocycle derivatives were developed as PET tracers, which could be used for imaging FAAH in brain.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The exploration was based on a lead compound <b>78</b> (<a class="ref internalNav" href="#fig33" aria-label="Figure 33">Figure 33</a>), which was previously identified as a potent FAAH inhibitor.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> However, compound <b>78</b> possessed an unfavorable lipophilicity (log <i>D</i> = 4.2 at pH 7.3) complicating the in vivo PET studies in rhesus monkeys. To optimize lipophilicity and brain penetration, several modifications were performed.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Notably, compound <b>79</b> (MK-3168, <a class="ref internalNav" href="#fig33" aria-label="Figure 33">Figure 33</a>), possessing an ideal hydrophilic parameter (log <i>D</i> = 3.3 at pH 7.3), was revealed to remarkably inhibit rat, rhesus, and human FAAH (IC<sub>50</sub> = 1.0, 5.5, and 1.7 nM, respectively).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The isotope labeled compound <b>79</b> could be used for the study of FAAH by imaging and for pharmacokinetics.</div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0034.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures of arylthioheterocycles developed as PET tracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 7. 3-Carboxamido-5-arylisoxazoles</h3><div class="NLM_p">A new series of FAAH inhibitors based on 3-carboxamido-5-arylisoxazole scaffold was disclosed in 2011.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112, 113)</a> The pharmacological results indicated that a 4-biphenyl ring at the 5-position of the isoxazole and N-substituted 2-(benzo[<i>d</i>][1,3]dioxol-5-yl)ethyl provided the optimal inhibitory efficacy.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Compound <b>80</b> (<a class="ref internalNav" href="#fig34" aria-label="Figure 34">Figure 34</a>) exerted potent capacity to suppress FAAH (IC<sub>50</sub> = 88 nM) and produced protective efficacy and anti-inflammatory potency in 2,4,6-trinitrobenzenesulfonic acid (TNBS) induced colitis in mice at a 10 mg/kg oral dose.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The molecular modeling of compound <b>80</b> suggested that its isoxazole and carboxamide moieties interact with the oxyanion hole and form hydrogen bonds with Ile138 and Lys142, respectively. The rigid biphenyl group was assumed to establish a π–π interaction with Phe194. Additionally, the benzodioxole group was presumed to serve as a hydrogen bond acceptor and bind to Gln273.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><figure id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0035.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Structures of representative 3-carboxamido-5-arylisoxazole-based FAAH inhibitors and CB<sub>2</sub> agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It was noteworthy that a series of CB<sub>2</sub> agonists were concurrently explored based on the same 3-carboxamido-5-arylisoxazole scaffold.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Interestingly, during the exploration of CB<sub>2</sub> agonists, some compounds were found to be more potent as FAAH inhibitors.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> For instance, compound <b>81</b> (<a class="ref internalNav" href="#fig34" aria-label="Figure 34">Figure 34</a>) was demonstrated as a potent CB<sub>2</sub> agonist. Nevertheless, modification of the phenyl ring substituents revealed that a shift of the pentoxy group from the ortho position to the para position gave rise to a complete loss of CB<sub>2</sub> agonism. Correspondingly, compound <b>82</b> (<a class="ref internalNav" href="#fig34" aria-label="Figure 34">Figure 34</a>) with a para-pentoxy substituent was discovered to drastically inhibit FAAH, compared with a modest FAAH inhibition of its meta analogue.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Moreover, compound <b>82</b> was determined to exhibit anti-inflammatory efficacy in dextran sulfate sodium (DSS) induced acute colitis in mice at a 10 mg/kg intraperitoneal dose.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Overall, the 3-carboxamido-5-arylisoxazole could be a favorable scaffold used for the exploration of FAAH inhibitors or CB<sub>2</sub> agonists.</div></div><div id="sec7_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 8. 1,3,4-Oxadiazol-2-ones</h3><div class="NLM_p">1,3,4-Oxadiazol-2-ones were initially reported to reversibly inhibit several EC hydrolases, such as FAAH and MAGL.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> For example, compound <b>83</b> (<a class="ref internalNav" href="#fig35" aria-label="Figure 35">Figure 35</a>) exhibited remarkable FAAH inhibitory potency at nanomolar doses (IC<sub>50</sub> = 6.1 nM) and approximately 20-fold selectivity over MAGL (IC<sub>50</sub> = 0.11–0.38 μM).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> To further improve the potency and selectivity, the exploration of N- and O-substituted phenyl groups was carried out.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> It was demonstrated that 1,3,4-oxadiazol-2-ones could be modified to fit either FAAH or MAGL by focusing on the different distinct characteristics of the catalytic center between FAAH and MAGL.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Recently, Patel and co-workers made a breakthrough in the improvement of the selectivity of 1,3,4-oxadiazol-2-ones. They hypothesized that the poor selectivity of previously prepared 1,3,4-oxadiazol-2-ones could be attributed to the directly linked phenyl–oxadiazole moiety.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> In this case, a chiral carbon linker was introduced between the phenyl ring and oxadiazole group to give molecular flexibility.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Structure–activity relationships illustrated that the chiral carbon linker (<b>84</b>, IC<sub>50</sub> = 23 nM) provided enhanced inhibitory potency against FAAH in comparison with the achiral methylene linker (<b>85</b>, IC<sub>50</sub> = 91 nM). Moreover, the <i>S</i>-isomer (<b>86</b>, IC<sub>50</sub> = 11 nM) was determined to show superior potency, as compared to its enantiomer (IC<sub>50</sub> = 240 nM).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Typically, compound <b>86</b> (JZP-327A, <a class="ref internalNav" href="#fig35" aria-label="Figure 35">Figure 35</a>) manifested optimal FAAH inhibitory potency and high selectivity over MAGL and COX isoenzymes. An ABPP assay indicated that <b>86</b> showed no off-target activity against other serine hydrolases (such as MAGL, ABHD6/12).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Compound <b>86</b> was identified as a reversible FAAH inhibitor, according to the recovery of enzyme activity after a rapid dilution.<a onclick="showRef(event, 'ref50 ref116'); return false;" href="javascript:void(0);" class="ref ref50 ref116">(50, 116)</a> Molecular modeling revealed the 1,3,4-oxadiazol-2-one core establishes a strong H-bond network with the oxyanion hole of FAAH.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> The introduction of a chiral carbon linker could encourage the development of new selective FAAH inhibitors. The 1,3,4-oxadiazol-2-one might be considered as a privileged scaffold for the further development of FAAH inhibitors, given the favorable strong interactions between 1,3,4-oxadiazol-2-ones and FAAH.</div><figure id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0036.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Structures of representative 1,3,4-oxadiazol-2-one-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 9. Other FAAH Inhibitors</h3><div class="NLM_p">Apart from these interesting scaffolds mentioned above, a number of miscellaneous structures were disclosed to inhibit FAAH.</div><div class="NLM_p">Compound <b>87</b> (<a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>), discovered at Abbott, was hypothesized to reversibly and noncovalently inhibit FAAH in the nanomolar range (IC<sub>50</sub>(rFAAH) = 18 nM).<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The determination of selectivity by ABPP indicated that compound <b>87</b> exerted no off-target activity against numerous enzymes (such as TGH, KIAA1363, and carboxy esterases).<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><figure id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0037.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Structures of other representative FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A series of noncovalent and reversible FAAH inhibitors was disclosed by Amgen in 2011.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Typically, compound <b>88</b> (<a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>) exerted potent capacity to disable FAAH-mediated hydrolysis. As exemplified by compound <b>88</b>, the X-ray crystal structure of <b>88</b>–FAAH adduct indicated that the 4-(2,3-dihydrobenzofuran-2-yl) substituent was located in the MAC, while piperidine moiety occupied the ABP.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Additionally, van der Waals interactions were present between the pyrimidine and several hydrophobic residues of FAAH, including Phe432, Leu433, Met436, Thr488, Ile491, and Trp531 (<a class="ref internalNav" href="#fig37" aria-label="Figure 37">Figure 37</a>).<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118, 119)</a> Compound <b>88</b> was determined to possess favorable pharmacokinetic parameters, including low clearance rate, suitable bioavailability (92%) in rats, and reasonable residence time (5.5 h after a 2 mg/kg dose).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div><figure id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0038.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Compound <b>88</b> (in yellow) is surrounded by Phe432, Leu433, Met436, Thr488, Ile491, and Trp531; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QJ9">3QJ9</a>.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Results were obtained using software programs from Dassault Systèmes BIOVIA, Discovery Studio Visualizer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Renovis, Inc. developed a series of tetrahydropyridopyridines as noncovalent and reversible FAAH inhibitors.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Among these compounds, compound <b>89</b> (RN-450, <a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>) exerted attractive FAAH inhibitory potency with IC<sub>50</sub> of 13 nM and 25 nM toward human and rat FAAH, respectively.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p">Compound <b>90</b> (<a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>) was disclosed to potently inhibit FAAH but exhibited poor metabolic stability due to rapid reduction by a carbonyl reductase.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><div class="NLM_p">Compound <b>91</b> (MM-433593, <a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>), a potent and selective FAAH inhibitor with an IC<sub>50</sub> in the nanomolar range, was disclosed by Ironwood Pharmaceuticals Inc.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> It was determined to only slightly antagonize CB<sub>1</sub> (IC<sub>50</sub> > 1 μM) and be devoid of effects on CB<sub>2</sub>, COX1/2, FAAH-2, other serine hydrolases, and a broad panel of receptors and channels.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Although compound <b>91</b> has been shown to interact with FAAH in a noncovalent fashion, it was proposed to be an irreversible FAAH inhibitor.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> It is interesting to know the binding mechanism between <b>91</b> and FAAH. Probably the noncovalent but irreversible property is attributed to the strong H-bonds interactions established between <b>91</b> and FAAH and/or the conformational change of FAAH induced by <b>91</b>. The detailed binding mechanism of <b>91</b> is expected to be disclosed. Moreover, compound <b>91</b> was shown to possess excellent pharmacokinetic parameters, moderate oral bioavailability (14–21%) in monkeys, and a long half-life (17–20 h) after a 10 mg/kg oral dose or a 1 mg/kg intravenous dose.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The detailed metabolic pathways and at least 18 metabolites of <b>91</b> in monkey were described. Compound <b>91</b> will be further studied in human clinical trials.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The discovery of <b>91</b> and its metabolic pathways in vivo is meaningful for the design and development of drug candidates.</div><div class="NLM_p last">Moreover, a series of 1-aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanol derivatives as competitive FAAH inhibitors were reported by Johnson & Johnson.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The extension of this series of FAAH inhibitors was encouraged by the HTS hit <b>92</b> (<a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>). Interestingly, unlike α-ketoheterocycles, carbamates, or ureas, compound <b>92</b> does not possess any covalently reactive function that is intended to interact with FAAH.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The <i>R</i>-isomer of compound <b>92</b>, rather than its <i>S</i>-isomer, was demonstrated to provide the principal inhibitory efficacy against FAAH (IC<sub>50</sub> = 17 nM and 10 μM, respectively). Indeed, the hydroxyl group of the <i>R</i>-isomer was identified to be amenable to forming an H-bond with Thr488. In this case, the exploration was performed based on the <i>R</i>-isomer. Numerous aromatic groups were introduced to replace the trifluoromethoxyphenyl moiety appended to the pyrimidine ring.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Generally, the compounds with substituted groups at the 2-position of the phenyl ring appended to the pyrimidine ring suffered from a substantial reduction of inhibitory capacity, whereas 3-/4-substituted hydrophobic groups contributed to the enhancement of inhibitory potency.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Several compounds (such as compounds <b>93</b>, <b>94</b>, <b>95</b>, and <b>96</b>, <a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>) exhibited remarkable capacity to block rat and human FAAH, although poor oral bioavailability and high clearance rate were detected in rats. Specifically, 3-chloro-4-trifluoromethylphenyl substituted derivative <b>97</b> (JNJ-40413269, <a class="ref internalNav" href="#fig36" aria-label="Figure 36">Figure 36</a>) was shown to exert potent FAAH inhibition activity (IC<sub>50</sub> = 5.3 nM) and advantageous pharmacokinetic properties including good oral bioavailability (94%), good brain penetration (brain/plasma ratio of ∼1), and prolonged half-life (<i>t</i><sub>1/2</sub> = 4.1 h) in rats.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Moreover, compound <b>97</b> was determined to produce a dose-dependent analgesic effect in a SNL model of neuropathic pain in rats after a 2/6/20 mg/kg oral administration.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Compound <b>97</b> was modeled in a crystal structure of humanized rat FAAH, which indicated that the hydroxyl group appended to the chiral carbon possibly formed a hydrogen bond with Thr488.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Given its advantageous pharmacokinetic properties, compound <b>97</b> might inspire the further development of reversible FAAH inhibitors.</div></div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">NAAA Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1. Substrate Inspired Inhibitors</h3><div class="NLM_p">Inspired by the structure of natural substrates, a series of PEA analogues were initially disclosed to inhibit NAAA. The PEA-analogue-based inhibitors contain a hydrophobic side chain and a reactive functionality, such as an amide, reverse amide, ester, reverse ester, or amino group. <i>N</i>-Pentadecylcyclohexanecarboxamide <b>98</b> (<a class="ref internalNav" href="#fig38" aria-label="Figure 38">Figure 38</a>) and <i>N</i>-pentadecylbenzamide <b>99</b>, belonging to first generation NAAA inhibitors, were revealed to inhibit rat lung NAAA.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> However, compound <b>98</b> was found to be unable to inhibit NAAA at 100 μM concentration when it was resynthesized by Yamano and co-workers.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Eventually, pentadecylamine <b>100</b>, an impurity detected in the first batch of <b>98</b>, was identified to strongly inhibit rat lung NAAA (around 90% inhibition) at 100 μM. Thus, the inhibitory activity of <b>99</b> is also uncertain and needs to be reevaluated, due to its similar chemical structure to <b>98</b>. According to this interesting discovery, a series of lipophilic amines derived from <b>100</b> was developed by Yamano and co-workers.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Especially, tridecyl 2-aminoacetate <b>101</b> (<a class="ref internalNav" href="#fig38" aria-label="Figure 38">Figure 38</a>) showed approximately 90% inhibition of rat lung NAAA at 100 μM via competitive mechanism (examined by a Lineweaver–Burk plot).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> The lipophilic amines might be protonated in solution while they were determined to inhibit NAAA at pH 5, the optimal catalytic pH of NAAA. Since the protonated and nonprotonated molecules interact with enzymes through different mechanisms, the selectivity over FAAH was evaluated at both pH 5 and pH 8.5, a suitable pH for FAAH. The result indicated that there was no detectable inhibitory activity against FAAH at pH 8.5, whereas compounds <b>100</b> and <b>101</b> slightly inhibited rat FAAH at pH 5 at a concentration of 100 μM.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div><figure id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0039.jpeg" id="gr38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Structures of representative substrate-based NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, the cyclobutyl palmitate <b>102</b> and cyclopentyl palmitate <b>103</b> compounds (<a class="ref internalNav" href="#fig38" aria-label="Figure 38">Figure 38</a>) were determined to block human recombinant NAAA at a concentration of 50 μM with 41% and 85% inhibition of NAAA activity, respectively.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Compound <b>103</b> was observed to drastically elevate PEA levels in intact HEK-NAAA cells without affecting the AEA and OEA signaling at 50 μM.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Furthermore, topical administration of compound <b>103</b> (200–400 μg/sponge, 1.5 cm<sup>3</sup>) in a model of carrageenan-induced inflammation in rats was found to reduce inflammation.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><div class="NLM_p">Compound <b>104</b> (<a class="ref internalNav" href="#fig38" aria-label="Figure 38">Figure 38</a>) was reported to be a weak dual inhibitor against NAAA and FAAH.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The replacement of the pyrrolidine ring with other cyclic functions led to a dramatic decrease of inhibitory potency against NAAA. The introduction of a biphenyl group on the acyl chain produced compound <b>105</b> (<a class="ref internalNav" href="#fig38" aria-label="Figure 38">Figure 38</a>), which potently inhibited rNAAA selectively vs rFAAH (IC<sub>50</sub> = 2.12 μM and >100 μM, respectively).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Furthermore, the optimal substrate-based NAAA inhibitor <b>106</b> (AM9023, IC<sub>50</sub> = 0.6 μM, <a class="ref internalNav" href="#fig38" aria-label="Figure 38">Figure 38</a>) to date was revealed.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> The isothiocyanate moiety of <b>106</b> was determined to interact reversibly with the cysteine of the enzyme catalytic triad by kinetic studies and using mass spectrometry. Compound <b>106</b> displayed moderate selectivity for human NAAA over human MAGL and rat FAAH (IC<sub>50</sub> > 10 μM).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Indeed, the electrophilicity of isothiocyanate enables it to interact with serines, cysteines, and amino groups in biomolecules. Therefore, isothiocyanate can be considered as an interesting scaffold for drug design. However, off-target effects of isothiocyanates should be considered with attention due to their highly reactive properties.</div><div class="NLM_p last">Overall, most substrate-based NAAA inhibitors only exert modest inhibitory activity and selectivity. Typically, compound <b>106</b> exhibits the optimal inhibitory potency, which could be used for the further research of interactive mechanisms with NAAA.</div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2. β-Lactones</h3><div class="NLM_p">The presence of the catalytic triad in NAAA has encouraged the development of a series of electrophilic function-dependent NAAA inhibitors. Since the nucleophilic reactive sulfhydryl cysteine group of NAAA was found to interact with the electrophilic carbonyl group of substrates during catalysis, the presence of the electrophilic function was proposed to provide inhibitory potency through the formation of a covalent bond with the thiol group. In this case, compounds with electrophilic functions were expected to be developed.</div><div class="NLM_p">Compound <b>107</b> (<a class="ref internalNav" href="#fig39" aria-label="Figure 39">Figure 39</a>), a serine-derived β-lactone, was initially reported to inhibit the cysteine protease hepatitis A virus 3C protease. Afterward, compound <b>107</b> was discovered to inhibit NAAA.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In this case, the β-lactone ring rather than the carbamate moiety appears to covalently bind to the NAAA active site, based on the structure–activity relationships showing that the removal of the β-lactone gives rise to a complete loss of potency.<a onclick="showRef(event, 'ref7 ref131'); return false;" href="javascript:void(0);" class="ref ref7 ref131">(7, 131)</a> Removal of the oxygen atom of the carbamate moiety produced compound <b>108</b> ((<i>S</i>)-OOPP, <a class="ref internalNav" href="#fig39" aria-label="Figure 39">Figure 39</a>), which exerted an approximately 7-fold increase in inhibition in comparison with compound <b>107</b> (IC<sub>50</sub> = 0.42 and 2.96 μM, respectively).<a onclick="showRef(event, 'ref7 ref131'); return false;" href="javascript:void(0);" class="ref ref7 ref131">(7, 131)</a> Interestingly, the (<i>R</i>)-enantiomer of <b>108</b> displayed a markedly lower inhibition with respect to its (<i>S</i>)-enantiomer (IC<sub>50</sub> = 6 μM). Kinetic analyses disclosed that <b>108</b> interacted with NAAA through a noncompetitive mechanism.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Compound <b>108</b> showed high selectivity for human NAAA over acid ceramidase and one kind of cysteine hydrolase that is very similar to the structure and function of NAAA. In addition, compound <b>108</b> was determined to be devoid of inhibitory potency against FAAH or other serine hydrolases.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Furthermore, compound <b>108</b> was shown to reduce neutrophil migration and alleviate injury in a model of traumatic spinal cord injury in mice (30 μg per mouse, intrathecal injection).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, lack of stability in plasma (half-life of <1 min)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> makes <b>108</b> a poor drug candidate for systemic application. To further improve potency and stability, the exploration of β-lactone-based NAAA inhibitors was performed (<a class="ref internalNav" href="#fig40" aria-label="Figure 40">Figure 40</a>). The replacement of the phenethyl ring with a hexyl chain maintained the capacity to inhibit NAAA (compound <b>109</b>, IC<sub>50</sub> = 460 nM).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> The introduction of lipophilic groups, such as naphthyl or biphenyl groups, was shown to be advantageous for inhibitory potency. Specially, compound <b>110</b> (<a class="ref internalNav" href="#fig40" aria-label="Figure 40">Figure 40</a>) exerted the optimal inhibitory efficacy against NAAA. Compound <b>110</b> was purported to covalently and reversibly bind to NAAA according to a slow recovery of enzyme activity following a 12 h dialysis. In addition, compound <b>110</b> was reported to possess the noncompetitive inhibitor property in which the increase of <b>110</b> concentration did not affect <i>K</i><sub>m</sub> but induced a decrease of <i>V</i><sub>max</sub>.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Compound <b>110</b> was shown to reduce carrageenan-induced inflammation after a 10 μL/sponge (1 cm<sup>3</sup>) topical administration.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Mass spectrometry studies indicated that the nucleophilic thiol group of the Cys131 of rat NAAA interacts with the carbonyl of β-lactone group to form an acyl–NAAA intermediate.<a onclick="showRef(event, 'ref7 ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref7 ref131 ref132">(7, 131, 132)</a></div><figure id="fig39" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0040.jpeg" id="gr39" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. Structures of representative β-lactone-based NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig40" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0041.jpeg" id="gr40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Structural modifications on the phenethyl group and the amide function of β-lactone-based NAAA inhibitor <b>108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The β-lactone group has been shown to react readily with nucleophiles and can be rapidly hydrolyzed in aqueous solution. In fact, most amide-based β-lactone derivatives were rapidly hydrolyzed in aqueous buffer at pH 7.4 with half-lives of less than 20 min, whereas the β-substituted methyl group endowed the β-lactone derivatives with improved stability (half-life of >70 min).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Afterward, urea- and carbamate-based β-lactone derivatives were identified to possess drastically increased chemical stability at both pH 5 and pH 7.4 in comparison with the corresponding amide-based β-lactone derivatives.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Structure–activity relationships revealed that the (<i>R</i>)-configuration of carbamate-based β-lactones was favorable for inhibitory capacity, whereas the (<i>S</i>)-configuration is suitable for urea-based β-lactones (<a class="ref internalNav" href="#fig40" aria-label="Figure 40">Figure 40</a>).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Although these urea/carbamate-based β-lactones manifested improved chemical stability in buffer solution, they were rapidly eliminated in the presence of bovine serum albumin. In particular, <i>tert</i>-butoxycarbonyl substitution increased the compounds’ stability in the presence of bovine serum albumin (<i>t</i><sub>1/2</sub> ≈ 2 h) and retained moderate inhibitory potency.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Nevertheless, they still possessed poor stability in rat plasma (<i>t</i><sub>1/2</sub> < 1 min). Chemical structure optimization gave rise to a potent NAAA inhibitor, compound <b>111</b> (URB913/ARN077, <a class="ref internalNav" href="#fig39" aria-label="Figure 39">Figure 39</a>), which manifested the optimal inhibitory efficacy against rat and human NAAA (IC<sub>50</sub> = 0.05 and 0.007 μM, respectively) and enhanced chemical stability in buffer solution (<i>t</i><sub>1/2</sub> > 110 min).<a onclick="showRef(event, 'ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref133 ref134">(133, 134)</a> Furthermore, compound <b>111</b> was shown to protect PEA and OEA from hydrolysis in mice ear skin after a topical administration (10% in acetone). It attenuated inflammation in a model of carrageenan-induced edema after a topical administration (30% in petrolatum/5% lauric acid) through the stimulation of PPAR-α, due to the blockage of anti-inflammatory effect in PPAR–/– deficient mice.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Compound <b>111</b> rapidly, noncompetitively, covalently, and reversibly combined with rat NAAA, whereas the inhibition of human NAAA was only partially reversible.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> The binding mechanism studies indicated that the thiol group of the active cysteine (Cys131 for rat NAAA, Cys126 for human NAAA) interacted with the carbonyl of β-lactone moiety of <b>111</b> to form a hydrolyzable thioester bond (<a class="ref internalNav" href="#fig41" aria-label="Figure 41">Figure 41</a>).<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Further investigation of the selectivity of <b>111</b> indicated that it was devoid of off-target effects in a panel of several targets including GPCRs, enzymes, transporters, and channels at a 10 μM concentration.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Due to the instability of compound <b>111</b> in plasma, it was administrated topically rather than systemically in mouse models of inflammation and nerve injury. The compound (10% in acetone) was effective in TPA-induced edema and CCI mouse models.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><figure id="fig41" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0042.jpeg" id="gr41" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. Putative interaction mechanism between NAAA and <b>111</b>: (a) S-acylation of enzyme; (b) S-deacylation of the enzyme–substrate adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Modification of the phenylpentyl moiety of <b>111</b> was performed. Removal of the phenyl ring or modification of the carbon chain length of the phenylpentyl group appeared to result in a notable decease of inhibition (<a class="ref internalNav" href="#fig42" aria-label="Figure 42">Figure 42</a>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> However, the extension of the alkyl chain after the removal of the phenyl ring brought about a recovery of inhibitory ability. Especially, the aliphatic chains with seven to eight carbon atoms length (<b>112</b> and <b>113</b>, IC<sub>50</sub>(rNAAA) = 0.04 and 0.03 μM, respectively, <a class="ref internalNav" href="#fig42" aria-label="Figure 42">Figure 42</a>) provided a slight increase of inhibitory potency in comparison with <b>111</b>. The replacement of the phenyl ring with the cyclohexyl group (<b>114</b>, <a class="ref internalNav" href="#fig42" aria-label="Figure 42">Figure 42</a>) led to an enhancement of inhibitory efficacy (IC<sub>50</sub>(rNAAA) = 0.013 μM). Moreover, the replacement of a carbon in the alkyl chain of <b>111</b> with an oxygen atom was tolerated.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> It was noteworthy that <b>115</b> (<a class="ref internalNav" href="#fig42" aria-label="Figure 42">Figure 42</a>) displayed optimal inhibitory potency in the single-digit nanomolar range against both rat and human NAAA (IC<sub>50</sub> = 0.007 μM), whereas its <i>m</i>-biphenylmethyl analogue was determined to only slightly inhibit rat NAAA (IC<sub>50</sub> = 23 μM).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Compound <b>115</b> showed no inhibitory activity against rat FAAH at 10 μM concentrations, whereas it was found to slightly inhibit rat acid ceramidase with 30% inhibition at the same concentration.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><figure id="fig42" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0043.jpeg" id="gr42" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. Structural modifications on the phenylpentyl group of β-lactone-based NAAA inhibitor <b>111</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further modification of the β-substituent on the β-lactone ring of NAAA inhibitors was carried out to improve their stability.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> In general, carbamate-based β-lactones exhibited enhanced inhibitory potency and improved chemical stability in comparison to urea-based β-lactone derivatives.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Bulky alkyl substituents (such as isopropyl and <i>tert</i>-butyl) at the β-position of the β-lactone ring resulted in improved chemical stability in buffer solution, although this resulted in a decrease of inhibitory efficacy against human NAAA (IC<sub>50</sub> = 0.063 and 0.302 μM, respectively, <a class="ref internalNav" href="#fig42" aria-label="Figure 42">Figure 42</a>).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Most β-lactone derivatives exerted poor plasma stability with a half-life less than 5 min. Notably, compounds <b>116</b> and <b>117</b> (IC<sub>50</sub>(hNAAA) = 0.234 and 0.507 μM, respectively) (<a class="ref internalNav" href="#fig42" aria-label="Figure 42">Figure 42</a>) possessed improved stability in plasma with a half-life greater than 5 min and exerted modest inhibitory potency against NAAA.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Although the result indicated that it was difficult to find a functional group providing both desirable stability and potent NAAA inhibitory potency for β-lactone derivatives, this investigation of stability could be considered as a favorable starting point for further development of NAAA inhibitors with suitable chemical and metabolic stability.</div><div class="NLM_p last">Most recently, the first three-dimensional quantitative structure–activity relationship (3D-QSAR) model was established based on the (2-methyl-4-oxooxetan-3-yl)carbamate-derived NAAA inhibitors to predict chemical structures that probably inhibit NAAA.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> This model was established using a training set comprising 33 compounds and the atomic property fields method. The squared correlation coefficients between the experimental pIC<sub>50</sub> and the predicted pIC<sub>50</sub> is 0.93, and the leave-one-out squared correlation coefficient <i>Q</i><sup>2</sup> is 0.69. Afterward, five predicted compounds were used to validate this model. The experimental pIC<sub>50</sub> values of these five compounds were found to be very close to the predicted values.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> This model has already been used to discover several potent NAAA inhibitors (such as <b>118</b> and <b>119</b>, <a class="ref internalNav" href="#fig39" aria-label="Figure 39">Figure 39</a>). Compound <b>118</b> blocks the catalytic activity of NAAA in the nanomolar range.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> From this 3D-QSAR model, the linear symmetrical structure of the aliphatic side chain appears to be advantageous for the inhibitory capacity against NAAA. This 3D-QSAR model is meaningful for the further design and prediction of potent NAAA inhibitors.</div></div><div id="sec7_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3. β-Lactams</h3><div class="NLM_p">Exploration of β-lactams as NAAA inhibitors was inspired by the structure of β-lactone-based inhibitors. Since the β-lactone moiety was identified to be unstable in plasma, its replacement with a more stable functionality was required and this was demonstrated to dramatically enhance the stability in plasma.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Structure–activity relationships indicated that the linear acyl chain seemed to be favorable for the inhibitory capacity of β-lactams against NAAA. For instance, the amide-based β-lactams with a 9- to 11-carbon-length acyl chain (<b>120</b>, <b>121</b>, <b>122</b>, and <b>123</b>) and the carbamate-based β-lactam with a 7-carbon-length <i>O</i>-alkyl chain (<b>124</b>) exerted potent activity against NAAA (<a class="ref internalNav" href="#fig43" aria-label="Figure 43">Figure 43</a>).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> The (<i>S</i>)-configuration rather than the (<i>R</i>)-configuration at the C3 position of the amide function is suitable for β-lactam-based NAAA inhibitors.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> For example, compound <b>120</b> exerted potent inhibitory activity against human NAAA without affecting human FAAH-mediated hydrolysis and possessed good oral bioavailability (67%) in rats.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Overall, the significantly improved stability affords β-lactams the potential for systemic application.</div><figure id="fig43" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0044.jpeg" id="gr43" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. Structures of representative β-lactam-based NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, compound <b>124</b> encouraged the development of carbamated-based β-lactams as potent NAAA inhibitors. Most recently, compound <b>125</b> (ARN726, <a class="ref internalNav" href="#fig43" aria-label="Figure 43">Figure 43</a>) was shown to markedly inhibit both rat and human NAAA (IC<sub>50</sub> = 63 and 27 nM, respectively) with approximately 9-fold enhanced activity in comparison with compound <b>124</b> (IC<sub>50</sub>(hNAAA) = 0.24 μM).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Nevertheless, the <i>R</i>-isomer of <b>125</b> showed weak affinity for NAAA (IC<sub>50</sub> = 3.1 μM). Compound <b>125</b> was determined to covalently and irreversibly interact with NAAA by mass spectrometry and dialysis studies, which indicated that the cysteine thiol group of NAAA interacted with the amide group of β-lactam moiety to generate the acyl–NAAA adduct (<a class="ref internalNav" href="#fig44" aria-label="Figure 44">Figure 44</a>).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Compound <b>125</b> was devoid of effects against rat FAAH and only marginally inactivated rat acid ceramidase. Compound <b>125</b> was further determined to have no effect on a panel of 28 biological targets including lipid-hydrolyzing enzymes and 79 common targets comprising ion channels, membrane transporters, and receptors (such as cannabinoid receptors) at a concentration of 10 μM.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Pharmacokinetic analyses revealed that <b>125</b> was rapidly eliminated in vivo (<i>C</i><sub>max</sub> = 1608 ng/kg in plasma with a <i>t</i><sub>1/2</sub> of ∼15 min and clearance of 139 mL min<sup>–1</sup> kg<sup>–1</sup>) after a 3 mg/kg intravenous dose in mice. These data were consistent with the ex vivo assay that <b>125</b> was efficiently eliminated in plasma (a <i>t</i><sub>1/2</sub> of 41 min in mice and 12 min in rats) and in liver microsomes (a <i>t</i><sub>1/2</sub> less than 5 min in both rats and mice). Nevertheless, the inhibition of NAAA-mediated hydrolysis in several organs was detected after intraperitoneal administration of <b>125</b> (3–30 mg/kg). For instance, the covalent adducts of NAAA–<b>125</b> were detected by mass spectrometry in mice lungs.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Notably, compound <b>125</b> was disclosed as the first β-lactam-derived NAAA inhibitor for systemic application. It reduced inflammation (30 mg/kg oral dose) in a model of carrageenan-induced inflammation in mice. Compound <b>125</b> possessed a short plasma <i>t</i><sub>1/2</sub> but exerted profound anti-inflammatory efficacy in vivo, which might indicate that NAAA-dependent modulation of anti-inflammation is efficient. The disclosure of <b>125</b> may encourage the exploration of β-lactam-based NAAA inhibitors with suitable properties for systemic administration.</div><figure id="fig44" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Figure 44</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0045.jpeg" id="gr44" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 44. Putative interaction mechanism between NAAA and <b>100</b>: formation of an enzyme–substrate tetrahedral adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig44"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recently, the optimization of the β-lactam moiety or the side chain of carbamate-based β-lactams was carried out.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> The investigation of structure–activity relationships disclosed that a linear and lipophilic side chain is favorable for NAAA inhibitory capacity, and (<i>S</i>)-configuration is preferred rather than its (<i>R</i>)-isomer. Specifically, compounds <b>126</b>, <b>127</b>, and <b>128</b> (<a class="ref internalNav" href="#fig43" aria-label="Figure 43">Figure 43</a>) possessed encouraging inhibitory potency toward NAAA (IC<sub>50</sub> = 12 nM, 7 nM, and 22 nM, respectively, evaluated by UPLC/MS-based assay). These three compounds were determined to be devoid of activity against FAAH and display a moderate selectivity ratio over human acid ceramidase (50 < SI < 400) at 10 μM. In addition, compound <b>128</b> manifested a superior stability (half-life of ≥25 min in rat plasma and rat/mouse liver) in comparison to <b>125</b>. Its metabolic stability is probably attributed to the phenyl ring adjacent to carbamate moiety. Its pharmacological properties will be disclosed in due course.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><div class="NLM_p">Generally speaking, β-lactams can be considered as a more suitable scaffold than β-lactones for the investigation of NAAA inhibitors, according to their relatively stable chemical structures. Although some β-lactam-derived NAAA inhibitors described herein (e.g., compounds <b>126</b>, <b>127</b>, and <b>128</b>) have been demonstrated not to affect FAAH, β-lactam derivatives have also been described as FAAH inhibitors.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Thus, the selectivity of β-lactams over NAAA or FAAH needs to be investigated. According to related data, structure–activity relationships are summarized in <a class="ref internalNav" href="#fig45" aria-label="Figure 45">Figure 45</a>. As illustrated, the R<sup>2</sup> group plays a crucial role in selectivity over NAAA or FAAH. Alkylation of the N–H function of β-lactam brings about a complete loss of NAAA inhibitory activity, whereas removal of R<sup>2</sup> group results in a sharp decrease of FAAH inhibitory activity. The different structural preference for a β-lactam-derived NAAA and FAAH inhibitor is probably due to their different binding mechanism. Indeed, the β-lactam moiety was predicted to form H-bonds with FAAH, whereas the β-lactam was identified to covalently react with NAAA.<a onclick="showRef(event, 'ref139 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref141">(139, 141)</a> Hence, the reactive secondary β-lactam function rather than tertiary β-lactam is preferred for NAAA.</div><figure id="fig45" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 45</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0046.jpeg" id="gr45" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 45. Modification of β-lactam derivative in favor of FAAH inhibitor or NAAA inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig45"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4. Other NAAA Inhibitors</h3><div class="NLM_p">In a recently published paper, compound AM9053 (structure not disclosed, IC<sub>50</sub> = 30 nM) was revealed as one of the first systemically active NAAA inhibitors that increased PEA rather than AEA levels in a model of inflammatory bowel disease (IBD) in mice.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> It showed excellent selectivity over FAAH (IC<sub>50</sub> > 100 μM) and produced PPAR-α-dependent anti-inflammatory effect, including the inhibition of proinflammatory cytokines (e.g., TNF-α, IL-1β) expression, in a model of TNBS-induced colitis after a 10 mg/kg intraperitoneal dose in mice.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div><div class="NLM_p">Compound <b>129</b> (diacerein, <a class="ref internalNav" href="#fig46" aria-label="Figure 46">Figure 46</a>) is an approved medicine for alleviating osteoarthritis (swelling and pain in the joints) through the inhibition of IL-1β.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Recently, it was shown to display time-dependent inhibition of human NAAA (IC<sub>50</sub> = 0.7–7.2 μM) in both the cell-free enzyme and intact cells.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Compound <b>129</b> showed no interaction with rat FAAH, human cannabinoid receptors (CB<sub>1</sub> and CB<sub>2</sub>), and human TRPV1 receptors at a 50 μM concentration.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> It was determined to alleviate inflammation and hyperalgesia with a long duration of action (>6 h) in a carrageenan-induced acute inflammatory pain model in rats after a 25 mg/kg oral dose.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Although <b>129</b> has been shown to inhibit NAAA in vitro, to produce anti-inflammation, and to elevate PEA levels in a carrageenan-induced acute inflammatory pain model, further investigation is needed in order to ascertain whether <b>129</b>-mediated anti-inflammation and increase of PEA levels can be specifically attributed to NAAA inhibition. In summary, the discovery of <b>129</b> as a potent NAAA inhibitor might encourage the development of new scaffold-based NAAA inhibitors with suitable duration of action for systemic administration. Compound <b>129</b> could be a useful tool for the investigation of other probable mechanisms in addition to the inhibition of IL-1β-dependent activities in vivo.</div><figure id="fig46" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Figure 46</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0047.jpeg" id="gr46" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 46. Structures of other representative NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig46"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most recently, compound <b>130</b> (F96, <a class="ref internalNav" href="#fig46" aria-label="Figure 46">Figure 46</a>) was revealed to be a potent inhibitor of NAAA and to have excellent chemical stability in buffer solution with a half-life of more than 24 h and dramatically improved metabolic stability in rat plasma with a half-life of nearly 200 min.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Compound <b>130</b> exhibited high selectivity for NAAA over FAAH and almost no activity against MAGL or acid ceramidase at a 10 μM concentration in vitro and was devoid of affinity for cannabinoid receptors and PPAR-α. The anti-inflammatory and antinociceptive effects of <b>130</b> can be reversed by a PPAR-α antagonist (1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-α,α-dimethyl-5-(1-methylethyl)-1<i>H</i>-indole-2-propanoic acid, MK886) but not by cannabinoid receptor antagonists <b>1</b> and rimonabant (<b>131</b>, <a class="ref internalNav" href="#fig47" aria-label="Figure 47">Figure 47</a>), which led to the conclusion that <b>130</b> produced anti-inflammation and analgesia through a PPAR-α-dependent activity rather than cannabinoid receptors.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> It is noteworthy that <b>130</b> elevated PEA levels via inactivation of NAAA without the alteration of AEA signaling. Compound <b>130</b> alleviated pain and inflammation (10 mg/kg intraperitoneal injection) in several animal models including 12-<i>O</i>-tetradecanoylphorbol 13-acetate (TPA) induced ear edema, sciatic nerve injury induced neuropathic pain, and acetic acid induced visceral pain in mice.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></div><figure id="fig47" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Figure 47</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0048.jpeg" id="gr47" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 47. Structure of rimonabant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig47"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>130</b> showed lower toxicity than ibuprofen (a widely used anti-inflammatory and antinociceptive drug) in zebrafish models.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Further investigation is needed to establish whether <b>130</b> is devoid of severe side effects in other in vivo animal models (e.g., mammals). In general, compound <b>130</b> possesses potent NAAA inhibitory efficacy and suitable metabolic stability in plasma. The advantageous properties of <b>130</b> might encourage the further development of NAAA inhibitors with a long duration of action in vivo. The investigation of the binding mechanism between <b>130</b> and NAAA is expected to be carried out in the future.</div></div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">MAGL Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Generally, MAGL is sensitive to some early described serine hydrolases inhibitors, such as compounds <b>2</b>–<b>4</b>,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> although these compounds usually manifest off-target potency against other serine hydrolases (such as FAAH). With respect to other serine hydrolases, MAGL has been demonstrated to additionally interact with sulfhydryl-sensitive substrates in line with its structural features, as it contains several active cysteine residues (such as Cys201, Cys208, and Cys242).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> This property was regarded as the starting point for the development of selective MAGL inhibitors over other serine hydrolases.</div><div id="sec7_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1. Maleimides</h3><div class="NLM_p">First generation MAGL inhibitors were described several decades ago. Some inhibitors, such as <i>N</i>-ethylmaleimide <b>132</b> (<a class="ref internalNav" href="#fig48" aria-label="Figure 48">Figure 48</a>a), comprise mercapto-specific functions. Moreover, a series of maleimide derivatives were identified to inhibit MAGL via a Michael addition with cysteine residue thiol groups by mass spectrometry and mutational analysis.<a onclick="showRef(event, 'ref46 ref146'); return false;" href="javascript:void(0);" class="ref ref46 ref146">(46, 146)</a> Structure–activity relationships indicated that N-substituted hydrophobic groups of maleimide derivatives have improved inhibition against MAGL in comparison with N-hydrophilic substituents.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Especially, compounds <b>133</b> (IC<sub>50</sub> = 0.14 μM) and <b>134</b> (IC<sub>50</sub> = 9.2 μM) exerted approximately 6-fold and 380-fold enhanced potency against MAGL-like enzyme in rat cerebellar membranes, respectively, compared to <b>132 (</b>IC<sub>50</sub> = 53 μM, <a class="ref internalNav" href="#fig48" aria-label="Figure 48">Figure 48</a>a).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The sulfhydryl group of cysteine residues was shown to interact covalently and irreversibly with the maleimide moiety through a Michael addition to yield a S-alkylated MAGL adduct (<a class="ref internalNav" href="#fig48" aria-label="Figure 48">Figure 48</a>b).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Moreover, the modification of the N-substituent of <b>133</b> led to the identification of <b>135</b> (<a class="ref internalNav" href="#fig48" aria-label="Figure 48">Figure 48</a>a) as a moderate and selective inhibitor with an IC<sub>50</sub> of 0.79 μM against hMAGL over hFAAH (SI > 20-fold).<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></div><figure id="fig48" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Figure 48</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0049.jpeg" id="gr48" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 48. (a) Structures of representative maleimide-based MAGL inhibitors. (b) Cysteine-dependent interactive mechanism between maleimides and MAGL, followed by formation of S-alkylated MAGL adduct through Michael addition. *IC<sub>50</sub> values were expressed as the inhibition of MAGL-like enzyme activity in rat cerebellar membranes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig48"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2. Disulfides</h3><div class="NLM_p">Compound <b>136</b> (disulfiram), an approved drug to treat alcoholism via suppression of aldehyde dehydrogenase, was reported to inhibit human MAGL at submicromolar concentrations (IC<sub>50</sub> = 0.36 μM, <a class="ref internalNav" href="#fig49" aria-label="Figure 49">Figure 49</a>).<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Additionally, two disulfide derivatives, compounds <b>137</b> (IC<sub>50</sub> = 1.6 μM) and <b>138</b> (IC<sub>50</sub> = 0.13 μM), were shown to inactivate MAGL-mediated activity in the micromolar range (<a class="ref internalNav" href="#fig49" aria-label="Figure 49">Figure 49</a>).<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> These disulfide derivatives were hypothesized to interact with the cysteine residues of MAGL to form a mixed adduct or a disulfide bond.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> The exploration of numerous analogs of <b>136</b> with different substitutions led to discovering a series of selective MAGL inhibitors. Typically, compound <b>139</b> (<a class="ref internalNav" href="#fig49" aria-label="Figure 49">Figure 49</a>) exerted optimal inhibitory capacity against hMAGL with an IC<sub>50</sub> of 0.11 μM and more than 1000-fold selectivity over hFAAH.<a onclick="showRef(event, 'ref45 ref149'); return false;" href="javascript:void(0);" class="ref ref45 ref149">(45, 149)</a> Compound <b>139</b> was presumed to interact irreversibly with MAGL, which might be accompanied by the formation of disulfide bond with cysteine.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></div><figure id="fig49" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Figure 49</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0050.jpeg" id="gr49" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 49. Structures of representative disulfide-based MAGL inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig49"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3. Isothiazolinones</h3><div class="NLM_p">Compound <b>140</b> (octhilinone, IC<sub>50</sub> = 88 nM, <a class="ref internalNav" href="#fig50" aria-label="Figure 50">Figure 50</a>a) was reported to be a potent MAGL inhibitor by King and co-workers when they investigated a series of sulfhydryl-specific candidates.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> It was shown to disable MAGL through a partially reversible mechanism, due to a recovery of enzyme activity after dilution. The introduction of a N-substituted long hydrophobic alkyl group (such as <b>141</b>, IC<sub>50</sub> = 43 nM) or replacement of isothiazolinone moiety with benzisothiazolinone (<b>142</b>, IC<sub>50</sub> = 20 nM) brought about a slight improvement of inhibitory potency (<a class="ref internalNav" href="#fig50" aria-label="Figure 50">Figure 50</a>a).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> To investigate a probable interactive mechanism, studies using a reducing agent dithiothreitol (DTT) were performed. The addition of DTT appeared to block <b>140</b>-induced inhibition of MAGL but did not affect <b>3</b>-mediated inhibition of MAGL. This finding indicated that <b>140</b>, rather than <b>3</b>, might form a reducible bond with MAGL, which was not consistent with the formation of a Michael addition product. Additionally, compound <b>142</b> exerted a comparable inhibitory activity to that of <b>140</b>, which supported that isothiazolinone-induced inhibition of MAGL was not attributed to their ability to undergo a Michael addition. Compound <b>140</b> was proposed to form a disulfide adduct with MAGL (<a class="ref internalNav" href="#fig50" aria-label="Figure 50">Figure 50</a>b). Furthermore, mutation studies showed that Cys208 rather than Cys201 or Cys242 played a crucial role in the reaction with compound <b>140</b>.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Isothiazolinone could be regarded as a favorable scaffold for the further exploration of potent MAGL inhibitors.</div><figure id="fig50" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Figure 50</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0051.jpeg" id="gr50" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 50. (a) Structures of representative isothiazolinone-based MAGL inhibitors. (b) Cysteine-dependent interactive mechanism between <b>140</b> and MAGL, followed by formation of a disulfide adduct with MAGL. Enzyme assays were performed by using recombinant purified rat MAGL overexpressed in <i>E. coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig50"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4. Ureas</h3><div class="NLM_p">Compound <b>50</b>, which was originally reported as an AEA transporter inhibitor, was also shown to exert off-target effects against several carboxylases and serine hydrolases (such as FAAH and MAGL).<a onclick="showRef(event, 'ref3 ref89'); return false;" href="javascript:void(0);" class="ref ref3 ref89">(3, 89)</a> Indeed, a 2,5-regioisomer of <b>50</b> (compound <b>143</b>, <a class="ref internalNav" href="#fig51" aria-label="Figure 51">Figure 51</a>) exhibited approximately 400 times more potent inhibition against MAGL-like enzyme in comparison to <b>50</b> (IC<sub>50</sub> = 0.02 and 8.10 μM, respectively).<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Unfortunately, compound <b>143</b> exerted poor selectivity over FAAH expressed in rat brain membranes (IC<sub>50</sub> = 0.033 μM). The investigation of its binding mechanism by mass spectrometry and mutational analysis showed that the hydroxyl group of Ser122 interacted with the urea moiety of <b>143</b> to produce a carbamylated enzyme adduct, accompanied by the release of the biphenylmethyl tetrazole moiety (<a class="ref internalNav" href="#fig52" aria-label="Figure 52">Figure 52</a>).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Moreover, Sanofi-Aventis disclosed a triazole urea <b>144</b> (SAR629, <a class="ref internalNav" href="#fig51" aria-label="Figure 51">Figure 51</a>) as a potent covalent MAGL inhibitor. Similar to compound <b>143</b>, the urea moiety of <b>144</b> was determined by X-ray to interact with Ser122 of MAGL followed by the formation of a carbamylated enzyme adduct (<a class="ref internalNav" href="#fig53" aria-label="Figure 53">Figure 53</a>), associated with the release of the triazole moiety. The <b>144</b>-induced inhibition of MAGL is proposed to be quasi-irreversible due to the possible hydrolysis of <b>144</b>–MAGL adduct by a water molecule. This hypothesis needs to be further examined.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Over the past few years, the exploration of numerous urea-based MAGL inhibitors has been performed. For example, compound <b>145</b> (ML30, IC<sub>50</sub>(hMAGL) = 0.54 nM, <a class="ref internalNav" href="#fig51" aria-label="Figure 51">Figure 51</a>) exerted a strong ability to irreversibly inhibit hMAGL in the subnanomolar range with more than a 1000-fold selectivity over FAAH.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Recently, a series of piperazine/piperidine triazole ureas were described as highly selective MAGL inhibitors.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Structure–activity relationships illustrated that the Y-type scaffold of triazole ureas favors selectivity over FAAH.</div><figure id="fig51" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Figure 51</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0052.jpeg" id="gr51" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 51. Structures of representative urea-based MAGL inhibitors and H antagonist loratadine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig51"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig52" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Figure 52</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0053.jpeg" id="gr52" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 52. Serine-dependent interactive mechanism between <b>143</b> and the enzyme, followed by formation of acyl–enzyme adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig52"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig53" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Figure 53</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0054.jpeg" id="gr53" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 53. X-ray cocrystal structure of MAGL combined with <b>144</b> (in cyan), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JWE">3JWE</a>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Hydrogen bonds and π–σ/σ–σ interactions are depicted as green and purple dashes, respectively. On the left, surfaces of ABP, catalytic triad, alcohol-binding channel, and glycerol exit channel are depicted in yellow, blue, green, and red, respectively. Results were obtained using software programs Discovery Studio Visualizer from Dassault Systèmes BIOVIA and open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig53"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The replacement of the triazole moiety with a 4-nitrophenoxy group or the removal of a nitrogen of the triazole resulted in a dramatic decrease of inhibitory potency (<a class="ref internalNav" href="#fig54" aria-label="Figure 54">Figure 54</a>).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Furthermore, compounds <b>146</b> (JJKK-046) and <b>147</b> (JJKK-048) (<a class="ref internalNav" href="#fig54" aria-label="Figure 54">Figure 54</a>) were determined to inhibit hMAGL in the subnanomolar range (IC<sub>50</sub> = 0.562 and 0.363 nM, respectively) and to exert appreciable selectivity over several serine hydrolases, as shown using ABPP assays, including FAAH (SI > 1200- and 11200-fold, respectively), ABHD6 (SI > 150- and 60- fold, respectively). In addition, these two compounds exhibited no detectable potency against ABHD12 at a 1 μM concentration.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> In addition, compound <b>147</b>, unlike <b>146</b>, was disclosed to selectively elevate 2-AG levels without affecting AEA signaling at a concentration of 1 μM in rat brain.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Indeed, the presence of a C═C bond was shown to favor the interaction with FAAH.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The presence of a further C═C bond might make <b>146</b> less selective than <b>147</b> over FAAH. The discovery of <b>147</b> could inspire the further development of highly selective MAGL inhibitors.</div><figure id="fig54" data-index="54" class="article__inlineFigure"><h2 class="fig-label">Figure 54</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0055.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0055.jpeg" id="gr54" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 54. Structural modifications of MAGL inhibitor <b>144</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0055.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig54"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">More recently, Patel’s group disclosed a novel series of urea-based MAGL inhibitors derived from loratadine (<a class="ref internalNav" href="#fig51" aria-label="Figure 51">Figure 51</a>), a histamine H<sub>1</sub> receptor antagonist.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Specially, compounds <b>148</b> and <b>149</b> (JZP-361, <a class="ref internalNav" href="#fig51" aria-label="Figure 51">Figure 51</a>) were determined to optimally and selectively inactivate human MAGL at submicromolar concentrations over human FAAH (SI > 140-fold and SI >150-fold, respectively), human ABHD6 (SI ≈ 38-fold and SI ≈ 19-fold, respectively), and human ABHD12 (no detectable inhibitory potency at a 10 μM concentration). Their inhibitory effects were determined to be slowly reversed after dilution.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> In addition, compound <b>149</b> exhibited no observable affinity for cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors at 10 μM concentration. However, both <b>148</b> and <b>149</b> maintained histamine H<sub>1</sub> receptor antagonistic activities comparable to loratadine. As a novel dual-action agent, compound <b>149</b> is desirable to be profiled in a model of inflammation.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div></div><div id="sec7_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5. Carbamates</h3><div class="NLM_p">In 2005, Hohmann and co-workers profiled a series of <i>N</i>-biphenyl carbamates and revealed <b>150</b> (URB602, <a class="ref internalNav" href="#fig55" aria-label="Figure 55">Figure 55</a>) as an inhibitor against MAGL with weak potency (IC<sub>50</sub> = 28 μM),<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> and it was further identified to inhibit FAAH as an off-target.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> The finding that <b>150</b> elevates 2-AG levels without affecting AEA levels at a 100 μM concentration in rat brain slice cultures<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> is probably due to the fact that more than 80% inhibition of FAAH is required for a detectable increase of AEA level.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Compound <b>150</b> was determined to covalently but partially reversibly bind to MAGL by dialysis experiments. The O-substituent of <b>150</b> was assumed to serve as the leaving group after hydrolysis.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><figure id="fig55" data-index="55" class="article__inlineFigure"><h2 class="fig-label">Figure 55</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0056.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0056.jpeg" id="gr55" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 55. Structures of representative carbamate-based MAGL inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0056.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig55"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The disclosure of a new series of carbamate-based MAGL inhibitors by Cravatt and co-workers was regarded as one of the most encouraging breakthroughs in this area.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> The profile of selectivity by ABPP assays led to the identification of <b>151</b> (JZL184, <a class="ref internalNav" href="#fig55" aria-label="Figure 55">Figure 55</a>) as a potent and selective MAGL inhibitor. Compound <b>151</b> was determined to inactivate MAGL-mediated activity at nanomolar levels and be devoid of off-target effect toward cannabinoid receptors and several serine enzymes (such as FAAH and ABHD6) at 1 μM concentration (IC<sub>50</sub>(mMAGL) = 8 nM, IC<sub>50</sub>(FAAH) = 4 μM).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Despite exerting the suppression of FAAH at a 10 μM concentration in vitro and 16 mg/kg in vivo, compound <b>151</b> still showed no detectable effect on the accumulation of AEA levels.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Indeed, this result is consistent with the previous demonstration that the observable elevation of AEA levels occurs in the case of more than 80% inhibition of FAAH.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> However, multidimensional protein identification technology (ABPP-MudPIT) assays implied that <b>151</b> inactivated esterase 1, esterase 1-like, and triacylglycerol hydrolase 2 as off-targets.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In addition, compound <b>151</b> was found to exert a long duration of action such that the increase of 2-AG signaling was detectable even 24 h after administration.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> The administration of <b>150</b> was shown to produce analgesic effects in several pain models, including acute thermal pain (16 mg/kg intraperitoneal injection), acetic acid induced visceral pain writhing (16 mg/kg intraperitoneal injection), and formalin induced edema pain (40 mg/kg oral dose) in mice. Compound <b>151</b> induced antinociception was reversed by a CB<sub>1</sub> antagonist (<b>131</b>). This observation indicated that <b>151</b>-induced pain relief was mediated by CB<sub>1</sub>-dependent activities.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> The administration of <b>151</b> at high doses (40 mg/kg) rather than low doses (4 mg/kg) gave rise to elevation of both AEA and 2-AG levels, which was accompanied by a decrease of body temperature and motility. These adverse effects following high-dose <b>151</b> treatment might be attributed to its off-target inhibition of FAAH, consistent with the previous finding that dual FAAH/MAGL inhibition produced cannabimimetic side effects.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159, 160)</a> Furthermore, the administration of <b>151</b> was demonstrated to produce gastroprotective and antidepressant-like effects after a 4 mg/kg intraperitoneal injection.<a onclick="showRef(event, 'ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref160 ref161">(160, 161)</a> The determination of the binding mechanism indicated that <b>151</b> covalently and irreversibly bound to MAGL through the formation of the carbamylated enzyme adduct (<a class="ref internalNav" href="#fig56" aria-label="Figure 56">Figure 56</a>). Overall, compound <b>151</b> is a selective MAGL inhibitor that exerts multiple CB<sub>1</sub>-dependent protective and antinociceptive effects through the elevation of 2-AG levels in the nervous system. Compound <b>151</b> could be regarded as a useful tool for the further investigation of the functional roles of MAGL. Nevertheless, the selectivity of <b>151</b> is still improvable. The further repeated administration of high-dose <b>151</b> resulted in the alteration of both 2-AG and AEA levels.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div><figure id="fig56" data-index="56" class="article__inlineFigure"><h2 class="fig-label">Figure 56</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0057.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0057.jpeg" id="gr56" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 56. Serine-dependent interactive mechanism between MAGL inhibitor <b>151</b> and enzyme: formation of acyl–enzyme adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0057.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig56"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Cravatt’s team reported a novel series of <i>O</i>-hexafluoropropyloxy carbamates as MAGL inhibitors.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> In comparison with <b>151</b>, compounds <b>152</b> (KML29), <b>153</b> (JW618), and <b>154</b> (JW642) exerted superior selectivity over mFAAH in ABPP assays (<a class="ref internalNav" href="#fig55" aria-label="Figure 55">Figure 55</a>). Specifically, compound <b>154</b> only slightly inhibited mFAAH at a 10 μM concentration, whereas compound <b>151</b> almost completely inhibited mFAAH at the same concentration.<a onclick="showRef(event, 'ref159 ref163'); return false;" href="javascript:void(0);" class="ref ref159 ref163">(159, 163)</a> Nevertheless, compound <b>154</b>, unlike compounds <b>152</b> and <b>153</b>, markedly inhibited mFAAH at a high concentration of 50 μM. Compound <b>152</b> inhibited ABHD6 at a 10 μM concentration, whereas compounds <b>153</b> and <b>154</b> resulted in a significant inhibition of ABHD6 at a 100 nM concentration. Thus, compounds <b>153</b> and <b>154</b> appear to be dual FAAH/ABHD6 inhibitors.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> It was noteworthy that <b>152</b> did not affect any serine hydrolases at a high dose of 40 mg/kg in mouse brain in ABPP studies. Moreover, compound <b>152</b> was determined to exhibit no off-target effects against any carboxylesterases even at 40 mg/kg concentrations in mouse liver in ABPP studies. On the contrary, compound <b>151</b> was observed to inhibit several carboxylesterases including esterase 1 and esterase 1-like.<a onclick="showRef(event, 'ref48 ref163'); return false;" href="javascript:void(0);" class="ref ref48 ref163">(48, 163)</a> Compound <b>152</b> only slightly inhibited carboxylesterase 1 as an off-target in mouse lung. Furthermore, compound <b>152</b> was determined to give maximal inhibition of MAGL in the brain by 1 h postdose, and such inhibitory action was still detectable 24 h postadministration.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Like most of carbamate-based MAGL inhibitors, compound <b>152</b> was shown to covalently and irreversibly interact with MAGL along with the formation of the carbamylated enzyme adduct and the release of a hexafluoropropyloxy group. Compound <b>152</b> exerted antinociceptive effects in a wide range of pain models (such as carrageenan-induced inflammatory pain and CCI neuropathic pain) after a 20–40 mg/kg intraperitoneal injection without resulting in cannabimimetic side effects including hypomotility, hypothermia, and catalepsy.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Its administration was accompanied by a dramatic elevation of 2-AG levels and was devoid of alteration of AEA, PEA, OEA levels in mouse brain. In addition, it was shown to alleviate NSAID (e.g., diclofenac sodium) induced gastric injury (hemorrhages) after a 40 kg/mg intraperitoneal injection. The <b>152</b>-induced gastroprotective effects were later identified to be CB<sub>1</sub>- rather than CB<sub>2</sub>-dependent, since this protective action was blocked by a CB<sub>1</sub> antagonist <b>131</b> but not by the CB<sub>2</sub> antagonist <b>1</b> (3 kg/mg intraperitoneal injection).<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> More recently, <b>152</b>-induced accumulation of 2-AG was revealed to be tissue-dependent. Indeed, the most pronounced elevation of 2-AG levels was observed in the brain and spinal cord.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> This observation indicated that <b>152</b>-mediated activity was more CNS-dependent. Compound <b>152</b> could be regarded as a promising agent for the therapy of CNS-related disorders.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></div><div class="NLM_p">In 2013, the screening of O-substituents of benzhydrylpiperazine carbamates by Cravatt and co-workers led to the identification of <b>155</b> (JW651) and <b>156</b> (MJN110) as potent selective MAGL inhibitors as shown using in vitro/in vivo competitive and click chemistry ABPP (<a class="ref internalNav" href="#fig55" aria-label="Figure 55">Figure 55</a>).<a onclick="showRef(event, 'ref166 ref167'); return false;" href="javascript:void(0);" class="ref ref166 ref167">(166, 167)</a> Compound <b>155</b> was determined to markedly inhibit MAGL at a 0.1 μM concentration in vitro and almost completely inactivate MAGL at low doses (5 mg/kg) in mouse brain. Apart from the inhibition of ABHD6 at 10 μM concentrations in vitro and 40 mg/kg doses in vivo, no off-target effect was detected even at high concentrations of 100 μM and a high dose of 40 mg/kg.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Replacement of the hexafluoropropyloxy group of <b>155</b> by a succinimidyl functionality produced another potent and selective MAGL inhibitor <b>156</b>.<a onclick="showRef(event, 'ref166 ref167'); return false;" href="javascript:void(0);" class="ref ref166 ref167">(166, 167)</a> The latter was assessed to almost completely inhibit MAGL at 1 μM concentrations. By either oral or intraperitoneal administration in mice, compound <b>156</b> manifested an impressive inhibitory capacity against MAGL at a low dose of 1 mg/kg in ABPP studies. The inhibition of MAGL induced by <b>156</b> was observed up to 24 h postdose. In addition, compound <b>156</b> showed no detectable off-target effects at a 10 μM concentration except ABHD6.<a onclick="showRef(event, 'ref166 ref167'); return false;" href="javascript:void(0);" class="ref ref166 ref167">(166, 167)</a> Moreover, it was identified to relieve chronic pain in a model of diabetes induced by a combination of high fat diet and streptozotocin in rats (5 mg/kg intraperitoneal injection).<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Recently, compound <b>156</b> was found to produce antiallodynia and antihyperalgesia through the increase of 2-AG levels along with the activation of cannabinoid receptors and μ opioid receptors in a CCI model of neuropathic pain (0.43 mg/kg intraperitoneal injection) and to be devoid of opioid/cannabinoid-dependent side effects (such as constipation).<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Compounds <b>155</b> and <b>156</b> can be further investigated for their clinical applications. The disclosure of these two potent, selective, and irreversible MAGL inhibitors could inspire the development of novel selective and irreversible MAGL inhibitors.</div><div class="NLM_p">Most recently, a novel potent and selective MAGL inhibitor, compound <b>157</b> (SAR127303, <a class="ref internalNav" href="#fig55" aria-label="Figure 55">Figure 55</a>), was revealed to inactivate MAGL at nanomolar levels (IC<sub>50</sub>(mMAGL) = 3.8 nM), to markedly elevate 2-AG levels in mice, and to produce analgesic effects in several models of inflammation and pain.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Notably, compound <b>157</b> displayed high selectivity over most human serine enzymes except ABHD6 and was devoid of effects on 170 kinases, ion channels, transporters, and cannabinoid receptors, including CB<sub>1</sub> and CB<sub>2</sub>. The administration of <b>157</b> resulted in a significant increase of 2-AG levels without affecting AEA, OEA, and PEA levels at a dose of 8 mg/kg. In addition, <b>157</b>-induced activity was detectable until 24 h postdose.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Compound <b>157</b> elicited antinociceptive activities in several models of pain and inflammation (such as phenylbenzoquinone (PBQ) induced writhing, 3 mg/kg oral dose). Moreover, compound <b>157</b> was identified to attenuate epilepsy symptoms. Interestingly, <b>157</b>-induced analgesic effects can be reversed by a CB<sub>1</sub> (<b>131</b>) but not by a CB<sub>2</sub> (<b>1</b>) antagonist, which indicated that <b>157</b> mainly produced analgesia through a CB<sub>1</sub>-dependent mechanism.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Although the administration of <b>157</b> was demonstrated to be devoid of inducing hypothermia, catalepsy, and hypomotility, it resulted in an alteration of learning and memory performance. This adverse property might limit the application of <b>157</b> in a clinical setting.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> The investigation of its binding mechanism indicated that the Ser132 of MAGL could interact with the carbamate moiety of <b>157</b> accompanied by the release of hexafluoropropyloxy group. The carbonyl oxygen of the carbamate moiety was suggested to serve as an H-bond acceptor and bind to Ala61/Met133. The piperidine moiety made contact with one side of Leu251 through van der Waals interactions. One oxygen atom of the sulfonyl moiety was found to interact with the main chain of Asn162 through the formation of H-bond as well as additionally make contact with the side chain of Asn162 and the main chain of Leu251 through water-mediated interactions (<a class="ref internalNav" href="#fig57" aria-label="Figure 57">Figure 57</a>).<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Like most <i>O</i>-hexafluoropropyloxy carbamates, the hexafluoropropyloxy moiety of <b>157</b> served as the leaving group during catalysis.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Furthermore, [<sup>11</sup>C]<b>157</b> has been synthesized as a radiotracer for investigating the density and distribution of MAGL, which could be used for the diagnosis of CNS-dependent disorders (such as nerve injury).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></div><figure id="fig57" data-index="57" class="article__inlineFigure"><h2 class="fig-label">Figure 57</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0058.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0058.jpeg" id="gr57" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 57. X-ray cocrystal structure of MAGL combined with <b>157</b> (in pink), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UUQ">4UUQ</a>.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Hydrogen bonds, alkyl-dependent van der Waals interactions, and water-mediated interactions are depicted as green, purple, and blue dashes, respectively. On the left, surfaces of ABP, catalytic triad, alcohol-binding channel, and glycerol exit channel are depicted in yellow, blue, green, and red, respectively. Results were obtained using software programs Discovery Studio Visualizer from Dassault Systèmes BIOVIA and open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0058.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig57"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 6. Other MAGL Inhibitors</h3><div class="NLM_p">Tetrahydrolipstatin (THL, <a class="ref internalNav" href="#fig58" aria-label="Figure 58">Figure 58</a>), also termed orlistat, is an approved drug to treat obesity through the inhibition of lipases.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> In 2003, THL was shown to additionally target DAGLα/β.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Furthermore, Di Marzo’s group developed a series of THL derivatives as modulators of 2-AG levels.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Notably, the screening of these synthesized THL analogues led to the identification of <b>158</b> (OMDM169, IC<sub>50</sub> = 2.8 μM, <a class="ref internalNav" href="#fig58" aria-label="Figure 58">Figure 58</a>) as a selective MAGL inhibitor over DAGLα (approximately 7-fold) and FAAH (>7-fold). Compound <b>158</b> also exerted poor affinity for CB<sub>1</sub> and CB<sub>2</sub> receptors.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Interestingly, compound <b>158</b> exhibited varied inhibitory potency against MAGL according to the different enzyme sources and species.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> In fact, compound <b>158</b> produced superior potency in rat brain and rat cerebellum rather than in the corresponding mouse tissues.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Compound <b>158</b> was detected to produce antinociception and elevate 2-AG levels without affecting AEA concentrations in mice pretreated with formalin. However, the elevation of 2-AG levels was only observed in the ipsilateral paw that was influenced by the administration of formalin but not in the contralateral paw.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> This result is consistent with the fact that 2-AG is produced “on demand”. Like most β-lactone-based enzyme inhibitors, the β-lactone moiety of <b>158</b> was suggested to covalently and reversibly interact with the Ser122 of MAGL to form an acyl–enzyme adduct (<a class="ref internalNav" href="#fig59" aria-label="Figure 59">Figure 59</a>).<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div><figure id="fig58" data-index="58" class="article__inlineFigure"><h2 class="fig-label">Figure 58</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0059.jpeg" id="gr58" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 58. Structures of other representative MAGL inhibitors and orlistat.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig58"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig59" data-index="59" class="article__inlineFigure"><h2 class="fig-label">Figure 59</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0060.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0060.jpeg" id="gr59" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 59. Serine-dependent interactive mechanism between MAGL inhibitor <b>158</b> and enzyme: formation of acyl–enzyme intermediate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0060.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig59"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2008, Poupaert and co-workers disclosed a series of arylthioamides derivatives as MAGL inhibitors. Although most of these derivatives only inhibited MAGL at millimole levels, log <i>P</i> values made arylthioamide a favorable scaffold for the further exploration of MAGL inhibitors.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Moreover, the modification of the amide moiety and the introduction of the sulfur atom appended to the thioamide group were performed based on an arylthioamide scaffold.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Especially, compounds <b>159</b> (CK16) and <b>160</b> (CK37) exerted weak activity against MAGL at submicromolar concentrations (IC<sub>50</sub> = 0.355 and 0.155 μM, respectively, <a class="ref internalNav" href="#fig58" aria-label="Figure 58">Figure 58</a>). Additionally, compound <b>159</b> possessed superior selectivity over FAAH (>2810-fold) in comparison with <b>160</b> (SI = 11).<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> This result is consistent with the hypothesis that the Y-type scaffold favors selectivity of MAGL inhibitors over other serine hydrolases. Interestingly, although compounds <b>159</b> and <b>160</b> manifested similar potencies against MAGL in vitro, compound <b>159</b> only slightly elevated 2-AG levels while the administration of <b>160</b> resulted in a dramatic increase of 2-AG levels in vivo. The different effects on the alteration of 2-AG levels could be attributed to the differences in stability of <b>159</b> and <b>160</b>.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Dilution studies indicated that <b>160</b> might covalently and irreversibly inactivate MAGL.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a></div><div class="NLM_p">In 2009, two natural terpenoids <b>161</b> (pristimerin) and <b>162</b> (euphol) (<a class="ref internalNav" href="#fig58" aria-label="Figure 58">Figure 58</a>) were reported to inhibit MAGL at submicromolar concentrations (IC<sub>50</sub> = 0.093 and 0.315 μM, respectively).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Specifically, compound <b>161</b> rather than <b>162</b> was shown to elevate 2-AG levels without alteration of AEA concentrations. Moreover, the administration of <b>161</b> led to an obvious increase of 2-AG levels in brain neurons. Compounds <b>161</b> and <b>162</b> were hypothesized to reversibly interact with Cys208 and Cys201 of MAGL, respectively. The discovery of <b>161</b> and <b>162</b> might inspire the exploration of novel reversible agents against MAGL.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p last">As previously described, numerous 1,3,4-oxadiazol-2-one derivatives were disclosed as dual MAGL/FAAH inhibitors. Among these derivatives, compound <b>163</b> (<a class="ref internalNav" href="#fig58" aria-label="Figure 58">Figure 58</a>) exerted optimal potency against human recombinant MAGL (IC<sub>50</sub> = 0.085 μM); however it also inactivated FAAH with IC<sub>50</sub> of 0.23 μM.<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114, 115)</a> Moreover, another 1,3,4-oxadiazol-2-one derivative <b>164</b> (CAY10499, <a class="ref internalNav" href="#fig58" aria-label="Figure 58">Figure 58</a>) was shown to irreversibly and time-dependently inhibit human recombinant MAGL in the nanomolar range (IC<sub>50</sub> = 0.092 μM).<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> Nevertheless, compound <b>164</b> was determined to lack selectivity over FAAH (IC<sub>50</sub> = 0.076 μM). Although <b>164</b> comprises two possible reactive groups, i.e., carbamate and 1,3,4-oxadiazol-2-one, the latter functional group is assumed to be responsible for the principal interaction with MAGL.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Following the observation that EC- and FAE-mediated biological responses produce analgesia, anti-inflammation, neuroprotection, gastroprotection, and other protective effects, the elevation of endogenous ligand levels through the inhibition of corresponding hydrolases (FAAH, NAAA, and MAGL) has been regarded as a potential therapeutic approach for pain, inflammation, depression, anxiety, and gastroprotection. Over recent decades, the development of selective FAAH, NAAA, and MAGL inhibitors has made many significant strides. Numerous molecules have been shown to inhibit relevant endogenous hydrolases at single-digit-nanomolar or subnanomolar concentrations and exert attractive analgesic, anti-inflammatory, or tissue-protective efficacy in animal models. Although MAGL inhibitors (such as <b>151</b>, a moderately selective inhibitor) rather than FAAH inhibitors were previously reported to induce CB<sub>1</sub>-dependent side effects (hypomotility and hypothermia),<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> a highly selective MAGL inhibitor <b>152</b> was recently identified to be devoid of these adverse effects. The <b>151</b>-induced side effects following high-dose treatment might be attributed to its off-target activity against FAAH, consistent with the previous finding that dual FAAH/MAGL inhibition resulted in cannabimimetic side effects. In this case, highly selective MAGL inhibitors are required for further investigation.</div><div class="NLM_p">Several FAAH inhibitors have been evaluated in clinical trials: compound <b>58</b> developed by Johnson & Johnson (phase II, treatment for depressive and anxiety disorders), compound <b>65</b> synthesized by Pfizer (phase II, treatment for pain, post-traumatic stress disorders, and Tourette syndrome, failed to relieve osteoarthritic knee induced pain in clinical trials), SSR-411298 (structure not disclosed) developed by Sanofi-Aventis (phase II, treatment for cancer pain and depressive disorders), compound <b>77</b> synthesized by Merck (phase I, treatment for pain), and V158866 (structure not disclosed) developed by Vernalis (phase II, failed to treat neuropathic pain) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> The lack of analgesia in clinical trials brings a new challenge in the development of FAAH inhibitors as antinociceptive agents. Producing analgesia in rodents but failing to treat pain in clinical trials may be attributed to the following reasons: (1) the discrepancies between animal pain models and human pain disorders. For instance, pain in an animal model is usually induced by external stimuli (e.g., proinflammatory compound injection, tissue damage), whereas human pain in clinical settings is due to complex factors and associated with other disorders (e.g., osteoarthritis, colitis, cancer). (2) Emotionality significantly influences pain observation in humans rather than in rodents. Anxiety and depression status should be considered in the treatment of patients with pain. (3) Biological responses might differ in various species. Is the activation of CB receptors induced by AEA elevation after FAAH inhibition equivalent to that induced by exogenous CB receptors agonists in humans? Does AEA elevation after FAAH inhibition induce CB-independent effects in humans rather than in rodents? Relevant research needs to be carried out in order to answer these issues. Additionally, detailed clinical data are often not reported, which also makes reasons for failure unclear. Preclinical pain models that are predictive of human pain should be reconsidered if these clinical trial failures are really attributed to species differences. In adition to pain, FAAH inhibitors have shown therapeutic potential in inflammation, anxiety, and depression in numerous preclinical assays. Of note, clinical trials of FAAH inhibitors in other disorders (e.g., depression, anxiety, post-traumatic stress disorders, and Tourette syndrome) are in progress. Hence, FAAH inhibition can be considered as an interesting target for neuroprotection and/or anti-inflammation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative FAAH Inhibitors Profiled in Clinical Trials</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">clinical candidate</th><th class="colsep0 rowsep0" align="center">company</th><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">clinical trial</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">Johnson & Johnson</td><td class="colsep0 rowsep0" align="left">Depressive and anxiety disorders</td><td class="colsep0 rowsep0" align="left">Phase II</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">Pfizer</td><td class="colsep0 rowsep0" align="left">Pain, post-traumatic stress disorders, and Tourette syndrome</td><td class="colsep0 rowsep0" align="left">Inactive for pain induced by osteoarthritic knee, no development reported for post-traumatic stress disorders, treatment for Tourette syndrome in phase II</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left">Pain</td><td class="colsep0 rowsep0" align="left">Phase I</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">V158866</td><td class="colsep0 rowsep0" align="left">Vernalis</td><td class="colsep0 rowsep0" align="left">Neuropathic pain induced by spinal cord injury</td><td class="colsep0 rowsep0" align="left">Phase II, inactive for neuropathic pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SSR-411298</td><td class="colsep0 rowsep0" align="left">Sanofi</td><td class="colsep0 rowsep0" align="left">Cancer pain and depressive disorders</td><td class="colsep0 rowsep0" align="left">Treatment for cancer pain, phase II, no development reported for depressive disorders</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>165</b></td><td class="colsep0 rowsep0" align="left">Bial-Portela</td><td class="colsep0 rowsep0" align="left">Treatment of pain and anxiety</td><td class="colsep0 rowsep0" align="left">Repeat administration of high doses inducing severe side effects (one participant dead) in phase I</td></tr></tbody></table></div></div><div class="NLM_p">Recently, a drug clinical trial tragedy at Bial-Portela Company occurred when oral administration of an irreversible FAAH inhibitor <b>165</b> (BIA 10-2474, <a class="ref internalNav" href="#fig60" aria-label="Figure 60">Figure 60</a>) induced severe side effects (i.e., one man died, five other participants had different degrees of brain injuries), which raises suspicions of FAAH inhibitor safety. In late April, a report of the French National Agency for Medicines and Health Products Safety (ANSM)<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> indicated that this tragedy might be attributed to <b>165</b>-induced off-target effects in the brain. Other pharmaceutical companies, including Johnson & Johnson, Pfizer, Sanofi-Aventis, Vernalis, and Merck, have developed several FAAH inhibitors that were administered to a large number of patients without observing such severe side effects. After this tragedy, Vernalis disclosed the detailed report of a reversible FAAH inhibitor V158866 (IC<sub>50</sub> ≈ 60 nM) in clinical trials.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> V158866 was rapidly absorbed with a <i>t</i><sub>1/2</sub> of 9.6–18.3 h after a 5–500 mg oral dose. There were no severe or serious adverse effects observed after a 5–300 mg daily dose and a 50–500 mg repeated dose. Mild adverse effects (i.e., headache, dizziness, somnolence, and fatigue) were mainly observed at the highest doses (500 mg daily).<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Overall, V158866 was tolerated and did not trigger severe adverse effects even after a high dose (500 mg daily). Accordingly, FAAH can be still regarded as a safe target for therapeutic intervention.</div><figure id="fig60" data-index="60" class="article__inlineFigure"><h2 class="fig-label">Figure 60</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0061.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0061.jpeg" id="gr60" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 60. Structure of <b>165</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0061.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig60"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The selectivity and potential off-targets of enzyme inhibitors used for clinical trials should be investigated and addressed carefully. In this case, PET ligands could be considered as useful tools for distribution and potential off-target studies in humans. To the best of our knowledge, an irreversible inhibitor seems to increase potential safety concerns due to its long duration of action.<a onclick="showRef(event, 'ref49 ref111'); return false;" href="javascript:void(0);" class="ref ref49 ref111">(49, 111)</a> Therefore, development of reversible rather than irreversible inhibitors appears to be more favorable for clinical application. Nevertheless, their ability to tightly interact with enzyme makes irreversible inhibitors useful tools for the investigation of enzyme function.</div><div class="NLM_p">Although there is no MAGL or NAAA inhibitor in clinical trials reported to date, several inhibitors of NAAA (such as AM9053 and <b>130</b>) or MAGL (such as <b>152</b>, <b>155</b>, and <b>156</b>) were disclosed to manifest attractive druglike properties (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These compounds could be further investigated for their potential preclinical or clinical applications in pain remission, anti-inflammation, and neuroprotection. Additionally, the metabolic stability of β-lactam-based NAAA inhibitors and the selectivity of carbamate-based MAGL inhibitors are still improvable for the development of potential systemic application.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Main Pharmacological Activities of Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">model</th><th class="colsep0 rowsep0" align="center">compounds tested</th><th class="colsep0 rowsep0" align="center">treatment</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Acetic acid induced writhing</td><td class="colsep0 rowsep0" align="left"><b>73</b> (FAAH inhibitor)</td><td class="colsep0 rowsep0" align="left">Peripheral pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>130</b> (NAAA inhibitor)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>151</b> (MAGL inhibitor)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Carrageenan-induced edema</td><td class="colsep0 rowsep0" align="left"><b>103</b>, <b>110</b>, <b>111</b>, <b>125</b>, <b>129</b> (NAAA inhibitors)</td><td class="colsep0 rowsep0" align="left">Peripheral inflammation and related pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>152</b> (MAGL inhibitor)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CFA-induced arthritis</td><td class="colsep0 rowsep0" align="left"><b>30</b>, <b>61</b>, <b>62</b>, <b>65</b>, <b>69</b>, <b>74</b>, <b>77</b> (FAAH inhibitors)</td><td class="colsep0 rowsep0" align="left">Peripheral inflammation and related pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DSS-induced colitis</td><td class="colsep0 rowsep0" align="left"><b>82</b> (FAAH inhibitor)</td><td class="colsep0 rowsep0" align="left">Intestinal inflammation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCI</td><td class="colsep0 rowsep0" align="left"><b>27</b>, <b>33</b> (FAAH inhibitors)</td><td class="colsep0 rowsep0" align="left">Neuropathic pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>111</b> (NAAA inhibitor)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>152</b>, <b>156</b> (MAGL inhibitors)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PBQ-induced writhing</td><td class="colsep0 rowsep0" align="left"><b>157</b> (MAGL inhibitor)</td><td class="colsep0 rowsep0" align="left">Peripheral pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Sciatic nerve injury</td><td class="colsep0 rowsep0" align="left"><b>130</b> (NAAA inhibitor)</td><td class="colsep0 rowsep0" align="left">Neuropathic pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SNI</td><td class="colsep0 rowsep0" align="left"><b>74</b> (FAAH inhibitor)</td><td class="colsep0 rowsep0" align="left">Neuropathic pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SNL</td><td class="colsep0 rowsep0" align="left"><b>56</b>, <b>58</b>, <b>77</b>, <b>97</b> (FAAH inhibitors)</td><td class="colsep0 rowsep0" align="left">Neuropathic pain</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TBI</td><td class="colsep0 rowsep0" align="left"><b>62</b> (FAAH inhibitor)</td><td class="colsep0 rowsep0" align="left">Central nervous system injury</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNBS-induced colitis</td><td class="colsep0 rowsep0" align="left"><b>80</b> (FAAH inhibitor), AM9053 (NAAA inhibitor)</td><td class="colsep0 rowsep0" align="left">Intestinal inflammation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPA-induced edema</td><td class="colsep0 rowsep0" align="left"><b>111</b>, <b>130</b> (NAAA inhibitor)</td><td class="colsep0 rowsep0" align="left">Peripheral inflammation and related pain</td></tr></tbody></table></div></div><div class="NLM_p">As another target in the endocannabinoid system, MAGL inhibitor studies might also be helpful for finding the explanation of clinical treatment failure with FAAH inhibitors and investigating potential roles of ECs in different disorders (such as inflammation, pain, anxiety, and depression). Do AEA and 2-AG contribute equally to anti-inflammation, analgesia, antianxiety, or antidepression? If not, how is the equilibrium between AEA and 2-AG regulated? More studies are required to answer these questions, since some controversy remains.</div><div class="NLM_p last">Unlike FAAH or MAGL, NAAA-inhibitor-induced PEA elevation appears to activate PPAR-α rather than cannabinoid receptors, which confers advantageous properties, such as lack of cannabinoid-dependent adverse effects (e.g., hypomotility and hypothermia). Additionally, PPAR-α activation after NAAA inhibition is followed by negative modulation of NF-κB thereby suppressing proinflammatory cytokines and COX-2 expression, which makes NAAA an ideal target for anti-inflammation and inflammatory pain relief due to the use of COX-2 and proinflammatory cytokine (e.g., IL-1β, TNF-α) inhibitors as approved anti-inflammatory medicines over several years.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00538" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Chavatte</span> - <span class="hlFld-Affiliation affiliation">Université de Lille, Inserm, CHU Lille, U995,
LIRIC, Lille Inflammation Research International Center, F-59000 Lille, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#04746c6d686d7474612a676c65726570706144716a6d7229686d686861362a6276"><span class="__cf_email__" data-cfemail="16667e7f7a7f66667338757e7760776262735663787f603b7a7f7a7a7324387064">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Tuo</span> - <span class="hlFld-Affiliation affiliation">Université de Lille, Inserm, CHU Lille, U995,
LIRIC, Lille Inflammation Research International Center, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natascha Leleu-Chavain</span> - <span class="hlFld-Affiliation affiliation">Université de Lille, Inserm, CHU Lille, U995,
LIRIC, Lille Inflammation Research International Center, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Spencer</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Supojjanee Sansook</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, School of Life Sciences, University of Sussex, Brighton BN1 9QJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Régis Millet</span> - <span class="hlFld-Affiliation affiliation">Université de Lille, Inserm, CHU Lille, U995,
LIRIC, Lille Inflammation Research International Center, F-59000 Lille, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="61" class="article__inlineFigure"><h2 class="fig-label">Wei Tuo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=BIO-d7e5971-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Wei Tuo</b> received his Master’s degree in Medicinal Chemistry on the design, synthesis, and biological evaluation of potential anticancer agents in 2013 at Wuhan University, China, followed by a Ph.D. in Medicinal Chemistry at the University of Lille 2, France, under the supervision of Profs. Philippe Chavatte and Régis Millet. His research is focused on the development of new FAAH inhibitors and CB<sub>2</sub> agonists against inflammatory bowel diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="62" class="article__inlineFigure"><h2 class="fig-label">Natascha Leleu-Chavain</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=BIO-d7e5979-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Natascha Leleu-Chavain</b> received her Ph.D. degree in Medicinal Chemistry at the University of Lille 1 in 2008. She published her Ph.D. thesis in the “Editions Universitaires Européennes” and received a Ph.D. award “International Research” from the European Doctoral College of Lille in 2009. After two postdoctoral positions at the Rega Institute for Medical Research (KU Leuven, Pr. Herdewijn) and at the ICPAL (Lille, Pr. Millet), she was appointed Assistant Professor of Medicinal Chemistry at the University of Lille 2 and undertakes her research in the Lille Inflammation Research International Center (U995, Inserm). Her research involves mainly the design and synthesis of anti-inflammatory molecules. She received in 2011 a research award and two poster awards at national and international symposiums.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="63" class="article__inlineFigure"><h2 class="fig-label">John Spencer</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=BIO-d7e5984-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>John Spencer</b> is a graduate of Sussex, receiving a Ph.D. (Michel Pfeffer, ULP, Strasbourg) with a postdoctoral stay at ETH (Antonio Togni). He spent 10 years in the pharmaceutical sector as a medicinal chemist, in small pharmaceutical organizations including the James Black Foundation. Afterward, he embarked on an academic career and was recruited as a Reader in Organic Chemistry, first at the University of Greenwich and, in 2012, at the University of Sussex, where he is now Professor of Bioorganic Chemistry. J.S. has authored over 120 publications, is inventor on 10 patents, and is editorial board member for <i>Future Medicinal Chemistry</i> and <i>Scientific Reports</i>. His research interests are on the synthesis of chemical probes in medicinal chemistry, mainly cancer. Such efforts employ parallel synthesis, microwave assisted organic synthesis (MAOS), and palladium catalysis.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="64" class="article__inlineFigure"><h2 class="fig-label">Supojjanee Sansook</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=BIO-d7e5995-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Supojjanee Sansook</b> graduated with her B.Sc. and M.Sc. degrees in Chemistry from the Prince of Songkla University and afterward became a lecturer in the Faculty of Science and Technology at the Princess of Naradhiwas University, Thailand. She received a Scholarship from The Royal Thai Government to carry out a Ph.D. with Prof. John Spencer at the University of Sussex and has been working on ferrocene-based bioinorganic probes.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="65" class="article__inlineFigure"><h2 class="fig-label">Régis Millet</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=BIO-d7e6000-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Régis Millet</b> is Professor of Medicinal Chemistry at the Albert Lespagnol Medicinal Chemistry Institute (ICPAL, University of Lille 2). His research has included contributions to the medicinal chemistry of NK1/NK2 neurokinin antagonists, inhibitors of farnesyltranferase, inhibitors of thioredoxine reductase, agonists CB<sub>2</sub>, and FAAH inhibitors. He is the author of 55 publications in international journals, 102 communications, and 3 patents. He is the recipient of several awards and distinctions. He received in 2008 the prize of Pharmaceutical Sciences assigned by the “Society of Science, Agriculture and Arts de Lille”, in 2002 the Encouragement Award for Research by the French Society of Medicinal Chemistry, and in 1999 the “Prize Servier” at 13th Days of Franco-Belgian in Medicinal Chemistry at Liege.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="66" class="article__inlineFigure"><h2 class="fig-label">Philippe Chavatte</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=BIO-d7e6011-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Philippe Chavatte</b> received his Doctorate of Pharmacy in 1983 and his Ph.D. in Microbiology in 1988 from the University of Lille 2, France. He received his Ph.D. in Life and Health Sciences in 1997 from the University of Lille 1, France. He joined the Faculty of Pharmacy at University of Lille 2 as Assistant Professor and currently is Professor of Medicinal Chemistry at the same institution. He is also Director of the Albert Lespagnol Pharmaceutical Chemistry Institute in Lille. His research interests lie in the application of molecular modeling to discover and develop new drugs against inflammatory bowel disease (IBD).</p></figure></div><div class="ack" id="ACK-d7e6016-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the China Scholarship Council (W.T.) and the Royal Thai Government (S.S.) for funding. We also thank the reviewers for insightful comments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used</h2><tr><td class="NLM_term">2-AG</td><td class="NLM_def"><p class="first last">2-arachidonoylglycerol</p></td></tr><tr><td class="NLM_term">3D-QSAR</td><td class="NLM_def"><p class="first last">three-dimensional quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">arachidonic acid</p></td></tr><tr><td class="NLM_term">ABHD12</td><td class="NLM_def"><p class="first last">α/β-hydrolase 12</p></td></tr><tr><td class="NLM_term">ABHD4</td><td class="NLM_def"><p class="first last">α/β-hydrolase 4</p></td></tr><tr><td class="NLM_term">ABHD6</td><td class="NLM_def"><p class="first last">α/β-hydrolase 6</p></td></tr><tr><td class="NLM_term">ABP</td><td class="NLM_def"><p class="first last">acyl binding pocket</p></td></tr><tr><td class="NLM_term">ABPP</td><td class="NLM_def"><p class="first last">activity-based protein profiling</p></td></tr><tr><td class="NLM_term">AEA</td><td class="NLM_def"><p class="first last">anandamide</p></td></tr><tr><td class="NLM_term">CCI</td><td class="NLM_def"><p class="first last">chronic constriction injury</p></td></tr><tr><td class="NLM_term">COX-2</td><td class="NLM_def"><p class="first last">cyclooxygenase 2</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete Freund’s adjuvant</p></td></tr><tr><td class="NLM_term">CP</td><td class="NLM_def"><p class="first last">cytosolic port</p></td></tr><tr><td class="NLM_term">DAG</td><td class="NLM_def"><p class="first last">1,2-diacylglycerol</p></td></tr><tr><td class="NLM_term">DAGL</td><td class="NLM_def"><p class="first last">diacylglycerol lipase</p></td></tr><tr><td class="NLM_term">DSS</td><td class="NLM_def"><p class="first last">dextran sulfate sodium</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">EC</td><td class="NLM_def"><p class="first last">endocannabinoid</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">FAAH-2</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase 2</p></td></tr><tr><td class="NLM_term">FAE</td><td class="NLM_def"><p class="first last">fatty acid ethanolamide</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">lyso-PLC</td><td class="NLM_def"><p class="first last">lyso-phospholipase C</p></td></tr><tr><td class="NLM_term">lyso-PLD</td><td class="NLM_def"><p class="first last">lyso-phospholipase D</p></td></tr><tr><td class="NLM_term">MAC</td><td class="NLM_def"><p class="first last">membrane access channel</p></td></tr><tr><td class="NLM_term">MAG</td><td class="NLM_def"><p class="first last">monoacylglycerol</p></td></tr><tr><td class="NLM_term">MAGL</td><td class="NLM_def"><p class="first last">monoacylglycerol lipase</p></td></tr><tr><td class="NLM_term">MudPIT</td><td class="NLM_def"><p class="first last">multidimensional protein identification technology</p></td></tr><tr><td class="NLM_term">NAAA</td><td class="NLM_def"><p class="first last"><i>N</i>-acylethanolamine acid amidase</p></td></tr><tr><td class="NLM_term">NAPE-PLD</td><td class="NLM_def"><p class="first last"><i>N</i>-acylphosphatidylethanolaminephospholipase D</p></td></tr><tr><td class="NLM_term">NAT</td><td class="NLM_def"><p class="first last"><i>N</i>-acyltransacylase</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">OEA</td><td class="NLM_def"><p class="first last">oleoylethanolamide</p></td></tr><tr><td class="NLM_term">PAF</td><td class="NLM_def"><p class="first last">platelet-activating factor</p></td></tr><tr><td class="NLM_term">PBQ</td><td class="NLM_def"><p class="first last">phenylbenzoquinone</p></td></tr><tr><td class="NLM_term">PEA</td><td class="NLM_def"><p class="first last">palmitoylethanolamide</p></td></tr><tr><td class="NLM_term">PGH<sub>2</sub></td><td class="NLM_def"><p class="first last">prostaglandin H<sub>2</sub></p></td></tr><tr><td class="NLM_term">PGH<sub>2</sub>-EA</td><td class="NLM_def"><p class="first last">prostaglandin H<sub>2</sub> ethanolamide</p></td></tr><tr><td class="NLM_term">PGH<sub>2</sub>-G</td><td class="NLM_def"><p class="first last">prostaglandin H<sub>2</sub> glycerol</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">phosphatidylinositol</p></td></tr><tr><td class="NLM_term">PIP2</td><td class="NLM_def"><p class="first last">phosphatidylinositol 4,5-bisphosphate, PLA1, phospholipase A1</p></td></tr><tr><td class="NLM_term">PLC</td><td class="NLM_def"><p class="first last">phospholipase C</p></td></tr><tr><td class="NLM_term">PLC-β</td><td class="NLM_def"><p class="first last">β-isoform phospholipase C</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">PTPN22</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase nonreceptor type 22</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">SNI</td><td class="NLM_def"><p class="first last">spared nerve injury</p></td></tr><tr><td class="NLM_term">SNL</td><td class="NLM_def"><p class="first last">spinal nerve ligation</p></td></tr><tr><td class="NLM_term">TAG</td><td class="NLM_def"><p class="first last">triacylglycerol</p></td></tr><tr><td class="NLM_term">TBI</td><td class="NLM_def"><p class="first last">traumatic brain injury</p></td></tr><tr><td class="NLM_term">TGH</td><td class="NLM_def"><p class="first last">triacylglycerol hydrolase</p></td></tr><tr><td class="NLM_term">THL</td><td class="NLM_def"><p class="first last">tetrahydrolipstatin</p></td></tr><tr><td class="NLM_term">TLR-4</td><td class="NLM_def"><p class="first last">Toll-like receptor 4</p></td></tr><tr><td class="NLM_term">TNBS</td><td class="NLM_def"><p class="first last">2,4,6-trinitrobenzenesulfonic acid</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">TPA</td><td class="NLM_def"><p class="first last">12-<i>O</i>-tetradecanoylphorbol 13-acetate</p></td></tr><tr><td class="NLM_term">TRPV1</td><td class="NLM_def"><p class="first last">transient receptor potential cation channel subfamily V member 1.</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 180 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasso, O.</span><span> </span><span class="NLM_article-title">Peripheral gating of pain signals by endogenous lipid mediators</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1038/nn.3612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.3612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24473264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=164-174&author=D.+Piomelliauthor=O.+Sasso&title=Peripheral+gating+of+pain+signals+by+endogenous+lipid+mediators&doi=10.1038%2Fnn.3612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral gating of pain signals by endogenous lipid mediators</span></div><div class="casAuthors">Piomelli, Daniele; Sasso, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Primary sensory afferents and their neighboring host-defense cells are a rich source of lipid-derived mediators that contribute to the sensation of pain caused by tissue damage and inflammation.  But an increasing no. of lipid mols. have been shown to act in an opposite way, to suppress the inflammatory process, restore homeostasis in damaged tissues and attenuate pain sensitivity by regulating neural pathways that transmit nociceptive signals from the periphery of the body to the CNS.  Here we review the mol. and cellular mechanisms that contribute to the modulatory actions of lipid mediators in peripheral nociceptive signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3SUeSBaNEzbVg90H21EOLACvtfcHk0lh07Z2XtSg9ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D&md5=cedccbc9ba2c37ec111eefdf19c065a6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnn.3612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3612%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DSasso%26aufirst%3DO.%26atitle%3DPeripheral%2520gating%2520of%2520pain%2520signals%2520by%2520endogenous%2520lipid%2520mediators%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D164%26epage%3D174%26doi%3D10.1038%2Fnn.3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Beltramo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Functional role of high-affinity anandamide transport, as revealed by selective inhibition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span><span class="refDoi"> DOI: 10.1126/science.277.5329.1094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1126%2Fscience.277.5329.1094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1094-1097&author=M.+Beltramoauthor=N.+Stellaauthor=A.+Calignanoauthor=S.+Linauthor=A.+Makriyannisauthor=D.+Piomelli&title=Functional+role+of+high-affinity+anandamide+transport%2C+as+revealed+by+selective+inhibition&doi=10.1126%2Fscience.277.5329.1094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.277.5329.1094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.277.5329.1094%26sid%3Dliteratum%253Aachs%26aulast%3DBeltramo%26aufirst%3DM.%26aulast%3DStella%26aufirst%3DN.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DFunctional%2520role%2520of%2520high-affinity%2520anandamide%2520transport%252C%2520as%2520revealed%2520by%2520selective%2520inhibition%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1094%26epage%3D1097%26doi%3D10.1126%2Fscience.277.5329.1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomikos, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickason-Chesterfield, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phebus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Identification of a high-affinity binding site involved in the transport of endocannabinoids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17852</span><span class="NLM_x">–</span> <span class="NLM_lpage">17857</span><span class="refDoi"> DOI: 10.1073/pnas.0507470102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.0507470102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17852-17857&author=S.+A.+Mooreauthor=G.+G.+Nomikosauthor=A.+K.+Dickason-Chesterfieldauthor=D.+A.+Schoberauthor=J.+M.+Schausauthor=B.+P.+Yingauthor=Y.+C.+Xuauthor=L.+Phebusauthor=R.+M.+Simmonsauthor=D.+Liauthor=S.+Iyengarauthor=C.+C.+Felder&title=Identification+of+a+high-affinity+binding+site+involved+in+the+transport+of+endocannabinoids&doi=10.1073%2Fpnas.0507470102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0507470102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0507470102%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26aulast%3DDickason-Chesterfield%26aufirst%3DA.%2BK.%26aulast%3DSchober%26aufirst%3DD.%2BA.%26aulast%3DSchaus%26aufirst%3DJ.%2BM.%26aulast%3DYing%26aufirst%3DB.%2BP.%26aulast%3DXu%26aufirst%3DY.%2BC.%26aulast%3DPhebus%26aufirst%3DL.%26aulast%3DSimmons%26aufirst%3DR.%2BM.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DIdentification%2520of%2520a%2520high-affinity%2520binding%2520site%2520involved%2520in%2520the%2520transport%2520of%2520endocannabinoids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17852%26epage%3D17857%26doi%3D10.1073%2Fpnas.0507470102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelbaum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span><span class="refDoi"> DOI: 10.1126/science.1470919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1126%2Fscience.1470919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1470919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1946-1949&author=W.+A.+Devaneauthor=L.+Hanusauthor=A.+Breuerauthor=R.+G.+Pertweeauthor=L.+A.+Stevensonauthor=G.+Griffinauthor=D.+Gibsonauthor=A.+Mandelbaumauthor=A.+Etingerauthor=R.+Mechoulam&title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor&doi=10.1126%2Fscience.1470919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Hanus, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5090</span>),
    <span class="NLM_cas:pages">1946-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Arachidonylethanolamide, an arachidonic acid deriv. in the porcine brain, was identified as an endogenous ligand for the cannabinoid receptor.  The structure of this compd., anandamide, was detd. by mass spectrometry and NMR spectroscopy and was confirmed by synthesis.  Anandamide inhibited the specific binding of a radiolabeled cannabinoid probe to synaptosomal membranes in a manner typical of competitive ligands and produced a concn.-dependent inhibition of the elec. evoked twitch responses of the mouse vas deferens, a characteristic effect of psychotropic cannabinoids.  Anandamide may function as a natural ligand for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqh5E4vHczbVg90H21EOLACvtfcHk0lh07Z2XtSg9ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D&md5=13c7aa7316cd687240779f7f192d086b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1470919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1470919%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DMandelbaum%26aufirst%3DA.%26aulast%3DEtinger%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520structure%2520of%2520a%2520brain%2520constituent%2520that%2520binds%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1946%26epage%3D1949%26doi%3D10.1126%2Fscience.1470919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Shabat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligumsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatz, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almog, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayewitch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, Z.</span><span> </span><span class="NLM_article-title">Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/0006-2952(95)00109-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2F0006-2952%2895%2900109-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=7605349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK2MXmsl2ks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=83-90&author=R.+Mechoulamauthor=S.+Ben-Shabatauthor=L.+Hanusauthor=M.+Ligumskyauthor=N.+E.+Kaminskiauthor=A.+R.+Schatzauthor=A.+Gopherauthor=S.+Almogauthor=B.+R.+Martinauthor=D.+R.+Comptonauthor=R.+G.+Pertweeauthor=G.+Griffinauthor=M.+Bayewitchauthor=J.+Bargauthor=Z.+Vogel&title=Identification+of+an+endogenous+2-monoglyceride%2C+present+in+canine+gut%2C+that+binds+to+cannabinoid+receptors&doi=10.1016%2F0006-2952%2895%2900109-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors</span></div><div class="casAuthors">Mechoulam, Raphael; Ben-Shabat, Shimon; Hanus, Lumir; Ligumsky, Moshe; Kaminski, Norbert E.; Schatz, Anthony R.; Gopher, Asher; Almog, Shlomo; Martin, Billy R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-90</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study reports the isolation of 2-arachidonylglycerol (2-Ara-Gl) from canine intestines.  Its structure was detd. by mass spectrometry and by direct comparison with a synthetic sample.  2-Ara-Gl bound to membranes from cells transiently transfected with expression plasmids carrying DNA of either CB1 or CB2 (the 2 cannabinoid receptors identified thus far), with Ki values of 472 and 1400 nM, resp.  In the presence of forskolin, 2-Ara-Gl inhibited adenylate cyclase in isolated mouse spleen cells, at a potency level similar to that of Δ9-tetrahydrocannabinol (Δ9-THC).  Upon i.v. administration to mice, 2-Ara-Gl caused the typical tetrad of effects produced by THC: antinociception, immobility, redn. of spontaneous activity, and lowering of the rectal temp.  2-Ara-Gl also shared the ability of Δ9-THC to inhibit elec. evoked contractions of mouse isolated vasa deferentia; however, it was less potent than Δ9-THC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPw_8rVdXsObVg90H21EOLACvtfcHk0lhXt22PBub9OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsl2ks7Y%253D&md5=3d058ab1c59390723beeb64ea7714553</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2900109-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252900109-D%26sid%3Dliteratum%253Aachs%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DBen-Shabat%26aufirst%3DS.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DLigumsky%26aufirst%3DM.%26aulast%3DKaminski%26aufirst%3DN.%2BE.%26aulast%3DSchatz%26aufirst%3DA.%2BR.%26aulast%3DGopher%26aufirst%3DA.%26aulast%3DAlmog%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DBayewitch%26aufirst%3DM.%26aulast%3DBarg%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DZ.%26atitle%3DIdentification%2520of%2520an%2520endogenous%25202-monoglyceride%252C%2520present%2520in%2520canine%2520gut%252C%2520that%2520binds%2520to%2520cannabinoid%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D83%26epage%3D90%26doi%3D10.1016%2F0006-2952%2895%2900109-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hillard, C. J.</span><span> </span><span class="NLM_article-title">Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/S0090-6980(00)00051-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0090-6980%2800%2900051-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10785538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjt1CltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=3-18&author=C.+J.+Hillard&title=Biochemistry+and+pharmacology+of+the+endocannabinoids+arachidonylethanolamide+and+2-arachidonylglycerol&doi=10.1016%2FS0090-6980%2800%2900051-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol</span></div><div class="casAuthors">Hillard, Cecilia J.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">3-18</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 130 refs.  The purpose of this review is to discuss the cellular synthesis and inactivation of two putative endogenous ligands of the cannabinoid receptor, N-arachidonylethanolamine (AEA) and 2-arachidonylglycerol (2-AG).  Both ligands are synthesized by neurons and brain tissue in response to increased intracellular calcium concns.  Both ligands are substrates for fatty acid amide hydrolase (FAAH).  Both AEA and 2-AG bind to the neuronal form of the cannabinoid receptor (CB1).  AEA binds the receptor with moderate affinity and has the characteristics of a partial agonist, whereas, 2-AG binds with low affinity but exhibits full efficacy.  Two possible physiol. roles of the endocannabinoids and the CB1 receptor are discussed: the regulation of gestation and the regulation of gastrointestinal motility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbntWQBAJlybVg90H21EOLACvtfcHk0lhXt22PBub9OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjt1CltLw%253D&md5=339536d597eca9bd93fa781868e45fac</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2800%2900051-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252800%252900051-4%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26atitle%3DBiochemistry%2520and%2520pharmacology%2520of%2520the%2520endocannabinoids%2520arachidonylethanolamide%2520and%25202-arachidonylglycerol%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2000%26volume%3D61%26spage%3D3%26epage%3D18%26doi%3D10.1016%2FS0090-6980%2800%2900051-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Solorzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battista, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonietti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Selective <i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">20966</span><span class="NLM_x">–</span> <span class="NLM_lpage">20971</span><span class="refDoi"> DOI: 10.1073/pnas.0907417106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.0907417106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19926854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20966-20971&author=C.+Solorzanoauthor=C.+Zhuauthor=N.+Battistaauthor=G.+Astaritaauthor=A.+Lodolaauthor=S.+Rivaraauthor=M.+Morauthor=R.+Russoauthor=M.+Maccarroneauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Cuzzocreaauthor=G.+Tarziaauthor=D.+Piomelli&title=Selective+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition+reveals+a+key+role+for+endogenous+palmitoylethanolamide+in+inflammation&doi=10.1073%2Fpnas.0907417106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span></div><div class="casAuthors">Solorzano, Carlos; Zhu, Chenggang; Battista, Natalia; Astarita, Giuseppe; Lodola, Alessio; Rivara, Silvia; Mor, Marco; Russo, Roberto; Maccarrone, Mauro; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Cuzzocrea, Salvatore; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">20966-20971, S20966/1-S20966/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Identifying points of control in inflammation is essential to discovering safe and effective antiinflammatory medicines.  Palmitoylethanolamide (PEA) is a naturally occurring lipid amide that, when administered as a drug, inhibits inflammatory responses by engaging peroxisome proliferator-activated receptor-α (PPAR-α).  PEA is preferentially hydrolyzed by the cysteine amidase N- acylethanolamine-hydrolyzing acid amidase (NAAA), which is highly expressed in macrophages.  Here we report the discovery of a potent and selective NAAA inhibitor, N-[(3S)-2-oxo-3-oxetanyl]-3-phenylpropanamide [(S)-OOPP], and show that this inhibitor increases PEA levels in activated leukocytes and blunts responses induced by inflammatory stimuli both in vitro and in vivo.  These effects are stereoselective, mimicked by exogenous PEA, and abolished by PPAR-α deletion.  (S)-OOPP also attenuates inflammation and tissue damage and improves recovery of motor function in mice subjected to spinal cord trauma.  The results suggest that PEA activation of PPAR-α in leukocytes serves as an early stop signal that contrasts the progress of inflammation.  The PEA-hydrolyzing amidase NAAA may provide a previously undescribed target for antiinflammatory medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUMad22TONbVg90H21EOLACvtfcHk0lhXt22PBub9OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D&md5=9e8f84c9aabfc0d7c9d382d5a4c57706</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907417106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907417106%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DBattista%26aufirst%3DN.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSelective%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520reveals%2520a%2520key%2520role%2520for%2520endogenous%2520palmitoylethanolamide%2520in%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D20966%26epage%3D20971%26doi%3D10.1073%2Fpnas.0907417106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lo Verme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1124/mol.104.006353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fmol.104.006353" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=15-19&author=J.+Lo+Vermeauthor=J.+Fuauthor=G.+Astaritaauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+nuclear+receptor+peroxisome+proliferator-activated+receptor-%CE%B1+mediates+the+anti-inflammatory+actions+of+palmitoylethanolamide&doi=10.1124%2Fmol.104.006353"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006353%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520nuclear%2520receptor%2520peroxisome%2520proliferator-activated%2520receptor-%25CE%25B1%2520mediates%2520the%2520anti-inflammatory%2520actions%2520of%2520palmitoylethanolamide%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D15%26epage%3D19%26doi%3D10.1124%2Fmol.104.006353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oveisi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Verme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez de Fonseca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosengarth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giacomo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1038/nature01921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnature01921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12955147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFansrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=90-93&author=J.+Fuauthor=S.+Gaetaniauthor=F.+Oveisiauthor=J.+Lo+Vermeauthor=A.+Serranoauthor=F.+Rodriguez+de+Fonsecaauthor=A.+Rosengarthauthor=H.+Lueckeauthor=B.+Di+Giacomoauthor=G.+Tarziaauthor=D.+Piomelli&title=Oleylethanolamide+regulates+feeding+and+body+weight+through+activation+of+the+nuclear+receptor+PPAR-%CE%B1&doi=10.1038%2Fnature01921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α</span></div><div class="casAuthors">Fu, Jin; Gaetani, Silvana; Oveisi, Fariba; Lo Verme, Jesse; Serrano, Antonia; Rodriguez de Fonseca, Fernando; Rosengarth, Anja; Luecke, Hartmut; Di Giacomo, Barbara; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6953</span>),
    <span class="NLM_cas:pages">90-93</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oleylethanolamide (OEA) is a naturally occurring lipid that regulates satiety and body wt.  Although structurally related to the endogenous cannabinoid anandamide, OEA does not bind to cannabinoid receptors and its mol. targets have not been defined.  OEA binds with high affinity to the peroxisome-proliferator-activated receptor-α (PPAR-α), a nuclear receptor that regulates several aspects of lipid metab.  Administration of OEA produces satiety and reduces body wt. gain in wild-type mice, but not in mice deficient in PPAR-α.  Two distinct PPAR-α agonists have similar effects that are also contingent on PPAR-α expression, whereas potent and selective agonists for PPAR-γ and PPAR-β/δ are ineffective.  In the small intestine of wild-type but not PPAR-α-null mice, OEA regulates the expression of several PPAR-α target genes: it initiates the transcription of proteins involved in lipid metab. and represses inducible nitric oxide synthase, an enzyme that may contribute to feeding stimulation.  The authors' results, which show that OEA induces satiety by activating PPAR-α, identify an unexpected role for this nuclear receptor in regulating behavior, and raise possibilities for the treatment of eating disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-C_8AHpl3SbVg90H21EOLACvtfcHk0lhM0DxvflM3kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFansrY%253D&md5=449ae587cd7d81339420ef58d790c9ac</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01921%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DOveisi%26aufirst%3DF.%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DSerrano%26aufirst%3DA.%26aulast%3DRodriguez%2Bde%2BFonseca%26aufirst%3DF.%26aulast%3DRosengarth%26aufirst%3DA.%26aulast%3DLuecke%26aufirst%3DH.%26aulast%3DDi%2BGiacomo%26aufirst%3DB.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DOleylethanolamide%2520regulates%2520feeding%2520and%2520body%2520weight%2520through%2520activation%2520of%2520the%2520nuclear%2520receptor%2520PPAR-%25CE%25B1%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D90%26epage%3D93%26doi%3D10.1038%2Fnature01921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Basavarajappa, B. S.</span><span> </span><span class="NLM_article-title">Critical enzymes involved in endocannabinoid metabolism</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.2174/092986607780090829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.2174%2F092986607780090829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17346227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVWmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=237-246&author=B.+S.+Basavarajappa&title=Critical+enzymes+involved+in+endocannabinoid+metabolism&doi=10.2174%2F092986607780090829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Critical enzymes involved in endocannabinoid metabolism</span></div><div class="casAuthors">Basavarajappa, Balapal S.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-246</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Investigations of the pathways involved in the metab. of endocannabinoids have grown exponentially in recent years following the discovery of cannabinoid receptors (CB) and their endogenous ligands, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG).  The in vivo biosynthesis of AEA has been shown to occur through several pathways mediated by N-acylphosphatidylethanolamide-phospholipase D (NAPE-PLD), a secretory PLA2 and PLC.  2-AG, a second endocannabinoid is generated through the action of selective enzymes such as phosphatidic acid phsophohydrolase, diacylglycerol lipase (DAGL), phosphoinositide-specific PLC (PI-PLC) and lyso-PLC.  A putative membrane transporter or facilitated diffusion is involved in the cellular uptake or release of endocannabinoids.  AEA is metabolized by fatty acid amidohydrolase (FAAH) and 2-AG is metabolized by both FAAH and monoacylglycerol lipase (MAGL).  The author presents an integrative overview of current research on the enzymes involved in the metab. of endocannabinoids and discusses possible therapeutic interventions for various diseases, including addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsOjUSQWqq0rVg90H21EOLACvtfcHk0lhM0DxvflM3kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVWmurw%253D&md5=ea37be15921314a665ccef8eb8b452c0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986607780090829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986607780090829%26sid%3Dliteratum%253Aachs%26aulast%3DBasavarajappa%26aufirst%3DB.%2BS.%26atitle%3DCritical%2520enzymes%2520involved%2520in%2520endocannabinoid%2520metabolism%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2007%26volume%3D14%26spage%3D237%26epage%3D246%26doi%3D10.2174%2F092986607780090829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Simon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-<i>N</i>-acyl ethanolamine precursors in mouse brain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">9341</span><span class="NLM_x">–</span> <span class="NLM_lpage">9349</span><span class="refDoi"> DOI: 10.1074/jbc.M707807200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M707807200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=9341-9349&author=G.+M.+Simonauthor=B.+F.+Cravatt&title=Anandamide+biosynthesis+catalyzed+by+the+phosphodiesterase+GDE1+and+detection+of+glycerophospho-N-acyl+ethanolamine+precursors+in+mouse+brain&doi=10.1074%2Fjbc.M707807200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707807200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707807200%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DAnandamide%2520biosynthesis%2520catalyzed%2520by%2520the%2520phosphodiesterase%2520GDE1%2520and%2520detection%2520of%2520glycerophospho-N-acyl%2520ethanolamine%2520precursors%2520in%2520mouse%2520brain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D9341%26epage%3D9349%26doi%3D10.1074%2Fjbc.M707807200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Izzo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, D. G.</span><span> </span><span class="NLM_article-title">Unique pathway for anandamide synthesis and liver regeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">6339</span><span class="NLM_x">–</span> <span class="NLM_lpage">6340</span><span class="refDoi"> DOI: 10.1073/pnas.1103566108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.1103566108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=6339-6340&author=A.+A.+Izzoauthor=D.+G.+Deutsch&title=Unique+pathway+for+anandamide+synthesis+and+liver+regeneration&doi=10.1073%2Fpnas.1103566108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1103566108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1103566108%26sid%3Dliteratum%253Aachs%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DDeutsch%26aufirst%3DD.%2BG.%26atitle%3DUnique%2520pathway%2520for%2520anandamide%2520synthesis%2520and%2520liver%2520regeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D6339%26epage%3D6340%26doi%3D10.1073%2Fpnas.1103566108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Alhouayek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span> </span><span class="NLM_article-title">Harnessing the anti-inflammatory potential of palmitoylethanolamide</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1632</span><span class="NLM_x">–</span> <span class="NLM_lpage">1639</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.drudis.2014.06.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1632-1639&author=M.+Alhouayekauthor=G.+G.+Muccioli&title=Harnessing+the+anti-inflammatory+potential+of+palmitoylethanolamide&doi=10.1016%2Fj.drudis.2014.06.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DHarnessing%2520the%2520anti-inflammatory%2520potential%2520of%2520palmitoylethanolamide%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1632%26epage%3D1639%26doi%3D10.1016%2Fj.drudis.2014.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Deutsch, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, S. A.</span><span> </span><span class="NLM_article-title">Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1016/0006-2952(93)90486-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2F0006-2952%2893%2990486-G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=791-796&author=D.+G.+Deutschauthor=S.+A.+Chin&title=Enzymatic+synthesis+and+degradation+of+anandamide%2C+a+cannabinoid+receptor+agonist&doi=10.1016%2F0006-2952%2893%2990486-G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990486-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990486-G%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DD.%2BG.%26aulast%3DChin%26aufirst%3DS.%2BA.%26atitle%3DEnzymatic%2520synthesis%2520and%2520degradation%2520of%2520anandamide%252C%2520a%2520cannabinoid%2520receptor%2520agonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D791%26epage%3D796%26doi%3D10.1016%2F0006-2952%2893%2990486-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5899</span><span class="NLM_x">–</span> <span class="NLM_lpage">5921</span><span class="refDoi"> DOI: 10.1021/cr2002799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2002799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=5899-5921&author=C.+A.+Rouzerauthor=L.+J.+Marnett&title=Endocannabinoid+oxygenation+by+cyclooxygenases%2C+lipoxygenases%2C+and+cytochromes+P450%3A+cross-talk+between+the+eicosanoid+and+endocannabinoid+signaling+pathways&doi=10.1021%2Fcr2002799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways</span></div><div class="casAuthors">Rouzer, Carol A.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5899-5921</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this review, the authors explore what is known about the interplay between the eicosanoid and endocannabinoid signaling networks and discuss the challenges and opportunities offered by this new field of inquiry.  The biosynthetic pathways for eicosanoids and endocannabinoids are reviewed and oxygenation of endocannabinoids by eicosanoid pathway enzymes is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQufJ-H9KlTbVg90H21EOLACvtfcHk0ljRZFv6QKTAOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu73I&md5=22c584636bbd21dd9caef72489b0074d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcr2002799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2002799%26sid%3Dliteratum%253Aachs%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DEndocannabinoid%2520oxygenation%2520by%2520cyclooxygenases%252C%2520lipoxygenases%252C%2520and%2520cytochromes%2520P450%253A%2520cross-talk%2520between%2520the%2520eicosanoid%2520and%2520endocannabinoid%2520signaling%2520pathways%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D5899%26epage%3D5921%26doi%3D10.1021%2Fcr2002799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sun, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Involvement of <i>N</i>-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other <i>N</i>-acylethanolamines in macrophages</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1736</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2005.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2005.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=16154384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1736&publication_year=2005&pages=211-220&author=Y.+X.+Sunauthor=K.+Tsuboiauthor=L.+Y.+Zhaoauthor=Y.+Okamotoauthor=D.+M.+Lambertauthor=N.+Ueda&title=Involvement+of+N-acylethanolamine-hydrolyzing+acid+amidase+in+the+degradation+of+anandamide+and+other+N-acylethanolamines+in+macrophages&doi=10.1016%2Fj.bbalip.2005.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages</span></div><div class="casAuthors">Sun, Yong-Xin; Tsuboi, Kazuhito; Zhao, Li-Ying; Okamoto, Yasuo; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1736</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-220</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines including the endocannabinoid anandamide are known to be hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  In addn., we recently cloned an isoenzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)", which is active only at acidic pH [Tsuboi, Sun, Okamoto, Araki, Tonai, Ueda, J. Biol. Chem. 285 (2005) 11082-11092].  However, physiol. roles of NAAA remained unclear.  Here, we examd. a possible contribution of NAAA to the degrdn. of various N-acylethanolamines in macrophage cells.  NAAA mRNA as well as FAAH mRNA was detected in several macrophage-like cells, including RAW264.7, and mouse peritoneal macrophages.  The homogenates of RAW264.7 cells showed both the NAAA and FAAH activities which were confirmed with the aid of their resp. specific inhibitors, N-cyclohexanecarbonylpentadecylamine (CCP) and URB597.  As analyzed with intact cells, RAW264.7 cells and peritoneal macrophages degraded anandamide, N-palmitoylethanolamine, N-oleoylethanolamine, and N-stearoylethanolamine.  Pretreatment of the cells with CCP or URB597 partially inhibited the degrdn., and a combination of the two compds. caused more profound inhibition.  In contrast, the anandamide hydrolysis in mouse brain appeared to be principally attributable to FAAH despite the expression of NAAA in the brain.  These results suggested that NAAA and FAAH cooperatively degraded various N-acylethanolamines in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRw2Yw4epuc7Vg90H21EOLACvtfcHk0ljRZFv6QKTAOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O&md5=d4dbefcb0a2c84be624e98f1ee78f213</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2005.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2005.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520in%2520the%2520degradation%2520of%2520anandamide%2520and%2520other%2520N-acylethanolamines%2520in%2520macrophages%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2005%26volume%3D1736%26spage%3D211%26epage%3D220%26doi%3D10.1016%2Fj.bbalip.2005.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2007.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2007.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18096503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1347-1356&author=J.+L.+Blankmanauthor=G.+M.+Simonauthor=B.+F.+Cravatt&title=A+comprehensive+profile+of+brain+enzymes+that+hydrolyze+the+endocannabinoid+2-arachidonoylglycerol&doi=10.1016%2Fj.chembiol.2007.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol</span></div><div class="casAuthors">Blankman, Jacqueline L.; Simon, Gabriel M.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1347-1356</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Endogenous ligands for cannabinoid receptors ("endocannabinoids") include the lipid transmitters anandamide and 2-arachidonoylglycerol (2-AG).  Endocannabinoids modulate a diverse set of physiol. processes and are tightly regulated by enzymic biosynthesis and degrdn.  Termination of anandamide signaling by fatty acid amide hydrolase (FAAH) is well characterized, but less is known about the inactivation of 2-AG, which can be hydrolyzed by multiple enzymes in vitro, including FAAH and monoacylglycerol lipase (MAGL).  Here, we have taken a functional proteomic approach to comprehensively map 2-AG hydrolases in the mouse brain.  Our data reveal that ∼85% of brain 2-AG hydrolase activity can be ascribed to MAGL, and that the remaining 15% is mostly catalyzed by two uncharacterized enzymes, ABHD6 and ABHD12.  Interestingly, MAGL, ABHD6, and ABHD12 display distinct subcellular distributions, suggesting that they may control different pools of 2-AG in the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF_Kmd_7v5urVg90H21EOLACvtfcHk0ljfK6XTa87z-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfE&md5=78c6355a3909bff3cbae25989ab6a956</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520comprehensive%2520profile%2520of%2520brain%2520enzymes%2520that%2520hydrolyze%2520the%2520endocannabinoid%25202-arachidonoylglycerol%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D1347%26epage%3D1356%26doi%3D10.1016%2Fj.chembiol.2007.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Marrs, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomazeau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodor, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodruff, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafourcade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzoni, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span> </span><span class="NLM_article-title">The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">957</span><span class="refDoi"> DOI: 10.1038/nn.2601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.2601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20657592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1artb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=951-957&author=W.+R.+Marrsauthor=J.+L.+Blankmanauthor=E.+A.+Horneauthor=A.+Thomazeauauthor=Y.+H.+Linauthor=J.+Coyauthor=A.+L.+Bodorauthor=G.+G.+Muccioliauthor=S.+S.+Huauthor=G.+Woodruffauthor=S.+Fungauthor=M.+Lafourcadeauthor=J.+P.+Alexanderauthor=J.+Z.+Longauthor=W.+Liauthor=C.+Xuauthor=T.+M%C3%B6llerauthor=K.+Mackieauthor=O.+J.+Manzoniauthor=B.+F.+Cravattauthor=N.+Stella&title=The+serine+hydrolase+ABHD6+controls+the+accumulation+and+efficacy+of+2-AG+at+cannabinoid+receptors&doi=10.1038%2Fnn.2601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors</span></div><div class="casAuthors">Marrs, William R.; Blankman, Jacqueline L.; Horne, Eric A.; Thomazeau, Aurore; Lin, Yi Hsing; Coy, Jonathan; Bodor, Agnes L.; Muccioli, Giulio G.; Hu, Sherry Shu-Jung; Woodruff, Grace; Fung, Susan; Lafourcade, Mathieu; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Xu, Cong; Moeller, Thomas; Mackie, Ken; Manzoni, Olivier J.; Cravatt, Benjamin F.; Stella, Nephi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">951-957</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The endocannabinoid 2-arachidonoylglycerol (2-AG) regulates neurotransmission and neuroinflammation by activating CB1 cannabinoid receptors on neurons and CB2 cannabinoid receptors on microglia.  Enzymes that hydrolyze 2-AG, such as monoacylglycerol lipase, regulate the accumulation and efficacy of 2-AG at cannabinoid receptors.  We found that the recently described serine hydrolase α-β-hydrolase domain 6 (ABHD6) also controls the accumulation and efficacy of 2-AG at cannabinoid receptors.  In cells from the BV-2 microglia cell line, ABHD6 knockdown reduced hydrolysis of 2-AG and increased the efficacy with which 2-AG can stimulate CB2-mediated cell migration.  ABHD6 was expressed by neurons in primary culture and its inhibition led to activity-dependent accumulation of 2-AG.  In adult mouse cortex, ABHD6 was located postsynaptically and its selective inhibition allowed the induction of CB1-dependent long-term depression by otherwise subthreshold stimulation.  Our results indicate that ABHD6 is a rate-limiting step of 2-AG signaling and is therefore a bona fide member of the endocannabinoid signaling system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6V8gdFxrZ37Vg90H21EOLACvtfcHk0ljfK6XTa87z-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1artb8%253D&md5=a095d28f808dd34ecdd7b469b7ad37bc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnn.2601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2601%26sid%3Dliteratum%253Aachs%26aulast%3DMarrs%26aufirst%3DW.%2BR.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DHorne%26aufirst%3DE.%2BA.%26aulast%3DThomazeau%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DY.%2BH.%26aulast%3DCoy%26aufirst%3DJ.%26aulast%3DBodor%26aufirst%3DA.%2BL.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DHu%26aufirst%3DS.%2BS.%26aulast%3DWoodruff%26aufirst%3DG.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DLafourcade%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DM%25C3%25B6ller%26aufirst%3DT.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DManzoni%26aufirst%3DO.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStella%26aufirst%3DN.%26atitle%3DThe%2520serine%2520hydrolase%2520ABHD6%2520controls%2520the%2520accumulation%2520and%2520efficacy%2520of%25202-AG%2520at%2520cannabinoid%2520receptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D951%26epage%3D957%26doi%3D10.1038%2Fnn.2601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wei, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">A second fatty acid amide hydrolase with variable distribution among placental mammals</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">36569</span><span class="NLM_x">–</span> <span class="NLM_lpage">36578</span><span class="refDoi"> DOI: 10.1074/jbc.M606646200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M606646200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17015445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=36569-36578&author=B.+Q.+Weiauthor=T.+S.+Mikkelsenauthor=M.+K.+McKinneyauthor=E.+S.+Landerauthor=B.+F.+Cravatt&title=A+second+fatty+acid+amide+hydrolase+with+variable+distribution+among+placental+mammals&doi=10.1074%2Fjbc.M606646200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals</span></div><div class="casAuthors">Wei, Binqing Q.; Mikkelsen, Tarjei S.; McKinney, Michele K.; Lander, Eric S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">36569-36578</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fatty acid amides constitute a large and diverse class of lipid transmitters that includes the endogenous cannabinoid anandamide and the sleep-inducing substance oleamide.  The magnitude and duration of fatty acid amide signaling are controlled by enzymic hydrolysis in vivo.  Fatty acid amide hydrolase (FAAH) activity in mammals has been primarily attributed to a single integral membrane enzyme of the amidase signature (AS) family.  Here, we report the functional proteomic discovery of a second membrane-assocd. AS enzyme in humans that displays FAAH activity.  The gene that encodes this second FAAH enzyme was found in multiple primate genomes, marsupials, and more distantly related vertebrates, but, remarkably, not in a no. of lower placental mammals, including mouse and rat.  The two human FAAH enzymes, which share 20% sequence identity and are referred to hereafter as FAAH-1 and FAAH-2, hydrolyzed primary fatty acid amide substrates (e.g., oleamide) at equiv. rates, whereas FAAH-1 exhibited much greater activity with N-acyl ethanolamines (e.g., anandamide) and N-acyl taurines.  Both enzymes were sensitive to the principal classes of FAAH inhibitors synthesized to date, including O-aryl carbamates and α-keto heterocycles.  These data coupled with the overlapping, but distinct tissue distributions of FAAH-1 and FAAH-2 suggest that these proteins may collaborate to control fatty acid amide catabolism in primates.  The apparent loss of the FAAH-2 gene in some lower mammals should be taken into consideration when extrapolating genetic or pharmacol. findings on the fatty acid amide signaling system across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuV_6Ew68-CbVg90H21EOLACvtfcHk0lgz7A12eBt4hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP&md5=16273562700ac4fe3ef10c9917f0d3aa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606646200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606646200%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DB.%2BQ.%26aulast%3DMikkelsen%26aufirst%3DT.%2BS.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520second%2520fatty%2520acid%2520amide%2520hydrolase%2520with%2520variable%2520distribution%2520among%2520placental%2520mammals%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D36569%26epage%3D36578%26doi%3D10.1074%2Fjbc.M606646200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders</span> <span class="citation_source-journal">Chem. Phys. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1016/S0009-3084(00)00196-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0009-3084%2800%2900196-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2000&pages=191-209&author=L.+De+Petrocellisauthor=D.+Melckauthor=T.+Bisognoauthor=V.+Di+Marzo&title=Endocannabinoids+and+fatty+acid+amides+in+cancer%2C+inflammation+and+related+disorders&doi=10.1016%2FS0009-3084%2800%2900196-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0009-3084%2800%2900196-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-3084%252800%252900196-1%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DMelck%26aufirst%3DD.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoids%2520and%2520fatty%2520acid%2520amides%2520in%2520cancer%252C%2520inflammation%2520and%2520related%2520disorders%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2000%26volume%3D108%26spage%3D191%26epage%3D209%26doi%3D10.1016%2FS0009-3084%2800%2900196-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">De Fonseca, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Arco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermudez-Silva, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span> </span><span class="NLM_article-title">The endocannabinoid system: physiology and pharmacology</span> <span class="citation_source-journal">Alcohol Alcohol. (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1093/alcalc/agh110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1093%2Falcalc%2Fagh110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15550444" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=2-14&author=F.+R.+De+Fonsecaauthor=I.+Del+Arcoauthor=F.+J.+Bermudez-Silvaauthor=A.+Bilbaoauthor=A.+Cippitelliauthor=M.+Navarro&title=The+endocannabinoid+system%3A+physiology+and+pharmacology&doi=10.1093%2Falcalc%2Fagh110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Falcalc%2Fagh110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Falcalc%252Fagh110%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFonseca%26aufirst%3DF.%2BR.%26aulast%3DDel%2BArco%26aufirst%3DI.%26aulast%3DBermudez-Silva%26aufirst%3DF.%2BJ.%26aulast%3DBilbao%26aufirst%3DA.%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DM.%26atitle%3DThe%2520endocannabinoid%2520system%253A%2520physiology%2520and%2520pharmacology%26jtitle%3DAlcohol%2520Alcohol.%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2005%26volume%3D40%26spage%3D2%26epage%3D14%26doi%3D10.1093%2Falcalc%2Fagh110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistis, M.</span><span> </span><span class="NLM_article-title">Hub and switches: endocannabinoid signalling in midbrain dopamine neurons</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">3276</span><span class="NLM_x">–</span> <span class="NLM_lpage">3285</span><span class="refDoi"> DOI: 10.1098/rstb.2011.0383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1098%2Frstb.2011.0383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23108546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3276-3285&author=M.+Melisauthor=M.+Pistis&title=Hub+and+switches%3A+endocannabinoid+signalling+in+midbrain+dopamine+neurons&doi=10.1098%2Frstb.2011.0383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Hub and switches: endocannabinoid signalling in midbrain dopamine neurons</span></div><div class="casAuthors">Melis, Miriam; Pistis, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3276-3285</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The last decade has provided a wealth of exptl. data on the role played by lipids belonging to the endocannabinoid family in several facets of physiopathol. of dopamine neurons.  We currently suggest that these mols., being intimately connected with diverse metabolic and signalling pathways, might differently affect various functions of dopamine neurons through activation not only of surface receptors, but also of nuclear receptors.  It is now emerging how dopamine neurons can regulate their constituent biomols. to compensate for changes in either internal functions or external conditions.  Consequently, dopamine neurons use these lipid mols. as metabolic and homeostatic signal detectors, which can dynamically impact cell function and fitness.  Because dysfunctions of the dopamine system underlie diverse neuropsychiatric disorders, including schizophrenia and drug addiction, the importance of better understanding the correlation between an unbalanced endocannabinoid signal and the dopamine system is even greater.  Particularly, because dopamine neurons are crit. in controlling incentive-motivated behaviors, the involvement of endocannabinoid mols. in fine-tuning dopamine cell activity opened new avenues in both understanding and treating drug addiction.  Here, we review recent advances that have shed new light on the understanding of differential roles of endocannabinoids and their cognate mols. in the regulation of the reward circuit, and discuss their anti-addicting properties, particularly with a focus on their potential engagement in the prevention of relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFHivVY1Oe_bVg90H21EOLACvtfcHk0lgz7A12eBt4hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtL3N&md5=e3fef5ff99ab66f11496fb1b0d1c3120</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1098%2Frstb.2011.0383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2011.0383%26sid%3Dliteratum%253Aachs%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DPistis%26aufirst%3DM.%26atitle%3DHub%2520and%2520switches%253A%2520endocannabinoid%2520signalling%2520in%2520midbrain%2520dopamine%2520neurons%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D3276%26epage%3D3285%26doi%3D10.1098%2Frstb.2011.0383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hoesel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J. A.</span><span> </span><span class="NLM_article-title">The complexity of NF-κB signaling in inflammation and cancer</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1186/1476-4598-12-86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1186%2F1476-4598-12-86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23286373" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1-15&author=B.+Hoeselauthor=J.+A.+Schmid&title=The+complexity+of+NF-%CE%BAB+signaling+in+inflammation+and+cancer&doi=10.1186%2F1476-4598-12-86"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-12-86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-12-86%26sid%3Dliteratum%253Aachs%26aulast%3DHoesel%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520complexity%2520of%2520NF-%25CE%25BAB%2520signaling%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DMol.%2520Cancer%26date%3D2013%26volume%3D12%26spage%3D1%26epage%3D15%26doi%3D10.1186%2F1476-4598-12-86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wahli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalik, L.</span><span> </span><span class="NLM_article-title">PPARs at the crossroads of lipid signaling and inflammation</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span><span class="refDoi"> DOI: 10.1016/j.tem.2012.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.tem.2012.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22704720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFChur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=351-363&author=W.+Wahliauthor=L.+Michalik&title=PPARs+at+the+crossroads+of+lipid+signaling+and+inflammation&doi=10.1016%2Fj.tem.2012.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PPARs at the crossroads of lipid signaling and inflammation</span></div><div class="casAuthors">Wahli, Walter; Michalik, Liliane</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">351-363</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are ligand-dependent transcription factors whose activation affects genes controlling vital processes.  Among them, the peroxisome proliferator-activated receptors (PPARs) have emerged as links between lipids, metabolic diseases, and innate immunity.  PPARs are activated by fatty acids and their derivs., many of which also signal through membrane receptors, thereby creating a lipid signaling network between the cell surface and the nucleus.  Tissues that play a role in whole-body metabolic homeostasis, such as adipose tissue, liver, skeletal muscle, intestines, and blood vessel walls, are prone to inflammation when metab. is disturbed, a complication that promotes type 2 diabetes and cardiovascular disease.  This review discusses the protective roles of PPARs in inflammatory conditions and the therapeutic anti-inflammatory potential of PPAR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqYSg4LxUyOLVg90H21EOLACvtfcHk0lg0pBQlY48GUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFChur4%253D&md5=c75c774b268207244eb1ba0e476633ef</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2012.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2012.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DMichalik%26aufirst%3DL.%26atitle%3DPPARs%2520at%2520the%2520crossroads%2520of%2520lipid%2520signaling%2520and%2520inflammation%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D23%26spage%3D351%26epage%3D363%26doi%3D10.1016%2Fj.tem.2012.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ho, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, M. D.</span><span> </span><span class="NLM_article-title">‘Entourage’effects of <i>N</i>-palmitoylethanolamide and <i>N</i>-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1038/bjp.2008.324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fbjp.2008.324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18695637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=837-846&author=W.+S.+Hoauthor=D.+A.+Barrettauthor=M.+D.+Randall&title=%E2%80%98Entourage%E2%80%99effects+of+N-palmitoylethanolamide+and+N-oleoylethanolamide+on+vasorelaxation+to+anandamide+occur+through+TRPV1+receptors&doi=10.1038%2Fbjp.2008.324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors</span></div><div class="casAuthors">Ho, W.-S. V.; Barrett, D. A.; Randall, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-846</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The endocannabinoid N-arachidonoylethanolamide (anandamide) is co-synthesized with other N-acylethanolamides, namely N-palmitoylethanolamide (PEA) and N-oleoylethanolamide (OEA), which have been shown to potentiate anandamide responses (so-called entourage effects') in non-vascular tissues.  It remains unclear whether such interactions occur in the circulation.  In rat isolated small mesenteric arteries, the effects of PEA and OEA on relaxation to anandamide and tissue contents of the N-acylethanolamides were examd. under myog. conditions.  Anandamide-induced relaxation was potentiated by pretreatment with PEA (10 μ) or OEA (1 μ), or in combination.  The potentiation by PEA and OEA was endothelium-independent and abolished by treatment with capsaicin (10 μ), which desensitizes the transient receptor potential vanilloid type 1 (TRPV1) receptor system, or by the TRPV1 receptor antagonist, N-(3-methoxyphenyl)-4-chlorocinnamide (SB366791) (2 μ).  It was also obsd. at molar ratios of anandamide and PEA (or OEA) similar to those found in mesenteric arteries.  PEA and inhibition of anandamide hydrolysis by 3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate (URB597) (1 μ) additively potentiated anandamide responses.  On the other hand, PEA and OEA also induced vasorelaxation per se (rank order of potency: anandamide > OEA > PEA), but relaxation to the three N-acylethanolamides displayed different sensitivity to treatment with capsaicin, SB366791 and URB597.  For example, relaxations to anandamide and OEA, but not PEA, were attenuated by both capsaicin and SB366791.  This study shows that PEA and OEA potentiate relaxant responses to anandamide through TRPV1 receptors in rat small mesenteric arteries.  The congeners also induce vasorelaxation per se, suggesting a function for the N-acylethanolamides in vascular control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDBOPl-3Uj7bVg90H21EOLACvtfcHk0lg0pBQlY48GUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb7M&md5=6697529871a930663642fa67f0b0f85e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.324%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DW.%2BS.%26aulast%3DBarrett%26aufirst%3DD.%2BA.%26aulast%3DRandall%26aufirst%3DM.%2BD.%26atitle%3D%25E2%2580%2598Entourage%25E2%2580%2599effects%2520of%2520N-palmitoylethanolamide%2520and%2520N-oleoylethanolamide%2520on%2520vasorelaxation%2520to%2520anandamide%2520occur%2520through%2520TRPV1%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D837%26epage%3D846%26doi%3D10.1038%2Fbjp.2008.324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+La+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0lg0pBQlY48GUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giang, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayfield, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilula, N. B.</span><span> </span><span class="NLM_article-title">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1038/384083a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2F384083a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=8900284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=83-87&author=B.+F.+Cravattauthor=D.+K.+Giangauthor=S.+P.+Mayfieldauthor=D.+L.+Bogerauthor=R.+A.+Lernerauthor=N.+B.+Gilula&title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&doi=10.1038%2F384083a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span></div><div class="casAuthors">Cravatt, Benjamin F.; Giang, Dan K.; Mayfield, Stephen P.; Boger, Dale L.; Lerner, Richard A.; Gilula, Norton B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604</span>),
    <span class="NLM_cas:pages">83-87</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Endogenous neuromodulatory mols.. are commonly couples to specific metabolic enzymes to ensure rapid signal inactivation.  Thus, acetylcholine is hydrolyzed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases.  Previously, we reported the structure and sleep-deproved cats.  Cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results).  We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid.  We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes.  We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling mols., the fatty-acid amides.  Therefore we will hereafter refer to oelamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhJfsk7jdmLVg90H21EOLACvtfcHk0lg0pBQlY48GUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D&md5=155095116ad61669c06c4b6dcc25e28a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F384083a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384083a0%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DMayfield%26aufirst%3DS.%2BP.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DLerner%26aufirst%3DR.%2BA.%26aulast%3DGilula%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520characterization%2520of%2520an%2520enzyme%2520that%2520degrades%2520neuromodulatory%2520fatty-acid%2520amides%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D83%26epage%3D87%26doi%3D10.1038%2F384083a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Jonsson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1263</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0704199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsj.bjp.0704199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=11498512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFKhsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2001&pages=1263-1275&author=K.+O.+Jonssonauthor=S.+Vandevoordeauthor=D.+M.+Lambertauthor=G.+Tigerauthor=C.+J.+Fowler&title=Effects+of+homologues+and+analogues+of+palmitoylethanolamide+upon+the+inactivation+of+the+endocannabinoid+anandamide&doi=10.1038%2Fsj.bjp.0704199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide</span></div><div class="casAuthors">Jonsson, Kent-Olov; Vandevoorde, Severine; Lambert, Didier M.; Tiger, Gunnar; Fowler, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1263-1275</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The ability of a series of homologs and analogs of palmitoylethanolamide to inhibit the uptake and fatty acid amidohydrolase (FAAH)-catalyzed hydrolysis of [3H]-anandamide ([3H]-AEA) has been investigated.  2 Palmitoylethanolamide and homologs with chain lengths from 12-18 carbon atoms inhibited rat brain [3H]-AEA metab. with pI50 values of ∼ 5.  Homologues with chain lengths ≤eight carbon atoms gave <20% inhibition at 100 μM.  3 R-palmitoyl-(2-methyl)ethanolamide, palmitoylisopropylamide and oleoylethanolamide inhibited [3H]-AEA metab. with pI50 values of 5.39 (competitive inhibition), 4.89 (mixed type inhibition) and 5.33 (mixed type inhibition), resp.  4 With the exception of oleoylethanolamide, the compds. did not produce dramatic inhibition of [3H]-WIN 55,212-2 binding to human CB2 receptors expressed on CHO cells.  Palmitoylethanolamide, palmitoylisopropylamide and R-palmitoyl-(2-methyl)ethanolamide had modest effects upon [3H]-CP 55,940 binding to human CB1 receptors expressed on CHO cells.  5 Most of the compds. had little effect upon the uptake of [3H]-AEA into C6 and/or RBL-2H3 cells.  However, palmitoylcyclohexamide (100 μM) and palmitoylisopropylamide (30 and 100 μM) produced more inhibition of [3H]-AEA uptake than expected to result from inhibition of [3H]-AEA metab. alone.  6 In intact C6 cells, palmitoylisopropylamide and oleoylethanolamide inhibited formation of [3H]-ethanolamine from [3H]-AEA to a similar extent as AM404, whereas palmitoylethanolamide, palmitoylcyclohexamide and R-palmitoyl-(2-methyl)ethanolamide were less effective.  7 These data provide useful information upon the ability of palmitoylethanolamide analogs to act as "entourage" compds.  Palmitoylisopropylamide may prove useful as a template for design of compds. that reduce the cellular accumulation and metab. of AEA without affecting either CB1 or CB2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplw6RBYKt53rVg90H21EOLACvtfcHk0ljza8EiR7dzXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFKhsbg%253D&md5=90ab7c81ff1efa8beaa19e2d8b3d5c05</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704199%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DK.%2BO.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DTiger%26aufirst%3DG.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DEffects%2520of%2520homologues%2520and%2520analogues%2520of%2520palmitoylethanolamide%2520upon%2520the%2520inactivation%2520of%2520the%2520endocannabinoid%2520anandamide%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D133%26spage%3D1263%26epage%3D1275%26doi%3D10.1038%2Fsj.bjp.0704199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bracey, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1796</span><span class="refDoi"> DOI: 10.1126/science.1076535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1126%2Fscience.1076535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12459591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1793-1796&author=M.+H.+Braceyauthor=M.+A.+Hansonauthor=K.+R.+Masudaauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Structural+adaptations+in+a+membrane+enzyme+that+terminates+endocannabinoid+signaling&doi=10.1126%2Fscience.1076535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling</span></div><div class="casAuthors">Bracey, Michael H.; Hanson, Michael A.; Masuda, Kim R.; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5599</span>),
    <span class="NLM_cas:pages">1793-1796</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular communication in the nervous system is mediated by chem. messengers that include amino acids, monoamines, peptide hormones, and lipids.  An interesting question is how neurons regulate signals that are transmitted by membrane-embedded lipids.  Here, we report the 2.8 angstrom crystal structure of the integral membrane protein fatty acid amide hydrolase (FAAH), an enzyme that degrades members of the endocannabinoid class of signaling lipids and terminates their activity.  The structure of FAAH complexed with an arachidonyl inhibitor reveals how a set of discrete structural alterations allows this enzyme, in contrast to sol. hydrolases of the same family, to integrate into cell membranes and establish direct access to the bilayer from its active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTj6G-8THMiLVg90H21EOLACvtfcHk0ljza8EiR7dzXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D&md5=01545bfbd00f31af713db259f41cb0ba</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076535%26sid%3Dliteratum%253Aachs%26aulast%3DBracey%26aufirst%3DM.%2BH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructural%2520adaptations%2520in%2520a%2520membrane%2520enzyme%2520that%2520terminates%2520endocannabinoid%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1793%26epage%3D1796%26doi%3D10.1126%2Fscience.1076535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Palermo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campomanes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlisberger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span> </span><span class="NLM_article-title">Anandamide hydrolysis in FAAH reveals a dual strategy for efficient enzyme-assisted amide bond cleavage <i>via</i> nitrogen inversion</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1021/jp5052276</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp5052276" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2015&pages=789-801&author=G.+Palermoauthor=P.+Campomanesauthor=A.+Cavalliauthor=U.+Rothlisbergerauthor=M.+De+Vivo&title=Anandamide+hydrolysis+in+FAAH+reveals+a+dual+strategy+for+efficient+enzyme-assisted+amide+bond+cleavage+via+nitrogen+inversion&doi=10.1021%2Fjp5052276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide Hydrolysis in FAAH Reveals a Dual Strategy for Efficient Enzyme-Assisted Amide Bond Cleavage via Nitrogen Inversion</span></div><div class="casAuthors">Palermo, Giulia; Campomanes, Pablo; Cavalli, Andrea; Rothlisberger, Ursula; De Vivo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-801</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we combined classical mol. dynamics (MD) and quantum mech./mol. mechanics (QM/MM) simulations to unravel the whole catalytic cycle of fatty acid amide hydrolase (FAAH) in complex with anandamide, the main neurotransmitters involved in the control of pain.  While microsecond MD simulations of FAAH in a realistic membrane/water environment provided a solid model for the reactant state of the enzymic complex, QM/MM simulations depict now a highly concerted two-step catalytic mechanism characterized by (1) acyl-enzyme formation after hydrolysis of the substrate amide bond and (2) deacylation reaction with restoration of the catalytic machinery.  We found that a crucial event for anandamide hydrolysis is the inversion of the reactive nitrogen of the scissile amide bond, which occurs during the acylation rate-limiting step.  We show that FAAH uses an exquisite catalytic strategy to induce amide bond distortion, reactive nitrogen inversion, and amide bond hydrolysis, promoting catalysis to completion.  This new strategy is likely to be of general applicability to other amidases/peptidases that show similar catalytic site architectures, providing crucial insights for de novo enzyme design or drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkUuuanDLcJLVg90H21EOLACvtfcHk0ljza8EiR7dzXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsr7N&md5=b6c738e9eb18172771070f5d7e8974b4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjp5052276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp5052276%26sid%3Dliteratum%253Aachs%26aulast%3DPalermo%26aufirst%3DG.%26aulast%3DCampomanes%26aufirst%3DP.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRothlisberger%26aufirst%3DU.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26atitle%3DAnandamide%2520hydrolysis%2520in%2520FAAH%2520reveals%2520a%2520dual%2520strategy%2520for%2520efficient%2520enzyme-assisted%2520amide%2520bond%2520cleavage%2520via%2520nitrogen%2520inversion%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2015%26volume%3D119%26spage%3D789%26epage%3D801%26doi%3D10.1021%2Fjp5052276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Structure and function of fatty acid amide hydrolase</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.74.082803.133450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1146%2Fannurev.biochem.74.082803.133450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15952893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2005&pages=411-432&author=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Structure+and+function+of+fatty+acid+amide+hydrolase&doi=10.1146%2Fannurev.biochem.74.082803.133450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of fatty acid amide hydrolase</span></div><div class="casAuthors">McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that degrades the fatty acid amide family of endogenous signaling lipids, which includes the endogenous cannabinoid, anandamide, and the sleep-inducing substance, oleamide.  FAAH belongs to a large and diverse class of enzymes referred to as the amidase signature (AS) family.  Investigations into the structure and function of FAAH, in combination with complementary studies of other AS enzymes, have engendered provocative mol. models to explain how this enzyme integrates into cell membranes and terminates fatty acid amide signaling in vivo.  These studies, as well as their biol. and therapeutic implications, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO7TpUTr6n7Vg90H21EOLACvtfcHk0lifCQYq6vMwPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D&md5=d28b43f14feb6894d48e907064087867</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.74.082803.133450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.74.082803.133450%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructure%2520and%2520function%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2005%26volume%3D74%26spage%3D411%26epage%3D432%26doi%3D10.1146%2Fannurev.biochem.74.082803.133450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kamerlin, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshel, A.</span><span> </span><span class="NLM_article-title">On catalytic preorganization in oxyanion holes: highlighting the problems with the gas-phase modeling of oxyanion holes and illustrating the need for complete enzyme models</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">6391</span><span class="NLM_x">–</span> <span class="NLM_lpage">6401</span><span class="refDoi"> DOI: 10.1021/jo100651s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo100651s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaisbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=6391-6401&author=S.+C.+Kamerlinauthor=Z.+T.+Chuauthor=A.+Warshel&title=On+catalytic+preorganization+in+oxyanion+holes%3A+highlighting+the+problems+with+the+gas-phase+modeling+of+oxyanion+holes+and+illustrating+the+need+for+complete+enzyme+models&doi=10.1021%2Fjo100651s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">On Catalytic Preorganization in Oxyanion Holes: Highlighting the Problems with the Gas-Phase Modeling of Oxyanion Holes and Illustrating the Need for Complete Enzyme Models</span></div><div class="casAuthors">Kamerlin, Shina C. L.; Chu, Zhen T.; Warshel, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6391-6401</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxyanion holes play a major role in catalyzing enzymic reactions, yet the corresponding energetics is frequently misunderstood.  The main problem may be assocd. with the nontrivial nature of the electrostatic preorganization effect, without following the relevant formulation.  That is, although the energetics of oxyanion holes have been fully quantified in early studies (which include both the enzymic and ref. soln. reactions), the findings of these studies are sometimes overlooked, and, in some cases, it is assumed that gas-phase calcns. with a fixed model of an oxyanion hole are sufficient for assessing the corresponding effect in the protein.  Herein, we present a systematic anal. of this issue, clarifying the problems assocd. with modeling oxyanions by means of two fixed water mols. (or related constructs).  We then re-emphasize the point that the effect of the oxyanion hole is mainly due to the fact that the relevant dipoles are already set in an orientation that stabilizes the TS charges, whereas the corresponding dipoles in soln. are randomly oriented, resulting in the need to pay a very large reorganization energy.  Simply calcg. interaction energies with relatively fixed species cannot capture this crucial point, and considering it may help in advancing rational enzyme design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEyHEtFmbHwrVg90H21EOLACvtfcHk0lifCQYq6vMwPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaisbfJ&md5=29f4644716f9a5c2664a97db0fa4b8f9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo100651s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100651s%26sid%3Dliteratum%253Aachs%26aulast%3DKamerlin%26aufirst%3DS.%2BC.%26aulast%3DChu%26aufirst%3DZ.%2BT.%26aulast%3DWarshel%26aufirst%3DA.%26atitle%3DOn%2520catalytic%2520preorganization%2520in%2520oxyanion%2520holes%253A%2520highlighting%2520the%2520problems%2520with%2520the%2520gas-phase%2520modeling%2520of%2520oxyanion%2520holes%2520and%2520illustrating%2520the%2520need%2520for%2520complete%2520enzyme%2520models%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D6391%26epage%3D6401%26doi%3D10.1021%2Fjo100651s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by α-ketoheterocycle inhibitors revealed from cocrystal structures</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">10497</span><span class="NLM_x">–</span> <span class="NLM_lpage">10506</span><span class="refDoi"> DOI: 10.1021/ja902694n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja902694n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=10497-10506&author=M.+Mileniauthor=J.+Garfunkleauthor=J.+K.+DeMartinoauthor=B.+F.+Cravattauthor=D.+L.+Bogerauthor=R.+C.+Stevens&title=Binding+and+inactivation+mechanism+of+a+humanized+fatty+acid+amide+hydrolase+by+%CE%B1-ketoheterocycle+inhibitors+revealed+from+cocrystal+structures&doi=10.1021%2Fja902694n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja902694n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902694n%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DDeMartino%26aufirst%3DJ.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DBinding%2520and%2520inactivation%2520mechanism%2520of%2520a%2520humanized%2520fatty%2520acid%2520amide%2520hydrolase%2520by%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520revealed%2520from%2520cocrystal%2520structures%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D10497%26epage%3D10506%26doi%3D10.1021%2Fja902694n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Palermo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campomanes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlisberger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span> </span><span class="NLM_article-title">Keys to lipid selection in fatty acid amide hydrolase catalysis: structural flexibility, gating residues and multiple binding pockets</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1004231</span><span class="refDoi"> DOI: 10.1371/journal.pcbi.1004231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1371%2Fjournal.pcbi.1004231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26111155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsV2htLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004231&author=G.+Palermoauthor=I.+Bauerauthor=P.+Campomanesauthor=A.+Cavalliauthor=A.+Armirottiauthor=S.+Girottoauthor=U.+Rothlisbergerauthor=M.+De+Vivo&title=Keys+to+lipid+selection+in+fatty+acid+amide+hydrolase+catalysis%3A+structural+flexibility%2C+gating+residues+and+multiple+binding+pockets&doi=10.1371%2Fjournal.pcbi.1004231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Keys to lipid selection in fatty acid amide hydrolase catalysis: structural flexibility, gating residues and multiple binding pockets</span></div><div class="casAuthors">Palermo, Giulia; Bauer, Inga; Campomanes, Pablo; Cavalli, Andrea; Armirotti, Andrea; Girotto, Stefania; Rothlisberger, Ursula; De Vivo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1004231/1-e1004231/25</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The fatty acid amide hydrolase (FAAH) regulates the endocannabinoid system, cleaving primarily the lipid messenger anandamide.  FAAH has been well characterized over the years, and importantly, it represents a promising drug target to treat several diseases, including inflammatory-related diseases and cancer.  But its enzymic mechanism for lipid selection to specifically hydrolyze anandamide, rather than similar bioactive lipids, remains elusive.  Here, we clarify this mechanism in FAAH, examg. the role of the dynamic paddle, which is formed by the gating residues Phe432 and Trp531 at the boundary between two cavities that form the FAAH catalytic site (the "membrane-access" and the "acyl chain-binding" pockets).  We integrate microsecond-long MD simulations of wild type and double mutant model systems (Phe432Ala and Trp531Ala) of FAAH, embedded in a realistic membrane/water environment, with mutagenesis and kinetic expts.  We comparatively analyze three fatty acid substrates with different hydrolysis rates (anandamide > oleamide > palmitoylethanolamide).  Our findings identify FAAH's mechanism to selectively accommodate anandamide into a multi-pocket binding site, and to properly orient the substrate in pre-reactive conformations for efficient hydrolysis that is interceded by the dynamic paddle.  Our findings therefore endorse a structural framework for a lipid selection mechanism mediated by structural flexibility and gating residues between multiple binding cavities, as found in FAAH.  Based on the available structural data, this exquisite catalytic strategy for substrate specificity seems to be shared by other lipid-degrading enzymes with similar enzymic architecture.  The mechanistic insights for lipid selection might assist de novo enzyme design or drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjpXtbYx6P0LVg90H21EOLACvtfcHk0lifCQYq6vMwPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsV2htLY%253D&md5=33224e5dcd45d20a14b6e3f60f7ca8e6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1004231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1004231%26sid%3Dliteratum%253Aachs%26aulast%3DPalermo%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DCampomanes%26aufirst%3DP.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DGirotto%26aufirst%3DS.%26aulast%3DRothlisberger%26aufirst%3DU.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26atitle%3DKeys%2520to%2520lipid%2520selection%2520in%2520fatty%2520acid%2520amide%2520hydrolase%2520catalysis%253A%2520structural%2520flexibility%252C%2520gating%2520residues%2520and%2520multiple%2520binding%2520pockets%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3De1004231%26doi%3D10.1371%2Fjournal.pcbi.1004231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ueda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span> </span><span class="NLM_article-title">Purification and characterization of an acid amidase selective for <i>N</i>-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">35552</span><span class="NLM_x">–</span> <span class="NLM_lpage">35557</span><span class="refDoi"> DOI: 10.1074/jbc.M106261200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M106261200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=11463796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=35552-35557&author=N.+Uedaauthor=K.+Yamanakaauthor=S.+Yamamoto&title=Purification+and+characterization+of+an+acid+amidase+selective+for+N-palmitoylethanolamine%2C+a+putative+endogenous+anti-inflammatory+substance&doi=10.1074%2Fjbc.M106261200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span></div><div class="casAuthors">Ueda, Natsuo; Yamanaka, Kenji; Yamamoto, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">35552-35557</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Arachidonoylethanolamine (anandamide) is cannabimimetic, and N-palmitoylethanolamine is anti-inflammatory and immunosuppressive.  We found an amidase that is more active with the latter than the former in contrast to the previously known anandamide amidohydrolase for which N-palmitoylethanolamine is a poor substrate.  Proteins solubilized by freezing and thawing from the 12,000 × g pellet of various rat organs hydrolyzed [14C]N-palmitoylethanolamine to palmitic acid and ethanolamine.  The specific enzyme activity was higher in the order of lung > spleen > small intestine > thymus > cecum, and high activity was found in peritoneal and alveolar macrophages.  The enzyme with a mol. mass of 31 kDa was purified from rat lung to a specific activity of 1.8 μmol/min/mg protein.  Relative reactivities of the enzyme with various N-acylethanolamines (100 μM) were as follows: N-palmitoylethanolamine, 100%; N-myristoylethanolamine, 48%; N-stearoylethanolamine, 21%; N-oleoylethanolamine, 20%; N-linoleoylethanolamine, 13%; anandamide, 8%.  The enzyme was the most active at pH 5 and was activated 7-fold by Triton X-100.  The enzyme was almost insensitive to Me arachidonyl fluorophosphonate, which inhibited anandamide amidohydrolase potently.  Thus, the new enzyme referred to as N-palmitoylethanolamine hydrolase was clearly distinguishable from anandamide amidohydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UIYxO9poNrVg90H21EOLACvtfcHk0lgM7lo2tnLnBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D&md5=b7bb8c14c642547023582e27c4c1d79e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106261200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106261200%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DPurification%2520and%2520characterization%2520of%2520an%2520acid%2520amidase%2520selective%2520for%2520N-palmitoylethanolamine%252C%2520a%2520putative%2520endogenous%2520anti-inflammatory%2520substance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D35552%26epage%3D35557%26doi%3D10.1074%2Fjbc.M106261200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Molecular characterization of <i>N</i>-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">11082</span><span class="NLM_x">–</span> <span class="NLM_lpage">11092</span><span class="refDoi"> DOI: 10.1074/jbc.M413473200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M413473200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15655246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11082-11092&author=K.+Tsuboiauthor=Y.+X.+Sunauthor=Y.+Okamotoauthor=N.+Arakiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+novel+member+of+the+choloylglycine+hydrolase+family+with+structural+and+functional+similarity+to+acid+ceramidase&doi=10.1074%2Fjbc.M413473200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Sun, Yong-Xin; Okamoto, Yasuo; Araki, Nobukazu; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">11082-11092</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines, including anandamide (an endocannabinoid) and N-palmitoylethanolamine (an anti-inflammatory and neuroprotective substance), are hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase.  Moreover, we found another amidohydrolase catalyzing the same reaction only at acidic pH, and we purified it from rat lung (Ueda, N., Yamanaka, K., and Yamamoto, S. (2001) J. Biol. Chem. 276, 35552-35557).  Here we report complementary DNA cloning and functional expression of the enzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)" from human, rat, and mouse.  The deduced primary structures revealed that NAAA had no homol. to fatty acid amide hydrolase but belonged to the choloylglycine hydrolase family.  Human NAAA was essentially identical to a gene product that had been noted to resemble acid ceramidase but lacked ceramide hydrolyzing activity.  The recombinant human NAAA overexpressed in HEK293 cells hydrolyzed various N-acylethanolamines with N-palmitoylethanolamine as the most reactive substrate.  Most interestingly, a very low ceramide hydrolyzing activity was also detected with NAAA, and N-lauroylethanolamine hydrolyzing activity was obsd. with acid ceramidase.  By the use of tunicamycin and endoglycosidase, NAAA was found to be a glycoprotein.  Furthermore, the enzyme was proteolytically processed to a shorter form at pH 4.5 but not at pH 7.4.  Expression anal. of a green fluorescent protein-NAAA fusion protein showed a lysosome-like distribution in HEK293 cells.  The organ distribution of the mRNA in rats revealed its wide distribution with the highest expression in lung.  These results demonstrated that NAAA is a novel N-acylethanolamine-hydrolyzing enzyme that shows structural and functional similarity to acid ceramidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWVjmZKJjGKLVg90H21EOLACvtfcHk0lgM7lo2tnLnBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D&md5=2b108cd3e23441001b040085eea0fdc0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413473200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413473200%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DN.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520novel%2520member%2520of%2520the%2520choloylglycine%2520hydrolase%2520family%2520with%2520structural%2520and%2520functional%2520similarity%2520to%2520acid%2520ceramidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11082%26epage%3D11092%26doi%3D10.1074%2Fjbc.M413473200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takezaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">The <i>N</i>-acylethanolamine-hydrolyzing acid amidase (NAAA)</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1914</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span><span class="refDoi"> DOI: 10.1002/cbdv.200790159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbdv.200790159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17712833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVelsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=1914-1925&author=K.+Tsuboiauthor=N.+Takezakiauthor=N.+Ueda&title=The+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1002%2Fcbdv.200790159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Tsuboi, Kazuhito; Takezaki, Naoko; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-1925</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Ra review.  Bioactive N-acylethanolamines, including the endocannabinoid anandamide and anti-inflammatory N-palmitoylethanolamine, are hydrolyzed to fatty acids and ethanolamine in animal tissues by the catalysis of fatty acid amide hydrolase (FAAH).  We recently cloned cDNA of N-acylethanolamine-hydrolyzing acid amidase (NAAA), another enzyme catalyzing the same reaction, from human, rat, and mouse.  NAAA reveals no sequence homol. with FAAH and belongs to the choloylglycine hydrolase family.  The most striking catalytic property of NAAA is pH optimum at 4.5-5, which is consistent with its immunocytochem. localization in lysosomes.  In rat, NAAA is highly expressed in lung, spleen, thymus, and intestine.  Notably, the expression level of NAAA is exceptionally high in rat alveolar macrophages.  The primary structure of NAAA exhibits 33-35% amino acid identity to that of acid ceramidase, a lysosomal enzyme hydrolyzing ceramide to fatty acid and sphingosine.  NAAA actually showed a low, but detectable ceramide-hydrolyzing activity, while acid ceramidase hydrolyzed N-lauroylethanolamine.  Thus, NAAA is a novel lysosomal hydrolase, which is structurally and functionally similar to acid ceramidase.  These results suggest a unique role of NAAA in the degrdn. of N-acylethanolamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcno9P-bI5IrVg90H21EOLACvtfcHk0lgM7lo2tnLnBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVelsLzJ&md5=d2e7ca65c420146103a3331268c7c510</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200790159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200790159%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTakezaki%26aufirst%3DN.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DThe%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DChem.%2520Biodiversity%26date%3D2007%26volume%3D4%26spage%3D1914%26epage%3D1925%26doi%3D10.1002%2Fcbdv.200790159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zhao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Proteolytic activation and glycosylation of <i>N</i>-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1771</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2007.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17980170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=1397-1405&author=L.+Y.+Zhaoauthor=K.+Tsuboiauthor=Y.+Okamotoauthor=S.+Nagahataauthor=N.+Ueda&title=Proteolytic+activation+and+glycosylation+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+lysosomal+enzyme+involved+in+the+endocannabinoid+metabolism&doi=10.1016%2Fj.bbalip.2007.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span></div><div class="casAuthors">Zhao, Li-Ying; Tsuboi, Kazuhito; Okamoto, Yasuo; Nagahata, Shunichiro; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1397-1405</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme hydrolyzing bioactive N-acylethanolamines, including anandamide and N-palmitoylethanolamine.  Previously, we suggested that NAAA is glycosylated and proteolytically cleaved.  Here, we investigated the mechanism and significance of the cleavage of human NAAA overexpressed in human embryonic kidney 293 cells.  Western blotting with anti-NAAA antibody revealed that most of NAAA in the cell homogenate was the cleaved 30-kDa form.  However, some of NAAA were released outside the cells and the extracellular enzyme was mostly the uncleaved 48-kDa form.  When incubated at pH 4.5, the 48-kDa form was time-dependently converted to the 30-kDa form with concomitant increase in the N-palmitoylethanolamine-hydrolyzing activity.  The purified 48-kDa form was also cleaved and activated.  However, the cleavage did not proceed at pH 7.4 or in the presence of p-chloromercuribenzoic acid.  The mutant C126S was resistant to the cleavage and remained inactive.  These results suggested that this specific proteolysis is a self-catalyzed activation step.  We next detd. N-glycosylation sites of human NAAA by site-directed mutagenesis addressed to asparagine residues in six potential N-glycosylation sites.  The results exhibited that Asn-37, Asn-107, Asn-309, and Asn-333 are actual N-glycosylation sites.  The glycosylation appeared to play an important role in stabilizing the enzyme protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFuWgy8q2PbVg90H21EOLACvtfcHk0lgxQ6Vbc49r4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J&md5=db9d83135905d5558679f307517e92b7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DNagahata%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DProteolytic%2520activation%2520and%2520glycosylation%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520lysosomal%2520enzyme%2520involved%2520in%2520the%2520endocannabinoid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D1397%26epage%3D1405%26doi%3D10.1016%2Fj.bbalip.2007.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Amino acid residues crucial in pH regulation and proteolytic activation of <i>N</i>-acylethanolamine-hydrolyzing acid amidase</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2008.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18793752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=710-717&author=J.+Wangauthor=L.+Y.+Zhaoauthor=T.+Uyamaauthor=K.+Tsuboiauthor=T.+Tonaiauthor=N.+Ueda&title=Amino+acid+residues+crucial+in+pH+regulation+and+proteolytic+activation+of+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1016%2Fj.bbalip.2008.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase</span></div><div class="casAuthors">Wang, Jun; Zhao, Li-Ying; Uyama, Toru; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">710-717</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme which hydrolyzes bioactive N-acylethanolamines, including anandamide and N-palmitoylethanolamine.  NAAA shows acidic pH optimum in terms of both catalytic activity and maturation by specific proteolysis.  However, mol. mechanism involved in this characteristic pH dependency remained unclear.  Here we report the important role of Glu-195 of human NAAA by analyzing the mutants E195A and E195Q over-expressed in human embryonic kidney 293 cells.  Concanamycin A, which raises lysosomal pH, inhibited maturation of the wild-type, but not of the Glu-195 mutants.  The purified precursors of the mutants, but not the wild-type, were proteolytically cleaved at pH 7.4 during 24-h incubation.  Furthermore, when assayed for N-palmitoylethanolamine-hydrolyzing activity at different pH, the mutants did not exhibit a sharp peak around pH 4.5 in the pH-dependent activity profile.  Mutants of seven other glutamic acid residues did not show such an abnormality.  These results suggested a unique role of Glu-195 in the pH-dependent activity and proteolytic maturation.  Moreover, Arg-142, Asp-145, and Asn-287 as well as previously identified Cys-126 were shown to be essential for the proteolytic activation.  Since these residues were predicted to be catalytically important, the results strongly suggested that the proteolysis occurs through an autocatalytic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJjRnXSxv8kbVg90H21EOLACvtfcHk0lgxQ6Vbc49r4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7jL&md5=29181122ead930d1b718d85f1977cd2f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DUyama%26aufirst%3DT.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DAmino%2520acid%2520residues%2520crucial%2520in%2520pH%2520regulation%2520and%2520proteolytic%2520activation%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D710%26epage%3D717%26doi%3D10.1016%2Fj.bbalip.2008.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Advances in the discovery of <i>N</i>-acylethanolamine acid amidase inhibitors</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1016/j.phrs.2014.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.phrs.2014.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24798679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=11-17&author=T.+Bandieraauthor=S.+Ponzanoauthor=D.+Piomelli&title=Advances+in+the+discovery+of+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.phrs.2014.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the discovery of N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Bandiera, Tiziano; Ponzano, Stefano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-Acylethanolamine acid amidase (NAAA) is a cysteine amidase that hydrolyzes satd. or monounsatd. fatty acid ethanolamides, such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA has been shown to exert analgesic and anti-inflammatory effects by engaging peroxisome proliferator-activated receptor-α.  Like other fatty acid ethanolamides, PEA is not stored in cells, but produced on demand from cell membrane precursors, and its actions are terminated by intracellular hydrolysis by either fatty acid amide hydrolase or NAAA.  Endogenous levels of PEA and OEA have been shown to decrease during inflammation.  Modulation of the tissue levels of PEA by inhibition of enzymes responsible for the breakdown of this lipid mediator may represent therefore a new therapeutic strategy for the treatment of pain and inflammation.  While a large no. of inhibitors of fatty acid amide hydrolase have been discovered, few compds. have been reported to inhibit NAAA activity.  Here, we describe the most representative NAAA inhibitors and briefly highlight their pharmacol. profile.  A recent study has shown that a NAAA inhibitor attenuated heat hyperalgesia and mech. allodynia caused by local inflammation or nerve damage in animal models of pain and inflammation.  This finding encourages further exploration of the pharmacol. of NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUwRrGiJPWfbVg90H21EOLACvtfcHk0lgxQ6Vbc49r4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D&md5=a8673471686df8f77b19ec318316e192</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAdvances%2520in%2520the%2520discovery%2520of%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2014%26volume%3D86%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.phrs.2014.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ueda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyama, T.</span><span> </span><span class="NLM_article-title"><i>N</i>-acylethanolamine metabolism with special reference to <i>N</i>-acylethanolamine-hydrolyzing acid amidase (NAAA)</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1016/j.plipres.2010.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.plipres.2010.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20152858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=299-315&author=N.+Uedaauthor=K.+Tsuboiauthor=T.+Uyama&title=N-acylethanolamine+metabolism+with+special+reference+to+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1016%2Fj.plipres.2010.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-315</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-acylethanolamines (NAEs) constitute a class of bioactive lipid mols. present in animal and plant tissues.  Among the NAEs, N-arachidonoylethanolamine (anandamide), N-palmitoylethanolamine, and N-oleoylethanolamine attract much attention due to cannabimimetic activity as an endocannabinoid, anti-inflammatory and analgesic activities, and anorexic activity, resp.  In mammalian tissues, NAEs are formed from glycerophospholipids through the phosphodiesterase-transacylation pathway consisting of Ca2+-dependent N-acyltransferase and N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.  Recent studies revealed the presence of alternative pathways and enzymes responsible for the NAE formation.  As for the degrdn. of NAEs, fatty acid amide hydrolase (FAAH), which hydrolyzes NAEs to fatty acids and ethanolamine, plays a central role.  However, a lysosomal enzyme referred to as NAE-hydrolyzing acid amidase (NAAA) also catalyzes the same reaction and may be a new target for the development of therapeutic drugs.  In this article we discuss recent progress in the studies on the enzymes involved in the biosynthesis and degrdn. of NAEs with special ref. to NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqB2KZKbKuLVg90H21EOLACvtfcHk0likA1lpPcKUQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK&md5=286dd6b1ccaa5965fb5ca79abcf859af</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2010.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2010.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26atitle%3DN-acylethanolamine%2520metabolism%2520with%2520special%2520reference%2520to%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2010%26volume%3D49%26spage%3D299%26epage%3D315%26doi%3D10.1016%2Fj.plipres.2010.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Karlsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellman, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, C.</span><span> </span><span class="NLM_article-title">cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase evolutionary relationship to esterases, lysophospholipases, and haloperoxidases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">27218</span><span class="NLM_x">–</span> <span class="NLM_lpage">27223</span><span class="refDoi"> DOI: 10.1074/jbc.272.43.27218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.272.43.27218" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=27218-27223&author=M.+Karlssonauthor=J.+A.+Contrerasauthor=U.+Hellmanauthor=H.+Tornqvistauthor=C.+Holm&title=cDNA+cloning%2C+tissue+distribution%2C+and+identification+of+the+catalytic+triad+of+monoglyceride+lipase+evolutionary+relationship+to+esterases%2C+lysophospholipases%2C+and+haloperoxidases&doi=10.1074%2Fjbc.272.43.27218"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.43.27218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.43.27218%26sid%3Dliteratum%253Aachs%26aulast%3DKarlsson%26aufirst%3DM.%26aulast%3DContreras%26aufirst%3DJ.%2BA.%26aulast%3DHellman%26aufirst%3DU.%26aulast%3DTornqvist%26aufirst%3DH.%26aulast%3DHolm%26aufirst%3DC.%26atitle%3DcDNA%2520cloning%252C%2520tissue%2520distribution%252C%2520and%2520identification%2520of%2520the%2520catalytic%2520triad%2520of%2520monoglyceride%2520lipase%2520evolutionary%2520relationship%2520to%2520esterases%252C%2520lysophospholipases%252C%2520and%2520haloperoxidases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D27218%26epage%3D27223%26doi%3D10.1074%2Fjbc.272.43.27218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauvois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1002/cbic.200900621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbic.200900621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19957260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=218-227&author=G.+Labarauthor=C.+Bauvoisauthor=F.+Borelauthor=J.+L.+Ferrerauthor=J.+Woutersauthor=D.+M.+Lambert&title=Crystal+structure+of+the+human+monoacylglycerol+lipase%2C+a+key+actor+in+endocannabinoid+signaling&doi=10.1002%2Fcbic.200900621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling</span></div><div class="casAuthors">Labar, Geoffray; Bauvois, Cedric; Borel, Franck; Ferrer, Jean-Luc; Wouters, Johan; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-227</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol plays a major role in endocannabinoid signaling, and is tightly regulated by monoacylglycerol lipase (MAGL).  Here, the authors report the crystal structure of human MAGL.  The protein crystd. as a dimer, and despite structural homologies to haloperoxidases and esterases, it distinguished itself by a wide and hydrophobic access to the catalytic site.  An apolar helix covering the active site also gave structural insight into the amphotropic character of MAGL, and likely explains how MAGL interacts with membranes to recruit its substrate.  Docking of 2-arachidonoylglycerol highlighted a hydrophobic and a hydrophilic cavity that accommodated the lipid into the catalytic site.  Moreover, the authors identified Cys-201 as the crucial residue in MAGL inhibition by N-arachidonylmaleimide, a SH group-reactive compd.  In addn. to the advance in the knowledge of endocannabinoids degrdn. routes, the structure of MAGL paves the way for future medicinal chem. results aimed at the design of new drugs exploiting 2-arachidonoylglycerol transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomb-R4j6WugrVg90H21EOLACvtfcHk0likA1lpPcKUQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D&md5=3caddaf36eb688fa3aeea940f6441b36</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900621%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3DBorel%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.%2BL.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520monoacylglycerol%2520lipase%252C%2520a%2520key%2520actor%2520in%2520endocannabinoid%2520signaling%26jtitle%3DChemBioChem%26date%3D2010%26volume%3D11%26spage%3D218%26epage%3D227%26doi%3D10.1002%2Fcbic.200900621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheuret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoornaert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">Structural basis for human monoglyceride lipase inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.11.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.jmb.2009.11.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19962385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=663-673&author=T.+Bertrandauthor=F.+Aug%C3%A9author=J.+Houtmannauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=V.+Mikolauthor=P.+Berneauthor=N.+Michotauthor=D.+Cheuretauthor=C.+Hoornaertauthor=M.+Mathieu&title=Structural+basis+for+human+monoglyceride+lipase+inhibition&doi=10.1016%2Fj.jmb.2009.11.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Human Monoglyceride Lipase Inhibition</span></div><div class="casAuthors">Bertrand, T.; Auge, F.; Houtmann, J.; Rak, A.; Vallee, F.; Mikol, V.; Berne, P. F.; Michot, N.; Cheuret, D.; Hoornaert, C.; Mathieu, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) is a serine hydrolase that hydrolyzes 2-arachidonoylglycerol (2-AG) into arachidonic acid and glycerol.  2-AG is an endogenous ligand of cannabinoid receptors, involved in various physiol. processes in the brain.  We present here the first crystal structure of human MGL in its apo form and in complex with the covalent inhibitor SAR629.  MGL shares the classic fold of the α/β hydrolase family but depicts an unusually large hydrophobic occluded tunnel with a highly flexible lid at its entry and the catalytic triad buried at its end.  Structures reveal the configuration of the catalytic triad and the shape and nature of the binding site of 2-AG.  The bound structure of SAR629 highlights the key interactions for productive binding with MGL.  The shape of the tunnel suggests a high druggability of the protein and provides an attractive template for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRiDWkFIBQObVg90H21EOLACvtfcHk0lg3-AbcbD9VKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D&md5=149fa9052c872b50c71e4d95d3c967d7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.11.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.11.060%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DAug%25C3%25A9%26aufirst%3DF.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DBerne%26aufirst%3DP.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DCheuret%26aufirst%3DD.%26aulast%3DHoornaert%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520human%2520monoglyceride%2520lipase%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D396%26spage%3D663%26epage%3D673%26doi%3D10.1016%2Fj.jmb.2009.11.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><div class="note"><p class="first last">Bertrand and co-workers purified another isoform of human MAGL (Q6IBG9_HUMAN) consisting of 313 amino acids vs 303 for the previously described isoform (Q99685_HUMAN). Thus, X-ray crystal structures of MAGL disclosed by Bertrand’s team exhibit the numbering discrepancy (i.e., Ser132-Asp249-His279 acts as the catalytic triad instead of Ser-122-Asp239-His269).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bertrand+and+co-workers+purified+another+isoform+of+human+MAGL+%28Q6IBG9_HUMAN%29+consisting+of+313+amino+acids+vs+303+for+the+previously+described+isoform+%28Q99685_HUMAN%29.+Thus%2C+X-ray+crystal+structures+of+MAGL+disclosed+by+Bertrand%E2%80%99s+team+exhibit+the+numbering+discrepancy+%28i.e.%2C+Ser132-Asp249-His279+acts+as+the+catalytic+triad+instead+of+Ser-122-Asp239-His269%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2607</span><span class="refDoi"> DOI: 10.2174/092986710791859414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.2174%2F092986710791859414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20491633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2588-2607&author=G.+Labarauthor=J.+Woutersauthor=D.+M.+Lambert&title=A+review+on+the+monoacylglycerol+lipase%3A+at+the+interface+between+fat+and+endocannabinoid+signalling&doi=10.2174%2F092986710791859414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling</span></div><div class="casAuthors">Labar, G.; Wouters, J.; Lambert, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2588-2607</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Together with anandamide, 2-arachidonoylglycerol (2-AG) constitutes one of the main representatives of a family of endogenous lipids known as endocannabinoids.  These act by binding to CB1 and CB2 cannabinoid receptors, the mol. target of the psychoactive compd. Δ9-THC, both in the periphery and in the central nervous system, where they behave as retrograde messengers to modulate synaptic transmission.  These last years, evidence has accumulated to demonstrate the lead role played by the monoacylglycerol lipase (MAGL) in the regulation of 2-arachidonoylglycerol (2-AG) levels.  Considering the numerous physiol. functions played by this endocannabinoid, MAGL is now considered a promising target for therapeutics, as inhibitors of this enzyme could reveal useful for the treatment of pain and inflammatory disorders, as well as in cancer research, among others.  Here we review the milestones that punctuated MAGL history, from its discovery to recent advances in the field of inhibitors development.  An emphasis is given on the recent elucidation of the tridimensional structure of the enzyme, which could offer new opportunities for rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUHXu1GAauLVg90H21EOLACvtfcHk0lg3-AbcbD9VKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK&md5=bff89a0988768b26b17604ec38bf70df</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F092986710791859414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859414%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DA%2520review%2520on%2520the%2520monoacylglycerol%2520lipase%253A%2520at%2520the%2520interface%2520between%2520fat%2520and%2520endocannabinoid%2520signalling%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2588%26epage%3D2607%26doi%3D10.2174%2F092986710791859414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salo, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, R.</span><span> </span><span class="NLM_article-title">Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2005.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2005.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15975510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=649-656&author=S.+M.+Saarioauthor=O.+M.+Saloauthor=T.+Nevalainenauthor=A.+Posoauthor=J.+T.+Laitinenauthor=T.+J%C3%A4rvinenauthor=R.+Niemi&title=Characterization+of+the+sulfhydryl-sensitive+site+in+the+enzyme+responsible+for+hydrolysis+of+2-arachidonoyl-glycerol+in+rat+cerebellar+membranes&doi=10.1016%2Fj.chembiol.2005.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes</span></div><div class="casAuthors">Saario, Susanna M.; Salo, Outi M. H.; Nevalainen, Tapio; Poso, Antti; Laitinen, Jarmo T.; Jaervinen, Tomi; Niemi, Riku</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">649-656</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: We have previously reported that the endocannabinoid, 2-arachidonoyl-glycerol (2-AG), is hydrolyzed in rat cerebellar membranes by monoglyceride lipase (MGL)-like enzymic activity.  The present study shows that, like MGL, 2-AG-degrading enzymic activity is sensitive to inhibition by sulfhydryl-specific reagents.  Inhibition studies of this enzymic activity by N-ethylmaleimide analogs revealed that analogs with bulky hydrophobic N-substitution were more potent inhibitors than hydrophilic or less bulky agents.  Interestingly, the substrate analog N-arachidonylmaleimide was found to be the most potent inhibitor.  A comparison model of MGL was constructed to get a view on the cysteine residues located near the binding site.  These findings support our previous conclusion that the 2-AG-degrading enzymic activity in rat cerebellar membranes corresponds to MGL or MGL-like enzyme and should facilitate further efforts to develop potent and more selective MGL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIe8FWTM802bVg90H21EOLACvtfcHk0lhZ40P3iM5alw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7w%253D&md5=52dc6f35fc0954a0216df0ed1cb7e2e9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DSalo%26aufirst%3DO.%2BM.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DNiemi%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520the%2520sulfhydryl-sensitive%2520site%2520in%2520the%2520enzyme%2520responsible%2520for%2520hydrolysis%2520of%25202-arachidonoyl-glycerol%2520in%2520rat%2520cerebellar%2520membranes%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D649%26epage%3D656%26doi%3D10.1016%2Fj.chembiol.2005.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotsey, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghomian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Discovery of potent and reversible monoacylglycerol lipase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1052</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19875078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCnt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=1045-1052&author=A.+R.+Kingauthor=E.+Y.+Dotseyauthor=A.+Lodolaauthor=K.+M.+Jungauthor=A.+Ghomianauthor=Y.+Qiuauthor=J.+Fuauthor=M.+Morauthor=D.+Piomelli&title=Discovery+of+potent+and+reversible+monoacylglycerol+lipase+inhibitors&doi=10.1016%2Fj.chembiol.2009.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors</span></div><div class="casAuthors">King, Alvin R.; Dotsey, Emmanuel Y.; Lodola, Alessio; Jung, Kwang Mook; Ghomian, Azar; Qiu, Yan; Fu, Jin; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1045-1052</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Monoacylglycerol lipase (MGL) is a serine hydrolase involved in the biol. deactivation of the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG).  Previous efforts to design MGL inhibitors have focused on chem. scaffolds that irreversibly block the activity of this enzyme.  Here, we describe two naturally occurring terpenoids, pristimerin and euphol, which inhibit MGL activity with high potency (median effective concn., IC50 = 93 nM and 315 nM, resp.) through a reversible mechanism.  Mutational and modeling studies suggest that the two agents occupy a common hydrophobic pocket located within the putative lid domain of MGL, and each reversibly interacts with one of two adjacent cysteine residues (Cys201 and Cys208) flanking such pocket.  This previously unrecognized regulatory region might offer a mol. target for potent and reversible inhibitors of MGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywJC_pwcNjrVg90H21EOLACvtfcHk0lgY_Dd7aN0lbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCnt7bE&md5=b36dfed9cf065754986f599836d053a3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDotsey%26aufirst%3DE.%2BY.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DGhomian%26aufirst%3DA.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520reversible%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D1045%26epage%3D1052%26doi%3D10.1016%2Fj.chembiol.2009.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2009.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19635411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=744-753&author=J.+Z.+Longauthor=D.+K.+Nomuraauthor=B.+F.+Cravatt&title=Characterization+of+monoacylglycerol+lipase+inhibition+reveals+differences+in+central+and+peripheral+endocannabinoid+metabolism&doi=10.1016%2Fj.chembiol.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism</span></div><div class="casAuthors">Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">744-753</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Monoacylglycerol lipase (MAGL) is a principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG).  The authors recently reported a piperidine carbamate, JZL184, that inhibits MAGL with high potency and selectivity.  Here, the authors describe a comprehensive mechanistic characterization of JZL184.  The authors provide evidence that JZL184 irreversibly inhibits MAGL via carbamoylation of the enzyme's serine nucleophile.  Functional proteomic anal. of mice treated with JZL184 revealed that this inhibitor maintains good selectivity for MAGL across a wide range of central and peripheral tissues.  Interestingly, MAGL blockade produced marked, tissue-specific differences in monoglyceride metab., with brain showing the most dramatic elevations in 2-AG and peripheral tissues often showing greater changes in other monoglycerides.  Collectively, these studies indicate that MAGL exerts tissue-dependent control over endocannabinoid and monoglyceride metab. and designate JZL184 as a selective tool to characterize the functions of MAGL in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-iZXIq9TSLVg90H21EOLACvtfcHk0lgY_Dd7aN0lbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D&md5=020a5cb6ac9430ba9d3eac3c7b9ba216</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DCharacterization%2520of%2520monoacylglycerol%2520lipase%2520inhibition%2520reveals%2520differences%2520in%2520central%2520and%2520peripheral%2520endocannabinoid%2520metabolism%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D744%26epage%3D753%26doi%3D10.1016%2Fj.chembiol.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Sharma, R.</span><span> </span><span class="NLM_article-title">Enzyme Inhibition: Mechanisms and Scope</span>. In  <span class="citation_source-book">Enzyme Inhibition and Bioapplications</span>; <span class="NLM_contrib-group">Sharma, R.</span>, Ed.; <span class="NLM_publisher-name">InTech</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>DOI: <span class="refDoi"> DOI: 10.5772/39273</span> , <a href="http://www.intechopen.com/books/enzyme-inhibition-and-bioapplications/enzyme-inhibition-mechanisms-and-scope" class="extLink">http://www.intechopen.com/books/enzyme-inhibition-and-bioapplications/enzyme-inhibition-mechanisms-and-scope</a>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.5772%2F39273" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Sharmaauthor=R.+Sharma&title=Enzyme+Inhibition+and+Bioapplications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.5772%2F39273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F39273%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26atitle%3DEnzyme%2520Inhibition%253A%2520Mechanisms%2520and%2520Scope%26btitle%3DEnzyme%2520Inhibition%2520and%2520Bioapplications%26aulast%3DSharma%26aufirst%3DR.%26pub%3DInTech%26date%3D2012%26doi%3D10.5772%2F39273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">13019</span><span class="NLM_x">–</span> <span class="NLM_lpage">13030</span><span class="refDoi"> DOI: 10.1021/bi701378g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi701378g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyiurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=13019-13030&author=K.+Ahnauthor=D.+S.+Johnsonauthor=L.+R.+Fitzgeraldauthor=M.+Liimattaauthor=A.+Arendseauthor=T.+Stevensonauthor=E.+T.+Lundauthor=R.+A.+Nugentauthor=T.+K.+Nomanbhoyauthor=J.+P.+Alexanderauthor=B.+F.+Cravatt&title=Novel+mechanistic+class+of+fatty+acid+amide+hydrolase+inhibitors+with+remarkable+selectivity&doi=10.1021%2Fbi701378g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity</span></div><div class="casAuthors">Ahn, Kyunghye; Johnson, Douglas S.; Fitzgerald, Laura R.; Liimatta, Marya; Arendse, Andrea; Stevenson, Tracy; Lund, Eric. T.; Nugent, Richard A.; Nomanbhoy, Tyzoon K.; Alexander, Jessica P.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">13019-13030</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane enzyme that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic, anti-inflammatory, anxiolytic, and antidepressant phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for treatment of pain, inflammation, and other central nervous system disorders.  However, the FAAH inhibitors reported to date lack drug-like pharmacokinetic properties and/or selectivity.  Herein the authors describe piperidine/piperazine ureas represented by N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750) and N-phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide (PF-622) as a novel mechanistic class of FAAH inhibitors.  PF-750 and PF-622 show higher in vitro potencies than previously established classes of FAAH inhibitors.  Rather unexpectedly based on the high chem. stability of the urea functional group, PF-750 and PF-622 were found to inhibit FAAH in a time-dependent manner by covalently modifying the enzyme's active site serine nucleophile.  Activity-based proteomic profiling revealed that PF-750 and PF-622 were completely selective for FAAH relative to other mammalian serine hydrolases.  The authors hypothesize that this remarkable specificity derives, at least in part, from FAAH's special ability to function as a C(O)-N bond hydrolase, which distinguishes it from the vast majority of metabolic serine hydrolases in mammals that are restricted to hydrolyzing esters and/or thioesters.  The piperidine/piperazine urea may thus represent a privileged chem. scaffold for the synthesis of FAAH inhibitors that display an unprecedented combination of potency and selectivity for use as potential analgesic and anxiolytic/antidepressant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3NGZiH1DJ-rVg90H21EOLACvtfcHk0lgSxSY6Ai7h1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyiurjM&md5=eb6f7945ff233b6fc0fea6b8677ecc87</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi701378g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701378g%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DFitzgerald%26aufirst%3DL.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DArendse%26aufirst%3DA.%26aulast%3DStevenson%26aufirst%3DT.%26aulast%3DLund%26aufirst%3DE.%2BT.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DNovel%2520mechanistic%2520class%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520with%2520remarkable%2520selectivity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D13019%26epage%3D13030%26doi%3D10.1021%2Fbi701378g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7327</span><span class="NLM_x">–</span> <span class="NLM_lpage">7343</span><span class="refDoi"> DOI: 10.1021/jm800311k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800311k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7327-7343&author=M.+Seierstadauthor=J.+G.+Breitenbucher&title=Discovery+and+development+of+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1021%2Fjm800311k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm800311k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800311k%26sid%3Dliteratum%253Aachs%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7327%26epage%3D7343%26doi%3D10.1021%2Fjm800311k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Deutsch, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omeir, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arreaza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, A.</span><span> </span><span class="NLM_article-title">Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1016/S0006-2952(96)00830-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0006-2952%2896%2900830-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=255-260&author=D.+G.+Deutschauthor=R.+Omeirauthor=G.+Arreazaauthor=D.+Salehaniauthor=G.+D.+Prestwichauthor=Z.+Huangauthor=A.+Howlett&title=Methyl+arachidonyl+fluorophosphonate%3A+a+potent+irreversible+inhibitor+of+anandamide+amidase&doi=10.1016%2FS0006-2952%2896%2900830-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2896%2900830-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252896%252900830-1%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DD.%2BG.%26aulast%3DOmeir%26aufirst%3DR.%26aulast%3DArreaza%26aufirst%3DG.%26aulast%3DSalehani%26aufirst%3DD.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DHowlett%26aufirst%3DA.%26atitle%3DMethyl%2520arachidonyl%2520fluorophosphonate%253A%2520a%2520potent%2520irreversible%2520inhibitor%2520of%2520anandamide%2520amidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D53%26spage%3D255%26epage%3D260%26doi%3D10.1016%2FS0006-2952%2896%2900830-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1016/S0960-894X(98)00734-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0960-894X%2898%2900734-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=265-270&author=D.+L.+Bogerauthor=H.+Satoauthor=A.+E.+Lernerauthor=B.+J.+Austinauthor=J.+E.+Pattersonauthor=M.+P.+Patricelliauthor=B.+F.+Cravatt&title=Trifluoromethyl+ketone+inhibitors+of+fatty+acid+amide+hydrolase%3A+a+probe+of+structural+and+conformational+features+contributing+to+inhibition&doi=10.1016%2FS0960-894X%2898%2900734-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900734-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900734-3%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DLerner%26aufirst%3DA.%2BE.%26aulast%3DAustin%26aufirst%3DB.%2BJ.%26aulast%3DPatterson%26aufirst%3DJ.%2BE.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DTrifluoromethyl%2520ketone%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520a%2520probe%2520of%2520structural%2520and%2520conformational%2520features%2520contributing%2520to%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D265%26epage%3D270%26doi%3D10.1016%2FS0960-894X%2898%2900734-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">α-Ketoheterocycle-based inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1021/cn2001206</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn2001206" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=340-348&author=K.+Otrubovaauthor=D.+L.+Boger&title=%CE%B1-Ketoheterocycle-based+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1021%2Fcn2001206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">α-Ketoheterocycle-Based Inhibitors of Fatty Acid Amide Hydrolase (FAAH)</span></div><div class="casAuthors">Otrubova, Katerina; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">340-348</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A summary of the initial discovery and characterization of the enzyme fatty acid amide hydrolase (FAAH), and the subsequent advancement of an important class of competitive, reversible, potent, and selective inhibitors is presented.  Initially explored using substrate-inspired inhibitors bearing electrophilic carbonyls, the examn. of α-ketoheterocyle-based inhibitors of FAAH with the benefit of a unique activity-based protein-profiling (ABPP)-based proteome-wide selectivity assay, a powerful in vivo biomarker-based in vivo screen, and subsequent retrospective x-ray cocrystal structures with the enzyme, is summarized.  These efforts defined the impact of the central activating heterocycle and its key substituents, provided key simplifications in the C2 acyl side chain and clear interpretations for the unique role and subsequent optimization of the central activating heterocycle, and established the basis for the recent further conformational constraints in the C2 acyl side chain, providing potent, long-acting, orally active FAAH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4v_VJgMuMirVg90H21EOLACvtfcHk0lgSxSY6Ai7h1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtL3E&md5=e44d87e37c2f21bb7e7400bb1bc1f674</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fcn2001206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2001206%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3D%25CE%25B1-Ketoheterocycle-based%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D340%26epage%3D348%26doi%3D10.1021%2Fcn2001206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fecik, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5044</span><span class="NLM_x">–</span> <span class="NLM_lpage">5049</span><span class="refDoi"> DOI: 10.1073/pnas.97.10.5044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.97.10.5044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10805767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVWnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5044-5049&author=D.+L.+Bogerauthor=H.+Satoauthor=A.+E.+Lernerauthor=M.+P.+Hedrickauthor=R.+A.+Fecikauthor=H.+Miyauchiauthor=G.+D.+Wilkieauthor=B.+J.+Austinauthor=M.+P.+Patricelliauthor=B.+F.+Cravatt&title=Exceptionally+potent+inhibitors+of+fatty+acid+amide+hydrolase%3A+the+enzyme+responsible+for+degradation+of+endogenous+oleamide+and+anandamide&doi=10.1073%2Fpnas.97.10.5044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide</span></div><div class="casAuthors">Boger, Dale L.; Sato, Haruhiko; Lerner, Aaron E.; Hedrick, Michael P.; Fecik, Robert A.; Miyauchi, Hiroshi; Wilkie, Gordon D.; Austin, Bryce J.; Patricelli, Matthew P.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5044-5049</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The development of exceptionally potent inhibitors of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of oleamide (an endogenous sleep-inducing lipid), and anandamide (an endogenous ligand for cannabinoid receptors) is detailed.  The inhibitors may serve as useful tools to clarify the role of endogenous oleamide and anandamide and may prove to be useful therapeutic agents for the treatment of sleep disorders or pain.  The combination of several features-an optimal C12-C8 chain length, π-unsatn. introduction at the corresponding arachidonoyl Δ8,9/Δ11,12 and oleoyl Δ9,10 location, and an α-keto N4 oxazolopyridine with incorporation of a second weakly basic nitrogen provided FAAH inhibitors with Kis that drop below 200 pM and are 102-103 times more potent than the corresponding trifluoromethyl ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7Wa9yOfljbVg90H21EOLACvtfcHk0lgeVNbX6VLgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVWnsb8%253D&md5=1453ebc1c8382f0c44b93c029655a40f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.10.5044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.10.5044%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DLerner%26aufirst%3DA.%2BE.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DFecik%26aufirst%3DR.%2BA.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DWilkie%26aufirst%3DG.%2BD.%26aulast%3DAustin%26aufirst%3DB.%2BJ.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DExceptionally%2520potent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520the%2520enzyme%2520responsible%2520for%2520degradation%2520of%2520endogenous%2520oleamide%2520and%2520anandamide%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D5044%26epage%3D5049%26doi%3D10.1073%2Fpnas.97.10.5044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span> </span><span class="NLM_article-title">α-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and α-substitution</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1520</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00211-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0960-894X%2801%2900211-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1517-1520&author=D.+L.+Bogerauthor=H.+Miyauchiauthor=M.+P.+Hedrick&title=%CE%B1-Keto+heterocycle+inhibitors+of+fatty+acid+amide+hydrolase%3A+carbonyl+group+modification+and+%CE%B1-substitution&doi=10.1016%2FS0960-894X%2801%2900211-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900211-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900211-6%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26atitle%3D%25CE%25B1-Keto%2520heterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520carbonyl%2520group%2520modification%2520and%2520%25CE%25B1-substitution%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1517%26epage%3D1520%26doi%3D10.1016%2FS0960-894X%2801%2900211-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4100</span><span class="refDoi"> DOI: 10.1021/ja110877y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja110877y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=4092-4100&author=M.+Mileniauthor=J.+Garfunkleauthor=C.+Ezziliauthor=B.+F.+Cravattauthor=R.+C.+Stevensauthor=D.+L.+Boger&title=Fluoride-mediated+capture+of+a+noncovalent+bound+state+of+a+reversible+covalent+enzyme+inhibitor%3A+X-ray+crystallographic+analysis+of+an+exceptionally+potent+%CE%B1-ketoheterocycle+inhibitor+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fja110877y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja110877y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja110877y%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DFluoride-mediated%2520capture%2520of%2520a%2520noncovalent%2520bound%2520state%2520of%2520a%2520reversible%2520covalent%2520enzyme%2520inhibitor%253A%2520X-ray%2520crystallographic%2520analysis%2520of%2520an%2520exceptionally%2520potent%2520%25CE%25B1-ketoheterocycle%2520inhibitor%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D4092%26epage%3D4100%26doi%3D10.1021%2Fja110877y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fecik, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acevedo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimarães, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and efficacious class of reversible α-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span><span class="refDoi"> DOI: 10.1021/jm049614v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049614v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFSlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1849-1856&author=D.+L.+Bogerauthor=H.+Miyauchiauthor=W.+Duauthor=C.+Hardouinauthor=R.+A.+Fecikauthor=H.+Chengauthor=I.+Hwangauthor=M.+P.+Hedrickauthor=D.+Leungauthor=O.+Acevedoauthor=C.+R.+Guimar%C3%A3esauthor=W.+L.+Jorgensenauthor=B.+F.+Cravatt&title=Discovery+of+a+potent%2C+selective%2C+and+efficacious+class+of+reversible+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase+effective+as+analgesics&doi=10.1021%2Fjm049614v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics</span></div><div class="casAuthors">Boger, Dale L.; Miyauchi, Hiroshi; Du, Wu; Hardouin, Christophe; Fecik, Robert A.; Cheng, Heng; Hwang, Inkyu; Hedrick, Michael P.; Leung, Donmienne; Acevedo, Orlando; Guimaraes, Cristiano R. W.; Jorgensen, William L.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1849-1856</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) degrades neuromodulating fatty acid amides including anandamide (endogenous cannabinoid agonist) and oleamide (sleep-inducing lipid) at their sites of action and is intimately involved in their regulation.  Herein the authors report the discovery of a potent, selective, and efficacious class of reversible FAAH inhibitors that produce analgesia in animal models validating a new therapeutic target for pain intervention.  Key to the useful inhibitor discovery was the routine implementation of a proteomics-wide selectivity screen against the serine hydrolase superfamily ensuring selectivity for FAAH coupled with systematic in vivo examns. of candidate inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLT1X7kSm1TbVg90H21EOLACvtfcHk0lgeVNbX6VLgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFSlsrg%253D&md5=f840707597fa1c4cad6cf61329a4504e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm049614v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049614v%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DFecik%26aufirst%3DR.%2BA.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DAcevedo%26aufirst%3DO.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520class%2520of%2520reversible%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520effective%2520as%2520analgesics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1849%26epage%3D1856%26doi%3D10.1021%2Fjm049614v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2004.12.085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1423-1428&author=D.+Leungauthor=W.+Duauthor=C.+Hardouinauthor=H.+Chengauthor=I.+Hwangauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Discovery+of+an+exceptionally+potent+and+selective+class+of+fatty+acid+amide+hydrolase+inhibitors+enlisting+proteome-wide+selectivity+screening%3A+concurrent+optimization+of+enzyme+inhibitor+potency+and+selectivity&doi=10.1016%2Fj.bmcl.2004.12.085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.085%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DDiscovery%2520of%2520an%2520exceptionally%2520potent%2520and%2520selective%2520class%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520enlisting%2520proteome-wide%2520selectivity%2520screening%253A%2520concurrent%2520optimization%2520of%2520enzyme%2520inhibitor%2520potency%2520and%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1423%26epage%3D1428%26doi%3D10.1016%2Fj.bmcl.2004.12.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">DeMartino, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Exploration of a fundamental substituent effect of α-ketoheterocycle enzyme inhibitors: potent and selective inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5842</span><span class="NLM_x">–</span> <span class="NLM_lpage">5846</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2008.06.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5842-5846&author=J.+K.+DeMartinoauthor=J.+Garfunkleauthor=D.+G.+Hochstatterauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Exploration+of+a+fundamental+substituent+effect+of+%CE%B1-ketoheterocycle+enzyme+inhibitors%3A+potent+and+selective+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2008.06.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.084%26sid%3Dliteratum%253Aachs%26aulast%3DDeMartino%26aufirst%3DJ.%2BK.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DExploration%2520of%2520a%2520fundamental%2520substituent%2520effect%2520of%2520%25CE%25B1-ketoheterocycle%2520enzyme%2520inhibitors%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5842%26epage%3D5846%26doi%3D10.1016%2Fj.bmcl.2008.06.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span> </span><span class="NLM_article-title">Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsj.bjp.0706699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=16501580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2ltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=102-113&author=L.+Changauthor=L.+Luoauthor=J.+A.+Palmerauthor=S.+Suttonauthor=S.+J.+Wilsonauthor=A.+J.+Barbierauthor=J.+G.+Breitenbucherauthor=S.+R.+Chaplanauthor=M.+Webb&title=Inhibition+of+fatty+acid+amide+hydrolase+produces+analgesia+by+multiple+mechanisms&doi=10.1038%2Fsj.bjp.0706699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms</span></div><div class="casAuthors">Chang, Leon; Luo, Lin; Palmer, James A.; Sutton, Steven; Wilson, Sandy J.; Barbier, Ann J.; Breitenbucher, James Guy; Chaplan, Sandra R.; Webb, Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-113</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The reversible fatty acid amide hydrolase (FAAH) inhibitor OL135 reverses mech. allodynia in the spinal nerve ligation (SNL) and mild thermal injury (MTI) models in the rat.  The purpose of this study was to investigate the role of the cannabinoid and opioid systems in mediating this analgesic effect.  Elevated brain concns. of anandamide (350 pmol g-1 of tissue vs. 60 pmol g-1 in vehicle-treated controls) were found in brains of rats given OL135 (20 mg kg-1) i.p. 15 min prior to 20 mg kg-1 i.p. anandamide.  Predosing rats with OL135 (2-60 mg kg-1 i.p.) 30 min before administration of an irreversible FAAH inhibitor (URB597: 0.3 mg kg-1 intracardiac) was found to protect brain FAAH from irreversible inactivation.  The level of enzyme protection was correlated with the OL135 concns. in the same brains.  OL135 (100 mg kg-1 i.p.) reduced by 50% of the max. possible efficacy (MPE) mech. allodynia induced by MTI in FAAH+/+mice (von Frey filament measurement) 30 min after dosing, but was without effect in FAAH-/- mice.  OL135 given i.p. resulted in a dose-responsive reversal of mech. allodynia in both MTI and SNL models in the rat with an ED50 between 6 and 9 mg kg-1.  The plasma concn. at the ED50 in both models was 0.7 μM (240 ng ml-1).  In the rat SNL model, coadministration of the selective CB2 receptor antagonist SR144528 (5 mg kg-1 i.p.), with 20 mg kg-1 OL135 blocked the OL135-induced reversal of mech. allodynia, but the selective CB1 antagonist SR141716A (5 mg kg-1 i.p.) was without effect.  In the rat MTI model neither SR141716A or SR144528 (both at 5 mg kg-1 i.p.), or a combination of both antagonists coadministered with OL135 (20 mg kg-1) blocked reversal of mech. allodynia assessed 30 min after dosing.  In both the MTI model and SNL models in rats, naloxone (1 mg kg-1, i.p. 30 min after OL135) reversed the analgesia (to 15% of control levels in the MTI model, to zero in the SNL) produced by OL135.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBLOT_Ls83X7Vg90H21EOLACvtfcHk0lhu2yjv38R1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2ltrk%253D&md5=699f0b8b326af0ae0baecc3abbd6faa3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706699%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DWebb%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520produces%2520analgesia%2520by%2520multiple%2520mechanisms%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D102%26epage%3D113%26doi%3D10.1038%2Fsj.bjp.0706699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Potent and selective α-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span><span class="refDoi"> DOI: 10.1021/jm0611509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1058-1068&author=F.+A.+Romeroauthor=W.+Duauthor=I.+Hwangauthor=T.+J.+Raylauthor=F.+S.+Kimballauthor=D.+Leungauthor=H.+S.+Hooverauthor=R.+L.+Apodacaauthor=J.+G.+Breitenbucherauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Potent+and+selective+%CE%B1-ketoheterocycle-based+inhibitors+of+the+anandamide+and+oleamide+catabolizing+enzyme%2C+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm0611509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm0611509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611509%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DKimball%26aufirst%3DF.%2BS.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DHoover%26aufirst%3DH.%2BS.%26aulast%3DApodaca%26aufirst%3DR.%2BL.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPotent%2520and%2520selective%2520%25CE%25B1-ketoheterocycle-based%2520inhibitors%2520of%2520the%2520anandamide%2520and%2520oleamide%2520catabolizing%2520enzyme%252C%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1058%26epage%3D1068%26doi%3D10.1021%2Fjm0611509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelso, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of α-ketooxazole inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3359</span><span class="NLM_x">–</span> <span class="NLM_lpage">3368</span><span class="refDoi"> DOI: 10.1021/jm061414r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061414r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3359-3368&author=C.+Hardouinauthor=M.+J.+Kelsoauthor=F.+A.+Romeroauthor=T.+J.+Raylauthor=D.+Leungauthor=I.+Hwangauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Structure-activity+relationships+of+%CE%B1-ketooxazole+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm061414r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm061414r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061414r%26sid%3Dliteratum%253Aachs%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DKelso%26aufirst%3DM.%2BJ.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DStructure-activity%2520relationships%2520of%2520%25CE%25B1-ketooxazole%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3359%26epage%3D3368%26doi%3D10.1021%2Fjm061414r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Kimball, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Optimization of α-ketooxazole inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1021/jm701210y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701210y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=937-947&author=F.+S.+Kimballauthor=F.+A.+Romeroauthor=C.+Ezziliauthor=J.+Garfunkleauthor=T.+J.+Raylauthor=D.+G.+Hochstatterauthor=I.+Hwangauthor=D.+L.+Boger&title=Optimization+of+%CE%B1-ketooxazole+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm701210y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of α-Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Kimball, F. Scott; Romero, F. Anthony; Ezzili, Cyrine; Garfunkle, Joie; Rayl, Thomas J.; Hochstatter, Dustin G.; Hwang, Inkyu; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">937-947</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of α-ketooxazoles, e.g., I, contg. conformational constraints in the flexible C2 acyl side chain of II (OL-135) and representative oxazole C5 substituents were prepd. and examd. as inhibitors of fatty acid amide hydrolase (FAAH).  Exceptionally potent and selective FAAH inhibitors emerged from the series (e.g., 6, Ki = 200 and 260 pM for rat and rhFAAH).  With simple and small C5 oxazole substituents, each series bearing a biphenylethyl, phenoxyphenethyl, or (phenoxymethyl)phenethyl C2 side chain was found to follow a well-defined linear relationship between -log Ki and Hammett σp of a magnitude (ρ = 2.7-3.0) that indicates that the substituent electronic effect dominates, confirming its fundamental importance to the series and further establishing its predictive value.  Just as significantly, the nature of the C5 oxazole substituent substantially impacts the selectivity of the inhibitors whereas the effect of the C2 acyl chain was more subtle but still significant even in the small series examd.  Combination of these independent features, which display generalized trends across a range of inhibitor series, simultaneously improves FAAH potency and selectivity and can provide exquisitely selective and potent FAAH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKqc9Fjum927Vg90H21EOLACvtfcHk0lhtGlhuR7kBEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWju7Y%253D&md5=3e3e36903d135141f3e86b5f37adf9f2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm701210y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701210y%26sid%3Dliteratum%253Aachs%26aulast%3DKimball%26aufirst%3DF.%2BS.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DOptimization%2520of%2520%25CE%25B1-ketooxazole%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D937%26epage%3D947%26doi%3D10.1021%2Fjm701210y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Optimization of the central heterocycle of α-ketoheterocycle inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4392</span><span class="NLM_x">–</span> <span class="NLM_lpage">4403</span><span class="refDoi"> DOI: 10.1021/jm800136b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800136b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4392-4403&author=J.+Garfunkleauthor=C.+Ezziliauthor=T.+J.+Raylauthor=D.+G.+Hochstatterauthor=I.+Hwangauthor=D.+L.+Boger&title=Optimization+of+the+central+heterocycle+of+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm800136b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm800136b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800136b%26sid%3Dliteratum%253Aachs%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DOptimization%2520of%2520the%2520central%2520heterocycle%2520of%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4392%26epage%3D4403%26doi%3D10.1021%2Fjm800136b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2805</span><span class="NLM_x">–</span> <span class="NLM_lpage">2822</span><span class="refDoi"> DOI: 10.1021/jm101597x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101597x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2805-2822&author=C.+Ezziliauthor=M.+Mileniauthor=N.+McGlincheyauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=D.+G.+Hochstatterauthor=R.+C.+Stevensauthor=A.+H.+Lichtmanauthor=B.+F.+Cravattauthor=E.+J.+Bilskyauthor=D.+L.+Boger&title=Reversible+competitive+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase+containing+additional+conformational+constraints+in+the+acyl+side+chain%3A+orally+active%2C+long-acting+analgesics&doi=10.1021%2Fjm101597x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm101597x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101597x%26sid%3Dliteratum%253Aachs%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DMcGlinchey%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DReversible%2520competitive%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520containing%2520additional%2520conformational%2520constraints%2520in%2520the%2520acyl%2520side%2520chain%253A%2520orally%2520active%252C%2520long-acting%2520analgesics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2805%26epage%3D2822%26doi%3D10.1021%2Fjm101597x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span><span class="refDoi"> DOI: 10.1021/jm401820q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401820q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1079-1089&author=K.+Otrubovaauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Design%2C+synthesis%2C+and+characterization+of+%CE%B1-ketoheterocycles+that+additionally+target+the+cytosolic+port+Cys269+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm401820q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm401820q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401820q%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520%25CE%25B1-ketoheterocycles%2520that%2520additionally%2520target%2520the%2520cytosolic%2520port%2520Cys269%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1079%26epage%3D1089%26doi%3D10.1021%2Fjm401820q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neal, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">6289</span><span class="NLM_x">–</span> <span class="NLM_lpage">6299</span><span class="refDoi"> DOI: 10.1021/ja4014997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4014997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=6289-6299&author=K.+Otrubovaauthor=M.+Brownauthor=M.+S.+McCormickauthor=G.+W.+Hanauthor=S.+T.+O%E2%80%99Nealauthor=B.+F.+Cravattauthor=R.+C.+Stevensauthor=A.+H.+Lichtmanauthor=D.+L.+Boger&title=Rational+design+of+fatty+acid+amide+hydrolase+inhibitors+that+act+by+covalently+bonding+to+two+active+site+residues&doi=10.1021%2Fja4014997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fja4014997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4014997%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMcCormick%26aufirst%3DM.%2BS.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DS.%2BT.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DRational%2520design%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520that%2520act%2520by%2520covalently%2520bonding%2520to%2520two%2520active%2520site%2520residues%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D6289%26epage%3D6299%26doi%3D10.1021%2Fja4014997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiño, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tattoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Modulation of anxiety through blockade of anandamide hydrolysis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1038/nm803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnm803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12461523" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=76-81&author=S.+Kathuriaauthor=S.+Gaetaniauthor=D.+Fegleyauthor=F.+Vali%C3%B1oauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=G.+La+Ranaauthor=A.+Calignanoauthor=A.+Giustinoauthor=M.+Tattoliauthor=M.+Palmeryauthor=V.+Cuomoauthor=D.+Piomelli&title=Modulation+of+anxiety+through+blockade+of+anandamide+hydrolysis&doi=10.1038%2Fnm803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnm803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm803%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DVali%25C3%25B1o%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGiustino%26aufirst%3DA.%26aulast%3DTattoli%26aufirst%3DM.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DModulation%2520of%2520anxiety%2520through%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D9%26spage%3D76%26epage%3D81%26doi%3D10.1038%2Fnm803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plazzi, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Cyclohexylcarbamic acid 3′-or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4998</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span><span class="refDoi"> DOI: 10.1021/jm031140x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031140x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4998-5008&author=M.+Morauthor=S.+Rivaraauthor=A.+Lodolaauthor=P.+V.+Plazziauthor=G.+Tarziaauthor=A.+Durantiauthor=A.+Tontiniauthor=G.+Piersantiauthor=S.+Kathuriaauthor=D.+Piomelli&title=Cyclohexylcarbamic+acid+3%E2%80%B2-or+4%E2%80%B2-substituted+biphenyl-3-yl+esters+as+fatty+acid+amide+hydrolase+inhibitors%3A+synthesis%2C+quantitative+structure-activity+relationships%2C+and+molecular+modeling+studies&doi=10.1021%2Fjm031140x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm031140x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031140x%26sid%3Dliteratum%253Aachs%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DPlazzi%26aufirst%3DP.%2BV.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DCyclohexylcarbamic%2520acid%25203%25E2%2580%25B2-or%25204%25E2%2580%25B2-substituted%2520biphenyl-3-yl%2520esters%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%253A%2520synthesis%252C%2520quantitative%2520structure-activity%2520relationships%252C%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4998%26epage%3D5008%26doi%3D10.1021%2Fjm031140x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasse, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putman, D.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2006.00021.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1527-3458.2006.00021.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=16834756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos1yksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=21-38&author=D.+Piomelliauthor=G.+Tarziaauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=T.+R.+Comptonauthor=O.+Dasseauthor=E.+P.+Monaghanauthor=J.+A.+Parrottauthor=D.+Putman&title=Pharmacological+profile+of+the+selective+FAAH+inhibitor+KDS-4103+%28URB597%29&doi=10.1111%2Fj.1527-3458.2006.00021.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)</span></div><div class="casAuthors">Piomelli, Daniele; Tarzia, Giorgio; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Compton, Timothy R.; Dasse, Olivier; Monaghan, Edward P.; Parrott, Jeff A.; Putman, David</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  In the present article, we review the pharmacol. properties of KDS-4103 (URB597), a highly potent and selective inhibitor of the enzyme fatty-acid amide hydrolase (FAAH), which catalyzes the intracellular hydrolysis of the endocannabinoid anandamide.  In vitro, KDS-4103 inhibits FAAH activity with median inhibitory concns. (IC50) of 5 nM in rat brain membranes and 3 nM in human liver microsomes.  In vivo, KDS-4103 inhibits rat brain FAAH activity after i.p. administration with a median ID (ID50) of 0.15 mg/kg.  The compd. does not significantly interact with other cannabinoid-related targets, including cannabinoid receptors and anandamide transport, or with a broad panel of receptors, ion channels, transporters and enzymes.  By i.p. administration to rats and mice KDS-4103 elicits significant, anxiolytic-like, anti-depressant-like and analgesic effects, which are prevented by treatment with CB1 receptor antagonists.  By contrast, at doses that significantly inhibit FAAH activity and substantially raise brain anandamide levels, KDS-4103 does not evoke classical cannabinoid-like effects (e.g., catalepsy, hypothermia, hyperphagia), does not cause place preference, and does not produce generalization to the discriminative effects of the active ingredient of cannabis, Δ9-tetrahydrocannabinol (Δ9-THC).  These findings suggest that KDS-4103 acts by enhancing the tonic actions of anandamide on a subset of CB1 receptors, which may normally be engaged in controlling emotions and pain.  KDS-4103 is orally available in rats and cynomolgus monkeys.  Sub-chronic repeated dose studies (1500 mg/kg, per os) in these two species have not demonstrated systemic toxicity.  Likewise, no toxicity was noted in bacterial cytotoxicity tests in vitro and in the Ames test.  Furthermore, no deficits were obsd. in rats on the rotarod test after acute i.p. treatment with KDS-4103 at doses up to 5 mg/kg or in a functional observation battery after oral doses up to 1500 mg/kg.  The results suggest that KDS-4103 will offer a novel approach with a favorable therapeutic window for the treatment of anxiety, depression and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4yDW3FkE5dbVg90H21EOLACvtfcHk0lhmGDCZH3kP-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos1yksL0%253D&md5=3acddbfe31c13facb4d46fa35e8e4582</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2006.00021.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2006.00021.x%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCompton%26aufirst%3DT.%2BR.%26aulast%3DDasse%26aufirst%3DO.%26aulast%3DMonaghan%26aufirst%3DE.%2BP.%26aulast%3DParrott%26aufirst%3DJ.%2BA.%26aulast%3DPutman%26aufirst%3DD.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520selective%2520FAAH%2520inhibitor%2520KDS-4103%2520%2528URB597%2529%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D21%26epage%3D38%26doi%3D10.1111%2Fj.1527-3458.2006.00021.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saraf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannoye, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span> </span><span class="NLM_article-title">Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2006.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.neuropharm.2006.11.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1095-1105&author=D.+Zhangauthor=A.+Sarafauthor=T.+Kolasaauthor=P.+Bhatiaauthor=G.+Z.+Zhengauthor=M.+Patelauthor=G.+S.+Lannoyeauthor=P.+Richardsonauthor=A.+Stewartauthor=J.+C.+Rogersauthor=J.+D.+Brioniauthor=C.+S.+Surowy&title=Fatty+acid+amide+hydrolase+inhibitors+display+broad+selectivity+and+inhibit+multiple+carboxylesterases+as+off-targets&doi=10.1016%2Fj.neuropharm.2006.11.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DSaraf%26aufirst%3DA.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DBhatia%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DG.%2BZ.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DLannoye%26aufirst%3DG.%2BS.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DJ.%2BC.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26atitle%3DFatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520display%2520broad%2520selectivity%2520and%2520inhibit%2520multiple%2520carboxylesterases%2520as%2520off-targets%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D1095%26epage%3D1105%26doi%3D10.1016%2Fj.neuropharm.2006.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Bosier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB<sub>1</sub>-and FAAH-independent mechanisms</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02208.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1476-5381.2012.02208.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22970888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=794-807&author=B.+Bosierauthor=G.+G.+Muccioliauthor=D.+M.+Lambert&title=The+FAAH+inhibitor+URB597+efficiently+reduces+tyrosine+hydroxylase+expression+through+CB1-and+FAAH-independent+mechanisms&doi=10.1111%2Fj.1476-5381.2012.02208.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1- and FAAH-independent mechanisms</span></div><div class="casAuthors">Bosier, Barbara; Muccioli, Giulio G.; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">794-807</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Anandamide and 2-arachidonoylglycerol are neuromodulatory lipids interacting with cannabinoid receptors, whose availability is regulated by the balance between "on demand" generation and enzymic degrdn. [by fatty acid amide hydrolase (FAAH)/monoacylglycerol lipase].  Given the reported effects of anandamide on dopamine transmission, we investigated the influence of endocannabinoids and URB597, a well-known FAAH inhibitor, on the expression of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis.  Exptl. Approach: We investigated TH expression in N1E115 neuroblastoma using a reporter gene assay, as well as mRNA and protein quantifications.  FAAH inhibition was confirmed by measuring radiolabeled substrate hydrolysis and endogenous endocannabinoids.  Key Results: Anandamide decreased TH promoter activity in N1E115 cells through CB1 receptor activation.  Unexpectedly, URB597 reduced TH expression (pEC50 = 8.7 ± 0.2) through FAAH-independent mechanisms.  Indeed, four structurally unrelated inhibitors of FAAH had no influence on TH expression, although all the inhibitors increased endocannabinoid levels.  At variance with the endocannabinoid responses, the use of selective antagonists indicated that the URB597-mediated decrease in TH expression was not directed by the CB1 receptor, but rather by abnormal-cannabidiol-sensitive receptors and PPARs.  Further supporting the physiol. relevance of these in vitro data, URB597 administration resulted in reduced TH mRNA levels in mice brain.  Conclusions: While confirming the implication of endocannabinoids on the modulation of TH, we provide strong evidence for addnl. physiol. relevant off-target effects of URB597.  In light of the numerous preclin. studies involving URB597, particularly in anxiety and depression, the existence of non-CB1 and non-FAAH mediated influences of URB597 on key enzymes of the catecholaminergic transmission system should be taken into account when interpreting the data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2NSEki1ECkLVg90H21EOLACvtfcHk0ligIzp4TdUNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOiu7k%253D&md5=9d6f90a44e3e0dfd8d8e11a8323d133d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02208.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02208.x%26sid%3Dliteratum%253Aachs%26aulast%3DBosier%26aufirst%3DB.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DThe%2520FAAH%2520inhibitor%2520URB597%2520efficiently%2520reduces%2520tyrosine%2520hydroxylase%2520expression%2520through%2520CB1-and%2520FAAH-independent%2520mechanisms%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D794%26epage%3D807%26doi%3D10.1111%2Fj.1476-5381.2012.02208.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.jmb.2010.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20493882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1yrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=743-754&author=M.+Mileniauthor=S.+Kamtekarauthor=D.+C.+Woodauthor=T.+E.+Bensonauthor=B.+F.+Cravattauthor=R.+C.+Stevens&title=Crystal+structure+of+fatty+acid+amide+hydrolase+bound+to+the+carbamate+inhibitor+URB597%3A+discovery+of+a+deacylating+water+molecule+and+insight+into+enzyme+inactivation&doi=10.1016%2Fj.jmb.2010.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Fatty Acid Amide Hydrolase Bound to the Carbamate Inhibitor URB597: Discovery of a Deacylating Water Molecule and Insight into Enzyme Inactivation</span></div><div class="casAuthors">Mileni, Mauro; Kamtekar, Satwik; Wood, David C.; Benson, Timothy E.; Cravatt, Benjamin F.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-754</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoid system regulates a wide range of physiol. processes including pain, inflammation, and cognitive/emotional states.  URB597 is one of the best characterized covalent inhibitors of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH).  Here, we report the structure of the FAAH-URB597 complex at 2.3 Å resoln.  The structure provides insights into mechanistic details of enzyme inactivation and exptl. evidence of a previously uncharacterized active site water mol. that likely is involved in substrate deacylation.  This water mol. is part of an extensive hydrogen-bonding network and is coordinated indirectly to residues lining the cytosolic port of the enzyme.  In order to corroborate our hypothesis concerning the role of this water mol. in FAAH's catalytic mechanism, we detd. the structure of FAAH conjugated to a urea-based inhibitor, PF-3845, to a higher resoln. (2.4 Å) than previously reported.  The higher-resoln. structure confirms the presence of the water mol. in a virtually identical location in the active site.  Examn. of the structures of serine hydrolases that are non-homologous to FAAH, such as elastase, trypsin, or chymotrypsin, shows a similarly positioned hydrolytic water mol. and suggests a functional convergence between the amidase signature enzymes and serine proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJe7DwbZdBYLVg90H21EOLACvtfcHk0ligIzp4TdUNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1yrsrg%253D&md5=023c5ff35e41921df17c3f7df1d7f660</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DD.%2BC.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520bound%2520to%2520the%2520carbamate%2520inhibitor%2520URB597%253A%2520discovery%2520of%2520a%2520deacylating%2520water%2520molecule%2520and%2520insight%2520into%2520enzyme%2520inactivation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D743%26epage%3D754%26doi%3D10.1016%2Fj.jmb.2010.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity <i>in vivo</i></span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span><span class="refDoi"> DOI: 10.1002/cmdc.200900210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.200900210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19637155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKgtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1505-1513&author=J.+R.+Clapperauthor=F.+Vacondioauthor=A.+R.+Kingauthor=A.+Durantiauthor=A.+Tontiniauthor=C.+Silvaauthor=S.+Sanchiniauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=A+second+generation+of+carbamate-based+fatty+acid+amide+hydrolase+inhibitors+with+improved+activity+in+vivo&doi=10.1002%2Fcmdc.200900210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo</span></div><div class="casAuthors">Clapper, Jason R.; Vacondio, Federica; King, Alvin R.; Duranti, Andrea; Tontini, Andrea; Silva, Claudia; Sanchini, Silvano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1505-1513</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides are a class of signaling lipids that include agonists at cannabinoid and α type peroxisome proliferator-activated receptors (PPARα).  In the brain, these compds. are primarily hydrolyzed by the intracellular serine enzyme fatty acid amide hydrolase (FAAH).  O-aryl carbamate FAAH inhibitors such as URB597 are being evaluated clin. for the treatment of pain and anxiety, but interactions with carboxylesterases in liver might limit their usefulness.  Here we explore two strategies aimed at overcoming this limitation.  Lipophilic N-terminal substitutions, which enhance FAAH recognition, yield potent inhibitors but render such compds. susceptible to attack by broad-spectrum hydrolases and inactive in vivo.  By contrast, polar electron-donating O-aryl substituents, which decrease carbamate reactivity, yield compds., such as URB694, that are highly potent FAAH inhibitors in vivo and less reactive with off-target carboxylesterases.  The results suggest that an approach balancing inhibitor reactivity with target recognition produces FAAH inhibitors that display significantly improved drug-likeness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLif0z6dIbyLVg90H21EOLACvtfcHk0ligIzp4TdUNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKgtLnE&md5=fc73dbc173384549dfa0f319abb76479</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900210%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520second%2520generation%2520of%2520carbamate-based%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520with%2520improved%2520activity%2520in%2520vivo%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1505%26epage%3D1513%26doi%3D10.1002%2Fcmdc.200900210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciolino, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spradley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span><span class="refDoi"> DOI: 10.1038/nn.2632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.2632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20852626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1265-1270&author=J.+R.+Clapperauthor=G.+Moreno-Sanzauthor=R.+Russoauthor=A.+Guijarroauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=N.+R.+Sciolinoauthor=J.+M.+Spradleyauthor=A.+G.+Hohmannauthor=A.+Calignanoauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Anandamide+suppresses+pain+initiation+through+a+peripheral+endocannabinoid+mechanism&doi=10.1038%2Fnn.2632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span></div><div class="casAuthors">Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown.  To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of the endocannabinoid anandamide.  URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS.  Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing.  CB1 cannabinoid receptor blockade prevented these effects.  These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS.  Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AxNb5bVlE7Vg90H21EOLACvtfcHk0lhqnYfUjU2VOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O&md5=f75c13a37e3524ab4130b2ebd67d6348</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnn.2632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2632%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DSciolino%26aufirst%3DN.%2BR.%26aulast%3DSpradley%26aufirst%3DJ.%2BM.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520suppresses%2520pain%2520initiation%2520through%2520a%2520peripheral%2520endocannabinoid%2520mechanism%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1265%26epage%3D1270%26doi%3D10.1038%2Fnn.2632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Sit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertekap, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, K. D.</span><span> </span><span class="NLM_article-title">Oxime carbamate-discovery of a series of novel FAAH inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2009.11.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1272-1277&author=S.+Sitauthor=C.+M.+Conwayauthor=K.+Xieauthor=R.+Bertekapauthor=C.+Bourinauthor=K.+D.+Burris&title=Oxime+carbamate-discovery+of+a+series+of+novel+FAAH+inhibitors&doi=10.1016%2Fj.bmcl.2009.11.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.080%26sid%3Dliteratum%253Aachs%26aulast%3DSit%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBertekap%26aufirst%3DR.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DBurris%26aufirst%3DK.%2BD.%26atitle%3DOxime%2520carbamate-discovery%2520of%2520a%2520series%2520of%2520novel%2520FAAH%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1272%26epage%3D1277%26doi%3D10.1016%2Fj.bmcl.2009.11.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Gattinoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fezza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nannei, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amadio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quattrociocchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caprioli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span> </span><span class="NLM_article-title">Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1002/cmdc.200900472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.200900472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20112328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslens70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=357-360&author=S.+Gattinoniauthor=C.+De+Simoneauthor=S.+Dallavalleauthor=F.+Fezzaauthor=R.+Nanneiauthor=D.+Amadioauthor=P.+Minettiauthor=G.+Quattrociocchiauthor=A.+Caprioliauthor=F.+Borsiniauthor=W.+Cabriauthor=S.+Pencoauthor=L.+Merliniauthor=M.+Maccarrone&title=Enol+carbamates+as+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29+endowed+with+high+selectivity+for+FAAH+over+the+other+targets+of+the+endocannabinoid+system&doi=10.1002%2Fcmdc.200900472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system</span></div><div class="casAuthors">Gattinoni, Sonia; De Simone, Chiara; Dallavalle, Sabrina; Fezza, Filomena; Nannei, Raffaella; Amadio, Daniele; Minetti, Patrizia; Quattrociocchi, Gianandrea; Caprioli, Antonio; Borsini, Franco; Cabri, Walter; Penco, Sergio; Merlini, Lucio; Maccarrone, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-360</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein, we report the synthesis of a new series of enol carbamates, the most potent of which appear to reversibly inhibit FAAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt95rUNWsp3rVg90H21EOLACvtfcHk0lhqnYfUjU2VOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslens70%253D&md5=01280e2429e748cba7899ec68e2ca5b7</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900472%26sid%3Dliteratum%253Aachs%26aulast%3DGattinoni%26aufirst%3DS.%26aulast%3DDe%2BSimone%26aufirst%3DC.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DFezza%26aufirst%3DF.%26aulast%3DNannei%26aufirst%3DR.%26aulast%3DAmadio%26aufirst%3DD.%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DQuattrociocchi%26aufirst%3DG.%26aulast%3DCaprioli%26aufirst%3DA.%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DMerlini%26aufirst%3DL.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DEnol%2520carbamates%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520endowed%2520with%2520high%2520selectivity%2520for%2520FAAH%2520over%2520the%2520other%2520targets%2520of%2520the%2520endocannabinoid%2520system%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D357%26epage%3D360%26doi%3D10.1002%2Fcmdc.200900472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Caprioli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coccurello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Serio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Tommaso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vertechy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battista, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span> </span><span class="NLM_article-title">The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1124/jpet.111.191403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.111.191403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22514334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=188-195&author=A.+Caprioliauthor=R.+Coccurelloauthor=C.+Rapinoauthor=S.+Di+Serioauthor=M.+Di+Tommasoauthor=M.+Vertechyauthor=V.+Vaccaauthor=N.+Battistaauthor=F.+Pavoneauthor=M.+Maccarroneauthor=F.+Borsini&title=The+novel+reversible+fatty+acid+amide+hydrolase+inhibitor+ST4070+increases+endocannabinoid+brain+levels+and+counteracts+neuropathic+pain+in+different+animal+models&doi=10.1124%2Fjpet.111.191403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models</span></div><div class="casAuthors">Caprioli, Antonio; Coccurello, Roberto; Rapino, Cinzia; Di Serio, Stefano; Di Tommaso, Monia; Vertechy, Mario; Vacca, Valentina; Battista, Natalia; Pavone, Flaminia; Maccarrone, Mauro; Borsini, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effect of the enol carbamate 1-biphenyl-4-ylethenyl piperidine-1-carboxylate (ST4070), a novel reversible inhibitor of fatty acid amide hydrolase (FAAH), was investigated for acute pain sensitivity and neuropathic pain in rats and mice.  Brain enzymic activity of FAAH and the endogenous levels of its substrates, anandamide (AEA; N-arachidonoylethanolamine), 2-arachidonoylglycerol (2-AG), and N-palmitoylethanolamine (PEA), were measured in control and ST4070-treated mice.  ST4070 (10, 30, and 100 mg/kg) was orally administered to assess mech. nociceptive thresholds and allodynia by using the Randall-Selitto and von Frey tests, resp.  Neuropathy was induced in rats by either the chemotherapeutic agent vincristine or streptozotocin-induced diabetes, whereas the chronic constriction injury (CCI) model was chosen to evaluate neuropathy in mice.  ST4070 produced a significant increase of nociceptive threshold in rats and counteracted the decrease of nociceptive threshold in the three distinct models of neuropathic pain.  In diabetic mice, ST4070 inhibited FAAH activity and increased the brain levels of AEA and PEA, without affecting that of 2-AG.  The administration of ST4070 generated long-lasting pain relief compared with pregabalin and the FAAH inhibitors 1-oxo-1[5-(2-pyridyl)-2-yl]-7-phenylheptane (OL135) and cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-ylester (URB597) in CCI neuropathic mice.  The antiallodynic effects of ST4070 were prevented by pretreatment with cannabinoid type 1 and cannabinoid type 2 receptor antagonists and by the selective peroxisome proliferator-activated receptor α antagonist [(2S)-2-[[(1Z)-1-methyl-3-oxo-3-[4-(trifluoromethyl)phenyl]-1-propenyl]amino]-3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]propyl]-carbamic acid Et ester (GW6471).  The administration of ST4070 generated long-lasting neuropathic pain relief compared with pregabalin and the FAAH inhibitors OL135 and URB597.  Taken together, the reversible FAAH inhibitor ST4070 seems to be a promising novel therapeutic agent for the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJ30CfhsjTbVg90H21EOLACvtfcHk0ljduf84BZIidQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOktbvM&md5=c5055ead171864fa8a64730a5c3680b8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.191403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.191403%26sid%3Dliteratum%253Aachs%26aulast%3DCaprioli%26aufirst%3DA.%26aulast%3DCoccurello%26aufirst%3DR.%26aulast%3DRapino%26aufirst%3DC.%26aulast%3DDi%2BSerio%26aufirst%3DS.%26aulast%3DDi%2BTommaso%26aufirst%3DM.%26aulast%3DVertechy%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DV.%26aulast%3DBattista%26aufirst%3DN.%26aulast%3DPavone%26aufirst%3DF.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DBorsini%26aufirst%3DF.%26atitle%3DThe%2520novel%2520reversible%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520ST4070%2520increases%2520endocannabinoid%2520brain%2520levels%2520and%2520counteracts%2520neuropathic%2520pain%2520in%2520different%2520animal%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D188%26epage%3D195%26doi%3D10.1124%2Fjpet.111.191403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Colombano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daglian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span> </span><span class="NLM_article-title"><i>O</i>-(triazolyl) methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span><span class="refDoi"> DOI: 10.1002/cmdc.201402374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201402374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=380-395&author=G.+Colombanoauthor=C.+Albaniauthor=G.+Ottonelloauthor=A.+Ribeiroauthor=R.+Scarpelliauthor=G.+Tarozzoauthor=J.+Daglianauthor=K.+M.+Jungauthor=D.+Piomelliauthor=T.+Bandiera&title=O-%28triazolyl%29+methyl+carbamates+as+a+novel+and+potent+class+of+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1002%2Fcmdc.201402374"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402374%26sid%3Dliteratum%253Aachs%26aulast%3DColombano%26aufirst%3DG.%26aulast%3DAlbani%26aufirst%3DC.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DDaglian%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DO-%2528triazolyl%2529%2520methyl%2520carbamates%2520as%2520a%2520novel%2520and%2520potent%2520class%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D380%26epage%3D395%26doi%3D10.1002%2Fcmdc.201402374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggiero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span> </span><span class="NLM_article-title">Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.04.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejmech.2015.04.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=289-305&author=M.+A.+Tabriziauthor=P.+G.+Baraldiauthor=E.+Ruggieroauthor=G.+Saponaroauthor=S.+Baraldiauthor=R.+Romagnoliauthor=A.+Martinelliauthor=T.+Tuccinardi&title=Pyrazole+phenylcyclohexylcarbamates+as+inhibitors+of+human+fatty+acid+amide+hydrolases+%28FAAH%29&doi=10.1016%2Fj.ejmech.2015.04.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DRuggiero%26aufirst%3DE.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DTuccinardi%26aufirst%3DT.%26atitle%3DPyrazole%2520phenylcyclohexylcarbamates%2520as%2520inhibitors%2520of%2520human%2520fatty%2520acid%2520amide%2520hydrolases%2520%2528FAAH%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D97%26spage%3D289%26epage%3D305%26doi%3D10.1016%2Fj.ejmech.2015.04.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Terwege, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanekamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzinsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, M.</span><span> </span><span class="NLM_article-title">ω-Imidazolyl- and ω-tetrazolylalkylcarbamates as inhibitors of fatty acid amide hydrolase: biological activity and <i>in vitro</i> metabolic stability</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1002/cmdc.201500445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201500445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=429-443&author=T.+Terwegeauthor=W.+Hanekampauthor=D.+Garzinskyauthor=S.+Konigauthor=O.+Kochauthor=M.+Lehr&title=%CF%89-Imidazolyl-+and+%CF%89-tetrazolylalkylcarbamates+as+inhibitors+of+fatty+acid+amide+hydrolase%3A+biological+activity+and+in+vitro+metabolic+stability&doi=10.1002%2Fcmdc.201500445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500445%26sid%3Dliteratum%253Aachs%26aulast%3DTerwege%26aufirst%3DT.%26aulast%3DHanekamp%26aufirst%3DW.%26aulast%3DGarzinsky%26aufirst%3DD.%26aulast%3DKonig%26aufirst%3DS.%26aulast%3DKoch%26aufirst%3DO.%26aulast%3DLehr%26aufirst%3DM.%26atitle%3D%25CF%2589-Imidazolyl-%2520and%2520%25CF%2589-tetrazolylalkylcarbamates%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520biological%2520activity%2520and%2520in%2520vitro%2520metabolic%2520stability%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D429%26epage%3D443%26doi%3D10.1002%2Fcmdc.201500445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Deutsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arreaza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omeir, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1006/bbrc.1997.6072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1006%2Fbbrc.1997.6072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1997&pages=217-221&author=D.+Deutschauthor=S.+Linauthor=W.+Hillauthor=K.+Morseauthor=D.+Salehaniauthor=G.+Arreazaauthor=R.+Omeirauthor=A.+Makriyannis&title=Fatty+acid+sulfonyl+fluorides+inhibit+anandamide+metabolism+and+bind+to+the+cannabinoid+receptor&doi=10.1006%2Fbbrc.1997.6072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.6072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.6072%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DW.%26aulast%3DMorse%26aufirst%3DK.%26aulast%3DSalehani%26aufirst%3DD.%26aulast%3DArreaza%26aufirst%3DG.%26aulast%3DOmeir%26aufirst%3DR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DFatty%2520acid%2520sulfonyl%2520fluorides%2520inhibit%2520anandamide%2520metabolism%2520and%2520bind%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D231%26spage%3D217%26epage%3D221%26doi%3D10.1006%2Fbbrc.1997.6072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Horrevoets, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheij, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, G. H.</span><span> </span><span class="NLM_article-title">Inactivation of escherichia coli outer-membrane phospholipase A by the affinity label hexadecanesulfonyl fluoride. Evidence for an active-site serine</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1991.tb16008.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1432-1033.1991.tb16008.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=2040286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK3MXkvVyhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=1991&pages=247-253&author=A.+J.+Horrevoetsauthor=H.+M.+Verheijauthor=G.+H.+Haas&title=Inactivation+of+escherichia+coli+outer-membrane+phospholipase+A+by+the+affinity+label+hexadecanesulfonyl+fluoride.+Evidence+for+an+active-site+serine&doi=10.1111%2Fj.1432-1033.1991.tb16008.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Escherichia coli outer-membrane phospholipase A by the affinity label hexadecanesulfonyl fluoride.  Evidence for an active-site serine</span></div><div class="casAuthors">Horrevoets, Anton J. G.; Verheij, Hubertus M.; De Haas, Gerard H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-53</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The E. coli outer-membrane phospholipase A (OM PLA) is a membrane-bound acyl hydrolase with a broad substrate specificity.  To obtain more insight into the mechanism of action of this enzyme, an active-site-directed inhibitor for OM PLA was designed on the basis of the known substrate specificity as a first step in the elucidation of the catalytic mechanism of this enzyme.  The inhibitor, hexadecanesulfonyl fluoride, consists of a long hydrocarbon chain for high-affinity binding by the enzyme and a sulfonyl fluoride moiety as a reactive group.  The kinetics of the inactivation of OM PLA by hexadecanesulfonyl fluoride were studied in Triton X-100 micelles.  Inactivation is very fast, specific and shows the same characteristics with respect to acyl specificity, pH profile and metal ion requirement as the activity of OM PLA on substrates.  Incubation of OM PLA with a stoichiometric amt. of hexadecanesulfonyl fluoride leads to a total and irreversible loss of enzyme activity, resulting from the sulfonylation of Ser144.  This Ser144, which is suggested to be the active-site serine of OM PLA, is part of the sequence HDSNG, whereas in the water-sol. serine proteases and lipases the structural motif GXSXG is normally encountered.  On the basis of the kinetics of inactivation of OM PLA by hexadecanesulfonyl fluoride, a possible catalytic mechanism of the enzyme is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_avkGeSl-57Vg90H21EOLACvtfcHk0lgdgOujbsB0hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvVyhs7Y%253D&md5=67bd7349ea8d7f4e5aa62406741e29e1</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1991.tb16008.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1991.tb16008.x%26sid%3Dliteratum%253Aachs%26aulast%3DHorrevoets%26aufirst%3DA.%2BJ.%26aulast%3DVerheij%26aufirst%3DH.%2BM.%26aulast%3DHaas%26aufirst%3DG.%2BH.%26atitle%3DInactivation%2520of%2520escherichia%2520coli%2520outer-membrane%2520phospholipase%2520A%2520by%2520the%2520affinity%2520label%2520hexadecanesulfonyl%2520fluoride.%2520Evidence%2520for%2520an%2520active-site%2520serine%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1991%26volume%3D198%26spage%3D247%26epage%3D253%26doi%3D10.1111%2Fj.1432-1033.1991.tb16008.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Alapafuja, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikas, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharathan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasr, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvonok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Sulfonyl fluoride inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10074</span><span class="NLM_x">–</span> <span class="NLM_lpage">10089</span><span class="refDoi"> DOI: 10.1021/jm301205j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301205j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10074-10089&author=S.+O.+Alapafujaauthor=S.+P.+Nikasauthor=I.+T.+Bharathanauthor=V.+G.+Shuklaauthor=M.+L.+Nasrauthor=A.+L.+Bowmanauthor=N.+Zvonokauthor=J.+Liauthor=X.+Shiauthor=J.+R.+Engenauthor=A.+Makriyannis&title=Sulfonyl+fluoride+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm301205j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Alapafuja, Shakiru O.; Nikas, Spyros P.; Bharathan, Indu T.; Shukla, Vidyanand G.; Nasr, Mahmoud L.; Bowman, Anna L.; Zvonok, Nikolai; Li, Jing; Shi, Xiaomeng; Engen, John R.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10074-10089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sulfonyl fluorides are known to inhibit esterases.  Early work from our lab. has identified hexadecyl sulfonylfluoride (AM374) as a potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH).  We now report on later generation sulfonyl fluoride analogs that exhibit potent and selective inhibition of FAAH.  Using recombinant rat and human FAAH, we show that 5-(4-hydroxyphenyl)pentanesulfonyl fluoride (AM3506) has similar inhibitory activity for both the rat and the human enzyme, while rapid diln. assays and mass spectrometry anal. suggest that the compd. is a covalent modifier for FAAH and inhibits its action in an irreversible manner.  Our SAR results are highlighted by mol. docking of key analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpCw72isROHbVg90H21EOLACvtfcHk0lgdgOujbsB0hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK&md5=789d239141f8a92ccff2de9cb77f4f8b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm301205j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301205j%26sid%3Dliteratum%253Aachs%26aulast%3DAlapafuja%26aufirst%3DS.%2BO.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DBharathan%26aufirst%3DI.%2BT.%26aulast%3DShukla%26aufirst%3DV.%2BG.%26aulast%3DNasr%26aufirst%3DM.%2BL.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DSulfonyl%2520fluoride%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10074%26epage%3D10089%26doi%3D10.1021%2Fjm301205j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Godlewski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alapafuja, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bátkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikas, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offertáler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey-White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span> </span><span class="NLM_article-title">Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=21095576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1256-1266&author=G.+Godlewskiauthor=S.+O.+Alapafujaauthor=S.+B%C3%A1tkaiauthor=S.+P.+Nikasauthor=R.+Cinarauthor=L.+Offert%C3%A1lerauthor=D.+Osei-Hyiamanauthor=J.+Liuauthor=B.+Mukhopadhyayauthor=J.+Harvey-Whiteauthor=J.+Tamauthor=K.+Pacakauthor=J.+L.+Blankmanauthor=B.+F.+Cravattauthor=A.+Makriyannisauthor=G.+Kunos&title=Inhibitor+of+fatty+acid+amide+hydrolase+normalizes+cardiovascular+function+in+hypertension+without+adverse+metabolic+effects&doi=10.1016%2Fj.chembiol.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects</span></div><div class="casAuthors">Godlewski, Grzegorz; Alapafuja, Shakiru O.; Batkai, Sandor; Nikas, Spyros P.; Cinar, Resat; Offertaler, Laszlo; Osei-Hyiaman, Douglas; Liu, Jie; Mukhopadhyay, Bani; Harvey-White, Judith; Tam, Joseph; Pacak, Karel; Blankman, Jacqueline L.; Cravatt, Benjamin F.; Makriyannis, Alexandros; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1256-1266</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The enzyme fatty acid amide hydrolase (FAAH) catalyzes the in vivo degrdn. of the endocannabinoid anandamide, thus controlling its action at receptors.  A novel FAAH inhibitor, AM3506, normalizes the elevated blood pressure and cardiac contractility of spontaneously hypertensive rats (SHR) without affecting these parameters in normotensive rats.  These effects are due to blockade of FAAH and a corresponding rise in brain anandamide levels, resulting in CB1 receptor-mediated decrease in sympathetic tone.  The supersensitivity of SHR to CB1 receptor-mediated cardiovascular depression is related to increased G protein coupling of CB1 receptors.  Importantly, AM3506 does not elicit hyperglycemia and insulin resistance seen with other FAAH inhibitors or in FAAH-/- mice, which is related to its inability to inhibit FAAH in the liver due to rapid hepatic uptake and metab.  This unique activity profile offers improved therapeutic value in hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_IAXNnXfV77Vg90H21EOLACvtfcHk0lgdgOujbsB0hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfF&md5=eeca5f6ba5b35d435ebb84861a297410</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DGodlewski%26aufirst%3DG.%26aulast%3DAlapafuja%26aufirst%3DS.%2BO.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DCinar%26aufirst%3DR.%26aulast%3DOffert%25C3%25A1ler%26aufirst%3DL.%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMukhopadhyay%26aufirst%3DB.%26aulast%3DHarvey-White%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DPacak%26aufirst%3DK.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DInhibitor%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520normalizes%2520cardiovascular%2520function%2520in%2520hypertension%2520without%2520adverse%2520metabolic%2520effects%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1256%26epage%3D1266%26doi%3D10.1016%2Fj.chembiol.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePetrillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaeva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bátkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey-White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offertáler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span> </span><span class="NLM_article-title">Endocannabinoid activation at hepatic CB<sub>1</sub> receptors stimulates fatty acid synthesis and contributes to diet-induced obesity</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1298</span><span class="refDoi"> DOI: 10.1172/JCI200523057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1172%2FJCI200523057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15864349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFSktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=1298&author=D.+Osei-Hyiamanauthor=M.+DePetrilloauthor=P.+Pacherauthor=J.+Liuauthor=S.+Radaevaauthor=S.+B%C3%A1tkaiauthor=J.+Harvey-Whiteauthor=K.+Mackieauthor=L.+Offert%C3%A1lerauthor=L.+Wangauthor=G.+Kunos&title=Endocannabinoid+activation+at+hepatic+CB1+receptors+stimulates+fatty+acid+synthesis+and+contributes+to+diet-induced+obesity&doi=10.1172%2FJCI200523057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity</span></div><div class="casAuthors">Osei-Hyiaman, Douglas; DePetrillo, Michael; Pacher, Pal; Liu, Jie; Radaeva, Svetlana; Batkai, Sandor; Harvey-White, Judith; Mackie, Ken; Offertaler, Laszlo; Wang, Lei; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1298-1305</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Endogenous cannabinoids acting at CB1 receptors stimulate appetite, and CB1 antagonists show promise in the treatment of obesity.  CB1-/- mice are resistant to diet-induced obesity even though their caloric intake is similar to that of wild-type mice, suggesting that endocannabinoids also regulate fat metab.  Here, the authors investigated the possible role of endocannabinoids in the regulation of hepatic lipogenesis.  Activation of CB1 in mice increases the hepatic gene expression of the lipogenic transcription factor SREBP-1c and its targets acetyl-CoA carboxylase-1 and fatty acid synthase (FAS).  Treatment with a CB1 agonist also increases de novo fatty acid synthesis in the liver or in isolated hepatocytes, which express CB1.  High-fat diet increases hepatic levels of the endocannabinoid anandamide (arachidonoyl ethanolamide), CB1 d., and basal rates of fatty acid synthesis, and the latter is reduced by CB1 blockade.  In the hypothalamus, where FAS inhibitors elicit anorexia, SREBP-1c and FAS expression are similarly affected by CB1 ligands.  The authors conclude that anandamide acting at hepatic CB1 contributes to diet-induced obesity and that the FAS pathway may be a common mol. target for central appetitive and peripheral metabolic regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgtGH28MhbLVg90H21EOLACvtfcHk0ljJlwgnyV8guw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFSktLw%253D&md5=d2262aa9aa65d5f84683f8960e39ec6f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1172%2FJCI200523057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200523057%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26aulast%3DDePetrillo%26aufirst%3DM.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRadaeva%26aufirst%3DS.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DHarvey-White%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DOffert%25C3%25A1ler%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DEndocannabinoid%2520activation%2520at%2520hepatic%2520CB1%2520receptors%2520stimulates%2520fatty%2520acid%2520synthesis%2520and%2520contributes%2520to%2520diet-induced%2520obesity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D1298%26doi%3D10.1172%2FJCI200523057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godlewski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey-White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bátkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsicano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span> </span><span class="NLM_article-title">Hepatic CB<sub>1</sub> receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">3160</span><span class="refDoi"> DOI: 10.1172/JCI34827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1172%2FJCI34827" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=3160&author=D.+Osei-Hyiamanauthor=J.+Liuauthor=L.+Zhouauthor=G.+Godlewskiauthor=J.+Harvey-Whiteauthor=W.+I.+Jeongauthor=S.+B%C3%A1tkaiauthor=G.+Marsicanoauthor=B.+Lutzauthor=C.+Buettnerauthor=G.+Kunos&title=Hepatic+CB1+receptor+is+required+for+development+of+diet-induced+steatosis%2C+dyslipidemia%2C+and+insulin+and+leptin+resistance+in+mice&doi=10.1172%2FJCI34827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1172%2FJCI34827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI34827%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DGodlewski%26aufirst%3DG.%26aulast%3DHarvey-White%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DW.%2BI.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DMarsicano%26aufirst%3DG.%26aulast%3DLutz%26aufirst%3DB.%26aulast%3DBuettner%26aufirst%3DC.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DHepatic%2520CB1%2520receptor%2520is%2520required%2520for%2520development%2520of%2520diet-induced%2520steatosis%252C%2520dyslipidemia%252C%2520and%2520insulin%2520and%2520leptin%2520resistance%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D3160%26doi%3D10.1172%2FJCI34827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">9699</span><span class="NLM_x">–</span> <span class="NLM_lpage">9704</span><span class="refDoi"> DOI: 10.1021/ja062999h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja062999h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=9699-9704&author=J.+P.+Alexanderauthor=B.+F.+Cravatt&title=The+putative+endocannabinoid+transport+blocker+LY2183240+is+a+potent+inhibitor+of+FAAH+and+several+other+brain+serine+hydrolases&doi=10.1021%2Fja062999h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fja062999h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja062999h%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520putative%2520endocannabinoid%2520transport%2520blocker%2520LY2183240%2520is%2520a%2520potent%2520inhibitor%2520of%2520FAAH%2520and%2520several%2520other%2520brain%2520serine%2520hydrolases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D9699%26epage%3D9704%26doi%3D10.1021%2Fja062999h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Apodaca, R.; Breitenbucher, J.; Pattabiraman, K.; Seierstad, M.; Xiao, W.</span><span> </span><span class="NLM_article-title">Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase</span>. World Patent WO2006074025 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=R.+Apodaca&author=J.+Breitenbucher&author=K.+Pattabiraman&author=M.+Seierstad&author=W.+Xiao&title=Piperazinyl+and+piperidinyl+ureas+as+modulators+of+fatty+acid+amide+hydrolase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DApodaca%26aufirst%3DR.%26atitle%3DPiperazinyl%2520and%2520piperidinyl%2520ureas%2520as%2520modulators%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattabiraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tham, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4838</span><span class="NLM_x">–</span> <span class="NLM_lpage">4843</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2008.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4838-4843&author=J.+M.+Keithauthor=R.+Apodacaauthor=W.+Xiaoauthor=M.+Seierstadauthor=K.+Pattabiramanauthor=J.+Wuauthor=M.+Webbauthor=M.+J.+Karbarzauthor=S.+Brownauthor=S.+Wilsonauthor=B.+Scottauthor=C.+S.+Thamauthor=L.+Luoauthor=J.+Palmerauthor=M.+Wennerholmauthor=S.+Chaplanauthor=J.+G.+Breitenbucher&title=Thiadiazolopiperazinyl+ureas+as+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2008.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DApodaca%26aufirst%3DR.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPattabiraman%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%2BJ.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DTham%26aufirst%3DC.%2BS.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DWennerholm%26aufirst%3DM.%26aulast%3DChaplan%26aufirst%3DS.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DThiadiazolopiperazinyl%2520ureas%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4838%26epage%3D4843%26doi%3D10.1016%2Fj.bmcl.2008.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichenor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Aryl piperazinyl ureas as inhibitors of fatty acid amide hydrolase (FAAH) in rat, dog, and primate</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span><span class="refDoi"> DOI: 10.1021/ml300186g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300186g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1eksbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=823-827&author=J.+M.+Keithauthor=R.+Apodacaauthor=M.+Tichenorauthor=W.+Xiaoauthor=W.+Jonesauthor=J.+Pierceauthor=M.+Seierstadauthor=J.+Palmerauthor=M.+Webbauthor=M.+Karbarzauthor=B.+Scottauthor=S.+Wilsonauthor=L.+Luoauthor=M.+Wennerholmauthor=L.+Changauthor=S.+Brownauthor=M.+Rizzolioauthor=R.+Rynbergauthor=S.+Chaplanauthor=J.+G.+Breitenbucher&title=Aryl+piperazinyl+ureas+as+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29+in+rat%2C+dog%2C+and+primate&doi=10.1021%2Fml300186g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate</span></div><div class="casAuthors">Keith, John M.; Apodaca, Rich; Tichenor, Mark; Xiao, Wei; Jones, William; Pierce, Joan; Seierstad, Mark; Palmer, James; Webb, Michael; Karbarz, Mark; Scott, Brian; Wilson, Sandy; Luo, Lin; Wennerholm, Michelle; Chang, Leon; Brown, Sean; Rizzolio, Michele; Rynberg, Raymond; Chaplan, Sandra; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">823-827</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of aryl piperazinyl ureas that act as covalent inhibitors of fatty acid amide hydrolase (FAAH) is described.  A potent and selective (does not inhibit FAAH-2) member of this class, JNJ-40355003 (I), was found to elevate the plasma levels of three fatty acid amides: anandamide, oleoyl ethanolamide, and palmitoyl ethanolamide, in the rat, dog, and cynomolgous monkey.  The elevation of the levels of these lipids in the plasma of monkeys suggests that FAAH-2 may not play a significant role in regulating plasma levels of fatty acid ethanolamides in primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0G60tuqmh8LVg90H21EOLACvtfcHk0liUkObKfIcLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1eksbrN&md5=fbf5fb59244ac006d87a9b80918ae24e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fml300186g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300186g%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DApodaca%26aufirst%3DR.%26aulast%3DTichenor%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DW.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DRynberg%26aufirst%3DR.%26aulast%3DChaplan%26aufirst%3DS.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DAryl%2520piperazinyl%2520ureas%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520in%2520rat%252C%2520dog%252C%2520and%2520primate%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D823%26epage%3D827%26doi%3D10.1021%2Fml300186g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.12.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2013.12.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24433863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1OrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=737-741&author=J.+M.+Keithauthor=W.+M.+Jonesauthor=J.+M.+Pierceauthor=M.+Seierstadauthor=J.+A.+Palmerauthor=M.+Webbauthor=M.+J.+Karbarzauthor=B.+P.+Scottauthor=S.+J.+Wilsonauthor=L.+Luoauthor=M.+L.+Wennerholmauthor=L.+Changauthor=S.+M.+Brownauthor=M.+Rizzolioauthor=R.+Rynbergauthor=S.+R.+Chaplanauthor=J.+G.+Breitenbucher&title=Heteroarylureas+with+spirocyclic+diamine+cores+as+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2013.12.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase</span></div><div class="casAuthors">Keith, John M.; Jones, William M.; Pierce, Joan M.; Seierstad, Mark; Palmer, James A.; Webb, Michael; Karbarz, Mark J.; Scott, Brian P.; Wilson, Sandy J.; Luo, Lin; Wennerholm, Michelle L.; Chang, Leon; Brown, Sean M.; Rizzolio, Michele; Rynberg, Raymond; Chaplan, Sandra R.; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-741</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of mechanism based heteroaryl urea fatty acid amide hydrolase (FAAH) inhibitors with spirocyclic diamine cores is described.  A potent member of this class, (37), was found to inhibit FAAH centrally, elevate the brain levels of three fatty acid ethanolamides [FAAs: anandamide (AEA), oleoyl ethanolamide (OEA) and palmitoyl ethanolamide (PEA)], and was moderately efficacious in a rat model of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvAj0Nj_-tl7Vg90H21EOLACvtfcHk0liUkObKfIcLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1OrsQ%253D%253D&md5=60b527e68c94cba12a0385940bbcddef</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.12.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.12.113%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DJones%26aufirst%3DW.%2BM.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DB.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DS.%2BM.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DRynberg%26aufirst%3DR.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DHeteroarylureas%2520with%2520spirocyclic%2520diamine%2520cores%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D737%26epage%3D741%26doi%3D10.1016%2Fj.bmcl.2013.12.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichenor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the FAAH inhibitor JNJ-42165279</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00353</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00353" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1204-1208&author=J.+M.+Keithauthor=W.+M.+Jonesauthor=M.+Tichenorauthor=J.+Liuauthor=M.+Seierstadauthor=J.+A.+Palmerauthor=M.+Webbauthor=M.+Karbarzauthor=B.+P.+Scottauthor=S.+J.+Wilsonauthor=L.+Luoauthor=M.+L.+Wennerholmauthor=L.+Changauthor=M.+Rizzolioauthor=R.+Rynbergauthor=S.+R.+Chaplanauthor=J.+G.+Breitenbucher&title=Preclinical+characterization+of+the+FAAH+inhibitor+JNJ-42165279&doi=10.1021%2Facsmedchemlett.5b00353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Characterization of the FAAH Inhibitor JNJ-42165279</span></div><div class="casAuthors">Keith, John M.; Jones, William M.; Tichenor, Mark; Liu, Jing; Seierstad, Mark; Palmer, James A.; Webb, Michael; Karbarz, Mark; Scott, Brian P.; Wilson, Sandy J.; Luo, Lin; Wennerholm, Michelle L.; Chang, Leon; Rizzolio, Michele; Rynberg, Raymond; Chaplan, Sandra R.; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1204-1208</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The preclin. characterization of the aryl piperazinyl urea inhibitor of fatty acid amide hydrolase (FAAH) JNJ-42165279 I is described.  JNJ-42165279 covalently inactivates the FAAH enzyme, but is highly selective with regard to other enzymes, ion channels, transporters, and receptors.  JNJ-42165279 exhibited excellent ADME and pharmacodynamic properties as evidenced by its ability to block FAAH in the brain and periphery of rats and thereby cause an elevation of the concns. of anandamide (AEA), oleoyl ethanolamide (OEA), and palmitoyl ethanolamide (PEA).  The compd. was also efficacious in the spinal nerve ligation (SNL) model of neuropathic pain.  The combination of good phys., ADME, and PD properties of JNJ-42165279 supported it entering the clin. portfolio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomEbhvg1wiX7Vg90H21EOLACvtfcHk0liUkObKfIcLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGms73P&md5=fc681414ace29f39906fdd62c204114b</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00353%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DJones%26aufirst%3DW.%2BM.%26aulast%3DTichenor%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%26aulast%3DScott%26aufirst%3DB.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DRynberg%26aufirst%3DR.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520FAAH%2520inhibitor%2520JNJ-42165279%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1204%26epage%3D1208%26doi%3D10.1021%2Facsmedchemlett.5b00353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=M.+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+characterization+of+a+highly+selective+FAAH+inhibitor+that+reduces+inflammatory+pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0lizT-Vwar3jFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520selective%2520FAAH%2520inhibitor%2520that%2520reduces%2520inflammatory%2520pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everdeen, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">12820</span><span class="NLM_x">–</span> <span class="NLM_lpage">12824</span><span class="refDoi"> DOI: 10.1073/pnas.0806121105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.0806121105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18753625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=12820-12824&author=M.+Mileniauthor=D.+S.+Johnsonauthor=Z.+Wangauthor=D.+S.+Everdeenauthor=M.+Liimattaauthor=B.+Pabstauthor=K.+Bhattacharyaauthor=R.+A.+Nugentauthor=S.+Kamtekarauthor=B.+F.+Cravattauthor=K.+Ahnauthor=R.+C.+Stevens&title=Structure-guided+inhibitor+design+for+human+FAAH+by+interspecies+active+site+conversion&doi=10.1073%2Fpnas.0806121105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span></div><div class="casAuthors">Mileni, Mauro; Johnson, Douglas S.; Wang, Zhigang; Everdeen, Daniel S.; Liimatta, Marya; Pabst, Brandon; Bhattacharya, Keshab; Nugent, Richard A.; Kamtekar, Satwik; Cravatt, Benjamin F.; Ahn, Kay; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12820-12824</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The integral membrane enzyme fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and related amidated signaling lipids.  Genetic or pharmacol. inactivation of FAAH produces analgesic, anxiolytic, and antiinflammatory phenotypes but not the undesirable side effects of direct cannabinoid receptor agonists, indicating that FAAH may be a promising therapeutic target.  Structure-based inhibitor design has, however, been hampered by difficulties in expressing the human FAAH enzyme.  Here, we address this problem by interconverting the active sites of rat and human FAAH using site-directed mutagenesis.  The resulting humanized rat (h/r) FAAH protein exhibits the inhibitor sensitivity profiles of human FAAH but maintains the high-expression yield of the rat enzyme.  We report a 2.75-Å crystal structure of h/rFAAH complexed with an inhibitor, N-phenyl-4- (quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750), that shows strong preference for human FAAH.  This structure offers compelling insights to explain the species selectivity of FAAH inhibitors, which should guide future drug design programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq16BzSUEI2DbVg90H21EOLACvtfcHk0lizT-Vwar3jFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP&md5=bebc9409a5e71734f651c5ab89303fad</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806121105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806121105%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEverdeen%26aufirst%3DD.%2BS.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520for%2520human%2520FAAH%2520by%2520interspecies%2520active%2520site%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D12820%26epage%3D12824%26doi%3D10.1073%2Fpnas.0806121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, J. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2869</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2009.03.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19386497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2rtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2865-2869&author=D.+S.+Johnsonauthor=K.+Ahnauthor=S.+Kestenauthor=S.+E.+Lazerwithauthor=Y.+Songauthor=M.+Morrisauthor=L.+Fayauthor=T.+Gregoryauthor=C.+Stiffauthor=J.+B.+Dunbarauthor=M.+Liimattaauthor=D.+Beidlerauthor=S.+Smithauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravatt&title=Benzothiophene+piperazine+and+piperidine+urea+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1016%2Fj.bmcl.2009.03.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)</span></div><div class="casAuthors">Johnson, Douglas S.; Ahn, Kay; Kesten, Suzanne; Lazerwith, Scott E.; Song, Yuntao; Morris, Mark; Fay, Lorraine; Gregory, Tracy; Stiff, Cory; Dunbar, James B.; Liimatta, Marya; Beidler, David; Smith, Sarah; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2865-2869</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationships (SAR) of a series of benzothiophene piperazine and piperidine urea, e.g. I (R = i-Pr, n-Bu, CH2CH2OH, Ph, PhCH2, 3-pyridyl, etc.), as inhibitors of fatty acid amide hydrolase (FAAH) is described.  These compds. inhibit FAAH by covalently modifying the enzyme's active site serine nucleophile.  Activity-based protein profiling revealed that these urea inhibitors were completely selective for FAAH relative to other mammalian serine hydrolases.  Several compds. showed in vivo activity in a rat complete Freund's adjuvant model of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCAmK01iLBdrVg90H21EOLACvtfcHk0lgVqQhPqA9MNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2rtrk%253D&md5=45cd6689440a19fa1ec479dbd6622874</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.080%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DKesten%26aufirst%3DS.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DFay%26aufirst%3DL.%26aulast%3DGregory%26aufirst%3DT.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DDunbar%26aufirst%3DJ.%2BB.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DBenzothiophene%2520piperazine%2520and%2520piperidine%2520urea%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2865%26epage%3D2869%26doi%3D10.1016%2Fj.bmcl.2009.03.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Tchantchou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluett, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2014.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.neuropharm.2014.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24937045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyhtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=427-439&author=F.+Tchantchouauthor=L.+B.+Tuckerauthor=A.+H.+Fuauthor=R.+J.+Bluettauthor=J.+T.+McCabeauthor=S.+Patelauthor=Y.+Zhang&title=The+fatty+acid+amide+hydrolase+inhibitor+PF-3845+promotes+neuronal+survival%2C+attenuates+inflammation+and+improves+functional+recovery+in+mice+with+traumatic+brain+injury&doi=10.1016%2Fj.neuropharm.2014.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury</span></div><div class="casAuthors">Tchantchou, Flaubert; Tucker, Laura B.; Fu, Amanda H.; Bluett, Rebecca J.; McCabe, Joseph T.; Patel, Sachin; Zhang, Yumin</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">427-439</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Traumatic brain injury (TBI) is the leading cause of death in young adults in the United States, but there is still no effective agent for treatment.  N-arachidonoylethanolamine (anandamide, AEA) is a major endocannabinoid in the brain.  Its increase after brain injury is believed to be protective.  However, the compensatory role of AEA is transient due to its rapid hydrolysis by the fatty acid amide hydrolase (FAAH).  Thus, inhibition of FAAH can boost the endogenous levels of AEA and prolong its protective effect.  Using a TBI mouse model, we found that post-injury chronic treatment with PF3845, a selective and potent FAAH inhibitor, reversed TBI-induced impairments in fine motor movement, hippocampus dependent working memory and anxiety-like behavior.  Treatment with PF3845 inactivated FAAH activity and enhanced the AEA levels in the brain.  It reduced neurodegeneration in the dentate gyrus, and up-regulated the expression of Bcl-2 and Hsp70/72 in both cortex and hippocampus.  PF3845 also suppressed the increased prodn. of amyloid precursor protein, prevented dendritic loss and restored the levels of synaptophysin in the ipsilateral dentate gyrus.  Furthermore, PF3845 suppressed the expression of inducible nitric oxide synthase and cyclooxygenase-2 and enhanced the expression of arginase-1 post-TBI, suggesting a shift of microglia/macrophages from M1 to M2 phenotype.  The effects of PF3845 on TBI-induced behavioral deficits and neurodegeneration were mediated by activation of cannabinoid type 1 and 2 receptors and might be attributable to the phosphorylation of ERK1/2 and AKT.  These results suggest that selective inhibition of FAAH is likely to be beneficial for TBI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXGb0o16ycIrVg90H21EOLACvtfcHk0lgVqQhPqA9MNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyhtbzE&md5=af72ce58792e2b888995c58be94f7262</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2014.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2014.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DTchantchou%26aufirst%3DF.%26aulast%3DTucker%26aufirst%3DL.%2BB.%26aulast%3DFu%26aufirst%3DA.%2BH.%26aulast%3DBluett%26aufirst%3DR.%2BJ.%26aulast%3DMcCabe%26aufirst%3DJ.%2BT.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DThe%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520PF-3845%2520promotes%2520neuronal%2520survival%252C%2520attenuates%2520inflammation%2520and%2520improves%2520functional%2520recovery%2520in%2520mice%2520with%2520traumatic%2520brain%2520injury%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D85%26spage%3D427%26epage%3D439%26doi%3D10.1016%2Fj.neuropharm.2014.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1021/ml100190t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor&doi=10.1021%2Fml100190t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0lgVqQhPqA9MNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96%26doi%3D10.1021%2Fml100190t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1124/jpet.111.180257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.111.180257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=21505060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=114-124&author=K.+Ahnauthor=S.+E.+Smithauthor=M.+B.+Liimattaauthor=D.+Beidlerauthor=N.+Sadagopanauthor=D.+T.+Dudleyauthor=T.+Youngauthor=P.+Wrenauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=J.+L.+Blankmanauthor=D.+K.+Nomuraauthor=S.+N.+Bhattacharauthor=C.+Stiffauthor=T.+K.+Nomanbhoyauthor=E.+Weerapanaauthor=D.+S.+Johnsonauthor=B.+F.+Cravatt&title=Mechanistic+and+pharmacological+characterization+of+PF-04457845%3A+a+highly+potent+and+selective+fatty+acid+amide+hydrolase+inhibitor+that+reduces+inflammatory+and+noninflammatory+pain&doi=10.1124%2Fjpet.111.180257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain</span></div><div class="casAuthors">Ahn, Kay; Smith, Sarah E.; Liimatta, Marya B.; Beidler, David; Sadagopan, Nalini; Dudley, David T.; Young, Tim; Wren, Paul; Zhang, Yanhua; Swaney, Steven; Van Becelaere, Keri; Blankman, Jacqueline L.; Nomura, Daniel K.; Bhattachar, Shobha N.; Stiff, Cory; Nomanbhoy, Tyzoon K.; Weerapana, Eranthie; Johnson, Douglas S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-124</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous cannabinoid (endocannabinoid) anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH).  Pharmacol. blockade of FAAH has emerged as a potentially attractive strategy for augmenting endocannabinoid signaling and retaining the beneficial effects of cannabinoid receptor activation, while avoiding the undesirable side effects, such as wt. gain and impairments in cognition and motor control, obsd. with direct cannabinoid receptor 1 agonists.  Here, we report the detailed mechanistic and pharmacol. characterization of N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide (PF-04457845), a highly efficacious and selective FAAH inhibitor.  Mechanistic studies confirm that PF-04457845 is a time-dependent, covalent FAAH inhibitor that carbamylates FAAH's catalytic serine nucleophile.  PF-04457845 inhibits human FAAH with high potency (kinact/Ki = 40,300 M-1s-1; IC50 = 7.2 nM) and is exquisitely selective in vivo as detd. by activity-based protein profiling.  Oral administration of PF-04457845 produced potent antinociceptive effects in both inflammatory [complete Freund's adjuvant (CFA)] and noninflammatory (monosodium iodoacetate) pain models in rats, with a min. ED of 0.1 mg/kg (CFA model).  PF-04457845 displayed a long duration of action as a single oral administration at 1 mg/kg showed in vivo efficacy for 24 h with a concomitant near-complete inhibition of FAAH activity and maximal sustained elevation of anandamide in brain.  Significantly, PF-04457845-treated mice at 10 mg/kg elicited no effect in motility, catalepsy, and body temp.  Based on its exceptional selectivity and in vivo efficacy, combined with long duration of action and optimal pharmacokinetic properties, PF-04457845 is a clin. candidate for the treatment of pain and other nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd5BIw55W3OrVg90H21EOLACvtfcHk0ligQvhZ6ShVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCiurY%253D&md5=b32df795c9df175bd6403fdd5672eae2</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180257%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DWren%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DMechanistic%2520and%2520pharmacological%2520characterization%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%2520and%2520selective%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520that%2520reduces%2520inflammatory%2520and%2520noninflammatory%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D114%26epage%3D124%26doi%3D10.1124%2Fjpet.111.180257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Huggins, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1837</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span><span class="refDoi"> DOI: 10.1016/j.pain.2012.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.pain.2012.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22727500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKnurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=1837-1846&author=J.+P.+Hugginsauthor=T.+S.+Smartauthor=S.+Langmanauthor=L.+Taylorauthor=T.+Young&title=An+efficient+randomised%2C+placebo-controlled+clinical+trial+with+the+irreversible+fatty+acid+amide+hydrolase-1+inhibitor+PF-04457845%2C+which+modulates+endocannabinoids+but+fails+to+induce+effective+analgesia+in+patients+with+pain+due+to+osteoarthritis+of+the+knee&doi=10.1016%2Fj.pain.2012.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee</span></div><div class="casAuthors">Huggins, John P.; Smart, Trevor S.; Langman, Stephen; Taylor, Louise; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1837-1846</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A randomised, placebo-controlled clin. trial with PF-04457845, a novel irreversible fatty acid amide hydrolase-1 inhibitor, increases endocannabinoids, but does not induce analgesia in patients with osteoarthritis.  The effect of PF-04457845, a potent and selective fatty acid amide hydrolase-1 (FAAH1) inhibitor, on pain due to osteoarthritis of the knee was investigated in a randomised placebo and active-controlled clin. trial.  The trial involved 2 periods (sepd. by a 2-wk washout) consisting of a 1-wk wash-in phase followed by 2 wk double-blind treatment.  Patients received single-blind placebo throughout the wash-in and washout periods.  Patients were randomised to receive either 4 mg q.d.  PF-04457845 followed by placebo (or vice versa), or 500 mg b.i.d. naproxen followed by placebo (or vice versa).  The primary end point was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score.  The trial had predefined decision rules based on likelihood that PF-04457845 was better or worse than the std. of care (considered to be a 1.8 redn. in WOMAC pain score compared to placebo).  A total of 74 patients were randomised to 1 of 4 treatment sequences.  The mean differences (80% confidence intervals) from placebo in WOMAC pain score were 0.04 (-0.63 to 0.71) for PF-04457845 and -1.13 (-1.79 to -0.47) for naproxen, indicating that while naproxen seemed efficacious, PF-04457845 was not differentiated from placebo.  The study was stopped at the interim anal. for futility.  PF-04457845 decreased FAAH activity by >96% and substantially increased 4 endogenous substrates (fatty acid amides).  PF-04457845 was well tolerated in osteoarthritis patients, and there was no evidence of cannabinoid-type adverse events.  The lack of analgesic effect of FAAH1 inhibition in humans is in contrast to data from animal models.  This apparent disconnect between species needs further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbHcORiYgJbVg90H21EOLACvtfcHk0ligQvhZ6ShVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKnurrF&md5=2b63f10426d6cacef059d972a5a825c1</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DJ.%2BP.%26aulast%3DSmart%26aufirst%3DT.%2BS.%26aulast%3DLangman%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DAn%2520efficient%2520randomised%252C%2520placebo-controlled%2520clinical%2520trial%2520with%2520the%2520irreversible%2520fatty%2520acid%2520amide%2520hydrolase-1%2520inhibitor%2520PF-04457845%252C%2520which%2520modulates%2520endocannabinoids%2520but%2520fails%2520to%2520induce%2520effective%2520analgesia%2520in%2520patients%2520with%2520pain%2520due%2520to%2520osteoarthritis%2520of%2520the%2520knee%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D1837%26epage%3D1846%26doi%3D10.1016%2Fj.pain.2012.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Percie du Sert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span> </span><span class="NLM_article-title">Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">2951</span><span class="NLM_x">–</span> <span class="NLM_lpage">2963</span><span class="refDoi"> DOI: 10.1111/bph.12645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fbph.12645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24527763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFaht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=2951-2963&author=N.+Percie+du+Sertauthor=A.+S.+Rice&title=Improving+the+translation+of+analgesic+drugs+to+the+clinic%3A+animal+models+of+neuropathic+pain&doi=10.1111%2Fbph.12645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain</span></div><div class="casAuthors">Percie du Sert, N.; Rice, A. S. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2951-2963</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain remains an area of considerable unmet clin. need.  Research based on preclin. animal models has failed to deliver truly novel treatment options, questioning the predictive value of these models.  This review addresses the shortcomings of rodent in vivo models commonly used in the field and highlights approaches which could increase their predictivity, including more clin. relevant assays, outcome measures and animal characteristics.  The methodol. quality of animal studies also needs to be improved.  Low internal validity and incomplete reporting lead to a waste of valuable research resources and animal lives, and ultimately prevent an objective assessment of the true predictivity of in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ7teE3qz4b7Vg90H21EOLACvtfcHk0ligQvhZ6ShVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFaht7o%253D&md5=01c4dda8a78b402411a8ea882d998a12</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fbph.12645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12645%26sid%3Dliteratum%253Aachs%26aulast%3DPercie%2Bdu%2BSert%26aufirst%3DN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26atitle%3DImproving%2520the%2520translation%2520of%2520analgesic%2520drugs%2520to%2520the%2520clinic%253A%2520animal%2520models%2520of%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D2951%26epage%3D2963%26doi%3D10.1111%2Fbph.12645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Hicks, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadovski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of [<sup>11</sup>C-carbonyl] PF-04457845 for neuroimaging of fatty acid amide hydrolase</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2013.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.nucmedbio.2013.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23731552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=740-746&author=J.+W.+Hicksauthor=J.+Parkesauthor=O.+Sadovskiauthor=J.+Tongauthor=S.+Houleauthor=N.+Vasdevauthor=A.+A.+Wilson&title=Synthesis+and+preclinical+evaluation+of+%5B11C-carbonyl%5D+PF-04457845+for+neuroimaging+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.nucmedbio.2013.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase</span></div><div class="casAuthors">Hicks, Justin W.; Parkes, Jun; Sadovski, Oleg; Tong, Junchao; Houle, Sylvain; Vasdev, Neil; Wilson, Alan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">740-746</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) has a significant role in regulating endocannabinoid signaling in the central nervous system.  As such, FAAH inhibitors are being actively sought for pain, addiction, and other indications.  This has led to the recent pursuit of positron emission tomog. (PET) radiotracers targeting FAAH.  We report herein the prepn. and preclin. evaluation of [11C-carbonyl]PF-04457845, an isotopologue of the potent irreversible FAAH inhibitor.  PF-04457845 was radiolabeled at the carbonyl position via automated [11C]CO2-fixation.  Ex vivo brain biodistribution of [11C-carbonyl]PF-04457845 was carried out in conscious rats.  Specificity was detd. by pre-administration of PF-04457845 or URB597 prior to [11C-carbonyl]PF-04457845.  In a sep. expt., rats injected with the title radiotracer had whole brains excised, homogenized and extd. to examine irreversible binding to brain parenchyma.  The title compd. was prepd. in 5 ± 1% (n = 4) isolated radiochem. yield based on starting [11C]CO2 (decay uncorrected) within 25 min from end-of-bombardment in > 98% radiochem. purity and a specific activity of 73.5 ± 8.2 GBq/μmol at end-of-synthesis.  Uptake of [11C-carbonyl]PF-04457845 into the rat brain was high (range of 1.2-4.4 SUV), heterogeneous, and in accordance with reported FAAH distribution.  Saturable binding was demonstrated by a dose-dependent redn. in brain radioactivity uptake following pre-treatment with PF-04457845.  Pre-treatment with the prototypical FAAH inhibitor, URB597, reduced the brain radiotracer uptake in all regions by 71-81%, demonstrating specificity for FAAH.  The binding of [11C-carbonyl]PF-04457845 to FAAH at 40 min post injection was irreversible as 98% of the radioactivity in the brain could not be extd.  [11C-carbonyl]PF-04457845 was rapidly synthesized via an automated radiosynthesis.  Ex vivo biodistribution studies in conscious rodents demonstrate that [11C PF-04457845 is a promising candidate radiotracer for imaging FAAH in the brain with PET.  These results coupled with the known pharmacol. and toxicol. of PF-04457845 should facilitate clin. translation of this radiotracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3VVfFVnooC7Vg90H21EOLACvtfcHk0lhKLrkJimsScw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslWmt7o%253D&md5=17ff0759bc57b31cd49887f5e30b3afa</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2013.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2013.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DParkes%26aufirst%3DJ.%26aulast%3DSadovski%26aufirst%3DO.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520%255B11C-carbonyl%255D%2520PF-04457845%2520for%2520neuroimaging%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2013%26volume%3D40%26spage%3D740%26epage%3D746%26doi%3D10.1016%2Fj.nucmedbio.2013.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelc, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: Identification of 7-azaspiro [3.5] nonane and 1-oxa-8-azaspiro [4.5] decane as lead scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6538</span><span class="NLM_x">–</span> <span class="NLM_lpage">6544</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2011.08.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6538-6544&author=M.+J.+Meyersauthor=S.+A.+Longauthor=M.+J.+Pelcauthor=J.+L.+Wangauthor=S.+J.+Bowenauthor=M.+C.+Walkerauthor=B.+A.+Schweitzerauthor=H.+M.+Madsenauthor=R.+E.+Tenbrinkauthor=J.+McDonaldauthor=S.+E.+Smithauthor=S.+Foltinauthor=D.+Beidlerauthor=A.+Thorarensen&title=Discovery+of+novel+spirocyclic+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29.+Part+1%3A+Identification+of+7-azaspiro+%5B3.5%5D+nonane+and+1-oxa-8-azaspiro+%5B4.5%5D+decane+as+lead+scaffolds&doi=10.1016%2Fj.bmcl.2011.08.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.055%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPelc%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DBowen%26aufirst%3DS.%2BJ.%26aulast%3DWalker%26aufirst%3DM.%2BC.%26aulast%3DSchweitzer%26aufirst%3DB.%2BA.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DFoltin%26aufirst%3DS.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520novel%2520spirocyclic%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529.%2520Part%25201%253A%2520Identification%2520of%25207-azaspiro%2520%255B3.5%255D%2520nonane%2520and%25201-oxa-8-azaspiro%2520%255B4.5%255D%2520decane%2520as%2520lead%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6538%26epage%3D6544%26doi%3D10.1016%2Fj.bmcl.2011.08.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelc, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumsey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro [3.5] nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6545</span><span class="NLM_x">–</span> <span class="NLM_lpage">6553</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2011.08.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6545-6553&author=M.+J.+Meyersauthor=S.+A.+Longauthor=M.+J.+Pelcauthor=J.+L.+Wangauthor=S.+J.+Bowenauthor=B.+A.+Schweitzerauthor=M.+V.+Wilcoxauthor=J.+McDonaldauthor=S.+E.+Smithauthor=S.+Foltinauthor=J.+Rumseyauthor=Y.+S.+Yangauthor=M.+C.+Walkerauthor=S.+Kamtekarauthor=D.+Beidlerauthor=A.+Thorarensen&title=Discovery+of+novel+spirocyclic+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29.+Part+2.+Discovery+of+7-azaspiro+%5B3.5%5D+nonane+urea+PF-04862853%2C+an+orally+efficacious+inhibitor+of+fatty+acid+amide+hydrolase+%28FAAH%29+for+pain&doi=10.1016%2Fj.bmcl.2011.08.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.048%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPelc%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DBowen%26aufirst%3DS.%2BJ.%26aulast%3DSchweitzer%26aufirst%3DB.%2BA.%26aulast%3DWilcox%26aufirst%3DM.%2BV.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DFoltin%26aufirst%3DS.%26aulast%3DRumsey%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DWalker%26aufirst%3DM.%2BC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520novel%2520spirocyclic%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529.%2520Part%25202.%2520Discovery%2520of%25207-azaspiro%2520%255B3.5%255D%2520nonane%2520urea%2520PF-04862853%252C%2520an%2520orally%2520efficacious%2520inhibitor%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6545%26epage%3D6553%26doi%3D10.1016%2Fj.bmcl.2011.08.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Kono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2012.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=28-41&author=M.+Konoauthor=T.+Matsumotoauthor=T.+Kawamuraauthor=A.+Nishimuraauthor=Y.+Kiyotaauthor=H.+Okiauthor=J.+Miyazakiauthor=S.+Igakiauthor=C.+A.+Behnkeauthor=M.+Shimojoauthor=M.+Kori&title=Synthesis%2C+SAR+study%2C+and+biological+evaluation+of+a+series+of+piperazine+ureas+as+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1016%2Fj.bmc.2012.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DKiyota%26aufirst%3DY.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DIgaki%26aufirst%3DS.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520SAR%2520study%252C%2520and%2520biological%2520evaluation%2520of%2520a%2520series%2520of%2520piperazine%2520ureas%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D28%26epage%3D41%26doi%3D10.1016%2Fj.bmc.2012.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Kono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1468</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2013.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24440478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1468-1478&author=M.+Konoauthor=T.+Matsumotoauthor=T.+Imaedaauthor=T.+Kawamuraauthor=S.+Fujimotoauthor=Y.+Kosugiauthor=T.+Odaniauthor=Y.+Shimizuauthor=H.+Matsuiauthor=M.+Shimojoauthor=M.+Kori&title=Design%2C+synthesis%2C+and+biological+evaluation+of+a+series+of+piperazine+ureas+as+fatty+acid+amide+hydrolase+inhibitors&doi=10.1016%2Fj.bmc.2013.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors</span></div><div class="casAuthors">Kono, Mitsunori; Matsumoto, Takahiro; Imaeda, Toshihiro; Kawamura, Toru; Fujimoto, Shinji; Kosugi, Yohei; Odani, Tomoyuki; Shimizu, Yuji; Matsui, Hideki; Shimojo, Masato; Kori, Masakuni</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1468-1478</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of piperazine ureas were designed, synthesized, and evaluated for their potential as novel orally efficacious fatty acid amide hydrolase (FAAH) inhibitors for the treatment of neuropathic and inflammatory pain.  We carried out an optimization study of compd. 5 to improve its in vitro FAAH inhibitory activity, and identified the 2-pyrimidinylpiperazine deriv. 21d with potent inhibitory activity, favorable DMPK profile and brain permeability.  Compd. 21d showed robust and dose-dependent analgesic efficacy in animal models of both neuropathic and inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOGgRCmurOZbVg90H21EOLACvtfcHk0lgPST0B5KKDyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyktrg%253D&md5=38f9681ea9d7eb262642a423a87cdaa3</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DS.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520a%2520series%2520of%2520piperazine%2520ureas%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1468%26epage%3D1478%26doi%3D10.1016%2Fj.bmc.2013.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span> </span><span class="NLM_article-title">Boronic acid compounds as potential pharmaceutical agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1002/med.10043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fmed.10043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12647314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=346-368&author=W.+Yangauthor=X.+Gaoauthor=B.+Wang&title=Boronic+acid+compounds+as+potential+pharmaceutical+agents&doi=10.1002%2Fmed.10043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid compounds as potential pharmaceutical agents</span></div><div class="casAuthors">Yang, Wenqian; Gao, Xingming; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-368</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Boronic acid compds. have been used, because of their unique structural features, for the development of potent enzyme inhibitors, boron neutron capture agents for cancer therapy, and as antibody mimics that recognize biol. important saccharides.  Consequently, there has been a surge of interests in boronic acid compds.  This study reviews the recent development in this area during the last six years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB0CvJjV10BbVg90H21EOLACvtfcHk0lgPST0B5KKDyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D&md5=0b841477e2113218d55991e23133bd60</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1002%2Fmed.10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10043%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DBoronic%2520acid%2520compounds%2520as%2520potential%2520pharmaceutical%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D346%26epage%3D368%26doi%3D10.1002%2Fmed.10043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Minkkila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span> </span><span class="NLM_article-title">Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7057</span><span class="NLM_x">–</span> <span class="NLM_lpage">7060</span><span class="refDoi"> DOI: 10.1021/jm801051t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801051t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7057-7060&author=A.+Minkkilaauthor=S.+M.+Saarioauthor=H.+K%C3%A4sn%C3%A4nenauthor=J.+Lepp%C3%A4nenauthor=A.+Posoauthor=T.+Nevalainen&title=Discovery+of+boronic+acids+as+novel+and+potent+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm801051t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm801051t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801051t%26sid%3Dliteratum%253Aachs%26aulast%3DMinkkila%26aufirst%3DA.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520boronic%2520acids%2520as%2520novel%2520and%2520potent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7057%26epage%3D7060%26doi%3D10.1021%2Fjm801051t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chobanian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellureficio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terebetski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posavec, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVita, R. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-3168: a PET tracer for imaging brain fatty acid amide hydrolase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span><span class="refDoi"> DOI: 10.1021/ml4000996</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4000996" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ylu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=509-513&author=P.+Liuauthor=T.+G.+Hamillauthor=M.+Chiodaauthor=H.+Chobanianauthor=S.+Fungauthor=Y.+Guoauthor=L.+Changauthor=R.+Bakshiauthor=Q.+Hongauthor=J.+Dellureficioauthor=L.+S.+Linauthor=C.+Abbadieauthor=J.+Alexanderauthor=H.+Jinauthor=S.+Mandalaauthor=L.+L.+Shiaoauthor=W.+Liauthor=S.+Sanabriaauthor=D.+Williamsauthor=Z.+Zengauthor=R.+Hajduauthor=N.+Jochnowitzauthor=M.+Rosenbachauthor=B.+Karanamauthor=M.+Madeiraauthor=G.+Salituroauthor=J.+Powellauthor=L.+Xuauthor=J.+L.+Terebetskiauthor=J.+F.+Leoneauthor=P.+Millerauthor=J.+Cookauthor=M.+Holahanauthor=A.+Joshiauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=D.+Posavecauthor=T.+B.+Chenauthor=K.+Riffelauthor=M.+Williamsauthor=R.+Hargreavesauthor=K.+A.+Sullivanauthor=R.+P.+Nargundauthor=R.+J.+DeVita&title=Discovery+of+MK-3168%3A+a+PET+tracer+for+imaging+brain+fatty+acid+amide+hydrolase&doi=10.1021%2Fml4000996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Liu, Ping; Hamill, Terence G.; Chioda, Marc; Chobanian, Harry; Fung, Selena; Guo, Yan; Chang, Linda; Bakshi, Raman; Hong, Qingmei; Dellureficio, James; Lin, Linus S.; Abbadie, Catherine; Alexander, Jessica; Jin, Hong; Mandala, Suzanne; Shiao, Lin-Lin; Li, Wenping; Sanabria, Sandra; Williams, David; Zeng, Zhizhen; Hajdu, Richard; Jochnowitz, Nina; Rosenbach, Mark; Karanam, Bindhu; Madeira, Maria; Salituro, Gino; Powell, Joyce; Xu, Ling; Terebetski, Jenna L.; Leone, Joseph F.; Miller, Patricia; Cook, Jacquelynn; Holahan, Marie; Joshi, Aniket; O'Malley, Stacey; Purcell, Mona; Posavec, Diane; Chen, Tsing-Bau; Riffel, Kerry; Williams, Mangay; Hargreaves, Richard; Sullivan, Kathleen A.; Nargund, Ravi P.; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">509-513</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the discovery of a fatty acid amide hydrolase (FAAH) positron emission tomog. (PET) tracer.  Starting from a pyrazole lead, medicinal chem. efforts directed toward reducing lipophilicity led to the synthesis of a series of imidazole analogs.  Compd. 6 was chosen for further profiling due to its appropriate phys. chem. properties and excellent FAAH inhibition potency across species. [11C]-6 (MK-3168) exhibited good brain uptake and FAAH-specific signal in rhesus monkeys and is a suitable PET tracer for imaging FAAH in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ7TcIehUa5rVg90H21EOLACvtfcHk0lgPST0B5KKDyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ylu7Y%253D&md5=a5ec9a3750ed61f576732b8dfd541026</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fml4000996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000996%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DChioda%26aufirst%3DM.%26aulast%3DChobanian%26aufirst%3DH.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBakshi%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DDellureficio%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%2BS.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DAlexander%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DShiao%26aufirst%3DL.%2BL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSanabria%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTerebetski%26aufirst%3DJ.%2BL.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DPosavec%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DK.%2BA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-3168%253A%2520a%2520PET%2520tracer%2520for%2520imaging%2520brain%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D509%26epage%3D513%26doi%3D10.1021%2Fml4000996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Chobanian, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioda, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellureficio, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyk, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krska, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarewicz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martel, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terebetski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVita, R. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-4409, a novel oxazole FAAH inhibitor for the treatment of inflammatory and neuropathic pain</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span><span class="refDoi"> DOI: 10.1021/ml5001239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5001239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=717-721&author=H.+R.+Chobanianauthor=Y.+Guoauthor=P.+Liuauthor=M.+D.+Chiodaauthor=S.+Fungauthor=T.+J.+Lanzaauthor=L.+Changauthor=R.+K.+Bakshiauthor=J.+P.+Dellureficioauthor=Q.+Hongauthor=M.+McLaughlinauthor=K.+M.+Belykauthor=S.+W.+Krskaauthor=A.+K.+Makarewiczauthor=E.+J.+Martelauthor=J.+F.+Leoneauthor=L.+Freyauthor=B.+Karanamauthor=M.+Madeiraauthor=R.+Alvaroauthor=J.+Shumanauthor=G.+Salituroauthor=J.+L.+Terebetskiauthor=N.+Jochnowitzauthor=S.+Mistryauthor=E.+McGowanauthor=R.+Hajduauthor=M.+Rosenbachauthor=C.+Abbadieauthor=J.+P.+Alexanderauthor=L.+L.+Shiaoauthor=K.+M.+Sullivanauthor=R.+P.+Nargundauthor=M.+J.+Wyvrattauthor=L.+S.+Linauthor=R.+J.+DeVita&title=Discovery+of+MK-4409%2C+a+novel+oxazole+FAAH+inhibitor+for+the+treatment+of+inflammatory+and+neuropathic+pain&doi=10.1021%2Fml5001239"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fml5001239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5001239%26sid%3Dliteratum%253Aachs%26aulast%3DChobanian%26aufirst%3DH.%2BR.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DChioda%26aufirst%3DM.%2BD.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DDellureficio%26aufirst%3DJ.%2BP.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DMcLaughlin%26aufirst%3DM.%26aulast%3DBelyk%26aufirst%3DK.%2BM.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26aulast%3DMakarewicz%26aufirst%3DA.%2BK.%26aulast%3DMartel%26aufirst%3DE.%2BJ.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DFrey%26aufirst%3DL.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DAlvaro%26aufirst%3DR.%26aulast%3DShuman%26aufirst%3DJ.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DTerebetski%26aufirst%3DJ.%2BL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DShiao%26aufirst%3DL.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%2BM.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DLin%26aufirst%3DL.%2BS.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-4409%252C%2520a%2520novel%2520oxazole%2520FAAH%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D717%26epage%3D721%26doi%3D10.1021%2Fml5001239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Andrzejak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Body-Malapel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Bakali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djouina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavatte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desreumaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, R.</span><span> </span><span class="NLM_article-title">New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3786</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2011.04.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=21612933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3777-3786&author=V.+Andrzejakauthor=G.+G.+Muccioliauthor=M.+Body-Malapelauthor=J.+El+Bakaliauthor=M.+Djouinaauthor=N.+Renaultauthor=P.+Chavatteauthor=P.+Desreumauxauthor=D.+M.+Lambertauthor=R.+Millet&title=New+FAAH+inhibitors+based+on+3-carboxamido-5-aryl-isoxazole+scaffold+that+protect+against+experimental+colitis&doi=10.1016%2Fj.bmc.2011.04.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis</span></div><div class="casAuthors">Andrzejak, Virginie; Muccioli, Giulio G.; Body-Malapel, Mathilde; El Bakali, Jamal; Djouina, Madjid; Renault, Nicolas; Chavatte, Philippe; Desreumaux, Pierre; Lambert, Didier M.; Millet, Regis</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3777-3786</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Growing evidence suggests a role for the endocannabinoid (EC) system, in intestinal inflammation and compds. inhibiting anandamide degrdn. offer a promising therapeutic option for the treatment of inflammatory bowel diseases.  In this paper, we report the first series of carboxamides derivs. possessing FAAH inhibitory activities.  Among them, compd. 39 (I) displayed significant inhibitory FAAH activity (IC50 = 0.088 μM) and reduced colitis induced by intrarectal administration of TNBS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqreyUWekQBlbVg90H21EOLACvtfcHk0lj0ny952R9ynQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVyis7w%253D&md5=25a1961af5665d87d9a019e697a97321</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.057%26sid%3Dliteratum%253Aachs%26aulast%3DAndrzejak%26aufirst%3DV.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DBody-Malapel%26aufirst%3DM.%26aulast%3DEl%2BBakali%26aufirst%3DJ.%26aulast%3DDjouina%26aufirst%3DM.%26aulast%3DRenault%26aufirst%3DN.%26aulast%3DChavatte%26aufirst%3DP.%26aulast%3DDesreumaux%26aufirst%3DP.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMillet%26aufirst%3DR.%26atitle%3DNew%2520FAAH%2520inhibitors%2520based%2520on%25203-carboxamido-5-aryl-isoxazole%2520scaffold%2520that%2520protect%2520against%2520experimental%2520colitis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3777%26epage%3D3786%26doi%3D10.1016%2Fj.bmc.2011.04.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Tourteau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leleu-Chavain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Body-Malapel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrzejak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djouina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desreumaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavatte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, R.</span><span> </span><span class="NLM_article-title">Switching cannabinoid response from CB<sub>2</sub> agonists to FAAH inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2014.01.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1322-1326&author=A.+Tourteauauthor=N.+Leleu-Chavainauthor=M.+Body-Malapelauthor=V.+Andrzejakauthor=A.+Barczykauthor=M.+Djouinaauthor=B.+Rigoauthor=P.+Desreumauxauthor=P.+Chavatteauthor=R.+Millet&title=Switching+cannabinoid+response+from+CB2+agonists+to+FAAH+inhibitors&doi=10.1016%2Fj.bmcl.2014.01.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.056%26sid%3Dliteratum%253Aachs%26aulast%3DTourteau%26aufirst%3DA.%26aulast%3DLeleu-Chavain%26aufirst%3DN.%26aulast%3DBody-Malapel%26aufirst%3DM.%26aulast%3DAndrzejak%26aufirst%3DV.%26aulast%3DBarczyk%26aufirst%3DA.%26aulast%3DDjouina%26aufirst%3DM.%26aulast%3DRigo%26aufirst%3DB.%26aulast%3DDesreumaux%26aufirst%3DP.%26aulast%3DChavatte%26aufirst%3DP.%26aulast%3DMillet%26aufirst%3DR.%26atitle%3DSwitching%2520cannabinoid%2520response%2520from%2520CB2%2520agonists%2520to%2520FAAH%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1322%26epage%3D1326%26doi%3D10.1016%2Fj.bmcl.2014.01.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Minkkilä, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xhaard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span> </span><span class="NLM_article-title">Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1259</span><span class="refDoi"> DOI: 10.1002/cmdc.200900137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.200900137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1253-1259&author=A.+Minkkil%C3%A4author=J.+R.+Savinainenauthor=H.+K%C3%A4sn%C3%A4nenauthor=H.+Xhaardauthor=T.+Nevalainenauthor=J.+T.+Laitinenauthor=A.+Posoauthor=J.+Lepp%C3%A4nenauthor=S.+M.+Saario&title=Screening+of+various+hormone-sensitive+lipase+inhibitors+as+endocannabinoid-hydrolyzing+enzyme+inhibitors&doi=10.1002%2Fcmdc.200900137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900137%26sid%3Dliteratum%253Aachs%26aulast%3DMinkkil%25C3%25A4%26aufirst%3DA.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DXhaard%26aufirst%3DH.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26atitle%3DScreening%2520of%2520various%2520hormone-sensitive%2520lipase%2520inhibitors%2520as%2520endocannabinoid-hydrolyzing%2520enzyme%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1253%26epage%3D1259%26doi%3D10.1002%2Fcmdc.200900137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minkkilä, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taupila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span> </span><span class="NLM_article-title">1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: synthesis, <i>in vitro</i> evaluation and insight into potency and selectivity determinants by molecular modelling</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1016/j.ejps.2013.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejps.2013.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23557840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslWqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=423-433&author=H.+K%C3%A4sn%C3%A4nenauthor=A.+Minkkil%C3%A4author=S.+Taupilaauthor=J.+Z.+Patelauthor=T.+Parkkariauthor=M.+Lahtela-Kakkonenauthor=S.+M.+Saarioauthor=T.+Nevalainenauthor=A.+Poso&title=1%2C3%2C4-Oxadiazol-2-ones+as+fatty-acid+amide+hydrolase+and+monoacylglycerol+lipase+inhibitors%3A+synthesis%2C+in+vitro+evaluation+and+insight+into+potency+and+selectivity+determinants+by+molecular+modelling&doi=10.1016%2Fj.ejps.2013.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling</span></div><div class="casAuthors">Kasnanen, Heikki; Minkkila, Anna; Taupila, Susanna; Patel, Jayendra Z.; Parkkari, Teija; Lahtela-Kakkonen, Maija; Saario, Susanna M.; Nevalainen, Tapio; Poso, Antti</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">423-433</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of the key hydrolytic enzymes of the endocannabinoid system, fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), has been proposed as potential mode of action for various therapeutic applications.  Continuing our previous work, we take the first steps of structure-activity relationship exploration and show that 1,3,4-oxadiazol-2-ones can serve as scaffold for both selective FAAH and MAGL inhibitors, and also function as a dual FAAH/MAGL inhibitor at sub-micromolar IC50 values.  Moreover, 10-fold selectivity against MAGL over FAAH was achieved with compd. 3d (FAAH and MAGL IC50; 2.0 and 0.22 μM).  Lastly, enzyme and ligand features contributing to the potency and selectivity differences are analyzed by mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV1_s_EqIC6LVg90H21EOLACvtfcHk0lhO_wWXXCn2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslWqtb4%253D&md5=76a93279a6b9b1ac1f5f1aa7c84266ad</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DMinkkil%25C3%25A4%26aufirst%3DA.%26aulast%3DTaupila%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DJ.%2BZ.%26aulast%3DParkkari%26aufirst%3DT.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DPoso%26aufirst%3DA.%26atitle%3D1%252C3%252C4-Oxadiazol-2-ones%2520as%2520fatty-acid%2520amide%2520hydrolase%2520and%2520monoacylglycerol%2520lipase%2520inhibitors%253A%2520synthesis%252C%2520in%2520vitro%2520evaluation%2520and%2520insight%2520into%2520potency%2520and%2520selectivity%2520determinants%2520by%2520molecular%2520modelling%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D49%26spage%3D423%26epage%3D433%26doi%3D10.1016%2Fj.ejps.2013.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Patel, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczor, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipriano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshevoy, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span> </span><span class="NLM_article-title">Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8484</span><span class="NLM_x">–</span> <span class="NLM_lpage">8496</span><span class="refDoi"> DOI: 10.1021/jm400923s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400923s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8484-8496&author=J.+Z.+Patelauthor=T.+Parkkariauthor=T.+Laitinenauthor=A.+A.+Kaczorauthor=S.+M.+Saarioauthor=J.+R.+Savinainenauthor=D.+Navia-Paldaniusauthor=M.+Ciprianoauthor=J.+Lepp%C3%A4nenauthor=I.+O.+Koshevoyauthor=A.+Posoauthor=C.+J.+Fowlerauthor=J.+T.+Laitinenauthor=T.+Nevalainen&title=Chiral+1%2C3%2C4-oxadiazol-2-ones+as+highly+selective+FAAH+inhibitors&doi=10.1021%2Fjm400923s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fjm400923s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400923s%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DJ.%2BZ.%26aulast%3DParkkari%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DKaczor%26aufirst%3DA.%2BA.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DKoshevoy%26aufirst%3DI.%2BO.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DNevalainen%26aufirst%3DT.%26atitle%3DChiral%25201%252C3%252C4-oxadiazol-2-ones%2520as%2520highly%2520selective%2520FAAH%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8484%26epage%3D8496%26doi%3D10.1021%2Fjm400923s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kage, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Kouhen, O. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. O.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1021/jm801042a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801042a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=170-180&author=X.+Wangauthor=K.+Sarrisauthor=K.+Kageauthor=D.+Zhangauthor=S.+P.+Brownauthor=T.+Kolasaauthor=C.+Surowyauthor=O.+F.+El+Kouhenauthor=S.+W.+Muchmoreauthor=J.+D.+Brioniauthor=A.+O.+Stewart&title=Synthesis+and+evaluation+of+benzothiazole-based+analogues+as+novel%2C+potent%2C+and+selective+fatty+acid+amide+hydrolase+inhibitors&doi=10.1021%2Fjm801042a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm801042a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801042a%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSarris%26aufirst%3DK.%26aulast%3DKage%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DEl%2BKouhen%26aufirst%3DO.%2BF.%26aulast%3DMuchmore%26aufirst%3DS.%2BW.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520benzothiazole-based%2520analogues%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D170%26epage%3D180%26doi%3D10.1021%2Fjm801042a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Gustin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester-Zeiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meleza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span> </span><span class="NLM_article-title">Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2496</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2011.02.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2492-2496&author=D.+J.+Gustinauthor=Z.+Maauthor=X.+Minauthor=Y.+Liauthor=C.+Hedbergauthor=C.+Guimaraesauthor=A.+C.+Porterauthor=M.+Lindstromauthor=D.+Lester-Zeinerauthor=G.+Xuauthor=T.+J.+Carlsonauthor=S.+Xiaoauthor=C.+Melezaauthor=R.+Connorsauthor=Z.+Wangauthor=F.+Kayser&title=Identification+of+potent%2C+noncovalent+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1016%2Fj.bmcl.2011.02.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHedberg%26aufirst%3DC.%26aulast%3DGuimaraes%26aufirst%3DC.%26aulast%3DPorter%26aufirst%3DA.%2BC.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DMeleza%26aufirst%3DC.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKayser%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520potent%252C%2520noncovalent%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2492%26epage%3D2496%26doi%3D10.1016%2Fj.bmcl.2011.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">7379</span><span class="NLM_x">–</span> <span class="NLM_lpage">7384</span><span class="refDoi"> DOI: 10.1073/pnas.1016167108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.1016167108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7379-7384&author=X.+Minauthor=S.+T.+Thibaultauthor=A.+C.+Porterauthor=D.+J.+Gustinauthor=T.+J.+Carlsonauthor=H.+Xuauthor=M.+Lindstromauthor=G.+Xuauthor=C.+Uyedaauthor=Z.+Maauthor=Y.+Liauthor=F.+Kayserauthor=N.+P.+Walkerauthor=Z.+Wang&title=Discovery+and+molecular+basis+of+potent+noncovalent+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1073%2Fpnas.1016167108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016167108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016167108%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DX.%26aulast%3DThibault%26aufirst%3DS.%2BT.%26aulast%3DPorter%26aufirst%3DA.%2BC.%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DUyeda%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DDiscovery%2520and%2520molecular%2520basis%2520of%2520potent%2520noncovalent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7379%26epage%3D7384%26doi%3D10.1073%2Fpnas.1016167108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Gowlugari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFalco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerling, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, F.</span><span> </span><span class="NLM_article-title">Discovery of potent, non-carbonyl inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span><span class="refDoi"> DOI: 10.1039/c2md20146a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1039%2Fc2md20146a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1258-1263&author=S.+Gowlugariauthor=J.+DeFalcoauthor=M.+T.+Nguyenauthor=C.+Kaubauthor=C.+Chiauthor=M.+A.+Dunctonauthor=D.+E.+Emerlingauthor=M.+G.+Kellyauthor=J.+Kincaidauthor=F.+Vincent&title=Discovery+of+potent%2C+non-carbonyl+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1039%2Fc2md20146a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1039%2Fc2md20146a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20146a%26sid%3Dliteratum%253Aachs%26aulast%3DGowlugari%26aufirst%3DS.%26aulast%3DDeFalco%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DM.%2BT.%26aulast%3DKaub%26aufirst%3DC.%26aulast%3DChi%26aufirst%3DC.%26aulast%3DDuncton%26aufirst%3DM.%2BA.%26aulast%3DEmerling%26aufirst%3DD.%2BE.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3DKincaid%26aufirst%3DJ.%26aulast%3DVincent%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520potent%252C%2520non-carbonyl%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D1258%26epage%3D1263%26doi%3D10.1039%2Fc2md20146a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Sundermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanekamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, M.</span><span> </span><span class="NLM_article-title">1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A<sub>2</sub>α and fatty acid amide hydrolase: effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2592</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2015.03.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2579-2592&author=T.+Sundermannauthor=J.+Fabianauthor=W.+Hanekampauthor=M.+Lehr&title=1-Heteroaryl-3-phenoxypropan-2-ones+as+inhibitors+of+cytosolic+phospholipase+A2%CE%B1+and+fatty+acid+amide+hydrolase%3A+effect+of+the+replacement+of+the+ether+oxygen+with+sulfur+and+nitrogen+moieties+on+enzyme+inhibition+and+metabolic+stability&doi=10.1016%2Fj.bmc.2015.03.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DSundermann%26aufirst%3DT.%26aulast%3DFabian%26aufirst%3DJ.%26aulast%3DHanekamp%26aufirst%3DW.%26aulast%3DLehr%26aufirst%3DM.%26atitle%3D1-Heteroaryl-3-phenoxypropan-2-ones%2520as%2520inhibitors%2520of%2520cytosolic%2520phospholipase%2520A2%25CE%25B1%2520and%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520effect%2520of%2520the%2520replacement%2520of%2520the%2520ether%2520oxygen%2520with%2520sulfur%2520and%2520nitrogen%2520moieties%2520on%2520enzyme%2520inhibition%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2579%26epage%3D2592%26doi%3D10.1016%2Fj.bmc.2015.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Pearson, J. P.; Bernier, S.; Jackson, C.; Wakefield, J. D.; Sykes, K. A.; Liong, E.; Carey, G.; Busby, R. W.; Currie, M. G.; Lichtman, A. H.; Milne, G. T.; Profy, A. T.</span><span> </span><span class="NLM_article-title">Oral treatment with the selecctive FAAH inhibitor MM-433593 relieves thermal hyperalgesia induced by <i>E.coli</i> lipopolysaccharide in C57BLACK6/J mice via cannabinoid CB<sub>1</sub> receptor</span>. Presented at the 22nd Annual Symposium of the International Cannabinoid Research Society, Freiburg, Germany,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+P.+Pearson&author=S.+Bernier&author=C.+Jackson&author=J.+D.+Wakefield&author=K.+A.+Sykes&author=E.+Liong&author=G.+Carey&author=R.+W.+Busby&author=M.+G.+Currie&author=A.+H.+Lichtman&author=G.+T.+Milne&author=A.+T.+Profy&title=Oral+treatment+with+the+selecctive+FAAH+inhibitor+MM-433593+relieves+thermal+hyperalgesia+induced+by+E.coli+lipopolysaccharide+in+C57BLACK6%2FJ+mice+via+cannabinoid+CB1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DJ.%2BP.%26atitle%3DOral%2520treatment%2520with%2520the%2520selecctive%2520FAAH%2520inhibitor%2520MM-433593%2520relieves%2520thermal%2520hyperalgesia%2520induced%2520by%2520E.coli%2520lipopolysaccharide%2520in%2520C57BLACK6%252FJ%2520mice%2520via%2520cannabinoid%2520CB1%2520receptor%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Banijamali, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakefield, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermerian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, R. W.</span><span> </span><span class="NLM_article-title">Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeys</span> <span class="citation_source-journal">Pharmacol. Res. Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00059</span><span class="refDoi"> DOI: 10.1002/prp2.59</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fprp2.59" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=e00059&author=A.+R.+Banijamaliauthor=J.+D.+Wakefieldauthor=A.+H.+Mermerianauthor=R.+W.+Busby&title=Metabolism+and+disposition+of+MM-433593%2C+a+selective+FAAH-1+inhibitor%2C+in+monkeys&doi=10.1002%2Fprp2.59"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1002%2Fprp2.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.59%26sid%3Dliteratum%253Aachs%26aulast%3DBanijamali%26aufirst%3DA.%2BR.%26aulast%3DWakefield%26aufirst%3DJ.%2BD.%26aulast%3DMermerian%26aufirst%3DA.%2BH.%26aulast%3DBusby%26aufirst%3DR.%2BW.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520MM-433593%252C%2520a%2520selective%2520FAAH-1%2520inhibitor%252C%2520in%2520monkeys%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2014%26volume%3D2%26spage%3De00059%26doi%3D10.1002%2Fprp2.59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">1-Aryl-2-((6-aryl) pyrimidin-4-yl) amino) ethanols as competitive inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2014.01.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1280-1284&author=J.+M.+Keithauthor=N.+Hawrylukauthor=R.+L.+Apodacaauthor=A.+Chambersauthor=J.+M.+Pierceauthor=M.+Seierstadauthor=J.+A.+Palmerauthor=M.+Webbauthor=M.+J.+Karbarzauthor=B.+P.+Scottauthor=S.+J.+Wilsonauthor=L.+Luoauthor=M.+L.+Wennerholmauthor=L.+Changauthor=M.+Rizzolioauthor=S.+R.+Chaplanauthor=J.+G.+Breitenbucher&title=1-Aryl-2-%28%286-aryl%29+pyrimidin-4-yl%29+amino%29+ethanols+as+competitive+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2014.01.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.064%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DHawryluk%26aufirst%3DN.%26aulast%3DApodaca%26aufirst%3DR.%2BL.%26aulast%3DChambers%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DB.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3D1-Aryl-2-%2528%25286-aryl%2529%2520pyrimidin-4-yl%2529%2520amino%2529%2520ethanols%2520as%2520competitive%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1280%26epage%3D1284%26doi%3D10.1016%2Fj.bmcl.2014.01.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilligsmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title"><i>N</i>-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing <i>N</i>-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1042/bj20031695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1042%2Fbj20031695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=14686878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2004&pages=99-106&author=K.+Tsuboiauthor=C.+Hilligsmannauthor=S.+Vandevoordeauthor=D.+Lambertauthor=N.+Ueda&title=N-Cyclohexanecarbonylpentadecylamine%3A+a+selective+inhibitor+of+the+acid+amidase+hydrolysing+N-acylethanolamines%2C+as+a+tool+to+distinguish+acid+amidase+from+fatty+acid+amide+hydrolase&doi=10.1042%2Fbj20031695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Hilligsmann, Christine; Vandevoorde, Severine; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) and other bioactive N -acylethanolamines are degraded to their corresponding fatty acids and ethanolamine.  This hydrolysis is mostly attributed to catalysis by FAAH (fatty acid amide hydrolase), which exhibits an alk. pH optimum.  In addn., we have identified another amidase which catalyzes the same reaction exclusively at acidic pH values [Ueda, Yamanaka and Yamamoto (2001) J. Biol. Chem. 276, 35552-35557].  In attempts to find selective inhibitors of this acid amidase, we screened various derivs. of palmitic acid, 1-hexadecanol, and 1-pentadecylamine with N -palmitoylethanolamine as substrate.  Here we show that N-cyclohexanecarbonylpentadecylamine inhibits the acid amidase from rat lung with an IC50 of 4.5 μM, without inhibiting FAAH at concns. up to 100 μM.  The inhibition was reversible and non-competitive.  This compd. also inhibited the acid amidase in intact alveolar macrophages.  With the aid of this inhibitor, it was revealed that rat basophilic leukemia cells possess the acid amidase as well as FAAH.  Thus the inhibitor may be a useful tool to distinguish the acid amidase from FAAH in various tissues and cells and to elucidate the physiol. role of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoieQh-ts3EC7Vg90H21EOLACvtfcHk0lgG3Y86g0jktw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D&md5=5ea93d8cafe6d3d3151f896bc2185547</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1042%2Fbj20031695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20031695%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHilligsmann%26aufirst%3DC.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DLambert%26aufirst%3DD.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DN-Cyclohexanecarbonylpentadecylamine%253A%2520a%2520selective%2520inhibitor%2520of%2520the%2520acid%2520amidase%2520hydrolysing%2520N-acylethanolamines%252C%2520as%2520a%2520tool%2520to%2520distinguish%2520acid%2520amidase%2520from%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D379%26spage%3D99%26epage%3D106%26doi%3D10.1042%2Fbj20031695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Yamano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hozaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, A.</span><span> </span><span class="NLM_article-title">Lipophilic amines as potent inhibitors of <i>N</i>-acylethanolamine-hydrolyzing acid amidase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3658</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2012.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22542283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3658-3665&author=Y.+Yamanoauthor=K.+Tsuboiauthor=Y.+Hozakiauthor=K.+Takahashiauthor=X.-H.+Jinauthor=N.+Uedaauthor=A.+Wada&title=Lipophilic+amines+as+potent+inhibitors+of+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmc.2012.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase</span></div><div class="casAuthors">Yamano, Yumiko; Tsuboi, Kazuhito; Hozaki, Yuki; Takahashi, Kiyohiro; Jin, Xing-Hua; Ueda, Natsuo; Wada, Akimori</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3658-3665</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines (NAEs) including N-arachidonoylethanolamine (anandamide) and N-palmitoylethanolamine are endogenous lipid mediators.  These mols. are degraded to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH) or NAE-hydrolyzing acid amidase (NAAA).  Lipophilic amines, esp. pentadecylamine (2c) and tridecyl 2-aminoacetate (11b), were found to exhibit potent NAAA inhibitory activities (IC50 = 5.7 and 11.8 μM), with much weaker effects on FAAH.  These simple structures would provide a scaffold for further improvement in NAAA inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4k9qI0AqY7Vg90H21EOLACvtfcHk0lgG3Y86g0jktw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D&md5=fbe85f4e5fdca44bee1f6d4902c4f1d0</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHozaki%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DX.-H.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DA.%26atitle%3DLipophilic%2520amines%2520as%2520potent%2520inhibitors%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3658%26epage%3D3665%26doi%3D10.1016%2Fj.bmc.2012.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Saturnino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new potential inhibitors of <i>N</i>-acylethanolamine hydrolyzing acid amidase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1210</span><span class="NLM_x">–</span> <span class="NLM_lpage">1213</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2009.11.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20022504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1210-1213&author=C.+Saturninoauthor=S.+Petrosinoauthor=A.+Ligrestiauthor=C.+Palladinoauthor=G.+De+Martinoauthor=T.+Bisognoauthor=V.+Di+Marzo&title=Synthesis+and+biological+evaluation+of+new+potential+inhibitors+of+N-acylethanolamine+hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmcl.2009.11.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase</span></div><div class="casAuthors">Saturnino, Carmela; Petrosino, Stefania; Ligresti, Alessia; Palladino, Chiara; De Martino, Giovanni; Bisogno, Tiziana; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1210-1213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines, including N-palmitoyl-ethanolamine (PEA), are hydrolyzed to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  Recently, N-acylethanolamine-hydrolyzing acid amidase (NAAA) was identified as being able to specifically hydrolyze PEA.  In order to find selective and effective inhibitors of this enzyme, we synthesized and screened several amides, retroamides, esters, retroesters and carbamates of palmitic acid (1-21) and esters with C15 and C17 alkyl chains (22-27).  Cyclopentylhexadecanoate (13) exhibited the highest inhibitory activity on NAAA (IC50 = 10.0 μM), without inhibiting FAAH up to 50 μM.  Compd. 13 may become a useful template to design new NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNWUZja4X4JbVg90H21EOLACvtfcHk0ljmhgSwGk90_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D&md5=fc638f889e58e9fbf3467a90effbcc80</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.134%26sid%3Dliteratum%253Aachs%26aulast%3DSaturnino%26aufirst%3DC.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPalladino%26aufirst%3DC.%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520potential%2520inhibitors%2520of%2520N-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1210%26epage%3D1213%26doi%3D10.1016%2Fj.bmcl.2009.11.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuvone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title"><i>N</i>-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1016/j.biochi.2010.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.biochi.2010.01.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=724-727&author=S.+Petrosinoauthor=T.+Iuvoneauthor=V.+Di+Marzo&title=N-palmitoyl-ethanolamine%3A+biochemistry+and+new+therapeutic+opportunities&doi=10.1016%2Fj.biochi.2010.01.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2010.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2010.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DIuvone%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DN-palmitoyl-ethanolamine%253A%2520biochemistry%2520and%2520new%2520therapeutic%2520opportunities%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26spage%3D724%26epage%3D727%26doi%3D10.1016%2Fj.biochi.2010.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent <i>N</i>-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e43023</span><span class="refDoi"> DOI: 10.1371/journal.pone.0043023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1371%2Fjournal.pone.0043023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22916199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43023&author=Y.+Liauthor=L.+Yangauthor=L.+Chenauthor=C.+Zhuauthor=R.+Huangauthor=X.+Zhengauthor=Y.+Qiuauthor=J.+Fu&title=Design+and+synthesis+of+potent+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29+inhibitor+as+anti-inflammatory+compounds&doi=10.1371%2Fjournal.pone.0043023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span></div><div class="casAuthors">Li, Yuhang; Yang, Longhe; Chen, Ling; Zhu, Chenggang; Huang, Rui; Zheng, Xiao; Qiu, Yan; Fu, Jin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43023</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme involved in biol. deactivation of N-palmitoylethanolamide (PEA), which exerts anti-inflammatory and analgesic effects through the activation of nuclear receptor peroxisome proliferator-activated receptor-alpha (PPAR-α).  To develop selective and potent NAAA inhibitors, we designed and synthesized a series of derivs. of 1-pentadecanyl-carbonyl pyrrolidine (compd. 1), a general amidase inhibitor.  Structure activity relationship (SAR) studies have identified a compd. 16, 1-(2-Biphenyl-4-yl)ethyl-carbonyl pyrrolidine, which has shown the highest inhibition on NAAA activity (IC50 = 2.12 ± 0.41 μM) and is characterized as a reversible and competitive NAAA inhibitor.  Computational docking anal. and mutagenesis study revealed that compd. 16 interacted with Asparagine 209 (Asn209) residue flanking the catalytic pocket of NAAA so as to block the substrate entrance.  In vitro pharmacol. studies demonstrated that compd. 16 dose-dependently reduced mRNA expression levels of iNOS and IL-6, along with an increase of intracellular PEA levels, in mouse macrophages with lipopolysaccharides (LPS) induced inflammation.  Our study discovered a novel NAAA inhibitor, compd. 16, that could serve as a potential anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjj_FwM6WnALVg90H21EOLACvtfcHk0ljmhgSwGk90_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ&md5=12369bcfbbe53a5f4c65c68df0a59945</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520as%2520anti-inflammatory%2520compounds%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43023%26doi%3D10.1371%2Fjournal.pone.0043023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">West, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvonok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitten, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadivel, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Biochemical and mass spectrometric characterization of human <i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibition</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e43877</span><span class="refDoi"> DOI: 10.1371/journal.pone.0043877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1371%2Fjournal.pone.0043877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22952796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43877&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=S.+K.+Vadivelauthor=A.+L.+Bowmanauthor=A.+Makriyannis&title=Biochemical+and+mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition&doi=10.1371%2Fjournal.pone.0043877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43877</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).  1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl--serine β-lactone (N-Cbz-serine β-lactone), inhibited hNAAA in a covalent and irreversible manner.  MS anal. of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the β-subunit, confirming a suggested mechanism of hNAAA inactivation by the β-lactone contg. inhibitors.  These expts. provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme.  They also provide a methodol. for the rapid screening and characterization of large libraries of compds. as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYtxfkhdQ5rVg90H21EOLACvtfcHk0ljmhgSwGk90_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E&md5=f1cedb03b771c71caef095bf138627bd</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043877%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DVadivel%26aufirst%3DS.%2BK.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43877%26doi%3D10.1371%2Fjournal.pone.0043877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Solorzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonietti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of <i>N</i>-(2-oxo-3-oxetanyl) amides as <i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5770</span><span class="NLM_x">–</span> <span class="NLM_lpage">5781</span><span class="refDoi"> DOI: 10.1021/jm100582w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100582w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5770-5781&author=C.+Solorzanoauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Lodolaauthor=F.+Vacondioauthor=G.+Tarziaauthor=D.+Piomelliauthor=M.+Mor&title=Synthesis+and+structure-activity+relationships+of+N-%282-oxo-3-oxetanyl%29+amides+as+N-acylethanolamine-hydrolyzing+acid+amidase+inhibitors&doi=10.1021%2Fjm100582w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm100582w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100582w%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-%25282-oxo-3-oxetanyl%2529%2520amides%2520as%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5770%26epage%3D5781%26doi%3D10.1021%2Fjm100582w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karacsonyi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">β-Lactones inhibit <i>N</i>-acylethanolamine acid amidase by <i>S</i>-acylation of the catalytic <i>N</i>-terminal cysteine</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1021/ml300056y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300056y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=422-426&author=A.+Armirottiauthor=E.+Romeoauthor=S.+Ponzanoauthor=L.+Mengattoauthor=M.+Dionisiauthor=C.+Karacsonyiauthor=F.+Bertozziauthor=G.+Garauauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=%CE%B2-Lactones+inhibit+N-acylethanolamine+acid+amidase+by+S-acylation+of+the+catalytic+N-terminal+cysteine&doi=10.1021%2Fml300056y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span></div><div class="casAuthors">Armirotti, Andrea; Romeo, Elisa; Ponzano, Stefano; Mengatto, Luisa; Dionisi, Mauro; Karacsonyi, Claudia; Bertozzi, Fabio; Garau, Gianpiero; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-426</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs.  We investigated the mechanism of inhibition of human NAAA by substituted β-lactones.  We characterized pharmacol. a representative member of this class, ARN077, and showed, using high-resoln. liq. chromatog.-tandem mass spectrometry, that this compd. forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooO8IxuG5LzLVg90H21EOLACvtfcHk0lgT3cqnw2qX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D&md5=482d17b3fb0c13c8356f27a4b3f97e93</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fml300056y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300056y%26sid%3Dliteratum%253Aachs%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DKaracsonyi%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D%25CE%25B2-Lactones%2520inhibit%2520N-acylethanolamine%2520acid%2520amidase%2520by%2520S-acylation%2520of%2520the%2520catalytic%2520N-terminal%2520cysteine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D422%26epage%3D426%26doi%3D10.1021%2Fml300056y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonietti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solorzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-(2-Oxo-3-oxetanyl) carbamic acid esters as <i>N</i>-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4824</span><span class="NLM_x">–</span> <span class="NLM_lpage">4836</span><span class="refDoi"> DOI: 10.1021/jm300349j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300349j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4824-4836&author=A.+Durantiauthor=A.+Tontiniauthor=F.+Antoniettiauthor=F.+Vacondioauthor=A.+Fioniauthor=C.+Silvaauthor=A.+Lodolaauthor=S.+Rivaraauthor=C.+Solorzanoauthor=D.+Piomelliauthor=G.+Tarziaauthor=M.+Mor&title=N-%282-Oxo-3-oxetanyl%29+carbamic+acid+esters+as+N-acylethanolamine+acid+amidase+inhibitors%3A+synthesis+and+structure-activity+and+structure-property+relationships&doi=10.1021%2Fjm300349j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm300349j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300349j%26sid%3Dliteratum%253Aachs%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-%25282-Oxo-3-oxetanyl%2529%2520carbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%253A%2520synthesis%2520and%2520structure-activity%2520and%2520structure-property%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4824%26epage%3D4836%26doi%3D10.1021%2Fjm300349j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6917</span><span class="NLM_x">–</span> <span class="NLM_lpage">6934</span><span class="refDoi"> DOI: 10.1021/jm400739u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400739u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6917-6934&author=S.+Ponzanoauthor=F.+Bertozziauthor=L.+Mengattoauthor=M.+Dionisiauthor=A.+Armirottiauthor=E.+Romeoauthor=A.+Berteottiauthor=C.+Fiorelliauthor=G.+Tarozzoauthor=A.+Reggianiauthor=A.+Durantiauthor=G.+Tarziaauthor=M.+Morauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandiera&title=Synthesis+and+structure-activity+relationship+%28SAR%29+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters%2C+a+class+of+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm400739u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fjm400739u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400739u%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%252C%2520a%2520class%2520of%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6917%26epage%3D6934%26doi%3D10.1021%2Fjm400739u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Sasso, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Realini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of the <i>N</i>-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0ljrey-zifd2YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Vitale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petracca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span> </span><span class="NLM_article-title">Synthesis, structure-activity, and structure-stability relationships of 2-substituted-<i>N</i>-(4-oxo-3-oxetanyl) <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1002/cmdc.201300416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201300416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24403170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=323-336&author=R.+Vitaleauthor=G.+Ottonelloauthor=R.+Petraccaauthor=S.+M.+Bertozziauthor=S.+Ponzanoauthor=A.+Armirottiauthor=A.+Berteottiauthor=M.+Dionisiauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandieraauthor=F.+Bertozzi&title=Synthesis%2C+structure-activity%2C+and+structure-stability+relationships+of+2-substituted-N-%284-oxo-3-oxetanyl%29+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1002%2Fcmdc.201300416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure-Activity, and Structure-Stability Relationships of 2-Substituted-N-(4-oxo-3-oxetanyl) N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Vitale, Romina; Ottonello, Giuliana; Petracca, Rita; Bertozzi, Sine Mandrup; Ponzano, Stefano; Armirotti, Andrea; Berteotti, Anna; Dionisi, Mauro; Cavalli, Andrea; Piomelli, Daniele; Bandiera, Tiziano; Bertozzi, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-336</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Racemic and nonracemic β-substituted α-amino-β-lactones such as I and II [R = Me, Et, i-Pr, t-Bu; R1 = R2, R3O; R2 = 4-PhCH2OC6H4, Ph(CH2)6; R3 = Ph(CH2)5, 4-PhC6H4CH2] were prepd. as inhibitors of N-acylethanolamine acid amidase (NAAA), a cysteine amidase that preferentially hydrolyzes satd. or monounsatd. fatty acid ethanolamide endogenous agonists of nuclear peroxisome proliferator-activated receptor-α, for potential use as antiinflammatory agents.  N-(alkoxycarbonylamino) β-lactones were both better inhibitors of NAAA and more stable than the corresponding N-acyl β-lactones; cis β-lactones I were more stable than the corresponding trans β-lactones II to both lactone hydrolysis and ring expansion to oxazolines.  Increasing the steric bulk of the β-substituent decreased inhibition of NAAA but improved hydrolytic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhV2S-BL4VubVg90H21EOLACvtfcHk0ljrey-zifd2YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D&md5=8ada8ce8bcd7f2f40376be631217d615</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300416%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520structure-activity%252C%2520and%2520structure-stability%2520relationships%2520of%25202-substituted-N-%25284-oxo-3-oxetanyl%2529%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D323%26epage%3D336%26doi%3D10.1002%2Fcmdc.201300416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petracca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span> </span><span class="NLM_article-title">Synthesis, Biological evaluation, and 3D QSAR study of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters as <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10101</span><span class="NLM_x">–</span> <span class="NLM_lpage">10111</span><span class="refDoi"> DOI: 10.1021/jm501455s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501455s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10101-10111&author=S.+Ponzanoauthor=A.+Berteottiauthor=R.+Petraccaauthor=R.+Vitaleauthor=L.+Mengattoauthor=T.+Bandieraauthor=A.+Cavalliauthor=D.+Piomelliauthor=F.+Bertozziauthor=G.+Bottegoni&title=Synthesis%2C+Biological+evaluation%2C+and+3D+QSAR+study+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm501455s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation, and 3D QSAR Study of 2-Methyl-4-oxo-3-oxetanylcarbamic Acid Esters as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Ponzano, Stefano; Berteotti, Anna; Petracca, Rita; Vitale, Romina; Mengatto, Luisa; Bandiera, Tiziano; Cavalli, Andrea; Piomelli, Daniele; Bertozzi, Fabio; Bottegoni, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10101-10111</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-(2-Oxo-3-oxetanyl)carbamic acid esters e. g., I, have recently been reported to be noncompetitive inhibitors of the N-acylethanolamine acid amidase (NAAA) potentially useful for the treatment of pain and inflammation.  In the present study, we further explored the structure-activity relationships of the carbamic acid ester side chain of 2-methyl-4-oxo-3-oxetanylcarbamic acid ester derivs.  Addnl. favorable features in the design of potent NAAA inhibitors have been found together with the identification of a single digit nanomolar inhibitor.  In addn., we devised a 3D QSAR using the at. property field method.  The model turned out to be able to account for the structural variability and was prospectively validated by designing, synthesizing, and testing novel inhibitors.  The fairly good agreement between predictions and exptl. potency values points to this 3D QSAR model as the first example of quant. structure-activity relationships in the field of NAAA inhibitors .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVpHkND7iUzbVg90H21EOLACvtfcHk0ljrey-zifd2YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN&md5=1c863895692bf0e2bd76956ae1c0fda4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm501455s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501455s%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520Biological%2520evaluation%252C%2520and%25203D%2520QSAR%2520study%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10101%26epage%3D10111%26doi%3D10.1021%2Fjm501455s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Fiasella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">3-Aminoazetidin-2-one derivatives as <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1614</span><span class="refDoi"> DOI: 10.1002/cmdc.201300546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201300546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24828120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1602-1614&author=A.+Fiasellaauthor=A.+Nuzziauthor=M.+Summaauthor=A.+Armirottiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=3-Aminoazetidin-2-one+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors+suitable+for+systemic+administration&doi=10.1002%2Fcmdc.201300546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoazetidin-2-one Derivatives as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors Suitable for Systemic Administration</span></div><div class="casAuthors">Fiasella, Annalisa; Nuzzi, Andrea; Summa, Maria; Armirotti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1602-1614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that catalyzes the hydrolysis of endogenous lipid mediators such as palmitoylethanolamide (PEA).  PEA has been shown to exert anti-inflammatory and antinociceptive effects in animals by engaging peroxisome proliferator-activated receptor α (PPAR-α).  Thus, preventing PEA degrdn. by inhibiting NAAA may provide a novel approach for the treatment of pain and inflammatory states.  Recently, 3-aminooxetan-2-one compds. were identified as a class of highly potent NAAA inhibitors.  The utility of these compds. is limited, however, by their low chem. and plasma stabilities.  In the present study, we synthesized and tested a series of N-(2-oxoazetidin-3-yl)amides as a novel class of NAAA inhibitors with good potency and improved physicochem. properties, suitable for systemic administration.  Moreover, we elucidated the main structural features of 3-aminoazetidin-2-one derivs. that are crit. for NAAA inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocn1G5QzPtHLVg90H21EOLACvtfcHk0lins3s98bQUww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D&md5=beee5cde68184abb3c47e4631c56497f</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300546%26sid%3Dliteratum%253Aachs%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D3-Aminoazetidin-2-one%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%2520suitable%2520for%2520systemic%2520administration%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1602%26epage%3D1614%26doi%3D10.1002%2Fcmdc.201300546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiurchiù, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiasella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A potent systemically active <i>N</i>-acylethanolamine acid amidase inhibitor that suppresses inflammation and human macrophage activation</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1838</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1838-1846&author=A.+Ribeiroauthor=S.+Pontisauthor=L.+Mengattoauthor=A.+Armirottiauthor=V.+Chiurchi%C3%B9author=V.+Capurroauthor=A.+Fiasellaauthor=A.+Nuzziauthor=E.+Romeoauthor=G.+Moreno-Sanzauthor=M.+Maccarroneauthor=A.+Reggianiauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=A+potent+systemically+active+N-acylethanolamine+acid+amidase+inhibitor+that+suppresses+inflammation+and+human+macrophage+activation&doi=10.1021%2Facschembio.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span></div><div class="casAuthors">Ribeiro, Alison; Pontis, Silvia; Mengatto, Luisa; Armirotti, Andrea; Chiurchiu, Valerio; Capurro, Valeria; Fiasella, Annalisa; Nuzzi, Andrea; Romeo, Elisa; Moreno-Sanz, Guillermo; Maccarrone, Mauro; Reggiani, Angelo; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1846</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type-α peroxisome proliferator-activated receptors (PPAR-α).  These bioactive substances are preferentially degraded by the cysteine hydrolase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages.  Here, we describe a new class of β-lactam derivs. that are potent, selective, and systemically active inhibitors of intracellular NAAA activity.  The prototype of this class deactivates NAAA by covalently binding the enzyme's catalytic cysteine and exerts profound anti-inflammatory effects in both mouse models and human macrophages.  This agent may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6Y2cNKursLVg90H21EOLACvtfcHk0lins3s98bQUww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D&md5=a240d871adfc85b99c7e148600573217</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520potent%2520systemically%2520active%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520that%2520suppresses%2520inflammation%2520and%2520human%2520macrophage%2520activation%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1838%26epage%3D1846%26doi%3D10.1021%2Facschembio.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Nuzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiasella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliuca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejmech.2016.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26866968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=138-159&author=A.+Nuzziauthor=A.+Fiasellaauthor=J.+A.+Ortegaauthor=C.+Pagliucaauthor=S.+Ponzanoauthor=D.+Pizziraniauthor=S.+M.+Bertozziauthor=G.+Ottonelloauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=F.+Bertozziauthor=D.+Piomelli&title=Potent+%CE%B1-amino-%CE%B2-lactam+carbamic+acid+ester+as+NAAA+inhibitors.+Synthesis+and+structure-activity+relationship+%28SAR%29+studies&doi=10.1016%2Fj.ejmech.2016.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span></div><div class="casAuthors">Nuzzi, Andrea; Fiasella, Annalisa; Ortega, Jose Antonio; Pagliuca, Chiara; Ponzano, Stefano; Pizzirani, Daniela; Bertozzi, Sine Mandrup; Ottonello, Giuliana; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Bertozzi, Fabio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate I is a potent, selective and systemically active inhibitor of intracellular NAAA activity, which produces profound anti-inflammatory effects in animal models.  In the present work, the authors describe structure-activity relationship (SAR) studies on 3-aminoazetidin-2-one derivs., which have led to the identification of I, and expand these studies to elucidate the principal structural and stereochem. features needed to achieve effective NAAA inhibition.  Investigations on the influence of the substitution at the β-position of the 2-oxo-3-azetidinyl ring as well as on the effect of size and shape of the carbamic acid ester side chain led to the discovery of II, a novel inhibitor of human NAAA that shows an improved physicochem. and drug-like profile relative to I.  This favorable profile, along with the structural diversity of the carbamic acid chain of I, identify this compd. as a promising new tool to investigate the potential of NAAA inhibitors as therapeutic agents for the treatment of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaN0JjRB6bmrVg90H21EOLACvtfcHk0lins3s98bQUww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D&md5=639c2848d70ba68008db89244c2c8657</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DJ.%2BA.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPotent%2520%25CE%25B1-amino-%25CE%25B2-lactam%2520carbamic%2520acid%2520ester%2520as%2520NAAA%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D111%26spage%3D138%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2016.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Feledziak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand-Brynaert, J.</span><span> </span><span class="NLM_article-title">β-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase <i>versus</i> human monoacylglycerol lipase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7054</span><span class="NLM_x">–</span> <span class="NLM_lpage">7068</span><span class="refDoi"> DOI: 10.1021/jm9008532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9008532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7054-7068&author=M.+Feledziakauthor=C.+Michauxauthor=A.+Urbachauthor=G.+Labarauthor=G.+G.+Muccioliauthor=D.+M.+Lambertauthor=J.+Marchand-Brynaert&title=%CE%B2-Lactams+derived+from+a+carbapenem+chiron+are+selective+inhibitors+of+human+fatty+acid+amide+hydrolase+versus+human+monoacylglycerol+lipase&doi=10.1021%2Fjm9008532"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm9008532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008532%26sid%3Dliteratum%253Aachs%26aulast%3DFeledziak%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DC.%26aulast%3DUrbach%26aufirst%3DA.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMarchand-Brynaert%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Lactams%2520derived%2520from%2520a%2520carbapenem%2520chiron%2520are%2520selective%2520inhibitors%2520of%2520human%2520fatty%2520acid%2520amide%2520hydrolase%2520versus%2520human%2520monoacylglycerol%2520lipase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7054%26epage%3D7068%26doi%3D10.1021%2Fjm9008532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Alhouayek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottemanne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cani, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span> </span><span class="NLM_article-title"><i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibition increases colon <i>N</i>-palmitoylethanolamine levels and counteracts murine colitis</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1096/fj.14-255208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1096%2Ffj.14-255208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=25384424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=650-661&author=M.+Alhouayekauthor=P.+Bottemanneauthor=K.+V.+Subramanianauthor=D.+M.+Lambertauthor=A.+Makriyannisauthor=P.+D.+Caniauthor=G.+G.+Muccioli&title=N-acylethanolamine-hydrolyzing+acid+amidase+inhibition+increases+colon+N-palmitoylethanolamine+levels+and+counteracts+murine+colitis&doi=10.1096%2Ffj.14-255208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span></div><div class="casAuthors">Alhouayek, Mireille; Bottemanne, Pauline; Subramanian, Kumar V.; Lambert, Didier M.; Makriyannis, Alexandros; Cani, Patrice D.; Muccioli, Giulio G.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-661, 10.1096/fj.14-255208</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory compd. that was recently shown to exert peroxisome proliferator-activated receptor-α-dependent beneficial effects on colon inflammation.  The actions of PEA are terminated following hydrolysis by 2 enzymes: fatty acid amide hydrolase (FAAH), and the less-studied N-acylethanolamine-hydrolyzing acid amidase (NAAA).  This study aims to investigate the effects of inhibiting the enzymes responsible for PEA hydrolysis in colon inflammation in order to propose a potential therapeutic target for inflammatory bowel diseases (IBDs).  Two murine models of IBD were used to assess the effects of NAAA inhibition, FAAH inhibition, and PEA on macroscopic signs of colon inflammation, macrophage/neutrophil infiltration, and the expression of proinflammatory mediators in the colon, as well as on the colitis-related systemic inflammation.  NAAA inhibition increases PEA levels in the colon and reduces colon inflammation and systemic inflammation, similarly to PEA.  FAAH inhibition, however, does not increase PEA levels in the colon and does not affect the macroscopic signs of colon inflammation or immune cell infiltration.  This is the first report of an anti-inflammatory effect of a systemically administered NAAA inhibitor.  Because NAAA is the enzyme responsible for the control of PEA levels in the colon, we put forth this enzyme as a potential therapeutic target in chronic inflammation in general and IBD in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1s3Cs4nu0sbVg90H21EOLACvtfcHk0lht-TEqPIvv-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D&md5=608b15a459887f1cde27f68e241d85b2</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-255208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-255208%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DK.%2BV.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DN-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520increases%2520colon%2520N-palmitoylethanolamine%2520levels%2520and%2520counteracts%2520murine%2520colitis%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D650%26epage%3D661%26doi%3D10.1096%2Ffj.14-255208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Fidelix, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macedo, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes Moça Trevisani, V.</span><span> </span><span class="NLM_article-title">Diacerein for osteoarthritis</span> <span class="citation_source-journal">Cochrane Database Syst. Rev. [Online]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005117</span><span class="refDoi"> DOI: 10.1002/14651858.CD005117.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2F14651858.CD005117.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=CD005117&author=T.+Fidelixauthor=C.+R.+Macedoauthor=L.+J.+Maxwellauthor=V.+Fernandes+Mo%C3%A7a+Trevisani&title=Diacerein+for+osteoarthritis&doi=10.1002%2F14651858.CD005117.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD005117.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD005117.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DFidelix%26aufirst%3DT.%26aulast%3DMacedo%26aufirst%3DC.%2BR.%26aulast%3DMaxwell%26aufirst%3DL.%2BJ.%26aulast%3DFernandes%2BMo%25C3%25A7a%2BTrevisani%26aufirst%3DV.%26atitle%3DDiacerein%2520for%2520osteoarthritis%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%2520%255BOnline%255D%26date%3D2014%26volume%3D2%26spage%3DCD005117%26doi%3D10.1002%2F14651858.CD005117.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcolongo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allarà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/j.phrs.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.phrs.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=25447594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2015&pages=9-14&author=S.+Petrosinoauthor=A.+Ahmadauthor=G.+Marcolongoauthor=E.+Espositoauthor=M.+Allar%C3%A0author=R.+Verdeauthor=S.+Cuzzocreaauthor=V.+Di+Marzo&title=Diacerein+is+a+potent+and+selective+inhibitor+of+palmitoylethanolamide+inactivation+with+analgesic+activity+in+a+rat+model+of+acute+inflammatory+pain&doi=10.1016%2Fj.phrs.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span></div><div class="casAuthors">Petrosino, Stefania; Ahmad, Akbar; Marcolongo, Gabriele; Esposito, Emanuela; Allara, Marco; Verde, Roberta; Cuzzocrea, Salvatore; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymic hydrolysis to palmitic acid and ethanolamine.  Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action.  Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein).  EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells).  EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan.  This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQUYAZlW4FrVg90H21EOLACvtfcHk0lht-TEqPIvv-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI&md5=2cc594bdb0bfc697de0d7b2189a7ecb9</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DMarcolongo%26aufirst%3DG.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DVerde%26aufirst%3DR.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DDiacerein%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520palmitoylethanolamide%2520inactivation%2520with%2520analgesic%2520activity%2520in%2520a%2520rat%2520model%2520of%2520acute%2520inflammatory%2520pain%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D91%26spage%3D9%26epage%3D14%26doi%3D10.1016%2Fj.phrs.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">Potential analgesic effects of a novel <i>N</i>-acylethanolamine acid amidase inhibitor F96 through PPAR-α. [Online]</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">13565</span><span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-%CE%B1.+%5BOnline%5D&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0ljNdbpHhogmiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-%25CE%25B1.%2520%255BOnline%255D%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Zvonok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandarinathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karageorgos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janero, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2008.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2008.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18721756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=854-862&author=N.+Zvonokauthor=L.+Pandarinathanauthor=J.+Williamsauthor=M.+Johnstonauthor=I.+Karageorgosauthor=D.+R.+Janeroauthor=S.+C.+Krishnanauthor=A.+Makriyannis&title=Covalent+inhibitors+of+human+monoacylglycerol+lipase%3A+ligand-assisted+characterization+of+the+catalytic+site+by+mass+spectrometry+and+mutational+analysis&doi=10.1016%2Fj.chembiol.2008.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Human Monoacylglycerol Lipase: Ligand-Assisted Characterization of the Catalytic Site by Mass Spectrometry and Mutational Analysis</span></div><div class="casAuthors">Zvonok, Nikolai; Pandarinathan, Lakshmipathi; Williams, John; Johnston, Meghan; Karageorgos, Ioannis; Janero, David R.; Krishnan, Srinivasan C.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">854-862</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The active site of recombinant hexa-histidine-tagged human monoacylglycerol lipase (hMGL) is characterized by mass spectrometry using the inhibitors 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701), and N-arachidonylmaleimide (NAM) as probes.  Carbamylation of Ser129 by AM6701 in the putative hMGL catalytic triad demonstrates this residue's essential role in catalysis.  Partial NAM alkylation of hMGL cysteine residues 215 and/or 249 was sufficient to achieve ∼80% enzyme inhibition.  Although Cys215 and/or Cys249 mutations to alanine(s) did not affect hMGL hydrolytic activity as compared with nonmutated hMGL, the C215A displayed heightened NAM sensitivity, whereas the C249A evidenced reduced NAM sensitivity.  These data conclusively demonstrate a sulfhydryl-based mechanism for NAM inhibition of hMGL in which Cys249 is of paramount importance.  Identification of amino acids crit. to the catalytic activity and pharmacol. modulation of hMGL informs the design of selective MGL inhibitors as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp1gDK0IgZgLVg90H21EOLACvtfcHk0ljNdbpHhogmiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO&md5=d135103e4d1543b7d9846c64642e49fc</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DPandarinathan%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DM.%26aulast%3DKarageorgos%26aufirst%3DI.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DKrishnan%26aufirst%3DS.%2BC.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DCovalent%2520inhibitors%2520of%2520human%2520monoacylglycerol%2520lipase%253A%2520ligand-assisted%2520characterization%2520of%2520the%2520catalytic%2520site%2520by%2520mass%2520spectrometry%2520and%2520mutational%2520analysis%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D854%26epage%3D862%26doi%3D10.1016%2Fj.chembiol.2008.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Matuszak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> evaluation of <i>N</i>-substituted maleimide derivatives as selective monoglyceride lipase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7410</span><span class="NLM_x">–</span> <span class="NLM_lpage">7420</span><span class="refDoi"> DOI: 10.1021/jm900461w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900461w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7410-7420&author=N.+Matuszakauthor=G.+G.+Muccioliauthor=G.+Labarauthor=D.+M.+Lambert&title=Synthesis+and+in+vitro+evaluation+of+N-substituted+maleimide+derivatives+as+selective+monoglyceride+lipase+inhibitors&doi=10.1021%2Fjm900461w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors</span></div><div class="casAuthors">Matuszak, Nicolas; Muccioli, Giulio G.; Labar, Geoffray; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7410-7420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of N-substituted maleimides and evaluation of their inhibition of recombinant human fatty acid amide hydrolase (FAAH) and purified human monoglyceride lipase (MGL) was reported.  Many of the maleimide derivs. showed low micromolar IC50 and high selectivity toward MGL vs FAAH.  The structure-activity relationships were investigated and, for instance, 1-biphenyl-4-ylmethylmaleimide inhibited MGL with an IC50 value of 790 nM.  Furthermore, rapid diln. expts. revealed that these compds. act as irreversible inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrighudB2erprVg90H21EOLACvtfcHk0ljNdbpHhogmiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot1ehsrs%253D&md5=224ec243450db93eb7d9c75e87d95b39</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm900461w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900461w%26sid%3Dliteratum%253Aachs%26aulast%3DMatuszak%26aufirst%3DN.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520N-substituted%2520maleimide%2520derivatives%2520as%2520selective%2520monoglyceride%2520lipase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7410%26epage%3D7420%26doi%3D10.1021%2Fjm900461w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauvois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1002/cbic.200700139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbic.200700139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17579916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos12rsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1293-1297&author=G.+Labarauthor=C.+Bauvoisauthor=G.+G.+Muccioliauthor=J.+Woutersauthor=D.+M.+Lambert&title=Disulfiram+is+an+inhibitor+of+human+purified+monoacylglycerol+lipase%2C+the+enzyme+regulating+2-arachidonoylglycerol+signaling&doi=10.1002%2Fcbic.200700139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling</span></div><div class="casAuthors">Labar, Geoffray; Bauvois, Cedric; Muccioli, Giulio G.; Wouters, Johan; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1293-1297</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a key enzyme responsible for the termination of endocannabinoid signaling.  Its crucial role in 2-arachidonoylglycerol (2-AG) metab., together with the numerous pharmacol. properties mediated by this endocannabinoid, emphasize the interest in MAGL as therapeutic target, along with the need to design potent and selective inhibitors.  Meanwhile, the complexity of 2-AG degrdn. pathways underscores the need to use a purified source of enzyme in evaluation studies of new inhibitors.  We report here the first heterologous expression and purifn. of human MAGL.  A highly pure protein was obtained and allowed us to measure the affinity of several MAGL inhibitors for the human enzyme.  Importantly, disulfiram (tetraethylthiuram disulfide), a compd. used to treat alcoholism, and other disulfide-contg. compds. were shown to inhibit MAGL with good potency, likely through an interaction with cysteine residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryGocIm_WXjbVg90H21EOLACvtfcHk0lhdyZo4B5-GjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos12rsbY%253D&md5=a76f97702838860f090769e6fdca3932</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700139%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DDisulfiram%2520is%2520an%2520inhibitor%2520of%2520human%2520purified%2520monoacylglycerol%2520lipase%252C%2520the%2520enzyme%2520regulating%25202-arachidonoylglycerol%2520signaling%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1293%26epage%3D1297%26doi%3D10.1002%2Fcbic.200700139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Kapanda, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Bis (dialkylaminethiocarbonyl) disulfides as potent and selective monoglyceride lipase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7310</span><span class="NLM_x">–</span> <span class="NLM_lpage">7314</span><span class="refDoi"> DOI: 10.1021/jm901323s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901323s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7310-7314&author=C.+N.+Kapandaauthor=G.+G.+Muccioliauthor=G.+Labarauthor=J.+H.+Poupaertauthor=D.+M.+Lambert&title=Bis+%28dialkylaminethiocarbonyl%29+disulfides+as+potent+and+selective+monoglyceride+lipase+inhibitors&doi=10.1021%2Fjm901323s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm901323s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901323s%26sid%3Dliteratum%253Aachs%26aulast%3DKapanda%26aufirst%3DC.%2BN.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DBis%2520%2528dialkylaminethiocarbonyl%2529%2520disulfides%2520as%2520potent%2520and%2520selective%2520monoglyceride%2520lipase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7310%26epage%3D7314%26doi%3D10.1021%2Fjm901323s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00276.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1476-5381.2009.00276.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19486005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVChu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=974-983&author=A.+Kingauthor=A.+Lodolaauthor=C.+Carmiauthor=J.+Fuauthor=M.+Morauthor=D.+Piomelli&title=A+critical+cysteine+residue+in+monoacylglycerol+lipase+is+targeted+by+a+new+class+of+isothiazolinone-based+enzyme+inhibitors&doi=10.1111%2Fj.1476-5381.2009.00276.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors</span></div><div class="casAuthors">King, A. R.; Lodola, A.; Carmi, C.; Fu, J.; Mor, M.; Piomelli, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">974-983</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MGL) is a presynaptic serine hydrolase that inactivates the endocannabinoid neurotransmitter, 2-arachidonoyl-sn-glycerol.  Recent studies suggest that cysteine residues proximal to the enzyme active site are important for MGL function.  In the present study, we characterize the role of cysteines in MGL function and identify a series of cysteine-reactive agents that inhibit MGL activity with nanomolar potencies by interacting with cysteine residue 208.  A series of cysteine traps were screened for the ability to inhibit MGL in vitro.  Rapid diln. assays were performed to det. reversibility of inhibition.  Mol. modeling and site-directed mutagenesis were utilized to identify cysteine residues targeted by the inhibitors.  The screening revealed that 2-octyl-4-isothiazolin-3-one (octhilinone) inhibited purified rat recombinant MGL (IC50 = 88 ± 12 nM) through a partially reversible mechanism.  Initial structure-activity relationship studies showed that substitution of the n-octyl group of octhilinone with a more lipophilic oleoyl group increased inhibitor potency (IC50 = 43 ± 8 nM), while substitution with a Me group produced the opposite effect (IC50 = 239 ± 68 nM).  The inhibitory potency of octhilinone was selectively decreased by mutating cysteine 208 in MGL to glycine (IC50; wild-type, 151 ± 17 nM; C208G, 722 ± 74 nM), but not by mutation of other cysteine residues (C32, C55, C201, C208 and C242).  The results indicated that cysteine 208 plays an important role in MGL function and identified a novel class of isothiazolinone-based MGL inhibitors with nanomolar potency in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs7LpQEIcKErVg90H21EOLACvtfcHk0lhdyZo4B5-GjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVChu7bP&md5=6f84ee295e1716a713616a073ef4c2b7</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00276.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00276.x%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DCarmi%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520critical%2520cysteine%2520residue%2520in%2520monoacylglycerol%2520lipase%2520is%2520targeted%2520by%2520a%2520new%2520class%2520of%2520isothiazolinone-based%2520enzyme%2520inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D974%26epage%3D983%26doi%3D10.1111%2Fj.1476-5381.2009.00276.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriello, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2007.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejmech.2007.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=62-72&author=G.+Ortarauthor=M.+G.+Cascioauthor=A.+S.+Morielloauthor=M.+Camalliauthor=E.+Moreraauthor=M.+Nalliauthor=V.+Di+Marzo&title=Carbamoyl+tetrazoles+as+inhibitors+of+endocannabinoid+inactivation%3A+a+critical+revisitation&doi=10.1016%2Fj.ejmech.2007.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DMoriello%26aufirst%3DA.%2BS.%26aulast%3DCamalli%26aufirst%3DM.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DNalli%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DCarbamoyl%2520tetrazoles%2520as%2520inhibitors%2520of%2520endocannabinoid%2520inactivation%253A%2520a%2520critical%2520revisitation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D62%26epage%3D72%26doi%3D10.1016%2Fj.ejmech.2007.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Morera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6260</span><span class="NLM_x">–</span> <span class="NLM_lpage">6275</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2012.09.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6260-6275&author=L.+Moreraauthor=G.+Labarauthor=G.+Ortarauthor=D.+M.+Lambert&title=Development+and+characterization+of+endocannabinoid+hydrolases+FAAH+and+MAGL+inhibitors+bearing+a+benzotriazol-1-yl+carboxamide+scaffold&doi=10.1016%2Fj.bmc.2012.09.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DMorera%26aufirst%3DL.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520endocannabinoid%2520hydrolases%2520FAAH%2520and%2520MAGL%2520inhibitors%2520bearing%2520a%2520benzotriazol-1-yl%2520carboxamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6260%26epage%3D6275%26doi%3D10.1016%2Fj.bmc.2012.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Aaltonen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönkkö, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuusisto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korhonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häyrinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takabe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantsar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasonen-Seppänen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span> </span><span class="NLM_article-title">Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23521796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=379-390&author=N.+Aaltonenauthor=J.+R.+Savinainenauthor=C.+R.+Ribasauthor=J.+R%C3%B6nkk%C3%B6author=A.+Kuusistoauthor=J.+Korhonenauthor=D.+Navia-Paldaniusauthor=J.+H%C3%A4yrinenauthor=P.+Takabeauthor=H.+K%C3%A4sn%C3%A4nenauthor=T.+Pantsarauthor=T.+Laitinenauthor=M.+Lehtonenauthor=S.+Pasonen-Sepp%C3%A4nenauthor=A.+Posoauthor=T.+Nevalainenauthor=J.+T.+Laitinen&title=Piperazine+and+piperidine+triazole+ureas+as+ultrapotent+and+highly+selective+inhibitors+of+monoacylglycerol+lipase&doi=10.1016%2Fj.chembiol.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase</span></div><div class="casAuthors">Aaltonen, Niina; Savinainen, Juha R.; Ribas, Casandra Riera; Ronkko, Jani; Kuusisto, Anne; Korhonen, Jani; Navia-Paldanius, Dina; Hayrinen, Jukka; Takabe, Piia; Kasnanen, Heikki; Pantsar, Tatu; Laitinen, Tuomo; Lehtonen, Marko; Pasonen-Seppanen, Sanna; Poso, Antti; Nevalainen, Tapio; Laitinen, Jarmo T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-390</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) terminates the signaling function of the endocannabinoid, 2-arachidonoylglycerol (2-AG).  During 2-AG hydrolysis, MAGL liberates arachidonic acid, feeding the principal substrate for the neuroinflammatory prostaglandins.  In cancer cells, MAGL redirects lipid stores toward protumorigenic signaling lipids.  Thus MAGL inhibitors may have great therapeutic potential.  Although potent and increasingly selective MAGL inhibitors have been described, their no. is still limited.  Here, we have characterized piperazine and piperidine triazole ureas that combine the high potency attributable to the triazole leaving group together with the bulky arom. benzodioxolyl moiety required for selectivity, culminating in compd. JJKK-048 that potently (IC50 < 0.4 nM) inhibited human and rodent MAGL.  JJKK-048 displayed low cross-reactivity with other endocannabinoid targets.  Activity-based protein profiling of mouse brain and human melanoma cell proteomes suggested high specificity also among the metabolic serine hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIDOxKwD3xf7Vg90H21EOLACvtfcHk0lhiDb374-f_Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D&md5=3061a03d341bfb1de6b25c8d925b5b9f</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DAaltonen%26aufirst%3DN.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DRibas%26aufirst%3DC.%2BR.%26aulast%3DR%25C3%25B6nkk%25C3%25B6%26aufirst%3DJ.%26aulast%3DKuusisto%26aufirst%3DA.%26aulast%3DKorhonen%26aufirst%3DJ.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DH%25C3%25A4yrinen%26aufirst%3DJ.%26aulast%3DTakabe%26aufirst%3DP.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DPantsar%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DPasonen-Sepp%25C3%25A4nen%26aufirst%3DS.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DPiperazine%2520and%2520piperidine%2520triazole%2520ureas%2520as%2520ultrapotent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520monoacylglycerol%2520lipase%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D379%26epage%3D390%26doi%3D10.1016%2Fj.chembiol.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Patel, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahenkorah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staszewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walczyński, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T. J.</span><span> </span><span class="NLM_article-title">Loratadine analogues as MAGL inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1436</span><span class="NLM_x">–</span> <span class="NLM_lpage">1442</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.02.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2015.02.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1436-1442&author=J.+Z.+Patelauthor=S.+Ahenkorahauthor=M.+Vaaraauthor=M.+Staszewskiauthor=Y.+Adamsauthor=T.+Laitinenauthor=D.+Navia-Paldaniusauthor=T.+Parkkariauthor=J.+R.+Savinainenauthor=K.+Walczy%C5%84skiauthor=J.+T.+Laitinenauthor=T.+J.+Nevalainen&title=Loratadine+analogues+as+MAGL+inhibitors&doi=10.1016%2Fj.bmcl.2015.02.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.02.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.02.037%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DJ.%2BZ.%26aulast%3DAhenkorah%26aufirst%3DS.%26aulast%3DVaara%26aufirst%3DM.%26aulast%3DStaszewski%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DY.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DParkkari%26aufirst%3DT.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DWalczy%25C5%2584ski%26aufirst%3DK.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DNevalainen%26aufirst%3DT.%2BJ.%26atitle%3DLoratadine%2520analogues%2520as%2520MAGL%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1436%26epage%3D1442%26doi%3D10.1016%2Fj.bmcl.2015.02.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suplita, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crystal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">An endocannabinoid mechanism for stress-induced analgesia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span><span class="refDoi"> DOI: 10.1038/nature03658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnature03658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15973410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltl2ntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=1108-1112&author=A.+G.+Hohmannauthor=R.+L.+Suplitaauthor=N.+M.+Boltonauthor=M.+H.+Neelyauthor=D.+Fegleyauthor=R.+Mangieriauthor=J.+F.+Kreyauthor=J.+M.+Walkerauthor=P.+V.+Holmesauthor=J.+D.+Crystalauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=An+endocannabinoid+mechanism+for+stress-induced+analgesia&doi=10.1038%2Fnature03658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">An endocannabinoid mechanism for stress-induced analgesia</span></div><div class="casAuthors">Hohmann, Andrea G.; Suplita, Richard L.; Bolton, Nathan M.; Neely, Mark H.; Fegley, Darren; Mangieri, Regina; Krey, Jocelyn F.; Walker, J. Michael; Holmes, Philip V.; Crystal, Jonathon D.; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7045</span>),
    <span class="NLM_cas:pages">1108-1112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acute stress suppresses pain by activating brain pathways that engage opioid or non-opioid mechanisms.  Here we show that an opioid-independent form of this phenomenon, termed stress-induced analgesia, is mediated by the release of endogenous marijuana-like (cannabinoid) compds. in the brain.  Blockade of cannabinoid CB1 receptors in the periaqueductal gray matter of the midbrain prevents non-opioid stress-induced analgesia.  In this region, stress elicits the rapid formation of two endogenous cannabinoids, the lipids 2-arachidonoyl glycerol (2-AG) and anandamide.  A newly developed inhibitor of the 2-AG-deactivating enzyme, monoacylglycerol lipase, selectively increases 2-AG concns. and, when injected into the periaqueductal gray matter, enhances stress-induced analgesia in a CB1-dependent manner.  Inhibitors of the anandamide-deactivating enzyme fatty-acid amide hydrolase, which selectively elevate anandamide concns., exert similar effects.  Our results indicate that the coordinated release of 2-AG and anandamide in the periaqueductal gray matter might mediate opioid-independent stress-induced analgesia.  These studies also identify monoacylglycerol lipase as a previously unrecognized therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5vxyGiLku-bVg90H21EOLACvtfcHk0lhiDb374-f_Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltl2ntrY%253D&md5=661a2667fa884ef865d098eca15f3c9b</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fnature03658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03658%26sid%3Dliteratum%253Aachs%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DSuplita%26aufirst%3DR.%2BL.%26aulast%3DBolton%26aufirst%3DN.%2BM.%26aulast%3DNeely%26aufirst%3DM.%2BH.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DMangieri%26aufirst%3DR.%26aulast%3DKrey%26aufirst%3DJ.%2BF.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DHolmes%26aufirst%3DP.%2BV.%26aulast%3DCrystal%26aufirst%3DJ.%2BD.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520endocannabinoid%2520mechanism%2520for%2520stress-induced%2520analgesia%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D1108%26epage%3D1112%26doi%3D10.1038%2Fnature03658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis <i>in vitro</i></span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsj.bjp.0706971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17143303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=186-191&author=S.+Vandevoordeauthor=K.+O.+Jonssonauthor=G.+Labarauthor=E.+Perssonauthor=D.+Lambertauthor=C.+J.+Fowler&title=Lack+of+selectivity+of+URB602+for+2-oleoylglycerol+compared+to+anandamide+hydrolysis+in+vitro&doi=10.1038%2Fsj.bjp.0706971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro</span></div><div class="casAuthors">Vandevoorde, S.; Jonsson, K-O.; Labar, G.; Persson, E.; Lambert, D. M.; Fowler, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-191</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two compds., URB602 and URB754, have been reported in the literature to be selective inhibitors of monoacylglycerol lipase, although a recent study has questioned their ability to prevent 2-arachidonoyl hydrolysis by brain homogenates and cerebellar membranes.  In the present study, the ability of these compds. to inhibit monoacylglycerol lipase and fatty acid amide hydrolase has been reinvestigated.  Exptl. approach: Homogenates and cell lines were incubated with test compds. and, thereafter, with either [3H]-2-oleoylglycerol or [3H]-anandamide.  Labeled reaction products were sepd. from substrate using chloroform: methanol extn.  In cytosolic fractions from rat brain, URB602 and URB754 inhibited the hydrolysis of 2-oleoylglycerol with IC50 values of 25 and 48 μM, resp.  Anandamide hydrolysis by brain membranes was not sensitive to URB754, but was inhibited by URB602 (IC50 value 17 μM).  Hydrolysis of 2-oleoylglycerol by human recombinant monoacylglycerol lipase was sensitive to URB602, but not URB754.  The lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis was also obsd. for intact RBL2H3 basophilic leukemia cells.  C6 glioma expressed mRNA for monoacylglycerol lipase, and hydrolyzed 2-oleoylglycerol in a manner sensitive to inhibition by Me arachidonoyl fluorophosphonate but not URB754 or URB597.  MC3T3-E1 mouse osteoblastic cells, which did not express mRNA for monoacylglycerol lipase, hydrolyzed 2-oleoylglycerol in the presence of URB597, but the hydrolysis was less sensitive to Me arachidonoyl fluorophosphonate than for C6 cells.  The data demonstrate that the compds. URB602 and URB754 do not behave as selective and/or potent inhibitors of monoacylglycerol lipase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtVRvNn0uv3LVg90H21EOLACvtfcHk0lhs-apeC9kpwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFeqsA%253D%253D&md5=0594f0eaca3ecbd7942c09687d2e54be</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706971%26sid%3Dliteratum%253Aachs%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DJonsson%26aufirst%3DK.%2BO.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DPersson%26aufirst%3DE.%26aulast%3DLambert%26aufirst%3DD.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DLack%2520of%2520selectivity%2520of%2520URB602%2520for%25202-oleoylglycerol%2520compared%2520to%2520anandamide%2520hydrolysis%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D186%26epage%3D191%26doi%3D10.1038%2Fsj.bjp.0706971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1124/jpet.104.078980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.104.078980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15579492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=352-358&author=D.+Fegleyauthor=S.+Gaetaniauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Characterization+of+the+fatty+acid+amide+hydrolase+inhibitor+cyclohexyl+carbamic+acid+3%E2%80%B2-carbamoyl-biphenyl-3-yl+ester+%28URB597%29%3A+effects+on+anandamide+and+oleoylethanolamide+deactivation&doi=10.1124%2Fjpet.104.078980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation</span></div><div class="casAuthors">Fegley, Darren; Gaetani, Silvana; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">352-358</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an intracellular serine enzyme that catalyzes the hydrolysis of bioactive fatty acid ethanolamides such as anandamide and oleoylethanolamide (OEA).  Genetic deletion of the faah gene in mice elevates brain anandamide levels and amplifies the effects of this endogenous cannabinoid agonist.  Here, we show that systemic administration of the selective FAAH inhibitor URB597 (cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester; 0.3 mg/kg i.p.) increases anandamide levels in the brain of rats and wild-type mice but has no such effect in FAAH-null mutants.  Moreover, URB597 enhances the hypothermic actions of anandamide (5 mg/kg i.p.) in wild-type mice but not in FAAH-null mice.  In contrast, the FAAH inhibitor does not affect anandamide or OEA levels in the rat duodenum at doses that completely inhibit FAAH activity.  In addn., URB597 does not alter the hypophagic response elicited by OEA (5 and 10 mg/kg i.p.), which is mediated by activation of peroxisome proliferator-activated receptor type-α.  Finally, exogenously administered OEA (5 mg/kg i.p.) was eliminated at comparable rates in wild-type and FAAH-/- mice.  Our results indicate that URB597 increases brain anandamide levels and magnifies anandamide responses by inhibiting intracellular FAAH activity.  The results also suggest that an enzyme distinct from FAAH catalyzes OEA hydrolysis in the duodenum, where this lipid substance acts as a local satiety factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQqcEldxrOALVg90H21EOLACvtfcHk0lhs-apeC9kpwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSntro%253D&md5=d09bb7f585012a0378a1498c7362f0c5</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.078980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.078980%26sid%3Dliteratum%253Aachs%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520the%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520cyclohexyl%2520carbamic%2520acid%25203%25E2%2580%25B2-carbamoyl-biphenyl-3-yl%2520ester%2520%2528URB597%2529%253A%2520effects%2520on%2520anandamide%2520and%2520oleoylethanolamide%2520deactivation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D352%26epage%3D358%26doi%3D10.1124%2Fjpet.104.078980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosengarth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geaga, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2007.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2007.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18096504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1357-1365&author=A.+R.+Kingauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Rosengarthauthor=J.+R.+Clapperauthor=G.+Astaritaauthor=J.+A.+Geagaauthor=H.+Lueckeauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=URB602+inhibits+monoacylglycerol+lipase+and+selectively+blocks+2-arachidonoylglycerol+degradation+in+intact+brain+slices&doi=10.1016%2Fj.chembiol.2007.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices</span></div><div class="casAuthors">King, Alvin R.; Duranti, Andrea; Tontini, Andrea; Rivara, Silvia; Rosengarth, Anja; Clapper, Jason R.; Astarita, Giuseppe; Geaga, Jennifer A.; Luecke, Hartmut; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1357-1365</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The N-aryl carbamate URB602 (biphenyl-3-ylcarbamic acid cyclohexyl ester) is an inhibitor of monoacylglycerol lipase (MGL), a serine hydrolase involved in the biol. deactivation of the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG).  Here, we investigated the mechanism by which URB602 inhibits purified recombinant rat MGL by using a combination of biochem. and structure-activity relationship (SAR) approaches.  We found that URB602 weakly inhibits recombinant MGL (IC50 = 223 ± 63 μM) through a rapid and non-competitive mechanism.  Dialysis expts. and SAR analyses suggest that URB602 acts through a partially reversible mechanism rather than by irreversible carbamoylation of MGL.  Finally, URB602 (100 μM) elevates 2-AG levels in hippocampal slice cultures without affecting levels of other endocannabinoid-related substances.  Thus, URB602 may provide a useful tool by which to investigate the physiol. roles of 2-AG and explore the potential interest of MGL as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVnXoAAqtub7Vg90H21EOLACvtfcHk0ljrom7qXETV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfF&md5=f0fd3b5bd25e049a49e6b0649ad32a34</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DRosengarth%26aufirst%3DA.%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DGeaga%26aufirst%3DJ.%2BA.%26aulast%3DLuecke%26aufirst%3DH.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DURB602%2520inhibits%2520monoacylglycerol%2520lipase%2520and%2520selectively%2520blocks%25202-arachidonoylglycerol%2520degradation%2520in%2520intact%2520brain%2520slices%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D1357%26epage%3D1365%26doi%3D10.1016%2Fj.chembiol.2007.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavón, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1038/nchembio.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnchembio.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19029917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=37-44&author=J.+Z.+Longauthor=W.+Liauthor=L.+Bookerauthor=J.+J.+Burstonauthor=S.+G.+Kinseyauthor=J.+E.+Schlosburgauthor=F.+J.+Pav%C3%B3nauthor=A.+M.+Serranoauthor=D.+E.+Selleyauthor=L.+H.+Parsonsauthor=A.+H.+Lichtmanauthor=B.+F.+Cravatt&title=Selective+blockade+of+2-arachidonoylglycerol+hydrolysis+produces+cannabinoid+behavioral+effects&doi=10.1038%2Fnchembio.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects</span></div><div class="casAuthors">Long, Jonathan Z.; Li, Weiwei; Booker, Lamont; Burston, James J.; Kinsey, Steven G.; Schlosburg, Joel E.; Pavon, Franciso J.; Serrano, Antonia M.; Selley, Dana E.; Parsons, Loren H.; Lichtman, Aron H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol (2-AG) and anandamide are endocannabinoids that activate the cannabinoid receptors CB1 and CB2.  Endocannabinoid signaling is terminated by enzymic hydrolysis, a process that for anandamide is mediated by fatty acid amide hydrolase (FAAH), and for 2-AG is thought to involve monoacylglycerol lipase (MAGL).  FAAH inhibitors produce a select subset of the behavioral effects obsd. with CB1 agonists, which suggests a functional segregation of endocannabinoid signaling pathways in vivo.  Testing this hypothesis, however, requires specific tools to independently block anandamide and 2-AG metab.  Here, we report a potent and selective inhibitor of MAGL called JZL184 that, upon administration to mice, raises brain 2-AG by eight-fold without altering anandamide.  JZL184-treated mice exhibited a broad array of CB1-dependent behavioral effects, including analgesia, hypothermia and hypomotility.  These data indicate that 2-AG endogenously modulates several behavioral processes classically assocd. with the pharmacol. of cannabinoids and point to overlapping and unique functions for 2-AG and anandamide in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY1sK0ulYFK7Vg90H21EOLACvtfcHk0ljrom7qXETV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F&md5=1ffee44019b0e52db5da38fe30a6e4d0</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.129%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DPav%25C3%25B3n%26aufirst%3DF.%2BJ.%26aulast%3DSerrano%26aufirst%3DA.%2BM.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DSelective%2520blockade%2520of%25202-arachidonoylglycerol%2520hydrolysis%2520produces%2520cannabinoid%2520behavioral%2520effects%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D37%26epage%3D44%26doi%3D10.1038%2Fnchembio.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1124/jpet.112.201426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.112.201426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23412396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=492-501&author=S.+G.+Kinseyauthor=L.+E.+Wiseauthor=D.+Rameshauthor=R.+Abdullahauthor=D.+E.+Selleyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Repeated+low-dose+administration+of+the+monoacylglycerol+lipase+inhibitor+JZL184+retains+cannabinoid+receptor+type+1-mediated+antinociceptive+and+gastroprotective+effects&doi=10.1124%2Fjpet.112.201426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects</span></div><div class="casAuthors">Kinsey, Steven G.; Wise, Laura E.; Ramesh, Divya; Abdullah, Rehab; Selley, Dana E.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The monoacylglycerol lipase (MAGL) inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) produces antinociceptive and anti-inflammatory effects.  However, repeated administration of high-dose JZL184 (40 mg/kg) causes dependence, antinociceptive tolerance, cross-tolerance to the pharmacol. effects of cannabinoid receptor agonists, and cannabinoid receptor type 1 (CB1) downregulation and desensitization.  This functional CB1 receptor tolerance poses a hurdle in the development of MAGL inhibitors for therapeutic use.  Consequently, the present study tested whether repeated administration of low-dose JZL184 maintains its antinociceptive actions in the chronic constriction injury of the sciatic nerve neuropathic pain model and protective effects in a model of nonsteroidal anti-inflammatory drug-induced gastric hemorrhages.  Mice given daily injections of high-dose JZL184 (≥16 mg/kg) for 6 days displayed decreased CB1 receptor d. and function in the brain, as assessed in [3H]SR141716A binding and CP55,940 [(-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol]-stimulated guanosine 5'-O-(3-[35S]thio)triphosphate binding assays, resp.  In contrast, normal CB1 receptor expression and function were maintained following repeated administration of low-dose JZL184 (≤8 mg/kg).  Likewise, the antinociceptive and gastroprotective effects of high-dose JZL184 underwent tolerance following repeated administration, but these effects were maintained following repeated low-dose JZL184 treatment.  Consistent with these observations, repeated high-dose JZL184, but not repeated low-dose JZL184, elicited cross-tolerance to the common pharmacol. effects of Δ9-tetrahydrocannabinol.  This same pattern of effects was found in a rimonabant [(5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide)]-pptd. withdrawal model of cannabinoid dependence.  Taken together, these results indicate that prolonged, partial MAGL inhibition maintains potentially beneficial antinociceptive and anti-inflammatory effects, without producing functional CB1 receptor tachyphylaxis/tolerance or cannabinoid dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZkkceF1Il2rVg90H21EOLACvtfcHk0ljrom7qXETV3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D&md5=ea906c8140fa02a53729ff4fcbdcd8a8</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201426%26sid%3Dliteratum%253Aachs%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DWise%26aufirst%3DL.%2BE.%26aulast%3DRamesh%26aufirst%3DD.%26aulast%3DAbdullah%26aufirst%3DR.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DRepeated%2520low-dose%2520administration%2520of%2520the%2520monoacylglycerol%2520lipase%2520inhibitor%2520JZL184%2520retains%2520cannabinoid%2520receptor%2520type%25201-mediated%2520antinociceptive%2520and%2520gastroprotective%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D345%26spage%3D492%26epage%3D501%26doi%3D10.1124%2Fjpet.112.201426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. S.</span><span> </span><span class="NLM_article-title">Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity</span> <span class="citation_source-journal">Hippocampus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1002/hipo.22344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fhipo.22344" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=16-26&author=Z.+Zhangauthor=W.+Wangauthor=P.+Zhongauthor=S.+J.+Liuauthor=J.+Z.+Longauthor=L.+Zhaoauthor=H.+Q.+Gaoauthor=B.+F.+Cravattauthor=Q.+S.+Liu&title=Blockade+of+2-arachidonoylglycerol+hydrolysis+produces+antidepressant-like+effects+and+enhances+adult+hippocampal+neurogenesis+and+synaptic+plasticity&doi=10.1002%2Fhipo.22344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1002%2Fhipo.22344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhipo.22344%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DS.%2BJ.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DH.%2BQ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLiu%26aufirst%3DQ.%2BS.%26atitle%3DBlockade%2520of%25202-arachidonoylglycerol%2520hydrolysis%2520produces%2520antidepressant-like%2520effects%2520and%2520enhances%2520adult%2520hippocampal%2520neurogenesis%2520and%2520synaptic%2520plasticity%26jtitle%3DHippocampus%26date%3D2015%26volume%3D25%26spage%3D16%26epage%3D26%26doi%3D10.1002%2Fhipo.22344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim-Selley, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1038/nn.2616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.2616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20729846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1113-1119&author=J.+E.+Schlosburgauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=D.+K.+Nomuraauthor=B.+Panauthor=S.+G.+Kinseyauthor=P.+T.+Nguyenauthor=D.+Rameshauthor=L.+Bookerauthor=J.+J.+Burstonauthor=E.+A.+Thomasauthor=D.+E.+Selleyauthor=L.+J.+Sim-Selleyauthor=Q.+S.+Liuauthor=A.+H.+Lichtmanauthor=B.+F.+Cravatt&title=Chronic+monoacylglycerol+lipase+blockade+causes+functional+antagonism+of+the+endocannabinoid+system&doi=10.1038%2Fnn.2616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system</span></div><div class="casAuthors">Schlosburg, Joel E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Pan, Bin; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Thomas, Elizabeth A.; Selley, Dana E.; Sim-Selley, Laura J.; Liu, Qing-song; Lichtman, Aron H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1113-1119</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prolonged exposure to drugs of abuse, such as cannabinoids and opioids, leads to pharmacol. tolerance and receptor desensitization in the nervous system.  We found that a similar form of functional antagonism was produced by sustained inactivation of monoacylglycerol lipase (MAGL), the principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol.  After repeated administration, the MAGL inhibitor JZL184 lost its analgesic activity and produced cross-tolerance to cannabinoid receptor (CB1) agonists in mice, effects that were phenocopied by genetic disruption of Mgll (encoding MAGL).  Chronic MAGL blockade also caused phys. dependence, impaired endocannabinoid-dependent synaptic plasticity and desensitized brain CB1 receptors.  These data contrast with blockade of fatty acid amide hydrolase, an enzyme that degrades the other major endocannabinoid anandamide, which produced sustained analgesia without impairing CB1 receptors.  Thus, individual endocannabinoids generate distinct analgesic profiles that are either sustained or transitory and assocd. with agonism and functional antagonism of the brain cannabinoid system, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrspBJ5YipLVg90H21EOLACvtfcHk0lgedF3c_3AhKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtb%252FK&md5=878d95dd379fc44ff642c2ae1b458a46</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fnn.2616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2616%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DNguyen%26aufirst%3DP.%2BT.%26aulast%3DRamesh%26aufirst%3DD.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DThomas%26aufirst%3DE.%2BA.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DSim-Selley%26aufirst%3DL.%2BJ.%26aulast%3DLiu%26aufirst%3DQ.%2BS.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DChronic%2520monoacylglycerol%2520lipase%2520blockade%2520causes%2520functional%2520antagonism%2520of%2520the%2520endocannabinoid%2520system%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1113%26epage%3D1119%26doi%3D10.1038%2Fnn.2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buczynski, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=579-588&author=J.+W.+Changauthor=M.+J.+Niphakisauthor=K.+M.+Lumauthor=A.+B.+Cognettaauthor=C.+Wangauthor=M.+L.+Matthewsauthor=S.+Niessenauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=B.+F.+Cravatt&title=Highly+selective+inhibitors+of+monoacylglycerol+lipase+bearing+a+reactive+group+that+is+bioisosteric+with+endocannabinoid+substrates&doi=10.1016%2Fj.chembiol.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span></div><div class="casAuthors">Chang, Jae Won; Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B.; Wang, Chu; Matthews, Megan L.; Niessen, Sherry; Buczynski, Matthew W.; Parsons, Loren H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), resp.  The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo.  Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biol. studies.  Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH.  These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWEmTTUlQHCLVg90H21EOLACvtfcHk0lgedF3c_3AhKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D&md5=d318d890c4c799d1579daab2e2c201f4</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DHighly%2520selective%2520inhibitors%2520of%2520monoacylglycerol%2520lipase%2520bearing%2520a%2520reactive%2520group%2520that%2520is%2520bioisosteric%2520with%2520endocannabinoid%2520substrates%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D579%26epage%3D588%26doi%3D10.1016%2Fj.chembiol.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Ignatowska-Jankowska, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neal, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walentiny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">1392</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span><span class="refDoi"> DOI: 10.1111/bph.12298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fbph.12298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23848221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVentrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=1392-1407&author=B.+M.+Ignatowska-Jankowskaauthor=S.+Ghoshauthor=M.+S.+Croweauthor=S.+G.+Kinseyauthor=M.+J.+Niphakisauthor=R.+A.+Abdullahauthor=Q.+Taoauthor=S.+T.+O%E2%80%99Nealauthor=D.+M.+Walentinyauthor=J.+L.+Wileyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=In+vivo+characterization+of+the+highly+selective+monoacylglycerol+lipase+inhibitor+KML29%3A+antinociceptive+activity+without+cannabimimetic+side+effects&doi=10.1111%2Fbph.12298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects</span></div><div class="casAuthors">Ignatowska-Jankowska, B. M.; Ghosh, S.; Crowe, M. S.; Kinsey, S. G.; Niphakis, M. J.; Abdullah, R. A.; Tao, Q.; O'Neal, S. T.; Walentiny, D. M.; Wiley, J. L.; Cravatt, B. F.; Lichtman, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1392-1407</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Since monoacylglycerol lipase (MAGL) has been firmly established as the predominant catabolic enzyme of the endocannabinoid 2-arachidonoylglycerol (2-AG), a great need has emerged for the development of highly selective MAGL inhibitors.  Here, we tested the in vivo effects of one such compd., KML29 (1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo[d][1,3]dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate).  Exptl. Approach : In the present study, we tested KML29 in murine inflammatory (i.e. carrageenan) and sciatic nerve injury pain models, as well as the diclofenac-induced gastric hemorrhage model.  KML29 was also evaluated for cannabimimetic effects, including measurements of locomotor activity, body temp., catalepsy, and cannabinoid interoceptive effects in the drug discrimination paradigm.  Key Results: KML29 attenuated carrageenan-induced paw edema and completely reversed carrageenan-induced mech. allodynia.  These effects underwent tolerance after repeated administration of high-dose KML29, which were accompanied by cannabinoid receptor 1 (CB1) receptor desensitization.  Acute or repeated KML29 administration increased 2-AG levels and concomitantly reduced arachidonic acid levels, but without elevating anandamide (AEA) levels in the whole brain.  Furthermore, KML29 partially reversed allodynia in the sciatic nerve injury model and completely prevented diclofenac-induced gastric haemorrhages.  CB1 and CB2 receptors played differential roles in these pharmacol. effects of KML29.  In contrast, KML29 did not elicit cannabimimetic effects, including catalepsy, hypothermia and hypomotility.  Although KML29 did not substitute for Δ9-tetrahydrocannabinol (THC) in C57BL/6J mice, it fully and dose-dependantly substituted for AEA in fatty acid amide hydrolase (FAAH) (-/-) mice, consistent with previous work showing that dual FAAH and MAGL inhibition produces THC-like subjective effects.  Conclusions and Implications : These results indicate that KML29, a highly selective MAGL inhibitor, reduces inflammatory and neuropathic nociceptive behavior without occurrence of cannabimimetic side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_q-jS_ue8WLVg90H21EOLACvtfcHk0li_XvxLGD-k-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVentrk%253D&md5=63408213fe5c278fa49081f1d912a958</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fbph.12298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12298%26sid%3Dliteratum%253Aachs%26aulast%3DIgnatowska-Jankowska%26aufirst%3DB.%2BM.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DCrowe%26aufirst%3DM.%2BS.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DAbdullah%26aufirst%3DR.%2BA.%26aulast%3DTao%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DS.%2BT.%26aulast%3DWalentiny%26aufirst%3DD.%2BM.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DIn%2520vivo%2520characterization%2520of%2520the%2520highly%2520selective%2520monoacylglycerol%2520lipase%2520inhibitor%2520KML29%253A%2520antinociceptive%2520activity%2520without%2520cannabimimetic%2520side%2520effects%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D1392%26epage%3D1407%26doi%3D10.1111%2Fbph.12298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Pasquarelli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porazik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanselmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weydt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witting, A.</span><span> </span><span class="NLM_article-title">Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.neuropharm.2014.12.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2015&pages=148-156&author=N.+Pasquarelliauthor=C.+Porazikauthor=J.+Hanselmannauthor=P.+Weydtauthor=B.+Fergerauthor=A.+Witting&title=Comparative+biochemical+characterization+of+the+monoacylglycerol+lipase+inhibitor+KML29+in+brain%2C+spinal+cord%2C+liver%2C+spleen%2C+fat+and+muscle+tissue&doi=10.1016%2Fj.neuropharm.2014.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DPasquarelli%26aufirst%3DN.%26aulast%3DPorazik%26aufirst%3DC.%26aulast%3DHanselmann%26aufirst%3DJ.%26aulast%3DWeydt%26aufirst%3DP.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DWitting%26aufirst%3DA.%26atitle%3DComparative%2520biochemical%2520characterization%2520of%2520the%2520monoacylglycerol%2520lipase%2520inhibitor%2520KML29%2520in%2520brain%252C%2520spinal%2520cord%252C%2520liver%252C%2520spleen%252C%2520fat%2520and%2520muscle%2520tissue%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D91%26spage%3D148%26epage%3D156%26doi%3D10.1016%2Fj.neuropharm.2014.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1590</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span><span class="refDoi"> DOI: 10.1021/cb400261h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400261h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1590-1599&author=J.+W.+Changauthor=A.+B.+Cognettaauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Proteome-wide+reactivity+profiling+identifies+diverse+carbamate+chemotypes+tuned+for+serine+hydrolase+inhibition&doi=10.1021%2Fcb400261h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition</span></div><div class="casAuthors">Chang, Jae Won; Cognetta, Armand B., III; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1590-1599</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serine hydrolases are one of the largest and most diverse enzyme classes in Nature.  Inhibitors of serine hydrolases are used to treat many diseases, including obesity, diabetes, cognitive dementia, and bacterial and viral infections.  Nonetheless, the majority of the 200+ serine hydrolases in mammals still lack selective inhibitors for their functional characterization.  We and others have shown that activated carbamates, through covalent reaction with the conserved serine nucleophile of serine hydrolases, can serve as useful inhibitors for members of this enzyme family.  The extent to which carbamates, however, cross-react with other protein classes remains mostly unexplored.  Here, we address this problem by investigating the proteome-wide reactivity of a diverse set of activated carbamates in vitro and in vivo, using a combination of competitive and click chem. (CC)-activity-based protein profiling (ABPP).  We identify multiple classes of carbamates, including O-aryl, O-hexafluoroisopropyl (HFIP), and O-N-hydroxysuccinimidyl (NHS) carbamates that react selectively with serine hydrolases across entire mouse tissue proteomes in vivo.  We exploit the proteome-wide specificity of HFIP carbamates to create in situ imaging probes for the endocannabinoid hydrolases monoacylglycerol lipase (MAGL) and α-β hydrolase-6 (ABHD6).  These findings, taken together, designate the carbamate as a privileged reactive group for serine hydrolases that can accommodate diverse structural modifications to produce inhibitors that display exceptional potency and selectivity across the mammalian proteome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-176v-DnJrVg90H21EOLACvtfcHk0li_XvxLGD-k-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D&md5=7286011459791bcdea13f918b9ef97c3</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fcb400261h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400261h%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520reactivity%2520profiling%2520identifies%2520diverse%2520carbamate%2520chemotypes%2520tuned%2520for%2520serine%2520hydrolase%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1590%26epage%3D1599%26doi%3D10.1021%2Fcb400261h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buczynski, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1332</span><span class="refDoi"> DOI: 10.1021/cn400116z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400116z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFynsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1322-1332&author=M.+J.+Niphakisauthor=A.+B.+Cognettaauthor=J.+W.+Changauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=F.+Byrneauthor=J.+J.+Burstonauthor=V.+Chapmanauthor=B.+F.+Cravatt&title=Evaluation+of+NHS+carbamates+as+a+potent+and+selective+class+of+endocannabinoid+hydrolase+inhibitors&doi=10.1021%2Fcn400116z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of NHS Carbamates as a Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors</span></div><div class="casAuthors">Niphakis, Micah J.; Cognetta, Armand B.; Chang, Jae Won; Buczynski, Matthew W.; Parsons, Loren H.; Byrne, Frederika; Burston, James J.; Chapman, Victoria; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1322-1332</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a principal metabolic enzyme responsible for hydrolyzing the endogenous cannabinoid (endocannabinoid) 2-arachidonoylglycerol (2-AG).  Selective inhibitors of MAGL offer valuable probes to further understand the enzyme's function in biol. systems and may lead to drugs for treating a variety of diseases, including psychiatric disorders, neuroinflammation, and pain.  N-Hydroxysuccinimidyl (NHS) carbamates have recently been identified as a promising class of serine hydrolase inhibitors that shows minimal cross-reactivity with other proteins in the proteome.  Here, the authors explore NHS carbamates more broadly and demonstrate their potential as inhibitors of endocannabinoid hydrolases and addnl. enzymes from the serine hydrolase class.  The authors extensively characterize an NHS carbamate MJN110 as a potent, selective, and in-vivo-active MAGL inhibitor.  Finally, the authors demonstrate that MJN110 alleviates mech. allodynia in a rat model of diabetic neuropathy, marking NHS carbamates as a promising class of MAGL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAehyjU_mhIrVg90H21EOLACvtfcHk0lhDwERc6muCiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFynsbY%253D&md5=a85efb8cecdc97928ff889e63e46fe4d</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fcn400116z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400116z%26sid%3Dliteratum%253Aachs%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DByrne%26aufirst%3DF.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DChapman%26aufirst%3DV.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEvaluation%2520of%2520NHS%2520carbamates%2520as%2520a%2520potent%2520and%2520selective%2520class%2520of%2520endocannabinoid%2520hydrolase%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1322%26epage%3D1332%26doi%3D10.1021%2Fcn400116z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Wilkerson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grim, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poklis, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akbarali, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1124/jpet.115.229971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.115.229971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26791602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=145-156&author=J.+L.+Wilkersonauthor=M.+J.+Niphakisauthor=T.+W.+Grimauthor=M.+A.+Mustafaauthor=R.+A.+Abdullahauthor=J.+L.+Poklisauthor=W.+L.+Deweyauthor=H.+I.+Akbaraliauthor=M.+L.+Banksauthor=L.+E.+Wiseauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=The+selective+monoacylglycerol+lipase+inhibitor+MJN110+produces+opioid+sparing+effects+in+a+mouse+neuropathic+pain+model&doi=10.1124%2Fjpet.115.229971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">The selective monoacylglycerol lipase inhibitor MJN110 produces opioid-sparing effects in a mouse neuropathic pain model</span></div><div class="casAuthors">Wilkerson, Jenny L.; Niphakis, Micah J.; Grim, Travis W.; Mustafa, Mohammed A.; Abdullah, Rehab A.; Poklis, Justin L.; Dewey, William L.; Akbarali, Hamid; Banks, Matthew L.; Wise, Laura E.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-156</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Serious clin. liabilities assocd. with the prescription of opiates for pain control include constipation, respiratory depression, pruritus, tolerance, abuse, and addiction.  A recognized strategy to circumvent these side effects is to combine opioids with other antinociceptive agents.  The combination of opiates with the primary active constituent of cannabis (Δ9-tetrahydrocannabinol) produces enhanced antinociceptive actions, suggesting that cannabinoid receptor agonists can be opioid sparing.  Here, we tested whether elevating the endogenous cannabinoid 2-arachidonoylglycerol through the inhibition of its primary hydrolytic enzyme monoacylglycerol lipase (MAGL), will produce opioid-sparing effects in the mouse chronic constriction injury (CCI) of the sciatic nerve model of neuropathic pain.  The dose-response relationships of i.p. administration of morphine and the selective MAGL inhibitor 2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate (MJN110) were tested alone and in combination at equieffective doses for reversal of CCI-induced mech. allodynia and thermal hyperalgesia.  The resp. ED50 doses (95% confidence interval) of morphine and MJN110 were 2.4 (1.9-3.0) mg/kg and 0.43 (0.23-0.79) mg/kg.  Isobolog. anal. of these drugs in combination revealed synergistic antiallodynic effects.  Acute antinociceptive effects of the combination of morphine and MJN110 required μ-opioid, CB1, and CB2 receptors.  This combination did not reduce gastric motility or produce subjective cannabimimetic effects in the drug discrimination assay.  Importantly, combinations of MJN110 and morphine given repeatedly (i.e., twice a day for 6 days) continued to produce antiallodynic effects with no evidence of tolerance.  Taken together, these findings suggest that MAGL inhibition produces opiate-sparing events with diminished tolerance, constipation, and cannabimimetic side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvljtkgi35bVg90H21EOLACvtfcHk0lhDwERc6muCiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeksLg%253D&md5=dbcc89e040f2b5bc4257df943ce1e769</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229971%26sid%3Dliteratum%253Aachs%26aulast%3DWilkerson%26aufirst%3DJ.%2BL.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DGrim%26aufirst%3DT.%2BW.%26aulast%3DMustafa%26aufirst%3DM.%2BA.%26aulast%3DAbdullah%26aufirst%3DR.%2BA.%26aulast%3DPoklis%26aufirst%3DJ.%2BL.%26aulast%3DDewey%26aufirst%3DW.%2BL.%26aulast%3DAkbarali%26aufirst%3DH.%2BI.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DWise%26aufirst%3DL.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DThe%2520selective%2520monoacylglycerol%2520lipase%2520inhibitor%2520MJN110%2520produces%2520opioid%2520sparing%2520effects%2520in%2520a%2520mouse%2520neuropathic%2520pain%2520model%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26spage%3D145%26epage%3D156%26doi%3D10.1124%2Fjpet.115.229971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeské, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Françon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Even, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Grancha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstykh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brittain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederschain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escoubet, J.</span><span> </span><span class="NLM_article-title">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">7642</span><span class="refDoi"> DOI: 10.1038/srep07642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsrep07642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=25560837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=7642&author=G.+Griebelauthor=P.+Pichatauthor=S.+Beesk%C3%A9author=T.+Leroyauthor=N.+Redonauthor=A.+Jacquetauthor=D.+Fran%C3%A7onauthor=L.+Bertauthor=L.+Evenauthor=M.+Lopez-Granchaauthor=T.+Tolstykhauthor=F.+Sunauthor=Q.+Yuauthor=S.+Brittainauthor=H.+Arltauthor=T.+Heauthor=B.+Zhangauthor=D.+Wiederschainauthor=T.+Bertrandauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=N.+Michotauthor=F.+Aug%C3%A9author=V.+Menetauthor=O.+E.+Bergisauthor=P.+Georgeauthor=P.+Avenetauthor=V.+Mikolauthor=M.+Didierauthor=J.+Escoubet&title=Selective+blockade+of+the+hydrolysis+of+the+endocannabinoid+2-arachidonoylglycerol+impairs+learning+and+memory+performance+while+producing+antinociceptive+activity+in+rodents&doi=10.1038%2Fsrep07642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span></div><div class="casAuthors">Griebel, Guy; Pichat, Philippe; Beeske, Sandra; Leroy, Thibaud; Redon, Nicolas; Jacquet, Agnes; Francon, Dominique; Bert, Lionel; Even, Luc; Lopez-Grancha, Mati; Tolstykh, Tatiana; Sun, Fangxian; Yu, Qunyan; Brittain, Scott; Arlt, Heike; He, Timothy; Zhang, Bailin; Wiederschain, Dmitri; Bertrand, Thomas; Houtmann, Jacques; Rak, Alexey; Vallee, Francois; Michot, Nadine; Auge, Franck; Menet, Veronique; Bergis, Olivier E.; George, Pascal; Avenet, Patrick; Mikol, Vincent; Didier, Michel; Escoubet, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7642</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) represents a primary degrdn. enzyme of the endogenous cannabinoid (eCB), 2-arachidonoyglycerol (2-AG).  This study reports a potent covalent MAGL inhibitor, SAR127303.  The compd. behaves as a selective and competitive inhibitor of mouse and human MAGL, which potently elevates hippocampal levels of 2-AG in mice.  In vivo, SAR127303 produces antinociceptive effects in assays of inflammatory and visceral pain.  In addn., the drug alters learning performance in several assays related to episodic, working and spatial memory.  Moreover, long term potentiation (LTP) of CA1 synaptic transmission and acetylcholine release in the hippocampus, two hallmarks of memory function, are both decreased by SAR127303.  Although inactive in acute seizure tests, repeated administration of SAR127303 delays the acquisition and decreases kindled seizures in mice, indicating that the drug slows down epileptogenesis, a finding deserving further investigation to evaluate the potential of MAGL inhibitors as antiepileptics.  However, the observation that 2-AG hydrolysis blockade alters learning and memory performance, suggests that such drugs may have limited value as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiPpgk18M26bVg90H21EOLACvtfcHk0lhDwERc6muCiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL&md5=4160ed016b730ea80abb5c093e66a284</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1038%2Fsrep07642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07642%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBeesk%25C3%25A9%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DT.%26aulast%3DRedon%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DA.%26aulast%3DFran%25C3%25A7on%26aufirst%3DD.%26aulast%3DBert%26aufirst%3DL.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DLopez-Grancha%26aufirst%3DM.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBrittain%26aufirst%3DS.%26aulast%3DArlt%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DAug%25C3%25A9%26aufirst%3DF.%26aulast%3DMenet%26aufirst%3DV.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DDidier%26aufirst%3DM.%26aulast%3DEscoubet%26aufirst%3DJ.%26atitle%3DSelective%2520blockade%2520of%2520the%2520hydrolysis%2520of%2520the%2520endocannabinoid%25202-arachidonoylglycerol%2520impairs%2520learning%2520and%2520memory%2520performance%2520while%2520producing%2520antinociceptive%2520activity%2520in%2520rodents%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D7642%26doi%3D10.1038%2Fsrep07642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Placzek, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Bittner, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooker, J. M.</span><span> </span><span class="NLM_article-title">A Novel Radiotracer for imaging monoacylglycerol lipase in the brain using positron emission tomography</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=484-489&author=C.+Wangauthor=M.+S.+Placzekauthor=G.+C.+Van+de+Bittnerauthor=F.+A.+Schroederauthor=J.+M.+Hooker&title=A+Novel+Radiotracer+for+imaging+monoacylglycerol+lipase+in+the+brain+using+positron+emission+tomography&doi=10.1021%2Facschemneuro.5b00293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography</span></div><div class="casAuthors">Wang, Changning; Placzek, Michael S.; Van de Bittner, Genevieve C.; Schroeder, Frederick A.; Hooker, Jacob M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">484-489</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a serine hydrolase that hydrolyzes monoacylglycerols to glycerol and fatty acid and plays an important role in neuroinflammation.  MAGL inhibitors are a class of mols. with therapeutic potential for human diseases of the central nervous system (CNS), in areas such as pain and inflammation, immunol. disorders, and neurol. and psychiatric conditions.  Development of a noninvasive imaging probe would elucidate the distribution and functional roles of MAGL in the brain and accelerate medical research and drug discovery in this domain.  Herein, we describe the synthesis and pilot rodent imaging of a novel MAGL imaging agent, [11C]SAR127303.  Our imaging results demonstrate the high specificity, good selectivity, and appropriate kinetics and distribution of [11C]SAR127303, validating its utility for imaging MAGL in the brain.  Our findings support the translational potential for human CNS MAGL imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwFMlYYqhfbVg90H21EOLACvtfcHk0lgdvEb-rDDtNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP&md5=0cc854816045539b5ccb7b5d7819372b</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00293%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPlaczek%26aufirst%3DM.%2BS.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Novel%2520Radiotracer%2520for%2520imaging%2520monoacylglycerol%2520lipase%2520in%2520the%2520brain%2520using%2520positron%2520emission%2520tomography%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D484%26epage%3D489%26doi%3D10.1021%2Facschemneuro.5b00293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Lookene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skottova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivecrona, G.</span><span> </span><span class="NLM_article-title">Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat) R</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1994.tb18878.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1432-1033.1994.tb18878.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=8020477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=1994&pages=395-403&author=A.+Lookeneauthor=N.+Skottovaauthor=G.+Olivecrona&title=Interactions+of+lipoprotein+lipase+with+the+active-site+inhibitor+tetrahydrolipstatin+%28Orlistat%29+R&doi=10.1111%2Fj.1432-1033.1994.tb18878.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat)</span></div><div class="casAuthors">Lookene, Aivar; Skottova, Nina; Olivecrona, Gunilla</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Lipoprotein lipase (LPL) was rapidly inactivated by low concns. of the active-site inhibitor tetrahydrolipstatin (THL).  The presence of amphiphiles (e.g. long-chain fatty acids) or of lipid/water interfaces (lipid emulsions) was required for inhibition to occur.  Apolipoprotein CII increased the maximal inactivation rate const. by 1.8-fold in the presence of an emulsion of long-chain triacylglycerols, but had no effect in the presence of an emulsion of tributyrylglycerol.  The fully inhibited enzyme had a ratio of THL/LPL of nearly 2, indicating that both subunits of the LPL homo-dimer bound THL.  The THL-LPL complex was stable below pH 7.5.  At higher pH reactivation occurred indicating that THL was slowly turned over by the enzyme.  The apparent reactivation rate const. was increased about threefold by the presence of lipid/water interfaces.  Sucrose d. gradient centrifugation revealed that THL induces tetramerization or LPL.  This aggregation was reversible on reactivation of the inhibited enzyme.  Binding to heparin was not affected by THL.  In contrast, binding to lipid droplets and to lipoproteins was increased, indicating exposure to hydrophobic regions in the inhibited LPL.  It is suggested that THL induces local conformational changes in LPL, which may involve opening of the putative surface lid structure which covers the active-site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGnHKzl9eR57Vg90H21EOLACvtfcHk0lgdvEb-rDDtNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOjsrk%253D&md5=9e21f57df02ccfa116fdeec6a897fe43</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1994.tb18878.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1994.tb18878.x%26sid%3Dliteratum%253Aachs%26aulast%3DLookene%26aufirst%3DA.%26aulast%3DSkottova%26aufirst%3DN.%26aulast%3DOlivecrona%26aufirst%3DG.%26atitle%3DInteractions%2520of%2520lipoprotein%2520lipase%2520with%2520the%2520active-site%2520inhibitor%2520tetrahydrolipstatin%2520%2528Orlistat%2529%2520R%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1994%26volume%3D222%26spage%3D395%26epage%3D403%26doi%3D10.1111%2Fj.1432-1033.1994.tb18878.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matias, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiano-Moriello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, P.</span><span> </span><span class="NLM_article-title">Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1083/jcb.200305129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1083%2Fjcb.200305129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=14610053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2003&pages=463-468&author=T.+Bisognoauthor=F.+Howellauthor=G.+Williamsauthor=A.+Minassiauthor=M.+G.+Cascioauthor=A.+Ligrestiauthor=I.+Matiasauthor=A.+Schiano-Morielloauthor=P.+Paulauthor=E.+J.+Williamsauthor=U.+Gangadharanauthor=C.+Hobbsauthor=V.+Di+Marzoauthor=P.+Doherty&title=Cloning+of+the+first+sn1-DAG+lipases+points+to+the+spatial+and+temporal+regulation+of+endocannabinoid+signaling+in+the+brain&doi=10.1083%2Fjcb.200305129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain</span></div><div class="casAuthors">Bisogno, Tiziana; Howell, Fiona; Williams, Gareth; Minassi, Alberto; Grazia Cascio, Maria; Ligresti, Alessia; Matias, Isabel; Schiano-Moriello, Aniello; Paul, Praveen; Williams, Emma-Jane; Gangadharan, Uma; Hobbs, Carl; Di Marzo, Vincenzo; Doherty, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Diacylglycerol (DAG) lipase activity is required for axonal growth during development and for retrograde synaptic signaling at mature synapses.  This enzyme synthesizes the endocannabinoid 2-arachidonoyl-glycerol (2-AG), and the CB1 cannabinoid receptor is also required for the above responses.  We now report on the cloning and enzymic characterization of the first specific sn-1 DAG lipases.  Two closely related genes have been identified and their expression in cells correlated with 2-AG biosynthesis and release.  The expression of both enzymes changes from axonal tracts in the embryo to dendritic fields in the adult, and this correlates with the developmental change in requirement for 2-AG synthesis from the pre- to the postsynaptic compartment.  This switch provides a possible explanation for a fundamental change in endocannabinoid function during brain development.  Identification of these enzymes may offer new therapeutic opportunities for a wide range of disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolsTG3YamCQ7Vg90H21EOLACvtfcHk0lgdvEb-rDDtNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCnur8%253D&md5=37bfbb4e29da593151e155d4c9d22cfa</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200305129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200305129%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DHowell%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMatias%26aufirst%3DI.%26aulast%3DSchiano-Moriello%26aufirst%3DA.%26aulast%3DPaul%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DGangadharan%26aufirst%3DU.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDoherty%26aufirst%3DP.%26atitle%3DCloning%2520of%2520the%2520first%2520sn1-DAG%2520lipases%2520points%2520to%2520the%2520spatial%2520and%2520temporal%2520regulation%2520of%2520endocannabinoid%2520signaling%2520in%2520the%2520brain%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D163%26spage%3D463%26epage%3D468%26doi%3D10.1083%2Fjcb.200305129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6970</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span><span class="refDoi"> DOI: 10.1021/jm800978m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800978m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6970-6979&author=G.+Ortarauthor=T.+Bisognoauthor=A.+Ligrestiauthor=E.+Moreraauthor=M.+Nalliauthor=V.+Di+Marzo&title=Tetrahydrolipstatin+analogues+as+modulators+of+endocannabinoid+2-arachidonoylglycerol+metabolism&doi=10.1021%2Fjm800978m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fjm800978m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800978m%26sid%3Dliteratum%253Aachs%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DNalli%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DTetrahydrolipstatin%2520analogues%2520as%2520modulators%2520of%2520endocannabinoid%25202-arachidonoylglycerol%2520metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6970%26epage%3D6979%26doi%3D10.1021%2Fjm800978m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Endocannabinoid Research Group. Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity <i>in vivo</i></span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1791</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2008.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2008.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19027877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFagu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1791&publication_year=2009&pages=53-60&author=T.+Bisognoauthor=G.+Ortarauthor=S.+Petrosinoauthor=E.+Moreraauthor=E.+Palazzoauthor=M.+Nalliauthor=S.+Maioneauthor=V.+Di+Marzo&title=Endocannabinoid+Research+Group.+Development+of+a+potent+inhibitor+of+2-arachidonoylglycerol+hydrolysis+with+antinociceptive+activity+in+vivo&doi=10.1016%2Fj.bbalip.2008.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo</span></div><div class="casAuthors">Bisogno, Tiziana; Ortar, Giorgio; Petrosino, Stefania; Morera, Enrico; Palazzo, Enza; Nalli, Marianna; Maione, Sabatino; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1791</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Although inhibitors of the enzymic hydrolysis of the endocannabinoid 2-arachidonoylglycerol are available, they are either rather weak in vitro (IC50 > 30 μM) or their selectivity towards other proteins of the endocannabinoid system has not been tested.  Here we describe the synthesis and activity in vitro and in vivo of a tetrahydrolipstatin analog, OMDM169, as a potent inhibitor of 2-AG hydrolysis, capable of enhancing 2-AG levels and of exerting analgesic activity via indirect activation of cannabinoid receptors.  OMDM169 exhibited 0.13 μM < IC50 < 0.41 μM towards 2-AG hydrolyzing activities in COS-7 cells and rat cerebellum, and inhibited (IC50 = 0.89 μM) the human recombinant MAGL, while being inactive (Ki > 10 μM) at human CB1 and CB2 receptors.  However, OMDM169 shared with tetrahydrolipstatin the capability of inhibiting the human pancreatic lipase (IC50 = 0.6 μM).  OMDM169 inhibited fatty acid amide hydrolase and diacylglycerol lipase only at higher concns. (IC50 = 3.0 and 2.8 μM, resp.), and, accordingly, it increased by ∼ 1.6-fold the levels of 2-AG, but not anandamide, in intact ionomycin-stimulated N18TG2 neuroblastoma cells.  Acute i.p. administration of OMDM169 to mice inhibited the second phase of the formalin-induced nocifensive response with an IC50 of ∼ 2.5 mg/kg, and concomitantly elevated 2-AG, but not anandamide, levels in the ipsilateral paw of formalin-treated mice.  The antinociceptive effect of OMDM169 was antagonized by antagonists of CB1 and CB2 receptors, AM251 and AM630, resp. (1 mg/kg, i.p.).  OMDM69 might represent a template for the development of selective and even more potent inhibitors of 2-AG hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEpfVvAlBHLVg90H21EOLACvtfcHk0lghicbs_yVRkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFagu7jJ&md5=d5f2449b130900072128e7048cd3f29a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DPalazzo%26aufirst%3DE.%26aulast%3DNalli%26aufirst%3DM.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoid%2520Research%2520Group.%2520Development%2520of%2520a%2520potent%2520inhibitor%2520of%25202-arachidonoylglycerol%2520hydrolysis%2520with%2520antinociceptive%2520activity%2520in%2520vivo%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2009%26volume%3D1791%26spage%3D53%26epage%3D60%26doi%3D10.1016%2Fj.bbalip.2008.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Kapanda, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draoui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span> </span><span class="NLM_article-title">Search for monoglyceride lipase inhibitors: synthesis and screening of arylthioamides derivatives</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1007/s00044-008-9123-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1007%2Fs00044-008-9123-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltV2muro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=243-254&author=C.+N.+Kapandaauthor=G.+G.+Muccioliauthor=G.+Labarauthor=N.+Draouiauthor=D.+M.+Lambertauthor=J.+H.+Poupaert&title=Search+for+monoglyceride+lipase+inhibitors%3A+synthesis+and+screening+of+arylthioamides+derivatives&doi=10.1007%2Fs00044-008-9123-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Search for monoglyceride lipase inhibitors: synthesis and screening of arylthioamides derivatives</span></div><div class="casAuthors">Kapanda, Coco N.; Muccioli, Giulio G.; Labar, Geoffray; Draoui, Nihed; Lambert, Didier M.; Poupaert, Jacques H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">243-254</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) is the enzyme responsible for the termination of 2-arachidonoylglycerol (2-AG) signaling, an endogenous ligand for the G-protein coupled cannabinoid receptors CB1 and CB2.  Its known abundance and physiol. roles emphasize the interest of MGL as an attractive therapeutic target.  Search for MGL inhibitors was undertaken by screening an arylthioamide series.  The evaluation of arylthioamides derivs. activity as MGL inhibitors measured by the hydrolysis of [3H]-2-oleoylglycerol by human purified MGL led to the identification of (2-chloro-phenyl)-morpholin-4-yl-methanethione (2) and (3-nitro-phenyl) morpholin-4-yl-methanethione (12), which moreover exhibit good selectivity compared with human fatty acid amide hydrolase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSAT3V4kP9tbVg90H21EOLACvtfcHk0lghicbs_yVRkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltV2muro%253D&md5=22ecb52ac015379fcf8939d3e260e58a</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1007%2Fs00044-008-9123-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-008-9123-2%26sid%3Dliteratum%253Aachs%26aulast%3DKapanda%26aufirst%3DC.%2BN.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DDraoui%26aufirst%3DN.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26atitle%3DSearch%2520for%2520monoglyceride%2520lipase%2520inhibitors%253A%2520synthesis%2520and%2520screening%2520of%2520arylthioamides%2520derivatives%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2009%26volume%3D18%26spage%3D243%26epage%3D254%26doi%3D10.1007%2Fs00044-008-9123-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Kapanda, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masquelier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5774</span><span class="NLM_x">–</span> <span class="NLM_lpage">5783</span><span class="refDoi"> DOI: 10.1021/jm3006004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3006004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5774-5783&author=C.+N.+Kapandaauthor=J.+Masquelierauthor=G.+Labarauthor=G.+G.+Muccioliauthor=J.+H.+Poupaertauthor=D.+M.+Lambert&title=Synthesis+and+pharmacological+evaluation+of+2%2C4-dinitroaryldithiocarbamate+derivatives+as+novel+monoacylglycerol+lipase+inhibitors&doi=10.1021%2Fjm3006004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Evaluation of 2,4-Dinitroaryldithiocarbamate Derivatives as Novel Monoacylglycerol Lipase Inhibitors</span></div><div class="casAuthors">Kapanda, Coco N.; Masquelier, Julien; Labar, Geoffray; Muccioli, Giulio G.; Poupaert, Jacques H.; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5774-5783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is responsible for signal termination of 2-arachidonoylglycerol (2-AG), an endocannabinoid neurotransmitter endowed with several physiol. effects.  Previously, we showed that the arylthioamide scaffold represents a privileged template for designing MAGL inhibitors.  A series of 37 compds. resulting from pharmacomodulations around the arylthioamide template were synthesized and tested to evaluate their inhibitory potential on MAGL activity as well as their selectivity over fatty acid amide hydrolase (FAAH), another endocannabinoid-hydrolyzing enzyme.  We have identified 2,4-dinitroaryldithiocarbamate derivs. as a novel class of MAGL inhibitors.  Among the synthesized compds., we identified [2,4-dinitrophenyl-4-(4-tert-butylbenzyl)piperazine-1-carbodithioate] (CK37, I), as the most potent MAGL inhibitor within this series (IC50 = 154 nM).  We have also identified [2,4-dinitrophenyl-4-benzhydrylpiperazine-1-carbodithioate] (CK16 ,II) as a selective MAGL inhibitor.  These compds. are irreversible MAGL inhibitors that probably act by interacting with Cys208 or Cys242 and Ser122 residues of the enzyme.  Moreover, CK37 is able to raise 2-arachidonoylglycerol (2-AG) levels in intact cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaH_AWaHlO_7Vg90H21EOLACvtfcHk0lghicbs_yVRkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGrtb8%253D&md5=a729b3a8da7bbdfaf9f52ece8dae3c0c</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Fjm3006004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3006004%26sid%3Dliteratum%253Aachs%26aulast%3DKapanda%26aufirst%3DC.%2BN.%26aulast%3DMasquelier%26aufirst%3DJ.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%25202%252C4-dinitroaryldithiocarbamate%2520derivatives%2520as%2520novel%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5774%26epage%3D5783%26doi%3D10.1021%2Fjm3006004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2704</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span><span class="refDoi"> DOI: 10.1002/cbic.200800428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbic.200800428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18855964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2704-2710&author=G.+G.+Muccioliauthor=G.+Labarauthor=D.+M.+Lambert&title=CAY10499%2C+a+novel+monoglyceride+lipase+inhibitor+evidenced+by+an+expeditious+MGL+assay&doi=10.1002%2Fcbic.200800428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay</span></div><div class="casAuthors">Muccioli, Giulio G.; Labar, Geoffray; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2704-2710</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) plays a major role in the metab. of the lipid transmitter 2-arachidonoylglycerol (2-AG).  This endocannabinoid is known to mediate a large no. of physiol. processes, and its regulation is thought to be of great therapeutic potential.  However, the no. of available monoglyceride lipase inhibitors is limited, mostly due to the lack of rapid and accurate pharmacol. assays for the enzyme.  We have developed a 96-well-format assay for MGL using a nonradiolabeled substrate, 4-nitrophenylacetate.  The IC50 values that were obtained for known inhibitors of MGL using 4-nitrophenylacetate were similar to those reported by using the radiolabeled form of an endogenous substrate, 2-oleoylglycerol.  In a first small-scale screening, we identified CAY10499 as a novel monoglyceride lipase inhibitor.  Thus, we report the characterization of this submicromolar inhibitor, which acts on MGL through an unprecedented mechanism for inhibitors of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-uhUXVmPgPLVg90H21EOLACvtfcHk0lhDoUj3Ec1LxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjsbfL&md5=49f6ccccc96d3f76903fe8f897c9b3e9</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800428%26sid%3Dliteratum%253Aachs%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DCAY10499%252C%2520a%2520novel%2520monoglyceride%2520lipase%2520inhibitor%2520evidenced%2520by%2520an%2520expeditious%2520MGL%2520assay%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2704%26epage%3D2710%26doi%3D10.1002%2Fcbic.200800428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Feledziak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand-Brynaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span> </span><span class="NLM_article-title">Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid’s activity by preventing their hydrolysis</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.2174/157488912798842223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.2174%2F157488912798842223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=49-70&author=M.+Feledziakauthor=D.+M.+Lambertauthor=J.+Marchand-Brynaertauthor=G.+G.+Muccioli&title=Inhibitors+of+the+endocannabinoid-degrading+enzymes%2C+or+how+to+increase+endocannabinoid%E2%80%99s+activity+by+preventing+their+hydrolysis&doi=10.2174%2F157488912798842223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.2174%2F157488912798842223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488912798842223%26sid%3Dliteratum%253Aachs%26aulast%3DFeledziak%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMarchand-Brynaert%26aufirst%3DJ.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DInhibitors%2520of%2520the%2520endocannabinoid-degrading%2520enzymes%252C%2520or%2520how%2520to%2520increase%2520endocannabinoid%25E2%2580%2599s%2520activity%2520by%2520preventing%2520their%2520hydrolysis%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D49%26epage%3D70%26doi%3D10.2174%2F157488912798842223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span>Clinical information can be found at <a href="https://www.clinicaltrials.gov/" class="extLink">https://www.clinicaltrials.gov/</a>. JNJ-42165279, clinical identifiers NCT02432703, NCT02498392; PF-04457845, clinical identifiers NCT00981357, NCT02134080, NCT02216097, NCT01618656, NCT01665573; SSR411298, clinical identifiers NCT00822744, NCT01439919; V158866, clinical identifiers NCT01634529, NCT01748695. Clinical trial failure report of V158866 can be found at <a href="http://www.thepharmaletter.com/article/vernalis-s-v15886-fails-to-meet-primary-endpoint-and-seeks-partnering-on-further-development" class="extLink">http://www.thepharmaletter.com/article/vernalis-s-v15886-fails-to-meet-primary-endpoint-and-seeks-partnering-on-further-development</a>. The detailed report of ANSM can be found at <a href="http://www.thelancetnorway.com/pdfs/journals/lancet/PIIS0140-6736(16)30661-4.pdf" class="extLink">http://www.thelancetnorway.com/pdfs/journals/lancet/PIIS0140-6736(16)30661-4.pdf</a> and <a href="http://ansm.sante.fr/var/ansm_site/storage/original/application/744c7c6daf96b141bc9509e2f85c227e.pdf" class="extLink">http://ansm.sante.fr/var/ansm_site/storage/original/application/744c7c6daf96b141bc9509e2f85c227e.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+information+can+be+found+at+https%3A%2F%2Fwww.clinicaltrials.gov%2F.+JNJ-42165279%2C+clinical+identifiers+NCT02432703%2C+NCT02498392%3B+PF-04457845%2C+clinical+identifiers+NCT00981357%2C+NCT02134080%2C+NCT02216097%2C+NCT01618656%2C+NCT01665573%3B+SSR411298%2C+clinical+identifiers+NCT00822744%2C+NCT01439919%3B+V158866%2C+clinical+identifiers+NCT01634529%2C+NCT01748695.+Clinical+trial+failure+report+of+V158866+can+be+found+at+http%3A%2F%2Fwww.thepharmaletter.com%2Farticle%2Fvernalis-s-v15886-fails-to-meet-primary-endpoint-and-seeks-partnering-on-further-development.+The+detailed+report+of+ANSM+can+be+found+at+http%3A%2F%2Fwww.thelancetnorway.com%2Fpdfs%2Fjournals%2Flancet%2FPIIS0140-6736%2816%2930661-4.pdf+and+http%3A%2F%2Fansm.sante.fr%2Fvar%2Fansm_site%2Fstorage%2Foriginal%2Fapplication%2F744c7c6daf96b141bc9509e2f85c227e.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Pawsey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, S.</span><span> </span><span class="NLM_article-title">Safety, tolerability and pharmacokinetics of FAAH inhibitor V158866: a double-blind, randomised, placebo-controlled phase I study in healthy volunteers</span> <span class="citation_source-journal">Drugs R&D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1007/s40268-016-0127-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1007%2Fs40268-016-0127-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26987975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=181-191&author=S.+Pawseyauthor=M.+Woodauthor=H.+Browneauthor=K.+Donaldsonauthor=M.+Christieauthor=S.+Warrington&title=Safety%2C+tolerability+and+pharmacokinetics+of+FAAH+inhibitor+V158866%3A+a+double-blind%2C+randomised%2C+placebo-controlled+phase+I+study+in+healthy+volunteers&doi=10.1007%2Fs40268-016-0127-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1007%2Fs40268-016-0127-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-016-0127-y%26sid%3Dliteratum%253Aachs%26aulast%3DPawsey%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DDonaldson%26aufirst%3DK.%26aulast%3DChristie%26aufirst%3DM.%26aulast%3DWarrington%26aufirst%3DS.%26atitle%3DSafety%252C%2520tolerability%2520and%2520pharmacokinetics%2520of%2520FAAH%2520inhibitor%2520V158866%253A%2520a%2520double-blind%252C%2520randomised%252C%2520placebo-controlled%2520phase%2520I%2520study%2520in%2520healthy%2520volunteers%26jtitle%3DDrugs%2520R%2526D%26date%3D2016%26volume%3D16%26spage%3D181%26epage%3D191%26doi%3D10.1007%2Fs40268-016-0127-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44','cit44b'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 59 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Michael S. Malamas, Spiro Pavlopoulos, Shakiru O. Alapafuja, Shrouq I. Farah, Alexander Zvonok, Khadijah A. Mohammad, Jay West, Nicholas Thomas Perry, Dimitrios N. Pelekoudas, Girija Rajarshi, Christina Shields, Honrao Chandrashekhar, Jodi Wood, <span class="NLM_string-name hlFld-ContribAuthor">Alexandros Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5956-5972. <a href="https://doi.org/10.1021/acs.jmedchem.1c00076" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00076%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BIsothiocyanates%252Bas%252BPotent%252Band%252BSelective%252BN-Acylethanolamine-Hydrolyzing%252BAcid%252BAmidase%252BInhibitors%26aulast%3DMalamas%26aufirst%3DMichael%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D26042021%26volume%3D64%26issue%3D9%26spage%3D5956%26epage%3D5972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lu Hou, Jian Rong, Ahmed Haider, Daisuke Ogasawara, Cassis Varlow, Michael A. Schafroth, Linjing Mu, Jiefeng Gan, Hao Xu, Christopher J. Fowler, Ming-Rong Zhang, Neil Vasdev, Simon Ametamey, Benjamin F. Cravatt, Lu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 123-149. <a href="https://doi.org/10.1021/acs.jmedchem.0c01459" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositron%252BEmission%252BTomography%252BImaging%252Bof%252Bthe%252BEndocannabinoid%252BSystem%25253A%252BOpportunities%252Band%252BChallenges%252Bin%252BRadiotracer%252BDevelopment%26aulast%3DHou%26aufirst%3DLu%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D21082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D123%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laura Scalvini, Andrea Ghidini, Alessio Lodola, Donatella Callegari, Silvia Rivara, Daniele Piomelli, <span class="NLM_string-name hlFld-ContribAuthor">Marco Mor</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (20)
                                     , 11797-11813. <a href="https://doi.org/10.1021/acscatal.0c02903" title="DOI URL">https://doi.org/10.1021/acscatal.0c02903</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c02903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c02903%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DN-Acylethanolamine%252BAcid%252BAmidase%252B%252528NAAA%252529%25253A%252BMechanism%252Bof%252BPalmitoylethanolamide%252BHydrolysis%252BRevealed%252Bby%252BMechanistic%252BSimulations%26aulast%3DScalvini%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03072020%26date%3D10092020%26date%3D28092020%26date%3D15092020%26volume%3D10%26issue%3D20%26spage%3D11797%26epage%3D11813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniele Piomelli, Laura Scalvini, Yannick Fotio, Alessio Lodola, Gilberto Spadoni, Giorgio Tarzia, <span class="NLM_string-name hlFld-ContribAuthor">Marco Mor</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7475-7490. <a href="https://doi.org/10.1021/acs.jmedchem.0c00191" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00191%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-Acylethanolamine%252BAcid%252BAmidase%252B%252528NAAA%252529%25253A%252BStructure%25252C%252BFunction%25252C%252Band%252BInhibition%26aulast%3DPiomelli%26aufirst%3DDaniele%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03022020%26date%3D26032020%26date%3D19032020%26volume%3D63%26issue%3D14%26spage%3D7475%26epage%3D7490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiangge Tian, Tao Liu, Lu Li, Bo Shao, Dahong Yao, Lei Feng, Jingnan Cui, Tony D. James, <span class="NLM_string-name hlFld-ContribAuthor">Xiaochi Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Visual High-Throughput Screening for Developing a Fatty Acid Amide Hydrolase Natural Inhibitor Based on an Enzyme-Activated Fluorescent Probe. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2020,</strong> <em>92 </em>
                                    (14)
                                     , 9493-9500. <a href="https://doi.org/10.1021/acs.analchem.9b05826" title="DOI URL">https://doi.org/10.1021/acs.analchem.9b05826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.9b05826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.9b05826%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DVisual%252BHigh-Throughput%252BScreening%252Bfor%252BDeveloping%252Ba%252BFatty%252BAcid%252BAmide%252BHydrolase%252BNatural%252BInhibitor%252BBased%252Bon%252Ban%252BEnzyme-Activated%252BFluorescent%252BProbe%26aulast%3DTian%26aufirst%3DXiangge%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D27052020%26date%3D10062020%26date%3D27052020%26volume%3D92%26issue%3D14%26spage%3D9493%26epage%3D9500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhuoer Zhi, Wenting Zhang, Jingchun Yao, Yanguo Shang, Qingjing Hao, Zhong Liu, Yushan Ren, Jie Li, Guimin Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jinxin Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Aryl Formyl Piperidine Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5783-5796. <a href="https://doi.org/10.1021/acs.jmedchem.9b02137" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02137%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAryl%252BFormyl%252BPiperidine%252BDerivatives%252Bas%252BPotent%25252C%252BReversible%25252C%252Band%252BSelective%252BMonoacylglycerol%252BLipase%252BInhibitors%26aulast%3DZhi%26aufirst%3DZhuoer%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D21122019%26date%3D29052020%26date%3D20052020%26volume%3D63%26issue%3D11%26spage%3D5783%26epage%3D5796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, Giulia Bononi, Cristina Licari, Giulio Poli, Maguie el Boustani, Isabella Caligiuri, Flavio Rizzolio, Jürg Gertsch, Marco Macchia, Filippo Minutolo, Tiziano Tuccinardi, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Chicca</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1932-1958. <a href="https://doi.org/10.1021/acs.jmedchem.8b01483" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01483%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Ba%252BBenzoylpiperidine%252BClass%252BIdentifies%252Ba%252BHighly%252BPotent%252Band%252BSelective%252BReversible%252BMonoacylglycerol%252BLipase%252B%252528MAGL%252529%252BInhibitor%26aulast%3DGranchi%26aufirst%3DCarlotta%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D24092018%26date%3D11022019%26date%3D04022019%26volume%3D62%26issue%3D4%26spage%3D1932%26epage%3D1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Justin S. Cisar, Olivia D. Weber, Jason R. Clapper, Jacqueline L. Blankman, Cassandra L. Henry, Gabriel M. Simon, Jessica P. Alexander, Todd K. Jones, R. Alan B. Ezekowitz, Gary P. O’Neill, <span class="NLM_string-name hlFld-ContribAuthor">Cheryl A. Grice</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9062-9084. <a href="https://doi.org/10.1021/acs.jmedchem.8b00951" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00951%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BABX-1431%25252C%252Ba%252BSelective%252BInhibitor%252Bof%252BMonoacylglycerol%252BLipase%252Band%252BClinical%252BCandidate%252Bfor%252BTreatment%252Bof%252BNeurological%252BDisorders%26aulast%3DCisar%26aufirst%3DJustin%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D14062018%26date%3D23082018%26date%3D01082018%26volume%3D61%26issue%3D20%26spage%3D9062%26epage%3D9084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ran Cheng, Wakana Mori, Longle Ma, Mireille Alhouayek, Akiko Hatori, Yiding Zhang, Daisuke Ogasawara, Gengyang Yuan, Zhen Chen, Xiaofei Zhang, Hang Shi, Tomoteru Yamasaki, Lin Xie, Katsushi Kumata, Masayuki Fujinaga, Yuji Nagai, Takafumi Minamimoto, Mona Svensson, Lu Wang, Yunfei Du, Mary Jo Ondrechen, Neil Vasdev, Benjamin F. Cravatt, Christopher Fowler, Ming-Rong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and in Vivo Evaluation of 11C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2278-2291. <a href="https://doi.org/10.1021/acs.jmedchem.7b01400" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01400%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252B11C-Labeled%252BAzetidinecarboxylates%252Bfor%252BImaging%252BMonoacylglycerol%252BLipase%252Bby%252BPET%252BImaging%252BStudies%26aulast%3DCheng%26aufirst%3DRan%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21092017%26date%3D09032018%26date%3D26022018%26volume%3D61%26issue%3D6%26spage%3D2278%26epage%3D2291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Qinyue  Guo</span>, <span class="hlFld-ContribAuthor ">Kang  Huo</span>, <span class="hlFld-ContribAuthor ">Yinxue  Song</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Junkai  Du</span>. </span><span class="cited-content_cbyCitation_article-title">JZL184 protects hippocampal neurons from oxygen-glucose deprivation-induced injury via activating Nrf2/ARE signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Human & Experimental Toxicology</span><span> <strong>2021,</strong> <em>40 </em>
                                    (7)
                                     , 1084-1094. <a href="https://doi.org/10.1177/0960327120984220" title="DOI URL">https://doi.org/10.1177/0960327120984220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0960327120984220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0960327120984220%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520%2526%2520Experimental%2520Toxicology%26atitle%3DJZL184%252Bprotects%252Bhippocampal%252Bneurons%252Bfrom%252Boxygen-glucose%252Bdeprivation-induced%252Binjury%252Bvia%252Bactivating%252BNrf2%25252FARE%252Bsignaling%252Bpathway%26aulast%3DXu%26aufirst%3DJing%26date%3D2021%26date%3D2020%26volume%3D40%26issue%3D7%26spage%3D1084%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. J.  Fowler</span>. </span><span class="cited-content_cbyCitation_article-title">The endocannabinoid system – current implications for drug development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Internal Medicine</span><span> <strong>2021,</strong> <em>290 </em>
                                    (1)
                                     , 2-26. <a href="https://doi.org/10.1111/joim.13229" title="DOI URL">https://doi.org/10.1111/joim.13229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/joim.13229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjoim.13229%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Internal%2520Medicine%26atitle%3DThe%252Bendocannabinoid%252Bsystem%252B%2525E2%252580%252593%252Bcurrent%252Bimplications%252Bfor%252Bdrug%252Bdevelopment%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26date%3D2021%26date%3D2021%26volume%3D290%26issue%3D1%26spage%3D2%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Grabrijan</span>, <span class="hlFld-ContribAuthor ">Nika  Strašek</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">Monocyclic beta–lactams for therapeutic uses: a patent overview (2010–2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (3)
                                     , 247-266. <a href="https://doi.org/10.1080/13543776.2021.1865919" title="DOI URL">https://doi.org/10.1080/13543776.2021.1865919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1865919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1865919%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMonocyclic%252Bbeta%2525E2%252580%252593lactams%252Bfor%252Btherapeutic%252Buses%25253A%252Ba%252Bpatent%252Boverview%252B%2525282010%2525E2%252580%2525932020%252529%26aulast%3DGrabrijan%26aufirst%3DKatarina%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D3%26spage%3D247%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yitian  Li</span>, <span class="hlFld-ContribAuthor ">Sichen  Zhao</span>, <span class="hlFld-ContribAuthor ">Sennan  Xu</span>, <span class="hlFld-ContribAuthor ">Yuhang  Li</span>, <span class="hlFld-ContribAuthor ">Chaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Fei  Li</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Hu</span>, <span class="hlFld-ContribAuthor ">Kuantian  Lin</span>, <span class="hlFld-ContribAuthor ">Yan  Qiu</span>, <span class="hlFld-ContribAuthor ">Yanghui  Xiu</span>. </span><span class="cited-content_cbyCitation_article-title">Palmitoylethanolamide (PEA) reduces postoperative adhesions after experimental strabismus surgery in rabbits by suppressing canonical and non-canonical TGFβ signaling through PPARα. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>184 </em>, 114398. <a href="https://doi.org/10.1016/j.bcp.2020.114398" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114398%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DPalmitoylethanolamide%252B%252528PEA%252529%252Breduces%252Bpostoperative%252Badhesions%252Bafter%252Bexperimental%252Bstrabismus%252Bsurgery%252Bin%252Brabbits%252Bby%252Bsuppressing%252Bcanonical%252Band%252Bnon-canonical%252BTGF%2525CE%2525B2%252Bsignaling%252Bthrough%252BPPAR%2525CE%2525B1%26aulast%3DLi%26aufirst%3DYitian%26date%3D2021%26volume%3D184%26spage%3D114398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergiy  Tyukhtenko</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Ma</span>, <span class="hlFld-ContribAuthor ">Girija  Rajarshi</span>, <span class="hlFld-ContribAuthor ">Ioannis  Karageorgos</span>, <span class="hlFld-ContribAuthor ">Kyle W.  Anderson</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Hudgens</span>, <span class="hlFld-ContribAuthor ">Jason J.  Guo</span>, <span class="hlFld-ContribAuthor ">Mahmoud L.  Nasr</span>, <span class="hlFld-ContribAuthor ">Nikolai  Zvonok</span>, <span class="hlFld-ContribAuthor ">Kiran  Vemuri</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wagner</span>, <span class="hlFld-ContribAuthor ">Alexandros  Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational gating, dynamics and allostery in human monoacylglycerol lipase. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-75497-5" title="DOI URL">https://doi.org/10.1038/s41598-020-75497-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-75497-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-75497-5%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DConformational%252Bgating%25252C%252Bdynamics%252Band%252Ballostery%252Bin%252Bhuman%252Bmonoacylglycerol%252Blipase%26aulast%3DTyukhtenko%26aufirst%3DSergiy%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessia  D’Aloia</span>, <span class="hlFld-ContribAuthor ">Federica  Arrigoni</span>, <span class="hlFld-ContribAuthor ">Renata  Tisi</span>, <span class="hlFld-ContribAuthor ">Alessandro  Palmioli</span>, <span class="hlFld-ContribAuthor ">Michela  Ceriani</span>, <span class="hlFld-ContribAuthor ">Valentina  Artusa</span>, <span class="hlFld-ContribAuthor ">Cristina  Airoldi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Zampella</span>, <span class="hlFld-ContribAuthor ">Barbara  Costa</span>, <span class="hlFld-ContribAuthor ">Laura  Cipolla</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9074. <a href="https://doi.org/10.3390/ijms21239074" title="DOI URL">https://doi.org/10.3390/ijms21239074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239074%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%25252C%252BMolecular%252BModeling%252Band%252BBiological%252BEvaluation%252Bof%252BMetabolically%252BStable%252BAnalogues%252Bof%252Bthe%252BEndogenous%252BFatty%252BAcid%252BAmide%252BPalmitoylethanolamide%26aulast%3DD%25E2%2580%2599Aloia%26aufirst%3DAlessia%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longhe  Yang</span>, <span class="hlFld-ContribAuthor ">Chunyan  Ji</span>, <span class="hlFld-ContribAuthor ">Yitian  Li</span>, <span class="hlFld-ContribAuthor ">Fan  Hu</span>, <span class="hlFld-ContribAuthor ">Fang  Zhang</span>, <span class="hlFld-ContribAuthor ">Haiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Zhaokai  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.577319" title="DOI URL">https://doi.org/10.3389/fphar.2020.577319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.577319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.577319%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DNatural%252BPotent%252BNAAA%252BInhibitor%252BAtractylodin%252BCounteracts%252BLPS-Induced%252BMicroglial%252BActivation%26aulast%3DYang%26aufirst%3DLonghe%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Zhu</span>, <span class="hlFld-ContribAuthor ">Peter J.  Connolly</span>, <span class="hlFld-ContribAuthor ">Yue-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Mark E.  McDonnell</span>, <span class="hlFld-ContribAuthor ">Haiyan  Bian</span>, <span class="hlFld-ContribAuthor ">Shu-Chen  Lin</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Sui-Po  Zhang</span>, <span class="hlFld-ContribAuthor ">Kristen M.  Chevalier</span>, <span class="hlFld-ContribAuthor ">Michael R.  Brandt</span>, <span class="hlFld-ContribAuthor ">Cynthia M.  Milligan</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Flores</span>, <span class="hlFld-ContribAuthor ">Mark J.  Macielag</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127243. <a href="https://doi.org/10.1016/j.bmcl.2020.127243" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127243%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bazetidine-piperazine%252Bdi-amides%252Bas%252Bpotent%25252C%252Bselective%252Band%252Breversible%252Bmonoacylglycerol%252Blipase%252B%252528MAGL%252529%252Binhibitors%26aulast%3DZhu%26aufirst%3DBin%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Zhu</span>, <span class="hlFld-ContribAuthor ">Peter J.  Connolly</span>, <span class="hlFld-ContribAuthor ">Sui-Po  Zhang</span>, <span class="hlFld-ContribAuthor ">Kristen M.  Chevalier</span>, <span class="hlFld-ContribAuthor ">Cynthia M.  Milligan</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Flores</span>, <span class="hlFld-ContribAuthor ">Mark J.  Macielag</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (12)
                                     , 127198. <a href="https://doi.org/10.1016/j.bmcl.2020.127198" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127198%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bdiazetidinyl%252Bdiamides%252Bas%252Bpotent%252Band%252Breversible%252Binhibitors%252Bof%252Bmonoacylglycerol%252Blipase%252B%252528MAGL%252529%26aulast%3DZhu%26aufirst%3DBin%26date%3D2020%26volume%3D30%26issue%3D12%26spage%3D127198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanguo  Shang</span>, <span class="hlFld-ContribAuthor ">Qingjing  Hao</span>, <span class="hlFld-ContribAuthor ">Kaixuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Mengting  He</span>, <span class="hlFld-ContribAuthor ">Jinxin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of heterocyclic carbohydrazide derivatives as novel selective fatty acid amide hydrolase inhibitors: design, synthesis and anti-neuroinflammatory evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (10)
                                     , 127118. <a href="https://doi.org/10.1016/j.bmcl.2020.127118" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127118%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bheterocyclic%252Bcarbohydrazide%252Bderivatives%252Bas%252Bnovel%252Bselective%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Binhibitors%25253A%252Bdesign%25252C%252Bsynthesis%252Band%252Banti-neuroinflammatory%252Bevaluation%26aulast%3DShang%26aufirst%3DYanguo%26date%3D2020%26volume%3D30%26issue%3D10%26spage%3D127118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hermann AM  Mucke</span>. </span><span class="cited-content_cbyCitation_article-title">Patent highlights December 2019–January 2020. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2020,</strong> <em>9 </em>
                                    (3)
                                     , 67-74. <a href="https://doi.org/10.4155/ppa-2020-0005" title="DOI URL">https://doi.org/10.4155/ppa-2020-0005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2020-0005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2020-0005%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DPatent%252Bhighlights%252BDecember%252B2019%2525E2%252580%252593January%252B2020%26aulast%3DMucke%26aufirst%3DHermann%2BAM%26date%3D2020%26volume%3D9%26issue%3D3%26spage%3D67%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan M.  Wyatt</span>, <span class="hlFld-ContribAuthor ">Ian  Fraser</span>, <span class="hlFld-ContribAuthor ">Natalie  Welty</span>, <span class="hlFld-ContribAuthor ">Brian  Lord</span>, <span class="hlFld-ContribAuthor ">Michelle  Wennerholm</span>, <span class="hlFld-ContribAuthor ">Steven  Sutton</span>, <span class="hlFld-ContribAuthor ">Michael K.  Ameriks</span>, <span class="hlFld-ContribAuthor ">Christine  Dugovic</span>, <span class="hlFld-ContribAuthor ">Sujin  Yun</span>, <span class="hlFld-ContribAuthor ">Allison  White</span>, <span class="hlFld-ContribAuthor ">Leslie  Nguyen</span>, <span class="hlFld-ContribAuthor ">Tatiana  Koudriakova</span>, <span class="hlFld-ContribAuthor ">Gaochao  Tian</span>, <span class="hlFld-ContribAuthor ">Javier  Suarez</span>, <span class="hlFld-ContribAuthor ">Lawrence  Szewczuk</span>, <span class="hlFld-ContribAuthor ">William  Bonnette</span>, <span class="hlFld-ContribAuthor ">Kay  Ahn</span>, <span class="hlFld-ContribAuthor ">Brahma  Ghosh</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Flores</span>, <span class="hlFld-ContribAuthor ">Peter J.  Connolly</span>, <span class="hlFld-ContribAuthor ">Bin  Zhu</span>, <span class="hlFld-ContribAuthor ">Mark J.  Macielag</span>, <span class="hlFld-ContribAuthor ">Michael R.  Brandt</span>, <span class="hlFld-ContribAuthor ">Kristen  Chevalier</span>, <span class="hlFld-ContribAuthor ">Sui-Po  Zhang</span>, <span class="hlFld-ContribAuthor ">Timothy  Lovenberg</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonaventure</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2020,</strong> <em>372 </em>
                                    (3)
                                     , 339-353. <a href="https://doi.org/10.1124/jpet.119.262139" title="DOI URL">https://doi.org/10.1124/jpet.119.262139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.262139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.262139%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DPharmacologic%252BCharacterization%252Bof%252BJNJ-42226314%25252C%252B%25255B1-%2525284-Fluorophenyl%252529indol-5-yl%25255D-%25255B3-%25255B4-%252528thiazole-2-carbonyl%252529piperazin-1-yl%25255Dazetidin-1-yl%25255Dmethanone%25252C%252Ba%252BReversible%25252C%252BSelective%25252C%252Band%252BPotent%252BMonoacylglycerol%252BLipase%252BInhibitor%26aulast%3DWyatt%26aufirst%3DRyan%2BM.%26date%3D2020%26date%3D2019%26volume%3D372%26issue%3D3%26spage%3D339%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natasha L.  Grimsey</span>, <span class="hlFld-ContribAuthor ">Juha R.  Savinainen</span>, <span class="hlFld-ContribAuthor ">Bala  Attili</span>, <span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>. </span><span class="cited-content_cbyCitation_article-title">Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 330-343. <a href="https://doi.org/10.1016/j.drudis.2019.10.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRegulating%252Bmembrane%252Blipid%252Blevels%252Bat%252Bthe%252Bsynapse%252Bby%252Bsmall-molecule%252Binhibitors%252Bof%252Bmonoacylglycerol%252Blipase%25253A%252Bnew%252Bdevelopments%252Bin%252Btherapeutic%252Band%252BPET%252Bimaging%252Bapplications%26aulast%3DGrimsey%26aufirst%3DNatasha%2BL.%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D330%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>. </span><span class="cited-content_cbyCitation_article-title">A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 111953. <a href="https://doi.org/10.1016/j.ejmech.2019.111953" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111953%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bperspective%252Breview%252Bon%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252B%252528FAAH%252529%252Binhibitors%252Bas%252Bpotential%252Btherapeutic%252Bagents%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2020%26volume%3D188%26spage%3D111953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Murillo-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Henning  Budde</span>, <span class="hlFld-ContribAuthor ">André Barciela  Veras</span>, <span class="hlFld-ContribAuthor ">Nuno Barbosa  Rocha</span>, <span class="hlFld-ContribAuthor ">Diogo  Telles-Correia</span>, <span class="hlFld-ContribAuthor ">Diogo  Monteiro</span>, <span class="hlFld-ContribAuthor ">Luis  Cid</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Sérgio  Machado</span>, <span class="hlFld-ContribAuthor ">Pablo  Torterolo</span>. </span><span class="cited-content_cbyCitation_article-title">The Endocannabinoid System May Modulate Sleep Disorders in Aging. </span><span class="cited-content_cbyCitation_journal-name">Current Neuropharmacology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (2)
                                     , 97-108. <a href="https://doi.org/10.2174/1570159X17666190801155922" title="DOI URL">https://doi.org/10.2174/1570159X17666190801155922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570159X17666190801155922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570159X17666190801155922%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neuropharmacology%26atitle%3DThe%252BEndocannabinoid%252BSystem%252BMay%252BModulate%252BSleep%252BDisorders%252Bin%252BAging%26aulast%3DMurillo-Rodr%25C3%25ADguez%26aufirst%3DEric%26date%3D2020%26volume%3D18%26issue%3D2%26spage%3D97%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian M.  Dato</span>, <span class="hlFld-ContribAuthor ">Jörg-Martin  Neudörfl</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Bernd  Goldfuss</span>, <span class="hlFld-ContribAuthor ">Markus  Pietsch</span>. </span><span class="cited-content_cbyCitation_article-title">ω-Quinazolinonylalkyl aryl ureas as reversible inhibitors of monoacylglycerol lipase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103352. <a href="https://doi.org/10.1016/j.bioorg.2019.103352" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103352%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D%2525CF%252589-Quinazolinonylalkyl%252Baryl%252Bureas%252Bas%252Breversible%252Binhibitors%252Bof%252Bmonoacylglycerol%252Blipase%26aulast%3DDato%26aufirst%3DFlorian%2BM.%26date%3D2020%26volume%3D94%26spage%3D103352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Malamas</span>, <span class="hlFld-ContribAuthor ">Shrouq I.  Farah</span>, <span class="hlFld-ContribAuthor ">Manjunath  Lamani</span>, <span class="hlFld-ContribAuthor ">Dimitrios N.  Pelekoudas</span>, <span class="hlFld-ContribAuthor ">Nicholas Thomas  Perry</span>, <span class="hlFld-ContribAuthor ">Girija  Rajarshi</span>, <span class="hlFld-ContribAuthor ">Christina Yume  Miyabe</span>, <span class="hlFld-ContribAuthor ">Honrao  Chandrashekhar</span>, <span class="hlFld-ContribAuthor ">Jay  West</span>, <span class="hlFld-ContribAuthor ">Spiro  Pavlopoulos</span>, <span class="hlFld-ContribAuthor ">Alexandros  Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115195. <a href="https://doi.org/10.1016/j.bmc.2019.115195" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115195%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bcyanamides%252Bas%252Bpotent%252Band%252Bselective%252BN-acylethanolamine%252Bacid%252Bamidase%252Binhibitors%26aulast%3DMalamas%26aufirst%3DMichael%2BS.%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supojjanee  Sansook</span>, <span class="hlFld-ContribAuthor ">Storm  Hassell-Hart</span>, <span class="hlFld-ContribAuthor ">Cory  Ocasio</span>, <span class="hlFld-ContribAuthor ">John  Spencer</span>. </span><span class="cited-content_cbyCitation_article-title">Ferrocenes in medicinal chemistry; a personal perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organometallic Chemistry</span><span> <strong>2020,</strong> <em>905 </em>, 121017. <a href="https://doi.org/10.1016/j.jorganchem.2019.121017" title="DOI URL">https://doi.org/10.1016/j.jorganchem.2019.121017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jorganchem.2019.121017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jorganchem.2019.121017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organometallic%2520Chemistry%26atitle%3DFerrocenes%252Bin%252Bmedicinal%252Bchemistry%25253B%252Ba%252Bpersonal%252Bperspective%26aulast%3DSansook%26aufirst%3DSupojjanee%26date%3D2020%26volume%3D905%26spage%3D121017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Turgut Emrah  Bozkurt</span>. </span><span class="cited-content_cbyCitation_article-title">Endocannabinoid System in the Airways. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (24)
                                     , 4626. <a href="https://doi.org/10.3390/molecules24244626" title="DOI URL">https://doi.org/10.3390/molecules24244626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24244626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24244626%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEndocannabinoid%252BSystem%252Bin%252Bthe%252BAirways%26aulast%3DBozkurt%26aufirst%3DTurgut%2BEmrah%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D24%26spage%3D4626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Cramer</span>, <span class="hlFld-ContribAuthor ">Jacklyn  Johnson</span>, <span class="hlFld-ContribAuthor ">Thanh  Ngo</span>, <span class="hlFld-ContribAuthor ">Abir T.  El‐Alfy</span>, <span class="hlFld-ContribAuthor ">Jozef  Stec</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the Endocannabinoid System via Inhibition of Fatty Acid Amide Hydrolase (FAAH) by Novel Urea and Carbamate Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (39)
                                     , 11609-11614. <a href="https://doi.org/10.1002/slct.201903375" title="DOI URL">https://doi.org/10.1002/slct.201903375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903375%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DModulation%252Bof%252Bthe%252BEndocannabinoid%252BSystem%252Bvia%252BInhibition%252Bof%252BFatty%252BAcid%252BAmide%252BHydrolase%252B%252528FAAH%252529%252Bby%252BNovel%252BUrea%252Band%252BCarbamate%252BDerivatives%26aulast%3DCramer%26aufirst%3DSarah%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D39%26spage%3D11609%26epage%3D11614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed E. M.  Mekky</span>, <span class="hlFld-ContribAuthor ">Sherif M. H.  Sanad</span>, <span class="hlFld-ContribAuthor ">Ahmed A. M.  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave Assisted Three Component One‐pot Synthesis of Bis(aminoazolo[1,5‐
              a
              ]pyrimidines) and Bis(aminoazino[1,2‐
              a
              ]benzimidazoles) Bearing Thiazole Moiety. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (33)
                                     , 9710-9715. <a href="https://doi.org/10.1002/slct.201902828" title="DOI URL">https://doi.org/10.1002/slct.201902828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902828%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMicrowave%252BAssisted%252BThree%252BComponent%252BOne%2525E2%252580%252590pot%252BSynthesis%252Bof%252BBis%252528aminoazolo%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dpyrimidines%252529%252Band%252BBis%252528aminoazino%25255B1%25252C2%2525E2%252580%252590%252Ba%252B%25255Dbenzimidazoles%252529%252BBearing%252BThiazole%252BMoiety%26aulast%3DMekky%26aufirst%3DAhmed%2BE.%2BM.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D33%26spage%3D9710%26epage%3D9715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruben  Bartholomäus</span>, <span class="hlFld-ContribAuthor ">Simon  Nicolussi</span>, <span class="hlFld-ContribAuthor ">Alice  Baumann</span>, <span class="hlFld-ContribAuthor ">Mark  Rau</span>, <span class="hlFld-ContribAuthor ">Ana Catarina  Simão</span>, <span class="hlFld-ContribAuthor ">Jürg  Gertsch</span>, <span class="hlFld-ContribAuthor ">Karl‐Heinz  Altmann</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of the Endocannabinoid Uptake Inhibitor Guineensine and SAR Studies. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (17)
                                     , 1590-1596. <a href="https://doi.org/10.1002/cmdc.201900390" title="DOI URL">https://doi.org/10.1002/cmdc.201900390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900390%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTotal%252BSynthesis%252Bof%252Bthe%252BEndocannabinoid%252BUptake%252BInhibitor%252BGuineensine%252Band%252BSAR%252BStudies%26aulast%3DBartholom%25C3%25A4us%26aufirst%3DRuben%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D17%26spage%3D1590%26epage%3D1596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Yusuke  Kurihara</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Kuan  Hu</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and evaluation of a novel monoacylglycerol lipase radiotracer: 1,1,1,3,3,3-hexafluoropropan-2-yl-3-(1-benzyl-1H-pyrazol-3-yl)azetidine-1-[11C]carboxylate. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3568-3573. <a href="https://doi.org/10.1016/j.bmc.2019.06.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRadiosynthesis%252Band%252Bevaluation%252Bof%252Ba%252Bnovel%252Bmonoacylglycerol%252Blipase%252Bradiotracer%25253A%252B1%25252C1%25252C1%25252C3%25252C3%25252C3-hexafluoropropan-2-yl-3-%2525281-benzyl-1H-pyrazol-3-yl%252529azetidine-1-%25255B11C%25255Dcarboxylate%26aulast%3DMori%26aufirst%3DWakana%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3568%26epage%3D3573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kangni  Wu</span>, <span class="hlFld-ContribAuthor ">Yanghui  Xiu</span>, <span class="hlFld-ContribAuthor ">Pan  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Qiu</span>, <span class="hlFld-ContribAuthor ">Yuhang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00818" title="DOI URL">https://doi.org/10.3389/fphar.2019.00818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00818%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DA%252BNew%252BUse%252Bfor%252Ban%252BOld%252BDrug%25253A%252BCarmofur%252BAttenuates%252BLipopolysaccharide%252B%252528LPS%252529-Induced%252BAcute%252BLung%252BInjury%252Bvia%252BInhibition%252Bof%252BFAAH%252Band%252BNAAA%252BActivities%26aulast%3DWu%26aufirst%3DKangni%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bába  László-István</span>, <span class="hlFld-ContribAuthor ">Kolcsár  Melinda</span>, <span class="hlFld-ContribAuthor ">Hack  Beatrix</span>, <span class="hlFld-ContribAuthor ">Gáll  Zsolt</span>, <span class="hlFld-ContribAuthor ">Kun Imre  Zoltán</span>. </span><span class="cited-content_cbyCitation_article-title">The endocannabinoid system: from the receptors to therapy. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of Medical Sciences</span><span> <strong>2019,</strong> <em>92 </em>
                                    (1)
                                     , 1-14. <a href="https://doi.org/10.2478/orvtudert-2019-0002" title="DOI URL">https://doi.org/10.2478/orvtudert-2019-0002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2478/orvtudert-2019-0002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2478%2Forvtudert-2019-0002%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520Medical%2520Sciences%26atitle%3DThe%252Bendocannabinoid%252Bsystem%25253A%252Bfrom%252Bthe%252Breceptors%252Bto%252Btherapy%26aulast%3DL%25C3%25A1szl%25C3%25B3-Istv%25C3%25A1n%26aufirst%3DB%25C3%25A1ba%26date%3D2019%26volume%3D92%26issue%3D1%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matteo  Miceli</span>, <span class="hlFld-ContribAuthor ">Silvana  Casati</span>, <span class="hlFld-ContribAuthor ">Roberta  Ottria</span>, <span class="hlFld-ContribAuthor ">Simone  Di Leo</span>, <span class="hlFld-ContribAuthor ">Ivano  Eberini</span>, <span class="hlFld-ContribAuthor ">Luca  Palazzolo</span>, <span class="hlFld-ContribAuthor ">Chiara  Parravicini</span>, <span class="hlFld-ContribAuthor ">Pierangela  Ciuffreda</span>. </span><span class="cited-content_cbyCitation_article-title">Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2241. <a href="https://doi.org/10.3390/molecules24122241" title="DOI URL">https://doi.org/10.3390/molecules24122241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24122241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24122241%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSet-Up%252Band%252BValidation%252Bof%252Ba%252BHigh%252BThroughput%252BScreening%252BMethod%252Bfor%252BHuman%252BMonoacylglycerol%252BLipase%252B%252528MAGL%252529%252BBased%252Bon%252Ba%252BNew%252BRed%252BFluorescent%252BProbe%26aulast%3DMiceli%26aufirst%3DMatteo%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bright N  Okine</span>, <span class="hlFld-ContribAuthor ">Jessica C  Gaspar</span>, <span class="hlFld-ContribAuthor ">David P  Finn</span>. </span><span class="cited-content_cbyCitation_article-title">PPARs and pain. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (10)
                                     , 1421-1442. <a href="https://doi.org/10.1111/bph.14339" title="DOI URL">https://doi.org/10.1111/bph.14339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14339%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DPPARs%252Band%252Bpain%26aulast%3DOkine%26aufirst%3DBright%2BN%26date%3D2019%26date%3D2018%26volume%3D176%26issue%3D10%26spage%3D1421%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Nagarajan</span>, <span class="hlFld-ContribAuthor ">L.  Emmanuvel</span>. </span><span class="cited-content_cbyCitation_article-title">Unusual Cleavage of N-N Bond of 1-Arylamino-1,2,3-triazole Derivatives: A Simple and Alternate Approach to 4,5-Disubstituted-1H-1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2019,</strong> <em>31 </em>
                                    (5)
                                     , 1057-1061. <a href="https://doi.org/10.14233/ajchem.2019.21857" title="DOI URL">https://doi.org/10.14233/ajchem.2019.21857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2019.21857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2019.21857%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DUnusual%252BCleavage%252Bof%252BN-N%252BBond%252Bof%252B1-Arylamino-1%25252C2%25252C3-triazole%252BDerivatives%25253A%252BA%252BSimple%252Band%252BAlternate%252BApproach%252Bto%252B4%25252C5-Disubstituted-1H-1%25252C2%25252C3-triazoles%26aulast%3DNagarajan%26aufirst%3DR.%26date%3D2019%26date%3D2019%26volume%3D31%26issue%3D5%26spage%3D1057%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cui  Chen</span>, <span class="hlFld-ContribAuthor ">Weibing.  Liu</span>, <span class="hlFld-ContribAuthor ">Bifu.  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhou</span>, <span class="hlFld-ContribAuthor ">Hua  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Acylation of Arylamines with Triethylamine Derivatives in Combination with
              tert
              ‐Butyl Hydroperoxide. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>8 </em>
                                    (4)
                                     , 470-474. <a href="https://doi.org/10.1002/ajoc.201900119" title="DOI URL">https://doi.org/10.1002/ajoc.201900119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201900119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201900119%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAcylation%252Bof%252BArylamines%252Bwith%252BTriethylamine%252BDerivatives%252Bin%252BCombination%252Bwith%252Btert%252B%2525E2%252580%252590Butyl%252BHydroperoxide%26aulast%3DChen%26aufirst%3DCui%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D4%26spage%3D470%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David R.  Janero</span>, <span class="hlFld-ContribAuthor ">V.  Kiran Vemuri</span>, <span class="hlFld-ContribAuthor ">Alexandros  Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">The Molecular Basis of Cannabinoid Activity: Application to Therapeutics Design and Discovery for Cannabis Use Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 43-54. <a href="https://doi.org/10.1007/978-3-319-90365-1_6" title="DOI URL">https://doi.org/10.1007/978-3-319-90365-1_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-90365-1_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-90365-1_6%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BMolecular%252BBasis%252Bof%252BCannabinoid%252BActivity%25253A%252BApplication%252Bto%252BTherapeutics%252BDesign%252Band%252BDiscovery%252Bfor%252BCannabis%252BUse%252BDisorders%26aulast%3DJanero%26aufirst%3DDavid%2BR.%26date%3D2019%26date%3D2018%26spage%3D43%26epage%3D54%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCannabis%252BUse%252BDisorders%26aulast%3DMontoya%26aufirst%3DIvan%2BD.%26date%3D2019%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Yulia. B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The literature of heterocyclic chemistry, part XVII, 2017. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 337-418. <a href="https://doi.org/10.1016/bs.aihch.2019.01.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2019.01.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bliterature%252Bof%252Bheterocyclic%252Bchemistry%25252C%252Bpart%252BXVII%25252C%252B2017%26aulast%3DBelen%25E2%2580%2599kii%26aufirst%3DLeonid%2BI.%26date%3D2019%26spage%3D337%26epage%3D418%26pub%3DElsevier%26date%3D2019%26volume%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debnath  Bhuniya</span>, <span class="hlFld-ContribAuthor ">Rajendra K.  Kharul</span>, <span class="hlFld-ContribAuthor ">Atul  Hajare</span>, <span class="hlFld-ContribAuthor ">Nadim  Shaikh</span>, <span class="hlFld-ContribAuthor ">Sandeep  Bhosale</span>, <span class="hlFld-ContribAuthor ">Sandip  Balwe</span>, <span class="hlFld-ContribAuthor ">Fouzia  Begum</span>, <span class="hlFld-ContribAuthor ">Siddhartha  De</span>, <span class="hlFld-ContribAuthor ">Sonalee  Athavankar</span>, <span class="hlFld-ContribAuthor ">Dhananjay  Joshi</span>, <span class="hlFld-ContribAuthor ">Vamsi  Madgula</span>, <span class="hlFld-ContribAuthor ">Kaushal  Joshi</span>, <span class="hlFld-ContribAuthor ">Amol A.  Raje</span>, <span class="hlFld-ContribAuthor ">Ashwinkumar V.  Meru</span>, <span class="hlFld-ContribAuthor ">Amol  Magdum</span>, <span class="hlFld-ContribAuthor ">Kasim A.  Mookhtiar</span>, <span class="hlFld-ContribAuthor ">Rashmi  Barbhaiya</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (2)
                                     , 238-243. <a href="https://doi.org/10.1016/j.bmcl.2018.11.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bevaluation%252Bof%252Bnovel%252BFAAH%252Binhibitors%252Bin%252Bneuropathic%252Bpain%252Bmodel%26aulast%3DBhuniya%26aufirst%3DDebnath%26date%3D2019%26volume%3D29%26issue%3D2%26spage%3D238%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Cipriano</span>, <span class="hlFld-ContribAuthor ">Federica  Moraca</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Bruno  Catalanotti</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 562-576. <a href="https://doi.org/10.1080/14756366.2018.1532418" title="DOI URL">https://doi.org/10.1080/14756366.2018.1532418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1532418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1532418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DBenzylamides%252Band%252Bpiperazinoarylamides%252Bof%252Bibuprofen%252Bas%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Binhibitors%26aulast%3DDeplano%26aufirst%3DAlessandro%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D562%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien R.C.  Prevost</span>, <span class="hlFld-ContribAuthor ">Arina  Kozlova</span>, <span class="hlFld-ContribAuthor ">Bouazza  Es Saadi</span>, <span class="hlFld-ContribAuthor ">Esra  Yildiz</span>, <span class="hlFld-ContribAuthor ">Sara  Modaffari</span>, <span class="hlFld-ContribAuthor ">Didier M.  Lambert</span>, <span class="hlFld-ContribAuthor ">Lionel  Pochet</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>, <span class="hlFld-ContribAuthor ">Eduard  Dolušić</span>, <span class="hlFld-ContribAuthor ">Raphaël  Frédérick</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient one-pot formation of highly functionalized 5-bromo-2-aminothiazoles, potential endocannabinoid hydrolase MAGL inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (49)
                                     , 4315-4319. <a href="https://doi.org/10.1016/j.tetlet.2018.10.055" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.10.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.10.055%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DConvenient%252Bone-pot%252Bformation%252Bof%252Bhighly%252Bfunctionalized%252B5-bromo-2-aminothiazoles%25252C%252Bpotential%252Bendocannabinoid%252Bhydrolase%252BMAGL%252Binhibitors%26aulast%3DPrevost%26aufirst%3DJulien%2BR.C.%26date%3D2018%26volume%3D59%26issue%3D49%26spage%3D4315%26epage%3D4319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergiy  Tyukhtenko</span>, <span class="hlFld-ContribAuthor ">Girija  Rajarshi</span>, <span class="hlFld-ContribAuthor ">Ioannis  Karageorgos</span>, <span class="hlFld-ContribAuthor ">Nikolai  Zvonok</span>, <span class="hlFld-ContribAuthor ">Elyssia S.  Gallagher</span>, <span class="hlFld-ContribAuthor ">Hongwei  Huang</span>, <span class="hlFld-ContribAuthor ">Kiran  Vemuri</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Hudgens</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Ma</span>, <span class="hlFld-ContribAuthor ">Mahmoud L.  Nasr</span>, <span class="hlFld-ContribAuthor ">Spiro  Pavlopoulos</span>, <span class="hlFld-ContribAuthor ">Alexandros  Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Distal Mutations on the Structure, Dynamics and Catalysis of Human Monoacylglycerol Lipase. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-19135-7" title="DOI URL">https://doi.org/10.1038/s41598-017-19135-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-19135-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-19135-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DEffects%252Bof%252BDistal%252BMutations%252Bon%252Bthe%252BStructure%25252C%252BDynamics%252Band%252BCatalysis%252Bof%252BHuman%252BMonoacylglycerol%252BLipase%26aulast%3DTyukhtenko%26aufirst%3DSergiy%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Gil-Ordóñez</span>, <span class="hlFld-ContribAuthor ">Mar  Martín-Fontecha</span>, <span class="hlFld-ContribAuthor ">Silvia  Ortega-Gutiérrez</span>, <span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>. </span><span class="cited-content_cbyCitation_article-title">Monoacylglycerol lipase (MAGL) as a promising therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>157 </em>, 18-32. <a href="https://doi.org/10.1016/j.bcp.2018.07.036" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.07.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.07.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DMonoacylglycerol%252Blipase%252B%252528MAGL%252529%252Bas%252Ba%252Bpromising%252Btherapeutic%252Btarget%26aulast%3DGil-Ord%25C3%25B3%25C3%25B1ez%26aufirst%3DAna%26date%3D2018%26volume%3D157%26spage%3D18%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Koeberle</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>. </span><span class="cited-content_cbyCitation_article-title">Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology Advances</span><span> <strong>2018,</strong> <em>36 </em>
                                    (6)
                                     , 1709-1723. <a href="https://doi.org/10.1016/j.biotechadv.2018.02.010" title="DOI URL">https://doi.org/10.1016/j.biotechadv.2018.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biotechadv.2018.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biotechadv.2018.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520Advances%26atitle%3DNatural%252Bproducts%252Bas%252Binhibitors%252Bof%252Bprostaglandin%252BE2%252Band%252Bpro-inflammatory%252B5-lipoxygenase-derived%252Blipid%252Bmediator%252Bbiosynthesis%26aulast%3DKoeberle%26aufirst%3DAndreas%26date%3D2018%26volume%3D36%26issue%3D6%26spage%3D1709%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexei  Gorelik</span>, <span class="hlFld-ContribAuthor ">Ahmad  Gebai</span>, <span class="hlFld-ContribAuthor ">Katalin  Illes</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>, <span class="hlFld-ContribAuthor ">Bhushan  Nagar</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanism of activation of the immunoregulatory amidase NAAA. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (43)
                                     , E10032-E10040. <a href="https://doi.org/10.1073/pnas.1811759115" title="DOI URL">https://doi.org/10.1073/pnas.1811759115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1811759115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1811759115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DMolecular%252Bmechanism%252Bof%252Bactivation%252Bof%252Bthe%252Bimmunoregulatory%252Bamidase%252BNAAA%26aulast%3DGorelik%26aufirst%3DAlexei%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D43%26spage%3DE10032%26epage%3DE10040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László E.  Kiss</span>, <span class="hlFld-ContribAuthor ">Alexandre  Beliaev</span>, <span class="hlFld-ContribAuthor ">Humberto S.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Carla P.  Rosa</span>, <span class="hlFld-ContribAuthor ">Maria João  Bonifácio</span>, <span class="hlFld-ContribAuthor ">Ana I.  Loureiro</span>, <span class="hlFld-ContribAuthor ">Nuno M.  Pires</span>, <span class="hlFld-ContribAuthor ">P. Nuno  Palma</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (20)
                                     , 2177-2188. <a href="https://doi.org/10.1002/cmdc.201800393" title="DOI URL">https://doi.org/10.1002/cmdc.201800393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800393%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BLong-Acting%25252C%252Band%252BCNS-Active%252BInhibitor%252B%252528BIA%252B10-2474%252529%252Bof%252BFatty%252BAcid%252BAmide%252BHydrolase%26aulast%3DKiss%26aufirst%3DL%25C3%25A1szl%25C3%25B3%2BE.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D20%26spage%3D2177%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Gorzkiewicz</span>, <span class="hlFld-ContribAuthor ">Janusz  Szemraj</span>. </span><span class="cited-content_cbyCitation_article-title">Brain endocannabinoid signaling exhibits remarkable complexity. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2018,</strong> <em>142 </em>, 33-46. <a href="https://doi.org/10.1016/j.brainresbull.2018.06.012" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2018.06.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2018.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2018.06.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DBrain%252Bendocannabinoid%252Bsignaling%252Bexhibits%252Bremarkable%252Bcomplexity%26aulast%3DGorzkiewicz%26aufirst%3DAnna%26date%3D2018%26volume%3D142%26spage%3D33%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marek  Toczek</span>, <span class="hlFld-ContribAuthor ">Barbara  Malinowska</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced endocannabinoid tone as a potential target of pharmacotherapy. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2018,</strong> <em>204 </em>, 20-45. <a href="https://doi.org/10.1016/j.lfs.2018.04.054" title="DOI URL">https://doi.org/10.1016/j.lfs.2018.04.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2018.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2018.04.054%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DEnhanced%252Bendocannabinoid%252Btone%252Bas%252Ba%252Bpotential%252Btarget%252Bof%252Bpharmacotherapy%26aulast%3DToczek%26aufirst%3DMarek%26date%3D2018%26volume%3D204%26spage%3D20%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virna Margarita  Martín Giménez</span>, <span class="hlFld-ContribAuthor ">Sandra Edith  Noriega</span>, <span class="hlFld-ContribAuthor ">Diego Enrique  Kassuha</span>, <span class="hlFld-ContribAuthor ">Lucía Beatriz  Fuentes</span>, <span class="hlFld-ContribAuthor ">Walter  Manucha</span>. </span><span class="cited-content_cbyCitation_article-title">Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Cardiovascular Disease</span><span> <strong>2018,</strong> <em>12 </em>
                                    (7)
                                     , 177-190. <a href="https://doi.org/10.1177/1753944718773690" title="DOI URL">https://doi.org/10.1177/1753944718773690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1753944718773690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1753944718773690%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Cardiovascular%2520Disease%26atitle%3DAnandamide%252Band%252Bendocannabinoid%252Bsystem%25253A%252Ban%252Battractive%252Btherapeutic%252Bapproach%252Bfor%252Bcardiovascular%252Bdisease%26aulast%3DMart%25C3%25ADn%2BGim%25C3%25A9nez%26aufirst%3DVirna%2BMargarita%26date%3D2018%26date%3D2018%26volume%3D12%26issue%3D7%26spage%3D177%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian M.  Dato</span>, <span class="hlFld-ContribAuthor ">Andreas  Maaßen</span>, <span class="hlFld-ContribAuthor ">Bernd  Goldfuß</span>, <span class="hlFld-ContribAuthor ">Markus  Pietsch</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of fatty acid amide hydrolase activity by a fluorescence-based assay. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2018,</strong> <em>546 </em>, 50-57. <a href="https://doi.org/10.1016/j.ab.2018.01.026" title="DOI URL">https://doi.org/10.1016/j.ab.2018.01.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2018.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2018.01.026%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DCharacterization%252Bof%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Bactivity%252Bby%252Ba%252Bfluorescence-based%252Bassay%26aulast%3DDato%26aufirst%3DFlorian%2BM.%26date%3D2018%26volume%3D546%26spage%3D50%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supojjanee  Sansook</span>, <span class="hlFld-ContribAuthor ">Wei  Tuo</span>, <span class="hlFld-ContribAuthor ">Mélanie  Bollier</span>, <span class="hlFld-ContribAuthor ">Amélie  Barczyk</span>, <span class="hlFld-ContribAuthor ">Xavier  Dezitter</span>, <span class="hlFld-ContribAuthor ">Fredérique  Klupsch</span>, <span class="hlFld-ContribAuthor ">Natascha  Leleu-Chavain</span>, <span class="hlFld-ContribAuthor ">Amaury  Farce</span>, <span class="hlFld-ContribAuthor ">Graham J  Tizzard</span>, <span class="hlFld-ContribAuthor ">Simon J  Coles</span>, <span class="hlFld-ContribAuthor ">John  Spencer</span>, <span class="hlFld-ContribAuthor ">Régis  Millet</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of ferrocene-based cannabinoid receptor 2 ligands. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (6)
                                     , 631-638. <a href="https://doi.org/10.4155/fmc-2017-0200" title="DOI URL">https://doi.org/10.4155/fmc-2017-0200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0200%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bferrocene-based%252Bcannabinoid%252Breceptor%252B2%252Bligands%26aulast%3DSansook%26aufirst%3DSupojjanee%26date%3D2018%26volume%3D10%26issue%3D6%26spage%3D631%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Tuo</span>, <span class="hlFld-ContribAuthor ">Mélanie  Bollier</span>, <span class="hlFld-ContribAuthor ">Natascha  Leleu-Chavain</span>, <span class="hlFld-ContribAuthor ">Lucas  Lemaire</span>, <span class="hlFld-ContribAuthor ">Amélie  Barczyk</span>, <span class="hlFld-ContribAuthor ">Xavier  Dezitter</span>, <span class="hlFld-ContribAuthor ">Frédérique  Klupsch</span>, <span class="hlFld-ContribAuthor ">Fabien  Szczepanski</span>, <span class="hlFld-ContribAuthor ">John  Spencer</span>, <span class="hlFld-ContribAuthor ">Philippe  Chavatte</span>, <span class="hlFld-ContribAuthor ">Régis  Millet</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 68-78. <a href="https://doi.org/10.1016/j.ejmech.2018.01.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bnovel%252Boxazolo%25255B5%25252C4-d%25255Dpyrimidines%252Bas%252Bcompetitive%252BCB2%252Bneutral%252Bantagonists%252Bbased%252Bon%252Bscaffold%252Bhopping%26aulast%3DTuo%26aufirst%3DWei%26date%3D2018%26volume%3D146%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter H.  Hutson</span>, <span class="hlFld-ContribAuthor ">Iris M.  Balodis</span>, <span class="hlFld-ContribAuthor ">Marc N.  Potenza</span>. </span><span class="cited-content_cbyCitation_article-title">Binge-eating disorder: Clinical and therapeutic advances. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>182 </em>, 15-27. <a href="https://doi.org/10.1016/j.pharmthera.2017.08.002" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2017.08.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2017.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2017.08.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DBinge-eating%252Bdisorder%25253A%252BClinical%252Band%252Btherapeutic%252Badvances%26aulast%3DHutson%26aufirst%3DPeter%2BH.%26date%3D2018%26volume%3D182%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Karlsson</span>, <span class="hlFld-ContribAuthor ">Christopher J  Fowler</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of
              N
              -Acylethanolamines: To Phase II and Back Again. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-9. <a href="https://doi.org/10.1002/9780470015902.a0027664" title="DOI URL">https://doi.org/10.1002/9780470015902.a0027664</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470015902.a0027664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470015902.a0027664%26sid%3Dliteratum%253Aachs%26atitle%3DMetabolism%252Bof%252BN%252B-Acylethanolamines%25253A%252BTo%252BPhase%252BII%252Band%252BBack%252BAgain%26aulast%3DKarlsson%26aufirst%3DJessica%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D9%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DeLS%26aulast%3DJohn%2BWiley%2B%2526%2BSons%2BLtd%26date%3D2001%26date%3D2001%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuhang  Li</span>, <span class="hlFld-ContribAuthor ">Qi  Chen</span>, <span class="hlFld-ContribAuthor ">Longhe  Yang</span>, <span class="hlFld-ContribAuthor ">Yanting  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Qiu</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Canzhong  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of highly potent N -acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 214-221. <a href="https://doi.org/10.1016/j.ejmech.2017.08.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bhighly%252Bpotent%252BN%252B-acylethanolamine%252Bacid%252Bamidase%252B%252528NAAA%252529%252Binhibitors%25253A%252BOptimization%252Bof%252Bthe%252Bterminal%252Bphenyl%252Bmoiety%252Bof%252Boxazolidone%252Bderivatives%26aulast%3DLi%26aufirst%3DYuhang%26date%3D2017%26volume%3D139%26spage%3D214%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Carmine Marco  Morgillo</span>, <span class="hlFld-ContribAuthor ">Monica  Demurtas</span>, <span class="hlFld-ContribAuthor ">Emmelie  Björklund</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Cipriano</span>, <span class="hlFld-ContribAuthor ">Mona  Svensson</span>, <span class="hlFld-ContribAuthor ">Sanaz  Hashemian</span>, <span class="hlFld-ContribAuthor ">Giovanni  Smaldone</span>, <span class="hlFld-ContribAuthor ">Emilia  Pedone</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Maria G.  Cabiddu</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Bruno  Catalanotti</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">Novel propanamides as fatty acid amide hydrolase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>136 </em>, 523-542. <a href="https://doi.org/10.1016/j.ejmech.2017.05.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.05.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.05.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bpropanamides%252Bas%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Binhibitors%26aulast%3DDeplano%26aufirst%3DAlessandro%26date%3D2017%26volume%3D136%26spage%3D523%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael N.  Ruggiero</span>, <span class="hlFld-ContribAuthor ">Matheus T.  Rossignoli</span>, <span class="hlFld-ContribAuthor ">Jana B.  De Ross</span>, <span class="hlFld-ContribAuthor ">Jaime E. C.  Hallak</span>, <span class="hlFld-ContribAuthor ">Joao P.  Leite</span>, <span class="hlFld-ContribAuthor ">Lezio S.  Bueno-Junior</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fphar.2017.00399" title="DOI URL">https://doi.org/10.3389/fphar.2017.00399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2017.00399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2017.00399%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DCannabinoids%252Band%252BVanilloids%252Bin%252BSchizophrenia%25253A%252BNeurophysiological%252BEvidence%252Band%252BDirections%252Bfor%252BBasic%252BResearch%26aulast%3DRuggiero%26aufirst%3DRafael%2BN.%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0062.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0062.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biosynthesis and biodegradation of FAEs, including AEA, PEA, and OEA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Biosynthesis and biodegradation of 2-AG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) ECs and (b) related FAEs-mediated biological effects. This work was built upon Servier Medical Art by Servier, which is licensed under a Creative Commons Attribution 3.0 Unported License.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding pockets of FAAH, exemplified by X-ray cocrystal structure of FAAH combined with inhibitor (in cyan), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5">1MT5</a>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Membrane access channel (MAC), acyl-chain binding pocket (ABP), cytosolic port (CP), oxyanion hole, and catalytic triad are depicted in blue, yellow, red, green, and orange, respectively. The “gate” at the junction of MAC and ABP is formed by Phe432 and Trp531 (in purple). Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mechanism of FAAH-mediated hydrolysis of AEA: (a) formation of acylated FAAH and release of ethanolamine; (b) deacylation of acylated FAAH and release of AA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Equilibrium of “gate” in favor of “open” (left, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA">2VYA</a><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a>) or “closed” (right, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WAP">2WAP</a><a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a>) state and the extension of ABP induced by Phe432 rotation (bottom right). Surfaces of “gate”, MAC, ABP, and extended ABP are depicted in purple, blue, yellow, and orange, respectively. Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding pockets of MAGL, exemplified by X-ray crystal structure of MAGL, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HJU">3HJU</a>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> ABP, catalytic triad, alcohol-binding channel, and glycerol exit channel are depicted in yellow, blue, green, and red, respectively. The putative “gate” is formed by Phe93 and Phe209 (in purple). The three reactive cysteines are depicted in orange. Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Binding mechanism of reversible, slowly/partially irreversible, and irreversible inhibitor. This work was built upon Servier Medical Art by Servier, which is licensed under a Creative Commons Attribution 3.0 Unported License.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of representative first-generation FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structural modifications of the trifluoromethyl oleyl ketone <b>5</b>. Enzyme assays were performed by using either solubilized rat liver plasma membrane extracts or purified recombinant rat FAAH expressed in <i>E. coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (a) X-ray cocrystal structure of FAAH combined with <b>12</b> (in purple), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WJ2">2WJ2</a>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC. (b) Structural modifications of compound <b>12</b> on the pyridinyl and phenyl groups. (c) Plot of −log <i>K</i><sub>i</sub> (μM) versus σ<sub>p</sub>. Figure on the right is from ref <a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">62</a>. (d) Structural modifications of compound <b>12</b> on the acyl chain and the oxazole moiety. Enzyme assays were performed by using purified recombinant rat FAAH expressed in E. <i>coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (a) Structure of the phenylhexyl α-keto oxazole derivative <b>28</b>. (b) Interactions between compound <b>28</b> (in purple) and FAAH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J5P">4J5P</a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The carbonyl function of <b>28</b> is surrounded by the catalytic triad and the oxyanion hole. Hydrogen bonds and π–π interactions are depicted as green and purple dashes, respectively. Results were obtained using software programs from Dassault Systèmes BIOVIA, Discovery Studio Visualizer. (c) Mechanism of action of compound <b>28</b>: covalent and irreversible FAAH inhibition. Aside from the interaction with Ser241, the bromo group was identified to covalently interact with Cys269. Enzyme assays were performed by using purified recombinant rat FAAH expressed in <i>E. coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of representative covalent and irreversible carbamate-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (a) Mechanism of <b>30</b>-mediated covalent and irreversible FAAH inhibition: formation of an acyl–FAAH adduct. (b) X-ray cocrystal structure of FAAH–<b>30</b> (<i>N</i>-cyclohexylformamide moiety in yellow), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LJ7">3LJ7</a>.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Hydrogen bonds and π–σ interactions are depicted as green and violet dashes, respectively. Results were obtained using software programs from Dassault Systèmes BIOVIA, Discovery Studio Visualizer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Covalent adducts combined with <b>30</b> and <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures of representative triazolylmethyl cabamate based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of representative pyrazolylphenyl cabamate based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of representative ω-tetrazolylalkyl cabamate based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. (a) Structures of representative sulfonyl fluoride based FAAH inhibitors. (b) Compound <b>49</b> establishes H-bonds with Ser241 and Thr488 of FAAH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0022.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of representative urea-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0023.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structural modifications on the <i>N</i>-phenyl ring and the phenyl ring appended to the 1,2,4-thiadiazole ring of compound <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0024.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Mechanism of action of compound <b>51</b>, covalent and reversible FAAH inhibition: (a) acylation of FAAH; (b) deacylation of acylated FAAH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0025.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structural modifications on the piperazine, pyridine, and (4-chlorophenyoxy)benzyl groups of compound <b>52</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0026.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. X-ray cocrystal structure of <b>60</b>-combined FAAH, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA">2VYA</a>.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Compound <b>60</b> and oxyanion hole are depicted as purple and yellow, respectively. Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0027.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure–activity relationships of benzothiophene piperazine urea based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0028.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of representative piperidine urea based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0029.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. (a) Overlap of X-ray cocrystal structures of FAAH–<b>60</b> (in orange, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA">2VYA</a>)<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and FAAH–<b>62</b> (in green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WAP">2WAP</a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> (b) Surfaces of FAAH combined with <b>60</b> (left) and <b>62</b> (right). Results were obtained using software program open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0030.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of representative azaspiro urea based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0031.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structure of thiadiazolylpiperazine urea based FAAH inhibitor <b>71</b> obtained by incorporation of compounds <b>51</b> and <b>70</b> and structural modifications on the benzisoxazole, thiadiazole, and the phenyl groups of compound <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0032.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. (a) Structure of the boronic acid based FAAH inhibitor <b>75</b>. (b) Interactions between compound <b>75</b> and FAAH. Figure from ref <a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">109</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0033.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Structures of representative arylthioheterocycle-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0034.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures of arylthioheterocycles developed as PET tracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0035.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Structures of representative 3-carboxamido-5-arylisoxazole-based FAAH inhibitors and CB<sub>2</sub> agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0036.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Structures of representative 1,3,4-oxadiazol-2-one-based FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0037.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Structures of other representative FAAH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0038.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Compound <b>88</b> (in yellow) is surrounded by Phe432, Leu433, Met436, Thr488, Ile491, and Trp531; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QJ9">3QJ9</a>.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Results were obtained using software programs from Dassault Systèmes BIOVIA, Discovery Studio Visualizer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0039.jpeg" id="rightTab-gr38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Structures of representative substrate-based NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig39" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0040.jpeg" id="rightTab-gr39" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. Structures of representative β-lactone-based NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig40" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0041.jpeg" id="rightTab-gr40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Structural modifications on the phenethyl group and the amide function of β-lactone-based NAAA inhibitor <b>108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig41" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0042.jpeg" id="rightTab-gr41" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. Putative interaction mechanism between NAAA and <b>111</b>: (a) S-acylation of enzyme; (b) S-deacylation of the enzyme–substrate adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig42" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0043.jpeg" id="rightTab-gr42" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. Structural modifications on the phenylpentyl group of β-lactone-based NAAA inhibitor <b>111</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig43" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0044.jpeg" id="rightTab-gr43" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. Structures of representative β-lactam-based NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig44" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Figure 44</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0045.jpeg" id="rightTab-gr44" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 44. Putative interaction mechanism between NAAA and <b>100</b>: formation of an enzyme–substrate tetrahedral adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig44"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig45" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 45</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0046.jpeg" id="rightTab-gr45" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 45. Modification of β-lactam derivative in favor of FAAH inhibitor or NAAA inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig45"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig46" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Figure 46</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0047.jpeg" id="rightTab-gr46" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 46. Structures of other representative NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig46"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig47" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Figure 47</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0048.jpeg" id="rightTab-gr47" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 47. Structure of rimonabant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig47"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig48" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Figure 48</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0049.jpeg" id="rightTab-gr48" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 48. (a) Structures of representative maleimide-based MAGL inhibitors. (b) Cysteine-dependent interactive mechanism between maleimides and MAGL, followed by formation of S-alkylated MAGL adduct through Michael addition. *IC<sub>50</sub> values were expressed as the inhibition of MAGL-like enzyme activity in rat cerebellar membranes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig48"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig49" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Figure 49</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0050.jpeg" id="rightTab-gr49" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 49. Structures of representative disulfide-based MAGL inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig49"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig50" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Figure 50</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0051.jpeg" id="rightTab-gr50" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 50. (a) Structures of representative isothiazolinone-based MAGL inhibitors. (b) Cysteine-dependent interactive mechanism between <b>140</b> and MAGL, followed by formation of a disulfide adduct with MAGL. Enzyme assays were performed by using recombinant purified rat MAGL overexpressed in <i>E. coli</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig50"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig51" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Figure 51</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0052.jpeg" id="rightTab-gr51" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 51. Structures of representative urea-based MAGL inhibitors and H antagonist loratadine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig51"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig52" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Figure 52</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0053.jpeg" id="rightTab-gr52" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 52. Serine-dependent interactive mechanism between <b>143</b> and the enzyme, followed by formation of acyl–enzyme adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig52"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig53" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Figure 53</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0054.jpeg" id="rightTab-gr53" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 53. X-ray cocrystal structure of MAGL combined with <b>144</b> (in cyan), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JWE">3JWE</a>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Hydrogen bonds and π–σ/σ–σ interactions are depicted as green and purple dashes, respectively. On the left, surfaces of ABP, catalytic triad, alcohol-binding channel, and glycerol exit channel are depicted in yellow, blue, green, and red, respectively. Results were obtained using software programs Discovery Studio Visualizer from Dassault Systèmes BIOVIA and open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig53"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig54" data-index="54" class="article__inlineFigure"><h2 class="fig-label">Figure 54</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0055.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0055.jpeg" id="rightTab-gr54" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 54. Structural modifications of MAGL inhibitor <b>144</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0055.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig54"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig55" data-index="55" class="article__inlineFigure"><h2 class="fig-label">Figure 55</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0056.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0056.jpeg" id="rightTab-gr55" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 55. Structures of representative carbamate-based MAGL inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0056.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig55"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig56" data-index="56" class="article__inlineFigure"><h2 class="fig-label">Figure 56</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0057.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0057.jpeg" id="rightTab-gr56" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 56. Serine-dependent interactive mechanism between MAGL inhibitor <b>151</b> and enzyme: formation of acyl–enzyme adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0057.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig56"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig57" data-index="57" class="article__inlineFigure"><h2 class="fig-label">Figure 57</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0058.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0058.jpeg" id="rightTab-gr57" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 57. X-ray cocrystal structure of MAGL combined with <b>157</b> (in pink), PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UUQ">4UUQ</a>.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Hydrogen bonds, alkyl-dependent van der Waals interactions, and water-mediated interactions are depicted as green, purple, and blue dashes, respectively. On the left, surfaces of ABP, catalytic triad, alcohol-binding channel, and glycerol exit channel are depicted in yellow, blue, green, and red, respectively. Results were obtained using software programs Discovery Studio Visualizer from Dassault Systèmes BIOVIA and open source PyMOL, version 1.8, Schrödinger, LLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0058.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig57"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig58" data-index="58" class="article__inlineFigure"><h2 class="fig-label">Figure 58</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0059.jpeg" id="rightTab-gr58" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 58. Structures of other representative MAGL inhibitors and orlistat.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig58"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig59" data-index="59" class="article__inlineFigure"><h2 class="fig-label">Figure 59</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0060.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0060.jpeg" id="rightTab-gr59" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 59. Serine-dependent interactive mechanism between MAGL inhibitor <b>158</b> and enzyme: formation of acyl–enzyme intermediate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0060.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig59"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig60" data-index="60" class="article__inlineFigure"><h2 class="fig-label">Figure 60</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/medium/jm-2016-00538j_0061.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0061.jpeg" id="rightTab-gr60" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 60. Structure of <b>165</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00538/20170106/images/large/jm-2016-00538j_0061.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00538&amp;id=fig60"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 180 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasso, O.</span><span> </span><span class="NLM_article-title">Peripheral gating of pain signals by endogenous lipid mediators</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1038/nn.3612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.3612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24473264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=164-174&author=D.+Piomelliauthor=O.+Sasso&title=Peripheral+gating+of+pain+signals+by+endogenous+lipid+mediators&doi=10.1038%2Fnn.3612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral gating of pain signals by endogenous lipid mediators</span></div><div class="casAuthors">Piomelli, Daniele; Sasso, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Primary sensory afferents and their neighboring host-defense cells are a rich source of lipid-derived mediators that contribute to the sensation of pain caused by tissue damage and inflammation.  But an increasing no. of lipid mols. have been shown to act in an opposite way, to suppress the inflammatory process, restore homeostasis in damaged tissues and attenuate pain sensitivity by regulating neural pathways that transmit nociceptive signals from the periphery of the body to the CNS.  Here we review the mol. and cellular mechanisms that contribute to the modulatory actions of lipid mediators in peripheral nociceptive signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3SUeSBaNEzbVg90H21EOLACvtfcHk0ljoY_w1iqfzLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D&md5=cedccbc9ba2c37ec111eefdf19c065a6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnn.3612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3612%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DSasso%26aufirst%3DO.%26atitle%3DPeripheral%2520gating%2520of%2520pain%2520signals%2520by%2520endogenous%2520lipid%2520mediators%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D164%26epage%3D174%26doi%3D10.1038%2Fnn.3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Beltramo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Functional role of high-affinity anandamide transport, as revealed by selective inhibition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span><span class="refDoi"> DOI: 10.1126/science.277.5329.1094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1126%2Fscience.277.5329.1094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1094-1097&author=M.+Beltramoauthor=N.+Stellaauthor=A.+Calignanoauthor=S.+Linauthor=A.+Makriyannisauthor=D.+Piomelli&title=Functional+role+of+high-affinity+anandamide+transport%2C+as+revealed+by+selective+inhibition&doi=10.1126%2Fscience.277.5329.1094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.277.5329.1094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.277.5329.1094%26sid%3Dliteratum%253Aachs%26aulast%3DBeltramo%26aufirst%3DM.%26aulast%3DStella%26aufirst%3DN.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DFunctional%2520role%2520of%2520high-affinity%2520anandamide%2520transport%252C%2520as%2520revealed%2520by%2520selective%2520inhibition%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1094%26epage%3D1097%26doi%3D10.1126%2Fscience.277.5329.1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomikos, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickason-Chesterfield, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phebus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyengar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Identification of a high-affinity binding site involved in the transport of endocannabinoids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17852</span><span class="NLM_x">–</span> <span class="NLM_lpage">17857</span><span class="refDoi"> DOI: 10.1073/pnas.0507470102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.0507470102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17852-17857&author=S.+A.+Mooreauthor=G.+G.+Nomikosauthor=A.+K.+Dickason-Chesterfieldauthor=D.+A.+Schoberauthor=J.+M.+Schausauthor=B.+P.+Yingauthor=Y.+C.+Xuauthor=L.+Phebusauthor=R.+M.+Simmonsauthor=D.+Liauthor=S.+Iyengarauthor=C.+C.+Felder&title=Identification+of+a+high-affinity+binding+site+involved+in+the+transport+of+endocannabinoids&doi=10.1073%2Fpnas.0507470102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0507470102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0507470102%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26aulast%3DDickason-Chesterfield%26aufirst%3DA.%2BK.%26aulast%3DSchober%26aufirst%3DD.%2BA.%26aulast%3DSchaus%26aufirst%3DJ.%2BM.%26aulast%3DYing%26aufirst%3DB.%2BP.%26aulast%3DXu%26aufirst%3DY.%2BC.%26aulast%3DPhebus%26aufirst%3DL.%26aulast%3DSimmons%26aufirst%3DR.%2BM.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DIyengar%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DIdentification%2520of%2520a%2520high-affinity%2520binding%2520site%2520involved%2520in%2520the%2520transport%2520of%2520endocannabinoids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17852%26epage%3D17857%26doi%3D10.1073%2Fpnas.0507470102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelbaum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span><span class="refDoi"> DOI: 10.1126/science.1470919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1126%2Fscience.1470919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1470919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1946-1949&author=W.+A.+Devaneauthor=L.+Hanusauthor=A.+Breuerauthor=R.+G.+Pertweeauthor=L.+A.+Stevensonauthor=G.+Griffinauthor=D.+Gibsonauthor=A.+Mandelbaumauthor=A.+Etingerauthor=R.+Mechoulam&title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor&doi=10.1126%2Fscience.1470919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Hanus, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5090</span>),
    <span class="NLM_cas:pages">1946-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Arachidonylethanolamide, an arachidonic acid deriv. in the porcine brain, was identified as an endogenous ligand for the cannabinoid receptor.  The structure of this compd., anandamide, was detd. by mass spectrometry and NMR spectroscopy and was confirmed by synthesis.  Anandamide inhibited the specific binding of a radiolabeled cannabinoid probe to synaptosomal membranes in a manner typical of competitive ligands and produced a concn.-dependent inhibition of the elec. evoked twitch responses of the mouse vas deferens, a characteristic effect of psychotropic cannabinoids.  Anandamide may function as a natural ligand for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqh5E4vHczbVg90H21EOLACvtfcHk0liOfAuTJQ2kyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D&md5=13c7aa7316cd687240779f7f192d086b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1470919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1470919%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DMandelbaum%26aufirst%3DA.%26aulast%3DEtinger%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520structure%2520of%2520a%2520brain%2520constituent%2520that%2520binds%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1946%26epage%3D1949%26doi%3D10.1126%2Fscience.1470919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Shabat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligumsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatz, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almog, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayewitch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, Z.</span><span> </span><span class="NLM_article-title">Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/0006-2952(95)00109-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2F0006-2952%2895%2900109-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=7605349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK2MXmsl2ks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=83-90&author=R.+Mechoulamauthor=S.+Ben-Shabatauthor=L.+Hanusauthor=M.+Ligumskyauthor=N.+E.+Kaminskiauthor=A.+R.+Schatzauthor=A.+Gopherauthor=S.+Almogauthor=B.+R.+Martinauthor=D.+R.+Comptonauthor=R.+G.+Pertweeauthor=G.+Griffinauthor=M.+Bayewitchauthor=J.+Bargauthor=Z.+Vogel&title=Identification+of+an+endogenous+2-monoglyceride%2C+present+in+canine+gut%2C+that+binds+to+cannabinoid+receptors&doi=10.1016%2F0006-2952%2895%2900109-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors</span></div><div class="casAuthors">Mechoulam, Raphael; Ben-Shabat, Shimon; Hanus, Lumir; Ligumsky, Moshe; Kaminski, Norbert E.; Schatz, Anthony R.; Gopher, Asher; Almog, Shlomo; Martin, Billy R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-90</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study reports the isolation of 2-arachidonylglycerol (2-Ara-Gl) from canine intestines.  Its structure was detd. by mass spectrometry and by direct comparison with a synthetic sample.  2-Ara-Gl bound to membranes from cells transiently transfected with expression plasmids carrying DNA of either CB1 or CB2 (the 2 cannabinoid receptors identified thus far), with Ki values of 472 and 1400 nM, resp.  In the presence of forskolin, 2-Ara-Gl inhibited adenylate cyclase in isolated mouse spleen cells, at a potency level similar to that of Δ9-tetrahydrocannabinol (Δ9-THC).  Upon i.v. administration to mice, 2-Ara-Gl caused the typical tetrad of effects produced by THC: antinociception, immobility, redn. of spontaneous activity, and lowering of the rectal temp.  2-Ara-Gl also shared the ability of Δ9-THC to inhibit elec. evoked contractions of mouse isolated vasa deferentia; however, it was less potent than Δ9-THC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPw_8rVdXsObVg90H21EOLACvtfcHk0liOfAuTJQ2kyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsl2ks7Y%253D&md5=3d058ab1c59390723beeb64ea7714553</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2900109-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252900109-D%26sid%3Dliteratum%253Aachs%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DBen-Shabat%26aufirst%3DS.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DLigumsky%26aufirst%3DM.%26aulast%3DKaminski%26aufirst%3DN.%2BE.%26aulast%3DSchatz%26aufirst%3DA.%2BR.%26aulast%3DGopher%26aufirst%3DA.%26aulast%3DAlmog%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DBayewitch%26aufirst%3DM.%26aulast%3DBarg%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DZ.%26atitle%3DIdentification%2520of%2520an%2520endogenous%25202-monoglyceride%252C%2520present%2520in%2520canine%2520gut%252C%2520that%2520binds%2520to%2520cannabinoid%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D83%26epage%3D90%26doi%3D10.1016%2F0006-2952%2895%2900109-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hillard, C. J.</span><span> </span><span class="NLM_article-title">Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/S0090-6980(00)00051-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0090-6980%2800%2900051-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10785538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjt1CltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=3-18&author=C.+J.+Hillard&title=Biochemistry+and+pharmacology+of+the+endocannabinoids+arachidonylethanolamide+and+2-arachidonylglycerol&doi=10.1016%2FS0090-6980%2800%2900051-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol</span></div><div class="casAuthors">Hillard, Cecilia J.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">3-18</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 130 refs.  The purpose of this review is to discuss the cellular synthesis and inactivation of two putative endogenous ligands of the cannabinoid receptor, N-arachidonylethanolamine (AEA) and 2-arachidonylglycerol (2-AG).  Both ligands are synthesized by neurons and brain tissue in response to increased intracellular calcium concns.  Both ligands are substrates for fatty acid amide hydrolase (FAAH).  Both AEA and 2-AG bind to the neuronal form of the cannabinoid receptor (CB1).  AEA binds the receptor with moderate affinity and has the characteristics of a partial agonist, whereas, 2-AG binds with low affinity but exhibits full efficacy.  Two possible physiol. roles of the endocannabinoids and the CB1 receptor are discussed: the regulation of gestation and the regulation of gastrointestinal motility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbntWQBAJlybVg90H21EOLACvtfcHk0lgQbJDPGtp0iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjt1CltLw%253D&md5=339536d597eca9bd93fa781868e45fac</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2800%2900051-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252800%252900051-4%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26atitle%3DBiochemistry%2520and%2520pharmacology%2520of%2520the%2520endocannabinoids%2520arachidonylethanolamide%2520and%25202-arachidonylglycerol%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2000%26volume%3D61%26spage%3D3%26epage%3D18%26doi%3D10.1016%2FS0090-6980%2800%2900051-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Solorzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battista, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonietti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Selective <i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">20966</span><span class="NLM_x">–</span> <span class="NLM_lpage">20971</span><span class="refDoi"> DOI: 10.1073/pnas.0907417106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.0907417106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19926854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20966-20971&author=C.+Solorzanoauthor=C.+Zhuauthor=N.+Battistaauthor=G.+Astaritaauthor=A.+Lodolaauthor=S.+Rivaraauthor=M.+Morauthor=R.+Russoauthor=M.+Maccarroneauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Cuzzocreaauthor=G.+Tarziaauthor=D.+Piomelli&title=Selective+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition+reveals+a+key+role+for+endogenous+palmitoylethanolamide+in+inflammation&doi=10.1073%2Fpnas.0907417106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span></div><div class="casAuthors">Solorzano, Carlos; Zhu, Chenggang; Battista, Natalia; Astarita, Giuseppe; Lodola, Alessio; Rivara, Silvia; Mor, Marco; Russo, Roberto; Maccarrone, Mauro; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Cuzzocrea, Salvatore; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">20966-20971, S20966/1-S20966/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Identifying points of control in inflammation is essential to discovering safe and effective antiinflammatory medicines.  Palmitoylethanolamide (PEA) is a naturally occurring lipid amide that, when administered as a drug, inhibits inflammatory responses by engaging peroxisome proliferator-activated receptor-α (PPAR-α).  PEA is preferentially hydrolyzed by the cysteine amidase N- acylethanolamine-hydrolyzing acid amidase (NAAA), which is highly expressed in macrophages.  Here we report the discovery of a potent and selective NAAA inhibitor, N-[(3S)-2-oxo-3-oxetanyl]-3-phenylpropanamide [(S)-OOPP], and show that this inhibitor increases PEA levels in activated leukocytes and blunts responses induced by inflammatory stimuli both in vitro and in vivo.  These effects are stereoselective, mimicked by exogenous PEA, and abolished by PPAR-α deletion.  (S)-OOPP also attenuates inflammation and tissue damage and improves recovery of motor function in mice subjected to spinal cord trauma.  The results suggest that PEA activation of PPAR-α in leukocytes serves as an early stop signal that contrasts the progress of inflammation.  The PEA-hydrolyzing amidase NAAA may provide a previously undescribed target for antiinflammatory medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUMad22TONbVg90H21EOLACvtfcHk0lgQbJDPGtp0iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D&md5=9e8f84c9aabfc0d7c9d382d5a4c57706</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907417106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907417106%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DBattista%26aufirst%3DN.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSelective%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520reveals%2520a%2520key%2520role%2520for%2520endogenous%2520palmitoylethanolamide%2520in%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D20966%26epage%3D20971%26doi%3D10.1073%2Fpnas.0907417106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lo Verme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1124/mol.104.006353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fmol.104.006353" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=15-19&author=J.+Lo+Vermeauthor=J.+Fuauthor=G.+Astaritaauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+nuclear+receptor+peroxisome+proliferator-activated+receptor-%CE%B1+mediates+the+anti-inflammatory+actions+of+palmitoylethanolamide&doi=10.1124%2Fmol.104.006353"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006353%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520nuclear%2520receptor%2520peroxisome%2520proliferator-activated%2520receptor-%25CE%25B1%2520mediates%2520the%2520anti-inflammatory%2520actions%2520of%2520palmitoylethanolamide%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D15%26epage%3D19%26doi%3D10.1124%2Fmol.104.006353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oveisi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Verme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez de Fonseca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosengarth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giacomo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1038/nature01921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnature01921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12955147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFansrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=90-93&author=J.+Fuauthor=S.+Gaetaniauthor=F.+Oveisiauthor=J.+Lo+Vermeauthor=A.+Serranoauthor=F.+Rodriguez+de+Fonsecaauthor=A.+Rosengarthauthor=H.+Lueckeauthor=B.+Di+Giacomoauthor=G.+Tarziaauthor=D.+Piomelli&title=Oleylethanolamide+regulates+feeding+and+body+weight+through+activation+of+the+nuclear+receptor+PPAR-%CE%B1&doi=10.1038%2Fnature01921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α</span></div><div class="casAuthors">Fu, Jin; Gaetani, Silvana; Oveisi, Fariba; Lo Verme, Jesse; Serrano, Antonia; Rodriguez de Fonseca, Fernando; Rosengarth, Anja; Luecke, Hartmut; Di Giacomo, Barbara; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6953</span>),
    <span class="NLM_cas:pages">90-93</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oleylethanolamide (OEA) is a naturally occurring lipid that regulates satiety and body wt.  Although structurally related to the endogenous cannabinoid anandamide, OEA does not bind to cannabinoid receptors and its mol. targets have not been defined.  OEA binds with high affinity to the peroxisome-proliferator-activated receptor-α (PPAR-α), a nuclear receptor that regulates several aspects of lipid metab.  Administration of OEA produces satiety and reduces body wt. gain in wild-type mice, but not in mice deficient in PPAR-α.  Two distinct PPAR-α agonists have similar effects that are also contingent on PPAR-α expression, whereas potent and selective agonists for PPAR-γ and PPAR-β/δ are ineffective.  In the small intestine of wild-type but not PPAR-α-null mice, OEA regulates the expression of several PPAR-α target genes: it initiates the transcription of proteins involved in lipid metab. and represses inducible nitric oxide synthase, an enzyme that may contribute to feeding stimulation.  The authors' results, which show that OEA induces satiety by activating PPAR-α, identify an unexpected role for this nuclear receptor in regulating behavior, and raise possibilities for the treatment of eating disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-C_8AHpl3SbVg90H21EOLACvtfcHk0lhDGINs5HSIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFansrY%253D&md5=449ae587cd7d81339420ef58d790c9ac</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01921%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DOveisi%26aufirst%3DF.%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DSerrano%26aufirst%3DA.%26aulast%3DRodriguez%2Bde%2BFonseca%26aufirst%3DF.%26aulast%3DRosengarth%26aufirst%3DA.%26aulast%3DLuecke%26aufirst%3DH.%26aulast%3DDi%2BGiacomo%26aufirst%3DB.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DOleylethanolamide%2520regulates%2520feeding%2520and%2520body%2520weight%2520through%2520activation%2520of%2520the%2520nuclear%2520receptor%2520PPAR-%25CE%25B1%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D90%26epage%3D93%26doi%3D10.1038%2Fnature01921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Basavarajappa, B. S.</span><span> </span><span class="NLM_article-title">Critical enzymes involved in endocannabinoid metabolism</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.2174/092986607780090829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.2174%2F092986607780090829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17346227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVWmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=237-246&author=B.+S.+Basavarajappa&title=Critical+enzymes+involved+in+endocannabinoid+metabolism&doi=10.2174%2F092986607780090829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Critical enzymes involved in endocannabinoid metabolism</span></div><div class="casAuthors">Basavarajappa, Balapal S.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-246</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Investigations of the pathways involved in the metab. of endocannabinoids have grown exponentially in recent years following the discovery of cannabinoid receptors (CB) and their endogenous ligands, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG).  The in vivo biosynthesis of AEA has been shown to occur through several pathways mediated by N-acylphosphatidylethanolamide-phospholipase D (NAPE-PLD), a secretory PLA2 and PLC.  2-AG, a second endocannabinoid is generated through the action of selective enzymes such as phosphatidic acid phsophohydrolase, diacylglycerol lipase (DAGL), phosphoinositide-specific PLC (PI-PLC) and lyso-PLC.  A putative membrane transporter or facilitated diffusion is involved in the cellular uptake or release of endocannabinoids.  AEA is metabolized by fatty acid amidohydrolase (FAAH) and 2-AG is metabolized by both FAAH and monoacylglycerol lipase (MAGL).  The author presents an integrative overview of current research on the enzymes involved in the metab. of endocannabinoids and discusses possible therapeutic interventions for various diseases, including addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsOjUSQWqq0rVg90H21EOLACvtfcHk0lhDGINs5HSIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVWmurw%253D&md5=ea37be15921314a665ccef8eb8b452c0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986607780090829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986607780090829%26sid%3Dliteratum%253Aachs%26aulast%3DBasavarajappa%26aufirst%3DB.%2BS.%26atitle%3DCritical%2520enzymes%2520involved%2520in%2520endocannabinoid%2520metabolism%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2007%26volume%3D14%26spage%3D237%26epage%3D246%26doi%3D10.2174%2F092986607780090829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Simon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-<i>N</i>-acyl ethanolamine precursors in mouse brain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">9341</span><span class="NLM_x">–</span> <span class="NLM_lpage">9349</span><span class="refDoi"> DOI: 10.1074/jbc.M707807200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M707807200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=9341-9349&author=G.+M.+Simonauthor=B.+F.+Cravatt&title=Anandamide+biosynthesis+catalyzed+by+the+phosphodiesterase+GDE1+and+detection+of+glycerophospho-N-acyl+ethanolamine+precursors+in+mouse+brain&doi=10.1074%2Fjbc.M707807200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707807200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707807200%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DAnandamide%2520biosynthesis%2520catalyzed%2520by%2520the%2520phosphodiesterase%2520GDE1%2520and%2520detection%2520of%2520glycerophospho-N-acyl%2520ethanolamine%2520precursors%2520in%2520mouse%2520brain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D9341%26epage%3D9349%26doi%3D10.1074%2Fjbc.M707807200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Izzo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, D. G.</span><span> </span><span class="NLM_article-title">Unique pathway for anandamide synthesis and liver regeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">6339</span><span class="NLM_x">–</span> <span class="NLM_lpage">6340</span><span class="refDoi"> DOI: 10.1073/pnas.1103566108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.1103566108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=6339-6340&author=A.+A.+Izzoauthor=D.+G.+Deutsch&title=Unique+pathway+for+anandamide+synthesis+and+liver+regeneration&doi=10.1073%2Fpnas.1103566108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1103566108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1103566108%26sid%3Dliteratum%253Aachs%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DDeutsch%26aufirst%3DD.%2BG.%26atitle%3DUnique%2520pathway%2520for%2520anandamide%2520synthesis%2520and%2520liver%2520regeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D6339%26epage%3D6340%26doi%3D10.1073%2Fpnas.1103566108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Alhouayek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span> </span><span class="NLM_article-title">Harnessing the anti-inflammatory potential of palmitoylethanolamide</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1632</span><span class="NLM_x">–</span> <span class="NLM_lpage">1639</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.drudis.2014.06.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1632-1639&author=M.+Alhouayekauthor=G.+G.+Muccioli&title=Harnessing+the+anti-inflammatory+potential+of+palmitoylethanolamide&doi=10.1016%2Fj.drudis.2014.06.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DHarnessing%2520the%2520anti-inflammatory%2520potential%2520of%2520palmitoylethanolamide%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1632%26epage%3D1639%26doi%3D10.1016%2Fj.drudis.2014.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Deutsch, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, S. A.</span><span> </span><span class="NLM_article-title">Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1016/0006-2952(93)90486-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2F0006-2952%2893%2990486-G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=791-796&author=D.+G.+Deutschauthor=S.+A.+Chin&title=Enzymatic+synthesis+and+degradation+of+anandamide%2C+a+cannabinoid+receptor+agonist&doi=10.1016%2F0006-2952%2893%2990486-G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990486-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990486-G%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DD.%2BG.%26aulast%3DChin%26aufirst%3DS.%2BA.%26atitle%3DEnzymatic%2520synthesis%2520and%2520degradation%2520of%2520anandamide%252C%2520a%2520cannabinoid%2520receptor%2520agonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D791%26epage%3D796%26doi%3D10.1016%2F0006-2952%2893%2990486-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5899</span><span class="NLM_x">–</span> <span class="NLM_lpage">5921</span><span class="refDoi"> DOI: 10.1021/cr2002799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr2002799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=5899-5921&author=C.+A.+Rouzerauthor=L.+J.+Marnett&title=Endocannabinoid+oxygenation+by+cyclooxygenases%2C+lipoxygenases%2C+and+cytochromes+P450%3A+cross-talk+between+the+eicosanoid+and+endocannabinoid+signaling+pathways&doi=10.1021%2Fcr2002799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways</span></div><div class="casAuthors">Rouzer, Carol A.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5899-5921</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this review, the authors explore what is known about the interplay between the eicosanoid and endocannabinoid signaling networks and discuss the challenges and opportunities offered by this new field of inquiry.  The biosynthetic pathways for eicosanoids and endocannabinoids are reviewed and oxygenation of endocannabinoids by eicosanoid pathway enzymes is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQufJ-H9KlTbVg90H21EOLACvtfcHk0lhrL1PIY_1tvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu73I&md5=22c584636bbd21dd9caef72489b0074d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcr2002799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr2002799%26sid%3Dliteratum%253Aachs%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DEndocannabinoid%2520oxygenation%2520by%2520cyclooxygenases%252C%2520lipoxygenases%252C%2520and%2520cytochromes%2520P450%253A%2520cross-talk%2520between%2520the%2520eicosanoid%2520and%2520endocannabinoid%2520signaling%2520pathways%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D5899%26epage%3D5921%26doi%3D10.1021%2Fcr2002799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sun, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Involvement of <i>N</i>-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other <i>N</i>-acylethanolamines in macrophages</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1736</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2005.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2005.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=16154384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1736&publication_year=2005&pages=211-220&author=Y.+X.+Sunauthor=K.+Tsuboiauthor=L.+Y.+Zhaoauthor=Y.+Okamotoauthor=D.+M.+Lambertauthor=N.+Ueda&title=Involvement+of+N-acylethanolamine-hydrolyzing+acid+amidase+in+the+degradation+of+anandamide+and+other+N-acylethanolamines+in+macrophages&doi=10.1016%2Fj.bbalip.2005.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages</span></div><div class="casAuthors">Sun, Yong-Xin; Tsuboi, Kazuhito; Zhao, Li-Ying; Okamoto, Yasuo; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1736</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-220</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines including the endocannabinoid anandamide are known to be hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  In addn., we recently cloned an isoenzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)", which is active only at acidic pH [Tsuboi, Sun, Okamoto, Araki, Tonai, Ueda, J. Biol. Chem. 285 (2005) 11082-11092].  However, physiol. roles of NAAA remained unclear.  Here, we examd. a possible contribution of NAAA to the degrdn. of various N-acylethanolamines in macrophage cells.  NAAA mRNA as well as FAAH mRNA was detected in several macrophage-like cells, including RAW264.7, and mouse peritoneal macrophages.  The homogenates of RAW264.7 cells showed both the NAAA and FAAH activities which were confirmed with the aid of their resp. specific inhibitors, N-cyclohexanecarbonylpentadecylamine (CCP) and URB597.  As analyzed with intact cells, RAW264.7 cells and peritoneal macrophages degraded anandamide, N-palmitoylethanolamine, N-oleoylethanolamine, and N-stearoylethanolamine.  Pretreatment of the cells with CCP or URB597 partially inhibited the degrdn., and a combination of the two compds. caused more profound inhibition.  In contrast, the anandamide hydrolysis in mouse brain appeared to be principally attributable to FAAH despite the expression of NAAA in the brain.  These results suggested that NAAA and FAAH cooperatively degraded various N-acylethanolamines in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRw2Yw4epuc7Vg90H21EOLACvtfcHk0lhrL1PIY_1tvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O&md5=d4dbefcb0a2c84be624e98f1ee78f213</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2005.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2005.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520in%2520the%2520degradation%2520of%2520anandamide%2520and%2520other%2520N-acylethanolamines%2520in%2520macrophages%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2005%26volume%3D1736%26spage%3D211%26epage%3D220%26doi%3D10.1016%2Fj.bbalip.2005.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2007.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2007.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18096503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1347-1356&author=J.+L.+Blankmanauthor=G.+M.+Simonauthor=B.+F.+Cravatt&title=A+comprehensive+profile+of+brain+enzymes+that+hydrolyze+the+endocannabinoid+2-arachidonoylglycerol&doi=10.1016%2Fj.chembiol.2007.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol</span></div><div class="casAuthors">Blankman, Jacqueline L.; Simon, Gabriel M.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1347-1356</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Endogenous ligands for cannabinoid receptors ("endocannabinoids") include the lipid transmitters anandamide and 2-arachidonoylglycerol (2-AG).  Endocannabinoids modulate a diverse set of physiol. processes and are tightly regulated by enzymic biosynthesis and degrdn.  Termination of anandamide signaling by fatty acid amide hydrolase (FAAH) is well characterized, but less is known about the inactivation of 2-AG, which can be hydrolyzed by multiple enzymes in vitro, including FAAH and monoacylglycerol lipase (MAGL).  Here, we have taken a functional proteomic approach to comprehensively map 2-AG hydrolases in the mouse brain.  Our data reveal that ∼85% of brain 2-AG hydrolase activity can be ascribed to MAGL, and that the remaining 15% is mostly catalyzed by two uncharacterized enzymes, ABHD6 and ABHD12.  Interestingly, MAGL, ABHD6, and ABHD12 display distinct subcellular distributions, suggesting that they may control different pools of 2-AG in the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF_Kmd_7v5urVg90H21EOLACvtfcHk0lgeyMPtN7wEIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfE&md5=78c6355a3909bff3cbae25989ab6a956</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520comprehensive%2520profile%2520of%2520brain%2520enzymes%2520that%2520hydrolyze%2520the%2520endocannabinoid%25202-arachidonoylglycerol%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D1347%26epage%3D1356%26doi%3D10.1016%2Fj.chembiol.2007.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Marrs, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomazeau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodor, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodruff, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafourcade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzoni, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span> </span><span class="NLM_article-title">The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">957</span><span class="refDoi"> DOI: 10.1038/nn.2601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.2601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20657592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1artb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=951-957&author=W.+R.+Marrsauthor=J.+L.+Blankmanauthor=E.+A.+Horneauthor=A.+Thomazeauauthor=Y.+H.+Linauthor=J.+Coyauthor=A.+L.+Bodorauthor=G.+G.+Muccioliauthor=S.+S.+Huauthor=G.+Woodruffauthor=S.+Fungauthor=M.+Lafourcadeauthor=J.+P.+Alexanderauthor=J.+Z.+Longauthor=W.+Liauthor=C.+Xuauthor=T.+M%C3%B6llerauthor=K.+Mackieauthor=O.+J.+Manzoniauthor=B.+F.+Cravattauthor=N.+Stella&title=The+serine+hydrolase+ABHD6+controls+the+accumulation+and+efficacy+of+2-AG+at+cannabinoid+receptors&doi=10.1038%2Fnn.2601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors</span></div><div class="casAuthors">Marrs, William R.; Blankman, Jacqueline L.; Horne, Eric A.; Thomazeau, Aurore; Lin, Yi Hsing; Coy, Jonathan; Bodor, Agnes L.; Muccioli, Giulio G.; Hu, Sherry Shu-Jung; Woodruff, Grace; Fung, Susan; Lafourcade, Mathieu; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Xu, Cong; Moeller, Thomas; Mackie, Ken; Manzoni, Olivier J.; Cravatt, Benjamin F.; Stella, Nephi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">951-957</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The endocannabinoid 2-arachidonoylglycerol (2-AG) regulates neurotransmission and neuroinflammation by activating CB1 cannabinoid receptors on neurons and CB2 cannabinoid receptors on microglia.  Enzymes that hydrolyze 2-AG, such as monoacylglycerol lipase, regulate the accumulation and efficacy of 2-AG at cannabinoid receptors.  We found that the recently described serine hydrolase α-β-hydrolase domain 6 (ABHD6) also controls the accumulation and efficacy of 2-AG at cannabinoid receptors.  In cells from the BV-2 microglia cell line, ABHD6 knockdown reduced hydrolysis of 2-AG and increased the efficacy with which 2-AG can stimulate CB2-mediated cell migration.  ABHD6 was expressed by neurons in primary culture and its inhibition led to activity-dependent accumulation of 2-AG.  In adult mouse cortex, ABHD6 was located postsynaptically and its selective inhibition allowed the induction of CB1-dependent long-term depression by otherwise subthreshold stimulation.  Our results indicate that ABHD6 is a rate-limiting step of 2-AG signaling and is therefore a bona fide member of the endocannabinoid signaling system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6V8gdFxrZ37Vg90H21EOLACvtfcHk0ljglhSGlysj6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1artb8%253D&md5=a095d28f808dd34ecdd7b469b7ad37bc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnn.2601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2601%26sid%3Dliteratum%253Aachs%26aulast%3DMarrs%26aufirst%3DW.%2BR.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DHorne%26aufirst%3DE.%2BA.%26aulast%3DThomazeau%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DY.%2BH.%26aulast%3DCoy%26aufirst%3DJ.%26aulast%3DBodor%26aufirst%3DA.%2BL.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DHu%26aufirst%3DS.%2BS.%26aulast%3DWoodruff%26aufirst%3DG.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DLafourcade%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DM%25C3%25B6ller%26aufirst%3DT.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DManzoni%26aufirst%3DO.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStella%26aufirst%3DN.%26atitle%3DThe%2520serine%2520hydrolase%2520ABHD6%2520controls%2520the%2520accumulation%2520and%2520efficacy%2520of%25202-AG%2520at%2520cannabinoid%2520receptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D951%26epage%3D957%26doi%3D10.1038%2Fnn.2601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wei, B. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">A second fatty acid amide hydrolase with variable distribution among placental mammals</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">36569</span><span class="NLM_x">–</span> <span class="NLM_lpage">36578</span><span class="refDoi"> DOI: 10.1074/jbc.M606646200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M606646200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17015445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=36569-36578&author=B.+Q.+Weiauthor=T.+S.+Mikkelsenauthor=M.+K.+McKinneyauthor=E.+S.+Landerauthor=B.+F.+Cravatt&title=A+second+fatty+acid+amide+hydrolase+with+variable+distribution+among+placental+mammals&doi=10.1074%2Fjbc.M606646200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals</span></div><div class="casAuthors">Wei, Binqing Q.; Mikkelsen, Tarjei S.; McKinney, Michele K.; Lander, Eric S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">36569-36578</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fatty acid amides constitute a large and diverse class of lipid transmitters that includes the endogenous cannabinoid anandamide and the sleep-inducing substance oleamide.  The magnitude and duration of fatty acid amide signaling are controlled by enzymic hydrolysis in vivo.  Fatty acid amide hydrolase (FAAH) activity in mammals has been primarily attributed to a single integral membrane enzyme of the amidase signature (AS) family.  Here, we report the functional proteomic discovery of a second membrane-assocd. AS enzyme in humans that displays FAAH activity.  The gene that encodes this second FAAH enzyme was found in multiple primate genomes, marsupials, and more distantly related vertebrates, but, remarkably, not in a no. of lower placental mammals, including mouse and rat.  The two human FAAH enzymes, which share 20% sequence identity and are referred to hereafter as FAAH-1 and FAAH-2, hydrolyzed primary fatty acid amide substrates (e.g., oleamide) at equiv. rates, whereas FAAH-1 exhibited much greater activity with N-acyl ethanolamines (e.g., anandamide) and N-acyl taurines.  Both enzymes were sensitive to the principal classes of FAAH inhibitors synthesized to date, including O-aryl carbamates and α-keto heterocycles.  These data coupled with the overlapping, but distinct tissue distributions of FAAH-1 and FAAH-2 suggest that these proteins may collaborate to control fatty acid amide catabolism in primates.  The apparent loss of the FAAH-2 gene in some lower mammals should be taken into consideration when extrapolating genetic or pharmacol. findings on the fatty acid amide signaling system across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuV_6Ew68-CbVg90H21EOLACvtfcHk0ljglhSGlysj6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eltrvP&md5=16273562700ac4fe3ef10c9917f0d3aa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606646200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606646200%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DB.%2BQ.%26aulast%3DMikkelsen%26aufirst%3DT.%2BS.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520second%2520fatty%2520acid%2520amide%2520hydrolase%2520with%2520variable%2520distribution%2520among%2520placental%2520mammals%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D36569%26epage%3D36578%26doi%3D10.1074%2Fjbc.M606646200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">De Petrocellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders</span> <span class="citation_source-journal">Chem. Phys. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1016/S0009-3084(00)00196-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0009-3084%2800%2900196-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2000&pages=191-209&author=L.+De+Petrocellisauthor=D.+Melckauthor=T.+Bisognoauthor=V.+Di+Marzo&title=Endocannabinoids+and+fatty+acid+amides+in+cancer%2C+inflammation+and+related+disorders&doi=10.1016%2FS0009-3084%2800%2900196-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0009-3084%2800%2900196-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-3084%252800%252900196-1%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DMelck%26aufirst%3DD.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoids%2520and%2520fatty%2520acid%2520amides%2520in%2520cancer%252C%2520inflammation%2520and%2520related%2520disorders%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2000%26volume%3D108%26spage%3D191%26epage%3D209%26doi%3D10.1016%2FS0009-3084%2800%2900196-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">De Fonseca, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Arco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermudez-Silva, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span> </span><span class="NLM_article-title">The endocannabinoid system: physiology and pharmacology</span> <span class="citation_source-journal">Alcohol Alcohol. (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1093/alcalc/agh110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1093%2Falcalc%2Fagh110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15550444" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=2-14&author=F.+R.+De+Fonsecaauthor=I.+Del+Arcoauthor=F.+J.+Bermudez-Silvaauthor=A.+Bilbaoauthor=A.+Cippitelliauthor=M.+Navarro&title=The+endocannabinoid+system%3A+physiology+and+pharmacology&doi=10.1093%2Falcalc%2Fagh110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Falcalc%2Fagh110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Falcalc%252Fagh110%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFonseca%26aufirst%3DF.%2BR.%26aulast%3DDel%2BArco%26aufirst%3DI.%26aulast%3DBermudez-Silva%26aufirst%3DF.%2BJ.%26aulast%3DBilbao%26aufirst%3DA.%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DM.%26atitle%3DThe%2520endocannabinoid%2520system%253A%2520physiology%2520and%2520pharmacology%26jtitle%3DAlcohol%2520Alcohol.%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2005%26volume%3D40%26spage%3D2%26epage%3D14%26doi%3D10.1093%2Falcalc%2Fagh110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistis, M.</span><span> </span><span class="NLM_article-title">Hub and switches: endocannabinoid signalling in midbrain dopamine neurons</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">3276</span><span class="NLM_x">–</span> <span class="NLM_lpage">3285</span><span class="refDoi"> DOI: 10.1098/rstb.2011.0383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1098%2Frstb.2011.0383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23108546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3276-3285&author=M.+Melisauthor=M.+Pistis&title=Hub+and+switches%3A+endocannabinoid+signalling+in+midbrain+dopamine+neurons&doi=10.1098%2Frstb.2011.0383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Hub and switches: endocannabinoid signalling in midbrain dopamine neurons</span></div><div class="casAuthors">Melis, Miriam; Pistis, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3276-3285</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The last decade has provided a wealth of exptl. data on the role played by lipids belonging to the endocannabinoid family in several facets of physiopathol. of dopamine neurons.  We currently suggest that these mols., being intimately connected with diverse metabolic and signalling pathways, might differently affect various functions of dopamine neurons through activation not only of surface receptors, but also of nuclear receptors.  It is now emerging how dopamine neurons can regulate their constituent biomols. to compensate for changes in either internal functions or external conditions.  Consequently, dopamine neurons use these lipid mols. as metabolic and homeostatic signal detectors, which can dynamically impact cell function and fitness.  Because dysfunctions of the dopamine system underlie diverse neuropsychiatric disorders, including schizophrenia and drug addiction, the importance of better understanding the correlation between an unbalanced endocannabinoid signal and the dopamine system is even greater.  Particularly, because dopamine neurons are crit. in controlling incentive-motivated behaviors, the involvement of endocannabinoid mols. in fine-tuning dopamine cell activity opened new avenues in both understanding and treating drug addiction.  Here, we review recent advances that have shed new light on the understanding of differential roles of endocannabinoids and their cognate mols. in the regulation of the reward circuit, and discuss their anti-addicting properties, particularly with a focus on their potential engagement in the prevention of relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFHivVY1Oe_bVg90H21EOLACvtfcHk0lhbzMWg91A4Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtL3N&md5=e3fef5ff99ab66f11496fb1b0d1c3120</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1098%2Frstb.2011.0383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2011.0383%26sid%3Dliteratum%253Aachs%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DPistis%26aufirst%3DM.%26atitle%3DHub%2520and%2520switches%253A%2520endocannabinoid%2520signalling%2520in%2520midbrain%2520dopamine%2520neurons%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D3276%26epage%3D3285%26doi%3D10.1098%2Frstb.2011.0383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hoesel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J. A.</span><span> </span><span class="NLM_article-title">The complexity of NF-κB signaling in inflammation and cancer</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1186/1476-4598-12-86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1186%2F1476-4598-12-86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23286373" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1-15&author=B.+Hoeselauthor=J.+A.+Schmid&title=The+complexity+of+NF-%CE%BAB+signaling+in+inflammation+and+cancer&doi=10.1186%2F1476-4598-12-86"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-12-86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-12-86%26sid%3Dliteratum%253Aachs%26aulast%3DHoesel%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520complexity%2520of%2520NF-%25CE%25BAB%2520signaling%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DMol.%2520Cancer%26date%3D2013%26volume%3D12%26spage%3D1%26epage%3D15%26doi%3D10.1186%2F1476-4598-12-86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wahli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalik, L.</span><span> </span><span class="NLM_article-title">PPARs at the crossroads of lipid signaling and inflammation</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span><span class="refDoi"> DOI: 10.1016/j.tem.2012.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.tem.2012.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22704720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFChur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=351-363&author=W.+Wahliauthor=L.+Michalik&title=PPARs+at+the+crossroads+of+lipid+signaling+and+inflammation&doi=10.1016%2Fj.tem.2012.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PPARs at the crossroads of lipid signaling and inflammation</span></div><div class="casAuthors">Wahli, Walter; Michalik, Liliane</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">351-363</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are ligand-dependent transcription factors whose activation affects genes controlling vital processes.  Among them, the peroxisome proliferator-activated receptors (PPARs) have emerged as links between lipids, metabolic diseases, and innate immunity.  PPARs are activated by fatty acids and their derivs., many of which also signal through membrane receptors, thereby creating a lipid signaling network between the cell surface and the nucleus.  Tissues that play a role in whole-body metabolic homeostasis, such as adipose tissue, liver, skeletal muscle, intestines, and blood vessel walls, are prone to inflammation when metab. is disturbed, a complication that promotes type 2 diabetes and cardiovascular disease.  This review discusses the protective roles of PPARs in inflammatory conditions and the therapeutic anti-inflammatory potential of PPAR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqYSg4LxUyOLVg90H21EOLACvtfcHk0lhbzMWg91A4Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFChur4%253D&md5=c75c774b268207244eb1ba0e476633ef</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2012.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2012.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DWahli%26aufirst%3DW.%26aulast%3DMichalik%26aufirst%3DL.%26atitle%3DPPARs%2520at%2520the%2520crossroads%2520of%2520lipid%2520signaling%2520and%2520inflammation%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D23%26spage%3D351%26epage%3D363%26doi%3D10.1016%2Fj.tem.2012.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ho, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, M. D.</span><span> </span><span class="NLM_article-title">‘Entourage’effects of <i>N</i>-palmitoylethanolamide and <i>N</i>-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1038/bjp.2008.324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fbjp.2008.324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18695637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=837-846&author=W.+S.+Hoauthor=D.+A.+Barrettauthor=M.+D.+Randall&title=%E2%80%98Entourage%E2%80%99effects+of+N-palmitoylethanolamide+and+N-oleoylethanolamide+on+vasorelaxation+to+anandamide+occur+through+TRPV1+receptors&doi=10.1038%2Fbjp.2008.324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors</span></div><div class="casAuthors">Ho, W.-S. V.; Barrett, D. A.; Randall, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-846</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The endocannabinoid N-arachidonoylethanolamide (anandamide) is co-synthesized with other N-acylethanolamides, namely N-palmitoylethanolamide (PEA) and N-oleoylethanolamide (OEA), which have been shown to potentiate anandamide responses (so-called entourage effects') in non-vascular tissues.  It remains unclear whether such interactions occur in the circulation.  In rat isolated small mesenteric arteries, the effects of PEA and OEA on relaxation to anandamide and tissue contents of the N-acylethanolamides were examd. under myog. conditions.  Anandamide-induced relaxation was potentiated by pretreatment with PEA (10 μ) or OEA (1 μ), or in combination.  The potentiation by PEA and OEA was endothelium-independent and abolished by treatment with capsaicin (10 μ), which desensitizes the transient receptor potential vanilloid type 1 (TRPV1) receptor system, or by the TRPV1 receptor antagonist, N-(3-methoxyphenyl)-4-chlorocinnamide (SB366791) (2 μ).  It was also obsd. at molar ratios of anandamide and PEA (or OEA) similar to those found in mesenteric arteries.  PEA and inhibition of anandamide hydrolysis by 3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate (URB597) (1 μ) additively potentiated anandamide responses.  On the other hand, PEA and OEA also induced vasorelaxation per se (rank order of potency: anandamide > OEA > PEA), but relaxation to the three N-acylethanolamides displayed different sensitivity to treatment with capsaicin, SB366791 and URB597.  For example, relaxations to anandamide and OEA, but not PEA, were attenuated by both capsaicin and SB366791.  This study shows that PEA and OEA potentiate relaxant responses to anandamide through TRPV1 receptors in rat small mesenteric arteries.  The congeners also induce vasorelaxation per se, suggesting a function for the N-acylethanolamides in vascular control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDBOPl-3Uj7bVg90H21EOLACvtfcHk0lgJLx8j8hAKxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGhsb7M&md5=6697529871a930663642fa67f0b0f85e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.324%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DW.%2BS.%26aulast%3DBarrett%26aufirst%3DD.%2BA.%26aulast%3DRandall%26aufirst%3DM.%2BD.%26atitle%3D%25E2%2580%2598Entourage%25E2%2580%2599effects%2520of%2520N-palmitoylethanolamide%2520and%2520N-oleoylethanolamide%2520on%2520vasorelaxation%2520to%2520anandamide%2520occur%2520through%2520TRPV1%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D837%26epage%3D846%26doi%3D10.1038%2Fbjp.2008.324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+La+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0lgJLx8j8hAKxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giang, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayfield, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilula, N. B.</span><span> </span><span class="NLM_article-title">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1038/384083a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2F384083a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=8900284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=83-87&author=B.+F.+Cravattauthor=D.+K.+Giangauthor=S.+P.+Mayfieldauthor=D.+L.+Bogerauthor=R.+A.+Lernerauthor=N.+B.+Gilula&title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&doi=10.1038%2F384083a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</span></div><div class="casAuthors">Cravatt, Benjamin F.; Giang, Dan K.; Mayfield, Stephen P.; Boger, Dale L.; Lerner, Richard A.; Gilula, Norton B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6604</span>),
    <span class="NLM_cas:pages">83-87</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Endogenous neuromodulatory mols.. are commonly couples to specific metabolic enzymes to ensure rapid signal inactivation.  Thus, acetylcholine is hydrolyzed by acetylcholine esterase and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases.  Previously, we reported the structure and sleep-deproved cats.  Cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems and block gap-junction communication in glial cells (our unpublished results).  We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid.  We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase, from rat liver plasma membranes.  We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor, to arachidonic acid, indicating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling mols., the fatty-acid amides.  Therefore we will hereafter refer to oelamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEhJfsk7jdmLVg90H21EOLACvtfcHk0ljDKj51ybM3Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVegt7s%253D&md5=155095116ad61669c06c4b6dcc25e28a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F384083a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384083a0%26sid%3Dliteratum%253Aachs%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DMayfield%26aufirst%3DS.%2BP.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DLerner%26aufirst%3DR.%2BA.%26aulast%3DGilula%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520characterization%2520of%2520an%2520enzyme%2520that%2520degrades%2520neuromodulatory%2520fatty-acid%2520amides%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D83%26epage%3D87%26doi%3D10.1038%2F384083a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Jonsson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1263</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0704199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsj.bjp.0704199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=11498512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFKhsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2001&pages=1263-1275&author=K.+O.+Jonssonauthor=S.+Vandevoordeauthor=D.+M.+Lambertauthor=G.+Tigerauthor=C.+J.+Fowler&title=Effects+of+homologues+and+analogues+of+palmitoylethanolamide+upon+the+inactivation+of+the+endocannabinoid+anandamide&doi=10.1038%2Fsj.bjp.0704199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide</span></div><div class="casAuthors">Jonsson, Kent-Olov; Vandevoorde, Severine; Lambert, Didier M.; Tiger, Gunnar; Fowler, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1263-1275</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The ability of a series of homologs and analogs of palmitoylethanolamide to inhibit the uptake and fatty acid amidohydrolase (FAAH)-catalyzed hydrolysis of [3H]-anandamide ([3H]-AEA) has been investigated.  2 Palmitoylethanolamide and homologs with chain lengths from 12-18 carbon atoms inhibited rat brain [3H]-AEA metab. with pI50 values of ∼ 5.  Homologues with chain lengths ≤eight carbon atoms gave <20% inhibition at 100 μM.  3 R-palmitoyl-(2-methyl)ethanolamide, palmitoylisopropylamide and oleoylethanolamide inhibited [3H]-AEA metab. with pI50 values of 5.39 (competitive inhibition), 4.89 (mixed type inhibition) and 5.33 (mixed type inhibition), resp.  4 With the exception of oleoylethanolamide, the compds. did not produce dramatic inhibition of [3H]-WIN 55,212-2 binding to human CB2 receptors expressed on CHO cells.  Palmitoylethanolamide, palmitoylisopropylamide and R-palmitoyl-(2-methyl)ethanolamide had modest effects upon [3H]-CP 55,940 binding to human CB1 receptors expressed on CHO cells.  5 Most of the compds. had little effect upon the uptake of [3H]-AEA into C6 and/or RBL-2H3 cells.  However, palmitoylcyclohexamide (100 μM) and palmitoylisopropylamide (30 and 100 μM) produced more inhibition of [3H]-AEA uptake than expected to result from inhibition of [3H]-AEA metab. alone.  6 In intact C6 cells, palmitoylisopropylamide and oleoylethanolamide inhibited formation of [3H]-ethanolamine from [3H]-AEA to a similar extent as AM404, whereas palmitoylethanolamide, palmitoylcyclohexamide and R-palmitoyl-(2-methyl)ethanolamide were less effective.  7 These data provide useful information upon the ability of palmitoylethanolamide analogs to act as "entourage" compds.  Palmitoylisopropylamide may prove useful as a template for design of compds. that reduce the cellular accumulation and metab. of AEA without affecting either CB1 or CB2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplw6RBYKt53rVg90H21EOLACvtfcHk0ljDKj51ybM3Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFKhsbg%253D&md5=90ab7c81ff1efa8beaa19e2d8b3d5c05</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704199%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DK.%2BO.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DTiger%26aufirst%3DG.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DEffects%2520of%2520homologues%2520and%2520analogues%2520of%2520palmitoylethanolamide%2520upon%2520the%2520inactivation%2520of%2520the%2520endocannabinoid%2520anandamide%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D133%26spage%3D1263%26epage%3D1275%26doi%3D10.1038%2Fsj.bjp.0704199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bracey, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1796</span><span class="refDoi"> DOI: 10.1126/science.1076535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1126%2Fscience.1076535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12459591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1793-1796&author=M.+H.+Braceyauthor=M.+A.+Hansonauthor=K.+R.+Masudaauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Structural+adaptations+in+a+membrane+enzyme+that+terminates+endocannabinoid+signaling&doi=10.1126%2Fscience.1076535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling</span></div><div class="casAuthors">Bracey, Michael H.; Hanson, Michael A.; Masuda, Kim R.; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5599</span>),
    <span class="NLM_cas:pages">1793-1796</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular communication in the nervous system is mediated by chem. messengers that include amino acids, monoamines, peptide hormones, and lipids.  An interesting question is how neurons regulate signals that are transmitted by membrane-embedded lipids.  Here, we report the 2.8 angstrom crystal structure of the integral membrane protein fatty acid amide hydrolase (FAAH), an enzyme that degrades members of the endocannabinoid class of signaling lipids and terminates their activity.  The structure of FAAH complexed with an arachidonyl inhibitor reveals how a set of discrete structural alterations allows this enzyme, in contrast to sol. hydrolases of the same family, to integrate into cell membranes and establish direct access to the bilayer from its active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTj6G-8THMiLVg90H21EOLACvtfcHk0ljS77Ht-0D_tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D&md5=01545bfbd00f31af713db259f41cb0ba</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076535%26sid%3Dliteratum%253Aachs%26aulast%3DBracey%26aufirst%3DM.%2BH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructural%2520adaptations%2520in%2520a%2520membrane%2520enzyme%2520that%2520terminates%2520endocannabinoid%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1793%26epage%3D1796%26doi%3D10.1126%2Fscience.1076535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Palermo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campomanes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlisberger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span> </span><span class="NLM_article-title">Anandamide hydrolysis in FAAH reveals a dual strategy for efficient enzyme-assisted amide bond cleavage <i>via</i> nitrogen inversion</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1021/jp5052276</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp5052276" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2015&pages=789-801&author=G.+Palermoauthor=P.+Campomanesauthor=A.+Cavalliauthor=U.+Rothlisbergerauthor=M.+De+Vivo&title=Anandamide+hydrolysis+in+FAAH+reveals+a+dual+strategy+for+efficient+enzyme-assisted+amide+bond+cleavage+via+nitrogen+inversion&doi=10.1021%2Fjp5052276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide Hydrolysis in FAAH Reveals a Dual Strategy for Efficient Enzyme-Assisted Amide Bond Cleavage via Nitrogen Inversion</span></div><div class="casAuthors">Palermo, Giulia; Campomanes, Pablo; Cavalli, Andrea; Rothlisberger, Ursula; De Vivo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-801</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we combined classical mol. dynamics (MD) and quantum mech./mol. mechanics (QM/MM) simulations to unravel the whole catalytic cycle of fatty acid amide hydrolase (FAAH) in complex with anandamide, the main neurotransmitters involved in the control of pain.  While microsecond MD simulations of FAAH in a realistic membrane/water environment provided a solid model for the reactant state of the enzymic complex, QM/MM simulations depict now a highly concerted two-step catalytic mechanism characterized by (1) acyl-enzyme formation after hydrolysis of the substrate amide bond and (2) deacylation reaction with restoration of the catalytic machinery.  We found that a crucial event for anandamide hydrolysis is the inversion of the reactive nitrogen of the scissile amide bond, which occurs during the acylation rate-limiting step.  We show that FAAH uses an exquisite catalytic strategy to induce amide bond distortion, reactive nitrogen inversion, and amide bond hydrolysis, promoting catalysis to completion.  This new strategy is likely to be of general applicability to other amidases/peptidases that show similar catalytic site architectures, providing crucial insights for de novo enzyme design or drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkUuuanDLcJLVg90H21EOLACvtfcHk0ljS77Ht-0D_tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjsr7N&md5=b6c738e9eb18172771070f5d7e8974b4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjp5052276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp5052276%26sid%3Dliteratum%253Aachs%26aulast%3DPalermo%26aufirst%3DG.%26aulast%3DCampomanes%26aufirst%3DP.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRothlisberger%26aufirst%3DU.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26atitle%3DAnandamide%2520hydrolysis%2520in%2520FAAH%2520reveals%2520a%2520dual%2520strategy%2520for%2520efficient%2520enzyme-assisted%2520amide%2520bond%2520cleavage%2520via%2520nitrogen%2520inversion%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2015%26volume%3D119%26spage%3D789%26epage%3D801%26doi%3D10.1021%2Fjp5052276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Structure and function of fatty acid amide hydrolase</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.74.082803.133450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1146%2Fannurev.biochem.74.082803.133450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15952893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2005&pages=411-432&author=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Structure+and+function+of+fatty+acid+amide+hydrolase&doi=10.1146%2Fannurev.biochem.74.082803.133450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of fatty acid amide hydrolase</span></div><div class="casAuthors">McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that degrades the fatty acid amide family of endogenous signaling lipids, which includes the endogenous cannabinoid, anandamide, and the sleep-inducing substance, oleamide.  FAAH belongs to a large and diverse class of enzymes referred to as the amidase signature (AS) family.  Investigations into the structure and function of FAAH, in combination with complementary studies of other AS enzymes, have engendered provocative mol. models to explain how this enzyme integrates into cell membranes and terminates fatty acid amide signaling in vivo.  These studies, as well as their biol. and therapeutic implications, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO7TpUTr6n7Vg90H21EOLACvtfcHk0ljS77Ht-0D_tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D&md5=d28b43f14feb6894d48e907064087867</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.74.082803.133450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.74.082803.133450%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructure%2520and%2520function%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2005%26volume%3D74%26spage%3D411%26epage%3D432%26doi%3D10.1146%2Fannurev.biochem.74.082803.133450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kamerlin, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshel, A.</span><span> </span><span class="NLM_article-title">On catalytic preorganization in oxyanion holes: highlighting the problems with the gas-phase modeling of oxyanion holes and illustrating the need for complete enzyme models</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">6391</span><span class="NLM_x">–</span> <span class="NLM_lpage">6401</span><span class="refDoi"> DOI: 10.1021/jo100651s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo100651s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaisbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=6391-6401&author=S.+C.+Kamerlinauthor=Z.+T.+Chuauthor=A.+Warshel&title=On+catalytic+preorganization+in+oxyanion+holes%3A+highlighting+the+problems+with+the+gas-phase+modeling+of+oxyanion+holes+and+illustrating+the+need+for+complete+enzyme+models&doi=10.1021%2Fjo100651s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">On Catalytic Preorganization in Oxyanion Holes: Highlighting the Problems with the Gas-Phase Modeling of Oxyanion Holes and Illustrating the Need for Complete Enzyme Models</span></div><div class="casAuthors">Kamerlin, Shina C. L.; Chu, Zhen T.; Warshel, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6391-6401</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxyanion holes play a major role in catalyzing enzymic reactions, yet the corresponding energetics is frequently misunderstood.  The main problem may be assocd. with the nontrivial nature of the electrostatic preorganization effect, without following the relevant formulation.  That is, although the energetics of oxyanion holes have been fully quantified in early studies (which include both the enzymic and ref. soln. reactions), the findings of these studies are sometimes overlooked, and, in some cases, it is assumed that gas-phase calcns. with a fixed model of an oxyanion hole are sufficient for assessing the corresponding effect in the protein.  Herein, we present a systematic anal. of this issue, clarifying the problems assocd. with modeling oxyanions by means of two fixed water mols. (or related constructs).  We then re-emphasize the point that the effect of the oxyanion hole is mainly due to the fact that the relevant dipoles are already set in an orientation that stabilizes the TS charges, whereas the corresponding dipoles in soln. are randomly oriented, resulting in the need to pay a very large reorganization energy.  Simply calcg. interaction energies with relatively fixed species cannot capture this crucial point, and considering it may help in advancing rational enzyme design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEyHEtFmbHwrVg90H21EOLACvtfcHk0lhXzKnGt4yw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaisbfJ&md5=29f4644716f9a5c2664a97db0fa4b8f9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo100651s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100651s%26sid%3Dliteratum%253Aachs%26aulast%3DKamerlin%26aufirst%3DS.%2BC.%26aulast%3DChu%26aufirst%3DZ.%2BT.%26aulast%3DWarshel%26aufirst%3DA.%26atitle%3DOn%2520catalytic%2520preorganization%2520in%2520oxyanion%2520holes%253A%2520highlighting%2520the%2520problems%2520with%2520the%2520gas-phase%2520modeling%2520of%2520oxyanion%2520holes%2520and%2520illustrating%2520the%2520need%2520for%2520complete%2520enzyme%2520models%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D6391%26epage%3D6401%26doi%3D10.1021%2Fjo100651s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by α-ketoheterocycle inhibitors revealed from cocrystal structures</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">10497</span><span class="NLM_x">–</span> <span class="NLM_lpage">10506</span><span class="refDoi"> DOI: 10.1021/ja902694n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja902694n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=10497-10506&author=M.+Mileniauthor=J.+Garfunkleauthor=J.+K.+DeMartinoauthor=B.+F.+Cravattauthor=D.+L.+Bogerauthor=R.+C.+Stevens&title=Binding+and+inactivation+mechanism+of+a+humanized+fatty+acid+amide+hydrolase+by+%CE%B1-ketoheterocycle+inhibitors+revealed+from+cocrystal+structures&doi=10.1021%2Fja902694n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja902694n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902694n%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DDeMartino%26aufirst%3DJ.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DBinding%2520and%2520inactivation%2520mechanism%2520of%2520a%2520humanized%2520fatty%2520acid%2520amide%2520hydrolase%2520by%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520revealed%2520from%2520cocrystal%2520structures%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D10497%26epage%3D10506%26doi%3D10.1021%2Fja902694n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Palermo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campomanes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlisberger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span> </span><span class="NLM_article-title">Keys to lipid selection in fatty acid amide hydrolase catalysis: structural flexibility, gating residues and multiple binding pockets</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1004231</span><span class="refDoi"> DOI: 10.1371/journal.pcbi.1004231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1371%2Fjournal.pcbi.1004231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26111155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsV2htLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004231&author=G.+Palermoauthor=I.+Bauerauthor=P.+Campomanesauthor=A.+Cavalliauthor=A.+Armirottiauthor=S.+Girottoauthor=U.+Rothlisbergerauthor=M.+De+Vivo&title=Keys+to+lipid+selection+in+fatty+acid+amide+hydrolase+catalysis%3A+structural+flexibility%2C+gating+residues+and+multiple+binding+pockets&doi=10.1371%2Fjournal.pcbi.1004231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Keys to lipid selection in fatty acid amide hydrolase catalysis: structural flexibility, gating residues and multiple binding pockets</span></div><div class="casAuthors">Palermo, Giulia; Bauer, Inga; Campomanes, Pablo; Cavalli, Andrea; Armirotti, Andrea; Girotto, Stefania; Rothlisberger, Ursula; De Vivo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1004231/1-e1004231/25</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The fatty acid amide hydrolase (FAAH) regulates the endocannabinoid system, cleaving primarily the lipid messenger anandamide.  FAAH has been well characterized over the years, and importantly, it represents a promising drug target to treat several diseases, including inflammatory-related diseases and cancer.  But its enzymic mechanism for lipid selection to specifically hydrolyze anandamide, rather than similar bioactive lipids, remains elusive.  Here, we clarify this mechanism in FAAH, examg. the role of the dynamic paddle, which is formed by the gating residues Phe432 and Trp531 at the boundary between two cavities that form the FAAH catalytic site (the "membrane-access" and the "acyl chain-binding" pockets).  We integrate microsecond-long MD simulations of wild type and double mutant model systems (Phe432Ala and Trp531Ala) of FAAH, embedded in a realistic membrane/water environment, with mutagenesis and kinetic expts.  We comparatively analyze three fatty acid substrates with different hydrolysis rates (anandamide > oleamide > palmitoylethanolamide).  Our findings identify FAAH's mechanism to selectively accommodate anandamide into a multi-pocket binding site, and to properly orient the substrate in pre-reactive conformations for efficient hydrolysis that is interceded by the dynamic paddle.  Our findings therefore endorse a structural framework for a lipid selection mechanism mediated by structural flexibility and gating residues between multiple binding cavities, as found in FAAH.  Based on the available structural data, this exquisite catalytic strategy for substrate specificity seems to be shared by other lipid-degrading enzymes with similar enzymic architecture.  The mechanistic insights for lipid selection might assist de novo enzyme design or drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjpXtbYx6P0LVg90H21EOLACvtfcHk0lhXzKnGt4yw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsV2htLY%253D&md5=33224e5dcd45d20a14b6e3f60f7ca8e6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1004231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1004231%26sid%3Dliteratum%253Aachs%26aulast%3DPalermo%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DCampomanes%26aufirst%3DP.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DGirotto%26aufirst%3DS.%26aulast%3DRothlisberger%26aufirst%3DU.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26atitle%3DKeys%2520to%2520lipid%2520selection%2520in%2520fatty%2520acid%2520amide%2520hydrolase%2520catalysis%253A%2520structural%2520flexibility%252C%2520gating%2520residues%2520and%2520multiple%2520binding%2520pockets%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3De1004231%26doi%3D10.1371%2Fjournal.pcbi.1004231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ueda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span> </span><span class="NLM_article-title">Purification and characterization of an acid amidase selective for <i>N</i>-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">35552</span><span class="NLM_x">–</span> <span class="NLM_lpage">35557</span><span class="refDoi"> DOI: 10.1074/jbc.M106261200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M106261200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=11463796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=35552-35557&author=N.+Uedaauthor=K.+Yamanakaauthor=S.+Yamamoto&title=Purification+and+characterization+of+an+acid+amidase+selective+for+N-palmitoylethanolamine%2C+a+putative+endogenous+anti-inflammatory+substance&doi=10.1074%2Fjbc.M106261200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</span></div><div class="casAuthors">Ueda, Natsuo; Yamanaka, Kenji; Yamamoto, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">35552-35557</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-Arachidonoylethanolamine (anandamide) is cannabimimetic, and N-palmitoylethanolamine is anti-inflammatory and immunosuppressive.  We found an amidase that is more active with the latter than the former in contrast to the previously known anandamide amidohydrolase for which N-palmitoylethanolamine is a poor substrate.  Proteins solubilized by freezing and thawing from the 12,000 × g pellet of various rat organs hydrolyzed [14C]N-palmitoylethanolamine to palmitic acid and ethanolamine.  The specific enzyme activity was higher in the order of lung > spleen > small intestine > thymus > cecum, and high activity was found in peritoneal and alveolar macrophages.  The enzyme with a mol. mass of 31 kDa was purified from rat lung to a specific activity of 1.8 μmol/min/mg protein.  Relative reactivities of the enzyme with various N-acylethanolamines (100 μM) were as follows: N-palmitoylethanolamine, 100%; N-myristoylethanolamine, 48%; N-stearoylethanolamine, 21%; N-oleoylethanolamine, 20%; N-linoleoylethanolamine, 13%; anandamide, 8%.  The enzyme was the most active at pH 5 and was activated 7-fold by Triton X-100.  The enzyme was almost insensitive to Me arachidonyl fluorophosphonate, which inhibited anandamide amidohydrolase potently.  Thus, the new enzyme referred to as N-palmitoylethanolamine hydrolase was clearly distinguishable from anandamide amidohydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UIYxO9poNrVg90H21EOLACvtfcHk0lhXzKnGt4yw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFahs7g%253D&md5=b7bb8c14c642547023582e27c4c1d79e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106261200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106261200%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DPurification%2520and%2520characterization%2520of%2520an%2520acid%2520amidase%2520selective%2520for%2520N-palmitoylethanolamine%252C%2520a%2520putative%2520endogenous%2520anti-inflammatory%2520substance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D35552%26epage%3D35557%26doi%3D10.1074%2Fjbc.M106261200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Molecular characterization of <i>N</i>-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">11082</span><span class="NLM_x">–</span> <span class="NLM_lpage">11092</span><span class="refDoi"> DOI: 10.1074/jbc.M413473200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.M413473200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15655246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11082-11092&author=K.+Tsuboiauthor=Y.+X.+Sunauthor=Y.+Okamotoauthor=N.+Arakiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+novel+member+of+the+choloylglycine+hydrolase+family+with+structural+and+functional+similarity+to+acid+ceramidase&doi=10.1074%2Fjbc.M413473200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Sun, Yong-Xin; Okamoto, Yasuo; Araki, Nobukazu; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">11082-11092</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines, including anandamide (an endocannabinoid) and N-palmitoylethanolamine (an anti-inflammatory and neuroprotective substance), are hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase.  Moreover, we found another amidohydrolase catalyzing the same reaction only at acidic pH, and we purified it from rat lung (Ueda, N., Yamanaka, K., and Yamamoto, S. (2001) J. Biol. Chem. 276, 35552-35557).  Here we report complementary DNA cloning and functional expression of the enzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)" from human, rat, and mouse.  The deduced primary structures revealed that NAAA had no homol. to fatty acid amide hydrolase but belonged to the choloylglycine hydrolase family.  Human NAAA was essentially identical to a gene product that had been noted to resemble acid ceramidase but lacked ceramide hydrolyzing activity.  The recombinant human NAAA overexpressed in HEK293 cells hydrolyzed various N-acylethanolamines with N-palmitoylethanolamine as the most reactive substrate.  Most interestingly, a very low ceramide hydrolyzing activity was also detected with NAAA, and N-lauroylethanolamine hydrolyzing activity was obsd. with acid ceramidase.  By the use of tunicamycin and endoglycosidase, NAAA was found to be a glycoprotein.  Furthermore, the enzyme was proteolytically processed to a shorter form at pH 4.5 but not at pH 7.4.  Expression anal. of a green fluorescent protein-NAAA fusion protein showed a lysosome-like distribution in HEK293 cells.  The organ distribution of the mRNA in rats revealed its wide distribution with the highest expression in lung.  These results demonstrated that NAAA is a novel N-acylethanolamine-hydrolyzing enzyme that shows structural and functional similarity to acid ceramidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWVjmZKJjGKLVg90H21EOLACvtfcHk0ljdJHhC4lY_rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D&md5=2b108cd3e23441001b040085eea0fdc0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413473200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413473200%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DN.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520novel%2520member%2520of%2520the%2520choloylglycine%2520hydrolase%2520family%2520with%2520structural%2520and%2520functional%2520similarity%2520to%2520acid%2520ceramidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11082%26epage%3D11092%26doi%3D10.1074%2Fjbc.M413473200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takezaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">The <i>N</i>-acylethanolamine-hydrolyzing acid amidase (NAAA)</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1914</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span><span class="refDoi"> DOI: 10.1002/cbdv.200790159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbdv.200790159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17712833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVelsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=1914-1925&author=K.+Tsuboiauthor=N.+Takezakiauthor=N.+Ueda&title=The+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1002%2Fcbdv.200790159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Tsuboi, Kazuhito; Takezaki, Naoko; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-1925</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Ra review.  Bioactive N-acylethanolamines, including the endocannabinoid anandamide and anti-inflammatory N-palmitoylethanolamine, are hydrolyzed to fatty acids and ethanolamine in animal tissues by the catalysis of fatty acid amide hydrolase (FAAH).  We recently cloned cDNA of N-acylethanolamine-hydrolyzing acid amidase (NAAA), another enzyme catalyzing the same reaction, from human, rat, and mouse.  NAAA reveals no sequence homol. with FAAH and belongs to the choloylglycine hydrolase family.  The most striking catalytic property of NAAA is pH optimum at 4.5-5, which is consistent with its immunocytochem. localization in lysosomes.  In rat, NAAA is highly expressed in lung, spleen, thymus, and intestine.  Notably, the expression level of NAAA is exceptionally high in rat alveolar macrophages.  The primary structure of NAAA exhibits 33-35% amino acid identity to that of acid ceramidase, a lysosomal enzyme hydrolyzing ceramide to fatty acid and sphingosine.  NAAA actually showed a low, but detectable ceramide-hydrolyzing activity, while acid ceramidase hydrolyzed N-lauroylethanolamine.  Thus, NAAA is a novel lysosomal hydrolase, which is structurally and functionally similar to acid ceramidase.  These results suggest a unique role of NAAA in the degrdn. of N-acylethanolamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcno9P-bI5IrVg90H21EOLACvtfcHk0ljdJHhC4lY_rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVelsLzJ&md5=d2e7ca65c420146103a3331268c7c510</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200790159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200790159%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTakezaki%26aufirst%3DN.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DThe%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DChem.%2520Biodiversity%26date%3D2007%26volume%3D4%26spage%3D1914%26epage%3D1925%26doi%3D10.1002%2Fcbdv.200790159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zhao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Proteolytic activation and glycosylation of <i>N</i>-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1771</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2007.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17980170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=1397-1405&author=L.+Y.+Zhaoauthor=K.+Tsuboiauthor=Y.+Okamotoauthor=S.+Nagahataauthor=N.+Ueda&title=Proteolytic+activation+and+glycosylation+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+lysosomal+enzyme+involved+in+the+endocannabinoid+metabolism&doi=10.1016%2Fj.bbalip.2007.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span></div><div class="casAuthors">Zhao, Li-Ying; Tsuboi, Kazuhito; Okamoto, Yasuo; Nagahata, Shunichiro; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1397-1405</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme hydrolyzing bioactive N-acylethanolamines, including anandamide and N-palmitoylethanolamine.  Previously, we suggested that NAAA is glycosylated and proteolytically cleaved.  Here, we investigated the mechanism and significance of the cleavage of human NAAA overexpressed in human embryonic kidney 293 cells.  Western blotting with anti-NAAA antibody revealed that most of NAAA in the cell homogenate was the cleaved 30-kDa form.  However, some of NAAA were released outside the cells and the extracellular enzyme was mostly the uncleaved 48-kDa form.  When incubated at pH 4.5, the 48-kDa form was time-dependently converted to the 30-kDa form with concomitant increase in the N-palmitoylethanolamine-hydrolyzing activity.  The purified 48-kDa form was also cleaved and activated.  However, the cleavage did not proceed at pH 7.4 or in the presence of p-chloromercuribenzoic acid.  The mutant C126S was resistant to the cleavage and remained inactive.  These results suggested that this specific proteolysis is a self-catalyzed activation step.  We next detd. N-glycosylation sites of human NAAA by site-directed mutagenesis addressed to asparagine residues in six potential N-glycosylation sites.  The results exhibited that Asn-37, Asn-107, Asn-309, and Asn-333 are actual N-glycosylation sites.  The glycosylation appeared to play an important role in stabilizing the enzyme protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFuWgy8q2PbVg90H21EOLACvtfcHk0ljdJHhC4lY_rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J&md5=db9d83135905d5558679f307517e92b7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DNagahata%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DProteolytic%2520activation%2520and%2520glycosylation%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520lysosomal%2520enzyme%2520involved%2520in%2520the%2520endocannabinoid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D1397%26epage%3D1405%26doi%3D10.1016%2Fj.bbalip.2007.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title">Amino acid residues crucial in pH regulation and proteolytic activation of <i>N</i>-acylethanolamine-hydrolyzing acid amidase</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2008.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18793752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=710-717&author=J.+Wangauthor=L.+Y.+Zhaoauthor=T.+Uyamaauthor=K.+Tsuboiauthor=T.+Tonaiauthor=N.+Ueda&title=Amino+acid+residues+crucial+in+pH+regulation+and+proteolytic+activation+of+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1016%2Fj.bbalip.2008.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase</span></div><div class="casAuthors">Wang, Jun; Zhao, Li-Ying; Uyama, Toru; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">710-717</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme which hydrolyzes bioactive N-acylethanolamines, including anandamide and N-palmitoylethanolamine.  NAAA shows acidic pH optimum in terms of both catalytic activity and maturation by specific proteolysis.  However, mol. mechanism involved in this characteristic pH dependency remained unclear.  Here we report the important role of Glu-195 of human NAAA by analyzing the mutants E195A and E195Q over-expressed in human embryonic kidney 293 cells.  Concanamycin A, which raises lysosomal pH, inhibited maturation of the wild-type, but not of the Glu-195 mutants.  The purified precursors of the mutants, but not the wild-type, were proteolytically cleaved at pH 7.4 during 24-h incubation.  Furthermore, when assayed for N-palmitoylethanolamine-hydrolyzing activity at different pH, the mutants did not exhibit a sharp peak around pH 4.5 in the pH-dependent activity profile.  Mutants of seven other glutamic acid residues did not show such an abnormality.  These results suggested a unique role of Glu-195 in the pH-dependent activity and proteolytic maturation.  Moreover, Arg-142, Asp-145, and Asn-287 as well as previously identified Cys-126 were shown to be essential for the proteolytic activation.  Since these residues were predicted to be catalytically important, the results strongly suggested that the proteolysis occurs through an autocatalytic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJjRnXSxv8kbVg90H21EOLACvtfcHk0lh4Z7C_L6taiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7jL&md5=29181122ead930d1b718d85f1977cd2f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DUyama%26aufirst%3DT.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DAmino%2520acid%2520residues%2520crucial%2520in%2520pH%2520regulation%2520and%2520proteolytic%2520activation%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D710%26epage%3D717%26doi%3D10.1016%2Fj.bbalip.2008.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Advances in the discovery of <i>N</i>-acylethanolamine acid amidase inhibitors</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1016/j.phrs.2014.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.phrs.2014.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24798679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=11-17&author=T.+Bandieraauthor=S.+Ponzanoauthor=D.+Piomelli&title=Advances+in+the+discovery+of+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.phrs.2014.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the discovery of N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Bandiera, Tiziano; Ponzano, Stefano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-Acylethanolamine acid amidase (NAAA) is a cysteine amidase that hydrolyzes satd. or monounsatd. fatty acid ethanolamides, such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA has been shown to exert analgesic and anti-inflammatory effects by engaging peroxisome proliferator-activated receptor-α.  Like other fatty acid ethanolamides, PEA is not stored in cells, but produced on demand from cell membrane precursors, and its actions are terminated by intracellular hydrolysis by either fatty acid amide hydrolase or NAAA.  Endogenous levels of PEA and OEA have been shown to decrease during inflammation.  Modulation of the tissue levels of PEA by inhibition of enzymes responsible for the breakdown of this lipid mediator may represent therefore a new therapeutic strategy for the treatment of pain and inflammation.  While a large no. of inhibitors of fatty acid amide hydrolase have been discovered, few compds. have been reported to inhibit NAAA activity.  Here, we describe the most representative NAAA inhibitors and briefly highlight their pharmacol. profile.  A recent study has shown that a NAAA inhibitor attenuated heat hyperalgesia and mech. allodynia caused by local inflammation or nerve damage in animal models of pain and inflammation.  This finding encourages further exploration of the pharmacol. of NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUwRrGiJPWfbVg90H21EOLACvtfcHk0lh4Z7C_L6taiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFaqur0%253D&md5=a8673471686df8f77b19ec318316e192</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAdvances%2520in%2520the%2520discovery%2520of%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2014%26volume%3D86%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.phrs.2014.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ueda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyama, T.</span><span> </span><span class="NLM_article-title"><i>N</i>-acylethanolamine metabolism with special reference to <i>N</i>-acylethanolamine-hydrolyzing acid amidase (NAAA)</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1016/j.plipres.2010.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.plipres.2010.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20152858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=299-315&author=N.+Uedaauthor=K.+Tsuboiauthor=T.+Uyama&title=N-acylethanolamine+metabolism+with+special+reference+to+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1016%2Fj.plipres.2010.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-315</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-acylethanolamines (NAEs) constitute a class of bioactive lipid mols. present in animal and plant tissues.  Among the NAEs, N-arachidonoylethanolamine (anandamide), N-palmitoylethanolamine, and N-oleoylethanolamine attract much attention due to cannabimimetic activity as an endocannabinoid, anti-inflammatory and analgesic activities, and anorexic activity, resp.  In mammalian tissues, NAEs are formed from glycerophospholipids through the phosphodiesterase-transacylation pathway consisting of Ca2+-dependent N-acyltransferase and N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.  Recent studies revealed the presence of alternative pathways and enzymes responsible for the NAE formation.  As for the degrdn. of NAEs, fatty acid amide hydrolase (FAAH), which hydrolyzes NAEs to fatty acids and ethanolamine, plays a central role.  However, a lysosomal enzyme referred to as NAE-hydrolyzing acid amidase (NAAA) also catalyzes the same reaction and may be a new target for the development of therapeutic drugs.  In this article we discuss recent progress in the studies on the enzymes involved in the biosynthesis and degrdn. of NAEs with special ref. to NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqB2KZKbKuLVg90H21EOLACvtfcHk0lh4Z7C_L6taiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK&md5=286dd6b1ccaa5965fb5ca79abcf859af</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2010.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2010.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26atitle%3DN-acylethanolamine%2520metabolism%2520with%2520special%2520reference%2520to%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2010%26volume%3D49%26spage%3D299%26epage%3D315%26doi%3D10.1016%2Fj.plipres.2010.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Karlsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellman, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, C.</span><span> </span><span class="NLM_article-title">cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase evolutionary relationship to esterases, lysophospholipases, and haloperoxidases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">27218</span><span class="NLM_x">–</span> <span class="NLM_lpage">27223</span><span class="refDoi"> DOI: 10.1074/jbc.272.43.27218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1074%2Fjbc.272.43.27218" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=27218-27223&author=M.+Karlssonauthor=J.+A.+Contrerasauthor=U.+Hellmanauthor=H.+Tornqvistauthor=C.+Holm&title=cDNA+cloning%2C+tissue+distribution%2C+and+identification+of+the+catalytic+triad+of+monoglyceride+lipase+evolutionary+relationship+to+esterases%2C+lysophospholipases%2C+and+haloperoxidases&doi=10.1074%2Fjbc.272.43.27218"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.43.27218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.43.27218%26sid%3Dliteratum%253Aachs%26aulast%3DKarlsson%26aufirst%3DM.%26aulast%3DContreras%26aufirst%3DJ.%2BA.%26aulast%3DHellman%26aufirst%3DU.%26aulast%3DTornqvist%26aufirst%3DH.%26aulast%3DHolm%26aufirst%3DC.%26atitle%3DcDNA%2520cloning%252C%2520tissue%2520distribution%252C%2520and%2520identification%2520of%2520the%2520catalytic%2520triad%2520of%2520monoglyceride%2520lipase%2520evolutionary%2520relationship%2520to%2520esterases%252C%2520lysophospholipases%252C%2520and%2520haloperoxidases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D27218%26epage%3D27223%26doi%3D10.1074%2Fjbc.272.43.27218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauvois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1002/cbic.200900621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbic.200900621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19957260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=218-227&author=G.+Labarauthor=C.+Bauvoisauthor=F.+Borelauthor=J.+L.+Ferrerauthor=J.+Woutersauthor=D.+M.+Lambert&title=Crystal+structure+of+the+human+monoacylglycerol+lipase%2C+a+key+actor+in+endocannabinoid+signaling&doi=10.1002%2Fcbic.200900621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling</span></div><div class="casAuthors">Labar, Geoffray; Bauvois, Cedric; Borel, Franck; Ferrer, Jean-Luc; Wouters, Johan; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-227</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol plays a major role in endocannabinoid signaling, and is tightly regulated by monoacylglycerol lipase (MAGL).  Here, the authors report the crystal structure of human MAGL.  The protein crystd. as a dimer, and despite structural homologies to haloperoxidases and esterases, it distinguished itself by a wide and hydrophobic access to the catalytic site.  An apolar helix covering the active site also gave structural insight into the amphotropic character of MAGL, and likely explains how MAGL interacts with membranes to recruit its substrate.  Docking of 2-arachidonoylglycerol highlighted a hydrophobic and a hydrophilic cavity that accommodated the lipid into the catalytic site.  Moreover, the authors identified Cys-201 as the crucial residue in MAGL inhibition by N-arachidonylmaleimide, a SH group-reactive compd.  In addn. to the advance in the knowledge of endocannabinoids degrdn. routes, the structure of MAGL paves the way for future medicinal chem. results aimed at the design of new drugs exploiting 2-arachidonoylglycerol transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomb-R4j6WugrVg90H21EOLACvtfcHk0lh05IjJEaAGWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D&md5=3caddaf36eb688fa3aeea940f6441b36</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900621%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3DBorel%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.%2BL.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520monoacylglycerol%2520lipase%252C%2520a%2520key%2520actor%2520in%2520endocannabinoid%2520signaling%26jtitle%3DChemBioChem%26date%3D2010%26volume%3D11%26spage%3D218%26epage%3D227%26doi%3D10.1002%2Fcbic.200900621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheuret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoornaert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">Structural basis for human monoglyceride lipase inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.11.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.jmb.2009.11.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19962385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=663-673&author=T.+Bertrandauthor=F.+Aug%C3%A9author=J.+Houtmannauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=V.+Mikolauthor=P.+Berneauthor=N.+Michotauthor=D.+Cheuretauthor=C.+Hoornaertauthor=M.+Mathieu&title=Structural+basis+for+human+monoglyceride+lipase+inhibition&doi=10.1016%2Fj.jmb.2009.11.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Human Monoglyceride Lipase Inhibition</span></div><div class="casAuthors">Bertrand, T.; Auge, F.; Houtmann, J.; Rak, A.; Vallee, F.; Mikol, V.; Berne, P. F.; Michot, N.; Cheuret, D.; Hoornaert, C.; Mathieu, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) is a serine hydrolase that hydrolyzes 2-arachidonoylglycerol (2-AG) into arachidonic acid and glycerol.  2-AG is an endogenous ligand of cannabinoid receptors, involved in various physiol. processes in the brain.  We present here the first crystal structure of human MGL in its apo form and in complex with the covalent inhibitor SAR629.  MGL shares the classic fold of the α/β hydrolase family but depicts an unusually large hydrophobic occluded tunnel with a highly flexible lid at its entry and the catalytic triad buried at its end.  Structures reveal the configuration of the catalytic triad and the shape and nature of the binding site of 2-AG.  The bound structure of SAR629 highlights the key interactions for productive binding with MGL.  The shape of the tunnel suggests a high druggability of the protein and provides an attractive template for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRiDWkFIBQObVg90H21EOLACvtfcHk0lh05IjJEaAGWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D&md5=149fa9052c872b50c71e4d95d3c967d7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.11.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.11.060%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DAug%25C3%25A9%26aufirst%3DF.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DBerne%26aufirst%3DP.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DCheuret%26aufirst%3DD.%26aulast%3DHoornaert%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520human%2520monoglyceride%2520lipase%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D396%26spage%3D663%26epage%3D673%26doi%3D10.1016%2Fj.jmb.2009.11.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><div class="note"><p class="first last">Bertrand and co-workers purified another isoform of human MAGL (Q6IBG9_HUMAN) consisting of 313 amino acids vs 303 for the previously described isoform (Q99685_HUMAN). Thus, X-ray crystal structures of MAGL disclosed by Bertrand’s team exhibit the numbering discrepancy (i.e., Ser132-Asp249-His279 acts as the catalytic triad instead of Ser-122-Asp239-His269).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bertrand+and+co-workers+purified+another+isoform+of+human+MAGL+%28Q6IBG9_HUMAN%29+consisting+of+313+amino+acids+vs+303+for+the+previously+described+isoform+%28Q99685_HUMAN%29.+Thus%2C+X-ray+crystal+structures+of+MAGL+disclosed+by+Bertrand%E2%80%99s+team+exhibit+the+numbering+discrepancy+%28i.e.%2C+Ser132-Asp249-His279+acts+as+the+catalytic+triad+instead+of+Ser-122-Asp239-His269%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2607</span><span class="refDoi"> DOI: 10.2174/092986710791859414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.2174%2F092986710791859414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20491633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2588-2607&author=G.+Labarauthor=J.+Woutersauthor=D.+M.+Lambert&title=A+review+on+the+monoacylglycerol+lipase%3A+at+the+interface+between+fat+and+endocannabinoid+signalling&doi=10.2174%2F092986710791859414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling</span></div><div class="casAuthors">Labar, G.; Wouters, J.; Lambert, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2588-2607</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Together with anandamide, 2-arachidonoylglycerol (2-AG) constitutes one of the main representatives of a family of endogenous lipids known as endocannabinoids.  These act by binding to CB1 and CB2 cannabinoid receptors, the mol. target of the psychoactive compd. Δ9-THC, both in the periphery and in the central nervous system, where they behave as retrograde messengers to modulate synaptic transmission.  These last years, evidence has accumulated to demonstrate the lead role played by the monoacylglycerol lipase (MAGL) in the regulation of 2-arachidonoylglycerol (2-AG) levels.  Considering the numerous physiol. functions played by this endocannabinoid, MAGL is now considered a promising target for therapeutics, as inhibitors of this enzyme could reveal useful for the treatment of pain and inflammatory disorders, as well as in cancer research, among others.  Here we review the milestones that punctuated MAGL history, from its discovery to recent advances in the field of inhibitors development.  An emphasis is given on the recent elucidation of the tridimensional structure of the enzyme, which could offer new opportunities for rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUHXu1GAauLVg90H21EOLACvtfcHk0lh05IjJEaAGWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nK&md5=bff89a0988768b26b17604ec38bf70df</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F092986710791859414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859414%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DA%2520review%2520on%2520the%2520monoacylglycerol%2520lipase%253A%2520at%2520the%2520interface%2520between%2520fat%2520and%2520endocannabinoid%2520signalling%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2588%26epage%3D2607%26doi%3D10.2174%2F092986710791859414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salo, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemi, R.</span><span> </span><span class="NLM_article-title">Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2005.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2005.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15975510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=649-656&author=S.+M.+Saarioauthor=O.+M.+Saloauthor=T.+Nevalainenauthor=A.+Posoauthor=J.+T.+Laitinenauthor=T.+J%C3%A4rvinenauthor=R.+Niemi&title=Characterization+of+the+sulfhydryl-sensitive+site+in+the+enzyme+responsible+for+hydrolysis+of+2-arachidonoyl-glycerol+in+rat+cerebellar+membranes&doi=10.1016%2Fj.chembiol.2005.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes</span></div><div class="casAuthors">Saario, Susanna M.; Salo, Outi M. H.; Nevalainen, Tapio; Poso, Antti; Laitinen, Jarmo T.; Jaervinen, Tomi; Niemi, Riku</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">649-656</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: We have previously reported that the endocannabinoid, 2-arachidonoyl-glycerol (2-AG), is hydrolyzed in rat cerebellar membranes by monoglyceride lipase (MGL)-like enzymic activity.  The present study shows that, like MGL, 2-AG-degrading enzymic activity is sensitive to inhibition by sulfhydryl-specific reagents.  Inhibition studies of this enzymic activity by N-ethylmaleimide analogs revealed that analogs with bulky hydrophobic N-substitution were more potent inhibitors than hydrophilic or less bulky agents.  Interestingly, the substrate analog N-arachidonylmaleimide was found to be the most potent inhibitor.  A comparison model of MGL was constructed to get a view on the cysteine residues located near the binding site.  These findings support our previous conclusion that the 2-AG-degrading enzymic activity in rat cerebellar membranes corresponds to MGL or MGL-like enzyme and should facilitate further efforts to develop potent and more selective MGL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIe8FWTM802bVg90H21EOLACvtfcHk0ljf_um3xIps6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7w%253D&md5=52dc6f35fc0954a0216df0ed1cb7e2e9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DSalo%26aufirst%3DO.%2BM.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DNiemi%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520the%2520sulfhydryl-sensitive%2520site%2520in%2520the%2520enzyme%2520responsible%2520for%2520hydrolysis%2520of%25202-arachidonoyl-glycerol%2520in%2520rat%2520cerebellar%2520membranes%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D649%26epage%3D656%26doi%3D10.1016%2Fj.chembiol.2005.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotsey, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghomian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Discovery of potent and reversible monoacylglycerol lipase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1052</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19875078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCnt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=1045-1052&author=A.+R.+Kingauthor=E.+Y.+Dotseyauthor=A.+Lodolaauthor=K.+M.+Jungauthor=A.+Ghomianauthor=Y.+Qiuauthor=J.+Fuauthor=M.+Morauthor=D.+Piomelli&title=Discovery+of+potent+and+reversible+monoacylglycerol+lipase+inhibitors&doi=10.1016%2Fj.chembiol.2009.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors</span></div><div class="casAuthors">King, Alvin R.; Dotsey, Emmanuel Y.; Lodola, Alessio; Jung, Kwang Mook; Ghomian, Azar; Qiu, Yan; Fu, Jin; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1045-1052</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Monoacylglycerol lipase (MGL) is a serine hydrolase involved in the biol. deactivation of the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG).  Previous efforts to design MGL inhibitors have focused on chem. scaffolds that irreversibly block the activity of this enzyme.  Here, we describe two naturally occurring terpenoids, pristimerin and euphol, which inhibit MGL activity with high potency (median effective concn., IC50 = 93 nM and 315 nM, resp.) through a reversible mechanism.  Mutational and modeling studies suggest that the two agents occupy a common hydrophobic pocket located within the putative lid domain of MGL, and each reversibly interacts with one of two adjacent cysteine residues (Cys201 and Cys208) flanking such pocket.  This previously unrecognized regulatory region might offer a mol. target for potent and reversible inhibitors of MGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywJC_pwcNjrVg90H21EOLACvtfcHk0ljf_um3xIps6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCnt7bE&md5=b36dfed9cf065754986f599836d053a3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDotsey%26aufirst%3DE.%2BY.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DGhomian%26aufirst%3DA.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520reversible%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D1045%26epage%3D1052%26doi%3D10.1016%2Fj.chembiol.2009.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2009.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19635411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=744-753&author=J.+Z.+Longauthor=D.+K.+Nomuraauthor=B.+F.+Cravatt&title=Characterization+of+monoacylglycerol+lipase+inhibition+reveals+differences+in+central+and+peripheral+endocannabinoid+metabolism&doi=10.1016%2Fj.chembiol.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism</span></div><div class="casAuthors">Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">744-753</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Monoacylglycerol lipase (MAGL) is a principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG).  The authors recently reported a piperidine carbamate, JZL184, that inhibits MAGL with high potency and selectivity.  Here, the authors describe a comprehensive mechanistic characterization of JZL184.  The authors provide evidence that JZL184 irreversibly inhibits MAGL via carbamoylation of the enzyme's serine nucleophile.  Functional proteomic anal. of mice treated with JZL184 revealed that this inhibitor maintains good selectivity for MAGL across a wide range of central and peripheral tissues.  Interestingly, MAGL blockade produced marked, tissue-specific differences in monoglyceride metab., with brain showing the most dramatic elevations in 2-AG and peripheral tissues often showing greater changes in other monoglycerides.  Collectively, these studies indicate that MAGL exerts tissue-dependent control over endocannabinoid and monoglyceride metab. and designate JZL184 as a selective tool to characterize the functions of MAGL in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-iZXIq9TSLVg90H21EOLACvtfcHk0ljf_um3xIps6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D&md5=020a5cb6ac9430ba9d3eac3c7b9ba216</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DCharacterization%2520of%2520monoacylglycerol%2520lipase%2520inhibition%2520reveals%2520differences%2520in%2520central%2520and%2520peripheral%2520endocannabinoid%2520metabolism%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D744%26epage%3D753%26doi%3D10.1016%2Fj.chembiol.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Sharma, R.</span><span> </span><span class="NLM_article-title">Enzyme Inhibition: Mechanisms and Scope</span>. In  <span class="citation_source-book">Enzyme Inhibition and Bioapplications</span>; <span class="NLM_contrib-group">Sharma, R.</span>, Ed.; <span class="NLM_publisher-name">InTech</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>DOI: <span class="refDoi"> DOI: 10.5772/39273</span> , <a href="http://www.intechopen.com/books/enzyme-inhibition-and-bioapplications/enzyme-inhibition-mechanisms-and-scope" class="extLink">http://www.intechopen.com/books/enzyme-inhibition-and-bioapplications/enzyme-inhibition-mechanisms-and-scope</a>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.5772%2F39273" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Sharmaauthor=R.+Sharma&title=Enzyme+Inhibition+and+Bioapplications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.5772%2F39273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F39273%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26atitle%3DEnzyme%2520Inhibition%253A%2520Mechanisms%2520and%2520Scope%26btitle%3DEnzyme%2520Inhibition%2520and%2520Bioapplications%26aulast%3DSharma%26aufirst%3DR.%26pub%3DInTech%26date%3D2012%26doi%3D10.5772%2F39273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">13019</span><span class="NLM_x">–</span> <span class="NLM_lpage">13030</span><span class="refDoi"> DOI: 10.1021/bi701378g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi701378g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyiurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=13019-13030&author=K.+Ahnauthor=D.+S.+Johnsonauthor=L.+R.+Fitzgeraldauthor=M.+Liimattaauthor=A.+Arendseauthor=T.+Stevensonauthor=E.+T.+Lundauthor=R.+A.+Nugentauthor=T.+K.+Nomanbhoyauthor=J.+P.+Alexanderauthor=B.+F.+Cravatt&title=Novel+mechanistic+class+of+fatty+acid+amide+hydrolase+inhibitors+with+remarkable+selectivity&doi=10.1021%2Fbi701378g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity</span></div><div class="casAuthors">Ahn, Kyunghye; Johnson, Douglas S.; Fitzgerald, Laura R.; Liimatta, Marya; Arendse, Andrea; Stevenson, Tracy; Lund, Eric. T.; Nugent, Richard A.; Nomanbhoy, Tyzoon K.; Alexander, Jessica P.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">13019-13030</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane enzyme that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic, anti-inflammatory, anxiolytic, and antidepressant phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for treatment of pain, inflammation, and other central nervous system disorders.  However, the FAAH inhibitors reported to date lack drug-like pharmacokinetic properties and/or selectivity.  Herein the authors describe piperidine/piperazine ureas represented by N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750) and N-phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide (PF-622) as a novel mechanistic class of FAAH inhibitors.  PF-750 and PF-622 show higher in vitro potencies than previously established classes of FAAH inhibitors.  Rather unexpectedly based on the high chem. stability of the urea functional group, PF-750 and PF-622 were found to inhibit FAAH in a time-dependent manner by covalently modifying the enzyme's active site serine nucleophile.  Activity-based proteomic profiling revealed that PF-750 and PF-622 were completely selective for FAAH relative to other mammalian serine hydrolases.  The authors hypothesize that this remarkable specificity derives, at least in part, from FAAH's special ability to function as a C(O)-N bond hydrolase, which distinguishes it from the vast majority of metabolic serine hydrolases in mammals that are restricted to hydrolyzing esters and/or thioesters.  The piperidine/piperazine urea may thus represent a privileged chem. scaffold for the synthesis of FAAH inhibitors that display an unprecedented combination of potency and selectivity for use as potential analgesic and anxiolytic/antidepressant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3NGZiH1DJ-rVg90H21EOLACvtfcHk0lhmx0CajaXIMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyiurjM&md5=eb6f7945ff233b6fc0fea6b8677ecc87</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi701378g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701378g%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DFitzgerald%26aufirst%3DL.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DArendse%26aufirst%3DA.%26aulast%3DStevenson%26aufirst%3DT.%26aulast%3DLund%26aufirst%3DE.%2BT.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DNovel%2520mechanistic%2520class%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520with%2520remarkable%2520selectivity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D13019%26epage%3D13030%26doi%3D10.1021%2Fbi701378g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7327</span><span class="NLM_x">–</span> <span class="NLM_lpage">7343</span><span class="refDoi"> DOI: 10.1021/jm800311k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800311k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7327-7343&author=M.+Seierstadauthor=J.+G.+Breitenbucher&title=Discovery+and+development+of+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1021%2Fjm800311k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm800311k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800311k%26sid%3Dliteratum%253Aachs%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7327%26epage%3D7343%26doi%3D10.1021%2Fjm800311k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Deutsch, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omeir, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arreaza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestwich, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, A.</span><span> </span><span class="NLM_article-title">Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1016/S0006-2952(96)00830-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0006-2952%2896%2900830-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=255-260&author=D.+G.+Deutschauthor=R.+Omeirauthor=G.+Arreazaauthor=D.+Salehaniauthor=G.+D.+Prestwichauthor=Z.+Huangauthor=A.+Howlett&title=Methyl+arachidonyl+fluorophosphonate%3A+a+potent+irreversible+inhibitor+of+anandamide+amidase&doi=10.1016%2FS0006-2952%2896%2900830-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2896%2900830-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252896%252900830-1%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DD.%2BG.%26aulast%3DOmeir%26aufirst%3DR.%26aulast%3DArreaza%26aufirst%3DG.%26aulast%3DSalehani%26aufirst%3DD.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DHowlett%26aufirst%3DA.%26atitle%3DMethyl%2520arachidonyl%2520fluorophosphonate%253A%2520a%2520potent%2520irreversible%2520inhibitor%2520of%2520anandamide%2520amidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D53%26spage%3D255%26epage%3D260%26doi%3D10.1016%2FS0006-2952%2896%2900830-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1016/S0960-894X(98)00734-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0960-894X%2898%2900734-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=265-270&author=D.+L.+Bogerauthor=H.+Satoauthor=A.+E.+Lernerauthor=B.+J.+Austinauthor=J.+E.+Pattersonauthor=M.+P.+Patricelliauthor=B.+F.+Cravatt&title=Trifluoromethyl+ketone+inhibitors+of+fatty+acid+amide+hydrolase%3A+a+probe+of+structural+and+conformational+features+contributing+to+inhibition&doi=10.1016%2FS0960-894X%2898%2900734-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900734-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900734-3%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DLerner%26aufirst%3DA.%2BE.%26aulast%3DAustin%26aufirst%3DB.%2BJ.%26aulast%3DPatterson%26aufirst%3DJ.%2BE.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DTrifluoromethyl%2520ketone%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520a%2520probe%2520of%2520structural%2520and%2520conformational%2520features%2520contributing%2520to%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D265%26epage%3D270%26doi%3D10.1016%2FS0960-894X%2898%2900734-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">α-Ketoheterocycle-based inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1021/cn2001206</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn2001206" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=340-348&author=K.+Otrubovaauthor=D.+L.+Boger&title=%CE%B1-Ketoheterocycle-based+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1021%2Fcn2001206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">α-Ketoheterocycle-Based Inhibitors of Fatty Acid Amide Hydrolase (FAAH)</span></div><div class="casAuthors">Otrubova, Katerina; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">340-348</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A summary of the initial discovery and characterization of the enzyme fatty acid amide hydrolase (FAAH), and the subsequent advancement of an important class of competitive, reversible, potent, and selective inhibitors is presented.  Initially explored using substrate-inspired inhibitors bearing electrophilic carbonyls, the examn. of α-ketoheterocyle-based inhibitors of FAAH with the benefit of a unique activity-based protein-profiling (ABPP)-based proteome-wide selectivity assay, a powerful in vivo biomarker-based in vivo screen, and subsequent retrospective x-ray cocrystal structures with the enzyme, is summarized.  These efforts defined the impact of the central activating heterocycle and its key substituents, provided key simplifications in the C2 acyl side chain and clear interpretations for the unique role and subsequent optimization of the central activating heterocycle, and established the basis for the recent further conformational constraints in the C2 acyl side chain, providing potent, long-acting, orally active FAAH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4v_VJgMuMirVg90H21EOLACvtfcHk0lhoUq23rirs-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ChtL3E&md5=e44d87e37c2f21bb7e7400bb1bc1f674</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fcn2001206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2001206%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3D%25CE%25B1-Ketoheterocycle-based%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D340%26epage%3D348%26doi%3D10.1021%2Fcn2001206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fecik, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5044</span><span class="NLM_x">–</span> <span class="NLM_lpage">5049</span><span class="refDoi"> DOI: 10.1073/pnas.97.10.5044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.97.10.5044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10805767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVWnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5044-5049&author=D.+L.+Bogerauthor=H.+Satoauthor=A.+E.+Lernerauthor=M.+P.+Hedrickauthor=R.+A.+Fecikauthor=H.+Miyauchiauthor=G.+D.+Wilkieauthor=B.+J.+Austinauthor=M.+P.+Patricelliauthor=B.+F.+Cravatt&title=Exceptionally+potent+inhibitors+of+fatty+acid+amide+hydrolase%3A+the+enzyme+responsible+for+degradation+of+endogenous+oleamide+and+anandamide&doi=10.1073%2Fpnas.97.10.5044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide</span></div><div class="casAuthors">Boger, Dale L.; Sato, Haruhiko; Lerner, Aaron E.; Hedrick, Michael P.; Fecik, Robert A.; Miyauchi, Hiroshi; Wilkie, Gordon D.; Austin, Bryce J.; Patricelli, Matthew P.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5044-5049</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The development of exceptionally potent inhibitors of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of oleamide (an endogenous sleep-inducing lipid), and anandamide (an endogenous ligand for cannabinoid receptors) is detailed.  The inhibitors may serve as useful tools to clarify the role of endogenous oleamide and anandamide and may prove to be useful therapeutic agents for the treatment of sleep disorders or pain.  The combination of several features-an optimal C12-C8 chain length, π-unsatn. introduction at the corresponding arachidonoyl Δ8,9/Δ11,12 and oleoyl Δ9,10 location, and an α-keto N4 oxazolopyridine with incorporation of a second weakly basic nitrogen provided FAAH inhibitors with Kis that drop below 200 pM and are 102-103 times more potent than the corresponding trifluoromethyl ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7Wa9yOfljbVg90H21EOLACvtfcHk0lhoUq23rirs-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVWnsb8%253D&md5=1453ebc1c8382f0c44b93c029655a40f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.10.5044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.10.5044%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DLerner%26aufirst%3DA.%2BE.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DFecik%26aufirst%3DR.%2BA.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DWilkie%26aufirst%3DG.%2BD.%26aulast%3DAustin%26aufirst%3DB.%2BJ.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DExceptionally%2520potent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520the%2520enzyme%2520responsible%2520for%2520degradation%2520of%2520endogenous%2520oleamide%2520and%2520anandamide%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D5044%26epage%3D5049%26doi%3D10.1073%2Fpnas.97.10.5044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span> </span><span class="NLM_article-title">α-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and α-substitution</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1520</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00211-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2FS0960-894X%2801%2900211-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1517-1520&author=D.+L.+Bogerauthor=H.+Miyauchiauthor=M.+P.+Hedrick&title=%CE%B1-Keto+heterocycle+inhibitors+of+fatty+acid+amide+hydrolase%3A+carbonyl+group+modification+and+%CE%B1-substitution&doi=10.1016%2FS0960-894X%2801%2900211-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900211-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900211-6%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26atitle%3D%25CE%25B1-Keto%2520heterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520carbonyl%2520group%2520modification%2520and%2520%25CE%25B1-substitution%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1517%26epage%3D1520%26doi%3D10.1016%2FS0960-894X%2801%2900211-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4100</span><span class="refDoi"> DOI: 10.1021/ja110877y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja110877y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=4092-4100&author=M.+Mileniauthor=J.+Garfunkleauthor=C.+Ezziliauthor=B.+F.+Cravattauthor=R.+C.+Stevensauthor=D.+L.+Boger&title=Fluoride-mediated+capture+of+a+noncovalent+bound+state+of+a+reversible+covalent+enzyme+inhibitor%3A+X-ray+crystallographic+analysis+of+an+exceptionally+potent+%CE%B1-ketoheterocycle+inhibitor+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fja110877y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja110877y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja110877y%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DFluoride-mediated%2520capture%2520of%2520a%2520noncovalent%2520bound%2520state%2520of%2520a%2520reversible%2520covalent%2520enzyme%2520inhibitor%253A%2520X-ray%2520crystallographic%2520analysis%2520of%2520an%2520exceptionally%2520potent%2520%25CE%25B1-ketoheterocycle%2520inhibitor%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D4092%26epage%3D4100%26doi%3D10.1021%2Fja110877y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fecik, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acevedo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimarães, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and efficacious class of reversible α-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span><span class="refDoi"> DOI: 10.1021/jm049614v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049614v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFSlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1849-1856&author=D.+L.+Bogerauthor=H.+Miyauchiauthor=W.+Duauthor=C.+Hardouinauthor=R.+A.+Fecikauthor=H.+Chengauthor=I.+Hwangauthor=M.+P.+Hedrickauthor=D.+Leungauthor=O.+Acevedoauthor=C.+R.+Guimar%C3%A3esauthor=W.+L.+Jorgensenauthor=B.+F.+Cravatt&title=Discovery+of+a+potent%2C+selective%2C+and+efficacious+class+of+reversible+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase+effective+as+analgesics&doi=10.1021%2Fjm049614v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics</span></div><div class="casAuthors">Boger, Dale L.; Miyauchi, Hiroshi; Du, Wu; Hardouin, Christophe; Fecik, Robert A.; Cheng, Heng; Hwang, Inkyu; Hedrick, Michael P.; Leung, Donmienne; Acevedo, Orlando; Guimaraes, Cristiano R. W.; Jorgensen, William L.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1849-1856</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) degrades neuromodulating fatty acid amides including anandamide (endogenous cannabinoid agonist) and oleamide (sleep-inducing lipid) at their sites of action and is intimately involved in their regulation.  Herein the authors report the discovery of a potent, selective, and efficacious class of reversible FAAH inhibitors that produce analgesia in animal models validating a new therapeutic target for pain intervention.  Key to the useful inhibitor discovery was the routine implementation of a proteomics-wide selectivity screen against the serine hydrolase superfamily ensuring selectivity for FAAH coupled with systematic in vivo examns. of candidate inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLT1X7kSm1TbVg90H21EOLACvtfcHk0ljkbgbLxd6g8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFSlsrg%253D&md5=f840707597fa1c4cad6cf61329a4504e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm049614v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049614v%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DFecik%26aufirst%3DR.%2BA.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DAcevedo%26aufirst%3DO.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520class%2520of%2520reversible%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520effective%2520as%2520analgesics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1849%26epage%3D1856%26doi%3D10.1021%2Fjm049614v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2004.12.085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1423-1428&author=D.+Leungauthor=W.+Duauthor=C.+Hardouinauthor=H.+Chengauthor=I.+Hwangauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Discovery+of+an+exceptionally+potent+and+selective+class+of+fatty+acid+amide+hydrolase+inhibitors+enlisting+proteome-wide+selectivity+screening%3A+concurrent+optimization+of+enzyme+inhibitor+potency+and+selectivity&doi=10.1016%2Fj.bmcl.2004.12.085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.085%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DDiscovery%2520of%2520an%2520exceptionally%2520potent%2520and%2520selective%2520class%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520enlisting%2520proteome-wide%2520selectivity%2520screening%253A%2520concurrent%2520optimization%2520of%2520enzyme%2520inhibitor%2520potency%2520and%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1423%26epage%3D1428%26doi%3D10.1016%2Fj.bmcl.2004.12.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">DeMartino, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Exploration of a fundamental substituent effect of α-ketoheterocycle enzyme inhibitors: potent and selective inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5842</span><span class="NLM_x">–</span> <span class="NLM_lpage">5846</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2008.06.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5842-5846&author=J.+K.+DeMartinoauthor=J.+Garfunkleauthor=D.+G.+Hochstatterauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Exploration+of+a+fundamental+substituent+effect+of+%CE%B1-ketoheterocycle+enzyme+inhibitors%3A+potent+and+selective+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2008.06.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.084%26sid%3Dliteratum%253Aachs%26aulast%3DDeMartino%26aufirst%3DJ.%2BK.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DExploration%2520of%2520a%2520fundamental%2520substituent%2520effect%2520of%2520%25CE%25B1-ketoheterocycle%2520enzyme%2520inhibitors%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5842%26epage%3D5846%26doi%3D10.1016%2Fj.bmcl.2008.06.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span> </span><span class="NLM_article-title">Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsj.bjp.0706699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=16501580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2ltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=102-113&author=L.+Changauthor=L.+Luoauthor=J.+A.+Palmerauthor=S.+Suttonauthor=S.+J.+Wilsonauthor=A.+J.+Barbierauthor=J.+G.+Breitenbucherauthor=S.+R.+Chaplanauthor=M.+Webb&title=Inhibition+of+fatty+acid+amide+hydrolase+produces+analgesia+by+multiple+mechanisms&doi=10.1038%2Fsj.bjp.0706699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms</span></div><div class="casAuthors">Chang, Leon; Luo, Lin; Palmer, James A.; Sutton, Steven; Wilson, Sandy J.; Barbier, Ann J.; Breitenbucher, James Guy; Chaplan, Sandra R.; Webb, Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-113</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The reversible fatty acid amide hydrolase (FAAH) inhibitor OL135 reverses mech. allodynia in the spinal nerve ligation (SNL) and mild thermal injury (MTI) models in the rat.  The purpose of this study was to investigate the role of the cannabinoid and opioid systems in mediating this analgesic effect.  Elevated brain concns. of anandamide (350 pmol g-1 of tissue vs. 60 pmol g-1 in vehicle-treated controls) were found in brains of rats given OL135 (20 mg kg-1) i.p. 15 min prior to 20 mg kg-1 i.p. anandamide.  Predosing rats with OL135 (2-60 mg kg-1 i.p.) 30 min before administration of an irreversible FAAH inhibitor (URB597: 0.3 mg kg-1 intracardiac) was found to protect brain FAAH from irreversible inactivation.  The level of enzyme protection was correlated with the OL135 concns. in the same brains.  OL135 (100 mg kg-1 i.p.) reduced by 50% of the max. possible efficacy (MPE) mech. allodynia induced by MTI in FAAH+/+mice (von Frey filament measurement) 30 min after dosing, but was without effect in FAAH-/- mice.  OL135 given i.p. resulted in a dose-responsive reversal of mech. allodynia in both MTI and SNL models in the rat with an ED50 between 6 and 9 mg kg-1.  The plasma concn. at the ED50 in both models was 0.7 μM (240 ng ml-1).  In the rat SNL model, coadministration of the selective CB2 receptor antagonist SR144528 (5 mg kg-1 i.p.), with 20 mg kg-1 OL135 blocked the OL135-induced reversal of mech. allodynia, but the selective CB1 antagonist SR141716A (5 mg kg-1 i.p.) was without effect.  In the rat MTI model neither SR141716A or SR144528 (both at 5 mg kg-1 i.p.), or a combination of both antagonists coadministered with OL135 (20 mg kg-1) blocked reversal of mech. allodynia assessed 30 min after dosing.  In both the MTI model and SNL models in rats, naloxone (1 mg kg-1, i.p. 30 min after OL135) reversed the analgesia (to 15% of control levels in the MTI model, to zero in the SNL) produced by OL135.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBLOT_Ls83X7Vg90H21EOLACvtfcHk0ljkbgbLxd6g8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2ltrk%253D&md5=699f0b8b326af0ae0baecc3abbd6faa3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706699%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DWebb%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520produces%2520analgesia%2520by%2520multiple%2520mechanisms%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D102%26epage%3D113%26doi%3D10.1038%2Fsj.bjp.0706699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Potent and selective α-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span><span class="refDoi"> DOI: 10.1021/jm0611509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1058-1068&author=F.+A.+Romeroauthor=W.+Duauthor=I.+Hwangauthor=T.+J.+Raylauthor=F.+S.+Kimballauthor=D.+Leungauthor=H.+S.+Hooverauthor=R.+L.+Apodacaauthor=J.+G.+Breitenbucherauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Potent+and+selective+%CE%B1-ketoheterocycle-based+inhibitors+of+the+anandamide+and+oleamide+catabolizing+enzyme%2C+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm0611509"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm0611509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611509%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DKimball%26aufirst%3DF.%2BS.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DHoover%26aufirst%3DH.%2BS.%26aulast%3DApodaca%26aufirst%3DR.%2BL.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DPotent%2520and%2520selective%2520%25CE%25B1-ketoheterocycle-based%2520inhibitors%2520of%2520the%2520anandamide%2520and%2520oleamide%2520catabolizing%2520enzyme%252C%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1058%26epage%3D1068%26doi%3D10.1021%2Fjm0611509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelso, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of α-ketooxazole inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3359</span><span class="NLM_x">–</span> <span class="NLM_lpage">3368</span><span class="refDoi"> DOI: 10.1021/jm061414r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061414r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3359-3368&author=C.+Hardouinauthor=M.+J.+Kelsoauthor=F.+A.+Romeroauthor=T.+J.+Raylauthor=D.+Leungauthor=I.+Hwangauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Structure-activity+relationships+of+%CE%B1-ketooxazole+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm061414r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm061414r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061414r%26sid%3Dliteratum%253Aachs%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DKelso%26aufirst%3DM.%2BJ.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DStructure-activity%2520relationships%2520of%2520%25CE%25B1-ketooxazole%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3359%26epage%3D3368%26doi%3D10.1021%2Fjm061414r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Kimball, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Optimization of α-ketooxazole inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1021/jm701210y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701210y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=937-947&author=F.+S.+Kimballauthor=F.+A.+Romeroauthor=C.+Ezziliauthor=J.+Garfunkleauthor=T.+J.+Raylauthor=D.+G.+Hochstatterauthor=I.+Hwangauthor=D.+L.+Boger&title=Optimization+of+%CE%B1-ketooxazole+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm701210y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of α-Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Kimball, F. Scott; Romero, F. Anthony; Ezzili, Cyrine; Garfunkle, Joie; Rayl, Thomas J.; Hochstatter, Dustin G.; Hwang, Inkyu; Boger, Dale L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">937-947</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of α-ketooxazoles, e.g., I, contg. conformational constraints in the flexible C2 acyl side chain of II (OL-135) and representative oxazole C5 substituents were prepd. and examd. as inhibitors of fatty acid amide hydrolase (FAAH).  Exceptionally potent and selective FAAH inhibitors emerged from the series (e.g., 6, Ki = 200 and 260 pM for rat and rhFAAH).  With simple and small C5 oxazole substituents, each series bearing a biphenylethyl, phenoxyphenethyl, or (phenoxymethyl)phenethyl C2 side chain was found to follow a well-defined linear relationship between -log Ki and Hammett σp of a magnitude (ρ = 2.7-3.0) that indicates that the substituent electronic effect dominates, confirming its fundamental importance to the series and further establishing its predictive value.  Just as significantly, the nature of the C5 oxazole substituent substantially impacts the selectivity of the inhibitors whereas the effect of the C2 acyl chain was more subtle but still significant even in the small series examd.  Combination of these independent features, which display generalized trends across a range of inhibitor series, simultaneously improves FAAH potency and selectivity and can provide exquisitely selective and potent FAAH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKqc9Fjum927Vg90H21EOLACvtfcHk0lhSZE9aVbrVOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWju7Y%253D&md5=3e3e36903d135141f3e86b5f37adf9f2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm701210y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701210y%26sid%3Dliteratum%253Aachs%26aulast%3DKimball%26aufirst%3DF.%2BS.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DOptimization%2520of%2520%25CE%25B1-ketooxazole%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D937%26epage%3D947%26doi%3D10.1021%2Fjm701210y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Garfunkle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayl, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Optimization of the central heterocycle of α-ketoheterocycle inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4392</span><span class="NLM_x">–</span> <span class="NLM_lpage">4403</span><span class="refDoi"> DOI: 10.1021/jm800136b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800136b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4392-4403&author=J.+Garfunkleauthor=C.+Ezziliauthor=T.+J.+Raylauthor=D.+G.+Hochstatterauthor=I.+Hwangauthor=D.+L.+Boger&title=Optimization+of+the+central+heterocycle+of+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm800136b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm800136b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800136b%26sid%3Dliteratum%253Aachs%26aulast%3DGarfunkle%26aufirst%3DJ.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DRayl%26aufirst%3DT.%2BJ.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DOptimization%2520of%2520the%2520central%2520heterocycle%2520of%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4392%26epage%3D4403%26doi%3D10.1021%2Fjm800136b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstatter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2805</span><span class="NLM_x">–</span> <span class="NLM_lpage">2822</span><span class="refDoi"> DOI: 10.1021/jm101597x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101597x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2805-2822&author=C.+Ezziliauthor=M.+Mileniauthor=N.+McGlincheyauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=D.+G.+Hochstatterauthor=R.+C.+Stevensauthor=A.+H.+Lichtmanauthor=B.+F.+Cravattauthor=E.+J.+Bilskyauthor=D.+L.+Boger&title=Reversible+competitive+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase+containing+additional+conformational+constraints+in+the+acyl+side+chain%3A+orally+active%2C+long-acting+analgesics&doi=10.1021%2Fjm101597x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm101597x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101597x%26sid%3Dliteratum%253Aachs%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DMcGlinchey%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DHochstatter%26aufirst%3DD.%2BG.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBilsky%26aufirst%3DE.%2BJ.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DReversible%2520competitive%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520containing%2520additional%2520conformational%2520constraints%2520in%2520the%2520acyl%2520side%2520chain%253A%2520orally%2520active%252C%2520long-acting%2520analgesics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2805%26epage%3D2822%26doi%3D10.1021%2Fjm101597x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span><span class="refDoi"> DOI: 10.1021/jm401820q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401820q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1079-1089&author=K.+Otrubovaauthor=B.+F.+Cravattauthor=D.+L.+Boger&title=Design%2C+synthesis%2C+and+characterization+of+%CE%B1-ketoheterocycles+that+additionally+target+the+cytosolic+port+Cys269+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm401820q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm401820q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401820q%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520%25CE%25B1-ketoheterocycles%2520that%2520additionally%2520target%2520the%2520cytosolic%2520port%2520Cys269%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1079%26epage%3D1089%26doi%3D10.1021%2Fjm401820q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neal, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">6289</span><span class="NLM_x">–</span> <span class="NLM_lpage">6299</span><span class="refDoi"> DOI: 10.1021/ja4014997</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4014997" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=6289-6299&author=K.+Otrubovaauthor=M.+Brownauthor=M.+S.+McCormickauthor=G.+W.+Hanauthor=S.+T.+O%E2%80%99Nealauthor=B.+F.+Cravattauthor=R.+C.+Stevensauthor=A.+H.+Lichtmanauthor=D.+L.+Boger&title=Rational+design+of+fatty+acid+amide+hydrolase+inhibitors+that+act+by+covalently+bonding+to+two+active+site+residues&doi=10.1021%2Fja4014997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fja4014997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4014997%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMcCormick%26aufirst%3DM.%2BS.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DS.%2BT.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DRational%2520design%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520that%2520act%2520by%2520covalently%2520bonding%2520to%2520two%2520active%2520site%2520residues%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D6289%26epage%3D6299%26doi%3D10.1021%2Fja4014997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiño, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tattoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Modulation of anxiety through blockade of anandamide hydrolysis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1038/nm803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnm803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12461523" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=76-81&author=S.+Kathuriaauthor=S.+Gaetaniauthor=D.+Fegleyauthor=F.+Vali%C3%B1oauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=G.+La+Ranaauthor=A.+Calignanoauthor=A.+Giustinoauthor=M.+Tattoliauthor=M.+Palmeryauthor=V.+Cuomoauthor=D.+Piomelli&title=Modulation+of+anxiety+through+blockade+of+anandamide+hydrolysis&doi=10.1038%2Fnm803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnm803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm803%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DVali%25C3%25B1o%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGiustino%26aufirst%3DA.%26aulast%3DTattoli%26aufirst%3DM.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DModulation%2520of%2520anxiety%2520through%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D9%26spage%3D76%26epage%3D81%26doi%3D10.1038%2Fnm803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plazzi, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Cyclohexylcarbamic acid 3′-or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4998</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span><span class="refDoi"> DOI: 10.1021/jm031140x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031140x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4998-5008&author=M.+Morauthor=S.+Rivaraauthor=A.+Lodolaauthor=P.+V.+Plazziauthor=G.+Tarziaauthor=A.+Durantiauthor=A.+Tontiniauthor=G.+Piersantiauthor=S.+Kathuriaauthor=D.+Piomelli&title=Cyclohexylcarbamic+acid+3%E2%80%B2-or+4%E2%80%B2-substituted+biphenyl-3-yl+esters+as+fatty+acid+amide+hydrolase+inhibitors%3A+synthesis%2C+quantitative+structure-activity+relationships%2C+and+molecular+modeling+studies&doi=10.1021%2Fjm031140x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm031140x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031140x%26sid%3Dliteratum%253Aachs%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DPlazzi%26aufirst%3DP.%2BV.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DCyclohexylcarbamic%2520acid%25203%25E2%2580%25B2-or%25204%25E2%2580%25B2-substituted%2520biphenyl-3-yl%2520esters%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%253A%2520synthesis%252C%2520quantitative%2520structure-activity%2520relationships%252C%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4998%26epage%3D5008%26doi%3D10.1021%2Fjm031140x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasse, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putman, D.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2006.00021.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1527-3458.2006.00021.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=16834756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos1yksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=21-38&author=D.+Piomelliauthor=G.+Tarziaauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=T.+R.+Comptonauthor=O.+Dasseauthor=E.+P.+Monaghanauthor=J.+A.+Parrottauthor=D.+Putman&title=Pharmacological+profile+of+the+selective+FAAH+inhibitor+KDS-4103+%28URB597%29&doi=10.1111%2Fj.1527-3458.2006.00021.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)</span></div><div class="casAuthors">Piomelli, Daniele; Tarzia, Giorgio; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Compton, Timothy R.; Dasse, Olivier; Monaghan, Edward P.; Parrott, Jeff A.; Putman, David</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  In the present article, we review the pharmacol. properties of KDS-4103 (URB597), a highly potent and selective inhibitor of the enzyme fatty-acid amide hydrolase (FAAH), which catalyzes the intracellular hydrolysis of the endocannabinoid anandamide.  In vitro, KDS-4103 inhibits FAAH activity with median inhibitory concns. (IC50) of 5 nM in rat brain membranes and 3 nM in human liver microsomes.  In vivo, KDS-4103 inhibits rat brain FAAH activity after i.p. administration with a median ID (ID50) of 0.15 mg/kg.  The compd. does not significantly interact with other cannabinoid-related targets, including cannabinoid receptors and anandamide transport, or with a broad panel of receptors, ion channels, transporters and enzymes.  By i.p. administration to rats and mice KDS-4103 elicits significant, anxiolytic-like, anti-depressant-like and analgesic effects, which are prevented by treatment with CB1 receptor antagonists.  By contrast, at doses that significantly inhibit FAAH activity and substantially raise brain anandamide levels, KDS-4103 does not evoke classical cannabinoid-like effects (e.g., catalepsy, hypothermia, hyperphagia), does not cause place preference, and does not produce generalization to the discriminative effects of the active ingredient of cannabis, Δ9-tetrahydrocannabinol (Δ9-THC).  These findings suggest that KDS-4103 acts by enhancing the tonic actions of anandamide on a subset of CB1 receptors, which may normally be engaged in controlling emotions and pain.  KDS-4103 is orally available in rats and cynomolgus monkeys.  Sub-chronic repeated dose studies (1500 mg/kg, per os) in these two species have not demonstrated systemic toxicity.  Likewise, no toxicity was noted in bacterial cytotoxicity tests in vitro and in the Ames test.  Furthermore, no deficits were obsd. in rats on the rotarod test after acute i.p. treatment with KDS-4103 at doses up to 5 mg/kg or in a functional observation battery after oral doses up to 1500 mg/kg.  The results suggest that KDS-4103 will offer a novel approach with a favorable therapeutic window for the treatment of anxiety, depression and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4yDW3FkE5dbVg90H21EOLACvtfcHk0lhNceGym9zeSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos1yksL0%253D&md5=3acddbfe31c13facb4d46fa35e8e4582</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2006.00021.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2006.00021.x%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCompton%26aufirst%3DT.%2BR.%26aulast%3DDasse%26aufirst%3DO.%26aulast%3DMonaghan%26aufirst%3DE.%2BP.%26aulast%3DParrott%26aufirst%3DJ.%2BA.%26aulast%3DPutman%26aufirst%3DD.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520selective%2520FAAH%2520inhibitor%2520KDS-4103%2520%2528URB597%2529%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D21%26epage%3D38%26doi%3D10.1111%2Fj.1527-3458.2006.00021.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saraf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannoye, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span> </span><span class="NLM_article-title">Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2006.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.neuropharm.2006.11.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=1095-1105&author=D.+Zhangauthor=A.+Sarafauthor=T.+Kolasaauthor=P.+Bhatiaauthor=G.+Z.+Zhengauthor=M.+Patelauthor=G.+S.+Lannoyeauthor=P.+Richardsonauthor=A.+Stewartauthor=J.+C.+Rogersauthor=J.+D.+Brioniauthor=C.+S.+Surowy&title=Fatty+acid+amide+hydrolase+inhibitors+display+broad+selectivity+and+inhibit+multiple+carboxylesterases+as+off-targets&doi=10.1016%2Fj.neuropharm.2006.11.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DSaraf%26aufirst%3DA.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DBhatia%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DG.%2BZ.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DLannoye%26aufirst%3DG.%2BS.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DJ.%2BC.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26atitle%3DFatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520display%2520broad%2520selectivity%2520and%2520inhibit%2520multiple%2520carboxylesterases%2520as%2520off-targets%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D1095%26epage%3D1105%26doi%3D10.1016%2Fj.neuropharm.2006.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Bosier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB<sub>1</sub>-and FAAH-independent mechanisms</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02208.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1476-5381.2012.02208.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22970888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=794-807&author=B.+Bosierauthor=G.+G.+Muccioliauthor=D.+M.+Lambert&title=The+FAAH+inhibitor+URB597+efficiently+reduces+tyrosine+hydroxylase+expression+through+CB1-and+FAAH-independent+mechanisms&doi=10.1111%2Fj.1476-5381.2012.02208.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1- and FAAH-independent mechanisms</span></div><div class="casAuthors">Bosier, Barbara; Muccioli, Giulio G.; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">794-807</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Anandamide and 2-arachidonoylglycerol are neuromodulatory lipids interacting with cannabinoid receptors, whose availability is regulated by the balance between "on demand" generation and enzymic degrdn. [by fatty acid amide hydrolase (FAAH)/monoacylglycerol lipase].  Given the reported effects of anandamide on dopamine transmission, we investigated the influence of endocannabinoids and URB597, a well-known FAAH inhibitor, on the expression of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis.  Exptl. Approach: We investigated TH expression in N1E115 neuroblastoma using a reporter gene assay, as well as mRNA and protein quantifications.  FAAH inhibition was confirmed by measuring radiolabeled substrate hydrolysis and endogenous endocannabinoids.  Key Results: Anandamide decreased TH promoter activity in N1E115 cells through CB1 receptor activation.  Unexpectedly, URB597 reduced TH expression (pEC50 = 8.7 ± 0.2) through FAAH-independent mechanisms.  Indeed, four structurally unrelated inhibitors of FAAH had no influence on TH expression, although all the inhibitors increased endocannabinoid levels.  At variance with the endocannabinoid responses, the use of selective antagonists indicated that the URB597-mediated decrease in TH expression was not directed by the CB1 receptor, but rather by abnormal-cannabidiol-sensitive receptors and PPARs.  Further supporting the physiol. relevance of these in vitro data, URB597 administration resulted in reduced TH mRNA levels in mice brain.  Conclusions: While confirming the implication of endocannabinoids on the modulation of TH, we provide strong evidence for addnl. physiol. relevant off-target effects of URB597.  In light of the numerous preclin. studies involving URB597, particularly in anxiety and depression, the existence of non-CB1 and non-FAAH mediated influences of URB597 on key enzymes of the catecholaminergic transmission system should be taken into account when interpreting the data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2NSEki1ECkLVg90H21EOLACvtfcHk0li2gaSXXasZKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOiu7k%253D&md5=9d6f90a44e3e0dfd8d8e11a8323d133d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02208.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02208.x%26sid%3Dliteratum%253Aachs%26aulast%3DBosier%26aufirst%3DB.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DThe%2520FAAH%2520inhibitor%2520URB597%2520efficiently%2520reduces%2520tyrosine%2520hydroxylase%2520expression%2520through%2520CB1-and%2520FAAH-independent%2520mechanisms%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D794%26epage%3D807%26doi%3D10.1111%2Fj.1476-5381.2012.02208.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1016/j.jmb.2010.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.jmb.2010.05.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20493882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1yrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=743-754&author=M.+Mileniauthor=S.+Kamtekarauthor=D.+C.+Woodauthor=T.+E.+Bensonauthor=B.+F.+Cravattauthor=R.+C.+Stevens&title=Crystal+structure+of+fatty+acid+amide+hydrolase+bound+to+the+carbamate+inhibitor+URB597%3A+discovery+of+a+deacylating+water+molecule+and+insight+into+enzyme+inactivation&doi=10.1016%2Fj.jmb.2010.05.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Fatty Acid Amide Hydrolase Bound to the Carbamate Inhibitor URB597: Discovery of a Deacylating Water Molecule and Insight into Enzyme Inactivation</span></div><div class="casAuthors">Mileni, Mauro; Kamtekar, Satwik; Wood, David C.; Benson, Timothy E.; Cravatt, Benjamin F.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-754</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoid system regulates a wide range of physiol. processes including pain, inflammation, and cognitive/emotional states.  URB597 is one of the best characterized covalent inhibitors of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH).  Here, we report the structure of the FAAH-URB597 complex at 2.3 Å resoln.  The structure provides insights into mechanistic details of enzyme inactivation and exptl. evidence of a previously uncharacterized active site water mol. that likely is involved in substrate deacylation.  This water mol. is part of an extensive hydrogen-bonding network and is coordinated indirectly to residues lining the cytosolic port of the enzyme.  In order to corroborate our hypothesis concerning the role of this water mol. in FAAH's catalytic mechanism, we detd. the structure of FAAH conjugated to a urea-based inhibitor, PF-3845, to a higher resoln. (2.4 Å) than previously reported.  The higher-resoln. structure confirms the presence of the water mol. in a virtually identical location in the active site.  Examn. of the structures of serine hydrolases that are non-homologous to FAAH, such as elastase, trypsin, or chymotrypsin, shows a similarly positioned hydrolytic water mol. and suggests a functional convergence between the amidase signature enzymes and serine proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJe7DwbZdBYLVg90H21EOLACvtfcHk0li2gaSXXasZKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1yrsrg%253D&md5=023c5ff35e41921df17c3f7df1d7f660</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DD.%2BC.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520bound%2520to%2520the%2520carbamate%2520inhibitor%2520URB597%253A%2520discovery%2520of%2520a%2520deacylating%2520water%2520molecule%2520and%2520insight%2520into%2520enzyme%2520inactivation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D743%26epage%3D754%26doi%3D10.1016%2Fj.jmb.2010.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity <i>in vivo</i></span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span><span class="refDoi"> DOI: 10.1002/cmdc.200900210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.200900210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19637155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKgtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1505-1513&author=J.+R.+Clapperauthor=F.+Vacondioauthor=A.+R.+Kingauthor=A.+Durantiauthor=A.+Tontiniauthor=C.+Silvaauthor=S.+Sanchiniauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=A+second+generation+of+carbamate-based+fatty+acid+amide+hydrolase+inhibitors+with+improved+activity+in+vivo&doi=10.1002%2Fcmdc.200900210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo</span></div><div class="casAuthors">Clapper, Jason R.; Vacondio, Federica; King, Alvin R.; Duranti, Andrea; Tontini, Andrea; Silva, Claudia; Sanchini, Silvano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1505-1513</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides are a class of signaling lipids that include agonists at cannabinoid and α type peroxisome proliferator-activated receptors (PPARα).  In the brain, these compds. are primarily hydrolyzed by the intracellular serine enzyme fatty acid amide hydrolase (FAAH).  O-aryl carbamate FAAH inhibitors such as URB597 are being evaluated clin. for the treatment of pain and anxiety, but interactions with carboxylesterases in liver might limit their usefulness.  Here we explore two strategies aimed at overcoming this limitation.  Lipophilic N-terminal substitutions, which enhance FAAH recognition, yield potent inhibitors but render such compds. susceptible to attack by broad-spectrum hydrolases and inactive in vivo.  By contrast, polar electron-donating O-aryl substituents, which decrease carbamate reactivity, yield compds., such as URB694, that are highly potent FAAH inhibitors in vivo and less reactive with off-target carboxylesterases.  The results suggest that an approach balancing inhibitor reactivity with target recognition produces FAAH inhibitors that display significantly improved drug-likeness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLif0z6dIbyLVg90H21EOLACvtfcHk0ljl9DObZSMzeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKgtLnE&md5=fc73dbc173384549dfa0f319abb76479</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900210%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520second%2520generation%2520of%2520carbamate-based%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520with%2520improved%2520activity%2520in%2520vivo%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1505%26epage%3D1513%26doi%3D10.1002%2Fcmdc.200900210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciolino, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spradley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span><span class="refDoi"> DOI: 10.1038/nn.2632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.2632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20852626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1265-1270&author=J.+R.+Clapperauthor=G.+Moreno-Sanzauthor=R.+Russoauthor=A.+Guijarroauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=N.+R.+Sciolinoauthor=J.+M.+Spradleyauthor=A.+G.+Hohmannauthor=A.+Calignanoauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Anandamide+suppresses+pain+initiation+through+a+peripheral+endocannabinoid+mechanism&doi=10.1038%2Fnn.2632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span></div><div class="casAuthors">Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown.  To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of the endocannabinoid anandamide.  URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS.  Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing.  CB1 cannabinoid receptor blockade prevented these effects.  These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS.  Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AxNb5bVlE7Vg90H21EOLACvtfcHk0ljl9DObZSMzeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O&md5=f75c13a37e3524ab4130b2ebd67d6348</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnn.2632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2632%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DSciolino%26aufirst%3DN.%2BR.%26aulast%3DSpradley%26aufirst%3DJ.%2BM.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520suppresses%2520pain%2520initiation%2520through%2520a%2520peripheral%2520endocannabinoid%2520mechanism%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1265%26epage%3D1270%26doi%3D10.1038%2Fnn.2632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Sit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertekap, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, K. D.</span><span> </span><span class="NLM_article-title">Oxime carbamate-discovery of a series of novel FAAH inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2009.11.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1272-1277&author=S.+Sitauthor=C.+M.+Conwayauthor=K.+Xieauthor=R.+Bertekapauthor=C.+Bourinauthor=K.+D.+Burris&title=Oxime+carbamate-discovery+of+a+series+of+novel+FAAH+inhibitors&doi=10.1016%2Fj.bmcl.2009.11.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.080%26sid%3Dliteratum%253Aachs%26aulast%3DSit%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DC.%2BM.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBertekap%26aufirst%3DR.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DBurris%26aufirst%3DK.%2BD.%26atitle%3DOxime%2520carbamate-discovery%2520of%2520a%2520series%2520of%2520novel%2520FAAH%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1272%26epage%3D1277%26doi%3D10.1016%2Fj.bmcl.2009.11.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Gattinoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fezza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nannei, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amadio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quattrociocchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caprioli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span> </span><span class="NLM_article-title">Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1002/cmdc.200900472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.200900472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20112328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslens70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=357-360&author=S.+Gattinoniauthor=C.+De+Simoneauthor=S.+Dallavalleauthor=F.+Fezzaauthor=R.+Nanneiauthor=D.+Amadioauthor=P.+Minettiauthor=G.+Quattrociocchiauthor=A.+Caprioliauthor=F.+Borsiniauthor=W.+Cabriauthor=S.+Pencoauthor=L.+Merliniauthor=M.+Maccarrone&title=Enol+carbamates+as+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29+endowed+with+high+selectivity+for+FAAH+over+the+other+targets+of+the+endocannabinoid+system&doi=10.1002%2Fcmdc.200900472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system</span></div><div class="casAuthors">Gattinoni, Sonia; De Simone, Chiara; Dallavalle, Sabrina; Fezza, Filomena; Nannei, Raffaella; Amadio, Daniele; Minetti, Patrizia; Quattrociocchi, Gianandrea; Caprioli, Antonio; Borsini, Franco; Cabri, Walter; Penco, Sergio; Merlini, Lucio; Maccarrone, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-360</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein, we report the synthesis of a new series of enol carbamates, the most potent of which appear to reversibly inhibit FAAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt95rUNWsp3rVg90H21EOLACvtfcHk0ljl9DObZSMzeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslens70%253D&md5=01280e2429e748cba7899ec68e2ca5b7</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900472%26sid%3Dliteratum%253Aachs%26aulast%3DGattinoni%26aufirst%3DS.%26aulast%3DDe%2BSimone%26aufirst%3DC.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DFezza%26aufirst%3DF.%26aulast%3DNannei%26aufirst%3DR.%26aulast%3DAmadio%26aufirst%3DD.%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DQuattrociocchi%26aufirst%3DG.%26aulast%3DCaprioli%26aufirst%3DA.%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DMerlini%26aufirst%3DL.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DEnol%2520carbamates%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520endowed%2520with%2520high%2520selectivity%2520for%2520FAAH%2520over%2520the%2520other%2520targets%2520of%2520the%2520endocannabinoid%2520system%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D357%26epage%3D360%26doi%3D10.1002%2Fcmdc.200900472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Caprioli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coccurello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Serio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Tommaso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vertechy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battista, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span> </span><span class="NLM_article-title">The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1124/jpet.111.191403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.111.191403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22514334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=188-195&author=A.+Caprioliauthor=R.+Coccurelloauthor=C.+Rapinoauthor=S.+Di+Serioauthor=M.+Di+Tommasoauthor=M.+Vertechyauthor=V.+Vaccaauthor=N.+Battistaauthor=F.+Pavoneauthor=M.+Maccarroneauthor=F.+Borsini&title=The+novel+reversible+fatty+acid+amide+hydrolase+inhibitor+ST4070+increases+endocannabinoid+brain+levels+and+counteracts+neuropathic+pain+in+different+animal+models&doi=10.1124%2Fjpet.111.191403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models</span></div><div class="casAuthors">Caprioli, Antonio; Coccurello, Roberto; Rapino, Cinzia; Di Serio, Stefano; Di Tommaso, Monia; Vertechy, Mario; Vacca, Valentina; Battista, Natalia; Pavone, Flaminia; Maccarrone, Mauro; Borsini, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effect of the enol carbamate 1-biphenyl-4-ylethenyl piperidine-1-carboxylate (ST4070), a novel reversible inhibitor of fatty acid amide hydrolase (FAAH), was investigated for acute pain sensitivity and neuropathic pain in rats and mice.  Brain enzymic activity of FAAH and the endogenous levels of its substrates, anandamide (AEA; N-arachidonoylethanolamine), 2-arachidonoylglycerol (2-AG), and N-palmitoylethanolamine (PEA), were measured in control and ST4070-treated mice.  ST4070 (10, 30, and 100 mg/kg) was orally administered to assess mech. nociceptive thresholds and allodynia by using the Randall-Selitto and von Frey tests, resp.  Neuropathy was induced in rats by either the chemotherapeutic agent vincristine or streptozotocin-induced diabetes, whereas the chronic constriction injury (CCI) model was chosen to evaluate neuropathy in mice.  ST4070 produced a significant increase of nociceptive threshold in rats and counteracted the decrease of nociceptive threshold in the three distinct models of neuropathic pain.  In diabetic mice, ST4070 inhibited FAAH activity and increased the brain levels of AEA and PEA, without affecting that of 2-AG.  The administration of ST4070 generated long-lasting pain relief compared with pregabalin and the FAAH inhibitors 1-oxo-1[5-(2-pyridyl)-2-yl]-7-phenylheptane (OL135) and cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-ylester (URB597) in CCI neuropathic mice.  The antiallodynic effects of ST4070 were prevented by pretreatment with cannabinoid type 1 and cannabinoid type 2 receptor antagonists and by the selective peroxisome proliferator-activated receptor α antagonist [(2S)-2-[[(1Z)-1-methyl-3-oxo-3-[4-(trifluoromethyl)phenyl]-1-propenyl]amino]-3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]propyl]-carbamic acid Et ester (GW6471).  The administration of ST4070 generated long-lasting neuropathic pain relief compared with pregabalin and the FAAH inhibitors OL135 and URB597.  Taken together, the reversible FAAH inhibitor ST4070 seems to be a promising novel therapeutic agent for the management of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJ30CfhsjTbVg90H21EOLACvtfcHk0lioZPNLL4GZjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOktbvM&md5=c5055ead171864fa8a64730a5c3680b8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.191403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.191403%26sid%3Dliteratum%253Aachs%26aulast%3DCaprioli%26aufirst%3DA.%26aulast%3DCoccurello%26aufirst%3DR.%26aulast%3DRapino%26aufirst%3DC.%26aulast%3DDi%2BSerio%26aufirst%3DS.%26aulast%3DDi%2BTommaso%26aufirst%3DM.%26aulast%3DVertechy%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DV.%26aulast%3DBattista%26aufirst%3DN.%26aulast%3DPavone%26aufirst%3DF.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DBorsini%26aufirst%3DF.%26atitle%3DThe%2520novel%2520reversible%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520ST4070%2520increases%2520endocannabinoid%2520brain%2520levels%2520and%2520counteracts%2520neuropathic%2520pain%2520in%2520different%2520animal%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D188%26epage%3D195%26doi%3D10.1124%2Fjpet.111.191403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Colombano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daglian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span> </span><span class="NLM_article-title"><i>O</i>-(triazolyl) methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span><span class="refDoi"> DOI: 10.1002/cmdc.201402374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201402374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=380-395&author=G.+Colombanoauthor=C.+Albaniauthor=G.+Ottonelloauthor=A.+Ribeiroauthor=R.+Scarpelliauthor=G.+Tarozzoauthor=J.+Daglianauthor=K.+M.+Jungauthor=D.+Piomelliauthor=T.+Bandiera&title=O-%28triazolyl%29+methyl+carbamates+as+a+novel+and+potent+class+of+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1002%2Fcmdc.201402374"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402374%26sid%3Dliteratum%253Aachs%26aulast%3DColombano%26aufirst%3DG.%26aulast%3DAlbani%26aufirst%3DC.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DDaglian%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DO-%2528triazolyl%2529%2520methyl%2520carbamates%2520as%2520a%2520novel%2520and%2520potent%2520class%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D380%26epage%3D395%26doi%3D10.1002%2Fcmdc.201402374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggiero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saponaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span> </span><span class="NLM_article-title">Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.04.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejmech.2015.04.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=289-305&author=M.+A.+Tabriziauthor=P.+G.+Baraldiauthor=E.+Ruggieroauthor=G.+Saponaroauthor=S.+Baraldiauthor=R.+Romagnoliauthor=A.+Martinelliauthor=T.+Tuccinardi&title=Pyrazole+phenylcyclohexylcarbamates+as+inhibitors+of+human+fatty+acid+amide+hydrolases+%28FAAH%29&doi=10.1016%2Fj.ejmech.2015.04.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DRuggiero%26aufirst%3DE.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DTuccinardi%26aufirst%3DT.%26atitle%3DPyrazole%2520phenylcyclohexylcarbamates%2520as%2520inhibitors%2520of%2520human%2520fatty%2520acid%2520amide%2520hydrolases%2520%2528FAAH%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D97%26spage%3D289%26epage%3D305%26doi%3D10.1016%2Fj.ejmech.2015.04.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Terwege, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanekamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garzinsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, M.</span><span> </span><span class="NLM_article-title">ω-Imidazolyl- and ω-tetrazolylalkylcarbamates as inhibitors of fatty acid amide hydrolase: biological activity and <i>in vitro</i> metabolic stability</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1002/cmdc.201500445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201500445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=429-443&author=T.+Terwegeauthor=W.+Hanekampauthor=D.+Garzinskyauthor=S.+Konigauthor=O.+Kochauthor=M.+Lehr&title=%CF%89-Imidazolyl-+and+%CF%89-tetrazolylalkylcarbamates+as+inhibitors+of+fatty+acid+amide+hydrolase%3A+biological+activity+and+in+vitro+metabolic+stability&doi=10.1002%2Fcmdc.201500445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500445%26sid%3Dliteratum%253Aachs%26aulast%3DTerwege%26aufirst%3DT.%26aulast%3DHanekamp%26aufirst%3DW.%26aulast%3DGarzinsky%26aufirst%3DD.%26aulast%3DKonig%26aufirst%3DS.%26aulast%3DKoch%26aufirst%3DO.%26aulast%3DLehr%26aufirst%3DM.%26atitle%3D%25CF%2589-Imidazolyl-%2520and%2520%25CF%2589-tetrazolylalkylcarbamates%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520biological%2520activity%2520and%2520in%2520vitro%2520metabolic%2520stability%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D429%26epage%3D443%26doi%3D10.1002%2Fcmdc.201500445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Deutsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arreaza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omeir, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1006/bbrc.1997.6072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1006%2Fbbrc.1997.6072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1997&pages=217-221&author=D.+Deutschauthor=S.+Linauthor=W.+Hillauthor=K.+Morseauthor=D.+Salehaniauthor=G.+Arreazaauthor=R.+Omeirauthor=A.+Makriyannis&title=Fatty+acid+sulfonyl+fluorides+inhibit+anandamide+metabolism+and+bind+to+the+cannabinoid+receptor&doi=10.1006%2Fbbrc.1997.6072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.6072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.6072%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DW.%26aulast%3DMorse%26aufirst%3DK.%26aulast%3DSalehani%26aufirst%3DD.%26aulast%3DArreaza%26aufirst%3DG.%26aulast%3DOmeir%26aufirst%3DR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DFatty%2520acid%2520sulfonyl%2520fluorides%2520inhibit%2520anandamide%2520metabolism%2520and%2520bind%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D231%26spage%3D217%26epage%3D221%26doi%3D10.1006%2Fbbrc.1997.6072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Horrevoets, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheij, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, G. H.</span><span> </span><span class="NLM_article-title">Inactivation of escherichia coli outer-membrane phospholipase A by the affinity label hexadecanesulfonyl fluoride. Evidence for an active-site serine</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1991.tb16008.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1432-1033.1991.tb16008.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=2040286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK3MXkvVyhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=1991&pages=247-253&author=A.+J.+Horrevoetsauthor=H.+M.+Verheijauthor=G.+H.+Haas&title=Inactivation+of+escherichia+coli+outer-membrane+phospholipase+A+by+the+affinity+label+hexadecanesulfonyl+fluoride.+Evidence+for+an+active-site+serine&doi=10.1111%2Fj.1432-1033.1991.tb16008.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Escherichia coli outer-membrane phospholipase A by the affinity label hexadecanesulfonyl fluoride.  Evidence for an active-site serine</span></div><div class="casAuthors">Horrevoets, Anton J. G.; Verheij, Hubertus M.; De Haas, Gerard H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-53</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The E. coli outer-membrane phospholipase A (OM PLA) is a membrane-bound acyl hydrolase with a broad substrate specificity.  To obtain more insight into the mechanism of action of this enzyme, an active-site-directed inhibitor for OM PLA was designed on the basis of the known substrate specificity as a first step in the elucidation of the catalytic mechanism of this enzyme.  The inhibitor, hexadecanesulfonyl fluoride, consists of a long hydrocarbon chain for high-affinity binding by the enzyme and a sulfonyl fluoride moiety as a reactive group.  The kinetics of the inactivation of OM PLA by hexadecanesulfonyl fluoride were studied in Triton X-100 micelles.  Inactivation is very fast, specific and shows the same characteristics with respect to acyl specificity, pH profile and metal ion requirement as the activity of OM PLA on substrates.  Incubation of OM PLA with a stoichiometric amt. of hexadecanesulfonyl fluoride leads to a total and irreversible loss of enzyme activity, resulting from the sulfonylation of Ser144.  This Ser144, which is suggested to be the active-site serine of OM PLA, is part of the sequence HDSNG, whereas in the water-sol. serine proteases and lipases the structural motif GXSXG is normally encountered.  On the basis of the kinetics of inactivation of OM PLA by hexadecanesulfonyl fluoride, a possible catalytic mechanism of the enzyme is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_avkGeSl-57Vg90H21EOLACvtfcHk0ljpg28nGfhw4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvVyhs7Y%253D&md5=67bd7349ea8d7f4e5aa62406741e29e1</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1991.tb16008.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1991.tb16008.x%26sid%3Dliteratum%253Aachs%26aulast%3DHorrevoets%26aufirst%3DA.%2BJ.%26aulast%3DVerheij%26aufirst%3DH.%2BM.%26aulast%3DHaas%26aufirst%3DG.%2BH.%26atitle%3DInactivation%2520of%2520escherichia%2520coli%2520outer-membrane%2520phospholipase%2520A%2520by%2520the%2520affinity%2520label%2520hexadecanesulfonyl%2520fluoride.%2520Evidence%2520for%2520an%2520active-site%2520serine%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1991%26volume%3D198%26spage%3D247%26epage%3D253%26doi%3D10.1111%2Fj.1432-1033.1991.tb16008.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Alapafuja, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikas, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharathan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasr, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvonok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Sulfonyl fluoride inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10074</span><span class="NLM_x">–</span> <span class="NLM_lpage">10089</span><span class="refDoi"> DOI: 10.1021/jm301205j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301205j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10074-10089&author=S.+O.+Alapafujaauthor=S.+P.+Nikasauthor=I.+T.+Bharathanauthor=V.+G.+Shuklaauthor=M.+L.+Nasrauthor=A.+L.+Bowmanauthor=N.+Zvonokauthor=J.+Liauthor=X.+Shiauthor=J.+R.+Engenauthor=A.+Makriyannis&title=Sulfonyl+fluoride+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm301205j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Alapafuja, Shakiru O.; Nikas, Spyros P.; Bharathan, Indu T.; Shukla, Vidyanand G.; Nasr, Mahmoud L.; Bowman, Anna L.; Zvonok, Nikolai; Li, Jing; Shi, Xiaomeng; Engen, John R.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10074-10089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sulfonyl fluorides are known to inhibit esterases.  Early work from our lab. has identified hexadecyl sulfonylfluoride (AM374) as a potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH).  We now report on later generation sulfonyl fluoride analogs that exhibit potent and selective inhibition of FAAH.  Using recombinant rat and human FAAH, we show that 5-(4-hydroxyphenyl)pentanesulfonyl fluoride (AM3506) has similar inhibitory activity for both the rat and the human enzyme, while rapid diln. assays and mass spectrometry anal. suggest that the compd. is a covalent modifier for FAAH and inhibits its action in an irreversible manner.  Our SAR results are highlighted by mol. docking of key analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpCw72isROHbVg90H21EOLACvtfcHk0ljpg28nGfhw4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChsrfK&md5=789d239141f8a92ccff2de9cb77f4f8b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm301205j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301205j%26sid%3Dliteratum%253Aachs%26aulast%3DAlapafuja%26aufirst%3DS.%2BO.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DBharathan%26aufirst%3DI.%2BT.%26aulast%3DShukla%26aufirst%3DV.%2BG.%26aulast%3DNasr%26aufirst%3DM.%2BL.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DSulfonyl%2520fluoride%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10074%26epage%3D10089%26doi%3D10.1021%2Fjm301205j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Godlewski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alapafuja, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bátkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikas, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offertáler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey-White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span> </span><span class="NLM_article-title">Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=21095576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1256-1266&author=G.+Godlewskiauthor=S.+O.+Alapafujaauthor=S.+B%C3%A1tkaiauthor=S.+P.+Nikasauthor=R.+Cinarauthor=L.+Offert%C3%A1lerauthor=D.+Osei-Hyiamanauthor=J.+Liuauthor=B.+Mukhopadhyayauthor=J.+Harvey-Whiteauthor=J.+Tamauthor=K.+Pacakauthor=J.+L.+Blankmanauthor=B.+F.+Cravattauthor=A.+Makriyannisauthor=G.+Kunos&title=Inhibitor+of+fatty+acid+amide+hydrolase+normalizes+cardiovascular+function+in+hypertension+without+adverse+metabolic+effects&doi=10.1016%2Fj.chembiol.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects</span></div><div class="casAuthors">Godlewski, Grzegorz; Alapafuja, Shakiru O.; Batkai, Sandor; Nikas, Spyros P.; Cinar, Resat; Offertaler, Laszlo; Osei-Hyiaman, Douglas; Liu, Jie; Mukhopadhyay, Bani; Harvey-White, Judith; Tam, Joseph; Pacak, Karel; Blankman, Jacqueline L.; Cravatt, Benjamin F.; Makriyannis, Alexandros; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1256-1266</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The enzyme fatty acid amide hydrolase (FAAH) catalyzes the in vivo degrdn. of the endocannabinoid anandamide, thus controlling its action at receptors.  A novel FAAH inhibitor, AM3506, normalizes the elevated blood pressure and cardiac contractility of spontaneously hypertensive rats (SHR) without affecting these parameters in normotensive rats.  These effects are due to blockade of FAAH and a corresponding rise in brain anandamide levels, resulting in CB1 receptor-mediated decrease in sympathetic tone.  The supersensitivity of SHR to CB1 receptor-mediated cardiovascular depression is related to increased G protein coupling of CB1 receptors.  Importantly, AM3506 does not elicit hyperglycemia and insulin resistance seen with other FAAH inhibitors or in FAAH-/- mice, which is related to its inability to inhibit FAAH in the liver due to rapid hepatic uptake and metab.  This unique activity profile offers improved therapeutic value in hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_IAXNnXfV77Vg90H21EOLACvtfcHk0ljpg28nGfhw4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfF&md5=eeca5f6ba5b35d435ebb84861a297410</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DGodlewski%26aufirst%3DG.%26aulast%3DAlapafuja%26aufirst%3DS.%2BO.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DCinar%26aufirst%3DR.%26aulast%3DOffert%25C3%25A1ler%26aufirst%3DL.%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMukhopadhyay%26aufirst%3DB.%26aulast%3DHarvey-White%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DPacak%26aufirst%3DK.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DInhibitor%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520normalizes%2520cardiovascular%2520function%2520in%2520hypertension%2520without%2520adverse%2520metabolic%2520effects%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1256%26epage%3D1266%26doi%3D10.1016%2Fj.chembiol.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePetrillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaeva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bátkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey-White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offertáler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span> </span><span class="NLM_article-title">Endocannabinoid activation at hepatic CB<sub>1</sub> receptors stimulates fatty acid synthesis and contributes to diet-induced obesity</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1298</span><span class="refDoi"> DOI: 10.1172/JCI200523057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1172%2FJCI200523057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15864349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFSktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=1298&author=D.+Osei-Hyiamanauthor=M.+DePetrilloauthor=P.+Pacherauthor=J.+Liuauthor=S.+Radaevaauthor=S.+B%C3%A1tkaiauthor=J.+Harvey-Whiteauthor=K.+Mackieauthor=L.+Offert%C3%A1lerauthor=L.+Wangauthor=G.+Kunos&title=Endocannabinoid+activation+at+hepatic+CB1+receptors+stimulates+fatty+acid+synthesis+and+contributes+to+diet-induced+obesity&doi=10.1172%2FJCI200523057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity</span></div><div class="casAuthors">Osei-Hyiaman, Douglas; DePetrillo, Michael; Pacher, Pal; Liu, Jie; Radaeva, Svetlana; Batkai, Sandor; Harvey-White, Judith; Mackie, Ken; Offertaler, Laszlo; Wang, Lei; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1298-1305</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Endogenous cannabinoids acting at CB1 receptors stimulate appetite, and CB1 antagonists show promise in the treatment of obesity.  CB1-/- mice are resistant to diet-induced obesity even though their caloric intake is similar to that of wild-type mice, suggesting that endocannabinoids also regulate fat metab.  Here, the authors investigated the possible role of endocannabinoids in the regulation of hepatic lipogenesis.  Activation of CB1 in mice increases the hepatic gene expression of the lipogenic transcription factor SREBP-1c and its targets acetyl-CoA carboxylase-1 and fatty acid synthase (FAS).  Treatment with a CB1 agonist also increases de novo fatty acid synthesis in the liver or in isolated hepatocytes, which express CB1.  High-fat diet increases hepatic levels of the endocannabinoid anandamide (arachidonoyl ethanolamide), CB1 d., and basal rates of fatty acid synthesis, and the latter is reduced by CB1 blockade.  In the hypothalamus, where FAS inhibitors elicit anorexia, SREBP-1c and FAS expression are similarly affected by CB1 ligands.  The authors conclude that anandamide acting at hepatic CB1 contributes to diet-induced obesity and that the FAS pathway may be a common mol. target for central appetitive and peripheral metabolic regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgtGH28MhbLVg90H21EOLACvtfcHk0lg6rpwmnmipBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFSktLw%253D&md5=d2262aa9aa65d5f84683f8960e39ec6f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1172%2FJCI200523057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200523057%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26aulast%3DDePetrillo%26aufirst%3DM.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRadaeva%26aufirst%3DS.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DHarvey-White%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DOffert%25C3%25A1ler%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DEndocannabinoid%2520activation%2520at%2520hepatic%2520CB1%2520receptors%2520stimulates%2520fatty%2520acid%2520synthesis%2520and%2520contributes%2520to%2520diet-induced%2520obesity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D1298%26doi%3D10.1172%2FJCI200523057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godlewski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey-White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bátkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsicano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span> </span><span class="NLM_article-title">Hepatic CB<sub>1</sub> receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">3160</span><span class="refDoi"> DOI: 10.1172/JCI34827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1172%2FJCI34827" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=3160&author=D.+Osei-Hyiamanauthor=J.+Liuauthor=L.+Zhouauthor=G.+Godlewskiauthor=J.+Harvey-Whiteauthor=W.+I.+Jeongauthor=S.+B%C3%A1tkaiauthor=G.+Marsicanoauthor=B.+Lutzauthor=C.+Buettnerauthor=G.+Kunos&title=Hepatic+CB1+receptor+is+required+for+development+of+diet-induced+steatosis%2C+dyslipidemia%2C+and+insulin+and+leptin+resistance+in+mice&doi=10.1172%2FJCI34827"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1172%2FJCI34827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI34827%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DGodlewski%26aufirst%3DG.%26aulast%3DHarvey-White%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DW.%2BI.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DMarsicano%26aufirst%3DG.%26aulast%3DLutz%26aufirst%3DB.%26aulast%3DBuettner%26aufirst%3DC.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DHepatic%2520CB1%2520receptor%2520is%2520required%2520for%2520development%2520of%2520diet-induced%2520steatosis%252C%2520dyslipidemia%252C%2520and%2520insulin%2520and%2520leptin%2520resistance%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D3160%26doi%3D10.1172%2FJCI34827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">9699</span><span class="NLM_x">–</span> <span class="NLM_lpage">9704</span><span class="refDoi"> DOI: 10.1021/ja062999h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja062999h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=9699-9704&author=J.+P.+Alexanderauthor=B.+F.+Cravatt&title=The+putative+endocannabinoid+transport+blocker+LY2183240+is+a+potent+inhibitor+of+FAAH+and+several+other+brain+serine+hydrolases&doi=10.1021%2Fja062999h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fja062999h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja062999h%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520putative%2520endocannabinoid%2520transport%2520blocker%2520LY2183240%2520is%2520a%2520potent%2520inhibitor%2520of%2520FAAH%2520and%2520several%2520other%2520brain%2520serine%2520hydrolases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D9699%26epage%3D9704%26doi%3D10.1021%2Fja062999h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Apodaca, R.; Breitenbucher, J.; Pattabiraman, K.; Seierstad, M.; Xiao, W.</span><span> </span><span class="NLM_article-title">Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase</span>. World Patent WO2006074025 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=R.+Apodaca&author=J.+Breitenbucher&author=K.+Pattabiraman&author=M.+Seierstad&author=W.+Xiao&title=Piperazinyl+and+piperidinyl+ureas+as+modulators+of+fatty+acid+amide+hydrolase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DApodaca%26aufirst%3DR.%26atitle%3DPiperazinyl%2520and%2520piperidinyl%2520ureas%2520as%2520modulators%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattabiraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tham, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4838</span><span class="NLM_x">–</span> <span class="NLM_lpage">4843</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2008.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4838-4843&author=J.+M.+Keithauthor=R.+Apodacaauthor=W.+Xiaoauthor=M.+Seierstadauthor=K.+Pattabiramanauthor=J.+Wuauthor=M.+Webbauthor=M.+J.+Karbarzauthor=S.+Brownauthor=S.+Wilsonauthor=B.+Scottauthor=C.+S.+Thamauthor=L.+Luoauthor=J.+Palmerauthor=M.+Wennerholmauthor=S.+Chaplanauthor=J.+G.+Breitenbucher&title=Thiadiazolopiperazinyl+ureas+as+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2008.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DApodaca%26aufirst%3DR.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPattabiraman%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%2BJ.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DTham%26aufirst%3DC.%2BS.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DWennerholm%26aufirst%3DM.%26aulast%3DChaplan%26aufirst%3DS.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DThiadiazolopiperazinyl%2520ureas%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4838%26epage%3D4843%26doi%3D10.1016%2Fj.bmcl.2008.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichenor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Aryl piperazinyl ureas as inhibitors of fatty acid amide hydrolase (FAAH) in rat, dog, and primate</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span><span class="refDoi"> DOI: 10.1021/ml300186g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300186g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1eksbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=823-827&author=J.+M.+Keithauthor=R.+Apodacaauthor=M.+Tichenorauthor=W.+Xiaoauthor=W.+Jonesauthor=J.+Pierceauthor=M.+Seierstadauthor=J.+Palmerauthor=M.+Webbauthor=M.+Karbarzauthor=B.+Scottauthor=S.+Wilsonauthor=L.+Luoauthor=M.+Wennerholmauthor=L.+Changauthor=S.+Brownauthor=M.+Rizzolioauthor=R.+Rynbergauthor=S.+Chaplanauthor=J.+G.+Breitenbucher&title=Aryl+piperazinyl+ureas+as+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29+in+rat%2C+dog%2C+and+primate&doi=10.1021%2Fml300186g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate</span></div><div class="casAuthors">Keith, John M.; Apodaca, Rich; Tichenor, Mark; Xiao, Wei; Jones, William; Pierce, Joan; Seierstad, Mark; Palmer, James; Webb, Michael; Karbarz, Mark; Scott, Brian; Wilson, Sandy; Luo, Lin; Wennerholm, Michelle; Chang, Leon; Brown, Sean; Rizzolio, Michele; Rynberg, Raymond; Chaplan, Sandra; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">823-827</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of aryl piperazinyl ureas that act as covalent inhibitors of fatty acid amide hydrolase (FAAH) is described.  A potent and selective (does not inhibit FAAH-2) member of this class, JNJ-40355003 (I), was found to elevate the plasma levels of three fatty acid amides: anandamide, oleoyl ethanolamide, and palmitoyl ethanolamide, in the rat, dog, and cynomolgous monkey.  The elevation of the levels of these lipids in the plasma of monkeys suggests that FAAH-2 may not play a significant role in regulating plasma levels of fatty acid ethanolamides in primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0G60tuqmh8LVg90H21EOLACvtfcHk0lhU-gb_XXeJ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1eksbrN&md5=fbf5fb59244ac006d87a9b80918ae24e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fml300186g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300186g%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DApodaca%26aufirst%3DR.%26aulast%3DTichenor%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DW.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DRynberg%26aufirst%3DR.%26aulast%3DChaplan%26aufirst%3DS.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DAryl%2520piperazinyl%2520ureas%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520in%2520rat%252C%2520dog%252C%2520and%2520primate%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D823%26epage%3D827%26doi%3D10.1021%2Fml300186g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.12.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2013.12.113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24433863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1OrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=737-741&author=J.+M.+Keithauthor=W.+M.+Jonesauthor=J.+M.+Pierceauthor=M.+Seierstadauthor=J.+A.+Palmerauthor=M.+Webbauthor=M.+J.+Karbarzauthor=B.+P.+Scottauthor=S.+J.+Wilsonauthor=L.+Luoauthor=M.+L.+Wennerholmauthor=L.+Changauthor=S.+M.+Brownauthor=M.+Rizzolioauthor=R.+Rynbergauthor=S.+R.+Chaplanauthor=J.+G.+Breitenbucher&title=Heteroarylureas+with+spirocyclic+diamine+cores+as+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2013.12.113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase</span></div><div class="casAuthors">Keith, John M.; Jones, William M.; Pierce, Joan M.; Seierstad, Mark; Palmer, James A.; Webb, Michael; Karbarz, Mark J.; Scott, Brian P.; Wilson, Sandy J.; Luo, Lin; Wennerholm, Michelle L.; Chang, Leon; Brown, Sean M.; Rizzolio, Michele; Rynberg, Raymond; Chaplan, Sandra R.; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-741</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of mechanism based heteroaryl urea fatty acid amide hydrolase (FAAH) inhibitors with spirocyclic diamine cores is described.  A potent member of this class, (37), was found to inhibit FAAH centrally, elevate the brain levels of three fatty acid ethanolamides [FAAs: anandamide (AEA), oleoyl ethanolamide (OEA) and palmitoyl ethanolamide (PEA)], and was moderately efficacious in a rat model of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvAj0Nj_-tl7Vg90H21EOLACvtfcHk0lhU-gb_XXeJ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1OrsQ%253D%253D&md5=60b527e68c94cba12a0385940bbcddef</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.12.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.12.113%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DJones%26aufirst%3DW.%2BM.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DB.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DS.%2BM.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DRynberg%26aufirst%3DR.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DHeteroarylureas%2520with%2520spirocyclic%2520diamine%2520cores%2520as%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D737%26epage%3D741%26doi%3D10.1016%2Fj.bmcl.2013.12.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichenor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the FAAH inhibitor JNJ-42165279</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00353</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00353" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1204-1208&author=J.+M.+Keithauthor=W.+M.+Jonesauthor=M.+Tichenorauthor=J.+Liuauthor=M.+Seierstadauthor=J.+A.+Palmerauthor=M.+Webbauthor=M.+Karbarzauthor=B.+P.+Scottauthor=S.+J.+Wilsonauthor=L.+Luoauthor=M.+L.+Wennerholmauthor=L.+Changauthor=M.+Rizzolioauthor=R.+Rynbergauthor=S.+R.+Chaplanauthor=J.+G.+Breitenbucher&title=Preclinical+characterization+of+the+FAAH+inhibitor+JNJ-42165279&doi=10.1021%2Facsmedchemlett.5b00353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Characterization of the FAAH Inhibitor JNJ-42165279</span></div><div class="casAuthors">Keith, John M.; Jones, William M.; Tichenor, Mark; Liu, Jing; Seierstad, Mark; Palmer, James A.; Webb, Michael; Karbarz, Mark; Scott, Brian P.; Wilson, Sandy J.; Luo, Lin; Wennerholm, Michelle L.; Chang, Leon; Rizzolio, Michele; Rynberg, Raymond; Chaplan, Sandra R.; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1204-1208</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The preclin. characterization of the aryl piperazinyl urea inhibitor of fatty acid amide hydrolase (FAAH) JNJ-42165279 I is described.  JNJ-42165279 covalently inactivates the FAAH enzyme, but is highly selective with regard to other enzymes, ion channels, transporters, and receptors.  JNJ-42165279 exhibited excellent ADME and pharmacodynamic properties as evidenced by its ability to block FAAH in the brain and periphery of rats and thereby cause an elevation of the concns. of anandamide (AEA), oleoyl ethanolamide (OEA), and palmitoyl ethanolamide (PEA).  The compd. was also efficacious in the spinal nerve ligation (SNL) model of neuropathic pain.  The combination of good phys., ADME, and PD properties of JNJ-42165279 supported it entering the clin. portfolio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomEbhvg1wiX7Vg90H21EOLACvtfcHk0lhU-gb_XXeJ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGms73P&md5=fc681414ace29f39906fdd62c204114b</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00353%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DJones%26aufirst%3DW.%2BM.%26aulast%3DTichenor%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%26aulast%3DScott%26aufirst%3DB.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DRynberg%26aufirst%3DR.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520FAAH%2520inhibitor%2520JNJ-42165279%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1204%26epage%3D1208%26doi%3D10.1021%2Facsmedchemlett.5b00353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2009.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19389627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=411-420&author=K.+Ahnauthor=D.+S.+Johnsonauthor=M.+Mileniauthor=D.+Beidlerauthor=J.+Z.+Longauthor=M.+K.+McKinneyauthor=E.+Weerapanaauthor=N.+Sadagopanauthor=M.+Liimattaauthor=S.+E.+Smithauthor=S.+Lazerwithauthor=C.+Stiffauthor=S.+Kamtekarauthor=K.+Bhattacharyaauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Discovery+and+characterization+of+a+highly+selective+FAAH+inhibitor+that+reduces+inflammatory+pain&doi=10.1016%2Fj.chembiol.2009.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain</span></div><div class="casAuthors">Ahn, Kay; Johnson, Douglas S.; Mileni, Mauro; Beidler, David; Long, Jonathan Z.; McKinney, Michele K.; Weerapana, Eranthie; Sadagopan, Nalini; Liimatta, Marya; Smith, Sarah E.; Lazerwith, Scott; Stiff, Cory; Kamtekar, Satwik; Bhattacharya, Keshab; Zhang, Yanhua; Swaney, Stephen; Van Becelaere, Keri; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Endocannabinoids are lipid signaling mols. that regulate a wide range of mammalian behaviors, including pain, inflammation, and cognitive/emotional state.  The endocannabinoid anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH), and there is currently much interest in developing FAAH inhibitors to augment endocannabinoid signaling in vivo.  Here, we report the discovery and detailed characterization of a highly efficacious and selective FAAH inhibitor, PF-3845.  Mechanistic and structural studies confirm that PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile.  PF-3845 selectively inhibits FAAH in vivo, as detd. by activity-based protein profiling; raises brain anandamide levels for up to 24 h; and produces significant cannabinoid receptor-dependent redns. in inflammatory pain.  These data thus designate PF-3845 as a valuable pharmacol. tool for in vivo characterization of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWANdntofbhbVg90H21EOLACvtfcHk0lhPstF7SK2Jew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVCms7w%253D&md5=c418dbdf626109415af7001db5a7cb93</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLazerwith%26aufirst%3DS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520highly%2520selective%2520FAAH%2520inhibitor%2520that%2520reduces%2520inflammatory%2520pain%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D411%26epage%3D420%26doi%3D10.1016%2Fj.chembiol.2009.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Mileni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everdeen, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">12820</span><span class="NLM_x">–</span> <span class="NLM_lpage">12824</span><span class="refDoi"> DOI: 10.1073/pnas.0806121105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.0806121105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18753625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=12820-12824&author=M.+Mileniauthor=D.+S.+Johnsonauthor=Z.+Wangauthor=D.+S.+Everdeenauthor=M.+Liimattaauthor=B.+Pabstauthor=K.+Bhattacharyaauthor=R.+A.+Nugentauthor=S.+Kamtekarauthor=B.+F.+Cravattauthor=K.+Ahnauthor=R.+C.+Stevens&title=Structure-guided+inhibitor+design+for+human+FAAH+by+interspecies+active+site+conversion&doi=10.1073%2Fpnas.0806121105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided inhibitor design for human FAAH by interspecies active site conversion</span></div><div class="casAuthors">Mileni, Mauro; Johnson, Douglas S.; Wang, Zhigang; Everdeen, Daniel S.; Liimatta, Marya; Pabst, Brandon; Bhattacharya, Keshab; Nugent, Richard A.; Kamtekar, Satwik; Cravatt, Benjamin F.; Ahn, Kay; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">12820-12824</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The integral membrane enzyme fatty acid amide hydrolase (FAAH) hydrolyzes the endocannabinoid anandamide and related amidated signaling lipids.  Genetic or pharmacol. inactivation of FAAH produces analgesic, anxiolytic, and antiinflammatory phenotypes but not the undesirable side effects of direct cannabinoid receptor agonists, indicating that FAAH may be a promising therapeutic target.  Structure-based inhibitor design has, however, been hampered by difficulties in expressing the human FAAH enzyme.  Here, we address this problem by interconverting the active sites of rat and human FAAH using site-directed mutagenesis.  The resulting humanized rat (h/r) FAAH protein exhibits the inhibitor sensitivity profiles of human FAAH but maintains the high-expression yield of the rat enzyme.  We report a 2.75-Å crystal structure of h/rFAAH complexed with an inhibitor, N-phenyl-4- (quinolin-3-ylmethyl)piperidine-1-carboxamide (PF-750), that shows strong preference for human FAAH.  This structure offers compelling insights to explain the species selectivity of FAAH inhibitors, which should guide future drug design programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq16BzSUEI2DbVg90H21EOLACvtfcHk0lhPstF7SK2Jew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmtrvP&md5=bebc9409a5e71734f651c5ab89303fad</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806121105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806121105%26sid%3Dliteratum%253Aachs%26aulast%3DMileni%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEverdeen%26aufirst%3DD.%2BS.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520for%2520human%2520FAAH%2520by%2520interspecies%2520active%2520site%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D12820%26epage%3D12824%26doi%3D10.1073%2Fpnas.0806121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, J. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2869</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2009.03.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19386497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2rtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2865-2869&author=D.+S.+Johnsonauthor=K.+Ahnauthor=S.+Kestenauthor=S.+E.+Lazerwithauthor=Y.+Songauthor=M.+Morrisauthor=L.+Fayauthor=T.+Gregoryauthor=C.+Stiffauthor=J.+B.+Dunbarauthor=M.+Liimattaauthor=D.+Beidlerauthor=S.+Smithauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravatt&title=Benzothiophene+piperazine+and+piperidine+urea+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1016%2Fj.bmcl.2009.03.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)</span></div><div class="casAuthors">Johnson, Douglas S.; Ahn, Kay; Kesten, Suzanne; Lazerwith, Scott E.; Song, Yuntao; Morris, Mark; Fay, Lorraine; Gregory, Tracy; Stiff, Cory; Dunbar, James B.; Liimatta, Marya; Beidler, David; Smith, Sarah; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2865-2869</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationships (SAR) of a series of benzothiophene piperazine and piperidine urea, e.g. I (R = i-Pr, n-Bu, CH2CH2OH, Ph, PhCH2, 3-pyridyl, etc.), as inhibitors of fatty acid amide hydrolase (FAAH) is described.  These compds. inhibit FAAH by covalently modifying the enzyme's active site serine nucleophile.  Activity-based protein profiling revealed that these urea inhibitors were completely selective for FAAH relative to other mammalian serine hydrolases.  Several compds. showed in vivo activity in a rat complete Freund's adjuvant model of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCAmK01iLBdrVg90H21EOLACvtfcHk0lhPLkIUn_ukgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2rtrk%253D&md5=45cd6689440a19fa1ec479dbd6622874</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.080%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DKesten%26aufirst%3DS.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DFay%26aufirst%3DL.%26aulast%3DGregory%26aufirst%3DT.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DDunbar%26aufirst%3DJ.%2BB.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DBenzothiophene%2520piperazine%2520and%2520piperidine%2520urea%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2865%26epage%3D2869%26doi%3D10.1016%2Fj.bmcl.2009.03.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Tchantchou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluett, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2014.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.neuropharm.2014.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24937045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyhtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=427-439&author=F.+Tchantchouauthor=L.+B.+Tuckerauthor=A.+H.+Fuauthor=R.+J.+Bluettauthor=J.+T.+McCabeauthor=S.+Patelauthor=Y.+Zhang&title=The+fatty+acid+amide+hydrolase+inhibitor+PF-3845+promotes+neuronal+survival%2C+attenuates+inflammation+and+improves+functional+recovery+in+mice+with+traumatic+brain+injury&doi=10.1016%2Fj.neuropharm.2014.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury</span></div><div class="casAuthors">Tchantchou, Flaubert; Tucker, Laura B.; Fu, Amanda H.; Bluett, Rebecca J.; McCabe, Joseph T.; Patel, Sachin; Zhang, Yumin</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">427-439</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Traumatic brain injury (TBI) is the leading cause of death in young adults in the United States, but there is still no effective agent for treatment.  N-arachidonoylethanolamine (anandamide, AEA) is a major endocannabinoid in the brain.  Its increase after brain injury is believed to be protective.  However, the compensatory role of AEA is transient due to its rapid hydrolysis by the fatty acid amide hydrolase (FAAH).  Thus, inhibition of FAAH can boost the endogenous levels of AEA and prolong its protective effect.  Using a TBI mouse model, we found that post-injury chronic treatment with PF3845, a selective and potent FAAH inhibitor, reversed TBI-induced impairments in fine motor movement, hippocampus dependent working memory and anxiety-like behavior.  Treatment with PF3845 inactivated FAAH activity and enhanced the AEA levels in the brain.  It reduced neurodegeneration in the dentate gyrus, and up-regulated the expression of Bcl-2 and Hsp70/72 in both cortex and hippocampus.  PF3845 also suppressed the increased prodn. of amyloid precursor protein, prevented dendritic loss and restored the levels of synaptophysin in the ipsilateral dentate gyrus.  Furthermore, PF3845 suppressed the expression of inducible nitric oxide synthase and cyclooxygenase-2 and enhanced the expression of arginase-1 post-TBI, suggesting a shift of microglia/macrophages from M1 to M2 phenotype.  The effects of PF3845 on TBI-induced behavioral deficits and neurodegeneration were mediated by activation of cannabinoid type 1 and 2 receptors and might be attributable to the phosphorylation of ERK1/2 and AKT.  These results suggest that selective inhibition of FAAH is likely to be beneficial for TBI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXGb0o16ycIrVg90H21EOLACvtfcHk0lhPLkIUn_ukgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyhtbzE&md5=af72ce58792e2b888995c58be94f7262</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2014.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2014.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DTchantchou%26aufirst%3DF.%26aulast%3DTucker%26aufirst%3DL.%2BB.%26aulast%3DFu%26aufirst%3DA.%2BH.%26aulast%3DBluett%26aufirst%3DR.%2BJ.%26aulast%3DMcCabe%26aufirst%3DJ.%2BT.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DThe%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520PF-3845%2520promotes%2520neuronal%2520survival%252C%2520attenuates%2520inflammation%2520and%2520improves%2520functional%2520recovery%2520in%2520mice%2520with%2520traumatic%2520brain%2520injury%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D85%26spage%3D427%26epage%3D439%26doi%3D10.1016%2Fj.neuropharm.2014.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1021/ml100190t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor&doi=10.1021%2Fml100190t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0lhPLkIUn_ukgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96%26doi%3D10.1021%2Fml100190t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1124/jpet.111.180257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.111.180257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=21505060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=114-124&author=K.+Ahnauthor=S.+E.+Smithauthor=M.+B.+Liimattaauthor=D.+Beidlerauthor=N.+Sadagopanauthor=D.+T.+Dudleyauthor=T.+Youngauthor=P.+Wrenauthor=Y.+Zhangauthor=S.+Swaneyauthor=K.+Van+Becelaereauthor=J.+L.+Blankmanauthor=D.+K.+Nomuraauthor=S.+N.+Bhattacharauthor=C.+Stiffauthor=T.+K.+Nomanbhoyauthor=E.+Weerapanaauthor=D.+S.+Johnsonauthor=B.+F.+Cravatt&title=Mechanistic+and+pharmacological+characterization+of+PF-04457845%3A+a+highly+potent+and+selective+fatty+acid+amide+hydrolase+inhibitor+that+reduces+inflammatory+and+noninflammatory+pain&doi=10.1124%2Fjpet.111.180257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain</span></div><div class="casAuthors">Ahn, Kay; Smith, Sarah E.; Liimatta, Marya B.; Beidler, David; Sadagopan, Nalini; Dudley, David T.; Young, Tim; Wren, Paul; Zhang, Yanhua; Swaney, Steven; Van Becelaere, Keri; Blankman, Jacqueline L.; Nomura, Daniel K.; Bhattachar, Shobha N.; Stiff, Cory; Nomanbhoy, Tyzoon K.; Weerapana, Eranthie; Johnson, Douglas S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-124</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous cannabinoid (endocannabinoid) anandamide is principally degraded by the integral membrane enzyme fatty acid amide hydrolase (FAAH).  Pharmacol. blockade of FAAH has emerged as a potentially attractive strategy for augmenting endocannabinoid signaling and retaining the beneficial effects of cannabinoid receptor activation, while avoiding the undesirable side effects, such as wt. gain and impairments in cognition and motor control, obsd. with direct cannabinoid receptor 1 agonists.  Here, we report the detailed mechanistic and pharmacol. characterization of N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide (PF-04457845), a highly efficacious and selective FAAH inhibitor.  Mechanistic studies confirm that PF-04457845 is a time-dependent, covalent FAAH inhibitor that carbamylates FAAH's catalytic serine nucleophile.  PF-04457845 inhibits human FAAH with high potency (kinact/Ki = 40,300 M-1s-1; IC50 = 7.2 nM) and is exquisitely selective in vivo as detd. by activity-based protein profiling.  Oral administration of PF-04457845 produced potent antinociceptive effects in both inflammatory [complete Freund's adjuvant (CFA)] and noninflammatory (monosodium iodoacetate) pain models in rats, with a min. ED of 0.1 mg/kg (CFA model).  PF-04457845 displayed a long duration of action as a single oral administration at 1 mg/kg showed in vivo efficacy for 24 h with a concomitant near-complete inhibition of FAAH activity and maximal sustained elevation of anandamide in brain.  Significantly, PF-04457845-treated mice at 10 mg/kg elicited no effect in motility, catalepsy, and body temp.  Based on its exceptional selectivity and in vivo efficacy, combined with long duration of action and optimal pharmacokinetic properties, PF-04457845 is a clin. candidate for the treatment of pain and other nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd5BIw55W3OrVg90H21EOLACvtfcHk0lixCq9WGBJRjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCiurY%253D&md5=b32df795c9df175bd6403fdd5672eae2</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180257%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DWren%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSwaney%26aufirst%3DS.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DMechanistic%2520and%2520pharmacological%2520characterization%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%2520and%2520selective%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520that%2520reduces%2520inflammatory%2520and%2520noninflammatory%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D114%26epage%3D124%26doi%3D10.1124%2Fjpet.111.180257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Huggins, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1837</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span><span class="refDoi"> DOI: 10.1016/j.pain.2012.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.pain.2012.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22727500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKnurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=1837-1846&author=J.+P.+Hugginsauthor=T.+S.+Smartauthor=S.+Langmanauthor=L.+Taylorauthor=T.+Young&title=An+efficient+randomised%2C+placebo-controlled+clinical+trial+with+the+irreversible+fatty+acid+amide+hydrolase-1+inhibitor+PF-04457845%2C+which+modulates+endocannabinoids+but+fails+to+induce+effective+analgesia+in+patients+with+pain+due+to+osteoarthritis+of+the+knee&doi=10.1016%2Fj.pain.2012.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee</span></div><div class="casAuthors">Huggins, John P.; Smart, Trevor S.; Langman, Stephen; Taylor, Louise; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1837-1846</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A randomised, placebo-controlled clin. trial with PF-04457845, a novel irreversible fatty acid amide hydrolase-1 inhibitor, increases endocannabinoids, but does not induce analgesia in patients with osteoarthritis.  The effect of PF-04457845, a potent and selective fatty acid amide hydrolase-1 (FAAH1) inhibitor, on pain due to osteoarthritis of the knee was investigated in a randomised placebo and active-controlled clin. trial.  The trial involved 2 periods (sepd. by a 2-wk washout) consisting of a 1-wk wash-in phase followed by 2 wk double-blind treatment.  Patients received single-blind placebo throughout the wash-in and washout periods.  Patients were randomised to receive either 4 mg q.d.  PF-04457845 followed by placebo (or vice versa), or 500 mg b.i.d. naproxen followed by placebo (or vice versa).  The primary end point was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score.  The trial had predefined decision rules based on likelihood that PF-04457845 was better or worse than the std. of care (considered to be a 1.8 redn. in WOMAC pain score compared to placebo).  A total of 74 patients were randomised to 1 of 4 treatment sequences.  The mean differences (80% confidence intervals) from placebo in WOMAC pain score were 0.04 (-0.63 to 0.71) for PF-04457845 and -1.13 (-1.79 to -0.47) for naproxen, indicating that while naproxen seemed efficacious, PF-04457845 was not differentiated from placebo.  The study was stopped at the interim anal. for futility.  PF-04457845 decreased FAAH activity by >96% and substantially increased 4 endogenous substrates (fatty acid amides).  PF-04457845 was well tolerated in osteoarthritis patients, and there was no evidence of cannabinoid-type adverse events.  The lack of analgesic effect of FAAH1 inhibition in humans is in contrast to data from animal models.  This apparent disconnect between species needs further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbHcORiYgJbVg90H21EOLACvtfcHk0lixCq9WGBJRjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKnurrF&md5=2b63f10426d6cacef059d972a5a825c1</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DJ.%2BP.%26aulast%3DSmart%26aufirst%3DT.%2BS.%26aulast%3DLangman%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DAn%2520efficient%2520randomised%252C%2520placebo-controlled%2520clinical%2520trial%2520with%2520the%2520irreversible%2520fatty%2520acid%2520amide%2520hydrolase-1%2520inhibitor%2520PF-04457845%252C%2520which%2520modulates%2520endocannabinoids%2520but%2520fails%2520to%2520induce%2520effective%2520analgesia%2520in%2520patients%2520with%2520pain%2520due%2520to%2520osteoarthritis%2520of%2520the%2520knee%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D1837%26epage%3D1846%26doi%3D10.1016%2Fj.pain.2012.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Percie du Sert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span> </span><span class="NLM_article-title">Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">2951</span><span class="NLM_x">–</span> <span class="NLM_lpage">2963</span><span class="refDoi"> DOI: 10.1111/bph.12645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fbph.12645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24527763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFaht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=2951-2963&author=N.+Percie+du+Sertauthor=A.+S.+Rice&title=Improving+the+translation+of+analgesic+drugs+to+the+clinic%3A+animal+models+of+neuropathic+pain&doi=10.1111%2Fbph.12645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain</span></div><div class="casAuthors">Percie du Sert, N.; Rice, A. S. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2951-2963</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain remains an area of considerable unmet clin. need.  Research based on preclin. animal models has failed to deliver truly novel treatment options, questioning the predictive value of these models.  This review addresses the shortcomings of rodent in vivo models commonly used in the field and highlights approaches which could increase their predictivity, including more clin. relevant assays, outcome measures and animal characteristics.  The methodol. quality of animal studies also needs to be improved.  Low internal validity and incomplete reporting lead to a waste of valuable research resources and animal lives, and ultimately prevent an objective assessment of the true predictivity of in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ7teE3qz4b7Vg90H21EOLACvtfcHk0lixCq9WGBJRjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFaht7o%253D&md5=01c4dda8a78b402411a8ea882d998a12</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fbph.12645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12645%26sid%3Dliteratum%253Aachs%26aulast%3DPercie%2Bdu%2BSert%26aufirst%3DN.%26aulast%3DRice%26aufirst%3DA.%2BS.%26atitle%3DImproving%2520the%2520translation%2520of%2520analgesic%2520drugs%2520to%2520the%2520clinic%253A%2520animal%2520models%2520of%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D2951%26epage%3D2963%26doi%3D10.1111%2Fbph.12645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Hicks, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadovski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of [<sup>11</sup>C-carbonyl] PF-04457845 for neuroimaging of fatty acid amide hydrolase</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2013.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.nucmedbio.2013.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23731552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=740-746&author=J.+W.+Hicksauthor=J.+Parkesauthor=O.+Sadovskiauthor=J.+Tongauthor=S.+Houleauthor=N.+Vasdevauthor=A.+A.+Wilson&title=Synthesis+and+preclinical+evaluation+of+%5B11C-carbonyl%5D+PF-04457845+for+neuroimaging+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.nucmedbio.2013.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase</span></div><div class="casAuthors">Hicks, Justin W.; Parkes, Jun; Sadovski, Oleg; Tong, Junchao; Houle, Sylvain; Vasdev, Neil; Wilson, Alan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">740-746</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) has a significant role in regulating endocannabinoid signaling in the central nervous system.  As such, FAAH inhibitors are being actively sought for pain, addiction, and other indications.  This has led to the recent pursuit of positron emission tomog. (PET) radiotracers targeting FAAH.  We report herein the prepn. and preclin. evaluation of [11C-carbonyl]PF-04457845, an isotopologue of the potent irreversible FAAH inhibitor.  PF-04457845 was radiolabeled at the carbonyl position via automated [11C]CO2-fixation.  Ex vivo brain biodistribution of [11C-carbonyl]PF-04457845 was carried out in conscious rats.  Specificity was detd. by pre-administration of PF-04457845 or URB597 prior to [11C-carbonyl]PF-04457845.  In a sep. expt., rats injected with the title radiotracer had whole brains excised, homogenized and extd. to examine irreversible binding to brain parenchyma.  The title compd. was prepd. in 5 ± 1% (n = 4) isolated radiochem. yield based on starting [11C]CO2 (decay uncorrected) within 25 min from end-of-bombardment in > 98% radiochem. purity and a specific activity of 73.5 ± 8.2 GBq/μmol at end-of-synthesis.  Uptake of [11C-carbonyl]PF-04457845 into the rat brain was high (range of 1.2-4.4 SUV), heterogeneous, and in accordance with reported FAAH distribution.  Saturable binding was demonstrated by a dose-dependent redn. in brain radioactivity uptake following pre-treatment with PF-04457845.  Pre-treatment with the prototypical FAAH inhibitor, URB597, reduced the brain radiotracer uptake in all regions by 71-81%, demonstrating specificity for FAAH.  The binding of [11C-carbonyl]PF-04457845 to FAAH at 40 min post injection was irreversible as 98% of the radioactivity in the brain could not be extd.  [11C-carbonyl]PF-04457845 was rapidly synthesized via an automated radiosynthesis.  Ex vivo biodistribution studies in conscious rodents demonstrate that [11C PF-04457845 is a promising candidate radiotracer for imaging FAAH in the brain with PET.  These results coupled with the known pharmacol. and toxicol. of PF-04457845 should facilitate clin. translation of this radiotracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3VVfFVnooC7Vg90H21EOLACvtfcHk0liwTvGuJVFcnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslWmt7o%253D&md5=17ff0759bc57b31cd49887f5e30b3afa</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2013.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2013.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DParkes%26aufirst%3DJ.%26aulast%3DSadovski%26aufirst%3DO.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520%255B11C-carbonyl%255D%2520PF-04457845%2520for%2520neuroimaging%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2013%26volume%3D40%26spage%3D740%26epage%3D746%26doi%3D10.1016%2Fj.nucmedbio.2013.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelc, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: Identification of 7-azaspiro [3.5] nonane and 1-oxa-8-azaspiro [4.5] decane as lead scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6538</span><span class="NLM_x">–</span> <span class="NLM_lpage">6544</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2011.08.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6538-6544&author=M.+J.+Meyersauthor=S.+A.+Longauthor=M.+J.+Pelcauthor=J.+L.+Wangauthor=S.+J.+Bowenauthor=M.+C.+Walkerauthor=B.+A.+Schweitzerauthor=H.+M.+Madsenauthor=R.+E.+Tenbrinkauthor=J.+McDonaldauthor=S.+E.+Smithauthor=S.+Foltinauthor=D.+Beidlerauthor=A.+Thorarensen&title=Discovery+of+novel+spirocyclic+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29.+Part+1%3A+Identification+of+7-azaspiro+%5B3.5%5D+nonane+and+1-oxa-8-azaspiro+%5B4.5%5D+decane+as+lead+scaffolds&doi=10.1016%2Fj.bmcl.2011.08.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.055%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPelc%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DBowen%26aufirst%3DS.%2BJ.%26aulast%3DWalker%26aufirst%3DM.%2BC.%26aulast%3DSchweitzer%26aufirst%3DB.%2BA.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DFoltin%26aufirst%3DS.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520novel%2520spirocyclic%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529.%2520Part%25201%253A%2520Identification%2520of%25207-azaspiro%2520%255B3.5%255D%2520nonane%2520and%25201-oxa-8-azaspiro%2520%255B4.5%255D%2520decane%2520as%2520lead%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6538%26epage%3D6544%26doi%3D10.1016%2Fj.bmcl.2011.08.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelc, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumsey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamtekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro [3.5] nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6545</span><span class="NLM_x">–</span> <span class="NLM_lpage">6553</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2011.08.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6545-6553&author=M.+J.+Meyersauthor=S.+A.+Longauthor=M.+J.+Pelcauthor=J.+L.+Wangauthor=S.+J.+Bowenauthor=B.+A.+Schweitzerauthor=M.+V.+Wilcoxauthor=J.+McDonaldauthor=S.+E.+Smithauthor=S.+Foltinauthor=J.+Rumseyauthor=Y.+S.+Yangauthor=M.+C.+Walkerauthor=S.+Kamtekarauthor=D.+Beidlerauthor=A.+Thorarensen&title=Discovery+of+novel+spirocyclic+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29.+Part+2.+Discovery+of+7-azaspiro+%5B3.5%5D+nonane+urea+PF-04862853%2C+an+orally+efficacious+inhibitor+of+fatty+acid+amide+hydrolase+%28FAAH%29+for+pain&doi=10.1016%2Fj.bmcl.2011.08.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.048%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DLong%26aufirst%3DS.%2BA.%26aulast%3DPelc%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DBowen%26aufirst%3DS.%2BJ.%26aulast%3DSchweitzer%26aufirst%3DB.%2BA.%26aulast%3DWilcox%26aufirst%3DM.%2BV.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DFoltin%26aufirst%3DS.%26aulast%3DRumsey%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DWalker%26aufirst%3DM.%2BC.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520novel%2520spirocyclic%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529.%2520Part%25202.%2520Discovery%2520of%25207-azaspiro%2520%255B3.5%255D%2520nonane%2520urea%2520PF-04862853%252C%2520an%2520orally%2520efficacious%2520inhibitor%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6545%26epage%3D6553%26doi%3D10.1016%2Fj.bmcl.2011.08.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Kono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2012.11.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=28-41&author=M.+Konoauthor=T.+Matsumotoauthor=T.+Kawamuraauthor=A.+Nishimuraauthor=Y.+Kiyotaauthor=H.+Okiauthor=J.+Miyazakiauthor=S.+Igakiauthor=C.+A.+Behnkeauthor=M.+Shimojoauthor=M.+Kori&title=Synthesis%2C+SAR+study%2C+and+biological+evaluation+of+a+series+of+piperazine+ureas+as+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1016%2Fj.bmc.2012.11.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DKiyota%26aufirst%3DY.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DIgaki%26aufirst%3DS.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520SAR%2520study%252C%2520and%2520biological%2520evaluation%2520of%2520a%2520series%2520of%2520piperazine%2520ureas%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D28%26epage%3D41%26doi%3D10.1016%2Fj.bmc.2012.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Kono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosugi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1468</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2013.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24440478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1468-1478&author=M.+Konoauthor=T.+Matsumotoauthor=T.+Imaedaauthor=T.+Kawamuraauthor=S.+Fujimotoauthor=Y.+Kosugiauthor=T.+Odaniauthor=Y.+Shimizuauthor=H.+Matsuiauthor=M.+Shimojoauthor=M.+Kori&title=Design%2C+synthesis%2C+and+biological+evaluation+of+a+series+of+piperazine+ureas+as+fatty+acid+amide+hydrolase+inhibitors&doi=10.1016%2Fj.bmc.2013.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors</span></div><div class="casAuthors">Kono, Mitsunori; Matsumoto, Takahiro; Imaeda, Toshihiro; Kawamura, Toru; Fujimoto, Shinji; Kosugi, Yohei; Odani, Tomoyuki; Shimizu, Yuji; Matsui, Hideki; Shimojo, Masato; Kori, Masakuni</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1468-1478</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of piperazine ureas were designed, synthesized, and evaluated for their potential as novel orally efficacious fatty acid amide hydrolase (FAAH) inhibitors for the treatment of neuropathic and inflammatory pain.  We carried out an optimization study of compd. 5 to improve its in vitro FAAH inhibitory activity, and identified the 2-pyrimidinylpiperazine deriv. 21d with potent inhibitory activity, favorable DMPK profile and brain permeability.  Compd. 21d showed robust and dose-dependent analgesic efficacy in animal models of both neuropathic and inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOGgRCmurOZbVg90H21EOLACvtfcHk0lhDuI2t54e_IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyktrg%253D&md5=38f9681ea9d7eb262642a423a87cdaa3</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DS.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DOdani%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520a%2520series%2520of%2520piperazine%2520ureas%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1468%26epage%3D1478%26doi%3D10.1016%2Fj.bmc.2013.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span> </span><span class="NLM_article-title">Boronic acid compounds as potential pharmaceutical agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1002/med.10043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fmed.10043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=12647314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=346-368&author=W.+Yangauthor=X.+Gaoauthor=B.+Wang&title=Boronic+acid+compounds+as+potential+pharmaceutical+agents&doi=10.1002%2Fmed.10043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid compounds as potential pharmaceutical agents</span></div><div class="casAuthors">Yang, Wenqian; Gao, Xingming; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-368</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Boronic acid compds. have been used, because of their unique structural features, for the development of potent enzyme inhibitors, boron neutron capture agents for cancer therapy, and as antibody mimics that recognize biol. important saccharides.  Consequently, there has been a surge of interests in boronic acid compds.  This study reviews the recent development in this area during the last six years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB0CvJjV10BbVg90H21EOLACvtfcHk0lhDuI2t54e_IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D&md5=0b841477e2113218d55991e23133bd60</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1002%2Fmed.10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10043%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DBoronic%2520acid%2520compounds%2520as%2520potential%2520pharmaceutical%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D346%26epage%3D368%26doi%3D10.1002%2Fmed.10043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Minkkila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span> </span><span class="NLM_article-title">Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7057</span><span class="NLM_x">–</span> <span class="NLM_lpage">7060</span><span class="refDoi"> DOI: 10.1021/jm801051t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801051t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7057-7060&author=A.+Minkkilaauthor=S.+M.+Saarioauthor=H.+K%C3%A4sn%C3%A4nenauthor=J.+Lepp%C3%A4nenauthor=A.+Posoauthor=T.+Nevalainen&title=Discovery+of+boronic+acids+as+novel+and+potent+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1021%2Fjm801051t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm801051t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801051t%26sid%3Dliteratum%253Aachs%26aulast%3DMinkkila%26aufirst%3DA.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520boronic%2520acids%2520as%2520novel%2520and%2520potent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7057%26epage%3D7060%26doi%3D10.1021%2Fjm801051t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chobanian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellureficio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terebetski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posavec, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVita, R. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-3168: a PET tracer for imaging brain fatty acid amide hydrolase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span><span class="refDoi"> DOI: 10.1021/ml4000996</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4000996" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ylu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=509-513&author=P.+Liuauthor=T.+G.+Hamillauthor=M.+Chiodaauthor=H.+Chobanianauthor=S.+Fungauthor=Y.+Guoauthor=L.+Changauthor=R.+Bakshiauthor=Q.+Hongauthor=J.+Dellureficioauthor=L.+S.+Linauthor=C.+Abbadieauthor=J.+Alexanderauthor=H.+Jinauthor=S.+Mandalaauthor=L.+L.+Shiaoauthor=W.+Liauthor=S.+Sanabriaauthor=D.+Williamsauthor=Z.+Zengauthor=R.+Hajduauthor=N.+Jochnowitzauthor=M.+Rosenbachauthor=B.+Karanamauthor=M.+Madeiraauthor=G.+Salituroauthor=J.+Powellauthor=L.+Xuauthor=J.+L.+Terebetskiauthor=J.+F.+Leoneauthor=P.+Millerauthor=J.+Cookauthor=M.+Holahanauthor=A.+Joshiauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=D.+Posavecauthor=T.+B.+Chenauthor=K.+Riffelauthor=M.+Williamsauthor=R.+Hargreavesauthor=K.+A.+Sullivanauthor=R.+P.+Nargundauthor=R.+J.+DeVita&title=Discovery+of+MK-3168%3A+a+PET+tracer+for+imaging+brain+fatty+acid+amide+hydrolase&doi=10.1021%2Fml4000996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase</span></div><div class="casAuthors">Liu, Ping; Hamill, Terence G.; Chioda, Marc; Chobanian, Harry; Fung, Selena; Guo, Yan; Chang, Linda; Bakshi, Raman; Hong, Qingmei; Dellureficio, James; Lin, Linus S.; Abbadie, Catherine; Alexander, Jessica; Jin, Hong; Mandala, Suzanne; Shiao, Lin-Lin; Li, Wenping; Sanabria, Sandra; Williams, David; Zeng, Zhizhen; Hajdu, Richard; Jochnowitz, Nina; Rosenbach, Mark; Karanam, Bindhu; Madeira, Maria; Salituro, Gino; Powell, Joyce; Xu, Ling; Terebetski, Jenna L.; Leone, Joseph F.; Miller, Patricia; Cook, Jacquelynn; Holahan, Marie; Joshi, Aniket; O'Malley, Stacey; Purcell, Mona; Posavec, Diane; Chen, Tsing-Bau; Riffel, Kerry; Williams, Mangay; Hargreaves, Richard; Sullivan, Kathleen A.; Nargund, Ravi P.; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">509-513</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the discovery of a fatty acid amide hydrolase (FAAH) positron emission tomog. (PET) tracer.  Starting from a pyrazole lead, medicinal chem. efforts directed toward reducing lipophilicity led to the synthesis of a series of imidazole analogs.  Compd. 6 was chosen for further profiling due to its appropriate phys. chem. properties and excellent FAAH inhibition potency across species. [11C]-6 (MK-3168) exhibited good brain uptake and FAAH-specific signal in rhesus monkeys and is a suitable PET tracer for imaging FAAH in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ7TcIehUa5rVg90H21EOLACvtfcHk0lhDuI2t54e_IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ylu7Y%253D&md5=a5ec9a3750ed61f576732b8dfd541026</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fml4000996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000996%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DChioda%26aufirst%3DM.%26aulast%3DChobanian%26aufirst%3DH.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBakshi%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DDellureficio%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%2BS.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DAlexander%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DShiao%26aufirst%3DL.%2BL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSanabria%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTerebetski%26aufirst%3DJ.%2BL.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DPosavec%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%2BB.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DK.%2BA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-3168%253A%2520a%2520PET%2520tracer%2520for%2520imaging%2520brain%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D509%26epage%3D513%26doi%3D10.1021%2Fml4000996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Chobanian, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioda, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellureficio, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyk, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krska, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarewicz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martel, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terebetski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVita, R. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-4409, a novel oxazole FAAH inhibitor for the treatment of inflammatory and neuropathic pain</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span><span class="refDoi"> DOI: 10.1021/ml5001239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5001239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=717-721&author=H.+R.+Chobanianauthor=Y.+Guoauthor=P.+Liuauthor=M.+D.+Chiodaauthor=S.+Fungauthor=T.+J.+Lanzaauthor=L.+Changauthor=R.+K.+Bakshiauthor=J.+P.+Dellureficioauthor=Q.+Hongauthor=M.+McLaughlinauthor=K.+M.+Belykauthor=S.+W.+Krskaauthor=A.+K.+Makarewiczauthor=E.+J.+Martelauthor=J.+F.+Leoneauthor=L.+Freyauthor=B.+Karanamauthor=M.+Madeiraauthor=R.+Alvaroauthor=J.+Shumanauthor=G.+Salituroauthor=J.+L.+Terebetskiauthor=N.+Jochnowitzauthor=S.+Mistryauthor=E.+McGowanauthor=R.+Hajduauthor=M.+Rosenbachauthor=C.+Abbadieauthor=J.+P.+Alexanderauthor=L.+L.+Shiaoauthor=K.+M.+Sullivanauthor=R.+P.+Nargundauthor=M.+J.+Wyvrattauthor=L.+S.+Linauthor=R.+J.+DeVita&title=Discovery+of+MK-4409%2C+a+novel+oxazole+FAAH+inhibitor+for+the+treatment+of+inflammatory+and+neuropathic+pain&doi=10.1021%2Fml5001239"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fml5001239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5001239%26sid%3Dliteratum%253Aachs%26aulast%3DChobanian%26aufirst%3DH.%2BR.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DChioda%26aufirst%3DM.%2BD.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DDellureficio%26aufirst%3DJ.%2BP.%26aulast%3DHong%26aufirst%3DQ.%26aulast%3DMcLaughlin%26aufirst%3DM.%26aulast%3DBelyk%26aufirst%3DK.%2BM.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26aulast%3DMakarewicz%26aufirst%3DA.%2BK.%26aulast%3DMartel%26aufirst%3DE.%2BJ.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DFrey%26aufirst%3DL.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DAlvaro%26aufirst%3DR.%26aulast%3DShuman%26aufirst%3DJ.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DTerebetski%26aufirst%3DJ.%2BL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DAlexander%26aufirst%3DJ.%2BP.%26aulast%3DShiao%26aufirst%3DL.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%2BM.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DLin%26aufirst%3DL.%2BS.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-4409%252C%2520a%2520novel%2520oxazole%2520FAAH%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D717%26epage%3D721%26doi%3D10.1021%2Fml5001239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Andrzejak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Body-Malapel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Bakali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djouina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavatte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desreumaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, R.</span><span> </span><span class="NLM_article-title">New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3786</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2011.04.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=21612933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3777-3786&author=V.+Andrzejakauthor=G.+G.+Muccioliauthor=M.+Body-Malapelauthor=J.+El+Bakaliauthor=M.+Djouinaauthor=N.+Renaultauthor=P.+Chavatteauthor=P.+Desreumauxauthor=D.+M.+Lambertauthor=R.+Millet&title=New+FAAH+inhibitors+based+on+3-carboxamido-5-aryl-isoxazole+scaffold+that+protect+against+experimental+colitis&doi=10.1016%2Fj.bmc.2011.04.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis</span></div><div class="casAuthors">Andrzejak, Virginie; Muccioli, Giulio G.; Body-Malapel, Mathilde; El Bakali, Jamal; Djouina, Madjid; Renault, Nicolas; Chavatte, Philippe; Desreumaux, Pierre; Lambert, Didier M.; Millet, Regis</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3777-3786</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Growing evidence suggests a role for the endocannabinoid (EC) system, in intestinal inflammation and compds. inhibiting anandamide degrdn. offer a promising therapeutic option for the treatment of inflammatory bowel diseases.  In this paper, we report the first series of carboxamides derivs. possessing FAAH inhibitory activities.  Among them, compd. 39 (I) displayed significant inhibitory FAAH activity (IC50 = 0.088 μM) and reduced colitis induced by intrarectal administration of TNBS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqreyUWekQBlbVg90H21EOLACvtfcHk0lggYKrVL8HvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVyis7w%253D&md5=25a1961af5665d87d9a019e697a97321</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.057%26sid%3Dliteratum%253Aachs%26aulast%3DAndrzejak%26aufirst%3DV.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DBody-Malapel%26aufirst%3DM.%26aulast%3DEl%2BBakali%26aufirst%3DJ.%26aulast%3DDjouina%26aufirst%3DM.%26aulast%3DRenault%26aufirst%3DN.%26aulast%3DChavatte%26aufirst%3DP.%26aulast%3DDesreumaux%26aufirst%3DP.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMillet%26aufirst%3DR.%26atitle%3DNew%2520FAAH%2520inhibitors%2520based%2520on%25203-carboxamido-5-aryl-isoxazole%2520scaffold%2520that%2520protect%2520against%2520experimental%2520colitis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3777%26epage%3D3786%26doi%3D10.1016%2Fj.bmc.2011.04.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Tourteau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leleu-Chavain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Body-Malapel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrzejak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djouina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desreumaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavatte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, R.</span><span> </span><span class="NLM_article-title">Switching cannabinoid response from CB<sub>2</sub> agonists to FAAH inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2014.01.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1322-1326&author=A.+Tourteauauthor=N.+Leleu-Chavainauthor=M.+Body-Malapelauthor=V.+Andrzejakauthor=A.+Barczykauthor=M.+Djouinaauthor=B.+Rigoauthor=P.+Desreumauxauthor=P.+Chavatteauthor=R.+Millet&title=Switching+cannabinoid+response+from+CB2+agonists+to+FAAH+inhibitors&doi=10.1016%2Fj.bmcl.2014.01.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.056%26sid%3Dliteratum%253Aachs%26aulast%3DTourteau%26aufirst%3DA.%26aulast%3DLeleu-Chavain%26aufirst%3DN.%26aulast%3DBody-Malapel%26aufirst%3DM.%26aulast%3DAndrzejak%26aufirst%3DV.%26aulast%3DBarczyk%26aufirst%3DA.%26aulast%3DDjouina%26aufirst%3DM.%26aulast%3DRigo%26aufirst%3DB.%26aulast%3DDesreumaux%26aufirst%3DP.%26aulast%3DChavatte%26aufirst%3DP.%26aulast%3DMillet%26aufirst%3DR.%26atitle%3DSwitching%2520cannabinoid%2520response%2520from%2520CB2%2520agonists%2520to%2520FAAH%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1322%26epage%3D1326%26doi%3D10.1016%2Fj.bmcl.2014.01.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Minkkilä, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xhaard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span> </span><span class="NLM_article-title">Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1259</span><span class="refDoi"> DOI: 10.1002/cmdc.200900137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.200900137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1253-1259&author=A.+Minkkil%C3%A4author=J.+R.+Savinainenauthor=H.+K%C3%A4sn%C3%A4nenauthor=H.+Xhaardauthor=T.+Nevalainenauthor=J.+T.+Laitinenauthor=A.+Posoauthor=J.+Lepp%C3%A4nenauthor=S.+M.+Saario&title=Screening+of+various+hormone-sensitive+lipase+inhibitors+as+endocannabinoid-hydrolyzing+enzyme+inhibitors&doi=10.1002%2Fcmdc.200900137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900137%26sid%3Dliteratum%253Aachs%26aulast%3DMinkkil%25C3%25A4%26aufirst%3DA.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DXhaard%26aufirst%3DH.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26atitle%3DScreening%2520of%2520various%2520hormone-sensitive%2520lipase%2520inhibitors%2520as%2520endocannabinoid-hydrolyzing%2520enzyme%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1253%26epage%3D1259%26doi%3D10.1002%2Fcmdc.200900137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minkkilä, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taupila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span> </span><span class="NLM_article-title">1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: synthesis, <i>in vitro</i> evaluation and insight into potency and selectivity determinants by molecular modelling</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1016/j.ejps.2013.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejps.2013.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23557840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslWqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=423-433&author=H.+K%C3%A4sn%C3%A4nenauthor=A.+Minkkil%C3%A4author=S.+Taupilaauthor=J.+Z.+Patelauthor=T.+Parkkariauthor=M.+Lahtela-Kakkonenauthor=S.+M.+Saarioauthor=T.+Nevalainenauthor=A.+Poso&title=1%2C3%2C4-Oxadiazol-2-ones+as+fatty-acid+amide+hydrolase+and+monoacylglycerol+lipase+inhibitors%3A+synthesis%2C+in+vitro+evaluation+and+insight+into+potency+and+selectivity+determinants+by+molecular+modelling&doi=10.1016%2Fj.ejps.2013.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling</span></div><div class="casAuthors">Kasnanen, Heikki; Minkkila, Anna; Taupila, Susanna; Patel, Jayendra Z.; Parkkari, Teija; Lahtela-Kakkonen, Maija; Saario, Susanna M.; Nevalainen, Tapio; Poso, Antti</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">423-433</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of the key hydrolytic enzymes of the endocannabinoid system, fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), has been proposed as potential mode of action for various therapeutic applications.  Continuing our previous work, we take the first steps of structure-activity relationship exploration and show that 1,3,4-oxadiazol-2-ones can serve as scaffold for both selective FAAH and MAGL inhibitors, and also function as a dual FAAH/MAGL inhibitor at sub-micromolar IC50 values.  Moreover, 10-fold selectivity against MAGL over FAAH was achieved with compd. 3d (FAAH and MAGL IC50; 2.0 and 0.22 μM).  Lastly, enzyme and ligand features contributing to the potency and selectivity differences are analyzed by mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV1_s_EqIC6LVg90H21EOLACvtfcHk0ljY_DcPsZ5U5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslWqtb4%253D&md5=76a93279a6b9b1ac1f5f1aa7c84266ad</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DMinkkil%25C3%25A4%26aufirst%3DA.%26aulast%3DTaupila%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DJ.%2BZ.%26aulast%3DParkkari%26aufirst%3DT.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DPoso%26aufirst%3DA.%26atitle%3D1%252C3%252C4-Oxadiazol-2-ones%2520as%2520fatty-acid%2520amide%2520hydrolase%2520and%2520monoacylglycerol%2520lipase%2520inhibitors%253A%2520synthesis%252C%2520in%2520vitro%2520evaluation%2520and%2520insight%2520into%2520potency%2520and%2520selectivity%2520determinants%2520by%2520molecular%2520modelling%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D49%26spage%3D423%26epage%3D433%26doi%3D10.1016%2Fj.ejps.2013.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Patel, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczor, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipriano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshevoy, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span> </span><span class="NLM_article-title">Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8484</span><span class="NLM_x">–</span> <span class="NLM_lpage">8496</span><span class="refDoi"> DOI: 10.1021/jm400923s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400923s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8484-8496&author=J.+Z.+Patelauthor=T.+Parkkariauthor=T.+Laitinenauthor=A.+A.+Kaczorauthor=S.+M.+Saarioauthor=J.+R.+Savinainenauthor=D.+Navia-Paldaniusauthor=M.+Ciprianoauthor=J.+Lepp%C3%A4nenauthor=I.+O.+Koshevoyauthor=A.+Posoauthor=C.+J.+Fowlerauthor=J.+T.+Laitinenauthor=T.+Nevalainen&title=Chiral+1%2C3%2C4-oxadiazol-2-ones+as+highly+selective+FAAH+inhibitors&doi=10.1021%2Fjm400923s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fjm400923s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400923s%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DJ.%2BZ.%26aulast%3DParkkari%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DKaczor%26aufirst%3DA.%2BA.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DKoshevoy%26aufirst%3DI.%2BO.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DNevalainen%26aufirst%3DT.%26atitle%3DChiral%25201%252C3%252C4-oxadiazol-2-ones%2520as%2520highly%2520selective%2520FAAH%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8484%26epage%3D8496%26doi%3D10.1021%2Fjm400923s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kage, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Kouhen, O. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. O.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1021/jm801042a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801042a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=170-180&author=X.+Wangauthor=K.+Sarrisauthor=K.+Kageauthor=D.+Zhangauthor=S.+P.+Brownauthor=T.+Kolasaauthor=C.+Surowyauthor=O.+F.+El+Kouhenauthor=S.+W.+Muchmoreauthor=J.+D.+Brioniauthor=A.+O.+Stewart&title=Synthesis+and+evaluation+of+benzothiazole-based+analogues+as+novel%2C+potent%2C+and+selective+fatty+acid+amide+hydrolase+inhibitors&doi=10.1021%2Fjm801042a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm801042a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801042a%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSarris%26aufirst%3DK.%26aulast%3DKage%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DEl%2BKouhen%26aufirst%3DO.%2BF.%26aulast%3DMuchmore%26aufirst%3DS.%2BW.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520benzothiazole-based%2520analogues%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D170%26epage%3D180%26doi%3D10.1021%2Fjm801042a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Gustin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester-Zeiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meleza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span> </span><span class="NLM_article-title">Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2496</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2011.02.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2492-2496&author=D.+J.+Gustinauthor=Z.+Maauthor=X.+Minauthor=Y.+Liauthor=C.+Hedbergauthor=C.+Guimaraesauthor=A.+C.+Porterauthor=M.+Lindstromauthor=D.+Lester-Zeinerauthor=G.+Xuauthor=T.+J.+Carlsonauthor=S.+Xiaoauthor=C.+Melezaauthor=R.+Connorsauthor=Z.+Wangauthor=F.+Kayser&title=Identification+of+potent%2C+noncovalent+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors&doi=10.1016%2Fj.bmcl.2011.02.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHedberg%26aufirst%3DC.%26aulast%3DGuimaraes%26aufirst%3DC.%26aulast%3DPorter%26aufirst%3DA.%2BC.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DMeleza%26aufirst%3DC.%26aulast%3DConnors%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKayser%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520potent%252C%2520noncovalent%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2492%26epage%3D2496%26doi%3D10.1016%2Fj.bmcl.2011.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">7379</span><span class="NLM_x">–</span> <span class="NLM_lpage">7384</span><span class="refDoi"> DOI: 10.1073/pnas.1016167108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1073%2Fpnas.1016167108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7379-7384&author=X.+Minauthor=S.+T.+Thibaultauthor=A.+C.+Porterauthor=D.+J.+Gustinauthor=T.+J.+Carlsonauthor=H.+Xuauthor=M.+Lindstromauthor=G.+Xuauthor=C.+Uyedaauthor=Z.+Maauthor=Y.+Liauthor=F.+Kayserauthor=N.+P.+Walkerauthor=Z.+Wang&title=Discovery+and+molecular+basis+of+potent+noncovalent+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1073%2Fpnas.1016167108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1016167108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1016167108%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DX.%26aulast%3DThibault%26aufirst%3DS.%2BT.%26aulast%3DPorter%26aufirst%3DA.%2BC.%26aulast%3DGustin%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DT.%2BJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLindstrom%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DUyeda%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DDiscovery%2520and%2520molecular%2520basis%2520of%2520potent%2520noncovalent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7379%26epage%3D7384%26doi%3D10.1073%2Fpnas.1016167108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Gowlugari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFalco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerling, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, F.</span><span> </span><span class="NLM_article-title">Discovery of potent, non-carbonyl inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span><span class="refDoi"> DOI: 10.1039/c2md20146a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1039%2Fc2md20146a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1258-1263&author=S.+Gowlugariauthor=J.+DeFalcoauthor=M.+T.+Nguyenauthor=C.+Kaubauthor=C.+Chiauthor=M.+A.+Dunctonauthor=D.+E.+Emerlingauthor=M.+G.+Kellyauthor=J.+Kincaidauthor=F.+Vincent&title=Discovery+of+potent%2C+non-carbonyl+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29&doi=10.1039%2Fc2md20146a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1039%2Fc2md20146a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20146a%26sid%3Dliteratum%253Aachs%26aulast%3DGowlugari%26aufirst%3DS.%26aulast%3DDeFalco%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DM.%2BT.%26aulast%3DKaub%26aufirst%3DC.%26aulast%3DChi%26aufirst%3DC.%26aulast%3DDuncton%26aufirst%3DM.%2BA.%26aulast%3DEmerling%26aufirst%3DD.%2BE.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3DKincaid%26aufirst%3DJ.%26aulast%3DVincent%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520potent%252C%2520non-carbonyl%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D1258%26epage%3D1263%26doi%3D10.1039%2Fc2md20146a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Sundermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanekamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, M.</span><span> </span><span class="NLM_article-title">1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A<sub>2</sub>α and fatty acid amide hydrolase: effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2592</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2015.03.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2579-2592&author=T.+Sundermannauthor=J.+Fabianauthor=W.+Hanekampauthor=M.+Lehr&title=1-Heteroaryl-3-phenoxypropan-2-ones+as+inhibitors+of+cytosolic+phospholipase+A2%CE%B1+and+fatty+acid+amide+hydrolase%3A+effect+of+the+replacement+of+the+ether+oxygen+with+sulfur+and+nitrogen+moieties+on+enzyme+inhibition+and+metabolic+stability&doi=10.1016%2Fj.bmc.2015.03.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DSundermann%26aufirst%3DT.%26aulast%3DFabian%26aufirst%3DJ.%26aulast%3DHanekamp%26aufirst%3DW.%26aulast%3DLehr%26aufirst%3DM.%26atitle%3D1-Heteroaryl-3-phenoxypropan-2-ones%2520as%2520inhibitors%2520of%2520cytosolic%2520phospholipase%2520A2%25CE%25B1%2520and%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520effect%2520of%2520the%2520replacement%2520of%2520the%2520ether%2520oxygen%2520with%2520sulfur%2520and%2520nitrogen%2520moieties%2520on%2520enzyme%2520inhibition%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2579%26epage%3D2592%26doi%3D10.1016%2Fj.bmc.2015.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Pearson, J. P.; Bernier, S.; Jackson, C.; Wakefield, J. D.; Sykes, K. A.; Liong, E.; Carey, G.; Busby, R. W.; Currie, M. G.; Lichtman, A. H.; Milne, G. T.; Profy, A. T.</span><span> </span><span class="NLM_article-title">Oral treatment with the selecctive FAAH inhibitor MM-433593 relieves thermal hyperalgesia induced by <i>E.coli</i> lipopolysaccharide in C57BLACK6/J mice via cannabinoid CB<sub>1</sub> receptor</span>. Presented at the 22nd Annual Symposium of the International Cannabinoid Research Society, Freiburg, Germany,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+P.+Pearson&author=S.+Bernier&author=C.+Jackson&author=J.+D.+Wakefield&author=K.+A.+Sykes&author=E.+Liong&author=G.+Carey&author=R.+W.+Busby&author=M.+G.+Currie&author=A.+H.+Lichtman&author=G.+T.+Milne&author=A.+T.+Profy&title=Oral+treatment+with+the+selecctive+FAAH+inhibitor+MM-433593+relieves+thermal+hyperalgesia+induced+by+E.coli+lipopolysaccharide+in+C57BLACK6%2FJ+mice+via+cannabinoid+CB1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DJ.%2BP.%26atitle%3DOral%2520treatment%2520with%2520the%2520selecctive%2520FAAH%2520inhibitor%2520MM-433593%2520relieves%2520thermal%2520hyperalgesia%2520induced%2520by%2520E.coli%2520lipopolysaccharide%2520in%2520C57BLACK6%252FJ%2520mice%2520via%2520cannabinoid%2520CB1%2520receptor%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Banijamali, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakefield, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermerian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, R. W.</span><span> </span><span class="NLM_article-title">Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeys</span> <span class="citation_source-journal">Pharmacol. Res. Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00059</span><span class="refDoi"> DOI: 10.1002/prp2.59</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fprp2.59" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=e00059&author=A.+R.+Banijamaliauthor=J.+D.+Wakefieldauthor=A.+H.+Mermerianauthor=R.+W.+Busby&title=Metabolism+and+disposition+of+MM-433593%2C+a+selective+FAAH-1+inhibitor%2C+in+monkeys&doi=10.1002%2Fprp2.59"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1002%2Fprp2.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.59%26sid%3Dliteratum%253Aachs%26aulast%3DBanijamali%26aufirst%3DA.%2BR.%26aulast%3DWakefield%26aufirst%3DJ.%2BD.%26aulast%3DMermerian%26aufirst%3DA.%2BH.%26aulast%3DBusby%26aufirst%3DR.%2BW.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520MM-433593%252C%2520a%2520selective%2520FAAH-1%2520inhibitor%252C%2520in%2520monkeys%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2014%26volume%3D2%26spage%3De00059%26doi%3D10.1002%2Fprp2.59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Keith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apodaca, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karbarz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennerholm, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">1-Aryl-2-((6-aryl) pyrimidin-4-yl) amino) ethanols as competitive inhibitors of fatty acid amide hydrolase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2014.01.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1280-1284&author=J.+M.+Keithauthor=N.+Hawrylukauthor=R.+L.+Apodacaauthor=A.+Chambersauthor=J.+M.+Pierceauthor=M.+Seierstadauthor=J.+A.+Palmerauthor=M.+Webbauthor=M.+J.+Karbarzauthor=B.+P.+Scottauthor=S.+J.+Wilsonauthor=L.+Luoauthor=M.+L.+Wennerholmauthor=L.+Changauthor=M.+Rizzolioauthor=S.+R.+Chaplanauthor=J.+G.+Breitenbucher&title=1-Aryl-2-%28%286-aryl%29+pyrimidin-4-yl%29+amino%29+ethanols+as+competitive+inhibitors+of+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2014.01.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.064%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DJ.%2BM.%26aulast%3DHawryluk%26aufirst%3DN.%26aulast%3DApodaca%26aufirst%3DR.%2BL.%26aulast%3DChambers%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DJ.%2BA.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DKarbarz%26aufirst%3DM.%2BJ.%26aulast%3DScott%26aufirst%3DB.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DWennerholm%26aufirst%3DM.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DRizzolio%26aufirst%3DM.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3D1-Aryl-2-%2528%25286-aryl%2529%2520pyrimidin-4-yl%2529%2520amino%2529%2520ethanols%2520as%2520competitive%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1280%26epage%3D1284%26doi%3D10.1016%2Fj.bmcl.2014.01.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilligsmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span> </span><span class="NLM_article-title"><i>N</i>-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing <i>N</i>-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1042/bj20031695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1042%2Fbj20031695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=14686878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2004&pages=99-106&author=K.+Tsuboiauthor=C.+Hilligsmannauthor=S.+Vandevoordeauthor=D.+Lambertauthor=N.+Ueda&title=N-Cyclohexanecarbonylpentadecylamine%3A+a+selective+inhibitor+of+the+acid+amidase+hydrolysing+N-acylethanolamines%2C+as+a+tool+to+distinguish+acid+amidase+from+fatty+acid+amide+hydrolase&doi=10.1042%2Fbj20031695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Hilligsmann, Christine; Vandevoorde, Severine; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) and other bioactive N -acylethanolamines are degraded to their corresponding fatty acids and ethanolamine.  This hydrolysis is mostly attributed to catalysis by FAAH (fatty acid amide hydrolase), which exhibits an alk. pH optimum.  In addn., we have identified another amidase which catalyzes the same reaction exclusively at acidic pH values [Ueda, Yamanaka and Yamamoto (2001) J. Biol. Chem. 276, 35552-35557].  In attempts to find selective inhibitors of this acid amidase, we screened various derivs. of palmitic acid, 1-hexadecanol, and 1-pentadecylamine with N -palmitoylethanolamine as substrate.  Here we show that N-cyclohexanecarbonylpentadecylamine inhibits the acid amidase from rat lung with an IC50 of 4.5 μM, without inhibiting FAAH at concns. up to 100 μM.  The inhibition was reversible and non-competitive.  This compd. also inhibited the acid amidase in intact alveolar macrophages.  With the aid of this inhibitor, it was revealed that rat basophilic leukemia cells possess the acid amidase as well as FAAH.  Thus the inhibitor may be a useful tool to distinguish the acid amidase from FAAH in various tissues and cells and to elucidate the physiol. role of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoieQh-ts3EC7Vg90H21EOLACvtfcHk0lhOTgq8uY73DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D&md5=5ea93d8cafe6d3d3151f896bc2185547</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1042%2Fbj20031695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20031695%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHilligsmann%26aufirst%3DC.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DLambert%26aufirst%3DD.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DN-Cyclohexanecarbonylpentadecylamine%253A%2520a%2520selective%2520inhibitor%2520of%2520the%2520acid%2520amidase%2520hydrolysing%2520N-acylethanolamines%252C%2520as%2520a%2520tool%2520to%2520distinguish%2520acid%2520amidase%2520from%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D379%26spage%3D99%26epage%3D106%26doi%3D10.1042%2Fbj20031695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Yamano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hozaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, A.</span><span> </span><span class="NLM_article-title">Lipophilic amines as potent inhibitors of <i>N</i>-acylethanolamine-hydrolyzing acid amidase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3658</span><span class="NLM_x">–</span> <span class="NLM_lpage">3665</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2012.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22542283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3658-3665&author=Y.+Yamanoauthor=K.+Tsuboiauthor=Y.+Hozakiauthor=K.+Takahashiauthor=X.-H.+Jinauthor=N.+Uedaauthor=A.+Wada&title=Lipophilic+amines+as+potent+inhibitors+of+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmc.2012.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase</span></div><div class="casAuthors">Yamano, Yumiko; Tsuboi, Kazuhito; Hozaki, Yuki; Takahashi, Kiyohiro; Jin, Xing-Hua; Ueda, Natsuo; Wada, Akimori</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3658-3665</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines (NAEs) including N-arachidonoylethanolamine (anandamide) and N-palmitoylethanolamine are endogenous lipid mediators.  These mols. are degraded to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH) or NAE-hydrolyzing acid amidase (NAAA).  Lipophilic amines, esp. pentadecylamine (2c) and tridecyl 2-aminoacetate (11b), were found to exhibit potent NAAA inhibitory activities (IC50 = 5.7 and 11.8 μM), with much weaker effects on FAAH.  These simple structures would provide a scaffold for further improvement in NAAA inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4k9qI0AqY7Vg90H21EOLACvtfcHk0lhOTgq8uY73DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D&md5=fbe85f4e5fdca44bee1f6d4902c4f1d0</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHozaki%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DX.-H.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DA.%26atitle%3DLipophilic%2520amines%2520as%2520potent%2520inhibitors%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3658%26epage%3D3665%26doi%3D10.1016%2Fj.bmc.2012.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Saturnino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new potential inhibitors of <i>N</i>-acylethanolamine hydrolyzing acid amidase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1210</span><span class="NLM_x">–</span> <span class="NLM_lpage">1213</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2009.11.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20022504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1210-1213&author=C.+Saturninoauthor=S.+Petrosinoauthor=A.+Ligrestiauthor=C.+Palladinoauthor=G.+De+Martinoauthor=T.+Bisognoauthor=V.+Di+Marzo&title=Synthesis+and+biological+evaluation+of+new+potential+inhibitors+of+N-acylethanolamine+hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmcl.2009.11.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase</span></div><div class="casAuthors">Saturnino, Carmela; Petrosino, Stefania; Ligresti, Alessia; Palladino, Chiara; De Martino, Giovanni; Bisogno, Tiziana; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1210-1213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines, including N-palmitoyl-ethanolamine (PEA), are hydrolyzed to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  Recently, N-acylethanolamine-hydrolyzing acid amidase (NAAA) was identified as being able to specifically hydrolyze PEA.  In order to find selective and effective inhibitors of this enzyme, we synthesized and screened several amides, retroamides, esters, retroesters and carbamates of palmitic acid (1-21) and esters with C15 and C17 alkyl chains (22-27).  Cyclopentylhexadecanoate (13) exhibited the highest inhibitory activity on NAAA (IC50 = 10.0 μM), without inhibiting FAAH up to 50 μM.  Compd. 13 may become a useful template to design new NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNWUZja4X4JbVg90H21EOLACvtfcHk0lh1BUQXUilEUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D&md5=fc638f889e58e9fbf3467a90effbcc80</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.134%26sid%3Dliteratum%253Aachs%26aulast%3DSaturnino%26aufirst%3DC.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPalladino%26aufirst%3DC.%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520potential%2520inhibitors%2520of%2520N-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1210%26epage%3D1213%26doi%3D10.1016%2Fj.bmcl.2009.11.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuvone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title"><i>N</i>-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1016/j.biochi.2010.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.biochi.2010.01.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=724-727&author=S.+Petrosinoauthor=T.+Iuvoneauthor=V.+Di+Marzo&title=N-palmitoyl-ethanolamine%3A+biochemistry+and+new+therapeutic+opportunities&doi=10.1016%2Fj.biochi.2010.01.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2010.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2010.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DIuvone%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DN-palmitoyl-ethanolamine%253A%2520biochemistry%2520and%2520new%2520therapeutic%2520opportunities%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26spage%3D724%26epage%3D727%26doi%3D10.1016%2Fj.biochi.2010.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent <i>N</i>-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e43023</span><span class="refDoi"> DOI: 10.1371/journal.pone.0043023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1371%2Fjournal.pone.0043023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22916199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43023&author=Y.+Liauthor=L.+Yangauthor=L.+Chenauthor=C.+Zhuauthor=R.+Huangauthor=X.+Zhengauthor=Y.+Qiuauthor=J.+Fu&title=Design+and+synthesis+of+potent+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29+inhibitor+as+anti-inflammatory+compounds&doi=10.1371%2Fjournal.pone.0043023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span></div><div class="casAuthors">Li, Yuhang; Yang, Longhe; Chen, Ling; Zhu, Chenggang; Huang, Rui; Zheng, Xiao; Qiu, Yan; Fu, Jin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43023</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme involved in biol. deactivation of N-palmitoylethanolamide (PEA), which exerts anti-inflammatory and analgesic effects through the activation of nuclear receptor peroxisome proliferator-activated receptor-alpha (PPAR-α).  To develop selective and potent NAAA inhibitors, we designed and synthesized a series of derivs. of 1-pentadecanyl-carbonyl pyrrolidine (compd. 1), a general amidase inhibitor.  Structure activity relationship (SAR) studies have identified a compd. 16, 1-(2-Biphenyl-4-yl)ethyl-carbonyl pyrrolidine, which has shown the highest inhibition on NAAA activity (IC50 = 2.12 ± 0.41 μM) and is characterized as a reversible and competitive NAAA inhibitor.  Computational docking anal. and mutagenesis study revealed that compd. 16 interacted with Asparagine 209 (Asn209) residue flanking the catalytic pocket of NAAA so as to block the substrate entrance.  In vitro pharmacol. studies demonstrated that compd. 16 dose-dependently reduced mRNA expression levels of iNOS and IL-6, along with an increase of intracellular PEA levels, in mouse macrophages with lipopolysaccharides (LPS) induced inflammation.  Our study discovered a novel NAAA inhibitor, compd. 16, that could serve as a potential anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjj_FwM6WnALVg90H21EOLACvtfcHk0lh1BUQXUilEUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ&md5=12369bcfbbe53a5f4c65c68df0a59945</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520as%2520anti-inflammatory%2520compounds%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43023%26doi%3D10.1371%2Fjournal.pone.0043023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">West, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvonok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitten, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadivel, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Biochemical and mass spectrometric characterization of human <i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibition</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e43877</span><span class="refDoi"> DOI: 10.1371/journal.pone.0043877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1371%2Fjournal.pone.0043877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22952796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43877&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=S.+K.+Vadivelauthor=A.+L.+Bowmanauthor=A.+Makriyannis&title=Biochemical+and+mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition&doi=10.1371%2Fjournal.pone.0043877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43877</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).  1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl--serine β-lactone (N-Cbz-serine β-lactone), inhibited hNAAA in a covalent and irreversible manner.  MS anal. of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the β-subunit, confirming a suggested mechanism of hNAAA inactivation by the β-lactone contg. inhibitors.  These expts. provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme.  They also provide a methodol. for the rapid screening and characterization of large libraries of compds. as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYtxfkhdQ5rVg90H21EOLACvtfcHk0lh1BUQXUilEUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E&md5=f1cedb03b771c71caef095bf138627bd</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043877%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DVadivel%26aufirst%3DS.%2BK.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43877%26doi%3D10.1371%2Fjournal.pone.0043877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Solorzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonietti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of <i>N</i>-(2-oxo-3-oxetanyl) amides as <i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5770</span><span class="NLM_x">–</span> <span class="NLM_lpage">5781</span><span class="refDoi"> DOI: 10.1021/jm100582w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100582w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5770-5781&author=C.+Solorzanoauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Lodolaauthor=F.+Vacondioauthor=G.+Tarziaauthor=D.+Piomelliauthor=M.+Mor&title=Synthesis+and+structure-activity+relationships+of+N-%282-oxo-3-oxetanyl%29+amides+as+N-acylethanolamine-hydrolyzing+acid+amidase+inhibitors&doi=10.1021%2Fjm100582w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm100582w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100582w%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-%25282-oxo-3-oxetanyl%2529%2520amides%2520as%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5770%26epage%3D5781%26doi%3D10.1021%2Fjm100582w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karacsonyi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">β-Lactones inhibit <i>N</i>-acylethanolamine acid amidase by <i>S</i>-acylation of the catalytic <i>N</i>-terminal cysteine</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1021/ml300056y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300056y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=422-426&author=A.+Armirottiauthor=E.+Romeoauthor=S.+Ponzanoauthor=L.+Mengattoauthor=M.+Dionisiauthor=C.+Karacsonyiauthor=F.+Bertozziauthor=G.+Garauauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=%CE%B2-Lactones+inhibit+N-acylethanolamine+acid+amidase+by+S-acylation+of+the+catalytic+N-terminal+cysteine&doi=10.1021%2Fml300056y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span></div><div class="casAuthors">Armirotti, Andrea; Romeo, Elisa; Ponzano, Stefano; Mengatto, Luisa; Dionisi, Mauro; Karacsonyi, Claudia; Bertozzi, Fabio; Garau, Gianpiero; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-426</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs.  We investigated the mechanism of inhibition of human NAAA by substituted β-lactones.  We characterized pharmacol. a representative member of this class, ARN077, and showed, using high-resoln. liq. chromatog.-tandem mass spectrometry, that this compd. forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooO8IxuG5LzLVg90H21EOLACvtfcHk0lg-EgQk01sLQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D&md5=482d17b3fb0c13c8356f27a4b3f97e93</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fml300056y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300056y%26sid%3Dliteratum%253Aachs%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DKaracsonyi%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D%25CE%25B2-Lactones%2520inhibit%2520N-acylethanolamine%2520acid%2520amidase%2520by%2520S-acylation%2520of%2520the%2520catalytic%2520N-terminal%2520cysteine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D422%26epage%3D426%26doi%3D10.1021%2Fml300056y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonietti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solorzano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-(2-Oxo-3-oxetanyl) carbamic acid esters as <i>N</i>-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4824</span><span class="NLM_x">–</span> <span class="NLM_lpage">4836</span><span class="refDoi"> DOI: 10.1021/jm300349j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300349j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4824-4836&author=A.+Durantiauthor=A.+Tontiniauthor=F.+Antoniettiauthor=F.+Vacondioauthor=A.+Fioniauthor=C.+Silvaauthor=A.+Lodolaauthor=S.+Rivaraauthor=C.+Solorzanoauthor=D.+Piomelliauthor=G.+Tarziaauthor=M.+Mor&title=N-%282-Oxo-3-oxetanyl%29+carbamic+acid+esters+as+N-acylethanolamine+acid+amidase+inhibitors%3A+synthesis+and+structure-activity+and+structure-property+relationships&doi=10.1021%2Fjm300349j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm300349j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300349j%26sid%3Dliteratum%253Aachs%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-%25282-Oxo-3-oxetanyl%2529%2520carbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%253A%2520synthesis%2520and%2520structure-activity%2520and%2520structure-property%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4824%26epage%3D4836%26doi%3D10.1021%2Fjm300349j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6917</span><span class="NLM_x">–</span> <span class="NLM_lpage">6934</span><span class="refDoi"> DOI: 10.1021/jm400739u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400739u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6917-6934&author=S.+Ponzanoauthor=F.+Bertozziauthor=L.+Mengattoauthor=M.+Dionisiauthor=A.+Armirottiauthor=E.+Romeoauthor=A.+Berteottiauthor=C.+Fiorelliauthor=G.+Tarozzoauthor=A.+Reggianiauthor=A.+Durantiauthor=G.+Tarziaauthor=M.+Morauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandiera&title=Synthesis+and+structure-activity+relationship+%28SAR%29+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters%2C+a+class+of+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm400739u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fjm400739u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400739u%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%252C%2520a%2520class%2520of%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6917%26epage%3D6934%26doi%3D10.1021%2Fjm400739u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Sasso, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Realini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of the <i>N</i>-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0lgZPvT7o0600g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Vitale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petracca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span> </span><span class="NLM_article-title">Synthesis, structure-activity, and structure-stability relationships of 2-substituted-<i>N</i>-(4-oxo-3-oxetanyl) <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1002/cmdc.201300416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201300416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24403170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=323-336&author=R.+Vitaleauthor=G.+Ottonelloauthor=R.+Petraccaauthor=S.+M.+Bertozziauthor=S.+Ponzanoauthor=A.+Armirottiauthor=A.+Berteottiauthor=M.+Dionisiauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandieraauthor=F.+Bertozzi&title=Synthesis%2C+structure-activity%2C+and+structure-stability+relationships+of+2-substituted-N-%284-oxo-3-oxetanyl%29+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1002%2Fcmdc.201300416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure-Activity, and Structure-Stability Relationships of 2-Substituted-N-(4-oxo-3-oxetanyl) N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Vitale, Romina; Ottonello, Giuliana; Petracca, Rita; Bertozzi, Sine Mandrup; Ponzano, Stefano; Armirotti, Andrea; Berteotti, Anna; Dionisi, Mauro; Cavalli, Andrea; Piomelli, Daniele; Bandiera, Tiziano; Bertozzi, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-336</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Racemic and nonracemic β-substituted α-amino-β-lactones such as I and II [R = Me, Et, i-Pr, t-Bu; R1 = R2, R3O; R2 = 4-PhCH2OC6H4, Ph(CH2)6; R3 = Ph(CH2)5, 4-PhC6H4CH2] were prepd. as inhibitors of N-acylethanolamine acid amidase (NAAA), a cysteine amidase that preferentially hydrolyzes satd. or monounsatd. fatty acid ethanolamide endogenous agonists of nuclear peroxisome proliferator-activated receptor-α, for potential use as antiinflammatory agents.  N-(alkoxycarbonylamino) β-lactones were both better inhibitors of NAAA and more stable than the corresponding N-acyl β-lactones; cis β-lactones I were more stable than the corresponding trans β-lactones II to both lactone hydrolysis and ring expansion to oxazolines.  Increasing the steric bulk of the β-substituent decreased inhibition of NAAA but improved hydrolytic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhV2S-BL4VubVg90H21EOLACvtfcHk0lgZPvT7o0600g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvF2qtw%253D%253D&md5=8ada8ce8bcd7f2f40376be631217d615</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300416%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520structure-activity%252C%2520and%2520structure-stability%2520relationships%2520of%25202-substituted-N-%25284-oxo-3-oxetanyl%2529%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D323%26epage%3D336%26doi%3D10.1002%2Fcmdc.201300416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petracca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span> </span><span class="NLM_article-title">Synthesis, Biological evaluation, and 3D QSAR study of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters as <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10101</span><span class="NLM_x">–</span> <span class="NLM_lpage">10111</span><span class="refDoi"> DOI: 10.1021/jm501455s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501455s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10101-10111&author=S.+Ponzanoauthor=A.+Berteottiauthor=R.+Petraccaauthor=R.+Vitaleauthor=L.+Mengattoauthor=T.+Bandieraauthor=A.+Cavalliauthor=D.+Piomelliauthor=F.+Bertozziauthor=G.+Bottegoni&title=Synthesis%2C+Biological+evaluation%2C+and+3D+QSAR+study+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm501455s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation, and 3D QSAR Study of 2-Methyl-4-oxo-3-oxetanylcarbamic Acid Esters as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Ponzano, Stefano; Berteotti, Anna; Petracca, Rita; Vitale, Romina; Mengatto, Luisa; Bandiera, Tiziano; Cavalli, Andrea; Piomelli, Daniele; Bertozzi, Fabio; Bottegoni, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10101-10111</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-(2-Oxo-3-oxetanyl)carbamic acid esters e. g., I, have recently been reported to be noncompetitive inhibitors of the N-acylethanolamine acid amidase (NAAA) potentially useful for the treatment of pain and inflammation.  In the present study, we further explored the structure-activity relationships of the carbamic acid ester side chain of 2-methyl-4-oxo-3-oxetanylcarbamic acid ester derivs.  Addnl. favorable features in the design of potent NAAA inhibitors have been found together with the identification of a single digit nanomolar inhibitor.  In addn., we devised a 3D QSAR using the at. property field method.  The model turned out to be able to account for the structural variability and was prospectively validated by designing, synthesizing, and testing novel inhibitors.  The fairly good agreement between predictions and exptl. potency values points to this 3D QSAR model as the first example of quant. structure-activity relationships in the field of NAAA inhibitors .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVpHkND7iUzbVg90H21EOLACvtfcHk0lgZPvT7o0600g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN&md5=1c863895692bf0e2bd76956ae1c0fda4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm501455s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501455s%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520Biological%2520evaluation%252C%2520and%25203D%2520QSAR%2520study%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10101%26epage%3D10111%26doi%3D10.1021%2Fjm501455s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Fiasella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">3-Aminoazetidin-2-one derivatives as <i>N</i>-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1614</span><span class="refDoi"> DOI: 10.1002/cmdc.201300546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcmdc.201300546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=24828120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1602-1614&author=A.+Fiasellaauthor=A.+Nuzziauthor=M.+Summaauthor=A.+Armirottiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=3-Aminoazetidin-2-one+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors+suitable+for+systemic+administration&doi=10.1002%2Fcmdc.201300546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoazetidin-2-one Derivatives as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors Suitable for Systemic Administration</span></div><div class="casAuthors">Fiasella, Annalisa; Nuzzi, Andrea; Summa, Maria; Armirotti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1602-1614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that catalyzes the hydrolysis of endogenous lipid mediators such as palmitoylethanolamide (PEA).  PEA has been shown to exert anti-inflammatory and antinociceptive effects in animals by engaging peroxisome proliferator-activated receptor α (PPAR-α).  Thus, preventing PEA degrdn. by inhibiting NAAA may provide a novel approach for the treatment of pain and inflammatory states.  Recently, 3-aminooxetan-2-one compds. were identified as a class of highly potent NAAA inhibitors.  The utility of these compds. is limited, however, by their low chem. and plasma stabilities.  In the present study, we synthesized and tested a series of N-(2-oxoazetidin-3-yl)amides as a novel class of NAAA inhibitors with good potency and improved physicochem. properties, suitable for systemic administration.  Moreover, we elucidated the main structural features of 3-aminoazetidin-2-one derivs. that are crit. for NAAA inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocn1G5QzPtHLVg90H21EOLACvtfcHk0ljPXdhA8rra1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D&md5=beee5cde68184abb3c47e4631c56497f</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300546%26sid%3Dliteratum%253Aachs%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D3-Aminoazetidin-2-one%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%2520suitable%2520for%2520systemic%2520administration%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1602%26epage%3D1614%26doi%3D10.1002%2Fcmdc.201300546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengatto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiurchiù, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capurro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiasella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A potent systemically active <i>N</i>-acylethanolamine acid amidase inhibitor that suppresses inflammation and human macrophage activation</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1838</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1838-1846&author=A.+Ribeiroauthor=S.+Pontisauthor=L.+Mengattoauthor=A.+Armirottiauthor=V.+Chiurchi%C3%B9author=V.+Capurroauthor=A.+Fiasellaauthor=A.+Nuzziauthor=E.+Romeoauthor=G.+Moreno-Sanzauthor=M.+Maccarroneauthor=A.+Reggianiauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=A+potent+systemically+active+N-acylethanolamine+acid+amidase+inhibitor+that+suppresses+inflammation+and+human+macrophage+activation&doi=10.1021%2Facschembio.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span></div><div class="casAuthors">Ribeiro, Alison; Pontis, Silvia; Mengatto, Luisa; Armirotti, Andrea; Chiurchiu, Valerio; Capurro, Valeria; Fiasella, Annalisa; Nuzzi, Andrea; Romeo, Elisa; Moreno-Sanz, Guillermo; Maccarrone, Mauro; Reggiani, Angelo; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1846</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type-α peroxisome proliferator-activated receptors (PPAR-α).  These bioactive substances are preferentially degraded by the cysteine hydrolase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages.  Here, we describe a new class of β-lactam derivs. that are potent, selective, and systemically active inhibitors of intracellular NAAA activity.  The prototype of this class deactivates NAAA by covalently binding the enzyme's catalytic cysteine and exerts profound anti-inflammatory effects in both mouse models and human macrophages.  This agent may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6Y2cNKursLVg90H21EOLACvtfcHk0ljPXdhA8rra1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D&md5=a240d871adfc85b99c7e148600573217</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520potent%2520systemically%2520active%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520that%2520suppresses%2520inflammation%2520and%2520human%2520macrophage%2520activation%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1838%26epage%3D1846%26doi%3D10.1021%2Facschembio.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Nuzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiasella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliuca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottonello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejmech.2016.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26866968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=138-159&author=A.+Nuzziauthor=A.+Fiasellaauthor=J.+A.+Ortegaauthor=C.+Pagliucaauthor=S.+Ponzanoauthor=D.+Pizziraniauthor=S.+M.+Bertozziauthor=G.+Ottonelloauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=F.+Bertozziauthor=D.+Piomelli&title=Potent+%CE%B1-amino-%CE%B2-lactam+carbamic+acid+ester+as+NAAA+inhibitors.+Synthesis+and+structure-activity+relationship+%28SAR%29+studies&doi=10.1016%2Fj.ejmech.2016.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span></div><div class="casAuthors">Nuzzi, Andrea; Fiasella, Annalisa; Ortega, Jose Antonio; Pagliuca, Chiara; Ponzano, Stefano; Pizzirani, Daniela; Bertozzi, Sine Mandrup; Ottonello, Giuliana; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Bertozzi, Fabio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate I is a potent, selective and systemically active inhibitor of intracellular NAAA activity, which produces profound anti-inflammatory effects in animal models.  In the present work, the authors describe structure-activity relationship (SAR) studies on 3-aminoazetidin-2-one derivs., which have led to the identification of I, and expand these studies to elucidate the principal structural and stereochem. features needed to achieve effective NAAA inhibition.  Investigations on the influence of the substitution at the β-position of the 2-oxo-3-azetidinyl ring as well as on the effect of size and shape of the carbamic acid ester side chain led to the discovery of II, a novel inhibitor of human NAAA that shows an improved physicochem. and drug-like profile relative to I.  This favorable profile, along with the structural diversity of the carbamic acid chain of I, identify this compd. as a promising new tool to investigate the potential of NAAA inhibitors as therapeutic agents for the treatment of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaN0JjRB6bmrVg90H21EOLACvtfcHk0ljPXdhA8rra1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D&md5=639c2848d70ba68008db89244c2c8657</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DJ.%2BA.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPotent%2520%25CE%25B1-amino-%25CE%25B2-lactam%2520carbamic%2520acid%2520ester%2520as%2520NAAA%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D111%26spage%3D138%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2016.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Feledziak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand-Brynaert, J.</span><span> </span><span class="NLM_article-title">β-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase <i>versus</i> human monoacylglycerol lipase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7054</span><span class="NLM_x">–</span> <span class="NLM_lpage">7068</span><span class="refDoi"> DOI: 10.1021/jm9008532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9008532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7054-7068&author=M.+Feledziakauthor=C.+Michauxauthor=A.+Urbachauthor=G.+Labarauthor=G.+G.+Muccioliauthor=D.+M.+Lambertauthor=J.+Marchand-Brynaert&title=%CE%B2-Lactams+derived+from+a+carbapenem+chiron+are+selective+inhibitors+of+human+fatty+acid+amide+hydrolase+versus+human+monoacylglycerol+lipase&doi=10.1021%2Fjm9008532"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm9008532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008532%26sid%3Dliteratum%253Aachs%26aulast%3DFeledziak%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DC.%26aulast%3DUrbach%26aufirst%3DA.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMarchand-Brynaert%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Lactams%2520derived%2520from%2520a%2520carbapenem%2520chiron%2520are%2520selective%2520inhibitors%2520of%2520human%2520fatty%2520acid%2520amide%2520hydrolase%2520versus%2520human%2520monoacylglycerol%2520lipase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7054%26epage%3D7068%26doi%3D10.1021%2Fjm9008532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Alhouayek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottemanne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cani, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span> </span><span class="NLM_article-title"><i>N</i>-acylethanolamine-hydrolyzing acid amidase inhibition increases colon <i>N</i>-palmitoylethanolamine levels and counteracts murine colitis</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1096/fj.14-255208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1096%2Ffj.14-255208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=25384424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=650-661&author=M.+Alhouayekauthor=P.+Bottemanneauthor=K.+V.+Subramanianauthor=D.+M.+Lambertauthor=A.+Makriyannisauthor=P.+D.+Caniauthor=G.+G.+Muccioli&title=N-acylethanolamine-hydrolyzing+acid+amidase+inhibition+increases+colon+N-palmitoylethanolamine+levels+and+counteracts+murine+colitis&doi=10.1096%2Ffj.14-255208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span></div><div class="casAuthors">Alhouayek, Mireille; Bottemanne, Pauline; Subramanian, Kumar V.; Lambert, Didier M.; Makriyannis, Alexandros; Cani, Patrice D.; Muccioli, Giulio G.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-661, 10.1096/fj.14-255208</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory compd. that was recently shown to exert peroxisome proliferator-activated receptor-α-dependent beneficial effects on colon inflammation.  The actions of PEA are terminated following hydrolysis by 2 enzymes: fatty acid amide hydrolase (FAAH), and the less-studied N-acylethanolamine-hydrolyzing acid amidase (NAAA).  This study aims to investigate the effects of inhibiting the enzymes responsible for PEA hydrolysis in colon inflammation in order to propose a potential therapeutic target for inflammatory bowel diseases (IBDs).  Two murine models of IBD were used to assess the effects of NAAA inhibition, FAAH inhibition, and PEA on macroscopic signs of colon inflammation, macrophage/neutrophil infiltration, and the expression of proinflammatory mediators in the colon, as well as on the colitis-related systemic inflammation.  NAAA inhibition increases PEA levels in the colon and reduces colon inflammation and systemic inflammation, similarly to PEA.  FAAH inhibition, however, does not increase PEA levels in the colon and does not affect the macroscopic signs of colon inflammation or immune cell infiltration.  This is the first report of an anti-inflammatory effect of a systemically administered NAAA inhibitor.  Because NAAA is the enzyme responsible for the control of PEA levels in the colon, we put forth this enzyme as a potential therapeutic target in chronic inflammation in general and IBD in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1s3Cs4nu0sbVg90H21EOLACvtfcHk0lg31PIyQW_qxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D&md5=608b15a459887f1cde27f68e241d85b2</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-255208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-255208%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DK.%2BV.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DN-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520increases%2520colon%2520N-palmitoylethanolamine%2520levels%2520and%2520counteracts%2520murine%2520colitis%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D650%26epage%3D661%26doi%3D10.1096%2Ffj.14-255208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Fidelix, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macedo, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes Moça Trevisani, V.</span><span> </span><span class="NLM_article-title">Diacerein for osteoarthritis</span> <span class="citation_source-journal">Cochrane Database Syst. Rev. [Online]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005117</span><span class="refDoi"> DOI: 10.1002/14651858.CD005117.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2F14651858.CD005117.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=CD005117&author=T.+Fidelixauthor=C.+R.+Macedoauthor=L.+J.+Maxwellauthor=V.+Fernandes+Mo%C3%A7a+Trevisani&title=Diacerein+for+osteoarthritis&doi=10.1002%2F14651858.CD005117.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD005117.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD005117.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DFidelix%26aufirst%3DT.%26aulast%3DMacedo%26aufirst%3DC.%2BR.%26aulast%3DMaxwell%26aufirst%3DL.%2BJ.%26aulast%3DFernandes%2BMo%25C3%25A7a%2BTrevisani%26aufirst%3DV.%26atitle%3DDiacerein%2520for%2520osteoarthritis%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%2520%255BOnline%255D%26date%3D2014%26volume%3D2%26spage%3DCD005117%26doi%3D10.1002%2F14651858.CD005117.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcolongo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allarà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/j.phrs.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.phrs.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=25447594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2015&pages=9-14&author=S.+Petrosinoauthor=A.+Ahmadauthor=G.+Marcolongoauthor=E.+Espositoauthor=M.+Allar%C3%A0author=R.+Verdeauthor=S.+Cuzzocreaauthor=V.+Di+Marzo&title=Diacerein+is+a+potent+and+selective+inhibitor+of+palmitoylethanolamide+inactivation+with+analgesic+activity+in+a+rat+model+of+acute+inflammatory+pain&doi=10.1016%2Fj.phrs.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span></div><div class="casAuthors">Petrosino, Stefania; Ahmad, Akbar; Marcolongo, Gabriele; Esposito, Emanuela; Allara, Marco; Verde, Roberta; Cuzzocrea, Salvatore; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymic hydrolysis to palmitic acid and ethanolamine.  Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action.  Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein).  EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells).  EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan.  This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQUYAZlW4FrVg90H21EOLACvtfcHk0lg31PIyQW_qxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI&md5=2cc594bdb0bfc697de0d7b2189a7ecb9</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DMarcolongo%26aufirst%3DG.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DVerde%26aufirst%3DR.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DDiacerein%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520palmitoylethanolamide%2520inactivation%2520with%2520analgesic%2520activity%2520in%2520a%2520rat%2520model%2520of%2520acute%2520inflammatory%2520pain%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D91%26spage%3D9%26epage%3D14%26doi%3D10.1016%2Fj.phrs.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">Potential analgesic effects of a novel <i>N</i>-acylethanolamine acid amidase inhibitor F96 through PPAR-α. [Online]</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">13565</span><span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-%CE%B1.+%5BOnline%5D&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0li14oazBiG_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-%25CE%25B1.%2520%255BOnline%255D%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Zvonok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandarinathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karageorgos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janero, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2008.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2008.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18721756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=854-862&author=N.+Zvonokauthor=L.+Pandarinathanauthor=J.+Williamsauthor=M.+Johnstonauthor=I.+Karageorgosauthor=D.+R.+Janeroauthor=S.+C.+Krishnanauthor=A.+Makriyannis&title=Covalent+inhibitors+of+human+monoacylglycerol+lipase%3A+ligand-assisted+characterization+of+the+catalytic+site+by+mass+spectrometry+and+mutational+analysis&doi=10.1016%2Fj.chembiol.2008.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Human Monoacylglycerol Lipase: Ligand-Assisted Characterization of the Catalytic Site by Mass Spectrometry and Mutational Analysis</span></div><div class="casAuthors">Zvonok, Nikolai; Pandarinathan, Lakshmipathi; Williams, John; Johnston, Meghan; Karageorgos, Ioannis; Janero, David R.; Krishnan, Srinivasan C.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">854-862</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The active site of recombinant hexa-histidine-tagged human monoacylglycerol lipase (hMGL) is characterized by mass spectrometry using the inhibitors 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701), and N-arachidonylmaleimide (NAM) as probes.  Carbamylation of Ser129 by AM6701 in the putative hMGL catalytic triad demonstrates this residue's essential role in catalysis.  Partial NAM alkylation of hMGL cysteine residues 215 and/or 249 was sufficient to achieve ∼80% enzyme inhibition.  Although Cys215 and/or Cys249 mutations to alanine(s) did not affect hMGL hydrolytic activity as compared with nonmutated hMGL, the C215A displayed heightened NAM sensitivity, whereas the C249A evidenced reduced NAM sensitivity.  These data conclusively demonstrate a sulfhydryl-based mechanism for NAM inhibition of hMGL in which Cys249 is of paramount importance.  Identification of amino acids crit. to the catalytic activity and pharmacol. modulation of hMGL informs the design of selective MGL inhibitors as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp1gDK0IgZgLVg90H21EOLACvtfcHk0li14oazBiG_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVejtbjO&md5=d135103e4d1543b7d9846c64642e49fc</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DPandarinathan%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DM.%26aulast%3DKarageorgos%26aufirst%3DI.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DKrishnan%26aufirst%3DS.%2BC.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DCovalent%2520inhibitors%2520of%2520human%2520monoacylglycerol%2520lipase%253A%2520ligand-assisted%2520characterization%2520of%2520the%2520catalytic%2520site%2520by%2520mass%2520spectrometry%2520and%2520mutational%2520analysis%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D854%26epage%3D862%26doi%3D10.1016%2Fj.chembiol.2008.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Matuszak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> evaluation of <i>N</i>-substituted maleimide derivatives as selective monoglyceride lipase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7410</span><span class="NLM_x">–</span> <span class="NLM_lpage">7420</span><span class="refDoi"> DOI: 10.1021/jm900461w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900461w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7410-7420&author=N.+Matuszakauthor=G.+G.+Muccioliauthor=G.+Labarauthor=D.+M.+Lambert&title=Synthesis+and+in+vitro+evaluation+of+N-substituted+maleimide+derivatives+as+selective+monoglyceride+lipase+inhibitors&doi=10.1021%2Fjm900461w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors</span></div><div class="casAuthors">Matuszak, Nicolas; Muccioli, Giulio G.; Labar, Geoffray; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7410-7420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of N-substituted maleimides and evaluation of their inhibition of recombinant human fatty acid amide hydrolase (FAAH) and purified human monoglyceride lipase (MGL) was reported.  Many of the maleimide derivs. showed low micromolar IC50 and high selectivity toward MGL vs FAAH.  The structure-activity relationships were investigated and, for instance, 1-biphenyl-4-ylmethylmaleimide inhibited MGL with an IC50 value of 790 nM.  Furthermore, rapid diln. expts. revealed that these compds. act as irreversible inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrighudB2erprVg90H21EOLACvtfcHk0li14oazBiG_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot1ehsrs%253D&md5=224ec243450db93eb7d9c75e87d95b39</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm900461w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900461w%26sid%3Dliteratum%253Aachs%26aulast%3DMatuszak%26aufirst%3DN.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520N-substituted%2520maleimide%2520derivatives%2520as%2520selective%2520monoglyceride%2520lipase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7410%26epage%3D7420%26doi%3D10.1021%2Fjm900461w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauvois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1002/cbic.200700139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbic.200700139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17579916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos12rsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1293-1297&author=G.+Labarauthor=C.+Bauvoisauthor=G.+G.+Muccioliauthor=J.+Woutersauthor=D.+M.+Lambert&title=Disulfiram+is+an+inhibitor+of+human+purified+monoacylglycerol+lipase%2C+the+enzyme+regulating+2-arachidonoylglycerol+signaling&doi=10.1002%2Fcbic.200700139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling</span></div><div class="casAuthors">Labar, Geoffray; Bauvois, Cedric; Muccioli, Giulio G.; Wouters, Johan; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1293-1297</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a key enzyme responsible for the termination of endocannabinoid signaling.  Its crucial role in 2-arachidonoylglycerol (2-AG) metab., together with the numerous pharmacol. properties mediated by this endocannabinoid, emphasize the interest in MAGL as therapeutic target, along with the need to design potent and selective inhibitors.  Meanwhile, the complexity of 2-AG degrdn. pathways underscores the need to use a purified source of enzyme in evaluation studies of new inhibitors.  We report here the first heterologous expression and purifn. of human MAGL.  A highly pure protein was obtained and allowed us to measure the affinity of several MAGL inhibitors for the human enzyme.  Importantly, disulfiram (tetraethylthiuram disulfide), a compd. used to treat alcoholism, and other disulfide-contg. compds. were shown to inhibit MAGL with good potency, likely through an interaction with cysteine residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryGocIm_WXjbVg90H21EOLACvtfcHk0lifzaIfcx1ryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos12rsbY%253D&md5=a76f97702838860f090769e6fdca3932</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700139%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DDisulfiram%2520is%2520an%2520inhibitor%2520of%2520human%2520purified%2520monoacylglycerol%2520lipase%252C%2520the%2520enzyme%2520regulating%25202-arachidonoylglycerol%2520signaling%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1293%26epage%3D1297%26doi%3D10.1002%2Fcbic.200700139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Kapanda, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Bis (dialkylaminethiocarbonyl) disulfides as potent and selective monoglyceride lipase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7310</span><span class="NLM_x">–</span> <span class="NLM_lpage">7314</span><span class="refDoi"> DOI: 10.1021/jm901323s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901323s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7310-7314&author=C.+N.+Kapandaauthor=G.+G.+Muccioliauthor=G.+Labarauthor=J.+H.+Poupaertauthor=D.+M.+Lambert&title=Bis+%28dialkylaminethiocarbonyl%29+disulfides+as+potent+and+selective+monoglyceride+lipase+inhibitors&doi=10.1021%2Fjm901323s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm901323s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901323s%26sid%3Dliteratum%253Aachs%26aulast%3DKapanda%26aufirst%3DC.%2BN.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DBis%2520%2528dialkylaminethiocarbonyl%2529%2520disulfides%2520as%2520potent%2520and%2520selective%2520monoglyceride%2520lipase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7310%26epage%3D7314%26doi%3D10.1021%2Fjm901323s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">974</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00276.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1476-5381.2009.00276.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19486005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVChu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2009&pages=974-983&author=A.+Kingauthor=A.+Lodolaauthor=C.+Carmiauthor=J.+Fuauthor=M.+Morauthor=D.+Piomelli&title=A+critical+cysteine+residue+in+monoacylglycerol+lipase+is+targeted+by+a+new+class+of+isothiazolinone-based+enzyme+inhibitors&doi=10.1111%2Fj.1476-5381.2009.00276.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors</span></div><div class="casAuthors">King, A. R.; Lodola, A.; Carmi, C.; Fu, J.; Mor, M.; Piomelli, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">974-983</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MGL) is a presynaptic serine hydrolase that inactivates the endocannabinoid neurotransmitter, 2-arachidonoyl-sn-glycerol.  Recent studies suggest that cysteine residues proximal to the enzyme active site are important for MGL function.  In the present study, we characterize the role of cysteines in MGL function and identify a series of cysteine-reactive agents that inhibit MGL activity with nanomolar potencies by interacting with cysteine residue 208.  A series of cysteine traps were screened for the ability to inhibit MGL in vitro.  Rapid diln. assays were performed to det. reversibility of inhibition.  Mol. modeling and site-directed mutagenesis were utilized to identify cysteine residues targeted by the inhibitors.  The screening revealed that 2-octyl-4-isothiazolin-3-one (octhilinone) inhibited purified rat recombinant MGL (IC50 = 88 ± 12 nM) through a partially reversible mechanism.  Initial structure-activity relationship studies showed that substitution of the n-octyl group of octhilinone with a more lipophilic oleoyl group increased inhibitor potency (IC50 = 43 ± 8 nM), while substitution with a Me group produced the opposite effect (IC50 = 239 ± 68 nM).  The inhibitory potency of octhilinone was selectively decreased by mutating cysteine 208 in MGL to glycine (IC50; wild-type, 151 ± 17 nM; C208G, 722 ± 74 nM), but not by mutation of other cysteine residues (C32, C55, C201, C208 and C242).  The results indicated that cysteine 208 plays an important role in MGL function and identified a novel class of isothiazolinone-based MGL inhibitors with nanomolar potency in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs7LpQEIcKErVg90H21EOLACvtfcHk0lifzaIfcx1ryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVChu7bP&md5=6f84ee295e1716a713616a073ef4c2b7</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00276.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00276.x%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DCarmi%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520critical%2520cysteine%2520residue%2520in%2520monoacylglycerol%2520lipase%2520is%2520targeted%2520by%2520a%2520new%2520class%2520of%2520isothiazolinone-based%2520enzyme%2520inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D157%26spage%3D974%26epage%3D983%26doi%3D10.1111%2Fj.1476-5381.2009.00276.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriello, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2007.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.ejmech.2007.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=62-72&author=G.+Ortarauthor=M.+G.+Cascioauthor=A.+S.+Morielloauthor=M.+Camalliauthor=E.+Moreraauthor=M.+Nalliauthor=V.+Di+Marzo&title=Carbamoyl+tetrazoles+as+inhibitors+of+endocannabinoid+inactivation%3A+a+critical+revisitation&doi=10.1016%2Fj.ejmech.2007.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DMoriello%26aufirst%3DA.%2BS.%26aulast%3DCamalli%26aufirst%3DM.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DNalli%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DCarbamoyl%2520tetrazoles%2520as%2520inhibitors%2520of%2520endocannabinoid%2520inactivation%253A%2520a%2520critical%2520revisitation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D62%26epage%3D72%26doi%3D10.1016%2Fj.ejmech.2007.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Morera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6260</span><span class="NLM_x">–</span> <span class="NLM_lpage">6275</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmc.2012.09.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6260-6275&author=L.+Moreraauthor=G.+Labarauthor=G.+Ortarauthor=D.+M.+Lambert&title=Development+and+characterization+of+endocannabinoid+hydrolases+FAAH+and+MAGL+inhibitors+bearing+a+benzotriazol-1-yl+carboxamide+scaffold&doi=10.1016%2Fj.bmc.2012.09.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DMorera%26aufirst%3DL.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520endocannabinoid%2520hydrolases%2520FAAH%2520and%2520MAGL%2520inhibitors%2520bearing%2520a%2520benzotriazol-1-yl%2520carboxamide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6260%26epage%3D6275%26doi%3D10.1016%2Fj.bmc.2012.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Aaltonen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönkkö, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuusisto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korhonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häyrinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takabe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantsar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasonen-Seppänen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span> </span><span class="NLM_article-title">Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23521796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=379-390&author=N.+Aaltonenauthor=J.+R.+Savinainenauthor=C.+R.+Ribasauthor=J.+R%C3%B6nkk%C3%B6author=A.+Kuusistoauthor=J.+Korhonenauthor=D.+Navia-Paldaniusauthor=J.+H%C3%A4yrinenauthor=P.+Takabeauthor=H.+K%C3%A4sn%C3%A4nenauthor=T.+Pantsarauthor=T.+Laitinenauthor=M.+Lehtonenauthor=S.+Pasonen-Sepp%C3%A4nenauthor=A.+Posoauthor=T.+Nevalainenauthor=J.+T.+Laitinen&title=Piperazine+and+piperidine+triazole+ureas+as+ultrapotent+and+highly+selective+inhibitors+of+monoacylglycerol+lipase&doi=10.1016%2Fj.chembiol.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase</span></div><div class="casAuthors">Aaltonen, Niina; Savinainen, Juha R.; Ribas, Casandra Riera; Ronkko, Jani; Kuusisto, Anne; Korhonen, Jani; Navia-Paldanius, Dina; Hayrinen, Jukka; Takabe, Piia; Kasnanen, Heikki; Pantsar, Tatu; Laitinen, Tuomo; Lehtonen, Marko; Pasonen-Seppanen, Sanna; Poso, Antti; Nevalainen, Tapio; Laitinen, Jarmo T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-390</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) terminates the signaling function of the endocannabinoid, 2-arachidonoylglycerol (2-AG).  During 2-AG hydrolysis, MAGL liberates arachidonic acid, feeding the principal substrate for the neuroinflammatory prostaglandins.  In cancer cells, MAGL redirects lipid stores toward protumorigenic signaling lipids.  Thus MAGL inhibitors may have great therapeutic potential.  Although potent and increasingly selective MAGL inhibitors have been described, their no. is still limited.  Here, we have characterized piperazine and piperidine triazole ureas that combine the high potency attributable to the triazole leaving group together with the bulky arom. benzodioxolyl moiety required for selectivity, culminating in compd. JJKK-048 that potently (IC50 < 0.4 nM) inhibited human and rodent MAGL.  JJKK-048 displayed low cross-reactivity with other endocannabinoid targets.  Activity-based protein profiling of mouse brain and human melanoma cell proteomes suggested high specificity also among the metabolic serine hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIDOxKwD3xf7Vg90H21EOLACvtfcHk0lgN0unlZmkTxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D&md5=3061a03d341bfb1de6b25c8d925b5b9f</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DAaltonen%26aufirst%3DN.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DRibas%26aufirst%3DC.%2BR.%26aulast%3DR%25C3%25B6nkk%25C3%25B6%26aufirst%3DJ.%26aulast%3DKuusisto%26aufirst%3DA.%26aulast%3DKorhonen%26aufirst%3DJ.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DH%25C3%25A4yrinen%26aufirst%3DJ.%26aulast%3DTakabe%26aufirst%3DP.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DPantsar%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DPasonen-Sepp%25C3%25A4nen%26aufirst%3DS.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DPiperazine%2520and%2520piperidine%2520triazole%2520ureas%2520as%2520ultrapotent%2520and%2520highly%2520selective%2520inhibitors%2520of%2520monoacylglycerol%2520lipase%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D379%26epage%3D390%26doi%3D10.1016%2Fj.chembiol.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Patel, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahenkorah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staszewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walczyński, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T. J.</span><span> </span><span class="NLM_article-title">Loratadine analogues as MAGL inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1436</span><span class="NLM_x">–</span> <span class="NLM_lpage">1442</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.02.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bmcl.2015.02.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1436-1442&author=J.+Z.+Patelauthor=S.+Ahenkorahauthor=M.+Vaaraauthor=M.+Staszewskiauthor=Y.+Adamsauthor=T.+Laitinenauthor=D.+Navia-Paldaniusauthor=T.+Parkkariauthor=J.+R.+Savinainenauthor=K.+Walczy%C5%84skiauthor=J.+T.+Laitinenauthor=T.+J.+Nevalainen&title=Loratadine+analogues+as+MAGL+inhibitors&doi=10.1016%2Fj.bmcl.2015.02.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.02.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.02.037%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DJ.%2BZ.%26aulast%3DAhenkorah%26aufirst%3DS.%26aulast%3DVaara%26aufirst%3DM.%26aulast%3DStaszewski%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DY.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DParkkari%26aufirst%3DT.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DWalczy%25C5%2584ski%26aufirst%3DK.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26aulast%3DNevalainen%26aufirst%3DT.%2BJ.%26atitle%3DLoratadine%2520analogues%2520as%2520MAGL%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1436%26epage%3D1442%26doi%3D10.1016%2Fj.bmcl.2015.02.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suplita, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crystal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">An endocannabinoid mechanism for stress-induced analgesia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span><span class="refDoi"> DOI: 10.1038/nature03658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnature03658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15973410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltl2ntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=1108-1112&author=A.+G.+Hohmannauthor=R.+L.+Suplitaauthor=N.+M.+Boltonauthor=M.+H.+Neelyauthor=D.+Fegleyauthor=R.+Mangieriauthor=J.+F.+Kreyauthor=J.+M.+Walkerauthor=P.+V.+Holmesauthor=J.+D.+Crystalauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=An+endocannabinoid+mechanism+for+stress-induced+analgesia&doi=10.1038%2Fnature03658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">An endocannabinoid mechanism for stress-induced analgesia</span></div><div class="casAuthors">Hohmann, Andrea G.; Suplita, Richard L.; Bolton, Nathan M.; Neely, Mark H.; Fegley, Darren; Mangieri, Regina; Krey, Jocelyn F.; Walker, J. Michael; Holmes, Philip V.; Crystal, Jonathon D.; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7045</span>),
    <span class="NLM_cas:pages">1108-1112</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acute stress suppresses pain by activating brain pathways that engage opioid or non-opioid mechanisms.  Here we show that an opioid-independent form of this phenomenon, termed stress-induced analgesia, is mediated by the release of endogenous marijuana-like (cannabinoid) compds. in the brain.  Blockade of cannabinoid CB1 receptors in the periaqueductal gray matter of the midbrain prevents non-opioid stress-induced analgesia.  In this region, stress elicits the rapid formation of two endogenous cannabinoids, the lipids 2-arachidonoyl glycerol (2-AG) and anandamide.  A newly developed inhibitor of the 2-AG-deactivating enzyme, monoacylglycerol lipase, selectively increases 2-AG concns. and, when injected into the periaqueductal gray matter, enhances stress-induced analgesia in a CB1-dependent manner.  Inhibitors of the anandamide-deactivating enzyme fatty-acid amide hydrolase, which selectively elevate anandamide concns., exert similar effects.  Our results indicate that the coordinated release of 2-AG and anandamide in the periaqueductal gray matter might mediate opioid-independent stress-induced analgesia.  These studies also identify monoacylglycerol lipase as a previously unrecognized therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5vxyGiLku-bVg90H21EOLACvtfcHk0lgMOgVwSFR6DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltl2ntrY%253D&md5=661a2667fa884ef865d098eca15f3c9b</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fnature03658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03658%26sid%3Dliteratum%253Aachs%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DSuplita%26aufirst%3DR.%2BL.%26aulast%3DBolton%26aufirst%3DN.%2BM.%26aulast%3DNeely%26aufirst%3DM.%2BH.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DMangieri%26aufirst%3DR.%26aulast%3DKrey%26aufirst%3DJ.%2BF.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DHolmes%26aufirst%3DP.%2BV.%26aulast%3DCrystal%26aufirst%3DJ.%2BD.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520endocannabinoid%2520mechanism%2520for%2520stress-induced%2520analgesia%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D1108%26epage%3D1112%26doi%3D10.1038%2Fnature03658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis <i>in vitro</i></span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsj.bjp.0706971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=17143303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=186-191&author=S.+Vandevoordeauthor=K.+O.+Jonssonauthor=G.+Labarauthor=E.+Perssonauthor=D.+Lambertauthor=C.+J.+Fowler&title=Lack+of+selectivity+of+URB602+for+2-oleoylglycerol+compared+to+anandamide+hydrolysis+in+vitro&doi=10.1038%2Fsj.bjp.0706971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro</span></div><div class="casAuthors">Vandevoorde, S.; Jonsson, K-O.; Labar, G.; Persson, E.; Lambert, D. M.; Fowler, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-191</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two compds., URB602 and URB754, have been reported in the literature to be selective inhibitors of monoacylglycerol lipase, although a recent study has questioned their ability to prevent 2-arachidonoyl hydrolysis by brain homogenates and cerebellar membranes.  In the present study, the ability of these compds. to inhibit monoacylglycerol lipase and fatty acid amide hydrolase has been reinvestigated.  Exptl. approach: Homogenates and cell lines were incubated with test compds. and, thereafter, with either [3H]-2-oleoylglycerol or [3H]-anandamide.  Labeled reaction products were sepd. from substrate using chloroform: methanol extn.  In cytosolic fractions from rat brain, URB602 and URB754 inhibited the hydrolysis of 2-oleoylglycerol with IC50 values of 25 and 48 μM, resp.  Anandamide hydrolysis by brain membranes was not sensitive to URB754, but was inhibited by URB602 (IC50 value 17 μM).  Hydrolysis of 2-oleoylglycerol by human recombinant monoacylglycerol lipase was sensitive to URB602, but not URB754.  The lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis was also obsd. for intact RBL2H3 basophilic leukemia cells.  C6 glioma expressed mRNA for monoacylglycerol lipase, and hydrolyzed 2-oleoylglycerol in a manner sensitive to inhibition by Me arachidonoyl fluorophosphonate but not URB754 or URB597.  MC3T3-E1 mouse osteoblastic cells, which did not express mRNA for monoacylglycerol lipase, hydrolyzed 2-oleoylglycerol in the presence of URB597, but the hydrolysis was less sensitive to Me arachidonoyl fluorophosphonate than for C6 cells.  The data demonstrate that the compds. URB602 and URB754 do not behave as selective and/or potent inhibitors of monoacylglycerol lipase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtVRvNn0uv3LVg90H21EOLACvtfcHk0lgMOgVwSFR6DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFeqsA%253D%253D&md5=0594f0eaca3ecbd7942c09687d2e54be</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706971%26sid%3Dliteratum%253Aachs%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DJonsson%26aufirst%3DK.%2BO.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DPersson%26aufirst%3DE.%26aulast%3DLambert%26aufirst%3DD.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DLack%2520of%2520selectivity%2520of%2520URB602%2520for%25202-oleoylglycerol%2520compared%2520to%2520anandamide%2520hydrolysis%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D186%26epage%3D191%26doi%3D10.1038%2Fsj.bjp.0706971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1124/jpet.104.078980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.104.078980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=15579492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlSntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=352-358&author=D.+Fegleyauthor=S.+Gaetaniauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Characterization+of+the+fatty+acid+amide+hydrolase+inhibitor+cyclohexyl+carbamic+acid+3%E2%80%B2-carbamoyl-biphenyl-3-yl+ester+%28URB597%29%3A+effects+on+anandamide+and+oleoylethanolamide+deactivation&doi=10.1124%2Fjpet.104.078980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation</span></div><div class="casAuthors">Fegley, Darren; Gaetani, Silvana; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">352-358</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an intracellular serine enzyme that catalyzes the hydrolysis of bioactive fatty acid ethanolamides such as anandamide and oleoylethanolamide (OEA).  Genetic deletion of the faah gene in mice elevates brain anandamide levels and amplifies the effects of this endogenous cannabinoid agonist.  Here, we show that systemic administration of the selective FAAH inhibitor URB597 (cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester; 0.3 mg/kg i.p.) increases anandamide levels in the brain of rats and wild-type mice but has no such effect in FAAH-null mutants.  Moreover, URB597 enhances the hypothermic actions of anandamide (5 mg/kg i.p.) in wild-type mice but not in FAAH-null mice.  In contrast, the FAAH inhibitor does not affect anandamide or OEA levels in the rat duodenum at doses that completely inhibit FAAH activity.  In addn., URB597 does not alter the hypophagic response elicited by OEA (5 and 10 mg/kg i.p.), which is mediated by activation of peroxisome proliferator-activated receptor type-α.  Finally, exogenously administered OEA (5 mg/kg i.p.) was eliminated at comparable rates in wild-type and FAAH-/- mice.  Our results indicate that URB597 increases brain anandamide levels and magnifies anandamide responses by inhibiting intracellular FAAH activity.  The results also suggest that an enzyme distinct from FAAH catalyzes OEA hydrolysis in the duodenum, where this lipid substance acts as a local satiety factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQqcEldxrOALVg90H21EOLACvtfcHk0lgDmQq0LTxN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlSntro%253D&md5=d09bb7f585012a0378a1498c7362f0c5</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.078980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.078980%26sid%3Dliteratum%253Aachs%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520the%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitor%2520cyclohexyl%2520carbamic%2520acid%25203%25E2%2580%25B2-carbamoyl-biphenyl-3-yl%2520ester%2520%2528URB597%2529%253A%2520effects%2520on%2520anandamide%2520and%2520oleoylethanolamide%2520deactivation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D352%26epage%3D358%26doi%3D10.1124%2Fjpet.104.078980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosengarth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astarita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geaga, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2007.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2007.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18096504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1357-1365&author=A.+R.+Kingauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Rosengarthauthor=J.+R.+Clapperauthor=G.+Astaritaauthor=J.+A.+Geagaauthor=H.+Lueckeauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=URB602+inhibits+monoacylglycerol+lipase+and+selectively+blocks+2-arachidonoylglycerol+degradation+in+intact+brain+slices&doi=10.1016%2Fj.chembiol.2007.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices</span></div><div class="casAuthors">King, Alvin R.; Duranti, Andrea; Tontini, Andrea; Rivara, Silvia; Rosengarth, Anja; Clapper, Jason R.; Astarita, Giuseppe; Geaga, Jennifer A.; Luecke, Hartmut; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1357-1365</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The N-aryl carbamate URB602 (biphenyl-3-ylcarbamic acid cyclohexyl ester) is an inhibitor of monoacylglycerol lipase (MGL), a serine hydrolase involved in the biol. deactivation of the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG).  Here, we investigated the mechanism by which URB602 inhibits purified recombinant rat MGL by using a combination of biochem. and structure-activity relationship (SAR) approaches.  We found that URB602 weakly inhibits recombinant MGL (IC50 = 223 ± 63 μM) through a rapid and non-competitive mechanism.  Dialysis expts. and SAR analyses suggest that URB602 acts through a partially reversible mechanism rather than by irreversible carbamoylation of MGL.  Finally, URB602 (100 μM) elevates 2-AG levels in hippocampal slice cultures without affecting levels of other endocannabinoid-related substances.  Thus, URB602 may provide a useful tool by which to investigate the physiol. roles of 2-AG and explore the potential interest of MGL as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVnXoAAqtub7Vg90H21EOLACvtfcHk0lgDmQq0LTxN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOktrfF&md5=f0fd3b5bd25e049a49e6b0649ad32a34</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DRosengarth%26aufirst%3DA.%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DGeaga%26aufirst%3DJ.%2BA.%26aulast%3DLuecke%26aufirst%3DH.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DURB602%2520inhibits%2520monoacylglycerol%2520lipase%2520and%2520selectively%2520blocks%25202-arachidonoylglycerol%2520degradation%2520in%2520intact%2520brain%2520slices%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D1357%26epage%3D1365%26doi%3D10.1016%2Fj.chembiol.2007.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavón, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1038/nchembio.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnchembio.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19029917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=37-44&author=J.+Z.+Longauthor=W.+Liauthor=L.+Bookerauthor=J.+J.+Burstonauthor=S.+G.+Kinseyauthor=J.+E.+Schlosburgauthor=F.+J.+Pav%C3%B3nauthor=A.+M.+Serranoauthor=D.+E.+Selleyauthor=L.+H.+Parsonsauthor=A.+H.+Lichtmanauthor=B.+F.+Cravatt&title=Selective+blockade+of+2-arachidonoylglycerol+hydrolysis+produces+cannabinoid+behavioral+effects&doi=10.1038%2Fnchembio.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects</span></div><div class="casAuthors">Long, Jonathan Z.; Li, Weiwei; Booker, Lamont; Burston, James J.; Kinsey, Steven G.; Schlosburg, Joel E.; Pavon, Franciso J.; Serrano, Antonia M.; Selley, Dana E.; Parsons, Loren H.; Lichtman, Aron H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol (2-AG) and anandamide are endocannabinoids that activate the cannabinoid receptors CB1 and CB2.  Endocannabinoid signaling is terminated by enzymic hydrolysis, a process that for anandamide is mediated by fatty acid amide hydrolase (FAAH), and for 2-AG is thought to involve monoacylglycerol lipase (MAGL).  FAAH inhibitors produce a select subset of the behavioral effects obsd. with CB1 agonists, which suggests a functional segregation of endocannabinoid signaling pathways in vivo.  Testing this hypothesis, however, requires specific tools to independently block anandamide and 2-AG metab.  Here, we report a potent and selective inhibitor of MAGL called JZL184 that, upon administration to mice, raises brain 2-AG by eight-fold without altering anandamide.  JZL184-treated mice exhibited a broad array of CB1-dependent behavioral effects, including analgesia, hypothermia and hypomotility.  These data indicate that 2-AG endogenously modulates several behavioral processes classically assocd. with the pharmacol. of cannabinoids and point to overlapping and unique functions for 2-AG and anandamide in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY1sK0ulYFK7Vg90H21EOLACvtfcHk0lgDmQq0LTxN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F&md5=1ffee44019b0e52db5da38fe30a6e4d0</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.129%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DPav%25C3%25B3n%26aufirst%3DF.%2BJ.%26aulast%3DSerrano%26aufirst%3DA.%2BM.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DSelective%2520blockade%2520of%25202-arachidonoylglycerol%2520hydrolysis%2520produces%2520cannabinoid%2520behavioral%2520effects%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D37%26epage%3D44%26doi%3D10.1038%2Fnchembio.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1124/jpet.112.201426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.112.201426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23412396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=492-501&author=S.+G.+Kinseyauthor=L.+E.+Wiseauthor=D.+Rameshauthor=R.+Abdullahauthor=D.+E.+Selleyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Repeated+low-dose+administration+of+the+monoacylglycerol+lipase+inhibitor+JZL184+retains+cannabinoid+receptor+type+1-mediated+antinociceptive+and+gastroprotective+effects&doi=10.1124%2Fjpet.112.201426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects</span></div><div class="casAuthors">Kinsey, Steven G.; Wise, Laura E.; Ramesh, Divya; Abdullah, Rehab; Selley, Dana E.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The monoacylglycerol lipase (MAGL) inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) produces antinociceptive and anti-inflammatory effects.  However, repeated administration of high-dose JZL184 (40 mg/kg) causes dependence, antinociceptive tolerance, cross-tolerance to the pharmacol. effects of cannabinoid receptor agonists, and cannabinoid receptor type 1 (CB1) downregulation and desensitization.  This functional CB1 receptor tolerance poses a hurdle in the development of MAGL inhibitors for therapeutic use.  Consequently, the present study tested whether repeated administration of low-dose JZL184 maintains its antinociceptive actions in the chronic constriction injury of the sciatic nerve neuropathic pain model and protective effects in a model of nonsteroidal anti-inflammatory drug-induced gastric hemorrhages.  Mice given daily injections of high-dose JZL184 (≥16 mg/kg) for 6 days displayed decreased CB1 receptor d. and function in the brain, as assessed in [3H]SR141716A binding and CP55,940 [(-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol]-stimulated guanosine 5'-O-(3-[35S]thio)triphosphate binding assays, resp.  In contrast, normal CB1 receptor expression and function were maintained following repeated administration of low-dose JZL184 (≤8 mg/kg).  Likewise, the antinociceptive and gastroprotective effects of high-dose JZL184 underwent tolerance following repeated administration, but these effects were maintained following repeated low-dose JZL184 treatment.  Consistent with these observations, repeated high-dose JZL184, but not repeated low-dose JZL184, elicited cross-tolerance to the common pharmacol. effects of Δ9-tetrahydrocannabinol.  This same pattern of effects was found in a rimonabant [(5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide)]-pptd. withdrawal model of cannabinoid dependence.  Taken together, these results indicate that prolonged, partial MAGL inhibition maintains potentially beneficial antinociceptive and anti-inflammatory effects, without producing functional CB1 receptor tachyphylaxis/tolerance or cannabinoid dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZkkceF1Il2rVg90H21EOLACvtfcHk0lhhfhRoFTh9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D&md5=ea906c8140fa02a53729ff4fcbdcd8a8</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201426%26sid%3Dliteratum%253Aachs%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DWise%26aufirst%3DL.%2BE.%26aulast%3DRamesh%26aufirst%3DD.%26aulast%3DAbdullah%26aufirst%3DR.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DRepeated%2520low-dose%2520administration%2520of%2520the%2520monoacylglycerol%2520lipase%2520inhibitor%2520JZL184%2520retains%2520cannabinoid%2520receptor%2520type%25201-mediated%2520antinociceptive%2520and%2520gastroprotective%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D345%26spage%3D492%26epage%3D501%26doi%3D10.1124%2Fjpet.112.201426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. S.</span><span> </span><span class="NLM_article-title">Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity</span> <span class="citation_source-journal">Hippocampus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1002/hipo.22344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fhipo.22344" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=16-26&author=Z.+Zhangauthor=W.+Wangauthor=P.+Zhongauthor=S.+J.+Liuauthor=J.+Z.+Longauthor=L.+Zhaoauthor=H.+Q.+Gaoauthor=B.+F.+Cravattauthor=Q.+S.+Liu&title=Blockade+of+2-arachidonoylglycerol+hydrolysis+produces+antidepressant-like+effects+and+enhances+adult+hippocampal+neurogenesis+and+synaptic+plasticity&doi=10.1002%2Fhipo.22344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1002%2Fhipo.22344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhipo.22344%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DS.%2BJ.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DH.%2BQ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLiu%26aufirst%3DQ.%2BS.%26atitle%3DBlockade%2520of%25202-arachidonoylglycerol%2520hydrolysis%2520produces%2520antidepressant-like%2520effects%2520and%2520enhances%2520adult%2520hippocampal%2520neurogenesis%2520and%2520synaptic%2520plasticity%26jtitle%3DHippocampus%26date%3D2015%26volume%3D25%26spage%3D16%26epage%3D26%26doi%3D10.1002%2Fhipo.22344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim-Selley, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1038/nn.2616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fnn.2616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=20729846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1113-1119&author=J.+E.+Schlosburgauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=D.+K.+Nomuraauthor=B.+Panauthor=S.+G.+Kinseyauthor=P.+T.+Nguyenauthor=D.+Rameshauthor=L.+Bookerauthor=J.+J.+Burstonauthor=E.+A.+Thomasauthor=D.+E.+Selleyauthor=L.+J.+Sim-Selleyauthor=Q.+S.+Liuauthor=A.+H.+Lichtmanauthor=B.+F.+Cravatt&title=Chronic+monoacylglycerol+lipase+blockade+causes+functional+antagonism+of+the+endocannabinoid+system&doi=10.1038%2Fnn.2616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system</span></div><div class="casAuthors">Schlosburg, Joel E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Pan, Bin; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Thomas, Elizabeth A.; Selley, Dana E.; Sim-Selley, Laura J.; Liu, Qing-song; Lichtman, Aron H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1113-1119</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prolonged exposure to drugs of abuse, such as cannabinoids and opioids, leads to pharmacol. tolerance and receptor desensitization in the nervous system.  We found that a similar form of functional antagonism was produced by sustained inactivation of monoacylglycerol lipase (MAGL), the principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol.  After repeated administration, the MAGL inhibitor JZL184 lost its analgesic activity and produced cross-tolerance to cannabinoid receptor (CB1) agonists in mice, effects that were phenocopied by genetic disruption of Mgll (encoding MAGL).  Chronic MAGL blockade also caused phys. dependence, impaired endocannabinoid-dependent synaptic plasticity and desensitized brain CB1 receptors.  These data contrast with blockade of fatty acid amide hydrolase, an enzyme that degrades the other major endocannabinoid anandamide, which produced sustained analgesia without impairing CB1 receptors.  Thus, individual endocannabinoids generate distinct analgesic profiles that are either sustained or transitory and assocd. with agonism and functional antagonism of the brain cannabinoid system, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrspBJ5YipLVg90H21EOLACvtfcHk0lhhfhRoFTh9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtb%252FK&md5=878d95dd379fc44ff642c2ae1b458a46</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fnn.2616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2616%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DNguyen%26aufirst%3DP.%2BT.%26aulast%3DRamesh%26aufirst%3DD.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DThomas%26aufirst%3DE.%2BA.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DSim-Selley%26aufirst%3DL.%2BJ.%26aulast%3DLiu%26aufirst%3DQ.%2BS.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DChronic%2520monoacylglycerol%2520lipase%2520blockade%2520causes%2520functional%2520antagonism%2520of%2520the%2520endocannabinoid%2520system%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1113%26epage%3D1119%26doi%3D10.1038%2Fnn.2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buczynski, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.chembiol.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=22542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=579-588&author=J.+W.+Changauthor=M.+J.+Niphakisauthor=K.+M.+Lumauthor=A.+B.+Cognettaauthor=C.+Wangauthor=M.+L.+Matthewsauthor=S.+Niessenauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=B.+F.+Cravatt&title=Highly+selective+inhibitors+of+monoacylglycerol+lipase+bearing+a+reactive+group+that+is+bioisosteric+with+endocannabinoid+substrates&doi=10.1016%2Fj.chembiol.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span></div><div class="casAuthors">Chang, Jae Won; Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B.; Wang, Chu; Matthews, Megan L.; Niessen, Sherry; Buczynski, Matthew W.; Parsons, Loren H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), resp.  The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo.  Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biol. studies.  Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH.  These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWEmTTUlQHCLVg90H21EOLACvtfcHk0lhhfhRoFTh9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D&md5=d318d890c4c799d1579daab2e2c201f4</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DHighly%2520selective%2520inhibitors%2520of%2520monoacylglycerol%2520lipase%2520bearing%2520a%2520reactive%2520group%2520that%2520is%2520bioisosteric%2520with%2520endocannabinoid%2520substrates%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D579%26epage%3D588%26doi%3D10.1016%2Fj.chembiol.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Ignatowska-Jankowska, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neal, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walentiny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">1392</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span><span class="refDoi"> DOI: 10.1111/bph.12298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fbph.12298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=23848221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVentrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=1392-1407&author=B.+M.+Ignatowska-Jankowskaauthor=S.+Ghoshauthor=M.+S.+Croweauthor=S.+G.+Kinseyauthor=M.+J.+Niphakisauthor=R.+A.+Abdullahauthor=Q.+Taoauthor=S.+T.+O%E2%80%99Nealauthor=D.+M.+Walentinyauthor=J.+L.+Wileyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=In+vivo+characterization+of+the+highly+selective+monoacylglycerol+lipase+inhibitor+KML29%3A+antinociceptive+activity+without+cannabimimetic+side+effects&doi=10.1111%2Fbph.12298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects</span></div><div class="casAuthors">Ignatowska-Jankowska, B. M.; Ghosh, S.; Crowe, M. S.; Kinsey, S. G.; Niphakis, M. J.; Abdullah, R. A.; Tao, Q.; O'Neal, S. T.; Walentiny, D. M.; Wiley, J. L.; Cravatt, B. F.; Lichtman, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1392-1407</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Since monoacylglycerol lipase (MAGL) has been firmly established as the predominant catabolic enzyme of the endocannabinoid 2-arachidonoylglycerol (2-AG), a great need has emerged for the development of highly selective MAGL inhibitors.  Here, we tested the in vivo effects of one such compd., KML29 (1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo[d][1,3]dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate).  Exptl. Approach : In the present study, we tested KML29 in murine inflammatory (i.e. carrageenan) and sciatic nerve injury pain models, as well as the diclofenac-induced gastric hemorrhage model.  KML29 was also evaluated for cannabimimetic effects, including measurements of locomotor activity, body temp., catalepsy, and cannabinoid interoceptive effects in the drug discrimination paradigm.  Key Results: KML29 attenuated carrageenan-induced paw edema and completely reversed carrageenan-induced mech. allodynia.  These effects underwent tolerance after repeated administration of high-dose KML29, which were accompanied by cannabinoid receptor 1 (CB1) receptor desensitization.  Acute or repeated KML29 administration increased 2-AG levels and concomitantly reduced arachidonic acid levels, but without elevating anandamide (AEA) levels in the whole brain.  Furthermore, KML29 partially reversed allodynia in the sciatic nerve injury model and completely prevented diclofenac-induced gastric haemorrhages.  CB1 and CB2 receptors played differential roles in these pharmacol. effects of KML29.  In contrast, KML29 did not elicit cannabimimetic effects, including catalepsy, hypothermia and hypomotility.  Although KML29 did not substitute for Δ9-tetrahydrocannabinol (THC) in C57BL/6J mice, it fully and dose-dependantly substituted for AEA in fatty acid amide hydrolase (FAAH) (-/-) mice, consistent with previous work showing that dual FAAH and MAGL inhibition produces THC-like subjective effects.  Conclusions and Implications : These results indicate that KML29, a highly selective MAGL inhibitor, reduces inflammatory and neuropathic nociceptive behavior without occurrence of cannabimimetic side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_q-jS_ue8WLVg90H21EOLACvtfcHk0lgeubXHsBsVRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVentrk%253D&md5=63408213fe5c278fa49081f1d912a958</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fbph.12298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12298%26sid%3Dliteratum%253Aachs%26aulast%3DIgnatowska-Jankowska%26aufirst%3DB.%2BM.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DCrowe%26aufirst%3DM.%2BS.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DAbdullah%26aufirst%3DR.%2BA.%26aulast%3DTao%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DS.%2BT.%26aulast%3DWalentiny%26aufirst%3DD.%2BM.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DIn%2520vivo%2520characterization%2520of%2520the%2520highly%2520selective%2520monoacylglycerol%2520lipase%2520inhibitor%2520KML29%253A%2520antinociceptive%2520activity%2520without%2520cannabimimetic%2520side%2520effects%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D1392%26epage%3D1407%26doi%3D10.1111%2Fbph.12298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Pasquarelli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porazik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanselmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weydt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witting, A.</span><span> </span><span class="NLM_article-title">Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.neuropharm.2014.12.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2015&pages=148-156&author=N.+Pasquarelliauthor=C.+Porazikauthor=J.+Hanselmannauthor=P.+Weydtauthor=B.+Fergerauthor=A.+Witting&title=Comparative+biochemical+characterization+of+the+monoacylglycerol+lipase+inhibitor+KML29+in+brain%2C+spinal+cord%2C+liver%2C+spleen%2C+fat+and+muscle+tissue&doi=10.1016%2Fj.neuropharm.2014.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DPasquarelli%26aufirst%3DN.%26aulast%3DPorazik%26aufirst%3DC.%26aulast%3DHanselmann%26aufirst%3DJ.%26aulast%3DWeydt%26aufirst%3DP.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DWitting%26aufirst%3DA.%26atitle%3DComparative%2520biochemical%2520characterization%2520of%2520the%2520monoacylglycerol%2520lipase%2520inhibitor%2520KML29%2520in%2520brain%252C%2520spinal%2520cord%252C%2520liver%252C%2520spleen%252C%2520fat%2520and%2520muscle%2520tissue%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D91%26spage%3D148%26epage%3D156%26doi%3D10.1016%2Fj.neuropharm.2014.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1590</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span><span class="refDoi"> DOI: 10.1021/cb400261h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400261h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1590-1599&author=J.+W.+Changauthor=A.+B.+Cognettaauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Proteome-wide+reactivity+profiling+identifies+diverse+carbamate+chemotypes+tuned+for+serine+hydrolase+inhibition&doi=10.1021%2Fcb400261h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition</span></div><div class="casAuthors">Chang, Jae Won; Cognetta, Armand B., III; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1590-1599</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serine hydrolases are one of the largest and most diverse enzyme classes in Nature.  Inhibitors of serine hydrolases are used to treat many diseases, including obesity, diabetes, cognitive dementia, and bacterial and viral infections.  Nonetheless, the majority of the 200+ serine hydrolases in mammals still lack selective inhibitors for their functional characterization.  We and others have shown that activated carbamates, through covalent reaction with the conserved serine nucleophile of serine hydrolases, can serve as useful inhibitors for members of this enzyme family.  The extent to which carbamates, however, cross-react with other protein classes remains mostly unexplored.  Here, we address this problem by investigating the proteome-wide reactivity of a diverse set of activated carbamates in vitro and in vivo, using a combination of competitive and click chem. (CC)-activity-based protein profiling (ABPP).  We identify multiple classes of carbamates, including O-aryl, O-hexafluoroisopropyl (HFIP), and O-N-hydroxysuccinimidyl (NHS) carbamates that react selectively with serine hydrolases across entire mouse tissue proteomes in vivo.  We exploit the proteome-wide specificity of HFIP carbamates to create in situ imaging probes for the endocannabinoid hydrolases monoacylglycerol lipase (MAGL) and α-β hydrolase-6 (ABHD6).  These findings, taken together, designate the carbamate as a privileged reactive group for serine hydrolases that can accommodate diverse structural modifications to produce inhibitors that display exceptional potency and selectivity across the mammalian proteome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-176v-DnJrVg90H21EOLACvtfcHk0lgeubXHsBsVRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D&md5=7286011459791bcdea13f918b9ef97c3</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fcb400261h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400261h%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520reactivity%2520profiling%2520identifies%2520diverse%2520carbamate%2520chemotypes%2520tuned%2520for%2520serine%2520hydrolase%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1590%26epage%3D1599%26doi%3D10.1021%2Fcb400261h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buczynski, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1332</span><span class="refDoi"> DOI: 10.1021/cn400116z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400116z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFynsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1322-1332&author=M.+J.+Niphakisauthor=A.+B.+Cognettaauthor=J.+W.+Changauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=F.+Byrneauthor=J.+J.+Burstonauthor=V.+Chapmanauthor=B.+F.+Cravatt&title=Evaluation+of+NHS+carbamates+as+a+potent+and+selective+class+of+endocannabinoid+hydrolase+inhibitors&doi=10.1021%2Fcn400116z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of NHS Carbamates as a Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors</span></div><div class="casAuthors">Niphakis, Micah J.; Cognetta, Armand B.; Chang, Jae Won; Buczynski, Matthew W.; Parsons, Loren H.; Byrne, Frederika; Burston, James J.; Chapman, Victoria; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1322-1332</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a principal metabolic enzyme responsible for hydrolyzing the endogenous cannabinoid (endocannabinoid) 2-arachidonoylglycerol (2-AG).  Selective inhibitors of MAGL offer valuable probes to further understand the enzyme's function in biol. systems and may lead to drugs for treating a variety of diseases, including psychiatric disorders, neuroinflammation, and pain.  N-Hydroxysuccinimidyl (NHS) carbamates have recently been identified as a promising class of serine hydrolase inhibitors that shows minimal cross-reactivity with other proteins in the proteome.  Here, the authors explore NHS carbamates more broadly and demonstrate their potential as inhibitors of endocannabinoid hydrolases and addnl. enzymes from the serine hydrolase class.  The authors extensively characterize an NHS carbamate MJN110 as a potent, selective, and in-vivo-active MAGL inhibitor.  Finally, the authors demonstrate that MJN110 alleviates mech. allodynia in a rat model of diabetic neuropathy, marking NHS carbamates as a promising class of MAGL inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAehyjU_mhIrVg90H21EOLACvtfcHk0lhA5yrT37Gtyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFynsbY%253D&md5=a85efb8cecdc97928ff889e63e46fe4d</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fcn400116z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400116z%26sid%3Dliteratum%253Aachs%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DByrne%26aufirst%3DF.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DChapman%26aufirst%3DV.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEvaluation%2520of%2520NHS%2520carbamates%2520as%2520a%2520potent%2520and%2520selective%2520class%2520of%2520endocannabinoid%2520hydrolase%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1322%26epage%3D1332%26doi%3D10.1021%2Fcn400116z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Wilkerson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grim, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poklis, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akbarali, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1124/jpet.115.229971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1124%2Fjpet.115.229971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26791602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=145-156&author=J.+L.+Wilkersonauthor=M.+J.+Niphakisauthor=T.+W.+Grimauthor=M.+A.+Mustafaauthor=R.+A.+Abdullahauthor=J.+L.+Poklisauthor=W.+L.+Deweyauthor=H.+I.+Akbaraliauthor=M.+L.+Banksauthor=L.+E.+Wiseauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=The+selective+monoacylglycerol+lipase+inhibitor+MJN110+produces+opioid+sparing+effects+in+a+mouse+neuropathic+pain+model&doi=10.1124%2Fjpet.115.229971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">The selective monoacylglycerol lipase inhibitor MJN110 produces opioid-sparing effects in a mouse neuropathic pain model</span></div><div class="casAuthors">Wilkerson, Jenny L.; Niphakis, Micah J.; Grim, Travis W.; Mustafa, Mohammed A.; Abdullah, Rehab A.; Poklis, Justin L.; Dewey, William L.; Akbarali, Hamid; Banks, Matthew L.; Wise, Laura E.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-156</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Serious clin. liabilities assocd. with the prescription of opiates for pain control include constipation, respiratory depression, pruritus, tolerance, abuse, and addiction.  A recognized strategy to circumvent these side effects is to combine opioids with other antinociceptive agents.  The combination of opiates with the primary active constituent of cannabis (Δ9-tetrahydrocannabinol) produces enhanced antinociceptive actions, suggesting that cannabinoid receptor agonists can be opioid sparing.  Here, we tested whether elevating the endogenous cannabinoid 2-arachidonoylglycerol through the inhibition of its primary hydrolytic enzyme monoacylglycerol lipase (MAGL), will produce opioid-sparing effects in the mouse chronic constriction injury (CCI) of the sciatic nerve model of neuropathic pain.  The dose-response relationships of i.p. administration of morphine and the selective MAGL inhibitor 2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate (MJN110) were tested alone and in combination at equieffective doses for reversal of CCI-induced mech. allodynia and thermal hyperalgesia.  The resp. ED50 doses (95% confidence interval) of morphine and MJN110 were 2.4 (1.9-3.0) mg/kg and 0.43 (0.23-0.79) mg/kg.  Isobolog. anal. of these drugs in combination revealed synergistic antiallodynic effects.  Acute antinociceptive effects of the combination of morphine and MJN110 required μ-opioid, CB1, and CB2 receptors.  This combination did not reduce gastric motility or produce subjective cannabimimetic effects in the drug discrimination assay.  Importantly, combinations of MJN110 and morphine given repeatedly (i.e., twice a day for 6 days) continued to produce antiallodynic effects with no evidence of tolerance.  Taken together, these findings suggest that MAGL inhibition produces opiate-sparing events with diminished tolerance, constipation, and cannabimimetic side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvljtkgi35bVg90H21EOLACvtfcHk0lhA5yrT37Gtyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeksLg%253D&md5=dbcc89e040f2b5bc4257df943ce1e769</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229971%26sid%3Dliteratum%253Aachs%26aulast%3DWilkerson%26aufirst%3DJ.%2BL.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DGrim%26aufirst%3DT.%2BW.%26aulast%3DMustafa%26aufirst%3DM.%2BA.%26aulast%3DAbdullah%26aufirst%3DR.%2BA.%26aulast%3DPoklis%26aufirst%3DJ.%2BL.%26aulast%3DDewey%26aufirst%3DW.%2BL.%26aulast%3DAkbarali%26aufirst%3DH.%2BI.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DWise%26aufirst%3DL.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DThe%2520selective%2520monoacylglycerol%2520lipase%2520inhibitor%2520MJN110%2520produces%2520opioid%2520sparing%2520effects%2520in%2520a%2520mouse%2520neuropathic%2520pain%2520model%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26spage%3D145%26epage%3D156%26doi%3D10.1124%2Fjpet.115.229971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeské, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Françon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Even, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Grancha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstykh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brittain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederschain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escoubet, J.</span><span> </span><span class="NLM_article-title">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">7642</span><span class="refDoi"> DOI: 10.1038/srep07642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1038%2Fsrep07642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=25560837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=7642&author=G.+Griebelauthor=P.+Pichatauthor=S.+Beesk%C3%A9author=T.+Leroyauthor=N.+Redonauthor=A.+Jacquetauthor=D.+Fran%C3%A7onauthor=L.+Bertauthor=L.+Evenauthor=M.+Lopez-Granchaauthor=T.+Tolstykhauthor=F.+Sunauthor=Q.+Yuauthor=S.+Brittainauthor=H.+Arltauthor=T.+Heauthor=B.+Zhangauthor=D.+Wiederschainauthor=T.+Bertrandauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=N.+Michotauthor=F.+Aug%C3%A9author=V.+Menetauthor=O.+E.+Bergisauthor=P.+Georgeauthor=P.+Avenetauthor=V.+Mikolauthor=M.+Didierauthor=J.+Escoubet&title=Selective+blockade+of+the+hydrolysis+of+the+endocannabinoid+2-arachidonoylglycerol+impairs+learning+and+memory+performance+while+producing+antinociceptive+activity+in+rodents&doi=10.1038%2Fsrep07642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span></div><div class="casAuthors">Griebel, Guy; Pichat, Philippe; Beeske, Sandra; Leroy, Thibaud; Redon, Nicolas; Jacquet, Agnes; Francon, Dominique; Bert, Lionel; Even, Luc; Lopez-Grancha, Mati; Tolstykh, Tatiana; Sun, Fangxian; Yu, Qunyan; Brittain, Scott; Arlt, Heike; He, Timothy; Zhang, Bailin; Wiederschain, Dmitri; Bertrand, Thomas; Houtmann, Jacques; Rak, Alexey; Vallee, Francois; Michot, Nadine; Auge, Franck; Menet, Veronique; Bergis, Olivier E.; George, Pascal; Avenet, Patrick; Mikol, Vincent; Didier, Michel; Escoubet, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7642</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) represents a primary degrdn. enzyme of the endogenous cannabinoid (eCB), 2-arachidonoyglycerol (2-AG).  This study reports a potent covalent MAGL inhibitor, SAR127303.  The compd. behaves as a selective and competitive inhibitor of mouse and human MAGL, which potently elevates hippocampal levels of 2-AG in mice.  In vivo, SAR127303 produces antinociceptive effects in assays of inflammatory and visceral pain.  In addn., the drug alters learning performance in several assays related to episodic, working and spatial memory.  Moreover, long term potentiation (LTP) of CA1 synaptic transmission and acetylcholine release in the hippocampus, two hallmarks of memory function, are both decreased by SAR127303.  Although inactive in acute seizure tests, repeated administration of SAR127303 delays the acquisition and decreases kindled seizures in mice, indicating that the drug slows down epileptogenesis, a finding deserving further investigation to evaluate the potential of MAGL inhibitors as antiepileptics.  However, the observation that 2-AG hydrolysis blockade alters learning and memory performance, suggests that such drugs may have limited value as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiPpgk18M26bVg90H21EOLACvtfcHk0lhA5yrT37Gtyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL&md5=4160ed016b730ea80abb5c093e66a284</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1038%2Fsrep07642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07642%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBeesk%25C3%25A9%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DT.%26aulast%3DRedon%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DA.%26aulast%3DFran%25C3%25A7on%26aufirst%3DD.%26aulast%3DBert%26aufirst%3DL.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DLopez-Grancha%26aufirst%3DM.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBrittain%26aufirst%3DS.%26aulast%3DArlt%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DAug%25C3%25A9%26aufirst%3DF.%26aulast%3DMenet%26aufirst%3DV.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DDidier%26aufirst%3DM.%26aulast%3DEscoubet%26aufirst%3DJ.%26atitle%3DSelective%2520blockade%2520of%2520the%2520hydrolysis%2520of%2520the%2520endocannabinoid%25202-arachidonoylglycerol%2520impairs%2520learning%2520and%2520memory%2520performance%2520while%2520producing%2520antinociceptive%2520activity%2520in%2520rodents%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D7642%26doi%3D10.1038%2Fsrep07642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Placzek, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Bittner, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooker, J. M.</span><span> </span><span class="NLM_article-title">A Novel Radiotracer for imaging monoacylglycerol lipase in the brain using positron emission tomography</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=484-489&author=C.+Wangauthor=M.+S.+Placzekauthor=G.+C.+Van+de+Bittnerauthor=F.+A.+Schroederauthor=J.+M.+Hooker&title=A+Novel+Radiotracer+for+imaging+monoacylglycerol+lipase+in+the+brain+using+positron+emission+tomography&doi=10.1021%2Facschemneuro.5b00293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography</span></div><div class="casAuthors">Wang, Changning; Placzek, Michael S.; Van de Bittner, Genevieve C.; Schroeder, Frederick A.; Hooker, Jacob M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">484-489</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is a serine hydrolase that hydrolyzes monoacylglycerols to glycerol and fatty acid and plays an important role in neuroinflammation.  MAGL inhibitors are a class of mols. with therapeutic potential for human diseases of the central nervous system (CNS), in areas such as pain and inflammation, immunol. disorders, and neurol. and psychiatric conditions.  Development of a noninvasive imaging probe would elucidate the distribution and functional roles of MAGL in the brain and accelerate medical research and drug discovery in this domain.  Herein, we describe the synthesis and pilot rodent imaging of a novel MAGL imaging agent, [11C]SAR127303.  Our imaging results demonstrate the high specificity, good selectivity, and appropriate kinetics and distribution of [11C]SAR127303, validating its utility for imaging MAGL in the brain.  Our findings support the translational potential for human CNS MAGL imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwFMlYYqhfbVg90H21EOLACvtfcHk0lh8zrfJI6xY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7nP&md5=0cc854816045539b5ccb7b5d7819372b</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00293%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPlaczek%26aufirst%3DM.%2BS.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DSchroeder%26aufirst%3DF.%2BA.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Novel%2520Radiotracer%2520for%2520imaging%2520monoacylglycerol%2520lipase%2520in%2520the%2520brain%2520using%2520positron%2520emission%2520tomography%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D484%26epage%3D489%26doi%3D10.1021%2Facschemneuro.5b00293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Lookene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skottova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivecrona, G.</span><span> </span><span class="NLM_article-title">Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat) R</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1994.tb18878.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1111%2Fj.1432-1033.1994.tb18878.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=8020477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=1994&pages=395-403&author=A.+Lookeneauthor=N.+Skottovaauthor=G.+Olivecrona&title=Interactions+of+lipoprotein+lipase+with+the+active-site+inhibitor+tetrahydrolipstatin+%28Orlistat%29+R&doi=10.1111%2Fj.1432-1033.1994.tb18878.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat)</span></div><div class="casAuthors">Lookene, Aivar; Skottova, Nina; Olivecrona, Gunilla</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Lipoprotein lipase (LPL) was rapidly inactivated by low concns. of the active-site inhibitor tetrahydrolipstatin (THL).  The presence of amphiphiles (e.g. long-chain fatty acids) or of lipid/water interfaces (lipid emulsions) was required for inhibition to occur.  Apolipoprotein CII increased the maximal inactivation rate const. by 1.8-fold in the presence of an emulsion of long-chain triacylglycerols, but had no effect in the presence of an emulsion of tributyrylglycerol.  The fully inhibited enzyme had a ratio of THL/LPL of nearly 2, indicating that both subunits of the LPL homo-dimer bound THL.  The THL-LPL complex was stable below pH 7.5.  At higher pH reactivation occurred indicating that THL was slowly turned over by the enzyme.  The apparent reactivation rate const. was increased about threefold by the presence of lipid/water interfaces.  Sucrose d. gradient centrifugation revealed that THL induces tetramerization or LPL.  This aggregation was reversible on reactivation of the inhibited enzyme.  Binding to heparin was not affected by THL.  In contrast, binding to lipid droplets and to lipoproteins was increased, indicating exposure to hydrophobic regions in the inhibited LPL.  It is suggested that THL induces local conformational changes in LPL, which may involve opening of the putative surface lid structure which covers the active-site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGnHKzl9eR57Vg90H21EOLACvtfcHk0lh8zrfJI6xY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOjsrk%253D&md5=9e21f57df02ccfa116fdeec6a897fe43</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1994.tb18878.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1994.tb18878.x%26sid%3Dliteratum%253Aachs%26aulast%3DLookene%26aufirst%3DA.%26aulast%3DSkottova%26aufirst%3DN.%26aulast%3DOlivecrona%26aufirst%3DG.%26atitle%3DInteractions%2520of%2520lipoprotein%2520lipase%2520with%2520the%2520active-site%2520inhibitor%2520tetrahydrolipstatin%2520%2528Orlistat%2529%2520R%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1994%26volume%3D222%26spage%3D395%26epage%3D403%26doi%3D10.1111%2Fj.1432-1033.1994.tb18878.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matias, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiano-Moriello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, P.</span><span> </span><span class="NLM_article-title">Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1083/jcb.200305129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1083%2Fjcb.200305129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=14610053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2003&pages=463-468&author=T.+Bisognoauthor=F.+Howellauthor=G.+Williamsauthor=A.+Minassiauthor=M.+G.+Cascioauthor=A.+Ligrestiauthor=I.+Matiasauthor=A.+Schiano-Morielloauthor=P.+Paulauthor=E.+J.+Williamsauthor=U.+Gangadharanauthor=C.+Hobbsauthor=V.+Di+Marzoauthor=P.+Doherty&title=Cloning+of+the+first+sn1-DAG+lipases+points+to+the+spatial+and+temporal+regulation+of+endocannabinoid+signaling+in+the+brain&doi=10.1083%2Fjcb.200305129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain</span></div><div class="casAuthors">Bisogno, Tiziana; Howell, Fiona; Williams, Gareth; Minassi, Alberto; Grazia Cascio, Maria; Ligresti, Alessia; Matias, Isabel; Schiano-Moriello, Aniello; Paul, Praveen; Williams, Emma-Jane; Gangadharan, Uma; Hobbs, Carl; Di Marzo, Vincenzo; Doherty, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Diacylglycerol (DAG) lipase activity is required for axonal growth during development and for retrograde synaptic signaling at mature synapses.  This enzyme synthesizes the endocannabinoid 2-arachidonoyl-glycerol (2-AG), and the CB1 cannabinoid receptor is also required for the above responses.  We now report on the cloning and enzymic characterization of the first specific sn-1 DAG lipases.  Two closely related genes have been identified and their expression in cells correlated with 2-AG biosynthesis and release.  The expression of both enzymes changes from axonal tracts in the embryo to dendritic fields in the adult, and this correlates with the developmental change in requirement for 2-AG synthesis from the pre- to the postsynaptic compartment.  This switch provides a possible explanation for a fundamental change in endocannabinoid function during brain development.  Identification of these enzymes may offer new therapeutic opportunities for a wide range of disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolsTG3YamCQ7Vg90H21EOLACvtfcHk0lh8zrfJI6xY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCnur8%253D&md5=37bfbb4e29da593151e155d4c9d22cfa</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200305129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200305129%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DHowell%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMatias%26aufirst%3DI.%26aulast%3DSchiano-Moriello%26aufirst%3DA.%26aulast%3DPaul%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DGangadharan%26aufirst%3DU.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDoherty%26aufirst%3DP.%26atitle%3DCloning%2520of%2520the%2520first%2520sn1-DAG%2520lipases%2520points%2520to%2520the%2520spatial%2520and%2520temporal%2520regulation%2520of%2520endocannabinoid%2520signaling%2520in%2520the%2520brain%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D163%26spage%3D463%26epage%3D468%26doi%3D10.1083%2Fjcb.200305129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6970</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span><span class="refDoi"> DOI: 10.1021/jm800978m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800978m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6970-6979&author=G.+Ortarauthor=T.+Bisognoauthor=A.+Ligrestiauthor=E.+Moreraauthor=M.+Nalliauthor=V.+Di+Marzo&title=Tetrahydrolipstatin+analogues+as+modulators+of+endocannabinoid+2-arachidonoylglycerol+metabolism&doi=10.1021%2Fjm800978m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fjm800978m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800978m%26sid%3Dliteratum%253Aachs%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DNalli%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DTetrahydrolipstatin%2520analogues%2520as%2520modulators%2520of%2520endocannabinoid%25202-arachidonoylglycerol%2520metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6970%26epage%3D6979%26doi%3D10.1021%2Fjm800978m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span> </span><span class="NLM_article-title">Endocannabinoid Research Group. Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity <i>in vivo</i></span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1791</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2008.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1016%2Fj.bbalip.2008.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=19027877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFagu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1791&publication_year=2009&pages=53-60&author=T.+Bisognoauthor=G.+Ortarauthor=S.+Petrosinoauthor=E.+Moreraauthor=E.+Palazzoauthor=M.+Nalliauthor=S.+Maioneauthor=V.+Di+Marzo&title=Endocannabinoid+Research+Group.+Development+of+a+potent+inhibitor+of+2-arachidonoylglycerol+hydrolysis+with+antinociceptive+activity+in+vivo&doi=10.1016%2Fj.bbalip.2008.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo</span></div><div class="casAuthors">Bisogno, Tiziana; Ortar, Giorgio; Petrosino, Stefania; Morera, Enrico; Palazzo, Enza; Nalli, Marianna; Maione, Sabatino; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1791</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Although inhibitors of the enzymic hydrolysis of the endocannabinoid 2-arachidonoylglycerol are available, they are either rather weak in vitro (IC50 > 30 μM) or their selectivity towards other proteins of the endocannabinoid system has not been tested.  Here we describe the synthesis and activity in vitro and in vivo of a tetrahydrolipstatin analog, OMDM169, as a potent inhibitor of 2-AG hydrolysis, capable of enhancing 2-AG levels and of exerting analgesic activity via indirect activation of cannabinoid receptors.  OMDM169 exhibited 0.13 μM < IC50 < 0.41 μM towards 2-AG hydrolyzing activities in COS-7 cells and rat cerebellum, and inhibited (IC50 = 0.89 μM) the human recombinant MAGL, while being inactive (Ki > 10 μM) at human CB1 and CB2 receptors.  However, OMDM169 shared with tetrahydrolipstatin the capability of inhibiting the human pancreatic lipase (IC50 = 0.6 μM).  OMDM169 inhibited fatty acid amide hydrolase and diacylglycerol lipase only at higher concns. (IC50 = 3.0 and 2.8 μM, resp.), and, accordingly, it increased by ∼ 1.6-fold the levels of 2-AG, but not anandamide, in intact ionomycin-stimulated N18TG2 neuroblastoma cells.  Acute i.p. administration of OMDM169 to mice inhibited the second phase of the formalin-induced nocifensive response with an IC50 of ∼ 2.5 mg/kg, and concomitantly elevated 2-AG, but not anandamide, levels in the ipsilateral paw of formalin-treated mice.  The antinociceptive effect of OMDM169 was antagonized by antagonists of CB1 and CB2 receptors, AM251 and AM630, resp. (1 mg/kg, i.p.).  OMDM69 might represent a template for the development of selective and even more potent inhibitors of 2-AG hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEpfVvAlBHLVg90H21EOLACvtfcHk0liW2OVo_3wrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFagu7jJ&md5=d5f2449b130900072128e7048cd3f29a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DOrtar%26aufirst%3DG.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DPalazzo%26aufirst%3DE.%26aulast%3DNalli%26aufirst%3DM.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoid%2520Research%2520Group.%2520Development%2520of%2520a%2520potent%2520inhibitor%2520of%25202-arachidonoylglycerol%2520hydrolysis%2520with%2520antinociceptive%2520activity%2520in%2520vivo%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2009%26volume%3D1791%26spage%3D53%26epage%3D60%26doi%3D10.1016%2Fj.bbalip.2008.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Kapanda, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draoui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span> </span><span class="NLM_article-title">Search for monoglyceride lipase inhibitors: synthesis and screening of arylthioamides derivatives</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1007/s00044-008-9123-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1007%2Fs00044-008-9123-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltV2muro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=243-254&author=C.+N.+Kapandaauthor=G.+G.+Muccioliauthor=G.+Labarauthor=N.+Draouiauthor=D.+M.+Lambertauthor=J.+H.+Poupaert&title=Search+for+monoglyceride+lipase+inhibitors%3A+synthesis+and+screening+of+arylthioamides+derivatives&doi=10.1007%2Fs00044-008-9123-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Search for monoglyceride lipase inhibitors: synthesis and screening of arylthioamides derivatives</span></div><div class="casAuthors">Kapanda, Coco N.; Muccioli, Giulio G.; Labar, Geoffray; Draoui, Nihed; Lambert, Didier M.; Poupaert, Jacques H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">243-254</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) is the enzyme responsible for the termination of 2-arachidonoylglycerol (2-AG) signaling, an endogenous ligand for the G-protein coupled cannabinoid receptors CB1 and CB2.  Its known abundance and physiol. roles emphasize the interest of MGL as an attractive therapeutic target.  Search for MGL inhibitors was undertaken by screening an arylthioamide series.  The evaluation of arylthioamides derivs. activity as MGL inhibitors measured by the hydrolysis of [3H]-2-oleoylglycerol by human purified MGL led to the identification of (2-chloro-phenyl)-morpholin-4-yl-methanethione (2) and (3-nitro-phenyl) morpholin-4-yl-methanethione (12), which moreover exhibit good selectivity compared with human fatty acid amide hydrolase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSAT3V4kP9tbVg90H21EOLACvtfcHk0liW2OVo_3wrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltV2muro%253D&md5=22ecb52ac015379fcf8939d3e260e58a</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1007%2Fs00044-008-9123-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-008-9123-2%26sid%3Dliteratum%253Aachs%26aulast%3DKapanda%26aufirst%3DC.%2BN.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DDraoui%26aufirst%3DN.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26atitle%3DSearch%2520for%2520monoglyceride%2520lipase%2520inhibitors%253A%2520synthesis%2520and%2520screening%2520of%2520arylthioamides%2520derivatives%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2009%26volume%3D18%26spage%3D243%26epage%3D254%26doi%3D10.1007%2Fs00044-008-9123-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Kapanda, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masquelier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupaert, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5774</span><span class="NLM_x">–</span> <span class="NLM_lpage">5783</span><span class="refDoi"> DOI: 10.1021/jm3006004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3006004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5774-5783&author=C.+N.+Kapandaauthor=J.+Masquelierauthor=G.+Labarauthor=G.+G.+Muccioliauthor=J.+H.+Poupaertauthor=D.+M.+Lambert&title=Synthesis+and+pharmacological+evaluation+of+2%2C4-dinitroaryldithiocarbamate+derivatives+as+novel+monoacylglycerol+lipase+inhibitors&doi=10.1021%2Fjm3006004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Evaluation of 2,4-Dinitroaryldithiocarbamate Derivatives as Novel Monoacylglycerol Lipase Inhibitors</span></div><div class="casAuthors">Kapanda, Coco N.; Masquelier, Julien; Labar, Geoffray; Muccioli, Giulio G.; Poupaert, Jacques H.; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5774-5783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) is responsible for signal termination of 2-arachidonoylglycerol (2-AG), an endocannabinoid neurotransmitter endowed with several physiol. effects.  Previously, we showed that the arylthioamide scaffold represents a privileged template for designing MAGL inhibitors.  A series of 37 compds. resulting from pharmacomodulations around the arylthioamide template were synthesized and tested to evaluate their inhibitory potential on MAGL activity as well as their selectivity over fatty acid amide hydrolase (FAAH), another endocannabinoid-hydrolyzing enzyme.  We have identified 2,4-dinitroaryldithiocarbamate derivs. as a novel class of MAGL inhibitors.  Among the synthesized compds., we identified [2,4-dinitrophenyl-4-(4-tert-butylbenzyl)piperazine-1-carbodithioate] (CK37, I), as the most potent MAGL inhibitor within this series (IC50 = 154 nM).  We have also identified [2,4-dinitrophenyl-4-benzhydrylpiperazine-1-carbodithioate] (CK16 ,II) as a selective MAGL inhibitor.  These compds. are irreversible MAGL inhibitors that probably act by interacting with Cys208 or Cys242 and Ser122 residues of the enzyme.  Moreover, CK37 is able to raise 2-arachidonoylglycerol (2-AG) levels in intact cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaH_AWaHlO_7Vg90H21EOLACvtfcHk0liW2OVo_3wrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGrtb8%253D&md5=a729b3a8da7bbdfaf9f52ece8dae3c0c</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Fjm3006004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3006004%26sid%3Dliteratum%253Aachs%26aulast%3DKapanda%26aufirst%3DC.%2BN.%26aulast%3DMasquelier%26aufirst%3DJ.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DPoupaert%26aufirst%3DJ.%2BH.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%25202%252C4-dinitroaryldithiocarbamate%2520derivatives%2520as%2520novel%2520monoacylglycerol%2520lipase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5774%26epage%3D5783%26doi%3D10.1021%2Fjm3006004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Muccioli, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2704</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span><span class="refDoi"> DOI: 10.1002/cbic.200800428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1002%2Fcbic.200800428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=18855964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2704-2710&author=G.+G.+Muccioliauthor=G.+Labarauthor=D.+M.+Lambert&title=CAY10499%2C+a+novel+monoglyceride+lipase+inhibitor+evidenced+by+an+expeditious+MGL+assay&doi=10.1002%2Fcbic.200800428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay</span></div><div class="casAuthors">Muccioli, Giulio G.; Labar, Geoffray; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2704-2710</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) plays a major role in the metab. of the lipid transmitter 2-arachidonoylglycerol (2-AG).  This endocannabinoid is known to mediate a large no. of physiol. processes, and its regulation is thought to be of great therapeutic potential.  However, the no. of available monoglyceride lipase inhibitors is limited, mostly due to the lack of rapid and accurate pharmacol. assays for the enzyme.  We have developed a 96-well-format assay for MGL using a nonradiolabeled substrate, 4-nitrophenylacetate.  The IC50 values that were obtained for known inhibitors of MGL using 4-nitrophenylacetate were similar to those reported by using the radiolabeled form of an endogenous substrate, 2-oleoylglycerol.  In a first small-scale screening, we identified CAY10499 as a novel monoglyceride lipase inhibitor.  Thus, we report the characterization of this submicromolar inhibitor, which acts on MGL through an unprecedented mechanism for inhibitors of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-uhUXVmPgPLVg90H21EOLACvtfcHk0lg5jegpY2e5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjsbfL&md5=49f6ccccc96d3f76903fe8f897c9b3e9</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800428%26sid%3Dliteratum%253Aachs%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DCAY10499%252C%2520a%2520novel%2520monoglyceride%2520lipase%2520inhibitor%2520evidenced%2520by%2520an%2520expeditious%2520MGL%2520assay%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2704%26epage%3D2710%26doi%3D10.1002%2Fcbic.200800428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Feledziak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand-Brynaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, G. G.</span><span> </span><span class="NLM_article-title">Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid’s activity by preventing their hydrolysis</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.2174/157488912798842223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.2174%2F157488912798842223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=49-70&author=M.+Feledziakauthor=D.+M.+Lambertauthor=J.+Marchand-Brynaertauthor=G.+G.+Muccioli&title=Inhibitors+of+the+endocannabinoid-degrading+enzymes%2C+or+how+to+increase+endocannabinoid%E2%80%99s+activity+by+preventing+their+hydrolysis&doi=10.2174%2F157488912798842223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.2174%2F157488912798842223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488912798842223%26sid%3Dliteratum%253Aachs%26aulast%3DFeledziak%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMarchand-Brynaert%26aufirst%3DJ.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DInhibitors%2520of%2520the%2520endocannabinoid-degrading%2520enzymes%252C%2520or%2520how%2520to%2520increase%2520endocannabinoid%25E2%2580%2599s%2520activity%2520by%2520preventing%2520their%2520hydrolysis%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D49%26epage%3D70%26doi%3D10.2174%2F157488912798842223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span>Clinical information can be found at <a href="https://www.clinicaltrials.gov/" class="extLink">https://www.clinicaltrials.gov/</a>. JNJ-42165279, clinical identifiers NCT02432703, NCT02498392; PF-04457845, clinical identifiers NCT00981357, NCT02134080, NCT02216097, NCT01618656, NCT01665573; SSR411298, clinical identifiers NCT00822744, NCT01439919; V158866, clinical identifiers NCT01634529, NCT01748695. Clinical trial failure report of V158866 can be found at <a href="http://www.thepharmaletter.com/article/vernalis-s-v15886-fails-to-meet-primary-endpoint-and-seeks-partnering-on-further-development" class="extLink">http://www.thepharmaletter.com/article/vernalis-s-v15886-fails-to-meet-primary-endpoint-and-seeks-partnering-on-further-development</a>. The detailed report of ANSM can be found at <a href="http://www.thelancetnorway.com/pdfs/journals/lancet/PIIS0140-6736(16)30661-4.pdf" class="extLink">http://www.thelancetnorway.com/pdfs/journals/lancet/PIIS0140-6736(16)30661-4.pdf</a> and <a href="http://ansm.sante.fr/var/ansm_site/storage/original/application/744c7c6daf96b141bc9509e2f85c227e.pdf" class="extLink">http://ansm.sante.fr/var/ansm_site/storage/original/application/744c7c6daf96b141bc9509e2f85c227e.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+information+can+be+found+at+https%3A%2F%2Fwww.clinicaltrials.gov%2F.+JNJ-42165279%2C+clinical+identifiers+NCT02432703%2C+NCT02498392%3B+PF-04457845%2C+clinical+identifiers+NCT00981357%2C+NCT02134080%2C+NCT02216097%2C+NCT01618656%2C+NCT01665573%3B+SSR411298%2C+clinical+identifiers+NCT00822744%2C+NCT01439919%3B+V158866%2C+clinical+identifiers+NCT01634529%2C+NCT01748695.+Clinical+trial+failure+report+of+V158866+can+be+found+at+http%3A%2F%2Fwww.thepharmaletter.com%2Farticle%2Fvernalis-s-v15886-fails-to-meet-primary-endpoint-and-seeks-partnering-on-further-development.+The+detailed+report+of+ANSM+can+be+found+at+http%3A%2F%2Fwww.thelancetnorway.com%2Fpdfs%2Fjournals%2Flancet%2FPIIS0140-6736%2816%2930661-4.pdf+and+http%3A%2F%2Fansm.sante.fr%2Fvar%2Fansm_site%2Fstorage%2Foriginal%2Fapplication%2F744c7c6daf96b141bc9509e2f85c227e.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Pawsey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, S.</span><span> </span><span class="NLM_article-title">Safety, tolerability and pharmacokinetics of FAAH inhibitor V158866: a double-blind, randomised, placebo-controlled phase I study in healthy volunteers</span> <span class="citation_source-journal">Drugs R&D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1007/s40268-016-0127-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=10.1007%2Fs40268-016-0127-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;key=26987975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=181-191&author=S.+Pawseyauthor=M.+Woodauthor=H.+Browneauthor=K.+Donaldsonauthor=M.+Christieauthor=S.+Warrington&title=Safety%2C+tolerability+and+pharmacokinetics+of+FAAH+inhibitor+V158866%3A+a+double-blind%2C+randomised%2C+placebo-controlled+phase+I+study+in+healthy+volunteers&doi=10.1007%2Fs40268-016-0127-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1007%2Fs40268-016-0127-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-016-0127-y%26sid%3Dliteratum%253Aachs%26aulast%3DPawsey%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DDonaldson%26aufirst%3DK.%26aulast%3DChristie%26aufirst%3DM.%26aulast%3DWarrington%26aufirst%3DS.%26atitle%3DSafety%252C%2520tolerability%2520and%2520pharmacokinetics%2520of%2520FAAH%2520inhibitor%2520V158866%253A%2520a%2520double-blind%252C%2520randomised%252C%2520placebo-controlled%2520phase%2520I%2520study%2520in%2520healthy%2520volunteers%26jtitle%3DDrugs%2520R%2526D%26date%3D2016%26volume%3D16%26spage%3D181%26epage%3D191%26doi%3D10.1007%2Fs40268-016-0127-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5','PDB','1MT5'); return false;">PDB: 1MT5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VYA','PDB','2VYA'); return false;">PDB: 2VYA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WAP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WAP','PDB','2WAP'); return false;">PDB: 2WAP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HJU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HJU','PDB','3HJU'); return false;">PDB: 3HJU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PPM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PPM','PDB','3PPM'); return false;">PDB: 3PPM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WJ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WJ2','PDB','2WJ2'); return false;">PDB: 2WJ2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J5P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4J5P','PDB','4J5P'); return false;">PDB: 4J5P</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LJ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LJ7','PDB','3LJ7'); return false;">PDB: 3LJ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QJ9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QJ9','PDB','3QJ9'); return false;">PDB: 3QJ9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JWE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JWE','PDB','3JWE'); return false;">PDB: 3JWE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UUQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UUQ','PDB','4UUQ'); return false;">PDB: 4UUQ</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00538%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-1%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00538" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a1f7a58f92410","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
